id	sid	tid	token	lemma	pos
10_1101-2020_03_27_012757	1	1	67941284	67941284	CD
10_1101-2020_03_27_012757	1	2	1	1	CD
10_1101-2020_03_27_012757	1	3	2	2	CD
10_1101-2020_03_27_012757	1	4	3	3	CD
10_1101-2020_03_27_012757	1	5	4	4	CD
10_1101-2020_03_27_012757	1	6	5	5	CD
10_1101-2020_03_27_012757	1	7	6	6	CD
10_1101-2020_03_27_012757	1	8	Evaluating	evaluate	VBG
10_1101-2020_03_27_012757	1	9	the	the	DT
10_1101-2020_03_27_012757	1	10	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	1	11	fidelity	fidelity	NN
10_1101-2020_03_27_012757	1	12	of	of	IN
10_1101-2020_03_27_012757	1	13	cancer	cancer	NN
10_1101-2020_03_27_012757	1	14	models	model	NNS
10_1101-2020_03_27_012757	1	15	7	7	CD
10_1101-2020_03_27_012757	1	16	8	8	CD
10_1101-2020_03_27_012757	1	17	9	9	CD
10_1101-2020_03_27_012757	1	18	Da	da	NN
10_1101-2020_03_27_012757	1	19	Peng1	peng1	CD
10_1101-2020_03_27_012757	1	20	*	*	NFP
10_1101-2020_03_27_012757	1	21	,	,	,
10_1101-2020_03_27_012757	1	22	Rachel	Rachel	NNP
10_1101-2020_03_27_012757	1	23	Gleyzer2	Gleyzer2	NNP
10_1101-2020_03_27_012757	1	24	*	*	NFP
10_1101-2020_03_27_012757	1	25	,	,	,
10_1101-2020_03_27_012757	1	26	Wen	Wen	NNP
10_1101-2020_03_27_012757	1	27	-	-	HYPH
10_1101-2020_03_27_012757	1	28	Hsin	Hsin	NNP
10_1101-2020_03_27_012757	1	29	Tai2	Tai2	NNP
10_1101-2020_03_27_012757	1	30	,	,	,
10_1101-2020_03_27_012757	1	31	Pavithra	Pavithra	NNP
10_1101-2020_03_27_012757	1	32	Kumar2	Kumar2	NNP
10_1101-2020_03_27_012757	1	33	,	,	,
10_1101-2020_03_27_012757	1	34	Qin	Qin	NNP
10_1101-2020_03_27_012757	1	35	Bian2	bian2	NN
10_1101-2020_03_27_012757	1	36	,	,	,
10_1101-2020_03_27_012757	1	37	Bradley	Bradley	NNP
10_1101-2020_03_27_012757	1	38	Issacs2	Issacs2	NNP
10_1101-2020_03_27_012757	1	39	,	,	,
10_1101-2020_03_27_012757	1	40	10	10	CD
10_1101-2020_03_27_012757	1	41	Edroaldo	Edroaldo	NNP
10_1101-2020_03_27_012757	1	42	Lummertz	Lummertz	NNP
10_1101-2020_03_27_012757	1	43	da	da	NNP
10_1101-2020_03_27_012757	1	44	Rocha3	Rocha3	NNP
10_1101-2020_03_27_012757	1	45	,	,	,
10_1101-2020_03_27_012757	1	46	Stephanie	Stephanie	NNP
10_1101-2020_03_27_012757	1	47	Cai1	Cai1	NNP
10_1101-2020_03_27_012757	1	48	,	,	,
10_1101-2020_03_27_012757	1	49	Kathleen	Kathleen	NNP
10_1101-2020_03_27_012757	1	50	DiNapoli4,5	DiNapoli4,5	NNS
10_1101-2020_03_27_012757	1	51	,	,	,
10_1101-2020_03_27_012757	1	52	Franklin	Franklin	NNP
10_1101-2020_03_27_012757	1	53	W	W	NNP
10_1101-2020_03_27_012757	1	54	Huang6	Huang6	NNP
10_1101-2020_03_27_012757	1	55	,	,	,
10_1101-2020_03_27_012757	1	56	11	11	CD
10_1101-2020_03_27_012757	1	57	Patrick	Patrick	NNP
10_1101-2020_03_27_012757	1	58	Cahan1,2,7	Cahan1,2,7	NNP
10_1101-2020_03_27_012757	1	59	12	12	CD
10_1101-2020_03_27_012757	1	60	13	13	CD
10_1101-2020_03_27_012757	1	61	1Department	1department	CD
10_1101-2020_03_27_012757	1	62	of	of	IN
10_1101-2020_03_27_012757	1	63	Biomedical	Biomedical	NNP
10_1101-2020_03_27_012757	1	64	Engineering	Engineering	NNP
10_1101-2020_03_27_012757	1	65	,	,	,
10_1101-2020_03_27_012757	1	66	Johns	Johns	NNP
10_1101-2020_03_27_012757	1	67	Hopkins	Hopkins	NNP
10_1101-2020_03_27_012757	1	68	University	University	NNP
10_1101-2020_03_27_012757	1	69	School	School	NNP
10_1101-2020_03_27_012757	1	70	of	of	IN
10_1101-2020_03_27_012757	1	71	Medicine	Medicine	NNP
10_1101-2020_03_27_012757	1	72	,	,	,
10_1101-2020_03_27_012757	1	73	14	14	CD
10_1101-2020_03_27_012757	1	74	Baltimore	Baltimore	NNP
10_1101-2020_03_27_012757	1	75	MD	MD	NNP
10_1101-2020_03_27_012757	1	76	21205	21205	CD
10_1101-2020_03_27_012757	1	77	USA	USA	NNP
10_1101-2020_03_27_012757	1	78	15	15	CD
10_1101-2020_03_27_012757	1	79	16	16	CD
10_1101-2020_03_27_012757	1	80	2Institute	2institute	CD
10_1101-2020_03_27_012757	1	81	for	for	IN
10_1101-2020_03_27_012757	1	82	Cell	Cell	NNP
10_1101-2020_03_27_012757	1	83	Engineering	Engineering	NNP
10_1101-2020_03_27_012757	1	84	,	,	,
10_1101-2020_03_27_012757	1	85	Johns	Johns	NNP
10_1101-2020_03_27_012757	1	86	Hopkins	Hopkins	NNP
10_1101-2020_03_27_012757	1	87	University	University	NNP
10_1101-2020_03_27_012757	1	88	School	School	NNP
10_1101-2020_03_27_012757	1	89	of	of	IN
10_1101-2020_03_27_012757	1	90	Medicine	Medicine	NNP
10_1101-2020_03_27_012757	1	91	,	,	,
10_1101-2020_03_27_012757	1	92	17	17	CD
10_1101-2020_03_27_012757	1	93	Baltimore	Baltimore	NNP
10_1101-2020_03_27_012757	1	94	MD	MD	NNP
10_1101-2020_03_27_012757	1	95	21205	21205	CD
10_1101-2020_03_27_012757	1	96	USA	USA	NNP
10_1101-2020_03_27_012757	1	97	18	18	CD
10_1101-2020_03_27_012757	1	98	19	19	CD
10_1101-2020_03_27_012757	1	99	3Department	3department	CD
10_1101-2020_03_27_012757	1	100	of	of	IN
10_1101-2020_03_27_012757	1	101	Microbiology	Microbiology	NNP
10_1101-2020_03_27_012757	1	102	,	,	,
10_1101-2020_03_27_012757	1	103	Immunology	Immunology	NNP
10_1101-2020_03_27_012757	1	104	and	and	CC
10_1101-2020_03_27_012757	1	105	Parasitology	Parasitology	NNP
10_1101-2020_03_27_012757	1	106	,	,	,
10_1101-2020_03_27_012757	1	107	20	20	CD
10_1101-2020_03_27_012757	1	108	Federal	Federal	NNP
10_1101-2020_03_27_012757	1	109	University	University	NNP
10_1101-2020_03_27_012757	1	110	of	of	IN
10_1101-2020_03_27_012757	1	111	Santa	Santa	NNP
10_1101-2020_03_27_012757	1	112	Catarina	Catarina	NNP
10_1101-2020_03_27_012757	1	113	,	,	,
10_1101-2020_03_27_012757	1	114	Florianópolis	Florianópolis	NNP
10_1101-2020_03_27_012757	1	115	SC	SC	NNP
10_1101-2020_03_27_012757	1	116	,	,	,
10_1101-2020_03_27_012757	1	117	Brazil	Brazil	NNP
10_1101-2020_03_27_012757	1	118	21	21	CD
10_1101-2020_03_27_012757	1	119	22	22	CD
10_1101-2020_03_27_012757	1	120	4Department	4department	NN
10_1101-2020_03_27_012757	1	121	of	of	IN
10_1101-2020_03_27_012757	1	122	Cell	Cell	NNP
10_1101-2020_03_27_012757	1	123	Biology	Biology	NNP
10_1101-2020_03_27_012757	1	124	,	,	,
10_1101-2020_03_27_012757	1	125	Johns	Johns	NNP
10_1101-2020_03_27_012757	1	126	Hopkins	Hopkins	NNP
10_1101-2020_03_27_012757	1	127	University	University	NNP
10_1101-2020_03_27_012757	1	128	School	School	NNP
10_1101-2020_03_27_012757	1	129	of	of	IN
10_1101-2020_03_27_012757	1	130	Medicine	Medicine	NNP
10_1101-2020_03_27_012757	1	131	,	,	,
10_1101-2020_03_27_012757	1	132	23	23	CD
10_1101-2020_03_27_012757	1	133	Baltimore	Baltimore	NNP
10_1101-2020_03_27_012757	1	134	,	,	,
10_1101-2020_03_27_012757	1	135	MD	MD	NNP
10_1101-2020_03_27_012757	1	136	21205	21205	CD
10_1101-2020_03_27_012757	1	137	USA	USA	NNP
10_1101-2020_03_27_012757	1	138	24	24	CD
10_1101-2020_03_27_012757	1	139	25	25	CD
10_1101-2020_03_27_012757	1	140	5Department	5department	CD
10_1101-2020_03_27_012757	1	141	of	of	IN
10_1101-2020_03_27_012757	1	142	Electrical	Electrical	NNP
10_1101-2020_03_27_012757	1	143	and	and	CC
10_1101-2020_03_27_012757	1	144	Computer	Computer	NNP
10_1101-2020_03_27_012757	1	145	Engineering	Engineering	NNP
10_1101-2020_03_27_012757	1	146	,	,	,
10_1101-2020_03_27_012757	1	147	Johns	Johns	NNP
10_1101-2020_03_27_012757	1	148	Hopkins	Hopkins	NNP
10_1101-2020_03_27_012757	1	149	University	University	NNP
10_1101-2020_03_27_012757	1	150	,	,	,
10_1101-2020_03_27_012757	1	151	26	26	CD
10_1101-2020_03_27_012757	1	152	Baltimore	Baltimore	NNP
10_1101-2020_03_27_012757	1	153	MD	MD	NNP
10_1101-2020_03_27_012757	1	154	21218	21218	CD
10_1101-2020_03_27_012757	1	155	USA	USA	NNP
10_1101-2020_03_27_012757	1	156	27	27	CD
10_1101-2020_03_27_012757	1	157	28	28	CD
10_1101-2020_03_27_012757	1	158	6Division	6division	CD
10_1101-2020_03_27_012757	1	159	of	of	IN
10_1101-2020_03_27_012757	1	160	Hematology	Hematology	NNP
10_1101-2020_03_27_012757	1	161	/	/	SYM
10_1101-2020_03_27_012757	1	162	Oncology	Oncology	NNP
10_1101-2020_03_27_012757	1	163	,	,	,
10_1101-2020_03_27_012757	1	164	Department	Department	NNP
10_1101-2020_03_27_012757	1	165	of	of	IN
10_1101-2020_03_27_012757	1	166	Medicine	Medicine	NNP
10_1101-2020_03_27_012757	1	167	;	;	:
10_1101-2020_03_27_012757	1	168	Helen	Helen	NNP
10_1101-2020_03_27_012757	1	169	Diller	Diller	NNP
10_1101-2020_03_27_012757	1	170	Family	Family	NNP
10_1101-2020_03_27_012757	1	171	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	1	172	Center	Center	NNP
10_1101-2020_03_27_012757	1	173	;	;	:
10_1101-2020_03_27_012757	1	174	29	29	CD
10_1101-2020_03_27_012757	1	175	Bakar	Bakar	NNP
10_1101-2020_03_27_012757	1	176	Computational	Computational	NNP
10_1101-2020_03_27_012757	1	177	Health	Health	NNP
10_1101-2020_03_27_012757	1	178	Sciences	Sciences	NNPS
10_1101-2020_03_27_012757	1	179	Institute	Institute	NNP
10_1101-2020_03_27_012757	1	180	;	;	:
10_1101-2020_03_27_012757	1	181	Institute	Institute	NNP
10_1101-2020_03_27_012757	1	182	for	for	IN
10_1101-2020_03_27_012757	1	183	Human	Human	NNP
10_1101-2020_03_27_012757	1	184	Genetics	Genetics	NNPS
10_1101-2020_03_27_012757	1	185	;	;	:
10_1101-2020_03_27_012757	1	186	30	30	CD
10_1101-2020_03_27_012757	1	187	University	University	NNP
10_1101-2020_03_27_012757	1	188	of	of	IN
10_1101-2020_03_27_012757	1	189	California	California	NNP
10_1101-2020_03_27_012757	1	190	,	,	,
10_1101-2020_03_27_012757	1	191	San	San	NNP
10_1101-2020_03_27_012757	1	192	Francisco	Francisco	NNP
10_1101-2020_03_27_012757	1	193	,	,	,
10_1101-2020_03_27_012757	1	194	San	San	NNP
10_1101-2020_03_27_012757	1	195	Francisco	Francisco	NNP
10_1101-2020_03_27_012757	1	196	,	,	,
10_1101-2020_03_27_012757	1	197	CA	CA	NNP
10_1101-2020_03_27_012757	1	198	31	31	CD
10_1101-2020_03_27_012757	1	199	32	32	CD
10_1101-2020_03_27_012757	1	200	7Department	7department	CD
10_1101-2020_03_27_012757	1	201	of	of	IN
10_1101-2020_03_27_012757	1	202	Molecular	Molecular	NNP
10_1101-2020_03_27_012757	1	203	Biology	Biology	NNP
10_1101-2020_03_27_012757	1	204	and	and	CC
10_1101-2020_03_27_012757	1	205	Genetics	Genetics	NNP
10_1101-2020_03_27_012757	1	206	,	,	,
10_1101-2020_03_27_012757	1	207	Johns	Johns	NNP
10_1101-2020_03_27_012757	1	208	Hopkins	Hopkins	NNP
10_1101-2020_03_27_012757	1	209	University	University	NNP
10_1101-2020_03_27_012757	1	210	School	School	NNP
10_1101-2020_03_27_012757	1	211	of	of	IN
10_1101-2020_03_27_012757	1	212	Medicine	Medicine	NNP
10_1101-2020_03_27_012757	1	213	,	,	,
10_1101-2020_03_27_012757	1	214	33	33	CD
10_1101-2020_03_27_012757	1	215	Baltimore	Baltimore	NNP
10_1101-2020_03_27_012757	1	216	MD	MD	NNP
10_1101-2020_03_27_012757	1	217	21205	21205	CD
10_1101-2020_03_27_012757	1	218	USA	USA	NNP
10_1101-2020_03_27_012757	1	219	34	34	CD
10_1101-2020_03_27_012757	1	220	35	35	CD
10_1101-2020_03_27_012757	1	221	36	36	CD
10_1101-2020_03_27_012757	1	222	*	*	NFP
10_1101-2020_03_27_012757	1	223	These	these	DT
10_1101-2020_03_27_012757	1	224	authors	author	NNS
10_1101-2020_03_27_012757	1	225	made	make	VBD
10_1101-2020_03_27_012757	1	226	equal	equal	JJ
10_1101-2020_03_27_012757	1	227	contributions	contribution	NNS
10_1101-2020_03_27_012757	1	228	.	.	.
10_1101-2020_03_27_012757	2	1	37	37	CD
10_1101-2020_03_27_012757	2	2	38	38	CD
10_1101-2020_03_27_012757	2	3	39	39	CD
10_1101-2020_03_27_012757	2	4	Correspondence	Correspondence	NNP
10_1101-2020_03_27_012757	2	5	to	to	IN
10_1101-2020_03_27_012757	2	6	:	:	:
10_1101-2020_03_27_012757	2	7	patrick.cahan@jhmi.edu	patrick.cahan@jhmi.edu	ADD
10_1101-2020_03_27_012757	2	8	40	40	CD
10_1101-2020_03_27_012757	2	9	41	41	CD
10_1101-2020_03_27_012757	2	10	Article	article	NN
10_1101-2020_03_27_012757	2	11	type	type	NN
10_1101-2020_03_27_012757	2	12	:	:	:
10_1101-2020_03_27_012757	2	13	Research	research	NN
10_1101-2020_03_27_012757	2	14	42	42	CD
10_1101-2020_03_27_012757	2	15	43	43	CD
10_1101-2020_03_27_012757	2	16	Website	website	NN
10_1101-2020_03_27_012757	2	17	:	:	:
10_1101-2020_03_27_012757	2	18	http://www.cahanlab.org/resources/cancerCellNet_web	http://www.cahanlab.org/resources/cancercellnet_web	NN
10_1101-2020_03_27_012757	2	19	44	44	CD
10_1101-2020_03_27_012757	2	20	45	45	CD
10_1101-2020_03_27_012757	2	21	Code	Code	NNP
10_1101-2020_03_27_012757	2	22	:	:	:
10_1101-2020_03_27_012757	2	23	https://github.com/pcahan1/cancerCellNet	https://github.com/pcahan1/cancercellnet	NN
10_1101-2020_03_27_012757	2	24	46	46	CD
10_1101-2020_03_27_012757	2	25	47	47	CD
10_1101-2020_03_27_012757	2	26	48	48	CD
10_1101-2020_03_27_012757	2	27	49	49	CD
10_1101-2020_03_27_012757	2	28	50	50	CD
10_1101-2020_03_27_012757	2	29	.CC	.CC	:
10_1101-2020_03_27_012757	2	30	-	-	HYPH
10_1101-2020_03_27_012757	2	31	BY	by	IN
10_1101-2020_03_27_012757	2	32	-	-	HYPH
10_1101-2020_03_27_012757	2	33	NC	NC	NNP
10_1101-2020_03_27_012757	2	34	-	-	HYPH
10_1101-2020_03_27_012757	2	35	ND	ND	NNP
10_1101-2020_03_27_012757	2	36	4.0	4.0	CD
10_1101-2020_03_27_012757	2	37	International	International	NNP
10_1101-2020_03_27_012757	2	38	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	2	39	under	under	IN
10_1101-2020_03_27_012757	2	40	a	a	DT
10_1101-2020_03_27_012757	2	41	(	(	-LRB-
10_1101-2020_03_27_012757	2	42	which	which	WDT
10_1101-2020_03_27_012757	2	43	was	be	VBD
10_1101-2020_03_27_012757	2	44	not	not	RB
10_1101-2020_03_27_012757	2	45	certified	certify	VBN
10_1101-2020_03_27_012757	2	46	by	by	IN
10_1101-2020_03_27_012757	2	47	peer	peer	NN
10_1101-2020_03_27_012757	2	48	review	review	NN
10_1101-2020_03_27_012757	2	49	)	)	-RRB-
10_1101-2020_03_27_012757	2	50	is	be	VBZ
10_1101-2020_03_27_012757	2	51	the	the	DT
10_1101-2020_03_27_012757	2	52	author	author	NN
10_1101-2020_03_27_012757	2	53	/	/	SYM
10_1101-2020_03_27_012757	2	54	funder	funder	NN
10_1101-2020_03_27_012757	2	55	,	,	,
10_1101-2020_03_27_012757	2	56	who	who	WP
10_1101-2020_03_27_012757	2	57	has	have	VBZ
10_1101-2020_03_27_012757	2	58	granted	grant	VBN
10_1101-2020_03_27_012757	2	59	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	2	60	a	a	DT
10_1101-2020_03_27_012757	2	61	license	license	NN
10_1101-2020_03_27_012757	2	62	to	to	TO
10_1101-2020_03_27_012757	2	63	display	display	VB
10_1101-2020_03_27_012757	2	64	the	the	DT
10_1101-2020_03_27_012757	2	65	preprint	preprint	NN
10_1101-2020_03_27_012757	2	66	in	in	IN
10_1101-2020_03_27_012757	2	67	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	2	68	.	.	.
10_1101-2020_03_27_012757	3	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	3	2	is	be	VBZ
10_1101-2020_03_27_012757	3	3	made	make	VBN
10_1101-2020_03_27_012757	3	4	The	the	DT
10_1101-2020_03_27_012757	3	5	copyright	copyright	NN
10_1101-2020_03_27_012757	3	6	holder	holder	NN
10_1101-2020_03_27_012757	3	7	for	for	IN
10_1101-2020_03_27_012757	3	8	this	this	DT
10_1101-2020_03_27_012757	3	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	3	10	version	version	NN
10_1101-2020_03_27_012757	3	11	posted	post	VBD
10_1101-2020_03_27_012757	3	12	January	January	NNP
10_1101-2020_03_27_012757	3	13	9	9	CD
10_1101-2020_03_27_012757	3	14	,	,	,
10_1101-2020_03_27_012757	3	15	2021	2021	CD
10_1101-2020_03_27_012757	3	16	.	.	.
10_1101-2020_03_27_012757	3	17	;	;	:
10_1101-2020_03_27_012757	3	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	3	19	:	:	:
10_1101-2020_03_27_012757	3	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	3	21	preprint	preprint	NN
10_1101-2020_03_27_012757	3	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	3	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	3	24	2	2	CD
10_1101-2020_03_27_012757	3	25	ABSTRACT	ABSTRACT	NNP
10_1101-2020_03_27_012757	3	26	51	51	CD
10_1101-2020_03_27_012757	3	27	52	52	CD
10_1101-2020_03_27_012757	3	28	Background	background	NN
10_1101-2020_03_27_012757	3	29	:	:	:
10_1101-2020_03_27_012757	3	30	Cancer	cancer	NN
10_1101-2020_03_27_012757	3	31	researchers	researcher	NNS
10_1101-2020_03_27_012757	3	32	use	use	VBP
10_1101-2020_03_27_012757	3	33	cell	cell	NN
10_1101-2020_03_27_012757	3	34	lines	line	NNS
10_1101-2020_03_27_012757	3	35	,	,	,
10_1101-2020_03_27_012757	3	36	patient	patient	NNP
10_1101-2020_03_27_012757	3	37	derived	derive	VBN
10_1101-2020_03_27_012757	3	38	xenografts	xenograft	NNS
10_1101-2020_03_27_012757	3	39	,	,	,
10_1101-2020_03_27_012757	3	40	engineered	engineer	VBN
10_1101-2020_03_27_012757	3	41	mice	mouse	NNS
10_1101-2020_03_27_012757	3	42	,	,	,
10_1101-2020_03_27_012757	3	43	53	53	CD
10_1101-2020_03_27_012757	3	44	and	and	CC
10_1101-2020_03_27_012757	3	45	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	3	46	as	as	IN
10_1101-2020_03_27_012757	3	47	models	model	NNS
10_1101-2020_03_27_012757	3	48	to	to	TO
10_1101-2020_03_27_012757	3	49	investigate	investigate	VB
10_1101-2020_03_27_012757	3	50	tumor	tumor	NN
10_1101-2020_03_27_012757	3	51	biology	biology	NN
10_1101-2020_03_27_012757	3	52	and	and	CC
10_1101-2020_03_27_012757	3	53	to	to	TO
10_1101-2020_03_27_012757	3	54	identify	identify	VB
10_1101-2020_03_27_012757	3	55	therapies	therapy	NNS
10_1101-2020_03_27_012757	3	56	.	.	.
10_1101-2020_03_27_012757	4	1	The	the	DT
10_1101-2020_03_27_012757	4	2	54	54	CD
10_1101-2020_03_27_012757	4	3	generalizability	generalizability	NN
10_1101-2020_03_27_012757	4	4	and	and	CC
10_1101-2020_03_27_012757	4	5	power	power	NN
10_1101-2020_03_27_012757	4	6	of	of	IN
10_1101-2020_03_27_012757	4	7	a	a	DT
10_1101-2020_03_27_012757	4	8	model	model	NN
10_1101-2020_03_27_012757	4	9	derives	derive	VBZ
10_1101-2020_03_27_012757	4	10	from	from	IN
10_1101-2020_03_27_012757	4	11	the	the	DT
10_1101-2020_03_27_012757	4	12	fidelity	fidelity	NN
10_1101-2020_03_27_012757	4	13	with	with	IN
10_1101-2020_03_27_012757	4	14	which	which	WDT
10_1101-2020_03_27_012757	4	15	it	-PRON-	PRP
10_1101-2020_03_27_012757	4	16	represents	represent	VBZ
10_1101-2020_03_27_012757	4	17	the	the	DT
10_1101-2020_03_27_012757	4	18	tumor	tumor	NN
10_1101-2020_03_27_012757	4	19	55	55	CD
10_1101-2020_03_27_012757	4	20	type	type	NN
10_1101-2020_03_27_012757	4	21	under	under	IN
10_1101-2020_03_27_012757	4	22	investigation	investigation	NN
10_1101-2020_03_27_012757	4	23	,	,	,
10_1101-2020_03_27_012757	4	24	however	however	RB
10_1101-2020_03_27_012757	4	25	,	,	,
10_1101-2020_03_27_012757	4	26	the	the	DT
10_1101-2020_03_27_012757	4	27	extent	extent	NN
10_1101-2020_03_27_012757	4	28	to	to	TO
10_1101-2020_03_27_012757	4	29	which	which	WDT
10_1101-2020_03_27_012757	4	30	this	this	DT
10_1101-2020_03_27_012757	4	31	is	be	VBZ
10_1101-2020_03_27_012757	4	32	true	true	JJ
10_1101-2020_03_27_012757	4	33	is	be	VBZ
10_1101-2020_03_27_012757	4	34	often	often	RB
10_1101-2020_03_27_012757	4	35	unclear	unclear	JJ
10_1101-2020_03_27_012757	4	36	.	.	.
10_1101-2020_03_27_012757	5	1	The	the	DT
10_1101-2020_03_27_012757	5	2	56	56	CD
10_1101-2020_03_27_012757	5	3	preponderance	preponderance	NN
10_1101-2020_03_27_012757	5	4	of	of	IN
10_1101-2020_03_27_012757	5	5	models	model	NNS
10_1101-2020_03_27_012757	5	6	and	and	CC
10_1101-2020_03_27_012757	5	7	the	the	DT
10_1101-2020_03_27_012757	5	8	ability	ability	NN
10_1101-2020_03_27_012757	5	9	to	to	TO
10_1101-2020_03_27_012757	5	10	readily	readily	RB
10_1101-2020_03_27_012757	5	11	generate	generate	VB
10_1101-2020_03_27_012757	5	12	new	new	JJ
10_1101-2020_03_27_012757	5	13	ones	one	NNS
10_1101-2020_03_27_012757	5	14	has	have	VBZ
10_1101-2020_03_27_012757	5	15	created	create	VBN
10_1101-2020_03_27_012757	5	16	a	a	DT
10_1101-2020_03_27_012757	5	17	demand	demand	NN
10_1101-2020_03_27_012757	5	18	57	57	CD
10_1101-2020_03_27_012757	5	19	for	for	IN
10_1101-2020_03_27_012757	5	20	tools	tool	NNS
10_1101-2020_03_27_012757	5	21	that	that	WDT
10_1101-2020_03_27_012757	5	22	can	can	MD
10_1101-2020_03_27_012757	5	23	measure	measure	VB
10_1101-2020_03_27_012757	5	24	the	the	DT
10_1101-2020_03_27_012757	5	25	extent	extent	NN
10_1101-2020_03_27_012757	5	26	and	and	CC
10_1101-2020_03_27_012757	5	27	ways	way	NNS
10_1101-2020_03_27_012757	5	28	in	in	IN
10_1101-2020_03_27_012757	5	29	which	which	WDT
10_1101-2020_03_27_012757	5	30	cancer	cancer	NN
10_1101-2020_03_27_012757	5	31	models	model	NNS
10_1101-2020_03_27_012757	5	32	resemble	resemble	VBP
10_1101-2020_03_27_012757	5	33	or	or	CC
10_1101-2020_03_27_012757	5	34	diverge	diverge	VBP
10_1101-2020_03_27_012757	5	35	58	58	CD
10_1101-2020_03_27_012757	5	36	from	from	IN
10_1101-2020_03_27_012757	5	37	native	native	JJ
10_1101-2020_03_27_012757	5	38	tumors	tumor	NNS
10_1101-2020_03_27_012757	5	39	.	.	.
10_1101-2020_03_27_012757	6	1	59	59	CD
10_1101-2020_03_27_012757	6	2	60	60	CD
10_1101-2020_03_27_012757	6	3	Methods	method	NNS
10_1101-2020_03_27_012757	6	4	:	:	:
10_1101-2020_03_27_012757	6	5	We	-PRON-	PRP
10_1101-2020_03_27_012757	6	6	developed	develop	VBD
10_1101-2020_03_27_012757	6	7	a	a	DT
10_1101-2020_03_27_012757	6	8	machine	machine	NN
10_1101-2020_03_27_012757	6	9	learning	learn	VBG
10_1101-2020_03_27_012757	6	10	based	base	VBN
10_1101-2020_03_27_012757	6	11	computational	computational	JJ
10_1101-2020_03_27_012757	6	12	tool	tool	NN
10_1101-2020_03_27_012757	6	13	,	,	,
10_1101-2020_03_27_012757	6	14	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	6	15	,	,	,
10_1101-2020_03_27_012757	6	16	that	that	IN
10_1101-2020_03_27_012757	6	17	61	61	CD
10_1101-2020_03_27_012757	6	18	measures	measure	NNS
10_1101-2020_03_27_012757	6	19	the	the	DT
10_1101-2020_03_27_012757	6	20	similarity	similarity	NN
10_1101-2020_03_27_012757	6	21	of	of	IN
10_1101-2020_03_27_012757	6	22	cancer	cancer	NN
10_1101-2020_03_27_012757	6	23	models	model	NNS
10_1101-2020_03_27_012757	6	24	to	to	IN
10_1101-2020_03_27_012757	6	25	22	22	CD
10_1101-2020_03_27_012757	6	26	naturally	naturally	RB
10_1101-2020_03_27_012757	6	27	occurring	occur	VBG
10_1101-2020_03_27_012757	6	28	tumor	tumor	NN
10_1101-2020_03_27_012757	6	29	types	type	NNS
10_1101-2020_03_27_012757	6	30	and	and	CC
10_1101-2020_03_27_012757	6	31	36	36	CD
10_1101-2020_03_27_012757	6	32	subtypes	subtype	NNS
10_1101-2020_03_27_012757	6	33	,	,	,
10_1101-2020_03_27_012757	6	34	62	62	CD
10_1101-2020_03_27_012757	6	35	in	in	IN
10_1101-2020_03_27_012757	6	36	a	a	DT
10_1101-2020_03_27_012757	6	37	platform	platform	NN
10_1101-2020_03_27_012757	6	38	and	and	CC
10_1101-2020_03_27_012757	6	39	species	specie	VBZ
10_1101-2020_03_27_012757	6	40	agnostic	agnostic	JJ
10_1101-2020_03_27_012757	6	41	manner	manner	NN
10_1101-2020_03_27_012757	6	42	.	.	.
10_1101-2020_03_27_012757	7	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	7	2	applied	apply	VBD
10_1101-2020_03_27_012757	7	3	this	this	DT
10_1101-2020_03_27_012757	7	4	tool	tool	NN
10_1101-2020_03_27_012757	7	5	to	to	IN
10_1101-2020_03_27_012757	7	6	657	657	CD
10_1101-2020_03_27_012757	7	7	cancer	cancer	NN
10_1101-2020_03_27_012757	7	8	cell	cell	NN
10_1101-2020_03_27_012757	7	9	lines	line	NNS
10_1101-2020_03_27_012757	7	10	,	,	,
10_1101-2020_03_27_012757	7	11	415	415	CD
10_1101-2020_03_27_012757	7	12	63	63	CD
10_1101-2020_03_27_012757	7	13	patient	patient	NN
10_1101-2020_03_27_012757	7	14	derived	derive	VBN
10_1101-2020_03_27_012757	7	15	xenografts	xenograft	NNS
10_1101-2020_03_27_012757	7	16	,	,	,
10_1101-2020_03_27_012757	7	17	26	26	CD
10_1101-2020_03_27_012757	7	18	distinct	distinct	JJ
10_1101-2020_03_27_012757	7	19	genetically	genetically	RB
10_1101-2020_03_27_012757	7	20	engineered	engineer	VBN
10_1101-2020_03_27_012757	7	21	mouse	mouse	NN
10_1101-2020_03_27_012757	7	22	models	model	NNS
10_1101-2020_03_27_012757	7	23	,	,	,
10_1101-2020_03_27_012757	7	24	and	and	CC
10_1101-2020_03_27_012757	7	25	131	131	CD
10_1101-2020_03_27_012757	7	26	64	64	CD
10_1101-2020_03_27_012757	7	27	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	7	28	.	.	.
10_1101-2020_03_27_012757	8	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	8	2	validated	validate	VBD
10_1101-2020_03_27_012757	8	3	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	8	4	by	by	IN
10_1101-2020_03_27_012757	8	5	application	application	NN
10_1101-2020_03_27_012757	8	6	to	to	IN
10_1101-2020_03_27_012757	8	7	independent	independent	JJ
10_1101-2020_03_27_012757	8	8	data	datum	NNS
10_1101-2020_03_27_012757	8	9	,	,	,
10_1101-2020_03_27_012757	8	10	and	and	CC
10_1101-2020_03_27_012757	8	11	we	-PRON-	PRP
10_1101-2020_03_27_012757	8	12	tested	test	VBD
10_1101-2020_03_27_012757	8	13	65	65	CD
10_1101-2020_03_27_012757	8	14	several	several	JJ
10_1101-2020_03_27_012757	8	15	predictions	prediction	NNS
10_1101-2020_03_27_012757	8	16	with	with	IN
10_1101-2020_03_27_012757	8	17	immunofluorescence	immunofluorescence	NN
10_1101-2020_03_27_012757	8	18	.	.	.
10_1101-2020_03_27_012757	9	1	66	66	CD
10_1101-2020_03_27_012757	9	2	67	67	CD
10_1101-2020_03_27_012757	9	3	Results	result	NNS
10_1101-2020_03_27_012757	9	4	:	:	:
10_1101-2020_03_27_012757	9	5	We	-PRON-	PRP
10_1101-2020_03_27_012757	9	6	have	have	VBP
10_1101-2020_03_27_012757	9	7	documented	document	VBN
10_1101-2020_03_27_012757	9	8	the	the	DT
10_1101-2020_03_27_012757	9	9	cancer	cancer	NN
10_1101-2020_03_27_012757	9	10	models	model	NNS
10_1101-2020_03_27_012757	9	11	with	with	IN
10_1101-2020_03_27_012757	9	12	the	the	DT
10_1101-2020_03_27_012757	9	13	greatest	great	JJS
10_1101-2020_03_27_012757	9	14	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	9	15	fidelity	fidelity	NN
10_1101-2020_03_27_012757	9	16	to	to	IN
10_1101-2020_03_27_012757	9	17	68	68	CD
10_1101-2020_03_27_012757	9	18	natural	natural	JJ
10_1101-2020_03_27_012757	9	19	tumors	tumor	NNS
10_1101-2020_03_27_012757	9	20	,	,	,
10_1101-2020_03_27_012757	9	21	we	-PRON-	PRP
10_1101-2020_03_27_012757	9	22	have	have	VBP
10_1101-2020_03_27_012757	9	23	identified	identify	VBN
10_1101-2020_03_27_012757	9	24	cancers	cancer	NNS
10_1101-2020_03_27_012757	9	25	underserved	underserve	VBN
10_1101-2020_03_27_012757	9	26	by	by	IN
10_1101-2020_03_27_012757	9	27	adequate	adequate	JJ
10_1101-2020_03_27_012757	9	28	models	model	NNS
10_1101-2020_03_27_012757	9	29	,	,	,
10_1101-2020_03_27_012757	9	30	and	and	CC
10_1101-2020_03_27_012757	9	31	we	-PRON-	PRP
10_1101-2020_03_27_012757	9	32	have	have	VBP
10_1101-2020_03_27_012757	9	33	69	69	CD
10_1101-2020_03_27_012757	9	34	found	find	VBN
10_1101-2020_03_27_012757	9	35	models	model	NNS
10_1101-2020_03_27_012757	9	36	with	with	IN
10_1101-2020_03_27_012757	9	37	annotations	annotation	NNS
10_1101-2020_03_27_012757	9	38	that	that	WDT
10_1101-2020_03_27_012757	9	39	do	do	VBP
10_1101-2020_03_27_012757	9	40	not	not	RB
10_1101-2020_03_27_012757	9	41	match	match	VB
10_1101-2020_03_27_012757	9	42	their	-PRON-	PRP$
10_1101-2020_03_27_012757	9	43	classification	classification	NN
10_1101-2020_03_27_012757	9	44	.	.	.
10_1101-2020_03_27_012757	10	1	By	by	IN
10_1101-2020_03_27_012757	10	2	comparing	compare	VBG
10_1101-2020_03_27_012757	10	3	models	model	NNS
10_1101-2020_03_27_012757	10	4	70	70	CD
10_1101-2020_03_27_012757	10	5	across	across	IN
10_1101-2020_03_27_012757	10	6	modalities	modality	NNS
10_1101-2020_03_27_012757	10	7	,	,	,
10_1101-2020_03_27_012757	10	8	we	-PRON-	PRP
10_1101-2020_03_27_012757	10	9	report	report	VBP
10_1101-2020_03_27_012757	10	10	that	that	IN
10_1101-2020_03_27_012757	10	11	,	,	,
10_1101-2020_03_27_012757	10	12	on	on	IN
10_1101-2020_03_27_012757	10	13	average	average	JJ
10_1101-2020_03_27_012757	10	14	,	,	,
10_1101-2020_03_27_012757	10	15	genetically	genetically	RB
10_1101-2020_03_27_012757	10	16	engineered	engineer	VBN
10_1101-2020_03_27_012757	10	17	mice	mouse	NNS
10_1101-2020_03_27_012757	10	18	and	and	CC
10_1101-2020_03_27_012757	10	19	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	10	20	have	have	VBP
10_1101-2020_03_27_012757	10	21	71	71	CD
10_1101-2020_03_27_012757	10	22	higher	high	JJR
10_1101-2020_03_27_012757	10	23	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	10	24	fidelity	fidelity	NN
10_1101-2020_03_27_012757	10	25	than	than	IN
10_1101-2020_03_27_012757	10	26	patient	patient	NNP
10_1101-2020_03_27_012757	10	27	derived	derive	VBN
10_1101-2020_03_27_012757	10	28	xenografts	xenograft	NNS
10_1101-2020_03_27_012757	10	29	and	and	CC
10_1101-2020_03_27_012757	10	30	cell	cell	NN
10_1101-2020_03_27_012757	10	31	lines	line	NNS
10_1101-2020_03_27_012757	10	32	in	in	IN
10_1101-2020_03_27_012757	10	33	four	four	CD
10_1101-2020_03_27_012757	10	34	out	out	IN
10_1101-2020_03_27_012757	10	35	of	of	IN
10_1101-2020_03_27_012757	10	36	five	five	CD
10_1101-2020_03_27_012757	10	37	72	72	CD
10_1101-2020_03_27_012757	10	38	tumor	tumor	NN
10_1101-2020_03_27_012757	10	39	types	type	NNS
10_1101-2020_03_27_012757	10	40	.	.	.
10_1101-2020_03_27_012757	11	1	However	however	RB
10_1101-2020_03_27_012757	11	2	,	,	,
10_1101-2020_03_27_012757	11	3	several	several	JJ
10_1101-2020_03_27_012757	11	4	patient	patient	NN
10_1101-2020_03_27_012757	11	5	derived	derive	VBN
10_1101-2020_03_27_012757	11	6	xenografts	xenograft	NNS
10_1101-2020_03_27_012757	11	7	and	and	CC
10_1101-2020_03_27_012757	11	8	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	11	9	have	have	VBP
10_1101-2020_03_27_012757	11	10	classification	classification	NN
10_1101-2020_03_27_012757	11	11	73	73	CD
10_1101-2020_03_27_012757	11	12	scores	score	NNS
10_1101-2020_03_27_012757	11	13	that	that	WDT
10_1101-2020_03_27_012757	11	14	are	be	VBP
10_1101-2020_03_27_012757	11	15	on	on	IN
10_1101-2020_03_27_012757	11	16	par	par	NN
10_1101-2020_03_27_012757	11	17	with	with	IN
10_1101-2020_03_27_012757	11	18	native	native	JJ
10_1101-2020_03_27_012757	11	19	tumors	tumor	NNS
10_1101-2020_03_27_012757	11	20	,	,	,
10_1101-2020_03_27_012757	11	21	highlighting	highlight	VBG
10_1101-2020_03_27_012757	11	22	both	both	CC
10_1101-2020_03_27_012757	11	23	their	-PRON-	PRP$
10_1101-2020_03_27_012757	11	24	potential	potential	NN
10_1101-2020_03_27_012757	11	25	as	as	IN
10_1101-2020_03_27_012757	11	26	faithful	faithful	JJ
10_1101-2020_03_27_012757	11	27	model	model	NN
10_1101-2020_03_27_012757	11	28	74	74	CD
10_1101-2020_03_27_012757	11	29	classes	class	NNS
10_1101-2020_03_27_012757	11	30	and	and	CC
10_1101-2020_03_27_012757	11	31	their	-PRON-	PRP$
10_1101-2020_03_27_012757	11	32	heterogeneity	heterogeneity	NN
10_1101-2020_03_27_012757	11	33	.	.	.
10_1101-2020_03_27_012757	12	1	75	75	CD
10_1101-2020_03_27_012757	12	2	76	76	CD
10_1101-2020_03_27_012757	12	3	Conclusions	Conclusions	NNPS
10_1101-2020_03_27_012757	12	4	:	:	:
10_1101-2020_03_27_012757	12	5	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	12	6	enables	enable	VBZ
10_1101-2020_03_27_012757	12	7	the	the	DT
10_1101-2020_03_27_012757	12	8	rapid	rapid	JJ
10_1101-2020_03_27_012757	12	9	assessment	assessment	NN
10_1101-2020_03_27_012757	12	10	of	of	IN
10_1101-2020_03_27_012757	12	11	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	12	12	fidelity	fidelity	NN
10_1101-2020_03_27_012757	12	13	of	of	IN
10_1101-2020_03_27_012757	12	14	tumor	tumor	NNP
10_1101-2020_03_27_012757	12	15	77	77	CD
10_1101-2020_03_27_012757	12	16	models	model	NNS
10_1101-2020_03_27_012757	12	17	.	.	.
10_1101-2020_03_27_012757	13	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	13	2	have	have	VBP
10_1101-2020_03_27_012757	13	3	made	make	VBN
10_1101-2020_03_27_012757	13	4	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	13	5	available	available	JJ
10_1101-2020_03_27_012757	13	6	as	as	IN
10_1101-2020_03_27_012757	13	7	freely	freely	RB
10_1101-2020_03_27_012757	13	8	downloadable	downloadable	JJ
10_1101-2020_03_27_012757	13	9	software	software	NN
10_1101-2020_03_27_012757	13	10	and	and	CC
10_1101-2020_03_27_012757	13	11	as	as	IN
10_1101-2020_03_27_012757	13	12	a	a	DT
10_1101-2020_03_27_012757	13	13	web	web	NN
10_1101-2020_03_27_012757	13	14	78	78	CD
10_1101-2020_03_27_012757	13	15	application	application	NN
10_1101-2020_03_27_012757	13	16	that	that	WDT
10_1101-2020_03_27_012757	13	17	can	can	MD
10_1101-2020_03_27_012757	13	18	be	be	VB
10_1101-2020_03_27_012757	13	19	applied	apply	VBN
10_1101-2020_03_27_012757	13	20	to	to	IN
10_1101-2020_03_27_012757	13	21	new	new	JJ
10_1101-2020_03_27_012757	13	22	cancer	cancer	NN
10_1101-2020_03_27_012757	13	23	models	model	NNS
10_1101-2020_03_27_012757	13	24	that	that	WDT
10_1101-2020_03_27_012757	13	25	allows	allow	VBZ
10_1101-2020_03_27_012757	13	26	for	for	IN
10_1101-2020_03_27_012757	13	27	direct	direct	JJ
10_1101-2020_03_27_012757	13	28	comparison	comparison	NN
10_1101-2020_03_27_012757	13	29	to	to	IN
10_1101-2020_03_27_012757	13	30	the	the	DT
10_1101-2020_03_27_012757	13	31	79	79	CD
10_1101-2020_03_27_012757	13	32	cancer	cancer	NN
10_1101-2020_03_27_012757	13	33	models	model	NNS
10_1101-2020_03_27_012757	13	34	evaluated	evaluate	VBN
10_1101-2020_03_27_012757	13	35	here	here	RB
10_1101-2020_03_27_012757	13	36	.	.	.
10_1101-2020_03_27_012757	14	1	80	80	CD
10_1101-2020_03_27_012757	14	2	81	81	CD
10_1101-2020_03_27_012757	14	3	82	82	CD
10_1101-2020_03_27_012757	14	4	83	83	CD
10_1101-2020_03_27_012757	14	5	84	84	CD
10_1101-2020_03_27_012757	14	6	85	85	CD
10_1101-2020_03_27_012757	14	7	.CC	.cc	CD
10_1101-2020_03_27_012757	14	8	-	-	HYPH
10_1101-2020_03_27_012757	14	9	BY	by	IN
10_1101-2020_03_27_012757	14	10	-	-	HYPH
10_1101-2020_03_27_012757	14	11	NC	NC	NNP
10_1101-2020_03_27_012757	14	12	-	-	HYPH
10_1101-2020_03_27_012757	14	13	ND	ND	NNP
10_1101-2020_03_27_012757	14	14	4.0	4.0	CD
10_1101-2020_03_27_012757	14	15	International	International	NNP
10_1101-2020_03_27_012757	14	16	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	14	17	under	under	IN
10_1101-2020_03_27_012757	14	18	a	a	DT
10_1101-2020_03_27_012757	14	19	(	(	-LRB-
10_1101-2020_03_27_012757	14	20	which	which	WDT
10_1101-2020_03_27_012757	14	21	was	be	VBD
10_1101-2020_03_27_012757	14	22	not	not	RB
10_1101-2020_03_27_012757	14	23	certified	certify	VBN
10_1101-2020_03_27_012757	14	24	by	by	IN
10_1101-2020_03_27_012757	14	25	peer	peer	NN
10_1101-2020_03_27_012757	14	26	review	review	NN
10_1101-2020_03_27_012757	14	27	)	)	-RRB-
10_1101-2020_03_27_012757	14	28	is	be	VBZ
10_1101-2020_03_27_012757	14	29	the	the	DT
10_1101-2020_03_27_012757	14	30	author	author	NN
10_1101-2020_03_27_012757	14	31	/	/	SYM
10_1101-2020_03_27_012757	14	32	funder	funder	NN
10_1101-2020_03_27_012757	14	33	,	,	,
10_1101-2020_03_27_012757	14	34	who	who	WP
10_1101-2020_03_27_012757	14	35	has	have	VBZ
10_1101-2020_03_27_012757	14	36	granted	grant	VBN
10_1101-2020_03_27_012757	14	37	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	14	38	a	a	DT
10_1101-2020_03_27_012757	14	39	license	license	NN
10_1101-2020_03_27_012757	14	40	to	to	TO
10_1101-2020_03_27_012757	14	41	display	display	VB
10_1101-2020_03_27_012757	14	42	the	the	DT
10_1101-2020_03_27_012757	14	43	preprint	preprint	NN
10_1101-2020_03_27_012757	14	44	in	in	IN
10_1101-2020_03_27_012757	14	45	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	14	46	.	.	.
10_1101-2020_03_27_012757	15	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	15	2	is	be	VBZ
10_1101-2020_03_27_012757	15	3	made	make	VBN
10_1101-2020_03_27_012757	15	4	The	the	DT
10_1101-2020_03_27_012757	15	5	copyright	copyright	NN
10_1101-2020_03_27_012757	15	6	holder	holder	NN
10_1101-2020_03_27_012757	15	7	for	for	IN
10_1101-2020_03_27_012757	15	8	this	this	DT
10_1101-2020_03_27_012757	15	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	15	10	version	version	NN
10_1101-2020_03_27_012757	15	11	posted	post	VBD
10_1101-2020_03_27_012757	15	12	January	January	NNP
10_1101-2020_03_27_012757	15	13	9	9	CD
10_1101-2020_03_27_012757	15	14	,	,	,
10_1101-2020_03_27_012757	15	15	2021	2021	CD
10_1101-2020_03_27_012757	15	16	.	.	.
10_1101-2020_03_27_012757	15	17	;	;	:
10_1101-2020_03_27_012757	15	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	15	19	:	:	:
10_1101-2020_03_27_012757	15	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	15	21	preprint	preprint	NN
10_1101-2020_03_27_012757	15	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	15	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	15	24	3	3	CD
10_1101-2020_03_27_012757	15	25	INTRODUCTION	introduction	NN
10_1101-2020_03_27_012757	15	26	86	86	CD
10_1101-2020_03_27_012757	15	27	Models	model	NNS
10_1101-2020_03_27_012757	15	28	are	be	VBP
10_1101-2020_03_27_012757	15	29	widely	widely	RB
10_1101-2020_03_27_012757	15	30	used	use	VBN
10_1101-2020_03_27_012757	15	31	to	to	TO
10_1101-2020_03_27_012757	15	32	investigate	investigate	VB
10_1101-2020_03_27_012757	15	33	cancer	cancer	NN
10_1101-2020_03_27_012757	15	34	biology	biology	NN
10_1101-2020_03_27_012757	15	35	and	and	CC
10_1101-2020_03_27_012757	15	36	to	to	TO
10_1101-2020_03_27_012757	15	37	identify	identify	VB
10_1101-2020_03_27_012757	15	38	potential	potential	JJ
10_1101-2020_03_27_012757	15	39	therapeutics	therapeutic	NNS
10_1101-2020_03_27_012757	15	40	.	.	.
10_1101-2020_03_27_012757	16	1	87	87	CD
10_1101-2020_03_27_012757	16	2	Popular	popular	JJ
10_1101-2020_03_27_012757	16	3	modeling	modeling	NN
10_1101-2020_03_27_012757	16	4	modalities	modality	NNS
10_1101-2020_03_27_012757	16	5	are	be	VBP
10_1101-2020_03_27_012757	16	6	cancer	cancer	NN
10_1101-2020_03_27_012757	16	7	cell	cell	NN
10_1101-2020_03_27_012757	16	8	lines	line	NNS
10_1101-2020_03_27_012757	16	9	(	(	-LRB-
10_1101-2020_03_27_012757	16	10	CCLs)1	CCLs)1	NNP
10_1101-2020_03_27_012757	16	11	,	,	,
10_1101-2020_03_27_012757	16	12	genetically	genetically	RB
10_1101-2020_03_27_012757	16	13	engineered	engineer	VBN
10_1101-2020_03_27_012757	16	14	mouse	mouse	NN
10_1101-2020_03_27_012757	16	15	88	88	CD
10_1101-2020_03_27_012757	16	16	models	model	NNS
10_1101-2020_03_27_012757	16	17	(	(	-LRB-
10_1101-2020_03_27_012757	16	18	GEMMs)2	gemms)2	IN
10_1101-2020_03_27_012757	16	19	,	,	,
10_1101-2020_03_27_012757	16	20	patient	patient	JJ
10_1101-2020_03_27_012757	16	21	derived	derive	VBN
10_1101-2020_03_27_012757	16	22	xenografts	xenografts	NNP
10_1101-2020_03_27_012757	16	23	(	(	-LRB-
10_1101-2020_03_27_012757	16	24	PDXs)3	PDXs)3	NNP
10_1101-2020_03_27_012757	16	25	,	,	,
10_1101-2020_03_27_012757	16	26	and	and	CC
10_1101-2020_03_27_012757	16	27	tumoroids4	tumoroids4	NNP
10_1101-2020_03_27_012757	16	28	.	.	.
10_1101-2020_03_27_012757	17	1	These	these	DT
10_1101-2020_03_27_012757	17	2	classes	class	NNS
10_1101-2020_03_27_012757	17	3	of	of	IN
10_1101-2020_03_27_012757	17	4	89	89	CD
10_1101-2020_03_27_012757	17	5	models	model	NNS
10_1101-2020_03_27_012757	17	6	differ	differ	VBP
10_1101-2020_03_27_012757	17	7	in	in	IN
10_1101-2020_03_27_012757	17	8	the	the	DT
10_1101-2020_03_27_012757	17	9	types	type	NNS
10_1101-2020_03_27_012757	17	10	of	of	IN
10_1101-2020_03_27_012757	17	11	questions	question	NNS
10_1101-2020_03_27_012757	17	12	that	that	WDT
10_1101-2020_03_27_012757	17	13	they	-PRON-	PRP
10_1101-2020_03_27_012757	17	14	are	be	VBP
10_1101-2020_03_27_012757	17	15	designed	design	VBN
10_1101-2020_03_27_012757	17	16	to	to	TO
10_1101-2020_03_27_012757	17	17	address	address	VB
10_1101-2020_03_27_012757	17	18	.	.	.
10_1101-2020_03_27_012757	18	1	CCLs	ccl	NNS
10_1101-2020_03_27_012757	18	2	are	be	VBP
10_1101-2020_03_27_012757	18	3	often	often	RB
10_1101-2020_03_27_012757	18	4	used	use	VBN
10_1101-2020_03_27_012757	18	5	90	90	CD
10_1101-2020_03_27_012757	18	6	to	to	TO
10_1101-2020_03_27_012757	18	7	address	address	VB
10_1101-2020_03_27_012757	18	8	cell	cell	NN
10_1101-2020_03_27_012757	18	9	intrinsic	intrinsic	JJ
10_1101-2020_03_27_012757	18	10	mechanistic	mechanistic	JJ
10_1101-2020_03_27_012757	18	11	questions5	questions5	NN
10_1101-2020_03_27_012757	18	12	,	,	,
10_1101-2020_03_27_012757	18	13	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	18	14	to	to	TO
10_1101-2020_03_27_012757	18	15	chart	chart	VB
10_1101-2020_03_27_012757	18	16	progression	progression	NN
10_1101-2020_03_27_012757	18	17	of	of	IN
10_1101-2020_03_27_012757	18	18	molecularly	molecularly	RB
10_1101-2020_03_27_012757	18	19	91	91	CD
10_1101-2020_03_27_012757	18	20	defined	define	VBN
10_1101-2020_03_27_012757	18	21	-	-	HYPH
10_1101-2020_03_27_012757	18	22	disease6	disease6	NN
10_1101-2020_03_27_012757	18	23	,	,	,
10_1101-2020_03_27_012757	18	24	and	and	CC
10_1101-2020_03_27_012757	18	25	PDXs	pdx	NNS
10_1101-2020_03_27_012757	18	26	to	to	TO
10_1101-2020_03_27_012757	18	27	explore	explore	VB
10_1101-2020_03_27_012757	18	28	patient	patient	NN
10_1101-2020_03_27_012757	18	29	-	-	HYPH
10_1101-2020_03_27_012757	18	30	specific	specific	JJ
10_1101-2020_03_27_012757	18	31	response	response	NN
10_1101-2020_03_27_012757	18	32	to	to	IN
10_1101-2020_03_27_012757	18	33	therapy	therapy	NN
10_1101-2020_03_27_012757	18	34	in	in	IN
10_1101-2020_03_27_012757	18	35	a	a	DT
10_1101-2020_03_27_012757	18	36	physiologically	physiologically	RB
10_1101-2020_03_27_012757	18	37	92	92	CD
10_1101-2020_03_27_012757	18	38	relevant	relevant	JJ
10_1101-2020_03_27_012757	18	39	context7	context7	NN
10_1101-2020_03_27_012757	18	40	.	.	.
10_1101-2020_03_27_012757	19	1	More	more	RBR
10_1101-2020_03_27_012757	19	2	recently	recently	RB
10_1101-2020_03_27_012757	19	3	,	,	,
10_1101-2020_03_27_012757	19	4	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	19	5	have	have	VBP
10_1101-2020_03_27_012757	19	6	emerged	emerge	VBN
10_1101-2020_03_27_012757	19	7	as	as	RB
10_1101-2020_03_27_012757	19	8	relatively	relatively	RB
10_1101-2020_03_27_012757	19	9	inexpensive	inexpensive	JJ
10_1101-2020_03_27_012757	19	10	,	,	,
10_1101-2020_03_27_012757	19	11	93	93	CD
10_1101-2020_03_27_012757	19	12	physiological	physiological	JJ
10_1101-2020_03_27_012757	19	13	,	,	,
10_1101-2020_03_27_012757	19	14	in	in	IN
10_1101-2020_03_27_012757	19	15	vitro	vitro	FW
10_1101-2020_03_27_012757	19	16	3D	3D	NNP
10_1101-2020_03_27_012757	19	17	models	model	NNS
10_1101-2020_03_27_012757	19	18	of	of	IN
10_1101-2020_03_27_012757	19	19	tumor	tumor	NN
10_1101-2020_03_27_012757	19	20	epithelium	epithelium	NN
10_1101-2020_03_27_012757	19	21	with	with	IN
10_1101-2020_03_27_012757	19	22	applications	application	NNS
10_1101-2020_03_27_012757	19	23	ranging	range	VBG
10_1101-2020_03_27_012757	19	24	from	from	IN
10_1101-2020_03_27_012757	19	25	measuring	measure	VBG
10_1101-2020_03_27_012757	19	26	94	94	CD
10_1101-2020_03_27_012757	19	27	drug	drug	NN
10_1101-2020_03_27_012757	19	28	responsiveness	responsiveness	NN
10_1101-2020_03_27_012757	19	29	to	to	IN
10_1101-2020_03_27_012757	19	30	exploring	explore	VBG
10_1101-2020_03_27_012757	19	31	tumor	tumor	NN
10_1101-2020_03_27_012757	19	32	dependence	dependence	NN
10_1101-2020_03_27_012757	19	33	on	on	IN
10_1101-2020_03_27_012757	19	34	cancer	cancer	NN
10_1101-2020_03_27_012757	19	35	stem	stem	NN
10_1101-2020_03_27_012757	19	36	cells	cell	NNS
10_1101-2020_03_27_012757	19	37	.	.	.
10_1101-2020_03_27_012757	20	1	Models	model	NNS
10_1101-2020_03_27_012757	20	2	also	also	RB
10_1101-2020_03_27_012757	20	3	differ	differ	VBP
10_1101-2020_03_27_012757	20	4	in	in	IN
10_1101-2020_03_27_012757	20	5	95	95	CD
10_1101-2020_03_27_012757	20	6	the	the	DT
10_1101-2020_03_27_012757	20	7	extent	extent	NN
10_1101-2020_03_27_012757	20	8	to	to	TO
10_1101-2020_03_27_012757	20	9	which	which	WDT
10_1101-2020_03_27_012757	20	10	the	the	DT
10_1101-2020_03_27_012757	20	11	they	-PRON-	PRP
10_1101-2020_03_27_012757	20	12	represent	represent	VBP
10_1101-2020_03_27_012757	20	13	specific	specific	JJ
10_1101-2020_03_27_012757	20	14	aspects	aspect	NNS
10_1101-2020_03_27_012757	20	15	of	of	IN
10_1101-2020_03_27_012757	20	16	a	a	DT
10_1101-2020_03_27_012757	20	17	cancer	cancer	NN
10_1101-2020_03_27_012757	20	18	type8	type8	NN
10_1101-2020_03_27_012757	20	19	.	.	.
10_1101-2020_03_27_012757	21	1	Even	even	RB
10_1101-2020_03_27_012757	21	2	with	with	IN
10_1101-2020_03_27_012757	21	3	this	this	DT
10_1101-2020_03_27_012757	21	4	intra-	intra-	NNP
10_1101-2020_03_27_012757	21	5	96	96	CD
10_1101-2020_03_27_012757	21	6	and	and	CC
10_1101-2020_03_27_012757	21	7	inter	inter	JJ
10_1101-2020_03_27_012757	21	8	-	-	JJ
10_1101-2020_03_27_012757	21	9	class	class	JJ
10_1101-2020_03_27_012757	21	10	model	model	NN
10_1101-2020_03_27_012757	21	11	variation	variation	NN
10_1101-2020_03_27_012757	21	12	,	,	,
10_1101-2020_03_27_012757	21	13	all	all	DT
10_1101-2020_03_27_012757	21	14	models	model	NNS
10_1101-2020_03_27_012757	21	15	should	should	MD
10_1101-2020_03_27_012757	21	16	represent	represent	VB
10_1101-2020_03_27_012757	21	17	the	the	DT
10_1101-2020_03_27_012757	21	18	tumor	tumor	NN
10_1101-2020_03_27_012757	21	19	type	type	NN
10_1101-2020_03_27_012757	21	20	or	or	CC
10_1101-2020_03_27_012757	21	21	subtype	subtype	NN
10_1101-2020_03_27_012757	21	22	under	under	IN
10_1101-2020_03_27_012757	21	23	97	97	CD
10_1101-2020_03_27_012757	21	24	investigation	investigation	NN
10_1101-2020_03_27_012757	21	25	,	,	,
10_1101-2020_03_27_012757	21	26	and	and	CC
10_1101-2020_03_27_012757	21	27	not	not	RB
10_1101-2020_03_27_012757	21	28	another	another	DT
10_1101-2020_03_27_012757	21	29	type	type	NN
10_1101-2020_03_27_012757	21	30	of	of	IN
10_1101-2020_03_27_012757	21	31	tumor	tumor	NN
10_1101-2020_03_27_012757	21	32	,	,	,
10_1101-2020_03_27_012757	21	33	and	and	CC
10_1101-2020_03_27_012757	21	34	not	not	RB
10_1101-2020_03_27_012757	21	35	a	a	DT
10_1101-2020_03_27_012757	21	36	non	non	JJ
10_1101-2020_03_27_012757	21	37	-	-	JJ
10_1101-2020_03_27_012757	21	38	cancerous	cancerous	JJ
10_1101-2020_03_27_012757	21	39	tissue	tissue	NN
10_1101-2020_03_27_012757	21	40	.	.	.
10_1101-2020_03_27_012757	22	1	Therefore	therefore	RB
10_1101-2020_03_27_012757	22	2	,	,	,
10_1101-2020_03_27_012757	22	3	cancer-98	cancer-98	NN
10_1101-2020_03_27_012757	22	4	models	model	NNS
10_1101-2020_03_27_012757	22	5	should	should	MD
10_1101-2020_03_27_012757	22	6	be	be	VB
10_1101-2020_03_27_012757	22	7	selected	select	VBN
10_1101-2020_03_27_012757	22	8	not	not	RB
10_1101-2020_03_27_012757	22	9	only	only	RB
10_1101-2020_03_27_012757	22	10	based	base	VBN
10_1101-2020_03_27_012757	22	11	on	on	IN
10_1101-2020_03_27_012757	22	12	the	the	DT
10_1101-2020_03_27_012757	22	13	specific	specific	JJ
10_1101-2020_03_27_012757	22	14	biological	biological	JJ
10_1101-2020_03_27_012757	22	15	question	question	NN
10_1101-2020_03_27_012757	22	16	but	but	CC
10_1101-2020_03_27_012757	22	17	also	also	RB
10_1101-2020_03_27_012757	22	18	based	base	VBN
10_1101-2020_03_27_012757	22	19	on	on	IN
10_1101-2020_03_27_012757	22	20	99	99	CD
10_1101-2020_03_27_012757	22	21	the	the	DT
10_1101-2020_03_27_012757	22	22	similarity	similarity	NN
10_1101-2020_03_27_012757	22	23	of	of	IN
10_1101-2020_03_27_012757	22	24	the	the	DT
10_1101-2020_03_27_012757	22	25	model	model	NN
10_1101-2020_03_27_012757	22	26	to	to	IN
10_1101-2020_03_27_012757	22	27	the	the	DT
10_1101-2020_03_27_012757	22	28	cancer	cancer	NN
10_1101-2020_03_27_012757	22	29	type	type	NN
10_1101-2020_03_27_012757	22	30	under	under	IN
10_1101-2020_03_27_012757	22	31	investigation9,10	investigation9,10	NNP
10_1101-2020_03_27_012757	22	32	.	.	.
10_1101-2020_03_27_012757	23	1	100	100	CD
10_1101-2020_03_27_012757	23	2	Various	various	JJ
10_1101-2020_03_27_012757	23	3	methods	method	NNS
10_1101-2020_03_27_012757	23	4	have	have	VBP
10_1101-2020_03_27_012757	23	5	been	be	VBN
10_1101-2020_03_27_012757	23	6	proposed	propose	VBN
10_1101-2020_03_27_012757	23	7	to	to	TO
10_1101-2020_03_27_012757	23	8	determine	determine	VB
10_1101-2020_03_27_012757	23	9	the	the	DT
10_1101-2020_03_27_012757	23	10	similarity	similarity	NN
10_1101-2020_03_27_012757	23	11	of	of	IN
10_1101-2020_03_27_012757	23	12	cancer	cancer	NN
10_1101-2020_03_27_012757	23	13	models	model	NNS
10_1101-2020_03_27_012757	23	14	to	to	IN
10_1101-2020_03_27_012757	23	15	101	101	CD
10_1101-2020_03_27_012757	23	16	their	-PRON-	PRP$
10_1101-2020_03_27_012757	23	17	intended	intend	VBN
10_1101-2020_03_27_012757	23	18	subjects	subject	NNS
10_1101-2020_03_27_012757	23	19	.	.	.
10_1101-2020_03_27_012757	24	1	Domcke	Domcke	NNP
10_1101-2020_03_27_012757	24	2	et	et	NNP
10_1101-2020_03_27_012757	24	3	al	al	NNP
10_1101-2020_03_27_012757	24	4	devised	devise	VBD
10_1101-2020_03_27_012757	24	5	a	a	DT
10_1101-2020_03_27_012757	24	6	'	'	``
10_1101-2020_03_27_012757	24	7	suitability	suitability	NN
10_1101-2020_03_27_012757	24	8	score	score	NN
10_1101-2020_03_27_012757	24	9	'	'	''
10_1101-2020_03_27_012757	24	10	as	as	IN
10_1101-2020_03_27_012757	24	11	a	a	DT
10_1101-2020_03_27_012757	24	12	metric	metric	NN
10_1101-2020_03_27_012757	24	13	of	of	IN
10_1101-2020_03_27_012757	24	14	the	the	DT
10_1101-2020_03_27_012757	24	15	molecular	molecular	JJ
10_1101-2020_03_27_012757	24	16	102	102	CD
10_1101-2020_03_27_012757	24	17	similarity	similarity	NN
10_1101-2020_03_27_012757	24	18	of	of	IN
10_1101-2020_03_27_012757	24	19	CCLs	ccl	NNS
10_1101-2020_03_27_012757	24	20	to	to	IN
10_1101-2020_03_27_012757	24	21	high	high	JJ
10_1101-2020_03_27_012757	24	22	grade	grade	NN
10_1101-2020_03_27_012757	24	23	serous	serous	JJ
10_1101-2020_03_27_012757	24	24	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	24	25	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	24	26	based	base	VBN
10_1101-2020_03_27_012757	24	27	on	on	IN
10_1101-2020_03_27_012757	24	28	a	a	DT
10_1101-2020_03_27_012757	24	29	heuristic	heuristic	JJ
10_1101-2020_03_27_012757	24	30	weighting	weighting	NN
10_1101-2020_03_27_012757	24	31	of	of	IN
10_1101-2020_03_27_012757	24	32	103	103	CD
10_1101-2020_03_27_012757	24	33	copy	copy	NN
10_1101-2020_03_27_012757	24	34	number	number	NN
10_1101-2020_03_27_012757	24	35	alterations	alteration	NNS
10_1101-2020_03_27_012757	24	36	,	,	,
10_1101-2020_03_27_012757	24	37	mutation	mutation	NN
10_1101-2020_03_27_012757	24	38	status	status	NN
10_1101-2020_03_27_012757	24	39	of	of	IN
10_1101-2020_03_27_012757	24	40	several	several	JJ
10_1101-2020_03_27_012757	24	41	genes	gene	NNS
10_1101-2020_03_27_012757	24	42	that	that	WDT
10_1101-2020_03_27_012757	24	43	distinguish	distinguish	VBP
10_1101-2020_03_27_012757	24	44	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	24	45	cancer	cancer	NN
10_1101-2020_03_27_012757	24	46	104	104	CD
10_1101-2020_03_27_012757	24	47	subtypes	subtype	NNS
10_1101-2020_03_27_012757	24	48	,	,	,
10_1101-2020_03_27_012757	24	49	and	and	CC
10_1101-2020_03_27_012757	24	50	hypermutation	hypermutation	NN
10_1101-2020_03_27_012757	24	51	status11	status11	NN
10_1101-2020_03_27_012757	24	52	.	.	.
10_1101-2020_03_27_012757	25	1	Other	other	JJ
10_1101-2020_03_27_012757	25	2	studies	study	NNS
10_1101-2020_03_27_012757	25	3	have	have	VBP
10_1101-2020_03_27_012757	25	4	taken	take	VBN
10_1101-2020_03_27_012757	25	5	analogous	analogous	JJ
10_1101-2020_03_27_012757	25	6	approaches	approach	NNS
10_1101-2020_03_27_012757	25	7	by	by	IN
10_1101-2020_03_27_012757	25	8	105	105	CD
10_1101-2020_03_27_012757	25	9	either	either	CC
10_1101-2020_03_27_012757	25	10	focusing	focus	VBG
10_1101-2020_03_27_012757	25	11	on	on	IN
10_1101-2020_03_27_012757	25	12	transcriptomic	transcriptomic	JJ
10_1101-2020_03_27_012757	25	13	or	or	CC
10_1101-2020_03_27_012757	25	14	ensemble	ensemble	JJ
10_1101-2020_03_27_012757	25	15	molecular	molecular	JJ
10_1101-2020_03_27_012757	25	16	profiles	profile	NNS
10_1101-2020_03_27_012757	25	17	(	(	-LRB-
10_1101-2020_03_27_012757	25	18	e.g.	e.g.	RB
10_1101-2020_03_27_012757	26	1	transcriptomic	transcriptomic	NNP
10_1101-2020_03_27_012757	26	2	and	and	CC
10_1101-2020_03_27_012757	26	3	copy	copy	VBP
10_1101-2020_03_27_012757	26	4	106	106	CD
10_1101-2020_03_27_012757	26	5	number	number	NN
10_1101-2020_03_27_012757	26	6	alterations	alteration	NNS
10_1101-2020_03_27_012757	26	7	)	)	-RRB-
10_1101-2020_03_27_012757	26	8	to	to	TO
10_1101-2020_03_27_012757	26	9	quantify	quantify	VB
10_1101-2020_03_27_012757	26	10	the	the	DT
10_1101-2020_03_27_012757	26	11	similarity	similarity	NN
10_1101-2020_03_27_012757	26	12	of	of	IN
10_1101-2020_03_27_012757	26	13	cell	cell	NN
10_1101-2020_03_27_012757	26	14	lines	line	NNS
10_1101-2020_03_27_012757	26	15	to	to	IN
10_1101-2020_03_27_012757	26	16	tumors12–14	tumors12–14	NNP
10_1101-2020_03_27_012757	26	17	.	.	.
10_1101-2020_03_27_012757	27	1	These	these	DT
10_1101-2020_03_27_012757	27	2	studies	study	NNS
10_1101-2020_03_27_012757	27	3	were	be	VBD
10_1101-2020_03_27_012757	27	4	107	107	CD
10_1101-2020_03_27_012757	27	5	tumor	tumor	NN
10_1101-2020_03_27_012757	27	6	-	-	HYPH
10_1101-2020_03_27_012757	27	7	type	type	NN
10_1101-2020_03_27_012757	27	8	specific	specific	JJ
10_1101-2020_03_27_012757	27	9	,	,	,
10_1101-2020_03_27_012757	27	10	focusing	focus	VBG
10_1101-2020_03_27_012757	27	11	on	on	IN
10_1101-2020_03_27_012757	27	12	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	27	13	that	that	DT
10_1101-2020_03_27_012757	27	14	model	model	NN
10_1101-2020_03_27_012757	27	15	,	,	,
10_1101-2020_03_27_012757	27	16	for	for	IN
10_1101-2020_03_27_012757	27	17	example	example	NN
10_1101-2020_03_27_012757	27	18	,	,	,
10_1101-2020_03_27_012757	27	19	hepatocellular	hepatocellular	NN
10_1101-2020_03_27_012757	27	20	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	27	21	or	or	CC
10_1101-2020_03_27_012757	27	22	108	108	CD
10_1101-2020_03_27_012757	27	23	breast	breast	NN
10_1101-2020_03_27_012757	27	24	cancer	cancer	NN
10_1101-2020_03_27_012757	27	25	.	.	.
10_1101-2020_03_27_012757	28	1	Notably	notably	RB
10_1101-2020_03_27_012757	28	2	,	,	,
10_1101-2020_03_27_012757	28	3	Yu	Yu	NNP
10_1101-2020_03_27_012757	28	4	et	et	NNP
10_1101-2020_03_27_012757	28	5	al	al	NNP
10_1101-2020_03_27_012757	28	6	compared	compare	VBD
10_1101-2020_03_27_012757	28	7	the	the	DT
10_1101-2020_03_27_012757	28	8	transcriptomes	transcriptome	NNS
10_1101-2020_03_27_012757	28	9	of	of	IN
10_1101-2020_03_27_012757	28	10	CCLs	ccl	NNS
10_1101-2020_03_27_012757	28	11	to	to	IN
10_1101-2020_03_27_012757	28	12	The	the	DT
10_1101-2020_03_27_012757	28	13	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	28	14	Genome	Genome	NNP
10_1101-2020_03_27_012757	28	15	109	109	CD
10_1101-2020_03_27_012757	28	16	Atlas	atla	NNS
10_1101-2020_03_27_012757	28	17	(	(	-LRB-
10_1101-2020_03_27_012757	28	18	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	28	19	)	)	-RRB-
10_1101-2020_03_27_012757	28	20	by	by	IN
10_1101-2020_03_27_012757	28	21	correlation	correlation	NN
10_1101-2020_03_27_012757	28	22	analysis	analysis	NN
10_1101-2020_03_27_012757	28	23	,	,	,
10_1101-2020_03_27_012757	28	24	resulting	result	VBG
10_1101-2020_03_27_012757	28	25	in	in	IN
10_1101-2020_03_27_012757	28	26	a	a	DT
10_1101-2020_03_27_012757	28	27	panel	panel	NN
10_1101-2020_03_27_012757	28	28	of	of	IN
10_1101-2020_03_27_012757	28	29	CCLs	ccl	NNS
10_1101-2020_03_27_012757	28	30	recommended	recommend	VBD
10_1101-2020_03_27_012757	28	31	as	as	IN
10_1101-2020_03_27_012757	28	32	most	most	JJS
10_1101-2020_03_27_012757	28	33	110	110	CD
10_1101-2020_03_27_012757	28	34	representative	representative	NN
10_1101-2020_03_27_012757	28	35	of	of	IN
10_1101-2020_03_27_012757	28	36	22	22	CD
10_1101-2020_03_27_012757	28	37	tumor	tumor	NN
10_1101-2020_03_27_012757	28	38	types15	types15	NN
10_1101-2020_03_27_012757	28	39	.	.	.
10_1101-2020_03_27_012757	29	1	Most	most	RBS
10_1101-2020_03_27_012757	29	2	recently	recently	RB
10_1101-2020_03_27_012757	29	3	,	,	,
10_1101-2020_03_27_012757	29	4	Najgebauer	Najgebauer	NNP
10_1101-2020_03_27_012757	29	5	et	et	NNP
10_1101-2020_03_27_012757	29	6	al16	al16	NNP
10_1101-2020_03_27_012757	29	7	and	and	CC
10_1101-2020_03_27_012757	29	8	Salvadores	Salvadores	NNP
10_1101-2020_03_27_012757	29	9	et	et	NNP
10_1101-2020_03_27_012757	29	10	al17	al17	NNP
10_1101-2020_03_27_012757	29	11	111	111	CD
10_1101-2020_03_27_012757	29	12	.CC	.CC	:
10_1101-2020_03_27_012757	29	13	-	-	HYPH
10_1101-2020_03_27_012757	29	14	BY	by	IN
10_1101-2020_03_27_012757	29	15	-	-	HYPH
10_1101-2020_03_27_012757	29	16	NC	NC	NNP
10_1101-2020_03_27_012757	29	17	-	-	HYPH
10_1101-2020_03_27_012757	29	18	ND	ND	NNP
10_1101-2020_03_27_012757	29	19	4.0	4.0	CD
10_1101-2020_03_27_012757	29	20	International	International	NNP
10_1101-2020_03_27_012757	29	21	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	29	22	under	under	IN
10_1101-2020_03_27_012757	29	23	a	a	DT
10_1101-2020_03_27_012757	29	24	(	(	-LRB-
10_1101-2020_03_27_012757	29	25	which	which	WDT
10_1101-2020_03_27_012757	29	26	was	be	VBD
10_1101-2020_03_27_012757	29	27	not	not	RB
10_1101-2020_03_27_012757	29	28	certified	certify	VBN
10_1101-2020_03_27_012757	29	29	by	by	IN
10_1101-2020_03_27_012757	29	30	peer	peer	NN
10_1101-2020_03_27_012757	29	31	review	review	NN
10_1101-2020_03_27_012757	29	32	)	)	-RRB-
10_1101-2020_03_27_012757	29	33	is	be	VBZ
10_1101-2020_03_27_012757	29	34	the	the	DT
10_1101-2020_03_27_012757	29	35	author	author	NN
10_1101-2020_03_27_012757	29	36	/	/	SYM
10_1101-2020_03_27_012757	29	37	funder	funder	NN
10_1101-2020_03_27_012757	29	38	,	,	,
10_1101-2020_03_27_012757	29	39	who	who	WP
10_1101-2020_03_27_012757	29	40	has	have	VBZ
10_1101-2020_03_27_012757	29	41	granted	grant	VBN
10_1101-2020_03_27_012757	29	42	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	29	43	a	a	DT
10_1101-2020_03_27_012757	29	44	license	license	NN
10_1101-2020_03_27_012757	29	45	to	to	TO
10_1101-2020_03_27_012757	29	46	display	display	VB
10_1101-2020_03_27_012757	29	47	the	the	DT
10_1101-2020_03_27_012757	29	48	preprint	preprint	NN
10_1101-2020_03_27_012757	29	49	in	in	IN
10_1101-2020_03_27_012757	29	50	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	29	51	.	.	.
10_1101-2020_03_27_012757	30	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	30	2	is	be	VBZ
10_1101-2020_03_27_012757	30	3	made	make	VBN
10_1101-2020_03_27_012757	30	4	The	the	DT
10_1101-2020_03_27_012757	30	5	copyright	copyright	NN
10_1101-2020_03_27_012757	30	6	holder	holder	NN
10_1101-2020_03_27_012757	30	7	for	for	IN
10_1101-2020_03_27_012757	30	8	this	this	DT
10_1101-2020_03_27_012757	30	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	30	10	version	version	NN
10_1101-2020_03_27_012757	30	11	posted	post	VBD
10_1101-2020_03_27_012757	30	12	January	January	NNP
10_1101-2020_03_27_012757	30	13	9	9	CD
10_1101-2020_03_27_012757	30	14	,	,	,
10_1101-2020_03_27_012757	30	15	2021	2021	CD
10_1101-2020_03_27_012757	30	16	.	.	.
10_1101-2020_03_27_012757	30	17	;	;	:
10_1101-2020_03_27_012757	30	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	30	19	:	:	:
10_1101-2020_03_27_012757	30	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	30	21	preprint	preprint	NN
10_1101-2020_03_27_012757	30	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	30	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	30	24	4	4	CD
10_1101-2020_03_27_012757	30	25	have	have	VBP
10_1101-2020_03_27_012757	30	26	developed	develop	VBN
10_1101-2020_03_27_012757	30	27	methods	method	NNS
10_1101-2020_03_27_012757	30	28	to	to	TO
10_1101-2020_03_27_012757	30	29	assess	assess	VB
10_1101-2020_03_27_012757	30	30	CCLs	ccl	NNS
10_1101-2020_03_27_012757	30	31	using	use	VBG
10_1101-2020_03_27_012757	30	32	molecular	molecular	JJ
10_1101-2020_03_27_012757	30	33	traits	trait	NNS
10_1101-2020_03_27_012757	30	34	such	such	JJ
10_1101-2020_03_27_012757	30	35	as	as	IN
10_1101-2020_03_27_012757	30	36	copy	copy	NN
10_1101-2020_03_27_012757	30	37	number	number	NN
10_1101-2020_03_27_012757	30	38	112	112	CD
10_1101-2020_03_27_012757	30	39	alterations	alteration	NNS
10_1101-2020_03_27_012757	30	40	(	(	-LRB-
10_1101-2020_03_27_012757	30	41	CNA	CNA	NNP
10_1101-2020_03_27_012757	30	42	)	)	-RRB-
10_1101-2020_03_27_012757	30	43	,	,	,
10_1101-2020_03_27_012757	30	44	somatic	somatic	JJ
10_1101-2020_03_27_012757	30	45	mutations	mutation	NNS
10_1101-2020_03_27_012757	30	46	,	,	,
10_1101-2020_03_27_012757	30	47	DNA	dna	NN
10_1101-2020_03_27_012757	30	48	methylation	methylation	NN
10_1101-2020_03_27_012757	30	49	and	and	CC
10_1101-2020_03_27_012757	30	50	transcriptomics	transcriptomic	NNS
10_1101-2020_03_27_012757	30	51	.	.	.
10_1101-2020_03_27_012757	31	1	While	while	IN
10_1101-2020_03_27_012757	31	2	all	all	DT
10_1101-2020_03_27_012757	31	3	of	of	IN
10_1101-2020_03_27_012757	31	4	these	these	DT
10_1101-2020_03_27_012757	31	5	113	113	CD
10_1101-2020_03_27_012757	31	6	studies	study	NNS
10_1101-2020_03_27_012757	31	7	have	have	VBP
10_1101-2020_03_27_012757	31	8	provided	provide	VBN
10_1101-2020_03_27_012757	31	9	valuable	valuable	JJ
10_1101-2020_03_27_012757	31	10	information	information	NN
10_1101-2020_03_27_012757	31	11	,	,	,
10_1101-2020_03_27_012757	31	12	they	-PRON-	PRP
10_1101-2020_03_27_012757	31	13	leave	leave	VBP
10_1101-2020_03_27_012757	31	14	two	two	CD
10_1101-2020_03_27_012757	31	15	major	major	JJ
10_1101-2020_03_27_012757	31	16	challenges	challenge	NNS
10_1101-2020_03_27_012757	31	17	unmet	unmet	VBP
10_1101-2020_03_27_012757	31	18	.	.	.
10_1101-2020_03_27_012757	32	1	The	the	DT
10_1101-2020_03_27_012757	32	2	first	first	JJ
10_1101-2020_03_27_012757	32	3	114	114	CD
10_1101-2020_03_27_012757	32	4	challenge	challenge	NN
10_1101-2020_03_27_012757	32	5	is	be	VBZ
10_1101-2020_03_27_012757	32	6	to	to	TO
10_1101-2020_03_27_012757	32	7	determine	determine	VB
10_1101-2020_03_27_012757	32	8	the	the	DT
10_1101-2020_03_27_012757	32	9	fidelity	fidelity	NN
10_1101-2020_03_27_012757	32	10	of	of	IN
10_1101-2020_03_27_012757	32	11	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	32	12	,	,	,
10_1101-2020_03_27_012757	32	13	PDXs	pdx	NNS
10_1101-2020_03_27_012757	32	14	,	,	,
10_1101-2020_03_27_012757	32	15	and	and	CC
10_1101-2020_03_27_012757	32	16	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	32	17	,	,	,
10_1101-2020_03_27_012757	32	18	and	and	CC
10_1101-2020_03_27_012757	32	19	whether	whether	IN
10_1101-2020_03_27_012757	32	20	there	there	EX
10_1101-2020_03_27_012757	32	21	are	be	VBP
10_1101-2020_03_27_012757	32	22	115	115	CD
10_1101-2020_03_27_012757	32	23	stark	stark	JJ
10_1101-2020_03_27_012757	32	24	differences	difference	NNS
10_1101-2020_03_27_012757	32	25	between	between	IN
10_1101-2020_03_27_012757	32	26	these	these	DT
10_1101-2020_03_27_012757	32	27	classes	class	NNS
10_1101-2020_03_27_012757	32	28	of	of	IN
10_1101-2020_03_27_012757	32	29	models	model	NNS
10_1101-2020_03_27_012757	32	30	and	and	CC
10_1101-2020_03_27_012757	32	31	CCLs	ccl	NNS
10_1101-2020_03_27_012757	32	32	.	.	.
10_1101-2020_03_27_012757	33	1	The	the	DT
10_1101-2020_03_27_012757	33	2	other	other	JJ
10_1101-2020_03_27_012757	33	3	major	major	JJ
10_1101-2020_03_27_012757	33	4	unmet	unmet	NN
10_1101-2020_03_27_012757	33	5	challenge	challenge	NN
10_1101-2020_03_27_012757	33	6	116	116	CD
10_1101-2020_03_27_012757	33	7	is	be	VBZ
10_1101-2020_03_27_012757	33	8	to	to	TO
10_1101-2020_03_27_012757	33	9	enable	enable	VB
10_1101-2020_03_27_012757	33	10	the	the	DT
10_1101-2020_03_27_012757	33	11	rapid	rapid	JJ
10_1101-2020_03_27_012757	33	12	assessment	assessment	NN
10_1101-2020_03_27_012757	33	13	of	of	IN
10_1101-2020_03_27_012757	33	14	new	new	JJ
10_1101-2020_03_27_012757	33	15	,	,	,
10_1101-2020_03_27_012757	33	16	emerging	emerge	VBG
10_1101-2020_03_27_012757	33	17	cancer	cancer	NN
10_1101-2020_03_27_012757	33	18	models	model	NNS
10_1101-2020_03_27_012757	33	19	.	.	.
10_1101-2020_03_27_012757	34	1	This	this	DT
10_1101-2020_03_27_012757	34	2	challenge	challenge	NN
10_1101-2020_03_27_012757	34	3	is	be	VBZ
10_1101-2020_03_27_012757	34	4	especially	especially	RB
10_1101-2020_03_27_012757	34	5	117	117	CD
10_1101-2020_03_27_012757	34	6	relevant	relevant	JJ
10_1101-2020_03_27_012757	34	7	now	now	RB
10_1101-2020_03_27_012757	34	8	as	as	IN
10_1101-2020_03_27_012757	34	9	technical	technical	JJ
10_1101-2020_03_27_012757	34	10	barriers	barrier	NNS
10_1101-2020_03_27_012757	34	11	to	to	IN
10_1101-2020_03_27_012757	34	12	generating	generating	NN
10_1101-2020_03_27_012757	34	13	models	model	NNS
10_1101-2020_03_27_012757	34	14	have	have	VBP
10_1101-2020_03_27_012757	34	15	been	be	VBN
10_1101-2020_03_27_012757	34	16	substantially	substantially	RB
10_1101-2020_03_27_012757	34	17	lowered18,19	lowered18,19	JJ
10_1101-2020_03_27_012757	34	18	,	,	,
10_1101-2020_03_27_012757	34	19	118	118	CD
10_1101-2020_03_27_012757	34	20	and	and	CC
10_1101-2020_03_27_012757	34	21	because	because	IN
10_1101-2020_03_27_012757	34	22	new	new	JJ
10_1101-2020_03_27_012757	34	23	models	model	NNS
10_1101-2020_03_27_012757	34	24	such	such	JJ
10_1101-2020_03_27_012757	34	25	as	as	IN
10_1101-2020_03_27_012757	34	26	PDXs	pdx	NNS
10_1101-2020_03_27_012757	34	27	and	and	CC
10_1101-2020_03_27_012757	34	28	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	34	29	can	can	MD
10_1101-2020_03_27_012757	34	30	be	be	VB
10_1101-2020_03_27_012757	34	31	derived	derive	VBN
10_1101-2020_03_27_012757	34	32	on	on	IN
10_1101-2020_03_27_012757	34	33	patient	patient	NN
10_1101-2020_03_27_012757	34	34	-	-	HYPH
10_1101-2020_03_27_012757	34	35	specific	specific	JJ
10_1101-2020_03_27_012757	34	36	basis	basis	NN
10_1101-2020_03_27_012757	34	37	119	119	CD
10_1101-2020_03_27_012757	34	38	therefore	therefore	RB
10_1101-2020_03_27_012757	34	39	should	should	MD
10_1101-2020_03_27_012757	34	40	be	be	VB
10_1101-2020_03_27_012757	34	41	considered	consider	VBN
10_1101-2020_03_27_012757	34	42	a	a	DT
10_1101-2020_03_27_012757	34	43	distinct	distinct	JJ
10_1101-2020_03_27_012757	34	44	entity	entity	NN
10_1101-2020_03_27_012757	34	45	requiring	require	VBG
10_1101-2020_03_27_012757	34	46	individual	individual	JJ
10_1101-2020_03_27_012757	34	47	validation4,20	validation4,20	NNP
10_1101-2020_03_27_012757	34	48	.	.	.
10_1101-2020_03_27_012757	35	1	120	120	CD
10_1101-2020_03_27_012757	35	2	To	to	TO
10_1101-2020_03_27_012757	35	3	address	address	VB
10_1101-2020_03_27_012757	35	4	these	these	DT
10_1101-2020_03_27_012757	35	5	challenges	challenge	NNS
10_1101-2020_03_27_012757	35	6	,	,	,
10_1101-2020_03_27_012757	35	7	we	-PRON-	PRP
10_1101-2020_03_27_012757	35	8	developed	develop	VBD
10_1101-2020_03_27_012757	35	9	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	35	10	(	(	-LRB-
10_1101-2020_03_27_012757	35	11	CCN	CCN	NNP
10_1101-2020_03_27_012757	35	12	)	)	-RRB-
10_1101-2020_03_27_012757	35	13	,	,	,
10_1101-2020_03_27_012757	35	14	a	a	DT
10_1101-2020_03_27_012757	35	15	computational	computational	JJ
10_1101-2020_03_27_012757	35	16	tool	tool	NN
10_1101-2020_03_27_012757	35	17	121	121	CD
10_1101-2020_03_27_012757	35	18	that	that	WDT
10_1101-2020_03_27_012757	35	19	uses	use	VBZ
10_1101-2020_03_27_012757	35	20	transcriptomic	transcriptomic	JJ
10_1101-2020_03_27_012757	35	21	data	datum	NNS
10_1101-2020_03_27_012757	35	22	to	to	TO
10_1101-2020_03_27_012757	35	23	quantitatively	quantitatively	RB
10_1101-2020_03_27_012757	35	24	assess	assess	VB
10_1101-2020_03_27_012757	35	25	the	the	DT
10_1101-2020_03_27_012757	35	26	similarity	similarity	NN
10_1101-2020_03_27_012757	35	27	between	between	IN
10_1101-2020_03_27_012757	35	28	cancer	cancer	NN
10_1101-2020_03_27_012757	35	29	models	model	NNS
10_1101-2020_03_27_012757	35	30	and	and	CC
10_1101-2020_03_27_012757	35	31	122	122	CD
10_1101-2020_03_27_012757	35	32	22	22	CD
10_1101-2020_03_27_012757	35	33	naturally	naturally	RB
10_1101-2020_03_27_012757	35	34	occurring	occur	VBG
10_1101-2020_03_27_012757	35	35	tumor	tumor	NN
10_1101-2020_03_27_012757	35	36	types	type	NNS
10_1101-2020_03_27_012757	35	37	and	and	CC
10_1101-2020_03_27_012757	35	38	36	36	CD
10_1101-2020_03_27_012757	35	39	subtypes	subtype	NNS
10_1101-2020_03_27_012757	35	40	in	in	IN
10_1101-2020_03_27_012757	35	41	a	a	DT
10_1101-2020_03_27_012757	35	42	platform-	platform-	NN
10_1101-2020_03_27_012757	35	43	and	and	CC
10_1101-2020_03_27_012757	35	44	species	species	NN
10_1101-2020_03_27_012757	35	45	-	-	HYPH
10_1101-2020_03_27_012757	35	46	agnostic	agnostic	JJ
10_1101-2020_03_27_012757	35	47	manner	manner	NN
10_1101-2020_03_27_012757	35	48	.	.	.
10_1101-2020_03_27_012757	36	1	123	123	CD
10_1101-2020_03_27_012757	36	2	Here	here	RB
10_1101-2020_03_27_012757	36	3	,	,	,
10_1101-2020_03_27_012757	36	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	36	5	describe	describe	VBP
10_1101-2020_03_27_012757	36	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	36	7	’s	’s	POS
10_1101-2020_03_27_012757	36	8	performance	performance	NN
10_1101-2020_03_27_012757	36	9	,	,	,
10_1101-2020_03_27_012757	36	10	and	and	CC
10_1101-2020_03_27_012757	36	11	the	the	DT
10_1101-2020_03_27_012757	36	12	results	result	NNS
10_1101-2020_03_27_012757	36	13	of	of	IN
10_1101-2020_03_27_012757	36	14	applying	apply	VBG
10_1101-2020_03_27_012757	36	15	it	-PRON-	PRP
10_1101-2020_03_27_012757	36	16	to	to	TO
10_1101-2020_03_27_012757	36	17	assess	assess	VB
10_1101-2020_03_27_012757	36	18	657	657	CD
10_1101-2020_03_27_012757	36	19	CCLs	ccl	NNS
10_1101-2020_03_27_012757	36	20	,	,	,
10_1101-2020_03_27_012757	36	21	415	415	CD
10_1101-2020_03_27_012757	36	22	124	124	CD
10_1101-2020_03_27_012757	36	23	PDXs	pdx	NNS
10_1101-2020_03_27_012757	36	24	,	,	,
10_1101-2020_03_27_012757	36	25	26	26	CD
10_1101-2020_03_27_012757	36	26	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	36	27	,	,	,
10_1101-2020_03_27_012757	36	28	and	and	CC
10_1101-2020_03_27_012757	36	29	131	131	CD
10_1101-2020_03_27_012757	36	30	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	36	31	.	.	.
10_1101-2020_03_27_012757	37	1	This	this	DT
10_1101-2020_03_27_012757	37	2	has	have	VBZ
10_1101-2020_03_27_012757	37	3	allowed	allow	VBN
10_1101-2020_03_27_012757	37	4	us	-PRON-	PRP
10_1101-2020_03_27_012757	37	5	to	to	TO
10_1101-2020_03_27_012757	37	6	identify	identify	VB
10_1101-2020_03_27_012757	37	7	the	the	DT
10_1101-2020_03_27_012757	37	8	most	most	RBS
10_1101-2020_03_27_012757	37	9	faithful	faithful	JJ
10_1101-2020_03_27_012757	37	10	models	model	NNS
10_1101-2020_03_27_012757	37	11	125	125	CD
10_1101-2020_03_27_012757	37	12	currently	currently	RB
10_1101-2020_03_27_012757	37	13	available	available	JJ
10_1101-2020_03_27_012757	37	14	,	,	,
10_1101-2020_03_27_012757	37	15	to	to	IN
10_1101-2020_03_27_012757	37	16	document	document	VB
10_1101-2020_03_27_012757	37	17	cancers	cancer	NNS
10_1101-2020_03_27_012757	37	18	underserved	underserve	VBN
10_1101-2020_03_27_012757	37	19	by	by	IN
10_1101-2020_03_27_012757	37	20	adequate	adequate	JJ
10_1101-2020_03_27_012757	37	21	models	model	NNS
10_1101-2020_03_27_012757	37	22	,	,	,
10_1101-2020_03_27_012757	37	23	and	and	CC
10_1101-2020_03_27_012757	37	24	to	to	TO
10_1101-2020_03_27_012757	37	25	find	find	VB
10_1101-2020_03_27_012757	37	26	models	model	NNS
10_1101-2020_03_27_012757	37	27	126	126	CD
10_1101-2020_03_27_012757	37	28	with	with	IN
10_1101-2020_03_27_012757	37	29	inaccurate	inaccurate	JJ
10_1101-2020_03_27_012757	37	30	tumor	tumor	NN
10_1101-2020_03_27_012757	37	31	type	type	NN
10_1101-2020_03_27_012757	37	32	annotation	annotation	NN
10_1101-2020_03_27_012757	37	33	.	.	.
10_1101-2020_03_27_012757	38	1	Moreover	moreover	RB
10_1101-2020_03_27_012757	38	2	,	,	,
10_1101-2020_03_27_012757	38	3	because	because	IN
10_1101-2020_03_27_012757	38	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	38	5	is	be	VBZ
10_1101-2020_03_27_012757	38	6	open	open	JJ
10_1101-2020_03_27_012757	38	7	-	-	HYPH
10_1101-2020_03_27_012757	38	8	source	source	NN
10_1101-2020_03_27_012757	38	9	and	and	CC
10_1101-2020_03_27_012757	38	10	easy	easy	JJ
10_1101-2020_03_27_012757	38	11	to	to	TO
10_1101-2020_03_27_012757	38	12	127	127	CD
10_1101-2020_03_27_012757	38	13	use	use	NN
10_1101-2020_03_27_012757	38	14	,	,	,
10_1101-2020_03_27_012757	38	15	it	-PRON-	PRP
10_1101-2020_03_27_012757	38	16	can	can	MD
10_1101-2020_03_27_012757	38	17	be	be	VB
10_1101-2020_03_27_012757	38	18	readily	readily	RB
10_1101-2020_03_27_012757	38	19	applied	apply	VBN
10_1101-2020_03_27_012757	38	20	to	to	IN
10_1101-2020_03_27_012757	38	21	newly	newly	RB
10_1101-2020_03_27_012757	38	22	generated	generate	VBN
10_1101-2020_03_27_012757	38	23	cancer	cancer	NN
10_1101-2020_03_27_012757	38	24	models	model	NNS
10_1101-2020_03_27_012757	38	25	as	as	IN
10_1101-2020_03_27_012757	38	26	a	a	DT
10_1101-2020_03_27_012757	38	27	means	means	NN
10_1101-2020_03_27_012757	38	28	to	to	TO
10_1101-2020_03_27_012757	38	29	assess	assess	VB
10_1101-2020_03_27_012757	38	30	their	-PRON-	PRP$
10_1101-2020_03_27_012757	38	31	128	128	CD
10_1101-2020_03_27_012757	38	32	fidelity	fidelity	NN
10_1101-2020_03_27_012757	38	33	.	.	.
10_1101-2020_03_27_012757	39	1	129	129	CD
10_1101-2020_03_27_012757	39	2	130	130	CD
10_1101-2020_03_27_012757	39	3	RESULTS	results	NN
10_1101-2020_03_27_012757	39	4	131	131	CD
10_1101-2020_03_27_012757	39	5	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	39	6	classifies	classifie	NNS
10_1101-2020_03_27_012757	39	7	samples	sample	NNS
10_1101-2020_03_27_012757	39	8	accurately	accurately	RB
10_1101-2020_03_27_012757	39	9	across	across	IN
10_1101-2020_03_27_012757	39	10	species	specie	NNS
10_1101-2020_03_27_012757	39	11	and	and	CC
10_1101-2020_03_27_012757	39	12	technologies	technology	NNS
10_1101-2020_03_27_012757	39	13	132	132	CD
10_1101-2020_03_27_012757	39	14	Previously	previously	RB
10_1101-2020_03_27_012757	39	15	,	,	,
10_1101-2020_03_27_012757	39	16	we	-PRON-	PRP
10_1101-2020_03_27_012757	39	17	had	have	VBD
10_1101-2020_03_27_012757	39	18	developed	develop	VBN
10_1101-2020_03_27_012757	39	19	a	a	DT
10_1101-2020_03_27_012757	39	20	computational	computational	JJ
10_1101-2020_03_27_012757	39	21	tool	tool	NN
10_1101-2020_03_27_012757	39	22	using	use	VBG
10_1101-2020_03_27_012757	39	23	the	the	DT
10_1101-2020_03_27_012757	39	24	Random	Random	NNP
10_1101-2020_03_27_012757	39	25	Forest	Forest	NNP
10_1101-2020_03_27_012757	39	26	133	133	CD
10_1101-2020_03_27_012757	39	27	classification	classification	NN
10_1101-2020_03_27_012757	39	28	method	method	NN
10_1101-2020_03_27_012757	39	29	to	to	TO
10_1101-2020_03_27_012757	39	30	measure	measure	VB
10_1101-2020_03_27_012757	39	31	the	the	DT
10_1101-2020_03_27_012757	39	32	similarity	similarity	NN
10_1101-2020_03_27_012757	39	33	of	of	IN
10_1101-2020_03_27_012757	39	34	engineered	engineer	VBN
10_1101-2020_03_27_012757	39	35	cell	cell	NN
10_1101-2020_03_27_012757	39	36	populations	population	NNS
10_1101-2020_03_27_012757	39	37	to	to	IN
10_1101-2020_03_27_012757	39	38	their	-PRON-	PRP$
10_1101-2020_03_27_012757	39	39	in	in	IN
10_1101-2020_03_27_012757	39	40	vivo	vivo	NNP
10_1101-2020_03_27_012757	39	41	134	134	CD
10_1101-2020_03_27_012757	39	42	counterparts	counterpart	NNS
10_1101-2020_03_27_012757	39	43	based	base	VBN
10_1101-2020_03_27_012757	39	44	on	on	IN
10_1101-2020_03_27_012757	39	45	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	39	46	profiles21,22	profiles21,22	NNP
10_1101-2020_03_27_012757	39	47	.	.	.
10_1101-2020_03_27_012757	40	1	More	more	RBR
10_1101-2020_03_27_012757	40	2	recently	recently	RB
10_1101-2020_03_27_012757	40	3	,	,	,
10_1101-2020_03_27_012757	40	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	40	5	elaborated	elaborate	VBD
10_1101-2020_03_27_012757	40	6	on	on	IN
10_1101-2020_03_27_012757	40	7	this	this	DT
10_1101-2020_03_27_012757	40	8	135	135	CD
10_1101-2020_03_27_012757	40	9	approach	approach	NN
10_1101-2020_03_27_012757	40	10	to	to	TO
10_1101-2020_03_27_012757	40	11	allow	allow	VB
10_1101-2020_03_27_012757	40	12	for	for	IN
10_1101-2020_03_27_012757	40	13	classification	classification	NN
10_1101-2020_03_27_012757	40	14	of	of	IN
10_1101-2020_03_27_012757	40	15	single	single	JJ
10_1101-2020_03_27_012757	40	16	cell	cell	NN
10_1101-2020_03_27_012757	40	17	RNA	RNA	NNP
10_1101-2020_03_27_012757	40	18	-	-	HYPH
10_1101-2020_03_27_012757	40	19	seq	seq	NN
10_1101-2020_03_27_012757	40	20	data	datum	NNS
10_1101-2020_03_27_012757	40	21	in	in	IN
10_1101-2020_03_27_012757	40	22	a	a	DT
10_1101-2020_03_27_012757	40	23	manner	manner	NN
10_1101-2020_03_27_012757	40	24	that	that	WDT
10_1101-2020_03_27_012757	40	25	allows	allow	VBZ
10_1101-2020_03_27_012757	40	26	for	for	IN
10_1101-2020_03_27_012757	40	27	136	136	CD
10_1101-2020_03_27_012757	40	28	cross	cross	JJ
10_1101-2020_03_27_012757	40	29	-	-	NN
10_1101-2020_03_27_012757	40	30	platform	platform	NN
10_1101-2020_03_27_012757	40	31	and	and	CC
10_1101-2020_03_27_012757	40	32	cross	cross	NN
10_1101-2020_03_27_012757	40	33	-	-	NN
10_1101-2020_03_27_012757	40	34	species	species	JJ
10_1101-2020_03_27_012757	40	35	analysis23	analysis23	NNS
10_1101-2020_03_27_012757	40	36	.	.	.
10_1101-2020_03_27_012757	41	1	Here	here	RB
10_1101-2020_03_27_012757	41	2	,	,	,
10_1101-2020_03_27_012757	41	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	41	4	used	use	VBD
10_1101-2020_03_27_012757	41	5	an	an	DT
10_1101-2020_03_27_012757	41	6	analogous	analogous	JJ
10_1101-2020_03_27_012757	41	7	approach	approach	NN
10_1101-2020_03_27_012757	41	8	to	to	TO
10_1101-2020_03_27_012757	41	9	build	build	VB
10_1101-2020_03_27_012757	41	10	a	a	DT
10_1101-2020_03_27_012757	41	11	137	137	CD
10_1101-2020_03_27_012757	41	12	.CC	.CC	NFP
10_1101-2020_03_27_012757	41	13	-	-	HYPH
10_1101-2020_03_27_012757	41	14	BY	by	IN
10_1101-2020_03_27_012757	41	15	-	-	HYPH
10_1101-2020_03_27_012757	41	16	NC	NC	NNP
10_1101-2020_03_27_012757	41	17	-	-	HYPH
10_1101-2020_03_27_012757	41	18	ND	ND	NNP
10_1101-2020_03_27_012757	41	19	4.0	4.0	CD
10_1101-2020_03_27_012757	41	20	International	International	NNP
10_1101-2020_03_27_012757	41	21	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	41	22	under	under	IN
10_1101-2020_03_27_012757	41	23	a	a	DT
10_1101-2020_03_27_012757	41	24	(	(	-LRB-
10_1101-2020_03_27_012757	41	25	which	which	WDT
10_1101-2020_03_27_012757	41	26	was	be	VBD
10_1101-2020_03_27_012757	41	27	not	not	RB
10_1101-2020_03_27_012757	41	28	certified	certify	VBN
10_1101-2020_03_27_012757	41	29	by	by	IN
10_1101-2020_03_27_012757	41	30	peer	peer	NN
10_1101-2020_03_27_012757	41	31	review	review	NN
10_1101-2020_03_27_012757	41	32	)	)	-RRB-
10_1101-2020_03_27_012757	41	33	is	be	VBZ
10_1101-2020_03_27_012757	41	34	the	the	DT
10_1101-2020_03_27_012757	41	35	author	author	NN
10_1101-2020_03_27_012757	41	36	/	/	SYM
10_1101-2020_03_27_012757	41	37	funder	funder	NN
10_1101-2020_03_27_012757	41	38	,	,	,
10_1101-2020_03_27_012757	41	39	who	who	WP
10_1101-2020_03_27_012757	41	40	has	have	VBZ
10_1101-2020_03_27_012757	41	41	granted	grant	VBN
10_1101-2020_03_27_012757	41	42	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	41	43	a	a	DT
10_1101-2020_03_27_012757	41	44	license	license	NN
10_1101-2020_03_27_012757	41	45	to	to	TO
10_1101-2020_03_27_012757	41	46	display	display	VB
10_1101-2020_03_27_012757	41	47	the	the	DT
10_1101-2020_03_27_012757	41	48	preprint	preprint	NN
10_1101-2020_03_27_012757	41	49	in	in	IN
10_1101-2020_03_27_012757	41	50	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	41	51	.	.	.
10_1101-2020_03_27_012757	42	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	42	2	is	be	VBZ
10_1101-2020_03_27_012757	42	3	made	make	VBN
10_1101-2020_03_27_012757	42	4	The	the	DT
10_1101-2020_03_27_012757	42	5	copyright	copyright	NN
10_1101-2020_03_27_012757	42	6	holder	holder	NN
10_1101-2020_03_27_012757	42	7	for	for	IN
10_1101-2020_03_27_012757	42	8	this	this	DT
10_1101-2020_03_27_012757	42	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	42	10	version	version	NN
10_1101-2020_03_27_012757	42	11	posted	post	VBD
10_1101-2020_03_27_012757	42	12	January	January	NNP
10_1101-2020_03_27_012757	42	13	9	9	CD
10_1101-2020_03_27_012757	42	14	,	,	,
10_1101-2020_03_27_012757	42	15	2021	2021	CD
10_1101-2020_03_27_012757	42	16	.	.	.
10_1101-2020_03_27_012757	42	17	;	;	:
10_1101-2020_03_27_012757	42	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	42	19	:	:	:
10_1101-2020_03_27_012757	42	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	42	21	preprint	preprint	NN
10_1101-2020_03_27_012757	42	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NN
10_1101-2020_03_27_012757	42	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	42	24	5	5	CD
10_1101-2020_03_27_012757	42	25	platform	platform	NN
10_1101-2020_03_27_012757	42	26	that	that	WDT
10_1101-2020_03_27_012757	42	27	would	would	MD
10_1101-2020_03_27_012757	42	28	allow	allow	VB
10_1101-2020_03_27_012757	42	29	us	-PRON-	PRP
10_1101-2020_03_27_012757	42	30	to	to	TO
10_1101-2020_03_27_012757	42	31	quantitatively	quantitatively	RB
10_1101-2020_03_27_012757	42	32	compare	compare	VB
10_1101-2020_03_27_012757	42	33	cancer	cancer	NN
10_1101-2020_03_27_012757	42	34	models	model	NNS
10_1101-2020_03_27_012757	42	35	to	to	IN
10_1101-2020_03_27_012757	42	36	naturally	naturally	RB
10_1101-2020_03_27_012757	42	37	occurring	occur	VBG
10_1101-2020_03_27_012757	42	38	138	138	CD
10_1101-2020_03_27_012757	42	39	patient	patient	JJ
10_1101-2020_03_27_012757	42	40	tumors	tumor	NNS
10_1101-2020_03_27_012757	42	41	(	(	-LRB-
10_1101-2020_03_27_012757	42	42	Fig	fig	NN
10_1101-2020_03_27_012757	42	43	1A	1A	VBG
10_1101-2020_03_27_012757	42	44	)	)	-RRB-
10_1101-2020_03_27_012757	42	45	.	.	.
10_1101-2020_03_27_012757	43	1	In	in	IN
10_1101-2020_03_27_012757	43	2	brief	brief	NN
10_1101-2020_03_27_012757	43	3	,	,	,
10_1101-2020_03_27_012757	43	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	43	5	used	use	VBD
10_1101-2020_03_27_012757	43	6	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	43	7	RNA	RNA	NNP
10_1101-2020_03_27_012757	43	8	-	-	HYPH
10_1101-2020_03_27_012757	43	9	seq	seq	NN
10_1101-2020_03_27_012757	43	10	expression	expression	NN
10_1101-2020_03_27_012757	43	11	data	datum	NNS
10_1101-2020_03_27_012757	43	12	from	from	IN
10_1101-2020_03_27_012757	43	13	22	22	CD
10_1101-2020_03_27_012757	43	14	solid	solid	JJ
10_1101-2020_03_27_012757	43	15	tumor	tumor	NN
10_1101-2020_03_27_012757	43	16	139	139	CD
10_1101-2020_03_27_012757	43	17	types	type	NNS
10_1101-2020_03_27_012757	43	18	to	to	TO
10_1101-2020_03_27_012757	43	19	train	train	VB
10_1101-2020_03_27_012757	43	20	a	a	DT
10_1101-2020_03_27_012757	43	21	top	top	JJ
10_1101-2020_03_27_012757	43	22	-	-	HYPH
10_1101-2020_03_27_012757	43	23	pair	pair	NN
10_1101-2020_03_27_012757	43	24	multi	multi	JJ
10_1101-2020_03_27_012757	43	25	-	-	JJ
10_1101-2020_03_27_012757	43	26	class	class	JJ
10_1101-2020_03_27_012757	43	27	Random	random	JJ
10_1101-2020_03_27_012757	43	28	forest	forest	NN
10_1101-2020_03_27_012757	43	29	classifier	classifier	NN
10_1101-2020_03_27_012757	43	30	(	(	-LRB-
10_1101-2020_03_27_012757	43	31	Fig	fig	NN
10_1101-2020_03_27_012757	43	32	1B	1B	NNP
10_1101-2020_03_27_012757	43	33	)	)	-RRB-
10_1101-2020_03_27_012757	43	34	.	.	.
10_1101-2020_03_27_012757	44	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	44	2	combined	combine	VBD
10_1101-2020_03_27_012757	44	3	training	training	NN
10_1101-2020_03_27_012757	44	4	140	140	CD
10_1101-2020_03_27_012757	44	5	data	datum	NNS
10_1101-2020_03_27_012757	44	6	from	from	IN
10_1101-2020_03_27_012757	44	7	Rectal	Rectal	NNP
10_1101-2020_03_27_012757	44	8	Adenocarcinoma	Adenocarcinoma	NNP
10_1101-2020_03_27_012757	44	9	(	(	-LRB-
10_1101-2020_03_27_012757	44	10	READ	READ	NNP
10_1101-2020_03_27_012757	44	11	)	)	-RRB-
10_1101-2020_03_27_012757	44	12	and	and	CC
10_1101-2020_03_27_012757	44	13	Colon	Colon	NNP
10_1101-2020_03_27_012757	44	14	Adenocarcinoma	Adenocarcinoma	NNP
10_1101-2020_03_27_012757	44	15	(	(	-LRB-
10_1101-2020_03_27_012757	44	16	COAD	COAD	NNP
10_1101-2020_03_27_012757	44	17	)	)	-RRB-
10_1101-2020_03_27_012757	44	18	into	into	IN
10_1101-2020_03_27_012757	44	19	one	one	CD
10_1101-2020_03_27_012757	44	20	141	141	CD
10_1101-2020_03_27_012757	44	21	COAD_READ	coad_read	JJ
10_1101-2020_03_27_012757	44	22	category	category	NN
10_1101-2020_03_27_012757	44	23	because	because	IN
10_1101-2020_03_27_012757	44	24	READ	READ	NNP
10_1101-2020_03_27_012757	44	25	and	and	CC
10_1101-2020_03_27_012757	44	26	COAD	COAD	NNP
10_1101-2020_03_27_012757	44	27	are	be	VBP
10_1101-2020_03_27_012757	44	28	considered	consider	VBN
10_1101-2020_03_27_012757	44	29	to	to	TO
10_1101-2020_03_27_012757	44	30	be	be	VB
10_1101-2020_03_27_012757	44	31	virtually	virtually	RB
10_1101-2020_03_27_012757	44	32	142	142	CD
10_1101-2020_03_27_012757	44	33	indistinguishable	indistinguishable	JJ
10_1101-2020_03_27_012757	44	34	at	at	IN
10_1101-2020_03_27_012757	44	35	a	a	DT
10_1101-2020_03_27_012757	44	36	molecular	molecular	JJ
10_1101-2020_03_27_012757	44	37	level24	level24	NN
10_1101-2020_03_27_012757	44	38	.	.	.
10_1101-2020_03_27_012757	45	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	45	2	included	include	VBD
10_1101-2020_03_27_012757	45	3	an	an	DT
10_1101-2020_03_27_012757	45	4	‘	'	``
10_1101-2020_03_27_012757	45	5	Unknown	unknown	JJ
10_1101-2020_03_27_012757	45	6	’	'	''
10_1101-2020_03_27_012757	45	7	category	category	NN
10_1101-2020_03_27_012757	45	8	trained	train	VBD
10_1101-2020_03_27_012757	45	9	using	use	VBG
10_1101-2020_03_27_012757	45	10	143	143	CD
10_1101-2020_03_27_012757	45	11	randomly	randomly	RB
10_1101-2020_03_27_012757	45	12	shuffled	shuffle	VBN
10_1101-2020_03_27_012757	45	13	gene	gene	NN
10_1101-2020_03_27_012757	45	14	-	-	HYPH
10_1101-2020_03_27_012757	45	15	pair	pair	NN
10_1101-2020_03_27_012757	45	16	profiles	profile	NNS
10_1101-2020_03_27_012757	45	17	generated	generate	VBN
10_1101-2020_03_27_012757	45	18	from	from	IN
10_1101-2020_03_27_012757	45	19	the	the	DT
10_1101-2020_03_27_012757	45	20	training	training	NN
10_1101-2020_03_27_012757	45	21	data	datum	NNS
10_1101-2020_03_27_012757	45	22	of	of	IN
10_1101-2020_03_27_012757	45	23	22	22	CD
10_1101-2020_03_27_012757	45	24	tumor	tumor	NN
10_1101-2020_03_27_012757	45	25	types	type	NNS
10_1101-2020_03_27_012757	45	26	to	to	IN
10_1101-2020_03_27_012757	45	27	144	144	CD
10_1101-2020_03_27_012757	45	28	identify	identify	VB
10_1101-2020_03_27_012757	45	29	query	query	NN
10_1101-2020_03_27_012757	45	30	samples	sample	NNS
10_1101-2020_03_27_012757	45	31	that	that	WDT
10_1101-2020_03_27_012757	45	32	are	be	VBP
10_1101-2020_03_27_012757	45	33	not	not	RB
10_1101-2020_03_27_012757	45	34	reflective	reflective	JJ
10_1101-2020_03_27_012757	45	35	of	of	IN
10_1101-2020_03_27_012757	45	36	any	any	DT
10_1101-2020_03_27_012757	45	37	of	of	IN
10_1101-2020_03_27_012757	45	38	the	the	DT
10_1101-2020_03_27_012757	45	39	training	training	NN
10_1101-2020_03_27_012757	45	40	data	datum	NNS
10_1101-2020_03_27_012757	45	41	.	.	.
10_1101-2020_03_27_012757	46	1	To	to	TO
10_1101-2020_03_27_012757	46	2	estimate	estimate	VB
10_1101-2020_03_27_012757	46	3	the	the	DT
10_1101-2020_03_27_012757	46	4	145	145	CD
10_1101-2020_03_27_012757	46	5	performance	performance	NN
10_1101-2020_03_27_012757	46	6	of	of	IN
10_1101-2020_03_27_012757	46	7	CCN	CCN	NNP
10_1101-2020_03_27_012757	46	8	and	and	CC
10_1101-2020_03_27_012757	46	9	how	how	WRB
10_1101-2020_03_27_012757	46	10	it	-PRON-	PRP
10_1101-2020_03_27_012757	46	11	is	be	VBZ
10_1101-2020_03_27_012757	46	12	impacted	impact	VBN
10_1101-2020_03_27_012757	46	13	by	by	IN
10_1101-2020_03_27_012757	46	14	parameter	parameter	NN
10_1101-2020_03_27_012757	46	15	variation	variation	NN
10_1101-2020_03_27_012757	46	16	,	,	,
10_1101-2020_03_27_012757	46	17	we	-PRON-	PRP
10_1101-2020_03_27_012757	46	18	performed	perform	VBD
10_1101-2020_03_27_012757	46	19	a	a	DT
10_1101-2020_03_27_012757	46	20	parameter	parameter	NN
10_1101-2020_03_27_012757	46	21	146	146	CD
10_1101-2020_03_27_012757	46	22	sweep	sweep	NN
10_1101-2020_03_27_012757	46	23	with	with	IN
10_1101-2020_03_27_012757	46	24	a	a	DT
10_1101-2020_03_27_012757	46	25	5-fold	5-fold	CD
10_1101-2020_03_27_012757	46	26	2/3	2/3	CD
10_1101-2020_03_27_012757	46	27	cross	cross	NN
10_1101-2020_03_27_012757	46	28	-	-	JJ
10_1101-2020_03_27_012757	46	29	validation	validation	JJ
10_1101-2020_03_27_012757	46	30	strategy	strategy	NN
10_1101-2020_03_27_012757	46	31	(	(	-LRB-
10_1101-2020_03_27_012757	46	32	i.e.	i.e.	FW
10_1101-2020_03_27_012757	47	1	2/3	2/3	CD
10_1101-2020_03_27_012757	47	2	of	of	IN
10_1101-2020_03_27_012757	47	3	the	the	DT
10_1101-2020_03_27_012757	47	4	data	datum	NNS
10_1101-2020_03_27_012757	47	5	sampled	sample	VBN
10_1101-2020_03_27_012757	47	6	across	across	IN
10_1101-2020_03_27_012757	47	7	each	each	DT
10_1101-2020_03_27_012757	47	8	147	147	CD
10_1101-2020_03_27_012757	47	9	cancer	cancer	NN
10_1101-2020_03_27_012757	47	10	type	type	NN
10_1101-2020_03_27_012757	47	11	was	be	VBD
10_1101-2020_03_27_012757	47	12	used	use	VBN
10_1101-2020_03_27_012757	47	13	to	to	TO
10_1101-2020_03_27_012757	47	14	train	train	VB
10_1101-2020_03_27_012757	47	15	,	,	,
10_1101-2020_03_27_012757	47	16	1/3	1/3	CD
10_1101-2020_03_27_012757	47	17	was	be	VBD
10_1101-2020_03_27_012757	47	18	used	use	VBN
10_1101-2020_03_27_012757	47	19	to	to	TO
10_1101-2020_03_27_012757	47	20	validate	validate	VB
10_1101-2020_03_27_012757	47	21	)	)	-RRB-
10_1101-2020_03_27_012757	47	22	(	(	-LRB-
10_1101-2020_03_27_012757	47	23	Fig	fig	NN
10_1101-2020_03_27_012757	47	24	1C	1c	NN
10_1101-2020_03_27_012757	47	25	)	)	-RRB-
10_1101-2020_03_27_012757	47	26	.	.	.
10_1101-2020_03_27_012757	48	1	The	the	DT
10_1101-2020_03_27_012757	48	2	performance	performance	NN
10_1101-2020_03_27_012757	48	3	of	of	IN
10_1101-2020_03_27_012757	48	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	48	5	,	,	,
10_1101-2020_03_27_012757	48	6	as	as	IN
10_1101-2020_03_27_012757	48	7	148	148	CD
10_1101-2020_03_27_012757	48	8	measured	measure	VBN
10_1101-2020_03_27_012757	48	9	by	by	IN
10_1101-2020_03_27_012757	48	10	the	the	DT
10_1101-2020_03_27_012757	48	11	mean	mean	NNP
10_1101-2020_03_27_012757	48	12	area	area	NN
10_1101-2020_03_27_012757	48	13	under	under	IN
10_1101-2020_03_27_012757	48	14	the	the	DT
10_1101-2020_03_27_012757	48	15	precision	precision	NN
10_1101-2020_03_27_012757	48	16	recall	recall	NN
10_1101-2020_03_27_012757	48	17	curve	curve	NN
10_1101-2020_03_27_012757	48	18	(	(	-LRB-
10_1101-2020_03_27_012757	48	19	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	48	20	)	)	-RRB-
10_1101-2020_03_27_012757	48	21	,	,	,
10_1101-2020_03_27_012757	48	22	did	do	VBD
10_1101-2020_03_27_012757	48	23	not	not	RB
10_1101-2020_03_27_012757	48	24	fall	fall	VB
10_1101-2020_03_27_012757	48	25	below	below	IN
10_1101-2020_03_27_012757	48	26	0.945	0.945	CD
10_1101-2020_03_27_012757	48	27	149	149	CD
10_1101-2020_03_27_012757	48	28	and	and	CC
10_1101-2020_03_27_012757	48	29	remained	remain	VBD
10_1101-2020_03_27_012757	48	30	relatively	relatively	RB
10_1101-2020_03_27_012757	48	31	stable	stable	JJ
10_1101-2020_03_27_012757	48	32	across	across	IN
10_1101-2020_03_27_012757	48	33	parameter	parameter	NN
10_1101-2020_03_27_012757	48	34	sets	set	NNS
10_1101-2020_03_27_012757	48	35	(	(	-LRB-
10_1101-2020_03_27_012757	48	36	Supp	Supp	NNP
10_1101-2020_03_27_012757	48	37	Fig	Fig	NNP
10_1101-2020_03_27_012757	48	38	1A	1a	NN
10_1101-2020_03_27_012757	48	39	)	)	-RRB-
10_1101-2020_03_27_012757	48	40	.	.	.
10_1101-2020_03_27_012757	49	1	The	the	DT
10_1101-2020_03_27_012757	49	2	optimal	optimal	JJ
10_1101-2020_03_27_012757	49	3	parameters	parameter	VBZ
10_1101-2020_03_27_012757	49	4	150	150	CD
10_1101-2020_03_27_012757	49	5	resulted	result	VBD
10_1101-2020_03_27_012757	49	6	in	in	IN
10_1101-2020_03_27_012757	49	7	1,979	1,979	CD
10_1101-2020_03_27_012757	49	8	features	feature	NNS
10_1101-2020_03_27_012757	49	9	.	.	.
10_1101-2020_03_27_012757	50	1	The	the	DT
10_1101-2020_03_27_012757	50	2	mean	mean	JJ
10_1101-2020_03_27_012757	50	3	AUPRCs	AUPRCs	NNP
10_1101-2020_03_27_012757	50	4	exceeded	exceed	VBD
10_1101-2020_03_27_012757	50	5	0.95	0.95	CD
10_1101-2020_03_27_012757	50	6	in	in	IN
10_1101-2020_03_27_012757	50	7	most	most	JJS
10_1101-2020_03_27_012757	50	8	tumor	tumor	NN
10_1101-2020_03_27_012757	50	9	types	type	NNS
10_1101-2020_03_27_012757	50	10	with	with	IN
10_1101-2020_03_27_012757	50	11	this	this	DT
10_1101-2020_03_27_012757	50	12	151	151	CD
10_1101-2020_03_27_012757	50	13	optimal	optimal	JJ
10_1101-2020_03_27_012757	50	14	parameter	parameter	NN
10_1101-2020_03_27_012757	50	15	set	set	NN
10_1101-2020_03_27_012757	50	16	(	(	-LRB-
10_1101-2020_03_27_012757	50	17	Fig	fig	NN
10_1101-2020_03_27_012757	50	18	1D	1d	NN
10_1101-2020_03_27_012757	50	19	,	,	,
10_1101-2020_03_27_012757	50	20	Supp	Supp	NNP
10_1101-2020_03_27_012757	50	21	Fig	Fig	NNP
10_1101-2020_03_27_012757	50	22	1B	1b	NN
10_1101-2020_03_27_012757	50	23	)	)	-RRB-
10_1101-2020_03_27_012757	50	24	.	.	.
10_1101-2020_03_27_012757	51	1	The	the	DT
10_1101-2020_03_27_012757	51	2	AUPRCs	auprc	NNS
10_1101-2020_03_27_012757	51	3	of	of	IN
10_1101-2020_03_27_012757	51	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	51	5	applied	apply	VBN
10_1101-2020_03_27_012757	51	6	to	to	IN
10_1101-2020_03_27_012757	51	7	independent	independent	JJ
10_1101-2020_03_27_012757	51	8	152	152	CD
10_1101-2020_03_27_012757	51	9	data	datum	NNS
10_1101-2020_03_27_012757	51	10	RNA	RNA	NNP
10_1101-2020_03_27_012757	51	11	-	-	HYPH
10_1101-2020_03_27_012757	51	12	Seq	Seq	NNP
10_1101-2020_03_27_012757	51	13	data	datum	NNS
10_1101-2020_03_27_012757	51	14	from	from	IN
10_1101-2020_03_27_012757	51	15	725	725	CD
10_1101-2020_03_27_012757	51	16	tumors	tumor	NNS
10_1101-2020_03_27_012757	51	17	across	across	IN
10_1101-2020_03_27_012757	51	18	five	five	CD
10_1101-2020_03_27_012757	51	19	tumor	tumor	NN
10_1101-2020_03_27_012757	51	20	types	type	NNS
10_1101-2020_03_27_012757	51	21	from	from	IN
10_1101-2020_03_27_012757	51	22	the	the	DT
10_1101-2020_03_27_012757	51	23	International	International	NNP
10_1101-2020_03_27_012757	51	24	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	51	25	153	153	CD
10_1101-2020_03_27_012757	51	26	Genome	Genome	NNP
10_1101-2020_03_27_012757	51	27	Consortium	Consortium	NNP
10_1101-2020_03_27_012757	51	28	(	(	-LRB-
10_1101-2020_03_27_012757	51	29	ICGC)25	ICGC)25	NNP
10_1101-2020_03_27_012757	51	30	ranged	range	VBD
10_1101-2020_03_27_012757	51	31	from	from	IN
10_1101-2020_03_27_012757	51	32	0.93	0.93	CD
10_1101-2020_03_27_012757	51	33	to	to	IN
10_1101-2020_03_27_012757	51	34	0.99	0.99	CD
10_1101-2020_03_27_012757	51	35	,	,	,
10_1101-2020_03_27_012757	51	36	supporting	support	VBG
10_1101-2020_03_27_012757	51	37	the	the	DT
10_1101-2020_03_27_012757	51	38	notion	notion	NN
10_1101-2020_03_27_012757	51	39	that	that	IN
10_1101-2020_03_27_012757	51	40	the	the	DT
10_1101-2020_03_27_012757	51	41	platform	platform	NN
10_1101-2020_03_27_012757	51	42	154	154	CD
10_1101-2020_03_27_012757	51	43	is	be	VBZ
10_1101-2020_03_27_012757	51	44	able	able	JJ
10_1101-2020_03_27_012757	51	45	to	to	TO
10_1101-2020_03_27_012757	51	46	accurately	accurately	RB
10_1101-2020_03_27_012757	51	47	classify	classify	VB
10_1101-2020_03_27_012757	51	48	tumor	tumor	NN
10_1101-2020_03_27_012757	51	49	samples	sample	NNS
10_1101-2020_03_27_012757	51	50	from	from	IN
10_1101-2020_03_27_012757	51	51	diverse	diverse	JJ
10_1101-2020_03_27_012757	51	52	sources	source	NNS
10_1101-2020_03_27_012757	51	53	(	(	-LRB-
10_1101-2020_03_27_012757	51	54	Fig	fig	NN
10_1101-2020_03_27_012757	51	55	1E	1E	NNP
10_1101-2020_03_27_012757	51	56	)	)	-RRB-
10_1101-2020_03_27_012757	51	57	.	.	.
10_1101-2020_03_27_012757	52	1	155	155	CD
10_1101-2020_03_27_012757	52	2	As	as	IN
10_1101-2020_03_27_012757	52	3	one	one	CD
10_1101-2020_03_27_012757	52	4	of	of	IN
10_1101-2020_03_27_012757	52	5	the	the	DT
10_1101-2020_03_27_012757	52	6	central	central	JJ
10_1101-2020_03_27_012757	52	7	aims	aim	NNS
10_1101-2020_03_27_012757	52	8	of	of	IN
10_1101-2020_03_27_012757	52	9	our	-PRON-	PRP$
10_1101-2020_03_27_012757	52	10	study	study	NN
10_1101-2020_03_27_012757	52	11	is	be	VBZ
10_1101-2020_03_27_012757	52	12	to	to	TO
10_1101-2020_03_27_012757	52	13	compare	compare	VB
10_1101-2020_03_27_012757	52	14	distinct	distinct	JJ
10_1101-2020_03_27_012757	52	15	cancer	cancer	NN
10_1101-2020_03_27_012757	52	16	models	model	NNS
10_1101-2020_03_27_012757	52	17	,	,	,
10_1101-2020_03_27_012757	52	18	including	include	VBG
10_1101-2020_03_27_012757	52	19	156	156	CD
10_1101-2020_03_27_012757	52	20	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	52	21	,	,	,
10_1101-2020_03_27_012757	52	22	our	-PRON-	PRP$
10_1101-2020_03_27_012757	52	23	method	method	NN
10_1101-2020_03_27_012757	52	24	needed	need	VBD
10_1101-2020_03_27_012757	52	25	to	to	TO
10_1101-2020_03_27_012757	52	26	be	be	VB
10_1101-2020_03_27_012757	52	27	able	able	JJ
10_1101-2020_03_27_012757	52	28	to	to	TO
10_1101-2020_03_27_012757	52	29	classify	classify	VB
10_1101-2020_03_27_012757	52	30	samples	sample	NNS
10_1101-2020_03_27_012757	52	31	from	from	IN
10_1101-2020_03_27_012757	52	32	mouse	mouse	NN
10_1101-2020_03_27_012757	52	33	and	and	CC
10_1101-2020_03_27_012757	52	34	human	human	JJ
10_1101-2020_03_27_012757	52	35	samples	sample	NNS
10_1101-2020_03_27_012757	52	36	157	157	CD
10_1101-2020_03_27_012757	52	37	equivalently	equivalently	RB
10_1101-2020_03_27_012757	52	38	.	.	.
10_1101-2020_03_27_012757	53	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	53	2	used	use	VBD
10_1101-2020_03_27_012757	53	3	the	the	DT
10_1101-2020_03_27_012757	53	4	Top	Top	NNP
10_1101-2020_03_27_012757	53	5	-	-	HYPH
10_1101-2020_03_27_012757	53	6	Pair	Pair	NNP
10_1101-2020_03_27_012757	53	7	transform23	transform23	NNP
10_1101-2020_03_27_012757	53	8	to	to	TO
10_1101-2020_03_27_012757	53	9	achieve	achieve	VB
10_1101-2020_03_27_012757	53	10	this	this	DT
10_1101-2020_03_27_012757	53	11	and	and	CC
10_1101-2020_03_27_012757	53	12	we	-PRON-	PRP
10_1101-2020_03_27_012757	53	13	tested	test	VBD
10_1101-2020_03_27_012757	53	14	the	the	DT
10_1101-2020_03_27_012757	53	15	feasibility	feasibility	NN
10_1101-2020_03_27_012757	53	16	of	of	IN
10_1101-2020_03_27_012757	53	17	158	158	CD
10_1101-2020_03_27_012757	53	18	this	this	DT
10_1101-2020_03_27_012757	53	19	approach	approach	NN
10_1101-2020_03_27_012757	53	20	by	by	IN
10_1101-2020_03_27_012757	53	21	assessing	assess	VBG
10_1101-2020_03_27_012757	53	22	the	the	DT
10_1101-2020_03_27_012757	53	23	performance	performance	NN
10_1101-2020_03_27_012757	53	24	of	of	IN
10_1101-2020_03_27_012757	53	25	a	a	DT
10_1101-2020_03_27_012757	53	26	normal	normal	JJ
10_1101-2020_03_27_012757	53	27	(	(	-LRB-
10_1101-2020_03_27_012757	53	28	i.e.	i.e.	FW
10_1101-2020_03_27_012757	54	1	non	non	JJ
10_1101-2020_03_27_012757	54	2	-	-	JJ
10_1101-2020_03_27_012757	54	3	tumor	tumor	JJ
10_1101-2020_03_27_012757	54	4	)	)	-RRB-
10_1101-2020_03_27_012757	54	5	cell	cell	NN
10_1101-2020_03_27_012757	54	6	and	and	CC
10_1101-2020_03_27_012757	54	7	tissue	tissue	NN
10_1101-2020_03_27_012757	54	8	159	159	CD
10_1101-2020_03_27_012757	54	9	classifier	classifier	NN
10_1101-2020_03_27_012757	54	10	trained	train	VBN
10_1101-2020_03_27_012757	54	11	on	on	IN
10_1101-2020_03_27_012757	54	12	human	human	JJ
10_1101-2020_03_27_012757	54	13	data	datum	NNS
10_1101-2020_03_27_012757	54	14	as	as	IN
10_1101-2020_03_27_012757	54	15	applied	apply	VBN
10_1101-2020_03_27_012757	54	16	to	to	IN
10_1101-2020_03_27_012757	54	17	mouse	mouse	NN
10_1101-2020_03_27_012757	54	18	samples	sample	NNS
10_1101-2020_03_27_012757	54	19	.	.	.
10_1101-2020_03_27_012757	55	1	Consistent	consistent	JJ
10_1101-2020_03_27_012757	55	2	with	with	IN
10_1101-2020_03_27_012757	55	3	prior	prior	JJ
10_1101-2020_03_27_012757	55	4	160	160	CD
10_1101-2020_03_27_012757	55	5	applications23	applications23	NNS
10_1101-2020_03_27_012757	55	6	,	,	,
10_1101-2020_03_27_012757	55	7	we	-PRON-	PRP
10_1101-2020_03_27_012757	55	8	found	find	VBD
10_1101-2020_03_27_012757	55	9	that	that	IN
10_1101-2020_03_27_012757	55	10	the	the	DT
10_1101-2020_03_27_012757	55	11	cross	cross	JJ
10_1101-2020_03_27_012757	55	12	-	-	JJ
10_1101-2020_03_27_012757	55	13	species	species	JJ
10_1101-2020_03_27_012757	55	14	classifier	classifier	NN
10_1101-2020_03_27_012757	55	15	performed	perform	VBD
10_1101-2020_03_27_012757	55	16	well	well	RB
10_1101-2020_03_27_012757	55	17	,	,	,
10_1101-2020_03_27_012757	55	18	achieving	achieve	VBG
10_1101-2020_03_27_012757	55	19	mean	mean	VB
10_1101-2020_03_27_012757	55	20	161	161	CD
10_1101-2020_03_27_012757	55	21	AUPRC	AUPRC	NNS
10_1101-2020_03_27_012757	55	22	of	of	IN
10_1101-2020_03_27_012757	55	23	0.97	0.97	CD
10_1101-2020_03_27_012757	55	24	when	when	WRB
10_1101-2020_03_27_012757	55	25	applied	apply	VBN
10_1101-2020_03_27_012757	55	26	to	to	IN
10_1101-2020_03_27_012757	55	27	mouse	mouse	NN
10_1101-2020_03_27_012757	55	28	data	datum	NNS
10_1101-2020_03_27_012757	55	29	(	(	-LRB-
10_1101-2020_03_27_012757	55	30	Supp	Supp	NNP
10_1101-2020_03_27_012757	55	31	Fig	Fig	NNP
10_1101-2020_03_27_012757	55	32	1C	1c	NN
10_1101-2020_03_27_012757	55	33	)	)	-RRB-
10_1101-2020_03_27_012757	55	34	.	.	.
10_1101-2020_03_27_012757	56	1	162	162	CD
10_1101-2020_03_27_012757	56	2	.CC	.CC	:
10_1101-2020_03_27_012757	56	3	-	-	HYPH
10_1101-2020_03_27_012757	56	4	BY	by	IN
10_1101-2020_03_27_012757	56	5	-	-	HYPH
10_1101-2020_03_27_012757	56	6	NC	NC	NNP
10_1101-2020_03_27_012757	56	7	-	-	HYPH
10_1101-2020_03_27_012757	56	8	ND	ND	NNP
10_1101-2020_03_27_012757	56	9	4.0	4.0	CD
10_1101-2020_03_27_012757	56	10	International	International	NNP
10_1101-2020_03_27_012757	56	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	56	12	under	under	IN
10_1101-2020_03_27_012757	56	13	a	a	DT
10_1101-2020_03_27_012757	56	14	(	(	-LRB-
10_1101-2020_03_27_012757	56	15	which	which	WDT
10_1101-2020_03_27_012757	56	16	was	be	VBD
10_1101-2020_03_27_012757	56	17	not	not	RB
10_1101-2020_03_27_012757	56	18	certified	certify	VBN
10_1101-2020_03_27_012757	56	19	by	by	IN
10_1101-2020_03_27_012757	56	20	peer	peer	NN
10_1101-2020_03_27_012757	56	21	review	review	NN
10_1101-2020_03_27_012757	56	22	)	)	-RRB-
10_1101-2020_03_27_012757	56	23	is	be	VBZ
10_1101-2020_03_27_012757	56	24	the	the	DT
10_1101-2020_03_27_012757	56	25	author	author	NN
10_1101-2020_03_27_012757	56	26	/	/	SYM
10_1101-2020_03_27_012757	56	27	funder	funder	NN
10_1101-2020_03_27_012757	56	28	,	,	,
10_1101-2020_03_27_012757	56	29	who	who	WP
10_1101-2020_03_27_012757	56	30	has	have	VBZ
10_1101-2020_03_27_012757	56	31	granted	grant	VBN
10_1101-2020_03_27_012757	56	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	56	33	a	a	DT
10_1101-2020_03_27_012757	56	34	license	license	NN
10_1101-2020_03_27_012757	56	35	to	to	TO
10_1101-2020_03_27_012757	56	36	display	display	VB
10_1101-2020_03_27_012757	56	37	the	the	DT
10_1101-2020_03_27_012757	56	38	preprint	preprint	NN
10_1101-2020_03_27_012757	56	39	in	in	IN
10_1101-2020_03_27_012757	56	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	56	41	.	.	.
10_1101-2020_03_27_012757	57	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	57	2	is	be	VBZ
10_1101-2020_03_27_012757	57	3	made	make	VBN
10_1101-2020_03_27_012757	57	4	The	the	DT
10_1101-2020_03_27_012757	57	5	copyright	copyright	NN
10_1101-2020_03_27_012757	57	6	holder	holder	NN
10_1101-2020_03_27_012757	57	7	for	for	IN
10_1101-2020_03_27_012757	57	8	this	this	DT
10_1101-2020_03_27_012757	57	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	57	10	version	version	NN
10_1101-2020_03_27_012757	57	11	posted	post	VBD
10_1101-2020_03_27_012757	57	12	January	January	NNP
10_1101-2020_03_27_012757	57	13	9	9	CD
10_1101-2020_03_27_012757	57	14	,	,	,
10_1101-2020_03_27_012757	57	15	2021	2021	CD
10_1101-2020_03_27_012757	57	16	.	.	.
10_1101-2020_03_27_012757	57	17	;	;	:
10_1101-2020_03_27_012757	57	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	57	19	:	:	:
10_1101-2020_03_27_012757	57	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	57	21	preprint	preprint	NN
10_1101-2020_03_27_012757	57	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	57	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	57	24	6	6	CD
10_1101-2020_03_27_012757	57	25	To	to	TO
10_1101-2020_03_27_012757	57	26	evaluate	evaluate	VB
10_1101-2020_03_27_012757	57	27	cancer	cancer	NN
10_1101-2020_03_27_012757	57	28	models	model	NNS
10_1101-2020_03_27_012757	57	29	at	at	IN
10_1101-2020_03_27_012757	57	30	a	a	DT
10_1101-2020_03_27_012757	57	31	finer	fine	JJR
10_1101-2020_03_27_012757	57	32	resolution	resolution	NN
10_1101-2020_03_27_012757	57	33	,	,	,
10_1101-2020_03_27_012757	57	34	we	-PRON-	PRP
10_1101-2020_03_27_012757	57	35	also	also	RB
10_1101-2020_03_27_012757	57	36	developed	develop	VBD
10_1101-2020_03_27_012757	57	37	an	an	DT
10_1101-2020_03_27_012757	57	38	approach	approach	NN
10_1101-2020_03_27_012757	57	39	to	to	IN
10_1101-2020_03_27_012757	57	40	163	163	CD
10_1101-2020_03_27_012757	57	41	perform	perform	VB
10_1101-2020_03_27_012757	57	42	tumor	tumor	NN
10_1101-2020_03_27_012757	57	43	subtype	subtype	NN
10_1101-2020_03_27_012757	57	44	classifications	classification	NNS
10_1101-2020_03_27_012757	57	45	(	(	-LRB-
10_1101-2020_03_27_012757	57	46	Supp	Supp	NNP
10_1101-2020_03_27_012757	57	47	Fig	Fig	NNP
10_1101-2020_03_27_012757	57	48	1D	1d	NN
10_1101-2020_03_27_012757	57	49	)	)	-RRB-
10_1101-2020_03_27_012757	57	50	.	.	.
10_1101-2020_03_27_012757	58	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	58	2	constructed	construct	VBD
10_1101-2020_03_27_012757	58	3	11	11	CD
10_1101-2020_03_27_012757	58	4	different	different	JJ
10_1101-2020_03_27_012757	58	5	cancer	cancer	NN
10_1101-2020_03_27_012757	58	6	164	164	CD
10_1101-2020_03_27_012757	58	7	subtype	subtype	NN
10_1101-2020_03_27_012757	58	8	classifiers	classifier	NNS
10_1101-2020_03_27_012757	58	9	based	base	VBN
10_1101-2020_03_27_012757	58	10	on	on	IN
10_1101-2020_03_27_012757	58	11	the	the	DT
10_1101-2020_03_27_012757	58	12	availability	availability	NN
10_1101-2020_03_27_012757	58	13	of	of	IN
10_1101-2020_03_27_012757	58	14	expression	expression	NN
10_1101-2020_03_27_012757	58	15	or	or	CC
10_1101-2020_03_27_012757	58	16	histological	histological	JJ
10_1101-2020_03_27_012757	58	17	subtype	subtype	NN
10_1101-2020_03_27_012757	58	18	165	165	CD
10_1101-2020_03_27_012757	58	19	information24,26–36	information24,26–36	NNP
10_1101-2020_03_27_012757	58	20	.	.	.
10_1101-2020_03_27_012757	59	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	59	2	also	also	RB
10_1101-2020_03_27_012757	59	3	included	include	VBD
10_1101-2020_03_27_012757	59	4	non	non	JJ
10_1101-2020_03_27_012757	59	5	-	-	JJ
10_1101-2020_03_27_012757	59	6	cancerous	cancerous	JJ
10_1101-2020_03_27_012757	59	7	,	,	,
10_1101-2020_03_27_012757	59	8	normal	normal	JJ
10_1101-2020_03_27_012757	59	9	tissues	tissue	NNS
10_1101-2020_03_27_012757	59	10	as	as	IN
10_1101-2020_03_27_012757	59	11	categories	category	NNS
10_1101-2020_03_27_012757	59	12	for	for	IN
10_1101-2020_03_27_012757	59	13	several	several	JJ
10_1101-2020_03_27_012757	59	14	166	166	CD
10_1101-2020_03_27_012757	59	15	subtype	subtype	NN
10_1101-2020_03_27_012757	59	16	classifiers	classifier	NNS
10_1101-2020_03_27_012757	59	17	when	when	WRB
10_1101-2020_03_27_012757	59	18	sufficient	sufficient	JJ
10_1101-2020_03_27_012757	59	19	data	datum	NNS
10_1101-2020_03_27_012757	59	20	was	be	VBD
10_1101-2020_03_27_012757	59	21	available	available	JJ
10_1101-2020_03_27_012757	59	22	:	:	:
10_1101-2020_03_27_012757	59	23	breast	breast	NN
10_1101-2020_03_27_012757	59	24	invasive	invasive	JJ
10_1101-2020_03_27_012757	59	25	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	59	26	(	(	-LRB-
10_1101-2020_03_27_012757	59	27	BRCA	BRCA	NNP
10_1101-2020_03_27_012757	59	28	)	)	-RRB-
10_1101-2020_03_27_012757	59	29	,	,	,
10_1101-2020_03_27_012757	59	30	167	167	CD
10_1101-2020_03_27_012757	59	31	COAD_READ	COAD_READ	NNS
10_1101-2020_03_27_012757	59	32	,	,	,
10_1101-2020_03_27_012757	59	33	head	head	NN
10_1101-2020_03_27_012757	59	34	and	and	CC
10_1101-2020_03_27_012757	59	35	neck	neck	NN
10_1101-2020_03_27_012757	59	36	squamous	squamous	JJ
10_1101-2020_03_27_012757	59	37	cell	cell	NN
10_1101-2020_03_27_012757	59	38	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	59	39	(	(	-LRB-
10_1101-2020_03_27_012757	59	40	HNSC	HNSC	NNP
10_1101-2020_03_27_012757	59	41	)	)	-RRB-
10_1101-2020_03_27_012757	59	42	,	,	,
10_1101-2020_03_27_012757	59	43	kidney	kidney	NN
10_1101-2020_03_27_012757	59	44	renal	renal	JJ
10_1101-2020_03_27_012757	59	45	clear	clear	JJ
10_1101-2020_03_27_012757	59	46	cell	cell	NN
10_1101-2020_03_27_012757	59	47	168	168	CD
10_1101-2020_03_27_012757	59	48	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	59	49	(	(	-LRB-
10_1101-2020_03_27_012757	59	50	KIRC	KIRC	NNP
10_1101-2020_03_27_012757	59	51	)	)	-RRB-
10_1101-2020_03_27_012757	59	52	and	and	CC
10_1101-2020_03_27_012757	59	53	uterine	uterine	NNP
10_1101-2020_03_27_012757	59	54	corpus	corpus	NNP
10_1101-2020_03_27_012757	59	55	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	59	56	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	59	57	(	(	-LRB-
10_1101-2020_03_27_012757	59	58	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	59	59	)	)	-RRB-
10_1101-2020_03_27_012757	59	60	.	.	.
10_1101-2020_03_27_012757	60	1	The	the	DT
10_1101-2020_03_27_012757	60	2	11	11	CD
10_1101-2020_03_27_012757	60	3	subtype	subtype	NN
10_1101-2020_03_27_012757	60	4	169	169	CD
10_1101-2020_03_27_012757	60	5	classifiers	classifier	NNS
10_1101-2020_03_27_012757	60	6	all	all	DT
10_1101-2020_03_27_012757	60	7	achieved	achieve	VBN
10_1101-2020_03_27_012757	60	8	high	high	JJ
10_1101-2020_03_27_012757	60	9	overall	overall	JJ
10_1101-2020_03_27_012757	60	10	average	average	JJ
10_1101-2020_03_27_012757	60	11	AUPRs	aupr	NNS
10_1101-2020_03_27_012757	60	12	ranging	range	VBG
10_1101-2020_03_27_012757	60	13	from	from	IN
10_1101-2020_03_27_012757	60	14	0.80	0.80	CD
10_1101-2020_03_27_012757	60	15	to	to	IN
10_1101-2020_03_27_012757	60	16	0.99	0.99	CD
10_1101-2020_03_27_012757	60	17	(	(	-LRB-
10_1101-2020_03_27_012757	60	18	Supp	Supp	NNP
10_1101-2020_03_27_012757	60	19	Fig	Fig	NNP
10_1101-2020_03_27_012757	60	20	1E	1e	NN
10_1101-2020_03_27_012757	60	21	)	)	-RRB-
10_1101-2020_03_27_012757	60	22	.	.	.
10_1101-2020_03_27_012757	61	1	170	170	CD
10_1101-2020_03_27_012757	61	2	171	171	CD
10_1101-2020_03_27_012757	61	3	Fidelity	Fidelity	NNP
10_1101-2020_03_27_012757	61	4	of	of	IN
10_1101-2020_03_27_012757	61	5	cancer	cancer	NN
10_1101-2020_03_27_012757	61	6	cell	cell	NN
10_1101-2020_03_27_012757	61	7	lines	line	NNS
10_1101-2020_03_27_012757	61	8	172	172	CD
10_1101-2020_03_27_012757	61	9	Having	have	VBG
10_1101-2020_03_27_012757	61	10	validated	validate	VBD
10_1101-2020_03_27_012757	61	11	the	the	DT
10_1101-2020_03_27_012757	61	12	performance	performance	NN
10_1101-2020_03_27_012757	61	13	of	of	IN
10_1101-2020_03_27_012757	61	14	CCN	CCN	NNP
10_1101-2020_03_27_012757	61	15	,	,	,
10_1101-2020_03_27_012757	61	16	we	-PRON-	PRP
10_1101-2020_03_27_012757	61	17	then	then	RB
10_1101-2020_03_27_012757	61	18	used	use	VBD
10_1101-2020_03_27_012757	61	19	it	-PRON-	PRP
10_1101-2020_03_27_012757	61	20	to	to	TO
10_1101-2020_03_27_012757	61	21	determine	determine	VB
10_1101-2020_03_27_012757	61	22	the	the	DT
10_1101-2020_03_27_012757	61	23	fidelity	fidelity	NN
10_1101-2020_03_27_012757	61	24	of	of	IN
10_1101-2020_03_27_012757	61	25	173	173	CD
10_1101-2020_03_27_012757	61	26	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	61	27	.	.	.
10_1101-2020_03_27_012757	62	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	62	2	mined	mine	VBD
10_1101-2020_03_27_012757	62	3	RNA	RNA	NNP
10_1101-2020_03_27_012757	62	4	-	-	HYPH
10_1101-2020_03_27_012757	62	5	seq	seq	NN
10_1101-2020_03_27_012757	62	6	expression	expression	NN
10_1101-2020_03_27_012757	62	7	data	datum	NNS
10_1101-2020_03_27_012757	62	8	of	of	IN
10_1101-2020_03_27_012757	62	9	657	657	CD
10_1101-2020_03_27_012757	62	10	different	different	JJ
10_1101-2020_03_27_012757	62	11	cell	cell	NN
10_1101-2020_03_27_012757	62	12	lines	line	NNS
10_1101-2020_03_27_012757	62	13	across	across	IN
10_1101-2020_03_27_012757	62	14	20	20	CD
10_1101-2020_03_27_012757	62	15	cancer	cancer	NN
10_1101-2020_03_27_012757	62	16	types	type	NNS
10_1101-2020_03_27_012757	62	17	174	174	CD
10_1101-2020_03_27_012757	62	18	from	from	IN
10_1101-2020_03_27_012757	62	19	the	the	DT
10_1101-2020_03_27_012757	62	20	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	62	21	Cell	Cell	NNP
10_1101-2020_03_27_012757	62	22	Line	Line	NNP
10_1101-2020_03_27_012757	62	23	Encyclopedia	Encyclopedia	NNP
10_1101-2020_03_27_012757	62	24	(	(	-LRB-
10_1101-2020_03_27_012757	62	25	CCLE	CCLE	NNP
10_1101-2020_03_27_012757	62	26	)	)	-RRB-
10_1101-2020_03_27_012757	62	27	and	and	CC
10_1101-2020_03_27_012757	62	28	applied	apply	VBD
10_1101-2020_03_27_012757	62	29	CCN	CCN	NNP
10_1101-2020_03_27_012757	62	30	to	to	IN
10_1101-2020_03_27_012757	62	31	them	-PRON-	PRP
10_1101-2020_03_27_012757	62	32	,	,	,
10_1101-2020_03_27_012757	62	33	finding	find	VBG
10_1101-2020_03_27_012757	62	34	a	a	DT
10_1101-2020_03_27_012757	62	35	wide	wide	JJ
10_1101-2020_03_27_012757	62	36	175	175	CD
10_1101-2020_03_27_012757	62	37	classification	classification	NN
10_1101-2020_03_27_012757	62	38	range	range	NN
10_1101-2020_03_27_012757	62	39	for	for	IN
10_1101-2020_03_27_012757	62	40	cell	cell	NN
10_1101-2020_03_27_012757	62	41	lines	line	NNS
10_1101-2020_03_27_012757	62	42	of	of	IN
10_1101-2020_03_27_012757	62	43	each	each	DT
10_1101-2020_03_27_012757	62	44	tumor	tumor	NN
10_1101-2020_03_27_012757	62	45	type	type	NN
10_1101-2020_03_27_012757	62	46	(	(	-LRB-
10_1101-2020_03_27_012757	62	47	Fig	fig	NN
10_1101-2020_03_27_012757	62	48	2A	2a	NN
10_1101-2020_03_27_012757	62	49	,	,	,
10_1101-2020_03_27_012757	62	50	Supp	Supp	NNP
10_1101-2020_03_27_012757	62	51	Tab	Tab	NNP
10_1101-2020_03_27_012757	62	52	1	1	CD
10_1101-2020_03_27_012757	62	53	)	)	-RRB-
10_1101-2020_03_27_012757	62	54	.	.	.
10_1101-2020_03_27_012757	63	1	To	to	TO
10_1101-2020_03_27_012757	63	2	verify	verify	VB
10_1101-2020_03_27_012757	63	3	the	the	DT
10_1101-2020_03_27_012757	63	4	176	176	CD
10_1101-2020_03_27_012757	63	5	classification	classification	NN
10_1101-2020_03_27_012757	63	6	results	result	NNS
10_1101-2020_03_27_012757	63	7	,	,	,
10_1101-2020_03_27_012757	63	8	we	-PRON-	PRP
10_1101-2020_03_27_012757	63	9	applied	apply	VBD
10_1101-2020_03_27_012757	63	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	63	11	to	to	IN
10_1101-2020_03_27_012757	63	12	expression	expression	NN
10_1101-2020_03_27_012757	63	13	profiles	profile	NNS
10_1101-2020_03_27_012757	63	14	from	from	IN
10_1101-2020_03_27_012757	63	15	CCLE	CCLE	NNP
10_1101-2020_03_27_012757	63	16	generated	generate	VBN
10_1101-2020_03_27_012757	63	17	through	through	IN
10_1101-2020_03_27_012757	63	18	177	177	CD
10_1101-2020_03_27_012757	63	19	microarray	microarray	JJ
10_1101-2020_03_27_012757	63	20	expression	expression	NN
10_1101-2020_03_27_012757	63	21	profiling37	profiling37	NN
10_1101-2020_03_27_012757	63	22	.	.	.
10_1101-2020_03_27_012757	64	1	To	to	TO
10_1101-2020_03_27_012757	64	2	ensure	ensure	VB
10_1101-2020_03_27_012757	64	3	that	that	IN
10_1101-2020_03_27_012757	64	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	64	5	would	would	MD
10_1101-2020_03_27_012757	64	6	function	function	VB
10_1101-2020_03_27_012757	64	7	on	on	IN
10_1101-2020_03_27_012757	64	8	microarray	microarray	JJ
10_1101-2020_03_27_012757	64	9	data	datum	NNS
10_1101-2020_03_27_012757	64	10	,	,	,
10_1101-2020_03_27_012757	64	11	we	-PRON-	PRP
10_1101-2020_03_27_012757	64	12	178	178	CD
10_1101-2020_03_27_012757	64	13	first	first	RB
10_1101-2020_03_27_012757	64	14	tested	test	VBD
10_1101-2020_03_27_012757	64	15	it	-PRON-	PRP
10_1101-2020_03_27_012757	64	16	by	by	IN
10_1101-2020_03_27_012757	64	17	applying	apply	VBG
10_1101-2020_03_27_012757	64	18	a	a	DT
10_1101-2020_03_27_012757	64	19	CCN	CCN	NNP
10_1101-2020_03_27_012757	64	20	classifier	classifier	NN
10_1101-2020_03_27_012757	64	21	created	create	VBN
10_1101-2020_03_27_012757	64	22	to	to	TO
10_1101-2020_03_27_012757	64	23	test	test	VB
10_1101-2020_03_27_012757	64	24	microarray	microarray	JJ
10_1101-2020_03_27_012757	64	25	data	datum	NNS
10_1101-2020_03_27_012757	64	26	to	to	IN
10_1101-2020_03_27_012757	64	27	720	720	CD
10_1101-2020_03_27_012757	64	28	expression	expression	NN
10_1101-2020_03_27_012757	64	29	179	179	CD
10_1101-2020_03_27_012757	64	30	profiles	profile	NNS
10_1101-2020_03_27_012757	64	31	of	of	IN
10_1101-2020_03_27_012757	64	32	12	12	CD
10_1101-2020_03_27_012757	64	33	tumor	tumor	NN
10_1101-2020_03_27_012757	64	34	types	type	NNS
10_1101-2020_03_27_012757	64	35	.	.	.
10_1101-2020_03_27_012757	65	1	The	the	DT
10_1101-2020_03_27_012757	65	2	cross	cross	JJ
10_1101-2020_03_27_012757	65	3	-	-	JJ
10_1101-2020_03_27_012757	65	4	platform	platform	JJ
10_1101-2020_03_27_012757	65	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	65	6	classifier	classifier	NN
10_1101-2020_03_27_012757	65	7	performed	perform	VBD
10_1101-2020_03_27_012757	65	8	well	well	RB
10_1101-2020_03_27_012757	65	9	,	,	,
10_1101-2020_03_27_012757	65	10	based	base	VBN
10_1101-2020_03_27_012757	65	11	on	on	IN
10_1101-2020_03_27_012757	65	12	the	the	DT
10_1101-2020_03_27_012757	65	13	180	180	CD
10_1101-2020_03_27_012757	65	14	comparison	comparison	NN
10_1101-2020_03_27_012757	65	15	to	to	TO
10_1101-2020_03_27_012757	65	16	study	study	VB
10_1101-2020_03_27_012757	65	17	-	-	HYPH
10_1101-2020_03_27_012757	65	18	provided	provide	VBN
10_1101-2020_03_27_012757	65	19	annotation	annotation	NN
10_1101-2020_03_27_012757	65	20	,	,	,
10_1101-2020_03_27_012757	65	21	achieving	achieve	VBG
10_1101-2020_03_27_012757	65	22	a	a	DT
10_1101-2020_03_27_012757	65	23	mean	mean	JJ
10_1101-2020_03_27_012757	65	24	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	65	25	of	of	IN
10_1101-2020_03_27_012757	65	26	0.91	0.91	CD
10_1101-2020_03_27_012757	65	27	(	(	-LRB-
10_1101-2020_03_27_012757	65	28	Supp	Supp	NNP
10_1101-2020_03_27_012757	65	29	Fig	Fig	NNP
10_1101-2020_03_27_012757	65	30	2A	2a	NN
10_1101-2020_03_27_012757	65	31	)	)	-RRB-
10_1101-2020_03_27_012757	65	32	.	.	.
10_1101-2020_03_27_012757	66	1	181	181	CD
10_1101-2020_03_27_012757	66	2	Next	next	JJ
10_1101-2020_03_27_012757	66	3	,	,	,
10_1101-2020_03_27_012757	66	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	66	5	applied	apply	VBD
10_1101-2020_03_27_012757	66	6	this	this	DT
10_1101-2020_03_27_012757	66	7	cross	cross	JJ
10_1101-2020_03_27_012757	66	8	-	-	JJ
10_1101-2020_03_27_012757	66	9	platform	platform	JJ
10_1101-2020_03_27_012757	66	10	classifier	classifier	NN
10_1101-2020_03_27_012757	66	11	to	to	IN
10_1101-2020_03_27_012757	66	12	microarray	microarray	JJ
10_1101-2020_03_27_012757	66	13	expression	expression	NN
10_1101-2020_03_27_012757	66	14	profiles	profile	NNS
10_1101-2020_03_27_012757	66	15	from	from	IN
10_1101-2020_03_27_012757	66	16	CCLE	ccle	JJ
10_1101-2020_03_27_012757	66	17	182	182	CD
10_1101-2020_03_27_012757	66	18	(	(	-LRB-
10_1101-2020_03_27_012757	66	19	Supp	Supp	NNP
10_1101-2020_03_27_012757	66	20	Fig	Fig	NNP
10_1101-2020_03_27_012757	66	21	2B	2B	NNS
10_1101-2020_03_27_012757	66	22	)	)	-RRB-
10_1101-2020_03_27_012757	66	23	.	.	.
10_1101-2020_03_27_012757	67	1	From	from	IN
10_1101-2020_03_27_012757	67	2	the	the	DT
10_1101-2020_03_27_012757	67	3	classification	classification	NN
10_1101-2020_03_27_012757	67	4	results	result	NNS
10_1101-2020_03_27_012757	67	5	of	of	IN
10_1101-2020_03_27_012757	67	6	571	571	CD
10_1101-2020_03_27_012757	67	7	cell	cell	NN
10_1101-2020_03_27_012757	67	8	lines	line	NNS
10_1101-2020_03_27_012757	67	9	that	that	WDT
10_1101-2020_03_27_012757	67	10	have	have	VBP
10_1101-2020_03_27_012757	67	11	both	both	DT
10_1101-2020_03_27_012757	67	12	RNA	RNA	NNP
10_1101-2020_03_27_012757	67	13	-	-	HYPH
10_1101-2020_03_27_012757	67	14	seq	seq	NN
10_1101-2020_03_27_012757	67	15	and	and	CC
10_1101-2020_03_27_012757	67	16	183	183	CD
10_1101-2020_03_27_012757	67	17	microarray	microarray	JJ
10_1101-2020_03_27_012757	67	18	expression	expression	NN
10_1101-2020_03_27_012757	67	19	profiles	profile	NNS
10_1101-2020_03_27_012757	67	20	,	,	,
10_1101-2020_03_27_012757	67	21	we	-PRON-	PRP
10_1101-2020_03_27_012757	67	22	found	find	VBD
10_1101-2020_03_27_012757	67	23	a	a	DT
10_1101-2020_03_27_012757	67	24	strong	strong	JJ
10_1101-2020_03_27_012757	67	25	overall	overall	JJ
10_1101-2020_03_27_012757	67	26	positive	positive	JJ
10_1101-2020_03_27_012757	67	27	association	association	NN
10_1101-2020_03_27_012757	67	28	between	between	IN
10_1101-2020_03_27_012757	67	29	the	the	DT
10_1101-2020_03_27_012757	67	30	184	184	CD
10_1101-2020_03_27_012757	67	31	classification	classification	NN
10_1101-2020_03_27_012757	67	32	scores	score	NNS
10_1101-2020_03_27_012757	67	33	from	from	IN
10_1101-2020_03_27_012757	67	34	RNA	RNA	NNP
10_1101-2020_03_27_012757	67	35	-	-	HYPH
10_1101-2020_03_27_012757	67	36	seq	seq	NN
10_1101-2020_03_27_012757	67	37	and	and	CC
10_1101-2020_03_27_012757	67	38	those	those	DT
10_1101-2020_03_27_012757	67	39	from	from	IN
10_1101-2020_03_27_012757	67	40	microarray	microarray	JJ
10_1101-2020_03_27_012757	67	41	(	(	-LRB-
10_1101-2020_03_27_012757	67	42	Supp	Supp	NNP
10_1101-2020_03_27_012757	67	43	Fig	Fig	NNP
10_1101-2020_03_27_012757	67	44	2C	2c	NN
10_1101-2020_03_27_012757	67	45	)	)	-RRB-
10_1101-2020_03_27_012757	67	46	.	.	.
10_1101-2020_03_27_012757	68	1	This	this	DT
10_1101-2020_03_27_012757	68	2	comparison	comparison	NN
10_1101-2020_03_27_012757	68	3	185	185	CD
10_1101-2020_03_27_012757	68	4	supports	support	VBZ
10_1101-2020_03_27_012757	68	5	the	the	DT
10_1101-2020_03_27_012757	68	6	notion	notion	NN
10_1101-2020_03_27_012757	68	7	that	that	IN
10_1101-2020_03_27_012757	68	8	the	the	DT
10_1101-2020_03_27_012757	68	9	classification	classification	NN
10_1101-2020_03_27_012757	68	10	scores	score	NNS
10_1101-2020_03_27_012757	68	11	for	for	IN
10_1101-2020_03_27_012757	68	12	each	each	DT
10_1101-2020_03_27_012757	68	13	cell	cell	NN
10_1101-2020_03_27_012757	68	14	line	line	NN
10_1101-2020_03_27_012757	68	15	are	be	VBP
10_1101-2020_03_27_012757	68	16	not	not	RB
10_1101-2020_03_27_012757	68	17	artifacts	artifact	NNS
10_1101-2020_03_27_012757	68	18	of	of	IN
10_1101-2020_03_27_012757	68	19	profiling	profile	VBG
10_1101-2020_03_27_012757	68	20	186	186	CD
10_1101-2020_03_27_012757	68	21	methodology	methodology	NN
10_1101-2020_03_27_012757	68	22	.	.	.
10_1101-2020_03_27_012757	69	1	Moreover	moreover	RB
10_1101-2020_03_27_012757	69	2	,	,	,
10_1101-2020_03_27_012757	69	3	this	this	DT
10_1101-2020_03_27_012757	69	4	comparison	comparison	NN
10_1101-2020_03_27_012757	69	5	shows	show	VBZ
10_1101-2020_03_27_012757	69	6	that	that	IN
10_1101-2020_03_27_012757	69	7	the	the	DT
10_1101-2020_03_27_012757	69	8	scores	score	NNS
10_1101-2020_03_27_012757	69	9	are	be	VBP
10_1101-2020_03_27_012757	69	10	consistent	consistent	JJ
10_1101-2020_03_27_012757	69	11	between	between	IN
10_1101-2020_03_27_012757	69	12	the	the	DT
10_1101-2020_03_27_012757	69	13	187	187	CD
10_1101-2020_03_27_012757	69	14	times	time	NNS
10_1101-2020_03_27_012757	69	15	that	that	IN
10_1101-2020_03_27_012757	69	16	the	the	DT
10_1101-2020_03_27_012757	69	17	cell	cell	NN
10_1101-2020_03_27_012757	69	18	lines	line	NNS
10_1101-2020_03_27_012757	69	19	were	be	VBD
10_1101-2020_03_27_012757	69	20	first	first	RB
10_1101-2020_03_27_012757	69	21	assayed	assay	VBN
10_1101-2020_03_27_012757	69	22	by	by	IN
10_1101-2020_03_27_012757	69	23	microarray	microarray	JJ
10_1101-2020_03_27_012757	69	24	expression	expression	NN
10_1101-2020_03_27_012757	69	25	profiling	profiling	NN
10_1101-2020_03_27_012757	69	26	in	in	IN
10_1101-2020_03_27_012757	69	27	2012	2012	CD
10_1101-2020_03_27_012757	69	28	and	and	CC
10_1101-2020_03_27_012757	69	29	by	by	IN
10_1101-2020_03_27_012757	69	30	188	188	CD
10_1101-2020_03_27_012757	69	31	.CC	.CC	,
10_1101-2020_03_27_012757	69	32	-	-	HYPH
10_1101-2020_03_27_012757	69	33	BY	by	IN
10_1101-2020_03_27_012757	69	34	-	-	HYPH
10_1101-2020_03_27_012757	69	35	NC	NC	NNP
10_1101-2020_03_27_012757	69	36	-	-	HYPH
10_1101-2020_03_27_012757	69	37	ND	ND	NNP
10_1101-2020_03_27_012757	69	38	4.0	4.0	CD
10_1101-2020_03_27_012757	69	39	International	International	NNP
10_1101-2020_03_27_012757	69	40	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	69	41	under	under	IN
10_1101-2020_03_27_012757	69	42	a	a	DT
10_1101-2020_03_27_012757	69	43	(	(	-LRB-
10_1101-2020_03_27_012757	69	44	which	which	WDT
10_1101-2020_03_27_012757	69	45	was	be	VBD
10_1101-2020_03_27_012757	69	46	not	not	RB
10_1101-2020_03_27_012757	69	47	certified	certify	VBN
10_1101-2020_03_27_012757	69	48	by	by	IN
10_1101-2020_03_27_012757	69	49	peer	peer	NN
10_1101-2020_03_27_012757	69	50	review	review	NN
10_1101-2020_03_27_012757	69	51	)	)	-RRB-
10_1101-2020_03_27_012757	69	52	is	be	VBZ
10_1101-2020_03_27_012757	69	53	the	the	DT
10_1101-2020_03_27_012757	69	54	author	author	NN
10_1101-2020_03_27_012757	69	55	/	/	SYM
10_1101-2020_03_27_012757	69	56	funder	funder	NN
10_1101-2020_03_27_012757	69	57	,	,	,
10_1101-2020_03_27_012757	69	58	who	who	WP
10_1101-2020_03_27_012757	69	59	has	have	VBZ
10_1101-2020_03_27_012757	69	60	granted	grant	VBN
10_1101-2020_03_27_012757	69	61	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	69	62	a	a	DT
10_1101-2020_03_27_012757	69	63	license	license	NN
10_1101-2020_03_27_012757	69	64	to	to	TO
10_1101-2020_03_27_012757	69	65	display	display	VB
10_1101-2020_03_27_012757	69	66	the	the	DT
10_1101-2020_03_27_012757	69	67	preprint	preprint	NN
10_1101-2020_03_27_012757	69	68	in	in	IN
10_1101-2020_03_27_012757	69	69	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	69	70	.	.	.
10_1101-2020_03_27_012757	70	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	70	2	is	be	VBZ
10_1101-2020_03_27_012757	70	3	made	make	VBN
10_1101-2020_03_27_012757	70	4	The	the	DT
10_1101-2020_03_27_012757	70	5	copyright	copyright	NN
10_1101-2020_03_27_012757	70	6	holder	holder	NN
10_1101-2020_03_27_012757	70	7	for	for	IN
10_1101-2020_03_27_012757	70	8	this	this	DT
10_1101-2020_03_27_012757	70	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	70	10	version	version	NN
10_1101-2020_03_27_012757	70	11	posted	post	VBD
10_1101-2020_03_27_012757	70	12	January	January	NNP
10_1101-2020_03_27_012757	70	13	9	9	CD
10_1101-2020_03_27_012757	70	14	,	,	,
10_1101-2020_03_27_012757	70	15	2021	2021	CD
10_1101-2020_03_27_012757	70	16	.	.	.
10_1101-2020_03_27_012757	70	17	;	;	:
10_1101-2020_03_27_012757	70	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	70	19	:	:	:
10_1101-2020_03_27_012757	70	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	70	21	preprint	preprint	NN
10_1101-2020_03_27_012757	70	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	70	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	70	24	7	7	CD
10_1101-2020_03_27_012757	70	25	RNA	RNA	NNP
10_1101-2020_03_27_012757	70	26	-	-	HYPH
10_1101-2020_03_27_012757	70	27	Seq	Seq	NNP
10_1101-2020_03_27_012757	70	28	in	in	IN
10_1101-2020_03_27_012757	70	29	2019	2019	CD
10_1101-2020_03_27_012757	70	30	.	.	.
10_1101-2020_03_27_012757	71	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	71	2	also	also	RB
10_1101-2020_03_27_012757	71	3	observed	observe	VBD
10_1101-2020_03_27_012757	71	4	high	high	JJ
10_1101-2020_03_27_012757	71	5	level	level	NN
10_1101-2020_03_27_012757	71	6	of	of	IN
10_1101-2020_03_27_012757	71	7	correlation	correlation	NN
10_1101-2020_03_27_012757	71	8	between	between	IN
10_1101-2020_03_27_012757	71	9	our	-PRON-	PRP$
10_1101-2020_03_27_012757	71	10	analysis	analysis	NN
10_1101-2020_03_27_012757	71	11	and	and	CC
10_1101-2020_03_27_012757	71	12	the	the	DT
10_1101-2020_03_27_012757	71	13	189	189	CD
10_1101-2020_03_27_012757	71	14	analysis	analysis	NN
10_1101-2020_03_27_012757	71	15	done	do	VBN
10_1101-2020_03_27_012757	71	16	by	by	IN
10_1101-2020_03_27_012757	71	17	Yu	Yu	NNP
10_1101-2020_03_27_012757	71	18	et	et	NNP
10_1101-2020_03_27_012757	71	19	al15(Supp	al15(Supp	NNP
10_1101-2020_03_27_012757	71	20	Fig	Fig	NNP
10_1101-2020_03_27_012757	71	21	2D	2d	NN
10_1101-2020_03_27_012757	71	22	)	)	-RRB-
10_1101-2020_03_27_012757	71	23	,	,	,
10_1101-2020_03_27_012757	71	24	further	further	RB
10_1101-2020_03_27_012757	71	25	validating	validate	VBG
10_1101-2020_03_27_012757	71	26	the	the	DT
10_1101-2020_03_27_012757	71	27	robustness	robustness	NN
10_1101-2020_03_27_012757	71	28	of	of	IN
10_1101-2020_03_27_012757	71	29	the	the	DT
10_1101-2020_03_27_012757	71	30	CCN	CCN	NNP
10_1101-2020_03_27_012757	71	31	results	result	NNS
10_1101-2020_03_27_012757	71	32	.	.	.
10_1101-2020_03_27_012757	72	1	190	190	CD
10_1101-2020_03_27_012757	72	2	Next	next	JJ
10_1101-2020_03_27_012757	72	3	,	,	,
10_1101-2020_03_27_012757	72	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	72	5	assessed	assess	VBD
10_1101-2020_03_27_012757	72	6	the	the	DT
10_1101-2020_03_27_012757	72	7	extent	extent	NN
10_1101-2020_03_27_012757	72	8	to	to	TO
10_1101-2020_03_27_012757	72	9	which	which	WDT
10_1101-2020_03_27_012757	72	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	72	11	classifications	classification	NNS
10_1101-2020_03_27_012757	72	12	agreed	agree	VBD
10_1101-2020_03_27_012757	72	13	with	with	IN
10_1101-2020_03_27_012757	72	14	their	-PRON-	PRP$
10_1101-2020_03_27_012757	72	15	nominal	nominal	JJ
10_1101-2020_03_27_012757	72	16	191	191	CD
10_1101-2020_03_27_012757	72	17	tumor	tumor	NN
10_1101-2020_03_27_012757	72	18	type	type	NN
10_1101-2020_03_27_012757	72	19	of	of	IN
10_1101-2020_03_27_012757	72	20	origin	origin	NN
10_1101-2020_03_27_012757	72	21	,	,	,
10_1101-2020_03_27_012757	72	22	which	which	WDT
10_1101-2020_03_27_012757	72	23	entailed	entail	VBD
10_1101-2020_03_27_012757	72	24	translating	translate	VBG
10_1101-2020_03_27_012757	72	25	quantitative	quantitative	JJ
10_1101-2020_03_27_012757	72	26	CCN	CCN	NNP
10_1101-2020_03_27_012757	72	27	scores	score	NNS
10_1101-2020_03_27_012757	72	28	to	to	TO
10_1101-2020_03_27_012757	72	29	classification	classification	NN
10_1101-2020_03_27_012757	72	30	labels	label	NNS
10_1101-2020_03_27_012757	72	31	.	.	.
10_1101-2020_03_27_012757	73	1	192	192	CD
10_1101-2020_03_27_012757	73	2	To	to	TO
10_1101-2020_03_27_012757	73	3	achieve	achieve	VB
10_1101-2020_03_27_012757	73	4	this	this	DT
10_1101-2020_03_27_012757	73	5	,	,	,
10_1101-2020_03_27_012757	73	6	we	-PRON-	PRP
10_1101-2020_03_27_012757	73	7	selected	select	VBD
10_1101-2020_03_27_012757	73	8	a	a	DT
10_1101-2020_03_27_012757	73	9	decision	decision	NN
10_1101-2020_03_27_012757	73	10	threshold	threshold	NN
10_1101-2020_03_27_012757	73	11	that	that	WDT
10_1101-2020_03_27_012757	73	12	maximized	maximize	VBD
10_1101-2020_03_27_012757	73	13	the	the	DT
10_1101-2020_03_27_012757	73	14	Macro	Macro	NNP
10_1101-2020_03_27_012757	73	15	F1	F1	NNP
10_1101-2020_03_27_012757	73	16	measure	measure	NN
10_1101-2020_03_27_012757	73	17	,	,	,
10_1101-2020_03_27_012757	73	18	193	193	CD
10_1101-2020_03_27_012757	73	19	harmonic	harmonic	JJ
10_1101-2020_03_27_012757	73	20	mean	mean	NN
10_1101-2020_03_27_012757	73	21	of	of	IN
10_1101-2020_03_27_012757	73	22	precision	precision	NN
10_1101-2020_03_27_012757	73	23	and	and	CC
10_1101-2020_03_27_012757	73	24	recall	recall	NN
10_1101-2020_03_27_012757	73	25	,	,	,
10_1101-2020_03_27_012757	73	26	across	across	IN
10_1101-2020_03_27_012757	73	27	50	50	CD
10_1101-2020_03_27_012757	73	28	cross	cross	NN
10_1101-2020_03_27_012757	73	29	validations	validation	NNS
10_1101-2020_03_27_012757	73	30	.	.	.
10_1101-2020_03_27_012757	74	1	Then	then	RB
10_1101-2020_03_27_012757	74	2	,	,	,
10_1101-2020_03_27_012757	74	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	74	4	annotated	annotate	VBD
10_1101-2020_03_27_012757	74	5	cell	cell	NN
10_1101-2020_03_27_012757	74	6	194	194	CD
10_1101-2020_03_27_012757	74	7	lines	line	NNS
10_1101-2020_03_27_012757	74	8	based	base	VBD
10_1101-2020_03_27_012757	74	9	their	-PRON-	PRP$
10_1101-2020_03_27_012757	74	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	74	11	score	score	VBP
10_1101-2020_03_27_012757	74	12	profile	profile	RB
10_1101-2020_03_27_012757	74	13	as	as	IN
10_1101-2020_03_27_012757	74	14	follows	follow	VBZ
10_1101-2020_03_27_012757	74	15	.	.	.
10_1101-2020_03_27_012757	75	1	Cell	cell	NN
10_1101-2020_03_27_012757	75	2	lines	line	NNS
10_1101-2020_03_27_012757	75	3	with	with	IN
10_1101-2020_03_27_012757	75	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	75	5	scores	score	NNS
10_1101-2020_03_27_012757	75	6	>	>	XX
10_1101-2020_03_27_012757	75	7	threshold	threshold	NN
10_1101-2020_03_27_012757	75	8	for	for	IN
10_1101-2020_03_27_012757	75	9	the	the	DT
10_1101-2020_03_27_012757	75	10	195	195	CD
10_1101-2020_03_27_012757	75	11	tumor	tumor	NN
10_1101-2020_03_27_012757	75	12	type	type	NN
10_1101-2020_03_27_012757	75	13	of	of	IN
10_1101-2020_03_27_012757	75	14	origin	origin	NN
10_1101-2020_03_27_012757	75	15	were	be	VBD
10_1101-2020_03_27_012757	75	16	annotated	annotate	VBN
10_1101-2020_03_27_012757	75	17	as	as	IN
10_1101-2020_03_27_012757	75	18	'	'	``
10_1101-2020_03_27_012757	75	19	correct	correct	JJ
10_1101-2020_03_27_012757	75	20	'	'	''
10_1101-2020_03_27_012757	75	21	.	.	.
10_1101-2020_03_27_012757	76	1	Cell	cell	NN
10_1101-2020_03_27_012757	76	2	lines	line	NNS
10_1101-2020_03_27_012757	76	3	with	with	IN
10_1101-2020_03_27_012757	76	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	76	5	scores	score	NNS
10_1101-2020_03_27_012757	76	6	>	>	XX
10_1101-2020_03_27_012757	76	7	threshold	threshold	NN
10_1101-2020_03_27_012757	76	8	in	in	IN
10_1101-2020_03_27_012757	76	9	the	the	DT
10_1101-2020_03_27_012757	76	10	196	196	CD
10_1101-2020_03_27_012757	76	11	tumor	tumor	NN
10_1101-2020_03_27_012757	76	12	type	type	NN
10_1101-2020_03_27_012757	76	13	of	of	IN
10_1101-2020_03_27_012757	76	14	origin	origin	NN
10_1101-2020_03_27_012757	76	15	and	and	CC
10_1101-2020_03_27_012757	76	16	at	at	RB
10_1101-2020_03_27_012757	76	17	least	least	RBS
10_1101-2020_03_27_012757	76	18	one	one	CD
10_1101-2020_03_27_012757	76	19	other	other	JJ
10_1101-2020_03_27_012757	76	20	tumor	tumor	NN
10_1101-2020_03_27_012757	76	21	type	type	NN
10_1101-2020_03_27_012757	76	22	were	be	VBD
10_1101-2020_03_27_012757	76	23	annotated	annotate	VBN
10_1101-2020_03_27_012757	76	24	as	as	IN
10_1101-2020_03_27_012757	76	25	'	'	``
10_1101-2020_03_27_012757	76	26	mixed	mixed	JJ
10_1101-2020_03_27_012757	76	27	'	'	''
10_1101-2020_03_27_012757	76	28	.	.	.
10_1101-2020_03_27_012757	77	1	Cell	cell	NN
10_1101-2020_03_27_012757	77	2	lines	line	NNS
10_1101-2020_03_27_012757	77	3	with	with	IN
10_1101-2020_03_27_012757	77	4	197	197	CD
10_1101-2020_03_27_012757	77	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	77	6	scores	score	NNS
10_1101-2020_03_27_012757	77	7	>	>	XX
10_1101-2020_03_27_012757	77	8	threshold	threshold	NN
10_1101-2020_03_27_012757	77	9	for	for	IN
10_1101-2020_03_27_012757	77	10	tumor	tumor	NN
10_1101-2020_03_27_012757	77	11	types	type	NNS
10_1101-2020_03_27_012757	77	12	other	other	JJ
10_1101-2020_03_27_012757	77	13	than	than	IN
10_1101-2020_03_27_012757	77	14	that	that	DT
10_1101-2020_03_27_012757	77	15	of	of	IN
10_1101-2020_03_27_012757	77	16	the	the	DT
10_1101-2020_03_27_012757	77	17	cell	cell	NN
10_1101-2020_03_27_012757	77	18	line	line	NN
10_1101-2020_03_27_012757	77	19	's	's	POS
10_1101-2020_03_27_012757	77	20	origin	origin	NN
10_1101-2020_03_27_012757	77	21	were	be	VBD
10_1101-2020_03_27_012757	77	22	annotated	annotate	VBN
10_1101-2020_03_27_012757	77	23	198	198	CD
10_1101-2020_03_27_012757	77	24	as	as	IN
10_1101-2020_03_27_012757	77	25	'	'	``
10_1101-2020_03_27_012757	77	26	other	other	JJ
10_1101-2020_03_27_012757	77	27	'	'	''
10_1101-2020_03_27_012757	77	28	.	.	.
10_1101-2020_03_27_012757	78	1	Cell	cell	NN
10_1101-2020_03_27_012757	78	2	lines	line	NNS
10_1101-2020_03_27_012757	78	3	that	that	WDT
10_1101-2020_03_27_012757	78	4	did	do	VBD
10_1101-2020_03_27_012757	78	5	not	not	RB
10_1101-2020_03_27_012757	78	6	receive	receive	VB
10_1101-2020_03_27_012757	78	7	a	a	DT
10_1101-2020_03_27_012757	78	8	CCN	CCN	NNP
10_1101-2020_03_27_012757	78	9	score	score	NN
10_1101-2020_03_27_012757	78	10	>	>	XX
10_1101-2020_03_27_012757	78	11	threshold	threshold	NN
10_1101-2020_03_27_012757	78	12	for	for	IN
10_1101-2020_03_27_012757	78	13	any	any	DT
10_1101-2020_03_27_012757	78	14	tumor	tumor	NN
10_1101-2020_03_27_012757	78	15	type	type	NN
10_1101-2020_03_27_012757	78	16	were	be	VBD
10_1101-2020_03_27_012757	78	17	199	199	CD
10_1101-2020_03_27_012757	78	18	annotated	annotate	VBN
10_1101-2020_03_27_012757	78	19	as	as	IN
10_1101-2020_03_27_012757	78	20	'	'	``
10_1101-2020_03_27_012757	78	21	none	none	NN
10_1101-2020_03_27_012757	78	22	'	'	''
10_1101-2020_03_27_012757	78	23	(	(	-LRB-
10_1101-2020_03_27_012757	78	24	Fig	fig	NN
10_1101-2020_03_27_012757	78	25	2B	2b	NN
10_1101-2020_03_27_012757	78	26	)	)	-RRB-
10_1101-2020_03_27_012757	78	27	.	.	.
10_1101-2020_03_27_012757	79	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	79	2	found	find	VBD
10_1101-2020_03_27_012757	79	3	that	that	IN
10_1101-2020_03_27_012757	79	4	majority	majority	NN
10_1101-2020_03_27_012757	79	5	of	of	IN
10_1101-2020_03_27_012757	79	6	cell	cell	NN
10_1101-2020_03_27_012757	79	7	lines	line	NNS
10_1101-2020_03_27_012757	79	8	originally	originally	RB
10_1101-2020_03_27_012757	79	9	annotated	annotate	VBD
10_1101-2020_03_27_012757	79	10	as	as	IN
10_1101-2020_03_27_012757	79	11	Breast	Breast	NNP
10_1101-2020_03_27_012757	79	12	200	200	CD
10_1101-2020_03_27_012757	79	13	invasive	invasive	JJ
10_1101-2020_03_27_012757	79	14	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	79	15	(	(	-LRB-
10_1101-2020_03_27_012757	79	16	BRCA	BRCA	NNP
10_1101-2020_03_27_012757	79	17	)	)	-RRB-
10_1101-2020_03_27_012757	79	18	,	,	,
10_1101-2020_03_27_012757	79	19	Cervical	cervical	JJ
10_1101-2020_03_27_012757	79	20	squamous	squamous	JJ
10_1101-2020_03_27_012757	79	21	cell	cell	NN
10_1101-2020_03_27_012757	79	22	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	79	23	and	and	CC
10_1101-2020_03_27_012757	79	24	endocervical	endocervical	JJ
10_1101-2020_03_27_012757	79	25	201	201	CD
10_1101-2020_03_27_012757	79	26	adenocarcinoma	adenocarcinoma	NNS
10_1101-2020_03_27_012757	79	27	(	(	-LRB-
10_1101-2020_03_27_012757	79	28	CESC	CESC	NNP
10_1101-2020_03_27_012757	79	29	)	)	-RRB-
10_1101-2020_03_27_012757	79	30	,	,	,
10_1101-2020_03_27_012757	79	31	Skin	Skin	NNP
10_1101-2020_03_27_012757	79	32	Cutaneous	Cutaneous	NNP
10_1101-2020_03_27_012757	79	33	Melanoma	Melanoma	NNP
10_1101-2020_03_27_012757	79	34	(	(	-LRB-
10_1101-2020_03_27_012757	79	35	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	79	36	)	)	-RRB-
10_1101-2020_03_27_012757	79	37	,	,	,
10_1101-2020_03_27_012757	79	38	Colorectal	Colorectal	NNP
10_1101-2020_03_27_012757	79	39	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	79	40	202	202	CD
10_1101-2020_03_27_012757	79	41	(	(	-LRB-
10_1101-2020_03_27_012757	79	42	COAD_READ	coad_read	NN
10_1101-2020_03_27_012757	79	43	)	)	-RRB-
10_1101-2020_03_27_012757	79	44	and	and	CC
10_1101-2020_03_27_012757	79	45	Sarcoma	Sarcoma	NNP
10_1101-2020_03_27_012757	79	46	(	(	-LRB-
10_1101-2020_03_27_012757	79	47	SARC	SARC	NNP
10_1101-2020_03_27_012757	79	48	)	)	-RRB-
10_1101-2020_03_27_012757	79	49	fell	fall	VBD
10_1101-2020_03_27_012757	79	50	into	into	IN
10_1101-2020_03_27_012757	79	51	the	the	DT
10_1101-2020_03_27_012757	79	52	'	'	``
10_1101-2020_03_27_012757	79	53	correct	correct	JJ
10_1101-2020_03_27_012757	79	54	'	'	''
10_1101-2020_03_27_012757	79	55	category	category	NN
10_1101-2020_03_27_012757	79	56	(	(	-LRB-
10_1101-2020_03_27_012757	79	57	Fig	fig	NN
10_1101-2020_03_27_012757	79	58	2B	2b	NN
10_1101-2020_03_27_012757	79	59	)	)	-RRB-
10_1101-2020_03_27_012757	79	60	.	.	.
10_1101-2020_03_27_012757	80	1	On	on	IN
10_1101-2020_03_27_012757	80	2	the	the	DT
10_1101-2020_03_27_012757	80	3	other	other	JJ
10_1101-2020_03_27_012757	80	4	203	203	CD
10_1101-2020_03_27_012757	80	5	hand	hand	NN
10_1101-2020_03_27_012757	80	6	,	,	,
10_1101-2020_03_27_012757	80	7	no	no	DT
10_1101-2020_03_27_012757	80	8	Esophageal	esophageal	JJ
10_1101-2020_03_27_012757	80	9	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	80	10	(	(	-LRB-
10_1101-2020_03_27_012757	80	11	ESCA	ESCA	NNP
10_1101-2020_03_27_012757	80	12	)	)	-RRB-
10_1101-2020_03_27_012757	80	13	,	,	,
10_1101-2020_03_27_012757	80	14	Pancreatic	pancreatic	JJ
10_1101-2020_03_27_012757	80	15	adenocarcinoma	adenocarcinoma	NN
10_1101-2020_03_27_012757	80	16	(	(	-LRB-
10_1101-2020_03_27_012757	80	17	PAAD	PAAD	NNP
10_1101-2020_03_27_012757	80	18	)	)	-RRB-
10_1101-2020_03_27_012757	80	19	or	or	CC
10_1101-2020_03_27_012757	80	20	Brain	Brain	NNP
10_1101-2020_03_27_012757	80	21	Lower	low	JJR
10_1101-2020_03_27_012757	80	22	204	204	CD
10_1101-2020_03_27_012757	80	23	Grade	Grade	NNP
10_1101-2020_03_27_012757	80	24	Glioma	Glioma	NNP
10_1101-2020_03_27_012757	80	25	(	(	-LRB-
10_1101-2020_03_27_012757	80	26	LGG	LGG	NNP
10_1101-2020_03_27_012757	80	27	)	)	-RRB-
10_1101-2020_03_27_012757	80	28	were	be	VBD
10_1101-2020_03_27_012757	80	29	classified	classify	VBN
10_1101-2020_03_27_012757	80	30	as	as	IN
10_1101-2020_03_27_012757	80	31	'	'	``
10_1101-2020_03_27_012757	80	32	correct	correct	JJ
10_1101-2020_03_27_012757	80	33	'	'	''
10_1101-2020_03_27_012757	80	34	,	,	,
10_1101-2020_03_27_012757	80	35	demonstrating	demonstrate	VBG
10_1101-2020_03_27_012757	80	36	the	the	DT
10_1101-2020_03_27_012757	80	37	need	need	NN
10_1101-2020_03_27_012757	80	38	for	for	IN
10_1101-2020_03_27_012757	80	39	more	more	JJR
10_1101-2020_03_27_012757	80	40	205	205	CD
10_1101-2020_03_27_012757	80	41	transcriptionally	transcriptionally	RB
10_1101-2020_03_27_012757	80	42	faithful	faithful	JJ
10_1101-2020_03_27_012757	80	43	cell	cell	NN
10_1101-2020_03_27_012757	80	44	lines	line	NNS
10_1101-2020_03_27_012757	80	45	that	that	WDT
10_1101-2020_03_27_012757	80	46	model	model	VBP
10_1101-2020_03_27_012757	80	47	those	those	DT
10_1101-2020_03_27_012757	80	48	general	general	JJ
10_1101-2020_03_27_012757	80	49	cancer	cancer	NN
10_1101-2020_03_27_012757	80	50	types	type	NNS
10_1101-2020_03_27_012757	80	51	.	.	.
10_1101-2020_03_27_012757	81	1	206	206	CD
10_1101-2020_03_27_012757	81	2	There	there	EX
10_1101-2020_03_27_012757	81	3	are	be	VBP
10_1101-2020_03_27_012757	81	4	several	several	JJ
10_1101-2020_03_27_012757	81	5	possible	possible	JJ
10_1101-2020_03_27_012757	81	6	explanations	explanation	NNS
10_1101-2020_03_27_012757	81	7	for	for	IN
10_1101-2020_03_27_012757	81	8	cell	cell	NN
10_1101-2020_03_27_012757	81	9	lines	line	NNS
10_1101-2020_03_27_012757	81	10	not	not	RB
10_1101-2020_03_27_012757	81	11	receiving	receive	VBG
10_1101-2020_03_27_012757	81	12	a	a	DT
10_1101-2020_03_27_012757	81	13	'	'	``
10_1101-2020_03_27_012757	81	14	correct	correct	JJ
10_1101-2020_03_27_012757	81	15	'	'	''
10_1101-2020_03_27_012757	81	16	207	207	CD
10_1101-2020_03_27_012757	81	17	classification	classification	NN
10_1101-2020_03_27_012757	81	18	.	.	.
10_1101-2020_03_27_012757	82	1	One	one	CD
10_1101-2020_03_27_012757	82	2	possibility	possibility	NN
10_1101-2020_03_27_012757	82	3	is	be	VBZ
10_1101-2020_03_27_012757	82	4	that	that	IN
10_1101-2020_03_27_012757	82	5	the	the	DT
10_1101-2020_03_27_012757	82	6	sample	sample	NN
10_1101-2020_03_27_012757	82	7	was	be	VBD
10_1101-2020_03_27_012757	82	8	incorrectly	incorrectly	RB
10_1101-2020_03_27_012757	82	9	labeled	label	VBN
10_1101-2020_03_27_012757	82	10	in	in	IN
10_1101-2020_03_27_012757	82	11	the	the	DT
10_1101-2020_03_27_012757	82	12	study	study	NN
10_1101-2020_03_27_012757	82	13	from	from	IN
10_1101-2020_03_27_012757	82	14	which	which	WDT
10_1101-2020_03_27_012757	82	15	208	208	CD
10_1101-2020_03_27_012757	82	16	we	-PRON-	PRP
10_1101-2020_03_27_012757	82	17	harvested	harvest	VBD
10_1101-2020_03_27_012757	82	18	the	the	DT
10_1101-2020_03_27_012757	82	19	expression	expression	NN
10_1101-2020_03_27_012757	82	20	data	datum	NNS
10_1101-2020_03_27_012757	82	21	.	.	.
10_1101-2020_03_27_012757	83	1	Consistent	consistent	JJ
10_1101-2020_03_27_012757	83	2	with	with	IN
10_1101-2020_03_27_012757	83	3	this	this	DT
10_1101-2020_03_27_012757	83	4	explanation	explanation	NN
10_1101-2020_03_27_012757	83	5	,	,	,
10_1101-2020_03_27_012757	83	6	we	-PRON-	PRP
10_1101-2020_03_27_012757	83	7	found	find	VBD
10_1101-2020_03_27_012757	83	8	that	that	IN
10_1101-2020_03_27_012757	83	9	colorectal	colorectal	JJ
10_1101-2020_03_27_012757	83	10	209	209	CD
10_1101-2020_03_27_012757	83	11	cancer	cancer	NN
10_1101-2020_03_27_012757	83	12	line	line	NN
10_1101-2020_03_27_012757	83	13	NCI	NCI	NNP
10_1101-2020_03_27_012757	83	14	-	-	HYPH
10_1101-2020_03_27_012757	83	15	H68438,39	H68438,39	NNP
10_1101-2020_03_27_012757	83	16	,	,	,
10_1101-2020_03_27_012757	83	17	a	a	DT
10_1101-2020_03_27_012757	83	18	cell	cell	NN
10_1101-2020_03_27_012757	83	19	line	line	NN
10_1101-2020_03_27_012757	83	20	labelled	label	VBN
10_1101-2020_03_27_012757	83	21	as	as	IN
10_1101-2020_03_27_012757	83	22	liver	liver	NNP
10_1101-2020_03_27_012757	83	23	hepatocellular	hepatocellular	NNP
10_1101-2020_03_27_012757	83	24	carcinoma	carcinoma	NNP
10_1101-2020_03_27_012757	83	25	(	(	-LRB-
10_1101-2020_03_27_012757	83	26	LIHC	LIHC	NNP
10_1101-2020_03_27_012757	83	27	)	)	-RRB-
10_1101-2020_03_27_012757	83	28	by	by	IN
10_1101-2020_03_27_012757	83	29	CCLE	CCLE	NNP
10_1101-2020_03_27_012757	83	30	,	,	,
10_1101-2020_03_27_012757	83	31	210	210	CD
10_1101-2020_03_27_012757	83	32	was	be	VBD
10_1101-2020_03_27_012757	83	33	classified	classify	VBN
10_1101-2020_03_27_012757	83	34	strongly	strongly	RB
10_1101-2020_03_27_012757	83	35	as	as	IN
10_1101-2020_03_27_012757	83	36	COAD_READ	coad_read	RB
10_1101-2020_03_27_012757	83	37	(	(	-LRB-
10_1101-2020_03_27_012757	83	38	Supp	Supp	NNP
10_1101-2020_03_27_012757	83	39	Tab	Tab	NNP
10_1101-2020_03_27_012757	83	40	1	1	CD
10_1101-2020_03_27_012757	83	41	)	)	-RRB-
10_1101-2020_03_27_012757	83	42	.	.	.
10_1101-2020_03_27_012757	84	1	Another	another	DT
10_1101-2020_03_27_012757	84	2	possibility	possibility	NN
10_1101-2020_03_27_012757	84	3	to	to	TO
10_1101-2020_03_27_012757	84	4	explain	explain	VB
10_1101-2020_03_27_012757	84	5	low	low	JJ
10_1101-2020_03_27_012757	84	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	84	7	211	211	CD
10_1101-2020_03_27_012757	84	8	score	score	NN
10_1101-2020_03_27_012757	84	9	is	be	VBZ
10_1101-2020_03_27_012757	84	10	that	that	IN
10_1101-2020_03_27_012757	84	11	cell	cell	NN
10_1101-2020_03_27_012757	84	12	lines	line	NNS
10_1101-2020_03_27_012757	84	13	were	be	VBD
10_1101-2020_03_27_012757	84	14	derived	derive	VBN
10_1101-2020_03_27_012757	84	15	from	from	IN
10_1101-2020_03_27_012757	84	16	subtypes	subtype	NNS
10_1101-2020_03_27_012757	84	17	of	of	IN
10_1101-2020_03_27_012757	84	18	tumors	tumor	NNS
10_1101-2020_03_27_012757	84	19	that	that	WDT
10_1101-2020_03_27_012757	84	20	are	be	VBP
10_1101-2020_03_27_012757	84	21	not	not	RB
10_1101-2020_03_27_012757	84	22	well	well	RB
10_1101-2020_03_27_012757	84	23	-	-	HYPH
10_1101-2020_03_27_012757	84	24	represented	represent	VBN
10_1101-2020_03_27_012757	84	25	in	in	IN
10_1101-2020_03_27_012757	84	26	212	212	CD
10_1101-2020_03_27_012757	84	27	TCGA	tcga	NN
10_1101-2020_03_27_012757	84	28	.	.	.
10_1101-2020_03_27_012757	85	1	To	to	TO
10_1101-2020_03_27_012757	85	2	explore	explore	VB
10_1101-2020_03_27_012757	85	3	this	this	DT
10_1101-2020_03_27_012757	85	4	hypothesis	hypothesis	NN
10_1101-2020_03_27_012757	85	5	,	,	,
10_1101-2020_03_27_012757	85	6	we	-PRON-	PRP
10_1101-2020_03_27_012757	85	7	first	first	RB
10_1101-2020_03_27_012757	85	8	performed	perform	VBD
10_1101-2020_03_27_012757	85	9	tumor	tumor	NN
10_1101-2020_03_27_012757	85	10	subtype	subtype	NN
10_1101-2020_03_27_012757	85	11	classification	classification	NN
10_1101-2020_03_27_012757	85	12	on	on	IN
10_1101-2020_03_27_012757	85	13	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	85	14	from	from	IN
10_1101-2020_03_27_012757	85	15	213	213	CD
10_1101-2020_03_27_012757	85	16	11	11	CD
10_1101-2020_03_27_012757	85	17	tumor	tumor	NN
10_1101-2020_03_27_012757	85	18	types	type	NNS
10_1101-2020_03_27_012757	85	19	for	for	IN
10_1101-2020_03_27_012757	85	20	which	which	WDT
10_1101-2020_03_27_012757	85	21	we	-PRON-	PRP
10_1101-2020_03_27_012757	85	22	had	have	VBD
10_1101-2020_03_27_012757	85	23	trained	train	VBN
10_1101-2020_03_27_012757	85	24	subtype	subtype	NN
10_1101-2020_03_27_012757	85	25	classifiers	classifier	NNS
10_1101-2020_03_27_012757	85	26	(	(	-LRB-
10_1101-2020_03_27_012757	85	27	Supp	Supp	NNP
10_1101-2020_03_27_012757	85	28	Tab	Tab	NNP
10_1101-2020_03_27_012757	85	29	2	2	CD
10_1101-2020_03_27_012757	85	30	)	)	-RRB-
10_1101-2020_03_27_012757	85	31	.	.	.
10_1101-2020_03_27_012757	86	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	86	2	reasoned	reason	VBD
10_1101-2020_03_27_012757	86	3	that	that	IN
10_1101-2020_03_27_012757	86	4	if	if	IN
10_1101-2020_03_27_012757	86	5	214	214	CD
10_1101-2020_03_27_012757	86	6	.CC	.CC	NFP
10_1101-2020_03_27_012757	86	7	-	-	HYPH
10_1101-2020_03_27_012757	86	8	BY	by	IN
10_1101-2020_03_27_012757	86	9	-	-	HYPH
10_1101-2020_03_27_012757	86	10	NC	NC	NNP
10_1101-2020_03_27_012757	86	11	-	-	HYPH
10_1101-2020_03_27_012757	86	12	ND	ND	NNP
10_1101-2020_03_27_012757	86	13	4.0	4.0	CD
10_1101-2020_03_27_012757	86	14	International	International	NNP
10_1101-2020_03_27_012757	86	15	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	86	16	under	under	IN
10_1101-2020_03_27_012757	86	17	a	a	DT
10_1101-2020_03_27_012757	86	18	(	(	-LRB-
10_1101-2020_03_27_012757	86	19	which	which	WDT
10_1101-2020_03_27_012757	86	20	was	be	VBD
10_1101-2020_03_27_012757	86	21	not	not	RB
10_1101-2020_03_27_012757	86	22	certified	certify	VBN
10_1101-2020_03_27_012757	86	23	by	by	IN
10_1101-2020_03_27_012757	86	24	peer	peer	NN
10_1101-2020_03_27_012757	86	25	review	review	NN
10_1101-2020_03_27_012757	86	26	)	)	-RRB-
10_1101-2020_03_27_012757	86	27	is	be	VBZ
10_1101-2020_03_27_012757	86	28	the	the	DT
10_1101-2020_03_27_012757	86	29	author	author	NN
10_1101-2020_03_27_012757	86	30	/	/	SYM
10_1101-2020_03_27_012757	86	31	funder	funder	NN
10_1101-2020_03_27_012757	86	32	,	,	,
10_1101-2020_03_27_012757	86	33	who	who	WP
10_1101-2020_03_27_012757	86	34	has	have	VBZ
10_1101-2020_03_27_012757	86	35	granted	grant	VBN
10_1101-2020_03_27_012757	86	36	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	86	37	a	a	DT
10_1101-2020_03_27_012757	86	38	license	license	NN
10_1101-2020_03_27_012757	86	39	to	to	TO
10_1101-2020_03_27_012757	86	40	display	display	VB
10_1101-2020_03_27_012757	86	41	the	the	DT
10_1101-2020_03_27_012757	86	42	preprint	preprint	NN
10_1101-2020_03_27_012757	86	43	in	in	IN
10_1101-2020_03_27_012757	86	44	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	86	45	.	.	.
10_1101-2020_03_27_012757	87	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	87	2	is	be	VBZ
10_1101-2020_03_27_012757	87	3	made	make	VBN
10_1101-2020_03_27_012757	87	4	The	the	DT
10_1101-2020_03_27_012757	87	5	copyright	copyright	NN
10_1101-2020_03_27_012757	87	6	holder	holder	NN
10_1101-2020_03_27_012757	87	7	for	for	IN
10_1101-2020_03_27_012757	87	8	this	this	DT
10_1101-2020_03_27_012757	87	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	87	10	version	version	NN
10_1101-2020_03_27_012757	87	11	posted	post	VBD
10_1101-2020_03_27_012757	87	12	January	January	NNP
10_1101-2020_03_27_012757	87	13	9	9	CD
10_1101-2020_03_27_012757	87	14	,	,	,
10_1101-2020_03_27_012757	87	15	2021	2021	CD
10_1101-2020_03_27_012757	87	16	.	.	.
10_1101-2020_03_27_012757	87	17	;	;	:
10_1101-2020_03_27_012757	87	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	87	19	:	:	:
10_1101-2020_03_27_012757	87	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	87	21	preprint	preprint	NN
10_1101-2020_03_27_012757	87	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	87	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	87	24	8	8	CD
10_1101-2020_03_27_012757	87	25	a	a	DT
10_1101-2020_03_27_012757	87	26	cell	cell	NN
10_1101-2020_03_27_012757	87	27	was	be	VBD
10_1101-2020_03_27_012757	87	28	a	a	DT
10_1101-2020_03_27_012757	87	29	good	good	JJ
10_1101-2020_03_27_012757	87	30	model	model	NN
10_1101-2020_03_27_012757	87	31	for	for	IN
10_1101-2020_03_27_012757	87	32	a	a	DT
10_1101-2020_03_27_012757	87	33	rarer	rare	JJR
10_1101-2020_03_27_012757	87	34	subtype	subtype	NN
10_1101-2020_03_27_012757	87	35	,	,	,
10_1101-2020_03_27_012757	87	36	then	then	RB
10_1101-2020_03_27_012757	87	37	it	-PRON-	PRP
10_1101-2020_03_27_012757	87	38	would	would	MD
10_1101-2020_03_27_012757	87	39	receive	receive	VB
10_1101-2020_03_27_012757	87	40	a	a	DT
10_1101-2020_03_27_012757	87	41	poor	poor	JJ
10_1101-2020_03_27_012757	87	42	general	general	JJ
10_1101-2020_03_27_012757	87	43	classification	classification	NN
10_1101-2020_03_27_012757	87	44	215	215	CD
10_1101-2020_03_27_012757	87	45	but	but	CC
10_1101-2020_03_27_012757	87	46	a	a	DT
10_1101-2020_03_27_012757	87	47	high	high	JJ
10_1101-2020_03_27_012757	87	48	classification	classification	NN
10_1101-2020_03_27_012757	87	49	for	for	IN
10_1101-2020_03_27_012757	87	50	the	the	DT
10_1101-2020_03_27_012757	87	51	subtype	subtype	NN
10_1101-2020_03_27_012757	87	52	that	that	WDT
10_1101-2020_03_27_012757	87	53	it	-PRON-	PRP
10_1101-2020_03_27_012757	87	54	models	model	VBZ
10_1101-2020_03_27_012757	87	55	well	well	RB
10_1101-2020_03_27_012757	87	56	.	.	.
10_1101-2020_03_27_012757	88	1	Therefore	therefore	RB
10_1101-2020_03_27_012757	88	2	,	,	,
10_1101-2020_03_27_012757	88	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	88	4	counted	count	VBD
10_1101-2020_03_27_012757	88	5	the	the	DT
10_1101-2020_03_27_012757	88	6	number	number	NN
10_1101-2020_03_27_012757	88	7	of	of	IN
10_1101-2020_03_27_012757	88	8	216	216	CD
10_1101-2020_03_27_012757	88	9	lines	line	NNS
10_1101-2020_03_27_012757	88	10	that	that	WDT
10_1101-2020_03_27_012757	88	11	fit	fit	VBP
10_1101-2020_03_27_012757	88	12	this	this	DT
10_1101-2020_03_27_012757	88	13	pattern	pattern	NN
10_1101-2020_03_27_012757	88	14	.	.	.
10_1101-2020_03_27_012757	89	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	89	2	found	find	VBD
10_1101-2020_03_27_012757	89	3	that	that	DT
10_1101-2020_03_27_012757	89	4	of	of	IN
10_1101-2020_03_27_012757	89	5	the	the	DT
10_1101-2020_03_27_012757	89	6	188	188	CD
10_1101-2020_03_27_012757	89	7	lines	line	NNS
10_1101-2020_03_27_012757	89	8	with	with	IN
10_1101-2020_03_27_012757	89	9	no	no	DT
10_1101-2020_03_27_012757	89	10	general	general	JJ
10_1101-2020_03_27_012757	89	11	classification	classification	NN
10_1101-2020_03_27_012757	89	12	,	,	,
10_1101-2020_03_27_012757	89	13	25	25	CD
10_1101-2020_03_27_012757	89	14	(	(	-LRB-
10_1101-2020_03_27_012757	89	15	13	13	CD
10_1101-2020_03_27_012757	89	16	%	%	NN
10_1101-2020_03_27_012757	89	17	)	)	-RRB-
10_1101-2020_03_27_012757	89	18	217	217	CD
10_1101-2020_03_27_012757	89	19	were	be	VBD
10_1101-2020_03_27_012757	89	20	classified	classify	VBN
10_1101-2020_03_27_012757	89	21	as	as	IN
10_1101-2020_03_27_012757	89	22	a	a	DT
10_1101-2020_03_27_012757	89	23	specific	specific	JJ
10_1101-2020_03_27_012757	89	24	subtype	subtype	NN
10_1101-2020_03_27_012757	89	25	,	,	,
10_1101-2020_03_27_012757	89	26	suggesting	suggest	VBG
10_1101-2020_03_27_012757	89	27	that	that	IN
10_1101-2020_03_27_012757	89	28	derivation	derivation	NN
10_1101-2020_03_27_012757	89	29	from	from	IN
10_1101-2020_03_27_012757	89	30	rare	rare	JJ
10_1101-2020_03_27_012757	89	31	subtypes	subtype	NNS
10_1101-2020_03_27_012757	89	32	is	be	VBZ
10_1101-2020_03_27_012757	89	33	not	not	RB
10_1101-2020_03_27_012757	89	34	the	the	DT
10_1101-2020_03_27_012757	89	35	218	218	CD
10_1101-2020_03_27_012757	89	36	major	major	JJ
10_1101-2020_03_27_012757	89	37	contributor	contributor	NN
10_1101-2020_03_27_012757	89	38	to	to	IN
10_1101-2020_03_27_012757	89	39	the	the	DT
10_1101-2020_03_27_012757	89	40	poor	poor	JJ
10_1101-2020_03_27_012757	89	41	overall	overall	JJ
10_1101-2020_03_27_012757	89	42	fidelity	fidelity	NN
10_1101-2020_03_27_012757	89	43	of	of	IN
10_1101-2020_03_27_012757	89	44	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	89	45	.	.	.
10_1101-2020_03_27_012757	90	1	219	219	CD
10_1101-2020_03_27_012757	90	2	Another	another	DT
10_1101-2020_03_27_012757	90	3	potential	potential	JJ
10_1101-2020_03_27_012757	90	4	contributor	contributor	NN
10_1101-2020_03_27_012757	90	5	to	to	IN
10_1101-2020_03_27_012757	90	6	low	low	JJ
10_1101-2020_03_27_012757	90	7	scoring	score	VBG
10_1101-2020_03_27_012757	90	8	cell	cell	NN
10_1101-2020_03_27_012757	90	9	lines	line	NNS
10_1101-2020_03_27_012757	90	10	is	be	VBZ
10_1101-2020_03_27_012757	90	11	intra	intra	JJ
10_1101-2020_03_27_012757	90	12	-	-	JJ
10_1101-2020_03_27_012757	90	13	tumor	tumor	JJ
10_1101-2020_03_27_012757	90	14	stromal	stromal	NN
10_1101-2020_03_27_012757	90	15	and	and	CC
10_1101-2020_03_27_012757	90	16	immune	immune	JJ
10_1101-2020_03_27_012757	90	17	220	220	CD
10_1101-2020_03_27_012757	90	18	cell	cell	NN
10_1101-2020_03_27_012757	90	19	impurity	impurity	NN
10_1101-2020_03_27_012757	90	20	in	in	IN
10_1101-2020_03_27_012757	90	21	the	the	DT
10_1101-2020_03_27_012757	90	22	training	training	NN
10_1101-2020_03_27_012757	90	23	data	datum	NNS
10_1101-2020_03_27_012757	90	24	.	.	.
10_1101-2020_03_27_012757	91	1	If	if	IN
10_1101-2020_03_27_012757	91	2	impurity	impurity	NN
10_1101-2020_03_27_012757	91	3	were	be	VBD
10_1101-2020_03_27_012757	91	4	a	a	DT
10_1101-2020_03_27_012757	91	5	confounder	confounder	NN
10_1101-2020_03_27_012757	91	6	of	of	IN
10_1101-2020_03_27_012757	91	7	CCN	CCN	NNP
10_1101-2020_03_27_012757	91	8	scoring	score	VBG
10_1101-2020_03_27_012757	91	9	,	,	,
10_1101-2020_03_27_012757	91	10	then	then	RB
10_1101-2020_03_27_012757	91	11	we	-PRON-	PRP
10_1101-2020_03_27_012757	91	12	would	would	MD
10_1101-2020_03_27_012757	91	13	221	221	CD
10_1101-2020_03_27_012757	91	14	expect	expect	VB
10_1101-2020_03_27_012757	91	15	a	a	DT
10_1101-2020_03_27_012757	91	16	strong	strong	JJ
10_1101-2020_03_27_012757	91	17	positive	positive	JJ
10_1101-2020_03_27_012757	91	18	correlation	correlation	NN
10_1101-2020_03_27_012757	91	19	between	between	IN
10_1101-2020_03_27_012757	91	20	mean	mean	JJ
10_1101-2020_03_27_012757	91	21	purity	purity	NN
10_1101-2020_03_27_012757	91	22	and	and	CC
10_1101-2020_03_27_012757	91	23	mean	mean	VB
10_1101-2020_03_27_012757	91	24	CCN	CCN	NNP
10_1101-2020_03_27_012757	91	25	classification	classification	NN
10_1101-2020_03_27_012757	91	26	scores	score	NNS
10_1101-2020_03_27_012757	91	27	of	of	IN
10_1101-2020_03_27_012757	91	28	222	222	CD
10_1101-2020_03_27_012757	91	29	CCLs	ccl	NNS
10_1101-2020_03_27_012757	91	30	per	per	IN
10_1101-2020_03_27_012757	91	31	general	general	JJ
10_1101-2020_03_27_012757	91	32	tumor	tumor	NN
10_1101-2020_03_27_012757	91	33	type	type	NN
10_1101-2020_03_27_012757	91	34	.	.	.
10_1101-2020_03_27_012757	92	1	However	however	RB
10_1101-2020_03_27_012757	92	2	,	,	,
10_1101-2020_03_27_012757	92	3	the	the	DT
10_1101-2020_03_27_012757	92	4	Pearson	Pearson	NNP
10_1101-2020_03_27_012757	92	5	correlation	correlation	NN
10_1101-2020_03_27_012757	92	6	coefficient	coefficient	NN
10_1101-2020_03_27_012757	92	7	between	between	IN
10_1101-2020_03_27_012757	92	8	the	the	DT
10_1101-2020_03_27_012757	92	9	mean	mean	JJ
10_1101-2020_03_27_012757	92	10	223	223	CD
10_1101-2020_03_27_012757	92	11	purity	purity	NN
10_1101-2020_03_27_012757	92	12	of	of	IN
10_1101-2020_03_27_012757	92	13	general	general	JJ
10_1101-2020_03_27_012757	92	14	tumor	tumor	NN
10_1101-2020_03_27_012757	92	15	type	type	NN
10_1101-2020_03_27_012757	92	16	and	and	CC
10_1101-2020_03_27_012757	92	17	mean	mean	VB
10_1101-2020_03_27_012757	92	18	CCN	CCN	NNP
10_1101-2020_03_27_012757	92	19	classification	classification	NN
10_1101-2020_03_27_012757	92	20	scores	score	NNS
10_1101-2020_03_27_012757	92	21	of	of	IN
10_1101-2020_03_27_012757	92	22	CCLs	ccl	NNS
10_1101-2020_03_27_012757	92	23	in	in	IN
10_1101-2020_03_27_012757	92	24	the	the	DT
10_1101-2020_03_27_012757	92	25	corresponding	corresponding	JJ
10_1101-2020_03_27_012757	92	26	224	224	CD
10_1101-2020_03_27_012757	92	27	general	general	JJ
10_1101-2020_03_27_012757	92	28	tumor	tumor	NN
10_1101-2020_03_27_012757	92	29	type	type	NN
10_1101-2020_03_27_012757	92	30	was	be	VBD
10_1101-2020_03_27_012757	92	31	low	low	JJ
10_1101-2020_03_27_012757	92	32	(	(	-LRB-
10_1101-2020_03_27_012757	92	33	0.14	0.14	CD
10_1101-2020_03_27_012757	92	34	)	)	-RRB-
10_1101-2020_03_27_012757	92	35	,	,	,
10_1101-2020_03_27_012757	92	36	suggesting	suggest	VBG
10_1101-2020_03_27_012757	92	37	that	that	IN
10_1101-2020_03_27_012757	92	38	tumor	tumor	NN
10_1101-2020_03_27_012757	92	39	purity	purity	NN
10_1101-2020_03_27_012757	92	40	is	be	VBZ
10_1101-2020_03_27_012757	92	41	not	not	RB
10_1101-2020_03_27_012757	92	42	a	a	DT
10_1101-2020_03_27_012757	92	43	major	major	JJ
10_1101-2020_03_27_012757	92	44	contributor	contributor	NN
10_1101-2020_03_27_012757	92	45	to	to	IN
10_1101-2020_03_27_012757	92	46	the	the	DT
10_1101-2020_03_27_012757	92	47	225	225	CD
10_1101-2020_03_27_012757	92	48	low	low	JJ
10_1101-2020_03_27_012757	92	49	CCN	CCN	NNP
10_1101-2020_03_27_012757	92	50	scores	score	NNS
10_1101-2020_03_27_012757	92	51	across	across	IN
10_1101-2020_03_27_012757	92	52	CCLs	ccl	NNS
10_1101-2020_03_27_012757	92	53	(	(	-LRB-
10_1101-2020_03_27_012757	92	54	Supp	Supp	NNP
10_1101-2020_03_27_012757	92	55	Fig	Fig	NNP
10_1101-2020_03_27_012757	92	56	2E	2e	NN
10_1101-2020_03_27_012757	92	57	)	)	-RRB-
10_1101-2020_03_27_012757	92	58	.	.	.
10_1101-2020_03_27_012757	93	1	226	226	CD
10_1101-2020_03_27_012757	93	2	227	227	CD
10_1101-2020_03_27_012757	93	3	Comparison	Comparison	NNP
10_1101-2020_03_27_012757	93	4	of	of	IN
10_1101-2020_03_27_012757	93	5	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	93	6	and	and	CC
10_1101-2020_03_27_012757	93	7	GBM	GBM	NNP
10_1101-2020_03_27_012757	93	8	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	93	9	to	to	IN
10_1101-2020_03_27_012757	93	10	scRNA	scrna	CD
10_1101-2020_03_27_012757	93	11	-	-	HYPH
10_1101-2020_03_27_012757	93	12	seq	seq	NN
10_1101-2020_03_27_012757	93	13	228	228	CD
10_1101-2020_03_27_012757	93	14	To	to	TO
10_1101-2020_03_27_012757	93	15	more	more	RBR
10_1101-2020_03_27_012757	93	16	directly	directly	RB
10_1101-2020_03_27_012757	93	17	assess	assess	VB
10_1101-2020_03_27_012757	93	18	the	the	DT
10_1101-2020_03_27_012757	93	19	impact	impact	NN
10_1101-2020_03_27_012757	93	20	of	of	IN
10_1101-2020_03_27_012757	93	21	intra	intra	JJ
10_1101-2020_03_27_012757	93	22	-	-	JJ
10_1101-2020_03_27_012757	93	23	tumor	tumor	JJ
10_1101-2020_03_27_012757	93	24	heterogeneity	heterogeneity	NN
10_1101-2020_03_27_012757	93	25	in	in	IN
10_1101-2020_03_27_012757	93	26	the	the	DT
10_1101-2020_03_27_012757	93	27	training	training	NN
10_1101-2020_03_27_012757	93	28	data	datum	NNS
10_1101-2020_03_27_012757	93	29	on	on	IN
10_1101-2020_03_27_012757	93	30	229	229	CD
10_1101-2020_03_27_012757	93	31	evaluating	evaluate	VBG
10_1101-2020_03_27_012757	93	32	cell	cell	NN
10_1101-2020_03_27_012757	93	33	lines	line	NNS
10_1101-2020_03_27_012757	93	34	,	,	,
10_1101-2020_03_27_012757	93	35	we	-PRON-	PRP
10_1101-2020_03_27_012757	93	36	constructed	construct	VBD
10_1101-2020_03_27_012757	93	37	a	a	DT
10_1101-2020_03_27_012757	93	38	classifier	classifier	NN
10_1101-2020_03_27_012757	93	39	using	use	VBG
10_1101-2020_03_27_012757	93	40	cell	cell	NN
10_1101-2020_03_27_012757	93	41	types	type	NNS
10_1101-2020_03_27_012757	93	42	found	find	VBN
10_1101-2020_03_27_012757	93	43	in	in	IN
10_1101-2020_03_27_012757	93	44	human	human	JJ
10_1101-2020_03_27_012757	93	45	melanoma	melanoma	NN
10_1101-2020_03_27_012757	93	46	and	and	CC
10_1101-2020_03_27_012757	93	47	230	230	CD
10_1101-2020_03_27_012757	93	48	glioblastoma	glioblastoma	NN
10_1101-2020_03_27_012757	93	49	scRNA	scrna	NN
10_1101-2020_03_27_012757	93	50	-	-	HYPH
10_1101-2020_03_27_012757	93	51	seq	seq	NN
10_1101-2020_03_27_012757	93	52	data40,41	data40,41	NNP
10_1101-2020_03_27_012757	93	53	.	.	.
10_1101-2020_03_27_012757	94	1	Previously	previously	RB
10_1101-2020_03_27_012757	94	2	,	,	,
10_1101-2020_03_27_012757	94	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	94	4	have	have	VBP
10_1101-2020_03_27_012757	94	5	demonstrated	demonstrate	VBN
10_1101-2020_03_27_012757	94	6	the	the	DT
10_1101-2020_03_27_012757	94	7	feasibility	feasibility	NN
10_1101-2020_03_27_012757	94	8	of	of	IN
10_1101-2020_03_27_012757	94	9	using	use	VBG
10_1101-2020_03_27_012757	94	10	our	-PRON-	PRP$
10_1101-2020_03_27_012757	94	11	231	231	CD
10_1101-2020_03_27_012757	94	12	classification	classification	NN
10_1101-2020_03_27_012757	94	13	approach	approach	NN
10_1101-2020_03_27_012757	94	14	on	on	IN
10_1101-2020_03_27_012757	94	15	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	94	16	-	-	HYPH
10_1101-2020_03_27_012757	94	17	seq	seq	NN
10_1101-2020_03_27_012757	94	18	data23	data23	NN
10_1101-2020_03_27_012757	94	19	.	.	.
10_1101-2020_03_27_012757	95	1	Our	-PRON-	PRP$
10_1101-2020_03_27_012757	95	2	scRNA	scrna	JJ
10_1101-2020_03_27_012757	95	3	-	-	HYPH
10_1101-2020_03_27_012757	95	4	seq	seq	NN
10_1101-2020_03_27_012757	95	5	classifier	classifier	NN
10_1101-2020_03_27_012757	95	6	achieved	achieve	VBD
10_1101-2020_03_27_012757	95	7	a	a	DT
10_1101-2020_03_27_012757	95	8	high	high	JJ
10_1101-2020_03_27_012757	95	9	232	232	CD
10_1101-2020_03_27_012757	95	10	average	average	JJ
10_1101-2020_03_27_012757	95	11	AUPRC	AUPRC	NNS
10_1101-2020_03_27_012757	95	12	(	(	-LRB-
10_1101-2020_03_27_012757	95	13	0.95	0.95	CD
10_1101-2020_03_27_012757	95	14	)	)	-RRB-
10_1101-2020_03_27_012757	95	15	when	when	WRB
10_1101-2020_03_27_012757	95	16	applied	apply	VBN
10_1101-2020_03_27_012757	95	17	to	to	IN
10_1101-2020_03_27_012757	95	18	held	hold	VBN
10_1101-2020_03_27_012757	95	19	-	-	HYPH
10_1101-2020_03_27_012757	95	20	out	out	RP
10_1101-2020_03_27_012757	95	21	data	datum	NNS
10_1101-2020_03_27_012757	95	22	and	and	CC
10_1101-2020_03_27_012757	95	23	high	high	JJ
10_1101-2020_03_27_012757	95	24	mean	mean	JJ
10_1101-2020_03_27_012757	95	25	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	95	26	(	(	-LRB-
10_1101-2020_03_27_012757	95	27	0.99	0.99	CD
10_1101-2020_03_27_012757	95	28	)	)	-RRB-
10_1101-2020_03_27_012757	95	29	when	when	WRB
10_1101-2020_03_27_012757	95	30	233	233	CD
10_1101-2020_03_27_012757	95	31	applied	apply	VBD
10_1101-2020_03_27_012757	95	32	to	to	IN
10_1101-2020_03_27_012757	95	33	few	few	JJ
10_1101-2020_03_27_012757	95	34	purified	purify	VBN
10_1101-2020_03_27_012757	95	35	bulk	bulk	JJ
10_1101-2020_03_27_012757	95	36	testing	testing	NN
10_1101-2020_03_27_012757	95	37	samples	sample	NNS
10_1101-2020_03_27_012757	95	38	(	(	-LRB-
10_1101-2020_03_27_012757	95	39	Supp	Supp	NNP
10_1101-2020_03_27_012757	95	40	Fig	Fig	NNP
10_1101-2020_03_27_012757	95	41	3A	3A	NNP
10_1101-2020_03_27_012757	95	42	-	-	HYPH
10_1101-2020_03_27_012757	95	43	B	B	NNP
10_1101-2020_03_27_012757	95	44	)	)	-RRB-
10_1101-2020_03_27_012757	95	45	.	.	.
10_1101-2020_03_27_012757	96	1	Comparing	compare	VBG
10_1101-2020_03_27_012757	96	2	the	the	DT
10_1101-2020_03_27_012757	96	3	CCN	CCN	NNP
10_1101-2020_03_27_012757	96	4	score	score	NN
10_1101-2020_03_27_012757	96	5	from	from	IN
10_1101-2020_03_27_012757	96	6	234	234	CD
10_1101-2020_03_27_012757	96	7	bulk	bulk	NN
10_1101-2020_03_27_012757	96	8	RNA	RNA	NNP
10_1101-2020_03_27_012757	96	9	-	-	HYPH
10_1101-2020_03_27_012757	96	10	seq	seq	NN
10_1101-2020_03_27_012757	96	11	general	general	JJ
10_1101-2020_03_27_012757	96	12	classifier	classifier	NN
10_1101-2020_03_27_012757	96	13	and	and	CC
10_1101-2020_03_27_012757	96	14	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	96	15	-	-	HYPH
10_1101-2020_03_27_012757	96	16	seq	seq	NN
10_1101-2020_03_27_012757	96	17	classifier	classifier	NN
10_1101-2020_03_27_012757	96	18	,	,	,
10_1101-2020_03_27_012757	96	19	we	-PRON-	PRP
10_1101-2020_03_27_012757	96	20	observed	observe	VBD
10_1101-2020_03_27_012757	96	21	a	a	DT
10_1101-2020_03_27_012757	96	22	high	high	JJ
10_1101-2020_03_27_012757	96	23	level	level	NN
10_1101-2020_03_27_012757	96	24	of	of	IN
10_1101-2020_03_27_012757	96	25	235	235	CD
10_1101-2020_03_27_012757	96	26	correlation	correlation	NN
10_1101-2020_03_27_012757	96	27	(	(	-LRB-
10_1101-2020_03_27_012757	96	28	Pearson	Pearson	NNP
10_1101-2020_03_27_012757	96	29	correlation	correlation	NN
10_1101-2020_03_27_012757	96	30	of	of	IN
10_1101-2020_03_27_012757	96	31	0.89	0.89	CD
10_1101-2020_03_27_012757	96	32	)	)	-RRB-
10_1101-2020_03_27_012757	96	33	between	between	IN
10_1101-2020_03_27_012757	96	34	the	the	DT
10_1101-2020_03_27_012757	96	35	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	96	36	CCN	ccn	NN
10_1101-2020_03_27_012757	96	37	classification	classification	NN
10_1101-2020_03_27_012757	96	38	scores	score	NNS
10_1101-2020_03_27_012757	96	39	and	and	CC
10_1101-2020_03_27_012757	96	40	236	236	CD
10_1101-2020_03_27_012757	96	41	scRNA	scrna	CD
10_1101-2020_03_27_012757	96	42	-	-	HYPH
10_1101-2020_03_27_012757	96	43	seq	seq	NN
10_1101-2020_03_27_012757	96	44	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	96	45	malignant	malignant	JJ
10_1101-2020_03_27_012757	96	46	CCN	CCN	NNP
10_1101-2020_03_27_012757	96	47	classification	classification	NN
10_1101-2020_03_27_012757	96	48	scores	score	NNS
10_1101-2020_03_27_012757	96	49	for	for	IN
10_1101-2020_03_27_012757	96	50	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	96	51	cell	cell	NN
10_1101-2020_03_27_012757	96	52	lines	line	NNS
10_1101-2020_03_27_012757	96	53	(	(	-LRB-
10_1101-2020_03_27_012757	96	54	Fig	fig	NN
10_1101-2020_03_27_012757	96	55	2C	2c	NN
10_1101-2020_03_27_012757	96	56	,	,	,
10_1101-2020_03_27_012757	96	57	Supp	Supp	NNP
10_1101-2020_03_27_012757	96	58	Fig	Fig	NNP
10_1101-2020_03_27_012757	96	59	237	237	CD
10_1101-2020_03_27_012757	96	60	3C	3c	NN
10_1101-2020_03_27_012757	96	61	)	)	-RRB-
10_1101-2020_03_27_012757	96	62	.	.	.
10_1101-2020_03_27_012757	97	1	Of	of	IN
10_1101-2020_03_27_012757	97	2	the	the	DT
10_1101-2020_03_27_012757	97	3	41	41	CD
10_1101-2020_03_27_012757	97	4	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	97	5	cell	cell	NN
10_1101-2020_03_27_012757	97	6	lines	line	NNS
10_1101-2020_03_27_012757	97	7	that	that	WDT
10_1101-2020_03_27_012757	97	8	were	be	VBD
10_1101-2020_03_27_012757	97	9	classified	classify	VBN
10_1101-2020_03_27_012757	97	10	as	as	IN
10_1101-2020_03_27_012757	97	11	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	97	12	by	by	IN
10_1101-2020_03_27_012757	97	13	the	the	DT
10_1101-2020_03_27_012757	97	14	bulk	bulk	NN
10_1101-2020_03_27_012757	97	15	classifier	classifier	NN
10_1101-2020_03_27_012757	97	16	,	,	,
10_1101-2020_03_27_012757	97	17	37	37	CD
10_1101-2020_03_27_012757	97	18	were	be	VBD
10_1101-2020_03_27_012757	97	19	also	also	RB
10_1101-2020_03_27_012757	97	20	238	238	CD
10_1101-2020_03_27_012757	97	21	classified	classify	VBN
10_1101-2020_03_27_012757	97	22	as	as	IN
10_1101-2020_03_27_012757	97	23	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	97	24	malignant	malignant	JJ
10_1101-2020_03_27_012757	97	25	cells	cell	NNS
10_1101-2020_03_27_012757	97	26	by	by	IN
10_1101-2020_03_27_012757	97	27	the	the	DT
10_1101-2020_03_27_012757	97	28	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	97	29	-	-	HYPH
10_1101-2020_03_27_012757	97	30	seq	seq	NN
10_1101-2020_03_27_012757	97	31	classifier	classifier	NN
10_1101-2020_03_27_012757	97	32	.	.	.
10_1101-2020_03_27_012757	98	1	Interestingly	interestingly	RB
10_1101-2020_03_27_012757	98	2	,	,	,
10_1101-2020_03_27_012757	98	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	98	4	also	also	RB
10_1101-2020_03_27_012757	98	5	observed	observe	VBD
10_1101-2020_03_27_012757	98	6	239	239	CD
10_1101-2020_03_27_012757	98	7	a	a	DT
10_1101-2020_03_27_012757	98	8	high	high	JJ
10_1101-2020_03_27_012757	98	9	correlation	correlation	NN
10_1101-2020_03_27_012757	98	10	between	between	IN
10_1101-2020_03_27_012757	98	11	the	the	DT
10_1101-2020_03_27_012757	98	12	SARC	SARC	NNP
10_1101-2020_03_27_012757	98	13	CCN	CCN	NNP
10_1101-2020_03_27_012757	98	14	classification	classification	NN
10_1101-2020_03_27_012757	98	15	score	score	NN
10_1101-2020_03_27_012757	98	16	and	and	CC
10_1101-2020_03_27_012757	98	17	scRNA	scrna	NN
10_1101-2020_03_27_012757	98	18	-	-	HYPH
10_1101-2020_03_27_012757	98	19	seq	seq	NN
10_1101-2020_03_27_012757	98	20	cancer	cancer	NN
10_1101-2020_03_27_012757	98	21	240	240	CD
10_1101-2020_03_27_012757	98	22	.CC	.CC	:
10_1101-2020_03_27_012757	98	23	-	-	:
10_1101-2020_03_27_012757	98	24	BY	by	IN
10_1101-2020_03_27_012757	98	25	-	-	HYPH
10_1101-2020_03_27_012757	98	26	NC	NC	NNP
10_1101-2020_03_27_012757	98	27	-	-	HYPH
10_1101-2020_03_27_012757	98	28	ND	ND	NNP
10_1101-2020_03_27_012757	98	29	4.0	4.0	CD
10_1101-2020_03_27_012757	98	30	International	International	NNP
10_1101-2020_03_27_012757	98	31	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	98	32	under	under	IN
10_1101-2020_03_27_012757	98	33	a	a	DT
10_1101-2020_03_27_012757	98	34	(	(	-LRB-
10_1101-2020_03_27_012757	98	35	which	which	WDT
10_1101-2020_03_27_012757	98	36	was	be	VBD
10_1101-2020_03_27_012757	98	37	not	not	RB
10_1101-2020_03_27_012757	98	38	certified	certify	VBN
10_1101-2020_03_27_012757	98	39	by	by	IN
10_1101-2020_03_27_012757	98	40	peer	peer	NN
10_1101-2020_03_27_012757	98	41	review	review	NN
10_1101-2020_03_27_012757	98	42	)	)	-RRB-
10_1101-2020_03_27_012757	98	43	is	be	VBZ
10_1101-2020_03_27_012757	98	44	the	the	DT
10_1101-2020_03_27_012757	98	45	author	author	NN
10_1101-2020_03_27_012757	98	46	/	/	SYM
10_1101-2020_03_27_012757	98	47	funder	funder	NN
10_1101-2020_03_27_012757	98	48	,	,	,
10_1101-2020_03_27_012757	98	49	who	who	WP
10_1101-2020_03_27_012757	98	50	has	have	VBZ
10_1101-2020_03_27_012757	98	51	granted	grant	VBN
10_1101-2020_03_27_012757	98	52	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	98	53	a	a	DT
10_1101-2020_03_27_012757	98	54	license	license	NN
10_1101-2020_03_27_012757	98	55	to	to	TO
10_1101-2020_03_27_012757	98	56	display	display	VB
10_1101-2020_03_27_012757	98	57	the	the	DT
10_1101-2020_03_27_012757	98	58	preprint	preprint	NN
10_1101-2020_03_27_012757	98	59	in	in	IN
10_1101-2020_03_27_012757	98	60	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	98	61	.	.	.
10_1101-2020_03_27_012757	99	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	99	2	is	be	VBZ
10_1101-2020_03_27_012757	99	3	made	make	VBN
10_1101-2020_03_27_012757	99	4	The	the	DT
10_1101-2020_03_27_012757	99	5	copyright	copyright	NN
10_1101-2020_03_27_012757	99	6	holder	holder	NN
10_1101-2020_03_27_012757	99	7	for	for	IN
10_1101-2020_03_27_012757	99	8	this	this	DT
10_1101-2020_03_27_012757	99	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	99	10	version	version	NN
10_1101-2020_03_27_012757	99	11	posted	post	VBD
10_1101-2020_03_27_012757	99	12	January	January	NNP
10_1101-2020_03_27_012757	99	13	9	9	CD
10_1101-2020_03_27_012757	99	14	,	,	,
10_1101-2020_03_27_012757	99	15	2021	2021	CD
10_1101-2020_03_27_012757	99	16	.	.	.
10_1101-2020_03_27_012757	99	17	;	;	:
10_1101-2020_03_27_012757	99	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	99	19	:	:	:
10_1101-2020_03_27_012757	99	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	99	21	preprint	preprint	NN
10_1101-2020_03_27_012757	99	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	99	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	99	24	9	9	CD
10_1101-2020_03_27_012757	99	25	associated	associate	VBN
10_1101-2020_03_27_012757	99	26	fibroblast	fibroblast	NN
10_1101-2020_03_27_012757	99	27	(	(	-LRB-
10_1101-2020_03_27_012757	99	28	CAF	CAF	NNP
10_1101-2020_03_27_012757	99	29	)	)	-RRB-
10_1101-2020_03_27_012757	99	30	CCN	CCN	NNP
10_1101-2020_03_27_012757	99	31	classification	classification	NN
10_1101-2020_03_27_012757	99	32	scores	score	NNS
10_1101-2020_03_27_012757	99	33	(	(	-LRB-
10_1101-2020_03_27_012757	99	34	Pearson	Pearson	NNP
10_1101-2020_03_27_012757	99	35	correlation	correlation	NN
10_1101-2020_03_27_012757	99	36	of	of	IN
10_1101-2020_03_27_012757	99	37	0.92	0.92	CD
10_1101-2020_03_27_012757	99	38	)	)	-RRB-
10_1101-2020_03_27_012757	99	39	.	.	.
10_1101-2020_03_27_012757	100	1	Six	six	CD
10_1101-2020_03_27_012757	100	2	of	of	IN
10_1101-2020_03_27_012757	100	3	the	the	DT
10_1101-2020_03_27_012757	100	4	241	241	CD
10_1101-2020_03_27_012757	100	5	seven	seven	CD
10_1101-2020_03_27_012757	100	6	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	100	7	cell	cell	NN
10_1101-2020_03_27_012757	100	8	lines	line	NNS
10_1101-2020_03_27_012757	100	9	that	that	WDT
10_1101-2020_03_27_012757	100	10	had	have	VBD
10_1101-2020_03_27_012757	100	11	been	be	VBN
10_1101-2020_03_27_012757	100	12	classified	classify	VBN
10_1101-2020_03_27_012757	100	13	as	as	IN
10_1101-2020_03_27_012757	100	14	exclusively	exclusively	RB
10_1101-2020_03_27_012757	100	15	SARC	SARC	VBN
10_1101-2020_03_27_012757	100	16	by	by	IN
10_1101-2020_03_27_012757	100	17	CCN	CCN	NNP
10_1101-2020_03_27_012757	100	18	were	be	VBD
10_1101-2020_03_27_012757	100	19	classified	classify	VBN
10_1101-2020_03_27_012757	100	20	as	as	IN
10_1101-2020_03_27_012757	100	21	242	242	CD
10_1101-2020_03_27_012757	100	22	CAF	CAF	NNP
10_1101-2020_03_27_012757	100	23	by	by	IN
10_1101-2020_03_27_012757	100	24	the	the	DT
10_1101-2020_03_27_012757	100	25	scRNA	scrna	CD
10_1101-2020_03_27_012757	100	26	-	-	HYPH
10_1101-2020_03_27_012757	100	27	seq	seq	NN
10_1101-2020_03_27_012757	100	28	classifier	classifier	NN
10_1101-2020_03_27_012757	100	29	(	(	-LRB-
10_1101-2020_03_27_012757	100	30	Fig	fig	NN
10_1101-2020_03_27_012757	100	31	2D	2D	VBD
10_1101-2020_03_27_012757	100	32	,	,	,
10_1101-2020_03_27_012757	100	33	Supp	Supp	NNP
10_1101-2020_03_27_012757	100	34	Fig	Fig	NNP
10_1101-2020_03_27_012757	100	35	3C	3c	NN
10_1101-2020_03_27_012757	100	36	)	)	-RRB-
10_1101-2020_03_27_012757	100	37	,	,	,
10_1101-2020_03_27_012757	100	38	which	which	WDT
10_1101-2020_03_27_012757	100	39	suggests	suggest	VBZ
10_1101-2020_03_27_012757	100	40	the	the	DT
10_1101-2020_03_27_012757	100	41	possibility	possibility	NN
10_1101-2020_03_27_012757	100	42	that	that	IN
10_1101-2020_03_27_012757	100	43	243	243	CD
10_1101-2020_03_27_012757	100	44	these	these	DT
10_1101-2020_03_27_012757	100	45	cell	cell	NN
10_1101-2020_03_27_012757	100	46	lines	line	NNS
10_1101-2020_03_27_012757	100	47	were	be	VBD
10_1101-2020_03_27_012757	100	48	derived	derive	VBN
10_1101-2020_03_27_012757	100	49	from	from	IN
10_1101-2020_03_27_012757	100	50	CAF	CAF	NNP
10_1101-2020_03_27_012757	100	51	or	or	CC
10_1101-2020_03_27_012757	100	52	other	other	JJ
10_1101-2020_03_27_012757	100	53	mesenchymal	mesenchymal	JJ
10_1101-2020_03_27_012757	100	54	populations	population	NNS
10_1101-2020_03_27_012757	100	55	,	,	,
10_1101-2020_03_27_012757	100	56	or	or	CC
10_1101-2020_03_27_012757	100	57	that	that	IN
10_1101-2020_03_27_012757	100	58	they	-PRON-	PRP
10_1101-2020_03_27_012757	100	59	have	have	VBP
10_1101-2020_03_27_012757	100	60	244	244	CD
10_1101-2020_03_27_012757	100	61	acquired	acquire	VBN
10_1101-2020_03_27_012757	100	62	a	a	DT
10_1101-2020_03_27_012757	100	63	mesenchymal	mesenchymal	JJ
10_1101-2020_03_27_012757	100	64	character	character	NN
10_1101-2020_03_27_012757	100	65	through	through	IN
10_1101-2020_03_27_012757	100	66	their	-PRON-	PRP$
10_1101-2020_03_27_012757	100	67	derivation	derivation	NN
10_1101-2020_03_27_012757	100	68	.	.	.
10_1101-2020_03_27_012757	101	1	The	the	DT
10_1101-2020_03_27_012757	101	2	high	high	JJ
10_1101-2020_03_27_012757	101	3	level	level	NN
10_1101-2020_03_27_012757	101	4	of	of	IN
10_1101-2020_03_27_012757	101	5	agreement	agreement	NN
10_1101-2020_03_27_012757	101	6	245	245	CD
10_1101-2020_03_27_012757	101	7	between	between	IN
10_1101-2020_03_27_012757	101	8	scRNA	scrna	CD
10_1101-2020_03_27_012757	101	9	-	-	HYPH
10_1101-2020_03_27_012757	101	10	seq	seq	NN
10_1101-2020_03_27_012757	101	11	and	and	CC
10_1101-2020_03_27_012757	101	12	bulk	bulk	NNP
10_1101-2020_03_27_012757	101	13	RNA	RNA	NNP
10_1101-2020_03_27_012757	101	14	-	-	HYPH
10_1101-2020_03_27_012757	101	15	seq	seq	NN
10_1101-2020_03_27_012757	101	16	classification	classification	NN
10_1101-2020_03_27_012757	101	17	results	result	NNS
10_1101-2020_03_27_012757	101	18	shows	show	VBZ
10_1101-2020_03_27_012757	101	19	that	that	IN
10_1101-2020_03_27_012757	101	20	heterogeneity	heterogeneity	NN
10_1101-2020_03_27_012757	101	21	in	in	IN
10_1101-2020_03_27_012757	101	22	the	the	DT
10_1101-2020_03_27_012757	101	23	246	246	CD
10_1101-2020_03_27_012757	101	24	training	training	NN
10_1101-2020_03_27_012757	101	25	data	datum	NNS
10_1101-2020_03_27_012757	101	26	of	of	IN
10_1101-2020_03_27_012757	101	27	general	general	JJ
10_1101-2020_03_27_012757	101	28	CCN	CCN	NNP
10_1101-2020_03_27_012757	101	29	classifier	classifier	NN
10_1101-2020_03_27_012757	101	30	has	have	VBZ
10_1101-2020_03_27_012757	101	31	little	little	JJ
10_1101-2020_03_27_012757	101	32	impact	impact	NN
10_1101-2020_03_27_012757	101	33	in	in	IN
10_1101-2020_03_27_012757	101	34	the	the	DT
10_1101-2020_03_27_012757	101	35	classification	classification	NN
10_1101-2020_03_27_012757	101	36	of	of	IN
10_1101-2020_03_27_012757	101	37	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	101	38	cell	cell	NN
10_1101-2020_03_27_012757	101	39	lines	line	NNS
10_1101-2020_03_27_012757	101	40	.	.	.
10_1101-2020_03_27_012757	102	1	247	247	CD
10_1101-2020_03_27_012757	102	2	In	in	IN
10_1101-2020_03_27_012757	102	3	contrast	contrast	NN
10_1101-2020_03_27_012757	102	4	,	,	,
10_1101-2020_03_27_012757	102	5	we	-PRON-	PRP
10_1101-2020_03_27_012757	102	6	observed	observe	VBD
10_1101-2020_03_27_012757	102	7	a	a	DT
10_1101-2020_03_27_012757	102	8	weaker	weak	JJR
10_1101-2020_03_27_012757	102	9	correlation	correlation	NN
10_1101-2020_03_27_012757	102	10	between	between	IN
10_1101-2020_03_27_012757	102	11	GBM	GBM	NNP
10_1101-2020_03_27_012757	102	12	CCN	CCN	NNP
10_1101-2020_03_27_012757	102	13	classification	classification	NN
10_1101-2020_03_27_012757	102	14	scores	score	NNS
10_1101-2020_03_27_012757	102	15	248	248	CD
10_1101-2020_03_27_012757	102	16	and	and	CC
10_1101-2020_03_27_012757	102	17	scRNA	scrna	CD
10_1101-2020_03_27_012757	102	18	-	-	HYPH
10_1101-2020_03_27_012757	102	19	seq	seq	NN
10_1101-2020_03_27_012757	102	20	GBM	GBM	NNP
10_1101-2020_03_27_012757	102	21	neoplastic	neoplastic	JJ
10_1101-2020_03_27_012757	102	22	CCN	CCN	NNP
10_1101-2020_03_27_012757	102	23	classification	classification	NN
10_1101-2020_03_27_012757	102	24	scores	score	NNS
10_1101-2020_03_27_012757	102	25	(	(	-LRB-
10_1101-2020_03_27_012757	102	26	Pearson	Pearson	NNP
10_1101-2020_03_27_012757	102	27	correlation	correlation	NN
10_1101-2020_03_27_012757	102	28	of	of	IN
10_1101-2020_03_27_012757	102	29	0.72	0.72	CD
10_1101-2020_03_27_012757	102	30	)	)	-RRB-
10_1101-2020_03_27_012757	102	31	for	for	IN
10_1101-2020_03_27_012757	102	32	249	249	CD
10_1101-2020_03_27_012757	102	33	GBM	GBM	NNP
10_1101-2020_03_27_012757	102	34	cell	cell	NN
10_1101-2020_03_27_012757	102	35	lines	line	NNS
10_1101-2020_03_27_012757	102	36	(	(	-LRB-
10_1101-2020_03_27_012757	102	37	Fig	fig	NN
10_1101-2020_03_27_012757	102	38	2E	2e	NN
10_1101-2020_03_27_012757	102	39	,	,	,
10_1101-2020_03_27_012757	102	40	Supp	Supp	NNP
10_1101-2020_03_27_012757	102	41	Fig	Fig	NNP
10_1101-2020_03_27_012757	102	42	3D	3d	NN
10_1101-2020_03_27_012757	102	43	)	)	-RRB-
10_1101-2020_03_27_012757	102	44	.	.	.
10_1101-2020_03_27_012757	103	1	Of	of	IN
10_1101-2020_03_27_012757	103	2	the	the	DT
10_1101-2020_03_27_012757	103	3	31	31	CD
10_1101-2020_03_27_012757	103	4	GBM	GBM	NNP
10_1101-2020_03_27_012757	103	5	lines	line	NNS
10_1101-2020_03_27_012757	103	6	that	that	WDT
10_1101-2020_03_27_012757	103	7	were	be	VBD
10_1101-2020_03_27_012757	103	8	not	not	RB
10_1101-2020_03_27_012757	103	9	classified	classify	VBN
10_1101-2020_03_27_012757	103	10	as	as	IN
10_1101-2020_03_27_012757	103	11	GBM	GBM	NNP
10_1101-2020_03_27_012757	103	12	250	250	CD
10_1101-2020_03_27_012757	103	13	with	with	IN
10_1101-2020_03_27_012757	103	14	CCN	CCN	NNP
10_1101-2020_03_27_012757	103	15	,	,	,
10_1101-2020_03_27_012757	103	16	25	25	CD
10_1101-2020_03_27_012757	103	17	were	be	VBD
10_1101-2020_03_27_012757	103	18	classified	classify	VBN
10_1101-2020_03_27_012757	103	19	as	as	IN
10_1101-2020_03_27_012757	103	20	GBM	GBM	NNP
10_1101-2020_03_27_012757	103	21	neoplastic	neoplastic	JJ
10_1101-2020_03_27_012757	103	22	cells	cell	NNS
10_1101-2020_03_27_012757	103	23	with	with	IN
10_1101-2020_03_27_012757	103	24	the	the	DT
10_1101-2020_03_27_012757	103	25	scRNA	scrna	CD
10_1101-2020_03_27_012757	103	26	-	-	HYPH
10_1101-2020_03_27_012757	103	27	seq	seq	NN
10_1101-2020_03_27_012757	103	28	classifier	classifier	NN
10_1101-2020_03_27_012757	103	29	.	.	.
10_1101-2020_03_27_012757	104	1	Among	among	IN
10_1101-2020_03_27_012757	104	2	the	the	DT
10_1101-2020_03_27_012757	104	3	251	251	CD
10_1101-2020_03_27_012757	104	4	22	22	CD
10_1101-2020_03_27_012757	104	5	GBM	GBM	NNP
10_1101-2020_03_27_012757	104	6	lines	line	NNS
10_1101-2020_03_27_012757	104	7	that	that	WDT
10_1101-2020_03_27_012757	104	8	were	be	VBD
10_1101-2020_03_27_012757	104	9	classified	classify	VBN
10_1101-2020_03_27_012757	104	10	as	as	IN
10_1101-2020_03_27_012757	104	11	SARC	sarc	NN
10_1101-2020_03_27_012757	104	12	with	with	IN
10_1101-2020_03_27_012757	104	13	CCN	CCN	NNP
10_1101-2020_03_27_012757	104	14	,	,	,
10_1101-2020_03_27_012757	104	15	15	15	CD
10_1101-2020_03_27_012757	104	16	cell	cell	NN
10_1101-2020_03_27_012757	104	17	lines	line	NNS
10_1101-2020_03_27_012757	104	18	were	be	VBD
10_1101-2020_03_27_012757	104	19	classified	classify	VBN
10_1101-2020_03_27_012757	104	20	as	as	IN
10_1101-2020_03_27_012757	104	21	CAF	CAF	NNP
10_1101-2020_03_27_012757	104	22	(	(	-LRB-
10_1101-2020_03_27_012757	104	23	Fig	Fig	NNP
10_1101-2020_03_27_012757	104	24	252	252	CD
10_1101-2020_03_27_012757	104	25	2F	2f	CD
10_1101-2020_03_27_012757	104	26	)	)	-RRB-
10_1101-2020_03_27_012757	104	27	,	,	,
10_1101-2020_03_27_012757	104	28	10	10	CD
10_1101-2020_03_27_012757	104	29	which	which	WDT
10_1101-2020_03_27_012757	104	30	were	be	VBD
10_1101-2020_03_27_012757	104	31	classified	classify	VBN
10_1101-2020_03_27_012757	104	32	as	as	IN
10_1101-2020_03_27_012757	104	33	both	both	CC
10_1101-2020_03_27_012757	104	34	GBM	GBM	NNP
10_1101-2020_03_27_012757	104	35	neoplastic	neoplastic	NN
10_1101-2020_03_27_012757	104	36	and	and	CC
10_1101-2020_03_27_012757	104	37	CAF	CAF	NNP
10_1101-2020_03_27_012757	104	38	in	in	IN
10_1101-2020_03_27_012757	104	39	the	the	DT
10_1101-2020_03_27_012757	104	40	scRNA	scrna	JJ
10_1101-2020_03_27_012757	104	41	-	-	HYPH
10_1101-2020_03_27_012757	104	42	seq	seq	NN
10_1101-2020_03_27_012757	104	43	classifier	classifier	NN
10_1101-2020_03_27_012757	104	44	.	.	.
10_1101-2020_03_27_012757	105	1	253	253	CD
10_1101-2020_03_27_012757	105	2	Similar	similar	JJ
10_1101-2020_03_27_012757	105	3	to	to	IN
10_1101-2020_03_27_012757	105	4	the	the	DT
10_1101-2020_03_27_012757	105	5	situation	situation	NN
10_1101-2020_03_27_012757	105	6	with	with	IN
10_1101-2020_03_27_012757	105	7	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	105	8	lines	line	NNS
10_1101-2020_03_27_012757	105	9	that	that	WDT
10_1101-2020_03_27_012757	105	10	classify	classify	VBP
10_1101-2020_03_27_012757	105	11	as	as	IN
10_1101-2020_03_27_012757	105	12	CAF	CAF	NNP
10_1101-2020_03_27_012757	105	13	,	,	,
10_1101-2020_03_27_012757	105	14	this	this	DT
10_1101-2020_03_27_012757	105	15	result	result	NN
10_1101-2020_03_27_012757	105	16	is	be	VBZ
10_1101-2020_03_27_012757	105	17	consistent	consistent	JJ
10_1101-2020_03_27_012757	105	18	with	with	IN
10_1101-2020_03_27_012757	105	19	the	the	DT
10_1101-2020_03_27_012757	105	20	254	254	CD
10_1101-2020_03_27_012757	105	21	possibility	possibility	NN
10_1101-2020_03_27_012757	105	22	that	that	IN
10_1101-2020_03_27_012757	105	23	some	some	DT
10_1101-2020_03_27_012757	105	24	GBM	GBM	NNP
10_1101-2020_03_27_012757	105	25	lines	line	NNS
10_1101-2020_03_27_012757	105	26	classified	classify	VBD
10_1101-2020_03_27_012757	105	27	as	as	IN
10_1101-2020_03_27_012757	105	28	SARC	SARC	VBN
10_1101-2020_03_27_012757	105	29	by	by	IN
10_1101-2020_03_27_012757	105	30	CCN	CCN	NNP
10_1101-2020_03_27_012757	105	31	could	could	MD
10_1101-2020_03_27_012757	105	32	be	be	VB
10_1101-2020_03_27_012757	105	33	derived	derive	VBN
10_1101-2020_03_27_012757	105	34	from	from	IN
10_1101-2020_03_27_012757	105	35	255	255	CD
10_1101-2020_03_27_012757	105	36	mesenchymal	mesenchymal	JJ
10_1101-2020_03_27_012757	105	37	subtypes	subtype	NNS
10_1101-2020_03_27_012757	105	38	exhibiting	exhibit	VBG
10_1101-2020_03_27_012757	105	39	both	both	CC
10_1101-2020_03_27_012757	105	40	strong	strong	JJ
10_1101-2020_03_27_012757	105	41	mesenchymal	mesenchymal	JJ
10_1101-2020_03_27_012757	105	42	signatures	signature	NNS
10_1101-2020_03_27_012757	105	43	and	and	CC
10_1101-2020_03_27_012757	105	44	glioblastoma	glioblastoma	NNP
10_1101-2020_03_27_012757	105	45	256	256	CD
10_1101-2020_03_27_012757	105	46	signatures	signature	NNS
10_1101-2020_03_27_012757	105	47	or	or	CC
10_1101-2020_03_27_012757	105	48	that	that	IN
10_1101-2020_03_27_012757	105	49	they	-PRON-	PRP
10_1101-2020_03_27_012757	105	50	have	have	VBP
10_1101-2020_03_27_012757	105	51	acquired	acquire	VBN
10_1101-2020_03_27_012757	105	52	a	a	DT
10_1101-2020_03_27_012757	105	53	mesenchymal	mesenchymal	JJ
10_1101-2020_03_27_012757	105	54	character	character	NN
10_1101-2020_03_27_012757	105	55	through	through	IN
10_1101-2020_03_27_012757	105	56	their	-PRON-	PRP$
10_1101-2020_03_27_012757	105	57	derivation	derivation	NN
10_1101-2020_03_27_012757	105	58	.	.	.
10_1101-2020_03_27_012757	106	1	The	the	DT
10_1101-2020_03_27_012757	106	2	257	257	CD
10_1101-2020_03_27_012757	106	3	lower	low	JJR
10_1101-2020_03_27_012757	106	4	level	level	NN
10_1101-2020_03_27_012757	106	5	of	of	IN
10_1101-2020_03_27_012757	106	6	agreement	agreement	NN
10_1101-2020_03_27_012757	106	7	between	between	IN
10_1101-2020_03_27_012757	106	8	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	106	9	-	-	HYPH
10_1101-2020_03_27_012757	106	10	seq	seq	NN
10_1101-2020_03_27_012757	106	11	and	and	CC
10_1101-2020_03_27_012757	106	12	bulk	bulk	NNP
10_1101-2020_03_27_012757	106	13	RNA	RNA	NNP
10_1101-2020_03_27_012757	106	14	-	-	HYPH
10_1101-2020_03_27_012757	106	15	seq	seq	NN
10_1101-2020_03_27_012757	106	16	classification	classification	NN
10_1101-2020_03_27_012757	106	17	results	result	NNS
10_1101-2020_03_27_012757	106	18	for	for	IN
10_1101-2020_03_27_012757	106	19	GBM	GBM	NNP
10_1101-2020_03_27_012757	106	20	258	258	CD
10_1101-2020_03_27_012757	106	21	models	model	NNS
10_1101-2020_03_27_012757	106	22	suggests	suggest	VBZ
10_1101-2020_03_27_012757	106	23	that	that	IN
10_1101-2020_03_27_012757	106	24	the	the	DT
10_1101-2020_03_27_012757	106	25	heterogeneity	heterogeneity	NN
10_1101-2020_03_27_012757	106	26	of	of	IN
10_1101-2020_03_27_012757	106	27	glioblastomas42	glioblastomas42	NNP
10_1101-2020_03_27_012757	106	28	can	can	MD
10_1101-2020_03_27_012757	106	29	impact	impact	VB
10_1101-2020_03_27_012757	106	30	the	the	DT
10_1101-2020_03_27_012757	106	31	classification	classification	NN
10_1101-2020_03_27_012757	106	32	of	of	IN
10_1101-2020_03_27_012757	106	33	GBM	GBM	NNP
10_1101-2020_03_27_012757	106	34	259	259	CD
10_1101-2020_03_27_012757	106	35	cell	cell	NN
10_1101-2020_03_27_012757	106	36	lines	line	NNS
10_1101-2020_03_27_012757	106	37	,	,	,
10_1101-2020_03_27_012757	106	38	and	and	CC
10_1101-2020_03_27_012757	106	39	that	that	IN
10_1101-2020_03_27_012757	106	40	the	the	DT
10_1101-2020_03_27_012757	106	41	use	use	NN
10_1101-2020_03_27_012757	106	42	of	of	IN
10_1101-2020_03_27_012757	106	43	scRNA	scrna	JJ
10_1101-2020_03_27_012757	106	44	-	-	HYPH
10_1101-2020_03_27_012757	106	45	seq	seq	NN
10_1101-2020_03_27_012757	106	46	classifier	classifier	NN
10_1101-2020_03_27_012757	106	47	can	can	MD
10_1101-2020_03_27_012757	106	48	resolve	resolve	VB
10_1101-2020_03_27_012757	106	49	this	this	DT
10_1101-2020_03_27_012757	106	50	deficiency	deficiency	NN
10_1101-2020_03_27_012757	106	51	.	.	.
10_1101-2020_03_27_012757	107	1	260	260	CD
10_1101-2020_03_27_012757	107	2	261	261	CD
10_1101-2020_03_27_012757	107	3	Immunofluorescence	immunofluorescence	JJ
10_1101-2020_03_27_012757	107	4	confirmation	confirmation	NN
10_1101-2020_03_27_012757	107	5	of	of	IN
10_1101-2020_03_27_012757	107	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	107	7	predictions	prediction	NNS
10_1101-2020_03_27_012757	107	8	262	262	CD
10_1101-2020_03_27_012757	107	9	To	to	TO
10_1101-2020_03_27_012757	107	10	experimentally	experimentally	RB
10_1101-2020_03_27_012757	107	11	explore	explore	VB
10_1101-2020_03_27_012757	107	12	some	some	DT
10_1101-2020_03_27_012757	107	13	of	of	IN
10_1101-2020_03_27_012757	107	14	our	-PRON-	PRP$
10_1101-2020_03_27_012757	107	15	computational	computational	JJ
10_1101-2020_03_27_012757	107	16	analyses	analysis	NNS
10_1101-2020_03_27_012757	107	17	,	,	,
10_1101-2020_03_27_012757	107	18	we	-PRON-	PRP
10_1101-2020_03_27_012757	107	19	performed	perform	VBD
10_1101-2020_03_27_012757	107	20	263	263	CD
10_1101-2020_03_27_012757	107	21	immunofluorescence	immunofluorescence	NN
10_1101-2020_03_27_012757	107	22	on	on	IN
10_1101-2020_03_27_012757	107	23	three	three	CD
10_1101-2020_03_27_012757	107	24	cell	cell	NN
10_1101-2020_03_27_012757	107	25	lines	line	NNS
10_1101-2020_03_27_012757	107	26	that	that	WDT
10_1101-2020_03_27_012757	107	27	were	be	VBD
10_1101-2020_03_27_012757	107	28	not	not	RB
10_1101-2020_03_27_012757	107	29	classified	classify	VBN
10_1101-2020_03_27_012757	107	30	as	as	IN
10_1101-2020_03_27_012757	107	31	their	-PRON-	PRP$
10_1101-2020_03_27_012757	107	32	labelled	label	VBN
10_1101-2020_03_27_012757	107	33	categories	category	NNS
10_1101-2020_03_27_012757	107	34	:	:	:
10_1101-2020_03_27_012757	107	35	the	the	DT
10_1101-2020_03_27_012757	107	36	264	264	CD
10_1101-2020_03_27_012757	107	37	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	107	38	cancer	cancer	NN
10_1101-2020_03_27_012757	107	39	line	line	NN
10_1101-2020_03_27_012757	107	40	SK	SK	NNP
10_1101-2020_03_27_012757	107	41	-	-	HYPH
10_1101-2020_03_27_012757	107	42	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	107	43	had	have	VBD
10_1101-2020_03_27_012757	107	44	a	a	DT
10_1101-2020_03_27_012757	107	45	high	high	JJ
10_1101-2020_03_27_012757	107	46	UCEC	ucec	NN
10_1101-2020_03_27_012757	107	47	CCN	CCN	NNP
10_1101-2020_03_27_012757	107	48	score	score	NN
10_1101-2020_03_27_012757	107	49	(	(	-LRB-
10_1101-2020_03_27_012757	107	50	0.246	0.246	CD
10_1101-2020_03_27_012757	107	51	)	)	-RRB-
10_1101-2020_03_27_012757	107	52	,	,	,
10_1101-2020_03_27_012757	107	53	the	the	DT
10_1101-2020_03_27_012757	107	54	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	107	55	cancer	cancer	NN
10_1101-2020_03_27_012757	107	56	line	line	NN
10_1101-2020_03_27_012757	107	57	265	265	CD
10_1101-2020_03_27_012757	107	58	A2780	A2780	NNP
10_1101-2020_03_27_012757	107	59	had	have	VBD
10_1101-2020_03_27_012757	107	60	a	a	DT
10_1101-2020_03_27_012757	107	61	high	high	JJ
10_1101-2020_03_27_012757	107	62	Testicular	Testicular	NNP
10_1101-2020_03_27_012757	107	63	Germ	Germ	NNP
10_1101-2020_03_27_012757	107	64	Cell	Cell	NNP
10_1101-2020_03_27_012757	107	65	Tumors	Tumors	NNPS
10_1101-2020_03_27_012757	107	66	(	(	-LRB-
10_1101-2020_03_27_012757	107	67	TGCT	TGCT	NNP
10_1101-2020_03_27_012757	107	68	)	)	-RRB-
10_1101-2020_03_27_012757	107	69	CCN	CCN	NNP
10_1101-2020_03_27_012757	107	70	score	score	NN
10_1101-2020_03_27_012757	107	71	(	(	-LRB-
10_1101-2020_03_27_012757	107	72	0.327	0.327	CD
10_1101-2020_03_27_012757	107	73	)	)	-RRB-
10_1101-2020_03_27_012757	107	74	,	,	,
10_1101-2020_03_27_012757	107	75	and	and	CC
10_1101-2020_03_27_012757	107	76	the	the	DT
10_1101-2020_03_27_012757	107	77	prostate	prostate	NN
10_1101-2020_03_27_012757	107	78	266	266	CD
10_1101-2020_03_27_012757	107	79	.CC	.CC	,
10_1101-2020_03_27_012757	107	80	-	-	:
10_1101-2020_03_27_012757	107	81	BY	by	IN
10_1101-2020_03_27_012757	107	82	-	-	HYPH
10_1101-2020_03_27_012757	107	83	NC	NC	NNP
10_1101-2020_03_27_012757	107	84	-	-	HYPH
10_1101-2020_03_27_012757	107	85	ND	ND	NNP
10_1101-2020_03_27_012757	107	86	4.0	4.0	CD
10_1101-2020_03_27_012757	107	87	International	International	NNP
10_1101-2020_03_27_012757	107	88	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	107	89	under	under	IN
10_1101-2020_03_27_012757	107	90	a	a	DT
10_1101-2020_03_27_012757	107	91	(	(	-LRB-
10_1101-2020_03_27_012757	107	92	which	which	WDT
10_1101-2020_03_27_012757	107	93	was	be	VBD
10_1101-2020_03_27_012757	107	94	not	not	RB
10_1101-2020_03_27_012757	107	95	certified	certify	VBN
10_1101-2020_03_27_012757	107	96	by	by	IN
10_1101-2020_03_27_012757	107	97	peer	peer	NN
10_1101-2020_03_27_012757	107	98	review	review	NN
10_1101-2020_03_27_012757	107	99	)	)	-RRB-
10_1101-2020_03_27_012757	107	100	is	be	VBZ
10_1101-2020_03_27_012757	107	101	the	the	DT
10_1101-2020_03_27_012757	107	102	author	author	NN
10_1101-2020_03_27_012757	107	103	/	/	SYM
10_1101-2020_03_27_012757	107	104	funder	funder	NN
10_1101-2020_03_27_012757	107	105	,	,	,
10_1101-2020_03_27_012757	107	106	who	who	WP
10_1101-2020_03_27_012757	107	107	has	have	VBZ
10_1101-2020_03_27_012757	107	108	granted	grant	VBN
10_1101-2020_03_27_012757	107	109	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	107	110	a	a	DT
10_1101-2020_03_27_012757	107	111	license	license	NN
10_1101-2020_03_27_012757	107	112	to	to	TO
10_1101-2020_03_27_012757	107	113	display	display	VB
10_1101-2020_03_27_012757	107	114	the	the	DT
10_1101-2020_03_27_012757	107	115	preprint	preprint	NN
10_1101-2020_03_27_012757	107	116	in	in	IN
10_1101-2020_03_27_012757	107	117	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	107	118	.	.	.
10_1101-2020_03_27_012757	108	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	108	2	is	be	VBZ
10_1101-2020_03_27_012757	108	3	made	make	VBN
10_1101-2020_03_27_012757	108	4	The	the	DT
10_1101-2020_03_27_012757	108	5	copyright	copyright	NN
10_1101-2020_03_27_012757	108	6	holder	holder	NN
10_1101-2020_03_27_012757	108	7	for	for	IN
10_1101-2020_03_27_012757	108	8	this	this	DT
10_1101-2020_03_27_012757	108	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	108	10	version	version	NN
10_1101-2020_03_27_012757	108	11	posted	post	VBD
10_1101-2020_03_27_012757	108	12	January	January	NNP
10_1101-2020_03_27_012757	108	13	9	9	CD
10_1101-2020_03_27_012757	108	14	,	,	,
10_1101-2020_03_27_012757	108	15	2021	2021	CD
10_1101-2020_03_27_012757	108	16	.	.	.
10_1101-2020_03_27_012757	108	17	;	;	:
10_1101-2020_03_27_012757	108	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	108	19	:	:	:
10_1101-2020_03_27_012757	108	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	108	21	preprint	preprint	NN
10_1101-2020_03_27_012757	108	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	108	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	108	24	10	10	CD
10_1101-2020_03_27_012757	108	25	cancer	cancer	NN
10_1101-2020_03_27_012757	108	26	line	line	NN
10_1101-2020_03_27_012757	108	27	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	108	28	had	have	VBD
10_1101-2020_03_27_012757	108	29	a	a	DT
10_1101-2020_03_27_012757	108	30	high	high	JJ
10_1101-2020_03_27_012757	108	31	bladder	bladder	NN
10_1101-2020_03_27_012757	108	32	cancer	cancer	NN
10_1101-2020_03_27_012757	108	33	(	(	-LRB-
10_1101-2020_03_27_012757	108	34	BLCA	BLCA	NNP
10_1101-2020_03_27_012757	108	35	)	)	-RRB-
10_1101-2020_03_27_012757	108	36	score	score	NN
10_1101-2020_03_27_012757	108	37	(	(	-LRB-
10_1101-2020_03_27_012757	108	38	0.307	0.307	CD
10_1101-2020_03_27_012757	108	39	)	)	-RRB-
10_1101-2020_03_27_012757	108	40	(	(	-LRB-
10_1101-2020_03_27_012757	108	41	Supp	Supp	NNP
10_1101-2020_03_27_012757	108	42	Tab	Tab	NNP
10_1101-2020_03_27_012757	108	43	1	1	CD
10_1101-2020_03_27_012757	108	44	)	)	-RRB-
10_1101-2020_03_27_012757	108	45	.	.	.
10_1101-2020_03_27_012757	109	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	109	2	reasoned	reason	VBD
10_1101-2020_03_27_012757	109	3	267	267	CD
10_1101-2020_03_27_012757	109	4	that	that	IN
10_1101-2020_03_27_012757	109	5	if	if	IN
10_1101-2020_03_27_012757	109	6	SK	SK	NNP
10_1101-2020_03_27_012757	109	7	-	-	HYPH
10_1101-2020_03_27_012757	109	8	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	109	9	,	,	,
10_1101-2020_03_27_012757	109	10	A2780	A2780	NNP
10_1101-2020_03_27_012757	109	11	and	and	CC
10_1101-2020_03_27_012757	109	12	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	109	13	were	be	VBD
10_1101-2020_03_27_012757	109	14	classified	classify	VBN
10_1101-2020_03_27_012757	109	15	most	most	RBS
10_1101-2020_03_27_012757	109	16	strongly	strongly	RB
10_1101-2020_03_27_012757	109	17	as	as	IN
10_1101-2020_03_27_012757	109	18	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	109	19	,	,	,
10_1101-2020_03_27_012757	109	20	TGCT	TGCT	NNP
10_1101-2020_03_27_012757	109	21	and	and	CC
10_1101-2020_03_27_012757	109	22	BLCA	BLCA	NNP
10_1101-2020_03_27_012757	109	23	,	,	,
10_1101-2020_03_27_012757	109	24	268	268	CD
10_1101-2020_03_27_012757	109	25	respectively	respectively	RB
10_1101-2020_03_27_012757	109	26	,	,	,
10_1101-2020_03_27_012757	109	27	then	then	RB
10_1101-2020_03_27_012757	109	28	they	-PRON-	PRP
10_1101-2020_03_27_012757	109	29	would	would	MD
10_1101-2020_03_27_012757	109	30	express	express	VB
10_1101-2020_03_27_012757	109	31	proteins	protein	NNS
10_1101-2020_03_27_012757	109	32	that	that	WDT
10_1101-2020_03_27_012757	109	33	are	be	VBP
10_1101-2020_03_27_012757	109	34	indicative	indicative	JJ
10_1101-2020_03_27_012757	109	35	of	of	IN
10_1101-2020_03_27_012757	109	36	these	these	DT
10_1101-2020_03_27_012757	109	37	cancer	cancer	NN
10_1101-2020_03_27_012757	109	38	types	type	NNS
10_1101-2020_03_27_012757	109	39	.	.	.
10_1101-2020_03_27_012757	110	1	269	269	CD
10_1101-2020_03_27_012757	110	2	First	first	RB
10_1101-2020_03_27_012757	110	3	,	,	,
10_1101-2020_03_27_012757	110	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	110	5	measured	measure	VBD
10_1101-2020_03_27_012757	110	6	the	the	DT
10_1101-2020_03_27_012757	110	7	expression	expression	NN
10_1101-2020_03_27_012757	110	8	of	of	IN
10_1101-2020_03_27_012757	110	9	the	the	DT
10_1101-2020_03_27_012757	110	10	uterine	uterine	NN
10_1101-2020_03_27_012757	110	11	-	-	HYPH
10_1101-2020_03_27_012757	110	12	associated	associated	JJ
10_1101-2020_03_27_012757	110	13	transcription	transcription	NN
10_1101-2020_03_27_012757	110	14	factor	factor	NN
10_1101-2020_03_27_012757	110	15	270	270	CD
10_1101-2020_03_27_012757	110	16	HOXB643,44	HOXB643,44	NNS
10_1101-2020_03_27_012757	110	17	,	,	,
10_1101-2020_03_27_012757	110	18	and	and	CC
10_1101-2020_03_27_012757	110	19	the	the	DT
10_1101-2020_03_27_012757	110	20	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	110	21	serous	serous	JJ
10_1101-2020_03_27_012757	110	22	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	110	23	tumor	tumor	NN
10_1101-2020_03_27_012757	110	24	biomarker	biomarker	NN
10_1101-2020_03_27_012757	110	25	WT145	WT145	NNP
10_1101-2020_03_27_012757	110	26	in	in	IN
10_1101-2020_03_27_012757	110	27	SK	SK	NNP
10_1101-2020_03_27_012757	110	28	-	-	HYPH
10_1101-2020_03_27_012757	110	29	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	110	30	,	,	,
10_1101-2020_03_27_012757	110	31	in	in	IN
10_1101-2020_03_27_012757	110	32	the	the	DT
10_1101-2020_03_27_012757	110	33	OV	OV	NNP
10_1101-2020_03_27_012757	110	34	cell	cell	NN
10_1101-2020_03_27_012757	110	35	271	271	CD
10_1101-2020_03_27_012757	110	36	line	line	NN
10_1101-2020_03_27_012757	110	37	Caov-4	Caov-4	NNP
10_1101-2020_03_27_012757	110	38	,	,	,
10_1101-2020_03_27_012757	110	39	and	and	CC
10_1101-2020_03_27_012757	110	40	in	in	IN
10_1101-2020_03_27_012757	110	41	the	the	DT
10_1101-2020_03_27_012757	110	42	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	110	43	cell	cell	NN
10_1101-2020_03_27_012757	110	44	line	line	NN
10_1101-2020_03_27_012757	110	45	HEC-59	hec-59	RB
10_1101-2020_03_27_012757	110	46	.	.	.
10_1101-2020_03_27_012757	111	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	111	2	chose	choose	VBD
10_1101-2020_03_27_012757	111	3	Caov-4	Caov-4	NNP
10_1101-2020_03_27_012757	111	4	as	as	IN
10_1101-2020_03_27_012757	111	5	our	-PRON-	PRP$
10_1101-2020_03_27_012757	111	6	positive	positive	JJ
10_1101-2020_03_27_012757	111	7	control	control	NN
10_1101-2020_03_27_012757	111	8	for	for	IN
10_1101-2020_03_27_012757	111	9	OV	OV	NNP
10_1101-2020_03_27_012757	111	10	272	272	CD
10_1101-2020_03_27_012757	111	11	biomarker	biomarker	NN
10_1101-2020_03_27_012757	111	12	expression	expression	NN
10_1101-2020_03_27_012757	111	13	because	because	IN
10_1101-2020_03_27_012757	111	14	it	-PRON-	PRP
10_1101-2020_03_27_012757	111	15	was	be	VBD
10_1101-2020_03_27_012757	111	16	determined	determine	VBN
10_1101-2020_03_27_012757	111	17	by	by	IN
10_1101-2020_03_27_012757	111	18	our	-PRON-	PRP$
10_1101-2020_03_27_012757	111	19	analysis	analysis	NN
10_1101-2020_03_27_012757	111	20	and	and	CC
10_1101-2020_03_27_012757	111	21	others11,15	others11,15	JJ
10_1101-2020_03_27_012757	111	22	to	to	TO
10_1101-2020_03_27_012757	111	23	be	be	VB
10_1101-2020_03_27_012757	111	24	a	a	DT
10_1101-2020_03_27_012757	111	25	good	good	JJ
10_1101-2020_03_27_012757	111	26	273	273	CD
10_1101-2020_03_27_012757	111	27	model	model	NN
10_1101-2020_03_27_012757	111	28	of	of	IN
10_1101-2020_03_27_012757	111	29	OV	OV	NNP
10_1101-2020_03_27_012757	111	30	.	.	.
10_1101-2020_03_27_012757	112	1	Likewise	likewise	RB
10_1101-2020_03_27_012757	112	2	,	,	,
10_1101-2020_03_27_012757	112	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	112	4	chose	choose	VBD
10_1101-2020_03_27_012757	112	5	HEC-59	hec-59	JJ
10_1101-2020_03_27_012757	112	6	to	to	TO
10_1101-2020_03_27_012757	112	7	be	be	VB
10_1101-2020_03_27_012757	112	8	a	a	DT
10_1101-2020_03_27_012757	112	9	positive	positive	JJ
10_1101-2020_03_27_012757	112	10	control	control	NN
10_1101-2020_03_27_012757	112	11	for	for	IN
10_1101-2020_03_27_012757	112	12	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	112	13	.	.	.
10_1101-2020_03_27_012757	113	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	113	2	found	find	VBD
10_1101-2020_03_27_012757	113	3	that	that	IN
10_1101-2020_03_27_012757	113	4	SK-274	SK-274	NNP
10_1101-2020_03_27_012757	113	5	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	113	6	has	have	VBZ
10_1101-2020_03_27_012757	113	7	a	a	DT
10_1101-2020_03_27_012757	113	8	small	small	JJ
10_1101-2020_03_27_012757	113	9	percentage	percentage	NN
10_1101-2020_03_27_012757	113	10	(	(	-LRB-
10_1101-2020_03_27_012757	113	11	5	5	CD
10_1101-2020_03_27_012757	113	12	%	%	NN
10_1101-2020_03_27_012757	113	13	)	)	-RRB-
10_1101-2020_03_27_012757	113	14	of	of	IN
10_1101-2020_03_27_012757	113	15	cells	cell	NNS
10_1101-2020_03_27_012757	113	16	that	that	WDT
10_1101-2020_03_27_012757	113	17	expressed	express	VBD
10_1101-2020_03_27_012757	113	18	the	the	DT
10_1101-2020_03_27_012757	113	19	uterine	uterine	NN
10_1101-2020_03_27_012757	113	20	marker	marker	NN
10_1101-2020_03_27_012757	113	21	HOXB6	HOXB6	NNP
10_1101-2020_03_27_012757	113	22	and	and	CC
10_1101-2020_03_27_012757	113	23	a	a	DT
10_1101-2020_03_27_012757	113	24	275	275	CD
10_1101-2020_03_27_012757	113	25	large	large	JJ
10_1101-2020_03_27_012757	113	26	proportion	proportion	NN
10_1101-2020_03_27_012757	113	27	(	(	-LRB-
10_1101-2020_03_27_012757	113	28	73	73	CD
10_1101-2020_03_27_012757	113	29	%	%	NN
10_1101-2020_03_27_012757	113	30	)	)	-RRB-
10_1101-2020_03_27_012757	113	31	of	of	IN
10_1101-2020_03_27_012757	113	32	cells	cell	NNS
10_1101-2020_03_27_012757	113	33	that	that	WDT
10_1101-2020_03_27_012757	113	34	expressed	express	VBD
10_1101-2020_03_27_012757	113	35	WT1	WT1	NNP
10_1101-2020_03_27_012757	113	36	(	(	-LRB-
10_1101-2020_03_27_012757	113	37	Fig	Fig	NNP
10_1101-2020_03_27_012757	113	38	3A	3A	NNP
10_1101-2020_03_27_012757	113	39	)	)	-RRB-
10_1101-2020_03_27_012757	113	40	.	.	.
10_1101-2020_03_27_012757	114	1	In	in	IN
10_1101-2020_03_27_012757	114	2	contrast	contrast	NN
10_1101-2020_03_27_012757	114	3	,	,	,
10_1101-2020_03_27_012757	114	4	no	no	DT
10_1101-2020_03_27_012757	114	5	Caov-4	Caov-4	NNP
10_1101-2020_03_27_012757	114	6	cells	cell	NNS
10_1101-2020_03_27_012757	114	7	276	276	CD
10_1101-2020_03_27_012757	114	8	expressed	express	VBD
10_1101-2020_03_27_012757	114	9	HOXB6	HOXB6	NNS
10_1101-2020_03_27_012757	114	10	,	,	,
10_1101-2020_03_27_012757	114	11	whereas	whereas	IN
10_1101-2020_03_27_012757	114	12	85	85	CD
10_1101-2020_03_27_012757	114	13	%	%	NN
10_1101-2020_03_27_012757	114	14	of	of	IN
10_1101-2020_03_27_012757	114	15	cells	cell	NNS
10_1101-2020_03_27_012757	114	16	expressed	express	VBD
10_1101-2020_03_27_012757	114	17	WT1	WT1	NNP
10_1101-2020_03_27_012757	114	18	.	.	.
10_1101-2020_03_27_012757	115	1	This	this	DT
10_1101-2020_03_27_012757	115	2	suggests	suggest	VBZ
10_1101-2020_03_27_012757	115	3	that	that	IN
10_1101-2020_03_27_012757	115	4	SK	SK	NNP
10_1101-2020_03_27_012757	115	5	-	-	HYPH
10_1101-2020_03_27_012757	115	6	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	115	7	exhibits	exhibit	VBZ
10_1101-2020_03_27_012757	115	8	277	277	CD
10_1101-2020_03_27_012757	115	9	both	both	DT
10_1101-2020_03_27_012757	115	10	biomarkers	biomarker	NNS
10_1101-2020_03_27_012757	115	11	of	of	IN
10_1101-2020_03_27_012757	115	12	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	115	13	tumor	tumor	NN
10_1101-2020_03_27_012757	115	14	and	and	CC
10_1101-2020_03_27_012757	115	15	uterine	uterine	JJ
10_1101-2020_03_27_012757	115	16	tissue	tissue	NN
10_1101-2020_03_27_012757	115	17	.	.	.
10_1101-2020_03_27_012757	116	1	From	from	IN
10_1101-2020_03_27_012757	116	2	our	-PRON-	PRP$
10_1101-2020_03_27_012757	116	3	computational	computational	JJ
10_1101-2020_03_27_012757	116	4	analysis	analysis	NN
10_1101-2020_03_27_012757	116	5	and	and	CC
10_1101-2020_03_27_012757	116	6	278	278	CD
10_1101-2020_03_27_012757	116	7	experimental	experimental	JJ
10_1101-2020_03_27_012757	116	8	validation	validation	NN
10_1101-2020_03_27_012757	116	9	,	,	,
10_1101-2020_03_27_012757	116	10	SK	SK	NNP
10_1101-2020_03_27_012757	116	11	-	-	HYPH
10_1101-2020_03_27_012757	116	12	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	116	13	is	be	VBZ
10_1101-2020_03_27_012757	116	14	most	most	RBS
10_1101-2020_03_27_012757	116	15	likely	likely	RB
10_1101-2020_03_27_012757	116	16	an	an	DT
10_1101-2020_03_27_012757	116	17	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	116	18	subtype	subtype	NN
10_1101-2020_03_27_012757	116	19	of	of	IN
10_1101-2020_03_27_012757	116	20	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	116	21	cancer	cancer	NN
10_1101-2020_03_27_012757	116	22	.	.	.
10_1101-2020_03_27_012757	117	1	This	this	DT
10_1101-2020_03_27_012757	117	2	279	279	CD
10_1101-2020_03_27_012757	117	3	result	result	NN
10_1101-2020_03_27_012757	117	4	is	be	VBZ
10_1101-2020_03_27_012757	117	5	also	also	RB
10_1101-2020_03_27_012757	117	6	consistent	consistent	JJ
10_1101-2020_03_27_012757	117	7	with	with	IN
10_1101-2020_03_27_012757	117	8	prior	prior	JJ
10_1101-2020_03_27_012757	117	9	classification	classification	NN
10_1101-2020_03_27_012757	117	10	of	of	IN
10_1101-2020_03_27_012757	117	11	SK	SK	NNP
10_1101-2020_03_27_012757	117	12	-	-	HYPH
10_1101-2020_03_27_012757	117	13	OV-346	OV-346	NNP
10_1101-2020_03_27_012757	117	14	,	,	,
10_1101-2020_03_27_012757	117	15	and	and	CC
10_1101-2020_03_27_012757	117	16	the	the	DT
10_1101-2020_03_27_012757	117	17	fact	fact	NN
10_1101-2020_03_27_012757	117	18	that	that	IN
10_1101-2020_03_27_012757	117	19	SK	SK	NNP
10_1101-2020_03_27_012757	117	20	-	-	HYPH
10_1101-2020_03_27_012757	117	21	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	117	22	lacks	lack	VBZ
10_1101-2020_03_27_012757	117	23	280	280	CD
10_1101-2020_03_27_012757	117	24	p53	p53	NN
10_1101-2020_03_27_012757	117	25	mutations	mutation	NNS
10_1101-2020_03_27_012757	117	26	,	,	,
10_1101-2020_03_27_012757	117	27	which	which	WDT
10_1101-2020_03_27_012757	117	28	is	be	VBZ
10_1101-2020_03_27_012757	117	29	prevalent	prevalent	JJ
10_1101-2020_03_27_012757	117	30	in	in	IN
10_1101-2020_03_27_012757	117	31	high	high	JJ
10_1101-2020_03_27_012757	117	32	-	-	HYPH
10_1101-2020_03_27_012757	117	33	grade	grade	NN
10_1101-2020_03_27_012757	117	34	serous	serous	JJ
10_1101-2020_03_27_012757	117	35	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	117	36	cancer47	cancer47	NNP
10_1101-2020_03_27_012757	117	37	,	,	,
10_1101-2020_03_27_012757	117	38	and	and	CC
10_1101-2020_03_27_012757	117	39	it	-PRON-	PRP
10_1101-2020_03_27_012757	117	40	harbors	harbor	VBZ
10_1101-2020_03_27_012757	117	41	an	an	DT
10_1101-2020_03_27_012757	117	42	281	281	CD
10_1101-2020_03_27_012757	117	43	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	117	44	-	-	HYPH
10_1101-2020_03_27_012757	117	45	associated	associate	VBN
10_1101-2020_03_27_012757	117	46	mutation	mutation	NN
10_1101-2020_03_27_012757	117	47	in	in	IN
10_1101-2020_03_27_012757	117	48	ARID1A11,46,48	ARID1A11,46,48	NNP
10_1101-2020_03_27_012757	117	49	.	.	.
10_1101-2020_03_27_012757	118	1	Next	next	RB
10_1101-2020_03_27_012757	118	2	,	,	,
10_1101-2020_03_27_012757	118	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	118	4	measured	measure	VBD
10_1101-2020_03_27_012757	118	5	the	the	DT
10_1101-2020_03_27_012757	118	6	expression	expression	NN
10_1101-2020_03_27_012757	118	7	of	of	IN
10_1101-2020_03_27_012757	118	8	282	282	CD
10_1101-2020_03_27_012757	118	9	markers	marker	NNS
10_1101-2020_03_27_012757	118	10	of	of	IN
10_1101-2020_03_27_012757	118	11	OV	OV	NNP
10_1101-2020_03_27_012757	118	12	and	and	CC
10_1101-2020_03_27_012757	118	13	germ	germ	NNP
10_1101-2020_03_27_012757	118	14	cell	cell	NN
10_1101-2020_03_27_012757	118	15	cancers	cancer	NNS
10_1101-2020_03_27_012757	118	16	(	(	-LRB-
10_1101-2020_03_27_012757	118	17	LIN28A49	LIN28A49	NNP
10_1101-2020_03_27_012757	118	18	)	)	-RRB-
10_1101-2020_03_27_012757	118	19	in	in	IN
10_1101-2020_03_27_012757	118	20	the	the	DT
10_1101-2020_03_27_012757	118	21	OV	OV	NNP
10_1101-2020_03_27_012757	118	22	-	-	HYPH
10_1101-2020_03_27_012757	118	23	annotated	annotate	VBN
10_1101-2020_03_27_012757	118	24	cell	cell	NN
10_1101-2020_03_27_012757	118	25	line	line	NN
10_1101-2020_03_27_012757	118	26	A2780	A2780	NNP
10_1101-2020_03_27_012757	118	27	,	,	,
10_1101-2020_03_27_012757	118	28	which	which	WDT
10_1101-2020_03_27_012757	118	29	283	283	CD
10_1101-2020_03_27_012757	118	30	received	receive	VBD
10_1101-2020_03_27_012757	118	31	a	a	DT
10_1101-2020_03_27_012757	118	32	high	high	JJ
10_1101-2020_03_27_012757	118	33	TCGT	TCGT	NNP
10_1101-2020_03_27_012757	118	34	CCN	ccn	NN
10_1101-2020_03_27_012757	118	35	score	score	VBP
10_1101-2020_03_27_012757	118	36	.	.	.
10_1101-2020_03_27_012757	119	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	119	2	found	find	VBD
10_1101-2020_03_27_012757	119	3	that	that	IN
10_1101-2020_03_27_012757	119	4	54	54	CD
10_1101-2020_03_27_012757	119	5	%	%	NN
10_1101-2020_03_27_012757	119	6	of	of	IN
10_1101-2020_03_27_012757	119	7	A2780	A2780	NNP
10_1101-2020_03_27_012757	119	8	cells	cell	NNS
10_1101-2020_03_27_012757	119	9	expressed	express	VBD
10_1101-2020_03_27_012757	119	10	LIN28A	lin28a	IN
10_1101-2020_03_27_012757	119	11	284	284	CD
10_1101-2020_03_27_012757	119	12	whereas	whereas	IN
10_1101-2020_03_27_012757	119	13	it	-PRON-	PRP
10_1101-2020_03_27_012757	119	14	was	be	VBD
10_1101-2020_03_27_012757	119	15	not	not	RB
10_1101-2020_03_27_012757	119	16	detected	detect	VBN
10_1101-2020_03_27_012757	119	17	in	in	IN
10_1101-2020_03_27_012757	119	18	Caov-4	Caov-4	NNP
10_1101-2020_03_27_012757	119	19	(	(	-LRB-
10_1101-2020_03_27_012757	119	20	Fig	Fig	NNP
10_1101-2020_03_27_012757	119	21	3B	3b	NN
10_1101-2020_03_27_012757	119	22	)	)	-RRB-
10_1101-2020_03_27_012757	119	23	.	.	.
10_1101-2020_03_27_012757	120	1	The	the	DT
10_1101-2020_03_27_012757	120	2	OV	OV	NNP
10_1101-2020_03_27_012757	120	3	marker	marker	NN
10_1101-2020_03_27_012757	120	4	WT1	WT1	NNP
10_1101-2020_03_27_012757	120	5	was	be	VBD
10_1101-2020_03_27_012757	120	6	also	also	RB
10_1101-2020_03_27_012757	120	7	expressed	express	VBN
10_1101-2020_03_27_012757	120	8	in	in	IN
10_1101-2020_03_27_012757	120	9	285	285	CD
10_1101-2020_03_27_012757	120	10	fewer	few	JJR
10_1101-2020_03_27_012757	120	11	A2780	A2780	NNP
10_1101-2020_03_27_012757	120	12	cells	cell	NNS
10_1101-2020_03_27_012757	120	13	as	as	IN
10_1101-2020_03_27_012757	120	14	compared	compare	VBN
10_1101-2020_03_27_012757	120	15	to	to	IN
10_1101-2020_03_27_012757	120	16	Caov-4	Caov-4	NNP
10_1101-2020_03_27_012757	120	17	(	(	-LRB-
10_1101-2020_03_27_012757	120	18	48	48	CD
10_1101-2020_03_27_012757	120	19	%	%	NN
10_1101-2020_03_27_012757	120	20	vs	vs	IN
10_1101-2020_03_27_012757	120	21	85	85	CD
10_1101-2020_03_27_012757	120	22	%	%	NN
10_1101-2020_03_27_012757	120	23	)	)	-RRB-
10_1101-2020_03_27_012757	120	24	,	,	,
10_1101-2020_03_27_012757	120	25	which	which	WDT
10_1101-2020_03_27_012757	120	26	suggests	suggest	VBZ
10_1101-2020_03_27_012757	120	27	that	that	IN
10_1101-2020_03_27_012757	120	28	A2780	A2780	NNP
10_1101-2020_03_27_012757	120	29	could	could	MD
10_1101-2020_03_27_012757	120	30	be	be	VB
10_1101-2020_03_27_012757	120	31	a	a	DT
10_1101-2020_03_27_012757	120	32	286	286	CD
10_1101-2020_03_27_012757	120	33	germ	germ	NN
10_1101-2020_03_27_012757	120	34	cell	cell	NN
10_1101-2020_03_27_012757	120	35	derived	derive	VBD
10_1101-2020_03_27_012757	120	36	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	120	37	tumor	tumor	NN
10_1101-2020_03_27_012757	120	38	.	.	.
10_1101-2020_03_27_012757	121	1	Taken	take	VBN
10_1101-2020_03_27_012757	121	2	together	together	RB
10_1101-2020_03_27_012757	121	3	,	,	,
10_1101-2020_03_27_012757	121	4	our	-PRON-	PRP$
10_1101-2020_03_27_012757	121	5	results	result	NNS
10_1101-2020_03_27_012757	121	6	suggest	suggest	VBP
10_1101-2020_03_27_012757	121	7	that	that	IN
10_1101-2020_03_27_012757	121	8	SK	SK	NNP
10_1101-2020_03_27_012757	121	9	-	-	HYPH
10_1101-2020_03_27_012757	121	10	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	121	11	and	and	CC
10_1101-2020_03_27_012757	121	12	A2780	A2780	NNP
10_1101-2020_03_27_012757	121	13	287	287	CD
10_1101-2020_03_27_012757	121	14	could	could	MD
10_1101-2020_03_27_012757	121	15	represent	represent	VB
10_1101-2020_03_27_012757	121	16	OV	OV	NNP
10_1101-2020_03_27_012757	121	17	subtypes	subtype	NNS
10_1101-2020_03_27_012757	121	18	of	of	IN
10_1101-2020_03_27_012757	121	19	that	that	DT
10_1101-2020_03_27_012757	121	20	are	be	VBP
10_1101-2020_03_27_012757	121	21	not	not	RB
10_1101-2020_03_27_012757	121	22	well	well	RB
10_1101-2020_03_27_012757	121	23	represented	represent	VBN
10_1101-2020_03_27_012757	121	24	in	in	IN
10_1101-2020_03_27_012757	121	25	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	121	26	training	training	NN
10_1101-2020_03_27_012757	121	27	data	datum	NNS
10_1101-2020_03_27_012757	121	28	,	,	,
10_1101-2020_03_27_012757	121	29	which	which	WDT
10_1101-2020_03_27_012757	121	30	288	288	CD
10_1101-2020_03_27_012757	121	31	resulted	result	VBD
10_1101-2020_03_27_012757	121	32	in	in	IN
10_1101-2020_03_27_012757	121	33	a	a	DT
10_1101-2020_03_27_012757	121	34	low	low	JJ
10_1101-2020_03_27_012757	121	35	OV	OV	NNP
10_1101-2020_03_27_012757	121	36	score	score	NN
10_1101-2020_03_27_012757	121	37	and	and	CC
10_1101-2020_03_27_012757	121	38	higher	high	JJR
10_1101-2020_03_27_012757	121	39	CCN	CCN	NNP
10_1101-2020_03_27_012757	121	40	score	score	VBP
10_1101-2020_03_27_012757	121	41	in	in	IN
10_1101-2020_03_27_012757	121	42	other	other	JJ
10_1101-2020_03_27_012757	121	43	categories	category	NNS
10_1101-2020_03_27_012757	121	44	.	.	.
10_1101-2020_03_27_012757	122	1	289	289	CD
10_1101-2020_03_27_012757	122	2	Lastly	lastly	RB
10_1101-2020_03_27_012757	122	3	,	,	,
10_1101-2020_03_27_012757	122	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	122	5	examined	examine	VBD
10_1101-2020_03_27_012757	122	6	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	122	7	,	,	,
10_1101-2020_03_27_012757	122	8	annotated	annotate	VBD
10_1101-2020_03_27_012757	122	9	as	as	IN
10_1101-2020_03_27_012757	122	10	a	a	DT
10_1101-2020_03_27_012757	122	11	PRAD	PRAD	NNP
10_1101-2020_03_27_012757	122	12	cell	cell	NN
10_1101-2020_03_27_012757	122	13	line	line	NN
10_1101-2020_03_27_012757	122	14	but	but	CC
10_1101-2020_03_27_012757	122	15	classified	classify	VBD
10_1101-2020_03_27_012757	122	16	to	to	TO
10_1101-2020_03_27_012757	122	17	be	be	VB
10_1101-2020_03_27_012757	122	18	most	most	RBS
10_1101-2020_03_27_012757	122	19	290	290	CD
10_1101-2020_03_27_012757	122	20	similar	similar	JJ
10_1101-2020_03_27_012757	122	21	to	to	IN
10_1101-2020_03_27_012757	122	22	BLCA	BLCA	NNP
10_1101-2020_03_27_012757	122	23	.	.	.
10_1101-2020_03_27_012757	123	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	123	2	found	find	VBD
10_1101-2020_03_27_012757	123	3	that	that	IN
10_1101-2020_03_27_012757	123	4	30	30	CD
10_1101-2020_03_27_012757	123	5	%	%	NN
10_1101-2020_03_27_012757	123	6	of	of	IN
10_1101-2020_03_27_012757	123	7	the	the	DT
10_1101-2020_03_27_012757	123	8	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	123	9	cells	cell	NNS
10_1101-2020_03_27_012757	123	10	expressed	express	VBD
10_1101-2020_03_27_012757	123	11	PPARG	PPARG	NNP
10_1101-2020_03_27_012757	123	12	,	,	,
10_1101-2020_03_27_012757	123	13	a	a	DT
10_1101-2020_03_27_012757	123	14	contributor	contributor	NN
10_1101-2020_03_27_012757	123	15	to	to	IN
10_1101-2020_03_27_012757	123	16	291	291	CD
10_1101-2020_03_27_012757	123	17	urothelial	urothelial	JJ
10_1101-2020_03_27_012757	123	18	differentiation50	differentiation50	NNP
10_1101-2020_03_27_012757	123	19	that	that	WDT
10_1101-2020_03_27_012757	123	20	is	be	VBZ
10_1101-2020_03_27_012757	123	21	not	not	RB
10_1101-2020_03_27_012757	123	22	detected	detect	VBN
10_1101-2020_03_27_012757	123	23	in	in	IN
10_1101-2020_03_27_012757	123	24	the	the	DT
10_1101-2020_03_27_012757	123	25	PRAD	PRAD	NNP
10_1101-2020_03_27_012757	123	26	Vcap	Vcap	NNP
10_1101-2020_03_27_012757	123	27	cell	cell	NN
10_1101-2020_03_27_012757	123	28	line	line	NN
10_1101-2020_03_27_012757	123	29	but	but	CC
10_1101-2020_03_27_012757	123	30	is	be	VBZ
10_1101-2020_03_27_012757	123	31	highly	highly	RB
10_1101-2020_03_27_012757	123	32	expressed	express	VBN
10_1101-2020_03_27_012757	123	33	292	292	CD
10_1101-2020_03_27_012757	123	34	.CC	.CC	NFP
10_1101-2020_03_27_012757	123	35	-	-	HYPH
10_1101-2020_03_27_012757	123	36	BY	by	IN
10_1101-2020_03_27_012757	123	37	-	-	HYPH
10_1101-2020_03_27_012757	123	38	NC	NC	NNP
10_1101-2020_03_27_012757	123	39	-	-	HYPH
10_1101-2020_03_27_012757	123	40	ND	ND	NNP
10_1101-2020_03_27_012757	123	41	4.0	4.0	CD
10_1101-2020_03_27_012757	123	42	International	International	NNP
10_1101-2020_03_27_012757	123	43	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	123	44	under	under	IN
10_1101-2020_03_27_012757	123	45	a	a	DT
10_1101-2020_03_27_012757	123	46	(	(	-LRB-
10_1101-2020_03_27_012757	123	47	which	which	WDT
10_1101-2020_03_27_012757	123	48	was	be	VBD
10_1101-2020_03_27_012757	123	49	not	not	RB
10_1101-2020_03_27_012757	123	50	certified	certify	VBN
10_1101-2020_03_27_012757	123	51	by	by	IN
10_1101-2020_03_27_012757	123	52	peer	peer	NN
10_1101-2020_03_27_012757	123	53	review	review	NN
10_1101-2020_03_27_012757	123	54	)	)	-RRB-
10_1101-2020_03_27_012757	123	55	is	be	VBZ
10_1101-2020_03_27_012757	123	56	the	the	DT
10_1101-2020_03_27_012757	123	57	author	author	NN
10_1101-2020_03_27_012757	123	58	/	/	SYM
10_1101-2020_03_27_012757	123	59	funder	funder	NN
10_1101-2020_03_27_012757	123	60	,	,	,
10_1101-2020_03_27_012757	123	61	who	who	WP
10_1101-2020_03_27_012757	123	62	has	have	VBZ
10_1101-2020_03_27_012757	123	63	granted	grant	VBN
10_1101-2020_03_27_012757	123	64	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	123	65	a	a	DT
10_1101-2020_03_27_012757	123	66	license	license	NN
10_1101-2020_03_27_012757	123	67	to	to	TO
10_1101-2020_03_27_012757	123	68	display	display	VB
10_1101-2020_03_27_012757	123	69	the	the	DT
10_1101-2020_03_27_012757	123	70	preprint	preprint	NN
10_1101-2020_03_27_012757	123	71	in	in	IN
10_1101-2020_03_27_012757	123	72	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	123	73	.	.	.
10_1101-2020_03_27_012757	124	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	124	2	is	be	VBZ
10_1101-2020_03_27_012757	124	3	made	make	VBN
10_1101-2020_03_27_012757	124	4	The	the	DT
10_1101-2020_03_27_012757	124	5	copyright	copyright	NN
10_1101-2020_03_27_012757	124	6	holder	holder	NN
10_1101-2020_03_27_012757	124	7	for	for	IN
10_1101-2020_03_27_012757	124	8	this	this	DT
10_1101-2020_03_27_012757	124	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	124	10	version	version	NN
10_1101-2020_03_27_012757	124	11	posted	post	VBD
10_1101-2020_03_27_012757	124	12	January	January	NNP
10_1101-2020_03_27_012757	124	13	9	9	CD
10_1101-2020_03_27_012757	124	14	,	,	,
10_1101-2020_03_27_012757	124	15	2021	2021	CD
10_1101-2020_03_27_012757	124	16	.	.	.
10_1101-2020_03_27_012757	124	17	;	;	:
10_1101-2020_03_27_012757	124	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	124	19	:	:	:
10_1101-2020_03_27_012757	124	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	124	21	preprint	preprint	NN
10_1101-2020_03_27_012757	124	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	RB
10_1101-2020_03_27_012757	124	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	124	24	11	11	CD
10_1101-2020_03_27_012757	124	25	in	in	IN
10_1101-2020_03_27_012757	124	26	the	the	DT
10_1101-2020_03_27_012757	124	27	BLCA	BLCA	NNP
10_1101-2020_03_27_012757	124	28	RT4	RT4	NNP
10_1101-2020_03_27_012757	124	29	cell	cell	NN
10_1101-2020_03_27_012757	124	30	line	line	NN
10_1101-2020_03_27_012757	124	31	(	(	-LRB-
10_1101-2020_03_27_012757	124	32	Fig	fig	NN
10_1101-2020_03_27_012757	124	33	3C	3c	NN
10_1101-2020_03_27_012757	124	34	)	)	-RRB-
10_1101-2020_03_27_012757	124	35	.	.	.
10_1101-2020_03_27_012757	125	1	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	125	2	cells	cell	NNS
10_1101-2020_03_27_012757	125	3	also	also	RB
10_1101-2020_03_27_012757	125	4	expressed	express	VBD
10_1101-2020_03_27_012757	125	5	the	the	DT
10_1101-2020_03_27_012757	125	6	PRAD	PRAD	NNP
10_1101-2020_03_27_012757	125	7	biomarker	biomarker	NN
10_1101-2020_03_27_012757	125	8	FOLH151	FOLH151	NNP
10_1101-2020_03_27_012757	125	9	293	293	CD
10_1101-2020_03_27_012757	125	10	suggesting	suggest	VBG
10_1101-2020_03_27_012757	125	11	that	that	IN
10_1101-2020_03_27_012757	125	12	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	125	13	has	have	VBZ
10_1101-2020_03_27_012757	125	14	an	an	DT
10_1101-2020_03_27_012757	125	15	PRAD	PRAD	NNP
10_1101-2020_03_27_012757	125	16	origin	origin	NN
10_1101-2020_03_27_012757	125	17	and	and	CC
10_1101-2020_03_27_012757	125	18	gained	gain	VBD
10_1101-2020_03_27_012757	125	19	urothelial	urothelial	JJ
10_1101-2020_03_27_012757	125	20	or	or	CC
10_1101-2020_03_27_012757	125	21	luminal	luminal	JJ
10_1101-2020_03_27_012757	125	22	characteristics	characteristic	NNS
10_1101-2020_03_27_012757	125	23	294	294	CD
10_1101-2020_03_27_012757	125	24	through	through	IN
10_1101-2020_03_27_012757	125	25	the	the	DT
10_1101-2020_03_27_012757	125	26	derivation	derivation	NN
10_1101-2020_03_27_012757	125	27	process	process	NN
10_1101-2020_03_27_012757	125	28	.	.	.
10_1101-2020_03_27_012757	126	1	In	in	IN
10_1101-2020_03_27_012757	126	2	short	short	JJ
10_1101-2020_03_27_012757	126	3	,	,	,
10_1101-2020_03_27_012757	126	4	our	-PRON-	PRP$
10_1101-2020_03_27_012757	126	5	limited	limited	JJ
10_1101-2020_03_27_012757	126	6	experimental	experimental	JJ
10_1101-2020_03_27_012757	126	7	data	datum	NNS
10_1101-2020_03_27_012757	126	8	support	support	VBP
10_1101-2020_03_27_012757	126	9	the	the	DT
10_1101-2020_03_27_012757	126	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	126	11	295	295	CD
10_1101-2020_03_27_012757	126	12	classification	classification	NN
10_1101-2020_03_27_012757	126	13	results	result	NNS
10_1101-2020_03_27_012757	126	14	.	.	.
10_1101-2020_03_27_012757	127	1	296	296	CD
10_1101-2020_03_27_012757	127	2	297	297	CD
10_1101-2020_03_27_012757	127	3	Subtype	subtype	NN
10_1101-2020_03_27_012757	127	4	classification	classification	NN
10_1101-2020_03_27_012757	127	5	of	of	IN
10_1101-2020_03_27_012757	127	6	cancer	cancer	NN
10_1101-2020_03_27_012757	127	7	cell	cell	NN
10_1101-2020_03_27_012757	127	8	lines	line	NNS
10_1101-2020_03_27_012757	127	9	298	298	CD
10_1101-2020_03_27_012757	127	10	Next	next	RB
10_1101-2020_03_27_012757	127	11	,	,	,
10_1101-2020_03_27_012757	127	12	we	-PRON-	PRP
10_1101-2020_03_27_012757	127	13	explored	explore	VBD
10_1101-2020_03_27_012757	127	14	the	the	DT
10_1101-2020_03_27_012757	127	15	subtype	subtype	NN
10_1101-2020_03_27_012757	127	16	classification	classification	NN
10_1101-2020_03_27_012757	127	17	of	of	IN
10_1101-2020_03_27_012757	127	18	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	127	19	from	from	IN
10_1101-2020_03_27_012757	127	20	three	three	CD
10_1101-2020_03_27_012757	127	21	general	general	JJ
10_1101-2020_03_27_012757	127	22	tumor	tumor	NN
10_1101-2020_03_27_012757	127	23	types	type	NNS
10_1101-2020_03_27_012757	127	24	in	in	IN
10_1101-2020_03_27_012757	127	25	299	299	CD
10_1101-2020_03_27_012757	127	26	more	more	JJR
10_1101-2020_03_27_012757	127	27	depth	depth	NN
10_1101-2020_03_27_012757	127	28	.	.	.
10_1101-2020_03_27_012757	128	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	128	2	focused	focus	VBD
10_1101-2020_03_27_012757	128	3	our	-PRON-	PRP$
10_1101-2020_03_27_012757	128	4	subtype	subtype	NN
10_1101-2020_03_27_012757	128	5	visualization	visualization	NN
10_1101-2020_03_27_012757	128	6	(	(	-LRB-
10_1101-2020_03_27_012757	128	7	Fig	Fig	NNP
10_1101-2020_03_27_012757	128	8	4A	4A	NNP
10_1101-2020_03_27_012757	128	9	-	-	HYPH
10_1101-2020_03_27_012757	128	10	C	C	NNP
10_1101-2020_03_27_012757	128	11	)	)	-RRB-
10_1101-2020_03_27_012757	128	12	on	on	IN
10_1101-2020_03_27_012757	128	13	CCL	CCL	NNP
10_1101-2020_03_27_012757	128	14	models	model	NNS
10_1101-2020_03_27_012757	128	15	with	with	IN
10_1101-2020_03_27_012757	128	16	general	general	JJ
10_1101-2020_03_27_012757	128	17	CCN	CCN	NNP
10_1101-2020_03_27_012757	128	18	300	300	CD
10_1101-2020_03_27_012757	128	19	score	score	NN
10_1101-2020_03_27_012757	128	20	above	above	IN
10_1101-2020_03_27_012757	128	21	0.1	0.1	CD
10_1101-2020_03_27_012757	128	22	in	in	IN
10_1101-2020_03_27_012757	128	23	their	-PRON-	PRP$
10_1101-2020_03_27_012757	128	24	nominal	nominal	JJ
10_1101-2020_03_27_012757	128	25	cancer	cancer	NN
10_1101-2020_03_27_012757	128	26	type	type	NN
10_1101-2020_03_27_012757	128	27	as	as	IN
10_1101-2020_03_27_012757	128	28	this	this	DT
10_1101-2020_03_27_012757	128	29	allowed	allow	VBD
10_1101-2020_03_27_012757	128	30	us	-PRON-	PRP
10_1101-2020_03_27_012757	128	31	to	to	TO
10_1101-2020_03_27_012757	128	32	analyze	analyze	VB
10_1101-2020_03_27_012757	128	33	those	those	DT
10_1101-2020_03_27_012757	128	34	models	model	NNS
10_1101-2020_03_27_012757	128	35	that	that	WDT
10_1101-2020_03_27_012757	128	36	fell	fall	VBD
10_1101-2020_03_27_012757	128	37	301	301	CD
10_1101-2020_03_27_012757	128	38	below	below	IN
10_1101-2020_03_27_012757	128	39	the	the	DT
10_1101-2020_03_27_012757	128	40	general	general	JJ
10_1101-2020_03_27_012757	128	41	threshold	threshold	NN
10_1101-2020_03_27_012757	128	42	but	but	CC
10_1101-2020_03_27_012757	128	43	were	be	VBD
10_1101-2020_03_27_012757	128	44	classified	classify	VBN
10_1101-2020_03_27_012757	128	45	as	as	IN
10_1101-2020_03_27_012757	128	46	a	a	DT
10_1101-2020_03_27_012757	128	47	specific	specific	JJ
10_1101-2020_03_27_012757	128	48	sub	sub	JJ
10_1101-2020_03_27_012757	128	49	-	-	HYPH
10_1101-2020_03_27_012757	128	50	type	type	NN
10_1101-2020_03_27_012757	128	51	(	(	-LRB-
10_1101-2020_03_27_012757	128	52	Supp	Supp	NNP
10_1101-2020_03_27_012757	128	53	Tab	Tab	NNP
10_1101-2020_03_27_012757	128	54	1	1	CD
10_1101-2020_03_27_012757	128	55	-	-	SYM
10_1101-2020_03_27_012757	128	56	2	2	CD
10_1101-2020_03_27_012757	128	57	)	)	-RRB-
10_1101-2020_03_27_012757	128	58	.	.	.
10_1101-2020_03_27_012757	129	1	302	302	CD
10_1101-2020_03_27_012757	129	2	Focusing	focus	VBG
10_1101-2020_03_27_012757	129	3	first	first	RB
10_1101-2020_03_27_012757	129	4	on	on	IN
10_1101-2020_03_27_012757	129	5	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	129	6	,	,	,
10_1101-2020_03_27_012757	129	7	the	the	DT
10_1101-2020_03_27_012757	129	8	histologically	histologically	RB
10_1101-2020_03_27_012757	129	9	defined	define	VBN
10_1101-2020_03_27_012757	129	10	subtypes	subtype	NNS
10_1101-2020_03_27_012757	129	11	of	of	IN
10_1101-2020_03_27_012757	129	12	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	129	13	,	,	,
10_1101-2020_03_27_012757	129	14	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	129	15	and	and	CC
10_1101-2020_03_27_012757	129	16	serous	serous	JJ
10_1101-2020_03_27_012757	129	17	,	,	,
10_1101-2020_03_27_012757	129	18	303	303	CD
10_1101-2020_03_27_012757	129	19	differ	differ	NN
10_1101-2020_03_27_012757	129	20	in	in	IN
10_1101-2020_03_27_012757	129	21	prevalence	prevalence	NN
10_1101-2020_03_27_012757	129	22	,	,	,
10_1101-2020_03_27_012757	129	23	molecular	molecular	JJ
10_1101-2020_03_27_012757	129	24	properties	property	NNS
10_1101-2020_03_27_012757	129	25	,	,	,
10_1101-2020_03_27_012757	129	26	prognosis	prognosis	NN
10_1101-2020_03_27_012757	129	27	,	,	,
10_1101-2020_03_27_012757	129	28	and	and	CC
10_1101-2020_03_27_012757	129	29	treatment	treatment	NN
10_1101-2020_03_27_012757	129	30	.	.	.
10_1101-2020_03_27_012757	130	1	For	for	IN
10_1101-2020_03_27_012757	130	2	instance	instance	NN
10_1101-2020_03_27_012757	130	3	,	,	,
10_1101-2020_03_27_012757	130	4	the	the	DT
10_1101-2020_03_27_012757	130	5	304	304	CD
10_1101-2020_03_27_012757	130	6	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	130	7	subtype	subtype	NN
10_1101-2020_03_27_012757	130	8	,	,	,
10_1101-2020_03_27_012757	130	9	which	which	WDT
10_1101-2020_03_27_012757	130	10	accounts	account	VBZ
10_1101-2020_03_27_012757	130	11	for	for	IN
10_1101-2020_03_27_012757	130	12	approximately	approximately	RB
10_1101-2020_03_27_012757	130	13	80	80	CD
10_1101-2020_03_27_012757	130	14	%	%	NN
10_1101-2020_03_27_012757	130	15	of	of	IN
10_1101-2020_03_27_012757	130	16	uterine	uterine	JJ
10_1101-2020_03_27_012757	130	17	cancers	cancer	NNS
10_1101-2020_03_27_012757	130	18	,	,	,
10_1101-2020_03_27_012757	130	19	retains	retain	VBZ
10_1101-2020_03_27_012757	130	20	305	305	CD
10_1101-2020_03_27_012757	130	21	estrogen	estrogen	NN
10_1101-2020_03_27_012757	130	22	receptor	receptor	NN
10_1101-2020_03_27_012757	130	23	and	and	CC
10_1101-2020_03_27_012757	130	24	progesterone	progesterone	NN
10_1101-2020_03_27_012757	130	25	receptor	receptor	NN
10_1101-2020_03_27_012757	130	26	status	status	NN
10_1101-2020_03_27_012757	130	27	and	and	CC
10_1101-2020_03_27_012757	130	28	is	be	VBZ
10_1101-2020_03_27_012757	130	29	responsive	responsive	JJ
10_1101-2020_03_27_012757	130	30	towards	towards	IN
10_1101-2020_03_27_012757	130	31	progestin	progestin	NNP
10_1101-2020_03_27_012757	130	32	306	306	CD
10_1101-2020_03_27_012757	130	33	therapy52,53	therapy52,53	NNP
10_1101-2020_03_27_012757	130	34	.	.	.
10_1101-2020_03_27_012757	131	1	Serous	serous	JJ
10_1101-2020_03_27_012757	131	2	,	,	,
10_1101-2020_03_27_012757	131	3	a	a	DT
10_1101-2020_03_27_012757	131	4	more	more	RBR
10_1101-2020_03_27_012757	131	5	aggressive	aggressive	JJ
10_1101-2020_03_27_012757	131	6	subtype	subtype	NN
10_1101-2020_03_27_012757	131	7	,	,	,
10_1101-2020_03_27_012757	131	8	is	be	VBZ
10_1101-2020_03_27_012757	131	9	characterized	characterize	VBN
10_1101-2020_03_27_012757	131	10	by	by	IN
10_1101-2020_03_27_012757	131	11	the	the	DT
10_1101-2020_03_27_012757	131	12	loss	loss	NN
10_1101-2020_03_27_012757	131	13	of	of	IN
10_1101-2020_03_27_012757	131	14	estrogen	estrogen	NN
10_1101-2020_03_27_012757	131	15	and	and	CC
10_1101-2020_03_27_012757	131	16	307	307	CD
10_1101-2020_03_27_012757	131	17	progesterone	progesterone	NN
10_1101-2020_03_27_012757	131	18	receptor	receptor	NN
10_1101-2020_03_27_012757	131	19	and	and	CC
10_1101-2020_03_27_012757	131	20	is	be	VBZ
10_1101-2020_03_27_012757	131	21	not	not	RB
10_1101-2020_03_27_012757	131	22	responsive	responsive	JJ
10_1101-2020_03_27_012757	131	23	to	to	IN
10_1101-2020_03_27_012757	131	24	progestin	progestin	NNP
10_1101-2020_03_27_012757	131	25	therapy52,53	therapy52,53	NNP
10_1101-2020_03_27_012757	131	26	.	.	.
10_1101-2020_03_27_012757	132	1	CCN	CCN	NNP
10_1101-2020_03_27_012757	132	2	classified	classify	VBD
10_1101-2020_03_27_012757	132	3	the	the	DT
10_1101-2020_03_27_012757	132	4	308	308	CD
10_1101-2020_03_27_012757	132	5	majority	majority	NN
10_1101-2020_03_27_012757	132	6	of	of	IN
10_1101-2020_03_27_012757	132	7	the	the	DT
10_1101-2020_03_27_012757	132	8	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	132	9	cell	cell	NN
10_1101-2020_03_27_012757	132	10	lines	line	NNS
10_1101-2020_03_27_012757	132	11	as	as	IN
10_1101-2020_03_27_012757	132	12	serous	serous	JJ
10_1101-2020_03_27_012757	132	13	except	except	IN
10_1101-2020_03_27_012757	132	14	for	for	IN
10_1101-2020_03_27_012757	132	15	JHUEM-1	JHUEM-1	NNP
10_1101-2020_03_27_012757	132	16	which	which	WDT
10_1101-2020_03_27_012757	132	17	is	be	VBZ
10_1101-2020_03_27_012757	132	18	classified	classify	VBN
10_1101-2020_03_27_012757	132	19	as	as	IN
10_1101-2020_03_27_012757	132	20	mixed	mixed	JJ
10_1101-2020_03_27_012757	132	21	,	,	,
10_1101-2020_03_27_012757	132	22	with	with	IN
10_1101-2020_03_27_012757	132	23	309	309	CD
10_1101-2020_03_27_012757	132	24	similarities	similarity	NNS
10_1101-2020_03_27_012757	132	25	to	to	IN
10_1101-2020_03_27_012757	132	26	both	both	DT
10_1101-2020_03_27_012757	132	27	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	132	28	and	and	CC
10_1101-2020_03_27_012757	132	29	serous	serous	JJ
10_1101-2020_03_27_012757	132	30	(	(	-LRB-
10_1101-2020_03_27_012757	132	31	Fig	Fig	NNP
10_1101-2020_03_27_012757	132	32	4A	4A	NNP
10_1101-2020_03_27_012757	132	33	)	)	-RRB-
10_1101-2020_03_27_012757	132	34	.	.	.
10_1101-2020_03_27_012757	133	1	The	the	DT
10_1101-2020_03_27_012757	133	2	preponderance	preponderance	NN
10_1101-2020_03_27_012757	133	3	CCLE	ccle	JJ
10_1101-2020_03_27_012757	133	4	lines	line	NNS
10_1101-2020_03_27_012757	133	5	of	of	IN
10_1101-2020_03_27_012757	133	6	serous	serous	JJ
10_1101-2020_03_27_012757	133	7	310	310	CD
10_1101-2020_03_27_012757	133	8	versus	versus	IN
10_1101-2020_03_27_012757	133	9	endometroid	endometroid	JJ
10_1101-2020_03_27_012757	133	10	character	character	NN
10_1101-2020_03_27_012757	133	11	may	may	MD
10_1101-2020_03_27_012757	133	12	be	be	VB
10_1101-2020_03_27_012757	133	13	due	due	IN
10_1101-2020_03_27_012757	133	14	to	to	IN
10_1101-2020_03_27_012757	133	15	properties	property	NNS
10_1101-2020_03_27_012757	133	16	of	of	IN
10_1101-2020_03_27_012757	133	17	serous	serous	JJ
10_1101-2020_03_27_012757	133	18	cancer	cancer	NN
10_1101-2020_03_27_012757	133	19	cells	cell	NNS
10_1101-2020_03_27_012757	133	20	that	that	WDT
10_1101-2020_03_27_012757	133	21	promote	promote	VBP
10_1101-2020_03_27_012757	133	22	311	311	CD
10_1101-2020_03_27_012757	133	23	their	-PRON-	PRP$
10_1101-2020_03_27_012757	133	24	in	in	FW
10_1101-2020_03_27_012757	133	25	vitro	vitro	FW
10_1101-2020_03_27_012757	133	26	propagation	propagation	NN
10_1101-2020_03_27_012757	133	27	,	,	,
10_1101-2020_03_27_012757	133	28	such	such	JJ
10_1101-2020_03_27_012757	133	29	as	as	IN
10_1101-2020_03_27_012757	133	30	upregulation	upregulation	NN
10_1101-2020_03_27_012757	133	31	of	of	IN
10_1101-2020_03_27_012757	133	32	cell	cell	NN
10_1101-2020_03_27_012757	133	33	adhesion	adhesion	NN
10_1101-2020_03_27_012757	133	34	transcriptional	transcriptional	NNP
10_1101-2020_03_27_012757	133	35	programs54	programs54	NNP
10_1101-2020_03_27_012757	133	36	.	.	.
10_1101-2020_03_27_012757	134	1	312	312	CD
10_1101-2020_03_27_012757	134	2	Some	some	DT
10_1101-2020_03_27_012757	134	3	of	of	IN
10_1101-2020_03_27_012757	134	4	our	-PRON-	PRP$
10_1101-2020_03_27_012757	134	5	subtype	subtype	NN
10_1101-2020_03_27_012757	134	6	classification	classification	NN
10_1101-2020_03_27_012757	134	7	results	result	NNS
10_1101-2020_03_27_012757	134	8	are	be	VBP
10_1101-2020_03_27_012757	134	9	consistent	consistent	JJ
10_1101-2020_03_27_012757	134	10	with	with	IN
10_1101-2020_03_27_012757	134	11	prior	prior	JJ
10_1101-2020_03_27_012757	134	12	observations	observation	NNS
10_1101-2020_03_27_012757	134	13	.	.	.
10_1101-2020_03_27_012757	135	1	For	for	IN
10_1101-2020_03_27_012757	135	2	example	example	NN
10_1101-2020_03_27_012757	135	3	,	,	,
10_1101-2020_03_27_012757	135	4	313	313	CD
10_1101-2020_03_27_012757	135	5	HEC-1A	hec-1a	UH
10_1101-2020_03_27_012757	135	6	,	,	,
10_1101-2020_03_27_012757	135	7	HEC-1B	HEC-1B	NNP
10_1101-2020_03_27_012757	135	8	,	,	,
10_1101-2020_03_27_012757	135	9	and	and	CC
10_1101-2020_03_27_012757	135	10	KLE	KLE	NNP
10_1101-2020_03_27_012757	135	11	were	be	VBD
10_1101-2020_03_27_012757	135	12	previously	previously	RB
10_1101-2020_03_27_012757	135	13	characterized	characterize	VBN
10_1101-2020_03_27_012757	135	14	as	as	IN
10_1101-2020_03_27_012757	135	15	type	type	NN
10_1101-2020_03_27_012757	135	16	II	II	NNP
10_1101-2020_03_27_012757	135	17	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	135	18	cancer	cancer	NN
10_1101-2020_03_27_012757	135	19	,	,	,
10_1101-2020_03_27_012757	135	20	which	which	WDT
10_1101-2020_03_27_012757	135	21	314	314	CD
10_1101-2020_03_27_012757	135	22	includes	include	VBZ
10_1101-2020_03_27_012757	135	23	a	a	DT
10_1101-2020_03_27_012757	135	24	serous	serous	JJ
10_1101-2020_03_27_012757	135	25	histological	histological	JJ
10_1101-2020_03_27_012757	135	26	subtype55	subtype55	NN
10_1101-2020_03_27_012757	135	27	.	.	.
10_1101-2020_03_27_012757	136	1	On	on	IN
10_1101-2020_03_27_012757	136	2	the	the	DT
10_1101-2020_03_27_012757	136	3	other	other	JJ
10_1101-2020_03_27_012757	136	4	hand	hand	NN
10_1101-2020_03_27_012757	136	5	,	,	,
10_1101-2020_03_27_012757	136	6	our	-PRON-	PRP$
10_1101-2020_03_27_012757	136	7	subtype	subtype	NN
10_1101-2020_03_27_012757	136	8	classification	classification	NN
10_1101-2020_03_27_012757	136	9	results	result	VBZ
10_1101-2020_03_27_012757	136	10	315	315	CD
10_1101-2020_03_27_012757	136	11	contradict	contradict	NN
10_1101-2020_03_27_012757	136	12	prior	prior	JJ
10_1101-2020_03_27_012757	136	13	observations	observation	NNS
10_1101-2020_03_27_012757	136	14	in	in	IN
10_1101-2020_03_27_012757	136	15	at	at	RB
10_1101-2020_03_27_012757	136	16	least	least	RBS
10_1101-2020_03_27_012757	136	17	one	one	CD
10_1101-2020_03_27_012757	136	18	case	case	NN
10_1101-2020_03_27_012757	136	19	.	.	.
10_1101-2020_03_27_012757	137	1	For	for	IN
10_1101-2020_03_27_012757	137	2	instance	instance	NN
10_1101-2020_03_27_012757	137	3	,	,	,
10_1101-2020_03_27_012757	137	4	the	the	DT
10_1101-2020_03_27_012757	137	5	Ishikawa	Ishikawa	NNP
10_1101-2020_03_27_012757	137	6	cell	cell	NN
10_1101-2020_03_27_012757	137	7	line	line	NN
10_1101-2020_03_27_012757	137	8	was	be	VBD
10_1101-2020_03_27_012757	137	9	316	316	CD
10_1101-2020_03_27_012757	137	10	derived	derive	VBN
10_1101-2020_03_27_012757	137	11	from	from	IN
10_1101-2020_03_27_012757	137	12	type	type	NN
10_1101-2020_03_27_012757	137	13	I	-PRON-	PRP
10_1101-2020_03_27_012757	137	14	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	137	15	cancer	cancer	NN
10_1101-2020_03_27_012757	137	16	(	(	-LRB-
10_1101-2020_03_27_012757	137	17	endometrioid	endometrioid	NNP
10_1101-2020_03_27_012757	137	18	histological	histological	NNP
10_1101-2020_03_27_012757	137	19	subtype)55,56	subtype)55,56	NNP
10_1101-2020_03_27_012757	137	20	,	,	,
10_1101-2020_03_27_012757	137	21	however	however	RB
10_1101-2020_03_27_012757	137	22	CCN	CCN	NNP
10_1101-2020_03_27_012757	137	23	317	317	CD
10_1101-2020_03_27_012757	137	24	classified	classify	VBD
10_1101-2020_03_27_012757	137	25	a	a	DT
10_1101-2020_03_27_012757	137	26	derivative	derivative	NN
10_1101-2020_03_27_012757	137	27	of	of	IN
10_1101-2020_03_27_012757	137	28	this	this	DT
10_1101-2020_03_27_012757	137	29	line	line	NN
10_1101-2020_03_27_012757	137	30	,	,	,
10_1101-2020_03_27_012757	137	31	Ishikawa	Ishikawa	NNP
10_1101-2020_03_27_012757	137	32	02	02	CD
10_1101-2020_03_27_012757	137	33	ER-	ER-	NNP
10_1101-2020_03_27_012757	137	34	,	,	,
10_1101-2020_03_27_012757	137	35	as	as	RB
10_1101-2020_03_27_012757	137	36	serous	serous	JJ
10_1101-2020_03_27_012757	137	37	.	.	.
10_1101-2020_03_27_012757	138	1	The	the	DT
10_1101-2020_03_27_012757	138	2	high	high	JJ
10_1101-2020_03_27_012757	138	3	serous	serous	JJ
10_1101-2020_03_27_012757	138	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	138	5	score	score	VBP
10_1101-2020_03_27_012757	138	6	318	318	CD
10_1101-2020_03_27_012757	138	7	.CC	.CC	,
10_1101-2020_03_27_012757	138	8	-	-	HYPH
10_1101-2020_03_27_012757	138	9	BY	by	IN
10_1101-2020_03_27_012757	138	10	-	-	HYPH
10_1101-2020_03_27_012757	138	11	NC	NC	NNP
10_1101-2020_03_27_012757	138	12	-	-	HYPH
10_1101-2020_03_27_012757	138	13	ND	ND	NNP
10_1101-2020_03_27_012757	138	14	4.0	4.0	CD
10_1101-2020_03_27_012757	138	15	International	International	NNP
10_1101-2020_03_27_012757	138	16	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	138	17	under	under	IN
10_1101-2020_03_27_012757	138	18	a	a	DT
10_1101-2020_03_27_012757	138	19	(	(	-LRB-
10_1101-2020_03_27_012757	138	20	which	which	WDT
10_1101-2020_03_27_012757	138	21	was	be	VBD
10_1101-2020_03_27_012757	138	22	not	not	RB
10_1101-2020_03_27_012757	138	23	certified	certify	VBN
10_1101-2020_03_27_012757	138	24	by	by	IN
10_1101-2020_03_27_012757	138	25	peer	peer	NN
10_1101-2020_03_27_012757	138	26	review	review	NN
10_1101-2020_03_27_012757	138	27	)	)	-RRB-
10_1101-2020_03_27_012757	138	28	is	be	VBZ
10_1101-2020_03_27_012757	138	29	the	the	DT
10_1101-2020_03_27_012757	138	30	author	author	NN
10_1101-2020_03_27_012757	138	31	/	/	SYM
10_1101-2020_03_27_012757	138	32	funder	funder	NN
10_1101-2020_03_27_012757	138	33	,	,	,
10_1101-2020_03_27_012757	138	34	who	who	WP
10_1101-2020_03_27_012757	138	35	has	have	VBZ
10_1101-2020_03_27_012757	138	36	granted	grant	VBN
10_1101-2020_03_27_012757	138	37	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	138	38	a	a	DT
10_1101-2020_03_27_012757	138	39	license	license	NN
10_1101-2020_03_27_012757	138	40	to	to	TO
10_1101-2020_03_27_012757	138	41	display	display	VB
10_1101-2020_03_27_012757	138	42	the	the	DT
10_1101-2020_03_27_012757	138	43	preprint	preprint	NN
10_1101-2020_03_27_012757	138	44	in	in	IN
10_1101-2020_03_27_012757	138	45	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	138	46	.	.	.
10_1101-2020_03_27_012757	139	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	139	2	is	be	VBZ
10_1101-2020_03_27_012757	139	3	made	make	VBN
10_1101-2020_03_27_012757	139	4	The	the	DT
10_1101-2020_03_27_012757	139	5	copyright	copyright	NN
10_1101-2020_03_27_012757	139	6	holder	holder	NN
10_1101-2020_03_27_012757	139	7	for	for	IN
10_1101-2020_03_27_012757	139	8	this	this	DT
10_1101-2020_03_27_012757	139	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	139	10	version	version	NN
10_1101-2020_03_27_012757	139	11	posted	post	VBD
10_1101-2020_03_27_012757	139	12	January	January	NNP
10_1101-2020_03_27_012757	139	13	9	9	CD
10_1101-2020_03_27_012757	139	14	,	,	,
10_1101-2020_03_27_012757	139	15	2021	2021	CD
10_1101-2020_03_27_012757	139	16	.	.	.
10_1101-2020_03_27_012757	139	17	;	;	:
10_1101-2020_03_27_012757	139	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	139	19	:	:	:
10_1101-2020_03_27_012757	139	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	139	21	preprint	preprint	NN
10_1101-2020_03_27_012757	139	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	139	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	139	24	12	12	CD
10_1101-2020_03_27_012757	139	25	could	could	MD
10_1101-2020_03_27_012757	139	26	result	result	VB
10_1101-2020_03_27_012757	139	27	from	from	IN
10_1101-2020_03_27_012757	139	28	a	a	DT
10_1101-2020_03_27_012757	139	29	shift	shift	NN
10_1101-2020_03_27_012757	139	30	in	in	IN
10_1101-2020_03_27_012757	139	31	phenotype	phenotype	NN
10_1101-2020_03_27_012757	139	32	of	of	IN
10_1101-2020_03_27_012757	139	33	the	the	DT
10_1101-2020_03_27_012757	139	34	line	line	NN
10_1101-2020_03_27_012757	139	35	concomitant	concomitant	JJ
10_1101-2020_03_27_012757	139	36	with	with	IN
10_1101-2020_03_27_012757	139	37	its	-PRON-	PRP$
10_1101-2020_03_27_012757	139	38	loss	loss	NN
10_1101-2020_03_27_012757	139	39	of	of	IN
10_1101-2020_03_27_012757	139	40	estrogen	estrogen	NN
10_1101-2020_03_27_012757	139	41	receptor	receptor	NN
10_1101-2020_03_27_012757	139	42	319	319	CD
10_1101-2020_03_27_012757	139	43	(	(	-LRB-
10_1101-2020_03_27_012757	139	44	ER	ER	NNP
10_1101-2020_03_27_012757	139	45	)	)	-RRB-
10_1101-2020_03_27_012757	139	46	as	as	IN
10_1101-2020_03_27_012757	139	47	this	this	DT
10_1101-2020_03_27_012757	139	48	is	be	VBZ
10_1101-2020_03_27_012757	139	49	a	a	DT
10_1101-2020_03_27_012757	139	50	distinguishing	distinguish	VBG
10_1101-2020_03_27_012757	139	51	feature	feature	NN
10_1101-2020_03_27_012757	139	52	of	of	IN
10_1101-2020_03_27_012757	139	53	type	type	NN
10_1101-2020_03_27_012757	139	54	II	II	NNP
10_1101-2020_03_27_012757	139	55	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	139	56	cancer	cancer	NN
10_1101-2020_03_27_012757	139	57	(	(	-LRB-
10_1101-2020_03_27_012757	139	58	serous	serous	JJ
10_1101-2020_03_27_012757	139	59	histological	histological	NNP
10_1101-2020_03_27_012757	139	60	320	320	CD
10_1101-2020_03_27_012757	139	61	subtype)52	subtype)52	NNS
10_1101-2020_03_27_012757	139	62	.	.	.
10_1101-2020_03_27_012757	140	1	Taken	take	VBN
10_1101-2020_03_27_012757	140	2	together	together	RB
10_1101-2020_03_27_012757	140	3	,	,	,
10_1101-2020_03_27_012757	140	4	these	these	DT
10_1101-2020_03_27_012757	140	5	results	result	NNS
10_1101-2020_03_27_012757	140	6	indicate	indicate	VBP
10_1101-2020_03_27_012757	140	7	a	a	DT
10_1101-2020_03_27_012757	140	8	need	need	NN
10_1101-2020_03_27_012757	140	9	for	for	IN
10_1101-2020_03_27_012757	140	10	more	more	JJR
10_1101-2020_03_27_012757	140	11	endometroid	endometroid	NN
10_1101-2020_03_27_012757	140	12	-	-	HYPH
10_1101-2020_03_27_012757	140	13	like	like	JJ
10_1101-2020_03_27_012757	140	14	CCLs	ccl	NNS
10_1101-2020_03_27_012757	140	15	.	.	.
10_1101-2020_03_27_012757	141	1	321	321	CD
10_1101-2020_03_27_012757	141	2	Next	next	RB
10_1101-2020_03_27_012757	141	3	,	,	,
10_1101-2020_03_27_012757	141	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	141	5	examined	examine	VBD
10_1101-2020_03_27_012757	141	6	the	the	DT
10_1101-2020_03_27_012757	141	7	subtype	subtype	NN
10_1101-2020_03_27_012757	141	8	classification	classification	NN
10_1101-2020_03_27_012757	141	9	of	of	IN
10_1101-2020_03_27_012757	141	10	Lung	Lung	NNP
10_1101-2020_03_27_012757	141	11	Squamous	Squamous	NNP
10_1101-2020_03_27_012757	141	12	Cell	Cell	NNP
10_1101-2020_03_27_012757	141	13	Carcinoma	Carcinoma	NNP
10_1101-2020_03_27_012757	141	14	322	322	CD
10_1101-2020_03_27_012757	141	15	(	(	-LRB-
10_1101-2020_03_27_012757	141	16	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	141	17	)	)	-RRB-
10_1101-2020_03_27_012757	141	18	and	and	CC
10_1101-2020_03_27_012757	141	19	Lung	Lung	NNP
10_1101-2020_03_27_012757	141	20	adenocarcinoma	adenocarcinoma	NN
10_1101-2020_03_27_012757	141	21	(	(	-LRB-
10_1101-2020_03_27_012757	141	22	LUAD	luad	RB
10_1101-2020_03_27_012757	141	23	)	)	-RRB-
10_1101-2020_03_27_012757	141	24	cell	cell	NN
10_1101-2020_03_27_012757	141	25	lines	line	NNS
10_1101-2020_03_27_012757	141	26	(	(	-LRB-
10_1101-2020_03_27_012757	141	27	Fig	Fig	NNP
10_1101-2020_03_27_012757	141	28	4B	4b	NN
10_1101-2020_03_27_012757	141	29	-	-	HYPH
10_1101-2020_03_27_012757	141	30	C	c	NN
10_1101-2020_03_27_012757	141	31	)	)	-RRB-
10_1101-2020_03_27_012757	141	32	.	.	.
10_1101-2020_03_27_012757	142	1	All	all	PDT
10_1101-2020_03_27_012757	142	2	the	the	DT
10_1101-2020_03_27_012757	142	3	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	142	4	lines	line	NNS
10_1101-2020_03_27_012757	142	5	with	with	IN
10_1101-2020_03_27_012757	142	6	at	at	RB
10_1101-2020_03_27_012757	142	7	least	least	RBS
10_1101-2020_03_27_012757	142	8	323	323	CD
10_1101-2020_03_27_012757	142	9	one	one	CD
10_1101-2020_03_27_012757	142	10	subtype	subtype	NN
10_1101-2020_03_27_012757	142	11	classification	classification	NN
10_1101-2020_03_27_012757	142	12	had	have	VBD
10_1101-2020_03_27_012757	142	13	an	an	DT
10_1101-2020_03_27_012757	142	14	underlying	underlie	VBG
10_1101-2020_03_27_012757	142	15	primitive	primitive	JJ
10_1101-2020_03_27_012757	142	16	subtype	subtype	NN
10_1101-2020_03_27_012757	142	17	classification	classification	NN
10_1101-2020_03_27_012757	142	18	.	.	.
10_1101-2020_03_27_012757	143	1	This	this	DT
10_1101-2020_03_27_012757	143	2	is	be	VBZ
10_1101-2020_03_27_012757	143	3	consistent	consistent	JJ
10_1101-2020_03_27_012757	143	4	324	324	CD
10_1101-2020_03_27_012757	143	5	either	either	CC
10_1101-2020_03_27_012757	143	6	with	with	IN
10_1101-2020_03_27_012757	143	7	the	the	DT
10_1101-2020_03_27_012757	143	8	ease	ease	NN
10_1101-2020_03_27_012757	143	9	of	of	IN
10_1101-2020_03_27_012757	143	10	deriving	derive	VBG
10_1101-2020_03_27_012757	143	11	lines	line	NNS
10_1101-2020_03_27_012757	143	12	from	from	IN
10_1101-2020_03_27_012757	143	13	tumors	tumor	NNS
10_1101-2020_03_27_012757	143	14	with	with	IN
10_1101-2020_03_27_012757	143	15	a	a	DT
10_1101-2020_03_27_012757	143	16	primitive	primitive	JJ
10_1101-2020_03_27_012757	143	17	character	character	NN
10_1101-2020_03_27_012757	143	18	,	,	,
10_1101-2020_03_27_012757	143	19	or	or	CC
10_1101-2020_03_27_012757	143	20	with	with	IN
10_1101-2020_03_27_012757	143	21	a	a	DT
10_1101-2020_03_27_012757	143	22	process	process	NN
10_1101-2020_03_27_012757	143	23	by	by	IN
10_1101-2020_03_27_012757	143	24	325	325	CD
10_1101-2020_03_27_012757	143	25	which	which	WDT
10_1101-2020_03_27_012757	143	26	cell	cell	NN
10_1101-2020_03_27_012757	143	27	line	line	NN
10_1101-2020_03_27_012757	143	28	derivation	derivation	NN
10_1101-2020_03_27_012757	143	29	promotes	promote	VBZ
10_1101-2020_03_27_012757	143	30	similarity	similarity	NN
10_1101-2020_03_27_012757	143	31	to	to	IN
10_1101-2020_03_27_012757	143	32	more	more	RBR
10_1101-2020_03_27_012757	143	33	primitive	primitive	JJ
10_1101-2020_03_27_012757	143	34	subtype	subtype	NN
10_1101-2020_03_27_012757	143	35	,	,	,
10_1101-2020_03_27_012757	143	36	which	which	WDT
10_1101-2020_03_27_012757	143	37	is	be	VBZ
10_1101-2020_03_27_012757	143	38	marked	mark	VBN
10_1101-2020_03_27_012757	143	39	by	by	IN
10_1101-2020_03_27_012757	143	40	326	326	CD
10_1101-2020_03_27_012757	143	41	increased	increased	JJ
10_1101-2020_03_27_012757	143	42	cellular	cellular	JJ
10_1101-2020_03_27_012757	143	43	proliferation28	proliferation28	NNS
10_1101-2020_03_27_012757	143	44	.	.	.
10_1101-2020_03_27_012757	144	1	Some	some	DT
10_1101-2020_03_27_012757	144	2	of	of	IN
10_1101-2020_03_27_012757	144	3	our	-PRON-	PRP$
10_1101-2020_03_27_012757	144	4	results	result	NNS
10_1101-2020_03_27_012757	144	5	are	be	VBP
10_1101-2020_03_27_012757	144	6	consistent	consistent	JJ
10_1101-2020_03_27_012757	144	7	with	with	IN
10_1101-2020_03_27_012757	144	8	prior	prior	JJ
10_1101-2020_03_27_012757	144	9	reports	report	NNS
10_1101-2020_03_27_012757	144	10	that	that	WDT
10_1101-2020_03_27_012757	144	11	have	have	VBP
10_1101-2020_03_27_012757	144	12	327	327	CD
10_1101-2020_03_27_012757	144	13	investigated	investigate	VBN
10_1101-2020_03_27_012757	144	14	the	the	DT
10_1101-2020_03_27_012757	144	15	resemblance	resemblance	NN
10_1101-2020_03_27_012757	144	16	of	of	IN
10_1101-2020_03_27_012757	144	17	some	some	DT
10_1101-2020_03_27_012757	144	18	lines	line	NNS
10_1101-2020_03_27_012757	144	19	to	to	IN
10_1101-2020_03_27_012757	144	20	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	144	21	subtypes	subtype	NNS
10_1101-2020_03_27_012757	144	22	.	.	.
10_1101-2020_03_27_012757	145	1	For	for	IN
10_1101-2020_03_27_012757	145	2	example	example	NN
10_1101-2020_03_27_012757	145	3	,	,	,
10_1101-2020_03_27_012757	145	4	HCC-95	hcc-95	NN
10_1101-2020_03_27_012757	145	5	,	,	,
10_1101-2020_03_27_012757	145	6	328	328	CD
10_1101-2020_03_27_012757	145	7	previously	previously	RB
10_1101-2020_03_27_012757	145	8	been	be	VBN
10_1101-2020_03_27_012757	145	9	characterized	characterize	VBN
10_1101-2020_03_27_012757	145	10	as	as	IN
10_1101-2020_03_27_012757	145	11	classical28,57	classical28,57	NNP
10_1101-2020_03_27_012757	145	12	,	,	,
10_1101-2020_03_27_012757	145	13	had	have	VBD
10_1101-2020_03_27_012757	145	14	a	a	DT
10_1101-2020_03_27_012757	145	15	maximum	maximum	JJ
10_1101-2020_03_27_012757	145	16	CCN	CCN	NNP
10_1101-2020_03_27_012757	145	17	score	score	NN
10_1101-2020_03_27_012757	145	18	in	in	IN
10_1101-2020_03_27_012757	145	19	the	the	DT
10_1101-2020_03_27_012757	145	20	classical	classical	JJ
10_1101-2020_03_27_012757	145	21	329	329	CD
10_1101-2020_03_27_012757	145	22	subtype	subtype	NN
10_1101-2020_03_27_012757	145	23	(	(	-LRB-
10_1101-2020_03_27_012757	145	24	0.429	0.429	CD
10_1101-2020_03_27_012757	145	25	)	)	-RRB-
10_1101-2020_03_27_012757	145	26	.	.	.
10_1101-2020_03_27_012757	146	1	Similarly	similarly	RB
10_1101-2020_03_27_012757	146	2	,	,	,
10_1101-2020_03_27_012757	146	3	LUDLU-1	LUDLU-1	NNP
10_1101-2020_03_27_012757	146	4	and	and	CC
10_1101-2020_03_27_012757	146	5	EPLC-272H	eplc-272h	JJ
10_1101-2020_03_27_012757	146	6	,	,	,
10_1101-2020_03_27_012757	146	7	previously	previously	RB
10_1101-2020_03_27_012757	146	8	reported	report	VBN
10_1101-2020_03_27_012757	146	9	as	as	IN
10_1101-2020_03_27_012757	146	10	classical57	classical57	NNPS
10_1101-2020_03_27_012757	146	11	and	and	CC
10_1101-2020_03_27_012757	146	12	330	330	CD
10_1101-2020_03_27_012757	146	13	basal57	basal57	NNS
10_1101-2020_03_27_012757	146	14	respectively	respectively	RB
10_1101-2020_03_27_012757	146	15	,	,	,
10_1101-2020_03_27_012757	146	16	had	have	VBD
10_1101-2020_03_27_012757	146	17	maximal	maximal	JJ
10_1101-2020_03_27_012757	146	18	tumor	tumor	NN
10_1101-2020_03_27_012757	146	19	subtype	subtype	NN
10_1101-2020_03_27_012757	146	20	CCN	CCN	NNP
10_1101-2020_03_27_012757	146	21	scores	score	NNS
10_1101-2020_03_27_012757	146	22	for	for	IN
10_1101-2020_03_27_012757	146	23	these	these	DT
10_1101-2020_03_27_012757	146	24	sub	sub	NN
10_1101-2020_03_27_012757	146	25	-	-	NNS
10_1101-2020_03_27_012757	146	26	types	type	NNS
10_1101-2020_03_27_012757	146	27	(	(	-LRB-
10_1101-2020_03_27_012757	146	28	0.323	0.323	CD
10_1101-2020_03_27_012757	146	29	and	and	CC
10_1101-2020_03_27_012757	146	30	331	331	CD
10_1101-2020_03_27_012757	146	31	0.256	0.256	CD
10_1101-2020_03_27_012757	146	32	)	)	-RRB-
10_1101-2020_03_27_012757	146	33	(	(	-LRB-
10_1101-2020_03_27_012757	146	34	Fig	fig	NN
10_1101-2020_03_27_012757	146	35	4B	4b	NN
10_1101-2020_03_27_012757	146	36	,	,	,
10_1101-2020_03_27_012757	146	37	Supp	Supp	NNP
10_1101-2020_03_27_012757	146	38	Tab	Tab	NNP
10_1101-2020_03_27_012757	146	39	2	2	CD
10_1101-2020_03_27_012757	146	40	)	)	-RRB-
10_1101-2020_03_27_012757	146	41	despite	despite	IN
10_1101-2020_03_27_012757	146	42	classified	classify	VBN
10_1101-2020_03_27_012757	146	43	as	as	IN
10_1101-2020_03_27_012757	146	44	Unknown	unknown	JJ
10_1101-2020_03_27_012757	146	45	.	.	.
10_1101-2020_03_27_012757	147	1	Lastly	lastly	RB
10_1101-2020_03_27_012757	147	2	,	,	,
10_1101-2020_03_27_012757	147	3	the	the	DT
10_1101-2020_03_27_012757	147	4	LUAD	luad	JJ
10_1101-2020_03_27_012757	147	5	cell	cell	NN
10_1101-2020_03_27_012757	147	6	lines	line	NNS
10_1101-2020_03_27_012757	147	7	that	that	IN
10_1101-2020_03_27_012757	147	8	332	332	CD
10_1101-2020_03_27_012757	147	9	were	be	VBD
10_1101-2020_03_27_012757	147	10	classified	classify	VBN
10_1101-2020_03_27_012757	147	11	as	as	IN
10_1101-2020_03_27_012757	147	12	a	a	DT
10_1101-2020_03_27_012757	147	13	subtype	subtype	NN
10_1101-2020_03_27_012757	147	14	were	be	VBD
10_1101-2020_03_27_012757	147	15	either	either	CC
10_1101-2020_03_27_012757	147	16	classified	classify	VBN
10_1101-2020_03_27_012757	147	17	as	as	IN
10_1101-2020_03_27_012757	147	18	proximal	proximal	JJ
10_1101-2020_03_27_012757	147	19	inflammation	inflammation	NN
10_1101-2020_03_27_012757	147	20	or	or	CC
10_1101-2020_03_27_012757	147	21	proximal	proximal	JJ
10_1101-2020_03_27_012757	147	22	333	333	CD
10_1101-2020_03_27_012757	147	23	proliferation	proliferation	NN
10_1101-2020_03_27_012757	147	24	(	(	-LRB-
10_1101-2020_03_27_012757	147	25	Fig	Fig	NNP
10_1101-2020_03_27_012757	147	26	4C	4c	NN
10_1101-2020_03_27_012757	147	27	)	)	-RRB-
10_1101-2020_03_27_012757	147	28	.	.	.
10_1101-2020_03_27_012757	148	1	RERF	RERF	NNP
10_1101-2020_03_27_012757	148	2	-	-	HYPH
10_1101-2020_03_27_012757	148	3	LC	LC	NNP
10_1101-2020_03_27_012757	148	4	-	-	HYPH
10_1101-2020_03_27_012757	148	5	Ad1	Ad1	NNP
10_1101-2020_03_27_012757	148	6	had	have	VBD
10_1101-2020_03_27_012757	148	7	the	the	DT
10_1101-2020_03_27_012757	148	8	highest	high	JJS
10_1101-2020_03_27_012757	148	9	general	general	JJ
10_1101-2020_03_27_012757	148	10	classification	classification	NN
10_1101-2020_03_27_012757	148	11	score	score	NN
10_1101-2020_03_27_012757	148	12	and	and	CC
10_1101-2020_03_27_012757	148	13	the	the	DT
10_1101-2020_03_27_012757	148	14	334	334	CD
10_1101-2020_03_27_012757	148	15	highest	high	JJS
10_1101-2020_03_27_012757	148	16	proximal	proximal	JJ
10_1101-2020_03_27_012757	148	17	inflammation	inflammation	NN
10_1101-2020_03_27_012757	148	18	subtype	subtype	NN
10_1101-2020_03_27_012757	148	19	classification	classification	NN
10_1101-2020_03_27_012757	148	20	score	score	NN
10_1101-2020_03_27_012757	148	21	.	.	.
10_1101-2020_03_27_012757	149	1	Taken	take	VBN
10_1101-2020_03_27_012757	149	2	together	together	RB
10_1101-2020_03_27_012757	149	3	,	,	,
10_1101-2020_03_27_012757	149	4	these	these	DT
10_1101-2020_03_27_012757	149	5	subtype	subtype	NN
10_1101-2020_03_27_012757	149	6	335	335	CD
10_1101-2020_03_27_012757	149	7	classification	classification	NN
10_1101-2020_03_27_012757	149	8	results	result	NNS
10_1101-2020_03_27_012757	149	9	have	have	VBP
10_1101-2020_03_27_012757	149	10	revealed	reveal	VBN
10_1101-2020_03_27_012757	149	11	an	an	DT
10_1101-2020_03_27_012757	149	12	absence	absence	NN
10_1101-2020_03_27_012757	149	13	of	of	IN
10_1101-2020_03_27_012757	149	14	cell	cell	NN
10_1101-2020_03_27_012757	149	15	lines	line	NNS
10_1101-2020_03_27_012757	149	16	models	model	NNS
10_1101-2020_03_27_012757	149	17	for	for	IN
10_1101-2020_03_27_012757	149	18	basal	basal	NN
10_1101-2020_03_27_012757	149	19	and	and	CC
10_1101-2020_03_27_012757	149	20	secretory	secretory	RB
10_1101-2020_03_27_012757	149	21	336	336	CD
10_1101-2020_03_27_012757	149	22	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	149	23	,	,	,
10_1101-2020_03_27_012757	149	24	and	and	CC
10_1101-2020_03_27_012757	149	25	for	for	IN
10_1101-2020_03_27_012757	149	26	the	the	DT
10_1101-2020_03_27_012757	149	27	Terminal	Terminal	NNP
10_1101-2020_03_27_012757	149	28	respiratory	respiratory	JJ
10_1101-2020_03_27_012757	149	29	unit	unit	NN
10_1101-2020_03_27_012757	149	30	(	(	-LRB-
10_1101-2020_03_27_012757	149	31	TRU	tru	NN
10_1101-2020_03_27_012757	149	32	)	)	-RRB-
10_1101-2020_03_27_012757	149	33	LUAD	LUAD	NNP
10_1101-2020_03_27_012757	149	34	subtype	subtype	NN
10_1101-2020_03_27_012757	149	35	.	.	.
10_1101-2020_03_27_012757	150	1	337	337	CD
10_1101-2020_03_27_012757	150	2	338	338	CD
10_1101-2020_03_27_012757	150	3	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	150	4	cell	cell	NN
10_1101-2020_03_27_012757	150	5	lines	line	NNS
10_1101-2020_03_27_012757	150	6	’	’	POS
10_1101-2020_03_27_012757	150	7	popularity	popularity	NN
10_1101-2020_03_27_012757	150	8	and	and	CC
10_1101-2020_03_27_012757	150	9	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	150	10	fidelity	fidelity	NN
10_1101-2020_03_27_012757	150	11	339	339	CD
10_1101-2020_03_27_012757	150	12	Finally	finally	RB
10_1101-2020_03_27_012757	150	13	,	,	,
10_1101-2020_03_27_012757	150	14	we	-PRON-	PRP
10_1101-2020_03_27_012757	150	15	sought	seek	VBD
10_1101-2020_03_27_012757	150	16	to	to	TO
10_1101-2020_03_27_012757	150	17	measure	measure	VB
10_1101-2020_03_27_012757	150	18	the	the	DT
10_1101-2020_03_27_012757	150	19	extent	extent	NN
10_1101-2020_03_27_012757	150	20	to	to	TO
10_1101-2020_03_27_012757	150	21	which	which	WDT
10_1101-2020_03_27_012757	150	22	cell	cell	NN
10_1101-2020_03_27_012757	150	23	line	line	NN
10_1101-2020_03_27_012757	150	24	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	150	25	fidelity	fidelity	NNP
10_1101-2020_03_27_012757	150	26	related	relate	VBD
10_1101-2020_03_27_012757	150	27	340	340	CD
10_1101-2020_03_27_012757	150	28	to	to	TO
10_1101-2020_03_27_012757	150	29	model	model	NN
10_1101-2020_03_27_012757	150	30	prevalence	prevalence	NN
10_1101-2020_03_27_012757	150	31	.	.	.
10_1101-2020_03_27_012757	151	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	151	2	used	use	VBD
10_1101-2020_03_27_012757	151	3	the	the	DT
10_1101-2020_03_27_012757	151	4	number	number	NN
10_1101-2020_03_27_012757	151	5	of	of	IN
10_1101-2020_03_27_012757	151	6	papers	paper	NNS
10_1101-2020_03_27_012757	151	7	in	in	IN
10_1101-2020_03_27_012757	151	8	which	which	WDT
10_1101-2020_03_27_012757	151	9	a	a	DT
10_1101-2020_03_27_012757	151	10	model	model	NN
10_1101-2020_03_27_012757	151	11	was	be	VBD
10_1101-2020_03_27_012757	151	12	mentioned	mention	VBN
10_1101-2020_03_27_012757	151	13	,	,	,
10_1101-2020_03_27_012757	151	14	341	341	CD
10_1101-2020_03_27_012757	151	15	normalized	normalize	VBN
10_1101-2020_03_27_012757	151	16	by	by	IN
10_1101-2020_03_27_012757	151	17	the	the	DT
10_1101-2020_03_27_012757	151	18	number	number	NN
10_1101-2020_03_27_012757	151	19	of	of	IN
10_1101-2020_03_27_012757	151	20	years	year	NNS
10_1101-2020_03_27_012757	151	21	since	since	IN
10_1101-2020_03_27_012757	151	22	the	the	DT
10_1101-2020_03_27_012757	151	23	cell	cell	NN
10_1101-2020_03_27_012757	151	24	line	line	NN
10_1101-2020_03_27_012757	151	25	was	be	VBD
10_1101-2020_03_27_012757	151	26	documented	document	VBN
10_1101-2020_03_27_012757	151	27	,	,	,
10_1101-2020_03_27_012757	151	28	as	as	IN
10_1101-2020_03_27_012757	151	29	a	a	DT
10_1101-2020_03_27_012757	151	30	rough	rough	JJ
10_1101-2020_03_27_012757	151	31	342	342	CD
10_1101-2020_03_27_012757	151	32	approximation	approximation	NN
10_1101-2020_03_27_012757	151	33	of	of	IN
10_1101-2020_03_27_012757	151	34	model	model	NN
10_1101-2020_03_27_012757	151	35	prevalence	prevalence	NN
10_1101-2020_03_27_012757	151	36	.	.	.
10_1101-2020_03_27_012757	152	1	To	to	TO
10_1101-2020_03_27_012757	152	2	explore	explore	VB
10_1101-2020_03_27_012757	152	3	this	this	DT
10_1101-2020_03_27_012757	152	4	relationship	relationship	NN
10_1101-2020_03_27_012757	152	5	,	,	,
10_1101-2020_03_27_012757	152	6	we	-PRON-	PRP
10_1101-2020_03_27_012757	152	7	plotted	plot	VBD
10_1101-2020_03_27_012757	152	8	the	the	DT
10_1101-2020_03_27_012757	152	9	normalized	normalized	JJ
10_1101-2020_03_27_012757	152	10	343	343	CD
10_1101-2020_03_27_012757	152	11	citation	citation	NN
10_1101-2020_03_27_012757	152	12	count	count	NN
10_1101-2020_03_27_012757	152	13	versus	versus	IN
10_1101-2020_03_27_012757	152	14	general	general	JJ
10_1101-2020_03_27_012757	152	15	classification	classification	NN
10_1101-2020_03_27_012757	152	16	score	score	NN
10_1101-2020_03_27_012757	152	17	,	,	,
10_1101-2020_03_27_012757	152	18	labeling	label	VBG
10_1101-2020_03_27_012757	152	19	the	the	DT
10_1101-2020_03_27_012757	152	20	highest	highest	RBS
10_1101-2020_03_27_012757	152	21	cited	cited	JJ
10_1101-2020_03_27_012757	152	22	and	and	CC
10_1101-2020_03_27_012757	152	23	highest	high	JJS
10_1101-2020_03_27_012757	152	24	344	344	CD
10_1101-2020_03_27_012757	152	25	.CC	.CC	NFP
10_1101-2020_03_27_012757	152	26	-	-	HYPH
10_1101-2020_03_27_012757	152	27	BY	by	IN
10_1101-2020_03_27_012757	152	28	-	-	HYPH
10_1101-2020_03_27_012757	152	29	NC	NC	NNP
10_1101-2020_03_27_012757	152	30	-	-	HYPH
10_1101-2020_03_27_012757	152	31	ND	ND	NNP
10_1101-2020_03_27_012757	152	32	4.0	4.0	CD
10_1101-2020_03_27_012757	152	33	International	International	NNP
10_1101-2020_03_27_012757	152	34	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	152	35	under	under	IN
10_1101-2020_03_27_012757	152	36	a	a	DT
10_1101-2020_03_27_012757	152	37	(	(	-LRB-
10_1101-2020_03_27_012757	152	38	which	which	WDT
10_1101-2020_03_27_012757	152	39	was	be	VBD
10_1101-2020_03_27_012757	152	40	not	not	RB
10_1101-2020_03_27_012757	152	41	certified	certify	VBN
10_1101-2020_03_27_012757	152	42	by	by	IN
10_1101-2020_03_27_012757	152	43	peer	peer	NN
10_1101-2020_03_27_012757	152	44	review	review	NN
10_1101-2020_03_27_012757	152	45	)	)	-RRB-
10_1101-2020_03_27_012757	152	46	is	be	VBZ
10_1101-2020_03_27_012757	152	47	the	the	DT
10_1101-2020_03_27_012757	152	48	author	author	NN
10_1101-2020_03_27_012757	152	49	/	/	SYM
10_1101-2020_03_27_012757	152	50	funder	funder	NN
10_1101-2020_03_27_012757	152	51	,	,	,
10_1101-2020_03_27_012757	152	52	who	who	WP
10_1101-2020_03_27_012757	152	53	has	have	VBZ
10_1101-2020_03_27_012757	152	54	granted	grant	VBN
10_1101-2020_03_27_012757	152	55	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	152	56	a	a	DT
10_1101-2020_03_27_012757	152	57	license	license	NN
10_1101-2020_03_27_012757	152	58	to	to	TO
10_1101-2020_03_27_012757	152	59	display	display	VB
10_1101-2020_03_27_012757	152	60	the	the	DT
10_1101-2020_03_27_012757	152	61	preprint	preprint	NN
10_1101-2020_03_27_012757	152	62	in	in	IN
10_1101-2020_03_27_012757	152	63	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	152	64	.	.	.
10_1101-2020_03_27_012757	153	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	153	2	is	be	VBZ
10_1101-2020_03_27_012757	153	3	made	make	VBN
10_1101-2020_03_27_012757	153	4	The	the	DT
10_1101-2020_03_27_012757	153	5	copyright	copyright	NN
10_1101-2020_03_27_012757	153	6	holder	holder	NN
10_1101-2020_03_27_012757	153	7	for	for	IN
10_1101-2020_03_27_012757	153	8	this	this	DT
10_1101-2020_03_27_012757	153	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	153	10	version	version	NN
10_1101-2020_03_27_012757	153	11	posted	post	VBD
10_1101-2020_03_27_012757	153	12	January	January	NNP
10_1101-2020_03_27_012757	153	13	9	9	CD
10_1101-2020_03_27_012757	153	14	,	,	,
10_1101-2020_03_27_012757	153	15	2021	2021	CD
10_1101-2020_03_27_012757	153	16	.	.	.
10_1101-2020_03_27_012757	153	17	;	;	:
10_1101-2020_03_27_012757	153	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	153	19	:	:	:
10_1101-2020_03_27_012757	153	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	153	21	preprint	preprint	NN
10_1101-2020_03_27_012757	153	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	153	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	153	24	13	13	CD
10_1101-2020_03_27_012757	153	25	classified	classified	JJ
10_1101-2020_03_27_012757	153	26	cell	cell	NN
10_1101-2020_03_27_012757	153	27	lines	line	NNS
10_1101-2020_03_27_012757	153	28	from	from	IN
10_1101-2020_03_27_012757	153	29	each	each	DT
10_1101-2020_03_27_012757	153	30	general	general	JJ
10_1101-2020_03_27_012757	153	31	tumor	tumor	NN
10_1101-2020_03_27_012757	153	32	type	type	NN
10_1101-2020_03_27_012757	153	33	(	(	-LRB-
10_1101-2020_03_27_012757	153	34	Fig	Fig	NNP
10_1101-2020_03_27_012757	153	35	4D	4d	NN
10_1101-2020_03_27_012757	153	36	)	)	-RRB-
10_1101-2020_03_27_012757	153	37	.	.	.
10_1101-2020_03_27_012757	154	1	For	for	IN
10_1101-2020_03_27_012757	154	2	most	most	JJS
10_1101-2020_03_27_012757	154	3	of	of	IN
10_1101-2020_03_27_012757	154	4	the	the	DT
10_1101-2020_03_27_012757	154	5	general	general	JJ
10_1101-2020_03_27_012757	154	6	tumor	tumor	NN
10_1101-2020_03_27_012757	154	7	types	type	NNS
10_1101-2020_03_27_012757	154	8	,	,	,
10_1101-2020_03_27_012757	154	9	345	345	CD
10_1101-2020_03_27_012757	154	10	the	the	DT
10_1101-2020_03_27_012757	154	11	highest	highest	RBS
10_1101-2020_03_27_012757	154	12	cited	cited	JJ
10_1101-2020_03_27_012757	154	13	cell	cell	NN
10_1101-2020_03_27_012757	154	14	line	line	NN
10_1101-2020_03_27_012757	154	15	is	be	VBZ
10_1101-2020_03_27_012757	154	16	not	not	RB
10_1101-2020_03_27_012757	154	17	the	the	DT
10_1101-2020_03_27_012757	154	18	highest	high	JJS
10_1101-2020_03_27_012757	154	19	classified	classified	JJ
10_1101-2020_03_27_012757	154	20	cell	cell	NN
10_1101-2020_03_27_012757	154	21	line	line	NN
10_1101-2020_03_27_012757	154	22	except	except	IN
10_1101-2020_03_27_012757	154	23	for	for	IN
10_1101-2020_03_27_012757	154	24	Hep	Hep	NNP
10_1101-2020_03_27_012757	154	25	G2	G2	NNP
10_1101-2020_03_27_012757	154	26	,	,	,
10_1101-2020_03_27_012757	154	27	AGS	AGS	NNP
10_1101-2020_03_27_012757	154	28	and	and	CC
10_1101-2020_03_27_012757	154	29	ML-346	ML-346	NNP
10_1101-2020_03_27_012757	154	30	1	1	CD
10_1101-2020_03_27_012757	154	31	,	,	,
10_1101-2020_03_27_012757	154	32	representing	represent	VBG
10_1101-2020_03_27_012757	154	33	liver	liver	NN
10_1101-2020_03_27_012757	154	34	hepatocellular	hepatocellular	NN
10_1101-2020_03_27_012757	154	35	carcinoma	carcinoma	NNP
10_1101-2020_03_27_012757	154	36	(	(	-LRB-
10_1101-2020_03_27_012757	154	37	LIHC	LIHC	NNP
10_1101-2020_03_27_012757	154	38	)	)	-RRB-
10_1101-2020_03_27_012757	154	39	,	,	,
10_1101-2020_03_27_012757	154	40	stomach	stomach	NN
10_1101-2020_03_27_012757	154	41	adenocarcinoma	adenocarcinoma	NN
10_1101-2020_03_27_012757	154	42	(	(	-LRB-
10_1101-2020_03_27_012757	154	43	STAD	STAD	NNP
10_1101-2020_03_27_012757	154	44	)	)	-RRB-
10_1101-2020_03_27_012757	154	45	,	,	,
10_1101-2020_03_27_012757	154	46	and	and	CC
10_1101-2020_03_27_012757	154	47	347	347	CD
10_1101-2020_03_27_012757	154	48	thyroid	thyroid	NN
10_1101-2020_03_27_012757	154	49	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	154	50	(	(	-LRB-
10_1101-2020_03_27_012757	154	51	THCA	THCA	NNP
10_1101-2020_03_27_012757	154	52	)	)	-RRB-
10_1101-2020_03_27_012757	154	53	,	,	,
10_1101-2020_03_27_012757	154	54	respectively	respectively	RB
10_1101-2020_03_27_012757	154	55	.	.	.
10_1101-2020_03_27_012757	155	1	On	on	IN
10_1101-2020_03_27_012757	155	2	the	the	DT
10_1101-2020_03_27_012757	155	3	other	other	JJ
10_1101-2020_03_27_012757	155	4	hand	hand	NN
10_1101-2020_03_27_012757	155	5	,	,	,
10_1101-2020_03_27_012757	155	6	the	the	DT
10_1101-2020_03_27_012757	155	7	general	general	JJ
10_1101-2020_03_27_012757	155	8	scores	score	NNS
10_1101-2020_03_27_012757	155	9	of	of	IN
10_1101-2020_03_27_012757	155	10	the	the	DT
10_1101-2020_03_27_012757	155	11	highest	high	JJS
10_1101-2020_03_27_012757	155	12	348	348	CD
10_1101-2020_03_27_012757	155	13	cited	cite	VBN
10_1101-2020_03_27_012757	155	14	cell	cell	NN
10_1101-2020_03_27_012757	155	15	lines	line	NNS
10_1101-2020_03_27_012757	155	16	representing	represent	VBG
10_1101-2020_03_27_012757	155	17	BLCA	BLCA	NNP
10_1101-2020_03_27_012757	155	18	(	(	-LRB-
10_1101-2020_03_27_012757	155	19	T24	T24	NNP
10_1101-2020_03_27_012757	155	20	)	)	-RRB-
10_1101-2020_03_27_012757	155	21	,	,	,
10_1101-2020_03_27_012757	155	22	BRCA	BRCA	NNP
10_1101-2020_03_27_012757	155	23	(	(	-LRB-
10_1101-2020_03_27_012757	155	24	MDA	MDA	NNP
10_1101-2020_03_27_012757	155	25	-	-	HYPH
10_1101-2020_03_27_012757	155	26	MB-231	MB-231	NNP
10_1101-2020_03_27_012757	155	27	)	)	-RRB-
10_1101-2020_03_27_012757	155	28	,	,	,
10_1101-2020_03_27_012757	155	29	and	and	CC
10_1101-2020_03_27_012757	155	30	PRAD	PRAD	NNP
10_1101-2020_03_27_012757	155	31	(	(	-LRB-
10_1101-2020_03_27_012757	155	32	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	155	33	)	)	-RRB-
10_1101-2020_03_27_012757	155	34	fall	fall	VBP
10_1101-2020_03_27_012757	155	35	below	below	IN
10_1101-2020_03_27_012757	155	36	349	349	CD
10_1101-2020_03_27_012757	155	37	the	the	DT
10_1101-2020_03_27_012757	155	38	classification	classification	NN
10_1101-2020_03_27_012757	155	39	threshold	threshold	NN
10_1101-2020_03_27_012757	155	40	of	of	IN
10_1101-2020_03_27_012757	155	41	0.25	0.25	CD
10_1101-2020_03_27_012757	155	42	.	.	.
10_1101-2020_03_27_012757	156	1	Notably	notably	RB
10_1101-2020_03_27_012757	156	2	,	,	,
10_1101-2020_03_27_012757	156	3	each	each	DT
10_1101-2020_03_27_012757	156	4	of	of	IN
10_1101-2020_03_27_012757	156	5	these	these	DT
10_1101-2020_03_27_012757	156	6	tumor	tumor	NN
10_1101-2020_03_27_012757	156	7	types	type	NNS
10_1101-2020_03_27_012757	156	8	have	have	VBP
10_1101-2020_03_27_012757	156	9	other	other	JJ
10_1101-2020_03_27_012757	156	10	lines	line	NNS
10_1101-2020_03_27_012757	156	11	with	with	IN
10_1101-2020_03_27_012757	156	12	350	350	CD
10_1101-2020_03_27_012757	156	13	scores	score	NNS
10_1101-2020_03_27_012757	156	14	exceeding	exceed	VBG
10_1101-2020_03_27_012757	156	15	0.5	0.5	CD
10_1101-2020_03_27_012757	156	16	,	,	,
10_1101-2020_03_27_012757	156	17	which	which	WDT
10_1101-2020_03_27_012757	156	18	should	should	MD
10_1101-2020_03_27_012757	156	19	be	be	VB
10_1101-2020_03_27_012757	156	20	considered	consider	VBN
10_1101-2020_03_27_012757	156	21	as	as	IN
10_1101-2020_03_27_012757	156	22	more	more	RBR
10_1101-2020_03_27_012757	156	23	faithful	faithful	JJ
10_1101-2020_03_27_012757	156	24	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	156	25	models	model	NNS
10_1101-2020_03_27_012757	156	26	when	when	WRB
10_1101-2020_03_27_012757	156	27	351	351	CD
10_1101-2020_03_27_012757	156	28	selecting	select	VBG
10_1101-2020_03_27_012757	156	29	lines	line	NNS
10_1101-2020_03_27_012757	156	30	for	for	IN
10_1101-2020_03_27_012757	156	31	a	a	DT
10_1101-2020_03_27_012757	156	32	study	study	NN
10_1101-2020_03_27_012757	156	33	(	(	-LRB-
10_1101-2020_03_27_012757	156	34	Supp	Supp	NNP
10_1101-2020_03_27_012757	156	35	Tab	Tab	NNP
10_1101-2020_03_27_012757	156	36	1	1	CD
10_1101-2020_03_27_012757	156	37	and	and	CC
10_1101-2020_03_27_012757	156	38	352	352	CD
10_1101-2020_03_27_012757	156	39	http://www.cahanlab.org/resources/cancerCellNet_results/	http://www.cahanlab.org/resources/cancerCellNet_results/	NNS
10_1101-2020_03_27_012757	156	40	)	)	-RRB-
10_1101-2020_03_27_012757	156	41	.	.	.
10_1101-2020_03_27_012757	157	1	353	353	CD
10_1101-2020_03_27_012757	157	2	354	354	CD
10_1101-2020_03_27_012757	157	3	Evaluation	Evaluation	NNP
10_1101-2020_03_27_012757	157	4	of	of	IN
10_1101-2020_03_27_012757	157	5	patient	patient	JJ
10_1101-2020_03_27_012757	157	6	derived	derive	VBN
10_1101-2020_03_27_012757	157	7	xenografts	xenografts	NNP
10_1101-2020_03_27_012757	157	8	355	355	CD
10_1101-2020_03_27_012757	157	9	Next	Next	NNP
10_1101-2020_03_27_012757	157	10	,	,	,
10_1101-2020_03_27_012757	157	11	we	-PRON-	PRP
10_1101-2020_03_27_012757	157	12	sought	seek	VBD
10_1101-2020_03_27_012757	157	13	to	to	TO
10_1101-2020_03_27_012757	157	14	evaluate	evaluate	VB
10_1101-2020_03_27_012757	157	15	a	a	DT
10_1101-2020_03_27_012757	157	16	more	more	RBR
10_1101-2020_03_27_012757	157	17	recent	recent	JJ
10_1101-2020_03_27_012757	157	18	class	class	NN
10_1101-2020_03_27_012757	157	19	of	of	IN
10_1101-2020_03_27_012757	157	20	cancer	cancer	NN
10_1101-2020_03_27_012757	157	21	models	model	NNS
10_1101-2020_03_27_012757	157	22	:	:	:
10_1101-2020_03_27_012757	157	23	PDX	PDX	NNP
10_1101-2020_03_27_012757	157	24	.	.	.
10_1101-2020_03_27_012757	158	1	To	to	TO
10_1101-2020_03_27_012757	158	2	do	do	VB
10_1101-2020_03_27_012757	158	3	so	so	RB
10_1101-2020_03_27_012757	158	4	,	,	,
10_1101-2020_03_27_012757	158	5	we	-PRON-	PRP
10_1101-2020_03_27_012757	158	6	356	356	CD
10_1101-2020_03_27_012757	158	7	subjected	subject	VBD
10_1101-2020_03_27_012757	158	8	the	the	DT
10_1101-2020_03_27_012757	158	9	RNA	RNA	NNP
10_1101-2020_03_27_012757	158	10	-	-	HYPH
10_1101-2020_03_27_012757	158	11	seq	seq	NN
10_1101-2020_03_27_012757	158	12	expression	expression	NN
10_1101-2020_03_27_012757	158	13	profiles	profile	NNS
10_1101-2020_03_27_012757	158	14	of	of	IN
10_1101-2020_03_27_012757	158	15	415	415	CD
10_1101-2020_03_27_012757	158	16	PDX	PDX	NNP
10_1101-2020_03_27_012757	158	17	models	model	NNS
10_1101-2020_03_27_012757	158	18	from	from	IN
10_1101-2020_03_27_012757	158	19	13	13	CD
10_1101-2020_03_27_012757	158	20	different	different	JJ
10_1101-2020_03_27_012757	158	21	types	type	NNS
10_1101-2020_03_27_012757	158	22	of	of	IN
10_1101-2020_03_27_012757	158	23	cancer	cancer	NN
10_1101-2020_03_27_012757	158	24	357	357	CD
10_1101-2020_03_27_012757	158	25	types	type	NNS
10_1101-2020_03_27_012757	158	26	generated	generate	VBD
10_1101-2020_03_27_012757	158	27	previously20	previously20	NNP
10_1101-2020_03_27_012757	158	28	to	to	IN
10_1101-2020_03_27_012757	158	29	CCN	CCN	NNP
10_1101-2020_03_27_012757	158	30	.	.	.
10_1101-2020_03_27_012757	159	1	Similar	similar	JJ
10_1101-2020_03_27_012757	159	2	to	to	IN
10_1101-2020_03_27_012757	159	3	the	the	DT
10_1101-2020_03_27_012757	159	4	results	result	NNS
10_1101-2020_03_27_012757	159	5	of	of	IN
10_1101-2020_03_27_012757	159	6	CCLs	ccl	NNS
10_1101-2020_03_27_012757	159	7	,	,	,
10_1101-2020_03_27_012757	159	8	the	the	DT
10_1101-2020_03_27_012757	159	9	PDXs	pdx	NNS
10_1101-2020_03_27_012757	159	10	exhibited	exhibit	VBD
10_1101-2020_03_27_012757	159	11	a	a	DT
10_1101-2020_03_27_012757	159	12	wide	wide	JJ
10_1101-2020_03_27_012757	159	13	358	358	CD
10_1101-2020_03_27_012757	159	14	range	range	NN
10_1101-2020_03_27_012757	159	15	of	of	IN
10_1101-2020_03_27_012757	159	16	classification	classification	NN
10_1101-2020_03_27_012757	159	17	scores	score	NNS
10_1101-2020_03_27_012757	159	18	(	(	-LRB-
10_1101-2020_03_27_012757	159	19	Fig	fig	NN
10_1101-2020_03_27_012757	159	20	5A	5a	RB
10_1101-2020_03_27_012757	159	21	,	,	,
10_1101-2020_03_27_012757	159	22	Supp	Supp	NNP
10_1101-2020_03_27_012757	159	23	Tab	Tab	NNP
10_1101-2020_03_27_012757	159	24	3	3	CD
10_1101-2020_03_27_012757	159	25	)	)	-RRB-
10_1101-2020_03_27_012757	159	26	.	.	.
10_1101-2020_03_27_012757	160	1	By	by	IN
10_1101-2020_03_27_012757	160	2	categorizing	categorize	VBG
10_1101-2020_03_27_012757	160	3	the	the	DT
10_1101-2020_03_27_012757	160	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	160	5	scores	score	NNS
10_1101-2020_03_27_012757	160	6	of	of	IN
10_1101-2020_03_27_012757	160	7	PDX	PDX	NNP
10_1101-2020_03_27_012757	160	8	359	359	CD
10_1101-2020_03_27_012757	160	9	based	base	VBN
10_1101-2020_03_27_012757	160	10	on	on	IN
10_1101-2020_03_27_012757	160	11	the	the	DT
10_1101-2020_03_27_012757	160	12	proportion	proportion	NN
10_1101-2020_03_27_012757	160	13	of	of	IN
10_1101-2020_03_27_012757	160	14	samples	sample	NNS
10_1101-2020_03_27_012757	160	15	associated	associate	VBN
10_1101-2020_03_27_012757	160	16	with	with	IN
10_1101-2020_03_27_012757	160	17	each	each	DT
10_1101-2020_03_27_012757	160	18	tumor	tumor	NN
10_1101-2020_03_27_012757	160	19	type	type	NN
10_1101-2020_03_27_012757	160	20	that	that	WDT
10_1101-2020_03_27_012757	160	21	were	be	VBD
10_1101-2020_03_27_012757	160	22	correctly	correctly	RB
10_1101-2020_03_27_012757	160	23	360	360	CD
10_1101-2020_03_27_012757	160	24	classified	classify	VBD
10_1101-2020_03_27_012757	160	25	,	,	,
10_1101-2020_03_27_012757	160	26	we	-PRON-	PRP
10_1101-2020_03_27_012757	160	27	found	find	VBD
10_1101-2020_03_27_012757	160	28	that	that	IN
10_1101-2020_03_27_012757	160	29	SARC	SARC	NNP
10_1101-2020_03_27_012757	160	30	,	,	,
10_1101-2020_03_27_012757	160	31	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	160	32	,	,	,
10_1101-2020_03_27_012757	160	33	COAD_READ	COAD_READ	NNS
10_1101-2020_03_27_012757	160	34	and	and	CC
10_1101-2020_03_27_012757	160	35	BRCA	BRCA	NNP
10_1101-2020_03_27_012757	160	36	have	have	VBP
10_1101-2020_03_27_012757	160	37	higher	high	JJR
10_1101-2020_03_27_012757	160	38	proportion	proportion	NN
10_1101-2020_03_27_012757	160	39	of	of	IN
10_1101-2020_03_27_012757	160	40	361	361	CD
10_1101-2020_03_27_012757	160	41	correctly	correctly	RB
10_1101-2020_03_27_012757	160	42	classified	classify	VBN
10_1101-2020_03_27_012757	160	43	PDX	pdx	NN
10_1101-2020_03_27_012757	160	44	than	than	IN
10_1101-2020_03_27_012757	160	45	those	those	DT
10_1101-2020_03_27_012757	160	46	of	of	IN
10_1101-2020_03_27_012757	160	47	other	other	JJ
10_1101-2020_03_27_012757	160	48	cancer	cancer	NN
10_1101-2020_03_27_012757	160	49	categories	category	NNS
10_1101-2020_03_27_012757	160	50	(	(	-LRB-
10_1101-2020_03_27_012757	160	51	Fig	Fig	NNP
10_1101-2020_03_27_012757	160	52	5B	5b	NN
10_1101-2020_03_27_012757	160	53	)	)	-RRB-
10_1101-2020_03_27_012757	160	54	.	.	.
10_1101-2020_03_27_012757	161	1	In	in	IN
10_1101-2020_03_27_012757	161	2	contrast	contrast	NN
10_1101-2020_03_27_012757	161	3	to	to	IN
10_1101-2020_03_27_012757	161	4	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	161	5	,	,	,
10_1101-2020_03_27_012757	161	6	we	-PRON-	PRP
10_1101-2020_03_27_012757	161	7	362	362	CD
10_1101-2020_03_27_012757	161	8	found	find	VBD
10_1101-2020_03_27_012757	161	9	a	a	DT
10_1101-2020_03_27_012757	161	10	higher	high	JJR
10_1101-2020_03_27_012757	161	11	proportion	proportion	NN
10_1101-2020_03_27_012757	161	12	of	of	IN
10_1101-2020_03_27_012757	161	13	correctly	correctly	RB
10_1101-2020_03_27_012757	161	14	classified	classify	VBN
10_1101-2020_03_27_012757	161	15	PDX	PDX	NNP
10_1101-2020_03_27_012757	161	16	in	in	IN
10_1101-2020_03_27_012757	161	17	STAD	STAD	NNP
10_1101-2020_03_27_012757	161	18	,	,	,
10_1101-2020_03_27_012757	161	19	PAAD	PAAD	NNP
10_1101-2020_03_27_012757	161	20	and	and	CC
10_1101-2020_03_27_012757	161	21	KIRC	KIRC	NNP
10_1101-2020_03_27_012757	161	22	(	(	-LRB-
10_1101-2020_03_27_012757	161	23	Fig	Fig	NNP
10_1101-2020_03_27_012757	161	24	5B	5b	NN
10_1101-2020_03_27_012757	161	25	)	)	-RRB-
10_1101-2020_03_27_012757	161	26	.	.	.
10_1101-2020_03_27_012757	162	1	363	363	CD
10_1101-2020_03_27_012757	162	2	However	however	RB
10_1101-2020_03_27_012757	162	3	,	,	,
10_1101-2020_03_27_012757	162	4	similar	similar	JJ
10_1101-2020_03_27_012757	162	5	to	to	IN
10_1101-2020_03_27_012757	162	6	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	162	7	,	,	,
10_1101-2020_03_27_012757	162	8	no	no	DT
10_1101-2020_03_27_012757	162	9	ESCA	ESCA	NNP
10_1101-2020_03_27_012757	162	10	PDXs	pdx	NNS
10_1101-2020_03_27_012757	162	11	were	be	VBD
10_1101-2020_03_27_012757	162	12	classified	classify	VBN
10_1101-2020_03_27_012757	162	13	as	as	IN
10_1101-2020_03_27_012757	162	14	such	such	JJ
10_1101-2020_03_27_012757	162	15	.	.	.
10_1101-2020_03_27_012757	163	1	This	this	DT
10_1101-2020_03_27_012757	163	2	held	hold	VBN
10_1101-2020_03_27_012757	163	3	true	true	JJ
10_1101-2020_03_27_012757	163	4	when	when	WRB
10_1101-2020_03_27_012757	163	5	we	-PRON-	PRP
10_1101-2020_03_27_012757	163	6	364	364	CD
10_1101-2020_03_27_012757	163	7	performed	perform	VBN
10_1101-2020_03_27_012757	163	8	subtype	subtype	NN
10_1101-2020_03_27_012757	163	9	classification	classification	NN
10_1101-2020_03_27_012757	163	10	on	on	IN
10_1101-2020_03_27_012757	163	11	PDX	PDX	NNP
10_1101-2020_03_27_012757	163	12	samples	sample	NNS
10_1101-2020_03_27_012757	163	13	:	:	:
10_1101-2020_03_27_012757	163	14	none	none	NN
10_1101-2020_03_27_012757	163	15	of	of	IN
10_1101-2020_03_27_012757	163	16	the	the	DT
10_1101-2020_03_27_012757	163	17	PDX	PDX	NNP
10_1101-2020_03_27_012757	163	18	in	in	IN
10_1101-2020_03_27_012757	163	19	ESCA	ESCA	NNP
10_1101-2020_03_27_012757	163	20	were	be	VBD
10_1101-2020_03_27_012757	163	21	classified	classify	VBN
10_1101-2020_03_27_012757	163	22	as	as	IN
10_1101-2020_03_27_012757	163	23	365	365	CD
10_1101-2020_03_27_012757	163	24	any	any	DT
10_1101-2020_03_27_012757	163	25	of	of	IN
10_1101-2020_03_27_012757	163	26	the	the	DT
10_1101-2020_03_27_012757	163	27	ESCA	ESCA	NNP
10_1101-2020_03_27_012757	163	28	subtypes	subtype	NNS
10_1101-2020_03_27_012757	163	29	(	(	-LRB-
10_1101-2020_03_27_012757	163	30	Supp	Supp	NNP
10_1101-2020_03_27_012757	163	31	Tab	Tab	NNP
10_1101-2020_03_27_012757	163	32	4	4	CD
10_1101-2020_03_27_012757	163	33	)	)	-RRB-
10_1101-2020_03_27_012757	163	34	.	.	.
10_1101-2020_03_27_012757	164	1	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	164	2	PDXs	pdx	NNS
10_1101-2020_03_27_012757	164	3	had	have	VBD
10_1101-2020_03_27_012757	164	4	both	both	DT
10_1101-2020_03_27_012757	164	5	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	164	6	subtypes	subtype	NNS
10_1101-2020_03_27_012757	164	7	,	,	,
10_1101-2020_03_27_012757	164	8	serous	serous	JJ
10_1101-2020_03_27_012757	164	9	366	366	CD
10_1101-2020_03_27_012757	164	10	subtypes	subtype	NNS
10_1101-2020_03_27_012757	164	11	,	,	,
10_1101-2020_03_27_012757	164	12	and	and	CC
10_1101-2020_03_27_012757	164	13	mixed	mixed	JJ
10_1101-2020_03_27_012757	164	14	subtypes	subtype	NNS
10_1101-2020_03_27_012757	164	15	,	,	,
10_1101-2020_03_27_012757	164	16	which	which	WDT
10_1101-2020_03_27_012757	164	17	provided	provide	VBD
10_1101-2020_03_27_012757	164	18	a	a	DT
10_1101-2020_03_27_012757	164	19	broader	broad	JJR
10_1101-2020_03_27_012757	164	20	representation	representation	NN
10_1101-2020_03_27_012757	164	21	than	than	IN
10_1101-2020_03_27_012757	164	22	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	164	23	(	(	-LRB-
10_1101-2020_03_27_012757	164	24	Fig	fig	NN
10_1101-2020_03_27_012757	164	25	5C	5c	NN
10_1101-2020_03_27_012757	164	26	)	)	-RRB-
10_1101-2020_03_27_012757	164	27	.	.	.
10_1101-2020_03_27_012757	165	1	367	367	CD
10_1101-2020_03_27_012757	165	2	Several	several	JJ
10_1101-2020_03_27_012757	165	3	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	165	4	PDXs	pdx	NNS
10_1101-2020_03_27_012757	165	5	that	that	WDT
10_1101-2020_03_27_012757	165	6	were	be	VBD
10_1101-2020_03_27_012757	165	7	classified	classify	VBN
10_1101-2020_03_27_012757	165	8	as	as	IN
10_1101-2020_03_27_012757	165	9	a	a	DT
10_1101-2020_03_27_012757	165	10	subtype	subtype	NN
10_1101-2020_03_27_012757	165	11	were	be	VBD
10_1101-2020_03_27_012757	165	12	also	also	RB
10_1101-2020_03_27_012757	165	13	classified	classify	VBN
10_1101-2020_03_27_012757	165	14	as	as	IN
10_1101-2020_03_27_012757	165	15	Head	Head	NNP
10_1101-2020_03_27_012757	165	16	and	and	CC
10_1101-2020_03_27_012757	165	17	Neck	Neck	NNP
10_1101-2020_03_27_012757	165	18	368	368	CD
10_1101-2020_03_27_012757	165	19	squamous	squamous	JJ
10_1101-2020_03_27_012757	165	20	cell	cell	NN
10_1101-2020_03_27_012757	165	21	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	165	22	(	(	-LRB-
10_1101-2020_03_27_012757	165	23	HNSC	HNSC	NNP
10_1101-2020_03_27_012757	165	24	)	)	-RRB-
10_1101-2020_03_27_012757	165	25	or	or	CC
10_1101-2020_03_27_012757	165	26	mix	mix	VB
10_1101-2020_03_27_012757	165	27	HNSC	HNSC	NNP
10_1101-2020_03_27_012757	165	28	and	and	CC
10_1101-2020_03_27_012757	165	29	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	165	30	(	(	-LRB-
10_1101-2020_03_27_012757	165	31	Fig	Fig	NNP
10_1101-2020_03_27_012757	165	32	5D	5d	NN
10_1101-2020_03_27_012757	165	33	)	)	-RRB-
10_1101-2020_03_27_012757	165	34	.	.	.
10_1101-2020_03_27_012757	166	1	This	this	DT
10_1101-2020_03_27_012757	166	2	could	could	MD
10_1101-2020_03_27_012757	166	3	be	be	VB
10_1101-2020_03_27_012757	166	4	due	due	IN
10_1101-2020_03_27_012757	166	5	to	to	IN
10_1101-2020_03_27_012757	166	6	the	the	DT
10_1101-2020_03_27_012757	166	7	369	369	CD
10_1101-2020_03_27_012757	166	8	similarity	similarity	NN
10_1101-2020_03_27_012757	166	9	in	in	IN
10_1101-2020_03_27_012757	166	10	expression	expression	NN
10_1101-2020_03_27_012757	166	11	profiles	profile	NNS
10_1101-2020_03_27_012757	166	12	of	of	IN
10_1101-2020_03_27_012757	166	13	basal	basal	NN
10_1101-2020_03_27_012757	166	14	and	and	CC
10_1101-2020_03_27_012757	166	15	classical	classical	JJ
10_1101-2020_03_27_012757	166	16	subtypes	subtype	NNS
10_1101-2020_03_27_012757	166	17	of	of	IN
10_1101-2020_03_27_012757	166	18	HNSC	HNSC	NNP
10_1101-2020_03_27_012757	166	19	and	and	CC
10_1101-2020_03_27_012757	166	20	LUSC28,58	LUSC28,58	NNP
10_1101-2020_03_27_012757	166	21	,	,	,
10_1101-2020_03_27_012757	166	22	which	which	WDT
10_1101-2020_03_27_012757	166	23	is	be	VBZ
10_1101-2020_03_27_012757	166	24	370	370	CD
10_1101-2020_03_27_012757	166	25	.CC	.CC	,
10_1101-2020_03_27_012757	166	26	-	-	HYPH
10_1101-2020_03_27_012757	166	27	BY	by	IN
10_1101-2020_03_27_012757	166	28	-	-	HYPH
10_1101-2020_03_27_012757	166	29	NC	NC	NNP
10_1101-2020_03_27_012757	166	30	-	-	HYPH
10_1101-2020_03_27_012757	166	31	ND	ND	NNP
10_1101-2020_03_27_012757	166	32	4.0	4.0	CD
10_1101-2020_03_27_012757	166	33	International	International	NNP
10_1101-2020_03_27_012757	166	34	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	166	35	under	under	IN
10_1101-2020_03_27_012757	166	36	a	a	DT
10_1101-2020_03_27_012757	166	37	(	(	-LRB-
10_1101-2020_03_27_012757	166	38	which	which	WDT
10_1101-2020_03_27_012757	166	39	was	be	VBD
10_1101-2020_03_27_012757	166	40	not	not	RB
10_1101-2020_03_27_012757	166	41	certified	certify	VBN
10_1101-2020_03_27_012757	166	42	by	by	IN
10_1101-2020_03_27_012757	166	43	peer	peer	NN
10_1101-2020_03_27_012757	166	44	review	review	NN
10_1101-2020_03_27_012757	166	45	)	)	-RRB-
10_1101-2020_03_27_012757	166	46	is	be	VBZ
10_1101-2020_03_27_012757	166	47	the	the	DT
10_1101-2020_03_27_012757	166	48	author	author	NN
10_1101-2020_03_27_012757	166	49	/	/	SYM
10_1101-2020_03_27_012757	166	50	funder	funder	NN
10_1101-2020_03_27_012757	166	51	,	,	,
10_1101-2020_03_27_012757	166	52	who	who	WP
10_1101-2020_03_27_012757	166	53	has	have	VBZ
10_1101-2020_03_27_012757	166	54	granted	grant	VBN
10_1101-2020_03_27_012757	166	55	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	166	56	a	a	DT
10_1101-2020_03_27_012757	166	57	license	license	NN
10_1101-2020_03_27_012757	166	58	to	to	TO
10_1101-2020_03_27_012757	166	59	display	display	VB
10_1101-2020_03_27_012757	166	60	the	the	DT
10_1101-2020_03_27_012757	166	61	preprint	preprint	NN
10_1101-2020_03_27_012757	166	62	in	in	IN
10_1101-2020_03_27_012757	166	63	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	166	64	.	.	.
10_1101-2020_03_27_012757	167	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	167	2	is	be	VBZ
10_1101-2020_03_27_012757	167	3	made	make	VBN
10_1101-2020_03_27_012757	167	4	The	the	DT
10_1101-2020_03_27_012757	167	5	copyright	copyright	NN
10_1101-2020_03_27_012757	167	6	holder	holder	NN
10_1101-2020_03_27_012757	167	7	for	for	IN
10_1101-2020_03_27_012757	167	8	this	this	DT
10_1101-2020_03_27_012757	167	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	167	10	version	version	NN
10_1101-2020_03_27_012757	167	11	posted	post	VBD
10_1101-2020_03_27_012757	167	12	January	January	NNP
10_1101-2020_03_27_012757	167	13	9	9	CD
10_1101-2020_03_27_012757	167	14	,	,	,
10_1101-2020_03_27_012757	167	15	2021	2021	CD
10_1101-2020_03_27_012757	167	16	.	.	.
10_1101-2020_03_27_012757	167	17	;	;	:
10_1101-2020_03_27_012757	167	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	167	19	:	:	:
10_1101-2020_03_27_012757	167	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	167	21	preprint	preprint	NN
10_1101-2020_03_27_012757	167	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	167	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	167	24	14	14	CD
10_1101-2020_03_27_012757	167	25	consistent	consistent	JJ
10_1101-2020_03_27_012757	167	26	with	with	IN
10_1101-2020_03_27_012757	167	27	the	the	DT
10_1101-2020_03_27_012757	167	28	observation	observation	NN
10_1101-2020_03_27_012757	167	29	that	that	IN
10_1101-2020_03_27_012757	167	30	these	these	DT
10_1101-2020_03_27_012757	167	31	PDXs	pdx	NNS
10_1101-2020_03_27_012757	167	32	were	be	VBD
10_1101-2020_03_27_012757	167	33	also	also	RB
10_1101-2020_03_27_012757	167	34	subtyped	subtype	VBN
10_1101-2020_03_27_012757	167	35	as	as	IN
10_1101-2020_03_27_012757	167	36	classical	classical	JJ
10_1101-2020_03_27_012757	167	37	.	.	.
10_1101-2020_03_27_012757	168	1	No	no	DT
10_1101-2020_03_27_012757	168	2	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	168	3	371	371	CD
10_1101-2020_03_27_012757	168	4	PDXs	pdx	NNS
10_1101-2020_03_27_012757	168	5	were	be	VBD
10_1101-2020_03_27_012757	168	6	classified	classify	VBN
10_1101-2020_03_27_012757	168	7	as	as	IN
10_1101-2020_03_27_012757	168	8	the	the	DT
10_1101-2020_03_27_012757	168	9	secretory	secretory	JJ
10_1101-2020_03_27_012757	168	10	subtype	subtype	NN
10_1101-2020_03_27_012757	168	11	.	.	.
10_1101-2020_03_27_012757	169	1	In	in	IN
10_1101-2020_03_27_012757	169	2	contrast	contrast	NN
10_1101-2020_03_27_012757	169	3	to	to	IN
10_1101-2020_03_27_012757	169	4	LUAD	luad	JJ
10_1101-2020_03_27_012757	169	5	CCLs	ccl	NNS
10_1101-2020_03_27_012757	169	6	,	,	,
10_1101-2020_03_27_012757	169	7	four	four	CD
10_1101-2020_03_27_012757	169	8	of	of	IN
10_1101-2020_03_27_012757	169	9	the	the	DT
10_1101-2020_03_27_012757	169	10	five	five	CD
10_1101-2020_03_27_012757	169	11	LUAD	luad	RB
10_1101-2020_03_27_012757	169	12	372	372	CD
10_1101-2020_03_27_012757	169	13	PDXs	pdx	NNS
10_1101-2020_03_27_012757	169	14	with	with	IN
10_1101-2020_03_27_012757	169	15	a	a	DT
10_1101-2020_03_27_012757	169	16	discernible	discernible	JJ
10_1101-2020_03_27_012757	169	17	sub	sub	NN
10_1101-2020_03_27_012757	169	18	-	-	NN
10_1101-2020_03_27_012757	169	19	type	type	NN
10_1101-2020_03_27_012757	169	20	were	be	VBD
10_1101-2020_03_27_012757	169	21	classified	classify	VBN
10_1101-2020_03_27_012757	169	22	as	as	IN
10_1101-2020_03_27_012757	169	23	proximal	proximal	JJ
10_1101-2020_03_27_012757	169	24	inflammatory	inflammatory	NN
10_1101-2020_03_27_012757	169	25	(	(	-LRB-
10_1101-2020_03_27_012757	169	26	Fig	Fig	NNP
10_1101-2020_03_27_012757	169	27	5E	5e	NN
10_1101-2020_03_27_012757	169	28	)	)	-RRB-
10_1101-2020_03_27_012757	169	29	.	.	.
10_1101-2020_03_27_012757	170	1	On	on	IN
10_1101-2020_03_27_012757	170	2	the	the	DT
10_1101-2020_03_27_012757	170	3	373	373	CD
10_1101-2020_03_27_012757	170	4	other	other	JJ
10_1101-2020_03_27_012757	170	5	hand	hand	NN
10_1101-2020_03_27_012757	170	6	,	,	,
10_1101-2020_03_27_012757	170	7	similar	similar	JJ
10_1101-2020_03_27_012757	170	8	to	to	IN
10_1101-2020_03_27_012757	170	9	the	the	DT
10_1101-2020_03_27_012757	170	10	CCLs	ccl	NNS
10_1101-2020_03_27_012757	170	11	,	,	,
10_1101-2020_03_27_012757	170	12	there	there	EX
10_1101-2020_03_27_012757	170	13	were	be	VBD
10_1101-2020_03_27_012757	170	14	no	no	DT
10_1101-2020_03_27_012757	170	15	TRU	tru	NN
10_1101-2020_03_27_012757	170	16	subtypes	subtype	NNS
10_1101-2020_03_27_012757	170	17	in	in	IN
10_1101-2020_03_27_012757	170	18	the	the	DT
10_1101-2020_03_27_012757	170	19	LUAD	LUAD	NNP
10_1101-2020_03_27_012757	170	20	PDX	pdx	NN
10_1101-2020_03_27_012757	170	21	cohort	cohort	NN
10_1101-2020_03_27_012757	170	22	.	.	.
10_1101-2020_03_27_012757	171	1	In	in	IN
10_1101-2020_03_27_012757	171	2	374	374	CD
10_1101-2020_03_27_012757	171	3	summary	summary	NN
10_1101-2020_03_27_012757	171	4	,	,	,
10_1101-2020_03_27_012757	171	5	we	-PRON-	PRP
10_1101-2020_03_27_012757	171	6	found	find	VBD
10_1101-2020_03_27_012757	171	7	that	that	IN
10_1101-2020_03_27_012757	171	8	while	while	IN
10_1101-2020_03_27_012757	171	9	individual	individual	JJ
10_1101-2020_03_27_012757	171	10	PDXs	pdx	NNS
10_1101-2020_03_27_012757	171	11	can	can	MD
10_1101-2020_03_27_012757	171	12	reach	reach	VB
10_1101-2020_03_27_012757	171	13	extremely	extremely	RB
10_1101-2020_03_27_012757	171	14	high	high	JJ
10_1101-2020_03_27_012757	171	15	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	171	16	fidelity	fidelity	NN
10_1101-2020_03_27_012757	171	17	375	375	CD
10_1101-2020_03_27_012757	171	18	to	to	IN
10_1101-2020_03_27_012757	171	19	both	both	CC
10_1101-2020_03_27_012757	171	20	general	general	JJ
10_1101-2020_03_27_012757	171	21	tumor	tumor	NN
10_1101-2020_03_27_012757	171	22	types	type	NNS
10_1101-2020_03_27_012757	171	23	and	and	CC
10_1101-2020_03_27_012757	171	24	subtypes	subtype	NNS
10_1101-2020_03_27_012757	171	25	,	,	,
10_1101-2020_03_27_012757	171	26	many	many	JJ
10_1101-2020_03_27_012757	171	27	PDXs	pdx	NNS
10_1101-2020_03_27_012757	171	28	were	be	VBD
10_1101-2020_03_27_012757	171	29	not	not	RB
10_1101-2020_03_27_012757	171	30	classified	classify	VBN
10_1101-2020_03_27_012757	171	31	as	as	IN
10_1101-2020_03_27_012757	171	32	the	the	DT
10_1101-2020_03_27_012757	171	33	general	general	JJ
10_1101-2020_03_27_012757	171	34	tumor	tumor	NN
10_1101-2020_03_27_012757	171	35	376	376	CD
10_1101-2020_03_27_012757	171	36	type	type	NN
10_1101-2020_03_27_012757	171	37	from	from	IN
10_1101-2020_03_27_012757	171	38	which	which	WDT
10_1101-2020_03_27_012757	171	39	they	-PRON-	PRP
10_1101-2020_03_27_012757	171	40	originated	originate	VBD
10_1101-2020_03_27_012757	171	41	.	.	.
10_1101-2020_03_27_012757	172	1	377	377	CD
10_1101-2020_03_27_012757	172	2	378	378	CD
10_1101-2020_03_27_012757	172	3	Evaluation	evaluation	NN
10_1101-2020_03_27_012757	172	4	of	of	IN
10_1101-2020_03_27_012757	172	5	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	172	6	379	379	CD
10_1101-2020_03_27_012757	172	7	Next	next	RB
10_1101-2020_03_27_012757	172	8	,	,	,
10_1101-2020_03_27_012757	172	9	we	-PRON-	PRP
10_1101-2020_03_27_012757	172	10	used	use	VBD
10_1101-2020_03_27_012757	172	11	CCN	CCN	NNP
10_1101-2020_03_27_012757	172	12	to	to	TO
10_1101-2020_03_27_012757	172	13	evaluate	evaluate	VB
10_1101-2020_03_27_012757	172	14	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	172	15	of	of	IN
10_1101-2020_03_27_012757	172	16	six	six	CD
10_1101-2020_03_27_012757	172	17	general	general	JJ
10_1101-2020_03_27_012757	172	18	tumor	tumor	NN
10_1101-2020_03_27_012757	172	19	types	type	NNS
10_1101-2020_03_27_012757	172	20	from	from	IN
10_1101-2020_03_27_012757	172	21	nine	nine	CD
10_1101-2020_03_27_012757	172	22	studies	study	NNS
10_1101-2020_03_27_012757	172	23	for	for	IN
10_1101-2020_03_27_012757	172	24	380	380	CD
10_1101-2020_03_27_012757	172	25	which	which	WDT
10_1101-2020_03_27_012757	172	26	expression	expression	NN
10_1101-2020_03_27_012757	172	27	data	datum	NNS
10_1101-2020_03_27_012757	172	28	was	be	VBD
10_1101-2020_03_27_012757	172	29	publicly	publicly	RB
10_1101-2020_03_27_012757	172	30	available59–67	available59–67	VBN
10_1101-2020_03_27_012757	172	31	.	.	.
10_1101-2020_03_27_012757	173	1	As	as	IN
10_1101-2020_03_27_012757	173	2	was	be	VBD
10_1101-2020_03_27_012757	173	3	true	true	JJ
10_1101-2020_03_27_012757	173	4	for	for	IN
10_1101-2020_03_27_012757	173	5	CCLs	ccl	NNS
10_1101-2020_03_27_012757	173	6	and	and	CC
10_1101-2020_03_27_012757	173	7	PDXs	pdx	NNS
10_1101-2020_03_27_012757	173	8	,	,	,
10_1101-2020_03_27_012757	173	9	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	173	10	381	381	CD
10_1101-2020_03_27_012757	173	11	also	also	RB
10_1101-2020_03_27_012757	173	12	had	have	VBD
10_1101-2020_03_27_012757	173	13	a	a	DT
10_1101-2020_03_27_012757	173	14	wide	wide	JJ
10_1101-2020_03_27_012757	173	15	range	range	NN
10_1101-2020_03_27_012757	173	16	of	of	IN
10_1101-2020_03_27_012757	173	17	CCN	CCN	NNP
10_1101-2020_03_27_012757	173	18	scores	score	NNS
10_1101-2020_03_27_012757	173	19	(	(	-LRB-
10_1101-2020_03_27_012757	173	20	Fig	fig	NN
10_1101-2020_03_27_012757	173	21	6A	6a	NN
10_1101-2020_03_27_012757	173	22	,	,	,
10_1101-2020_03_27_012757	173	23	Supp	Supp	NNP
10_1101-2020_03_27_012757	173	24	Tab	Tab	NNP
10_1101-2020_03_27_012757	173	25	5	5	CD
10_1101-2020_03_27_012757	173	26	)	)	-RRB-
10_1101-2020_03_27_012757	173	27	.	.	.
10_1101-2020_03_27_012757	174	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	174	2	next	next	RB
10_1101-2020_03_27_012757	174	3	categorized	categorize	VBD
10_1101-2020_03_27_012757	174	4	the	the	DT
10_1101-2020_03_27_012757	174	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	174	6	382	382	CD
10_1101-2020_03_27_012757	174	7	scores	score	NNS
10_1101-2020_03_27_012757	174	8	based	base	VBN
10_1101-2020_03_27_012757	174	9	on	on	IN
10_1101-2020_03_27_012757	174	10	the	the	DT
10_1101-2020_03_27_012757	174	11	proportion	proportion	NN
10_1101-2020_03_27_012757	174	12	of	of	IN
10_1101-2020_03_27_012757	174	13	samples	sample	NNS
10_1101-2020_03_27_012757	174	14	associated	associate	VBN
10_1101-2020_03_27_012757	174	15	with	with	IN
10_1101-2020_03_27_012757	174	16	each	each	DT
10_1101-2020_03_27_012757	174	17	tumor	tumor	NN
10_1101-2020_03_27_012757	174	18	type	type	NN
10_1101-2020_03_27_012757	174	19	that	that	WDT
10_1101-2020_03_27_012757	174	20	were	be	VBD
10_1101-2020_03_27_012757	174	21	correctly	correctly	RB
10_1101-2020_03_27_012757	174	22	383	383	CD
10_1101-2020_03_27_012757	174	23	classified	classified	JJ
10_1101-2020_03_27_012757	174	24	(	(	-LRB-
10_1101-2020_03_27_012757	174	25	Fig	Fig	NNP
10_1101-2020_03_27_012757	174	26	6B	6b	NN
10_1101-2020_03_27_012757	174	27	)	)	-RRB-
10_1101-2020_03_27_012757	174	28	.	.	.
10_1101-2020_03_27_012757	175	1	In	in	IN
10_1101-2020_03_27_012757	175	2	contrast	contrast	NN
10_1101-2020_03_27_012757	175	3	to	to	IN
10_1101-2020_03_27_012757	175	4	LGG	LGG	NNP
10_1101-2020_03_27_012757	175	5	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	175	6	,	,	,
10_1101-2020_03_27_012757	175	7	LGG	LGG	NNP
10_1101-2020_03_27_012757	175	8	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	175	9	,	,	,
10_1101-2020_03_27_012757	175	10	generated	generate	VBN
10_1101-2020_03_27_012757	175	11	by	by	IN
10_1101-2020_03_27_012757	175	12	Nf1	Nf1	NNP
10_1101-2020_03_27_012757	175	13	mutations	mutation	NNS
10_1101-2020_03_27_012757	175	14	384	384	CD
10_1101-2020_03_27_012757	175	15	expressed	express	VBD
10_1101-2020_03_27_012757	175	16	in	in	IN
10_1101-2020_03_27_012757	175	17	different	different	JJ
10_1101-2020_03_27_012757	175	18	neural	neural	JJ
10_1101-2020_03_27_012757	175	19	progenitors	progenitor	NNS
10_1101-2020_03_27_012757	175	20	in	in	IN
10_1101-2020_03_27_012757	175	21	combination	combination	NN
10_1101-2020_03_27_012757	175	22	with	with	IN
10_1101-2020_03_27_012757	175	23	Pten	Pten	NNP
10_1101-2020_03_27_012757	175	24	deletion66	deletion66	NNP
10_1101-2020_03_27_012757	175	25	,	,	,
10_1101-2020_03_27_012757	175	26	consistently	consistently	RB
10_1101-2020_03_27_012757	175	27	were	be	VBD
10_1101-2020_03_27_012757	175	28	385	385	CD
10_1101-2020_03_27_012757	175	29	classified	classified	JJ
10_1101-2020_03_27_012757	175	30	as	as	IN
10_1101-2020_03_27_012757	175	31	LGG	LGG	NNP
10_1101-2020_03_27_012757	175	32	(	(	-LRB-
10_1101-2020_03_27_012757	175	33	Fig	fig	NN
10_1101-2020_03_27_012757	175	34	6A	6a	NN
10_1101-2020_03_27_012757	175	35	-	-	HYPH
10_1101-2020_03_27_012757	175	36	B	b	NN
10_1101-2020_03_27_012757	175	37	)	)	-RRB-
10_1101-2020_03_27_012757	175	38	.	.	.
10_1101-2020_03_27_012757	176	1	The	the	DT
10_1101-2020_03_27_012757	176	2	GEMM	GEMM	NNP
10_1101-2020_03_27_012757	176	3	dataset	dataset	NN
10_1101-2020_03_27_012757	176	4	included	include	VBD
10_1101-2020_03_27_012757	176	5	multiple	multiple	JJ
10_1101-2020_03_27_012757	176	6	replicates	replicate	NNS
10_1101-2020_03_27_012757	176	7	per	per	IN
10_1101-2020_03_27_012757	176	8	model	model	NN
10_1101-2020_03_27_012757	176	9	,	,	,
10_1101-2020_03_27_012757	176	10	which	which	WDT
10_1101-2020_03_27_012757	176	11	386	386	CD
10_1101-2020_03_27_012757	176	12	allowed	allow	VBD
10_1101-2020_03_27_012757	176	13	us	-PRON-	PRP
10_1101-2020_03_27_012757	176	14	to	to	TO
10_1101-2020_03_27_012757	176	15	examine	examine	VB
10_1101-2020_03_27_012757	176	16	intra	intra	JJ
10_1101-2020_03_27_012757	176	17	-	-	JJ
10_1101-2020_03_27_012757	176	18	GEMM	gemm	JJ
10_1101-2020_03_27_012757	176	19	variability	variability	NN
10_1101-2020_03_27_012757	176	20	.	.	.
10_1101-2020_03_27_012757	177	1	Both	both	DT
10_1101-2020_03_27_012757	177	2	at	at	IN
10_1101-2020_03_27_012757	177	3	the	the	DT
10_1101-2020_03_27_012757	177	4	level	level	NN
10_1101-2020_03_27_012757	177	5	of	of	IN
10_1101-2020_03_27_012757	177	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	177	7	score	score	NN
10_1101-2020_03_27_012757	177	8	and	and	CC
10_1101-2020_03_27_012757	177	9	at	at	IN
10_1101-2020_03_27_012757	177	10	the	the	DT
10_1101-2020_03_27_012757	177	11	level	level	NN
10_1101-2020_03_27_012757	177	12	of	of	IN
10_1101-2020_03_27_012757	177	13	387	387	CD
10_1101-2020_03_27_012757	177	14	categorization	categorization	NN
10_1101-2020_03_27_012757	177	15	,	,	,
10_1101-2020_03_27_012757	177	16	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	177	17	were	be	VBD
10_1101-2020_03_27_012757	177	18	invariant	invariant	JJ
10_1101-2020_03_27_012757	177	19	.	.	.
10_1101-2020_03_27_012757	178	1	For	for	IN
10_1101-2020_03_27_012757	178	2	example	example	NN
10_1101-2020_03_27_012757	178	3	,	,	,
10_1101-2020_03_27_012757	178	4	replicates	replicate	NNS
10_1101-2020_03_27_012757	178	5	of	of	IN
10_1101-2020_03_27_012757	178	6	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	178	7	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	178	8	driven	drive	VBN
10_1101-2020_03_27_012757	178	9	by	by	IN
10_1101-2020_03_27_012757	178	10	388	388	CD
10_1101-2020_03_27_012757	178	11	Prg(cre/+)Pten(lox	Prg(cre/+)Pten(lox	NNP
10_1101-2020_03_27_012757	178	12	/	/	SYM
10_1101-2020_03_27_012757	178	13	lox	lox	NN
10_1101-2020_03_27_012757	178	14	)	)	-RRB-
10_1101-2020_03_27_012757	178	15	received	receive	VBD
10_1101-2020_03_27_012757	178	16	almost	almost	RB
10_1101-2020_03_27_012757	178	17	identical	identical	JJ
10_1101-2020_03_27_012757	178	18	general	general	JJ
10_1101-2020_03_27_012757	178	19	CCN	CCN	NNP
10_1101-2020_03_27_012757	178	20	scores	score	NNS
10_1101-2020_03_27_012757	178	21	(	(	-LRB-
10_1101-2020_03_27_012757	178	22	Fig	fig	NN
10_1101-2020_03_27_012757	178	23	6C	6c	NN
10_1101-2020_03_27_012757	178	24	,	,	,
10_1101-2020_03_27_012757	178	25	Supp	Supp	NNP
10_1101-2020_03_27_012757	178	26	Tab	Tab	NNP
10_1101-2020_03_27_012757	178	27	6	6	CD
10_1101-2020_03_27_012757	178	28	)	)	-RRB-
10_1101-2020_03_27_012757	178	29	.	.	.
10_1101-2020_03_27_012757	179	1	389	389	CD
10_1101-2020_03_27_012757	179	2	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	179	3	sharing	share	VBG
10_1101-2020_03_27_012757	179	4	genotypes	genotype	NNS
10_1101-2020_03_27_012757	179	5	across	across	IN
10_1101-2020_03_27_012757	179	6	studies	study	NNS
10_1101-2020_03_27_012757	179	7	,	,	,
10_1101-2020_03_27_012757	179	8	such	such	JJ
10_1101-2020_03_27_012757	179	9	as	as	IN
10_1101-2020_03_27_012757	179	10	LUAD	luad	RB
10_1101-2020_03_27_012757	179	11	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	179	12	driven	drive	VBN
10_1101-2020_03_27_012757	179	13	by	by	IN
10_1101-2020_03_27_012757	179	14	Kras	Kras	NNP
10_1101-2020_03_27_012757	179	15	mutation	mutation	NN
10_1101-2020_03_27_012757	179	16	and	and	CC
10_1101-2020_03_27_012757	179	17	390	390	CD
10_1101-2020_03_27_012757	179	18	loss	loss	NN
10_1101-2020_03_27_012757	179	19	of	of	IN
10_1101-2020_03_27_012757	179	20	p5359,65,67	p5359,65,67	NNP
10_1101-2020_03_27_012757	179	21	,	,	,
10_1101-2020_03_27_012757	179	22	also	also	RB
10_1101-2020_03_27_012757	179	23	received	receive	VBD
10_1101-2020_03_27_012757	179	24	similar	similar	JJ
10_1101-2020_03_27_012757	179	25	general	general	JJ
10_1101-2020_03_27_012757	179	26	and	and	CC
10_1101-2020_03_27_012757	179	27	subtype	subtype	NN
10_1101-2020_03_27_012757	179	28	classification	classification	NN
10_1101-2020_03_27_012757	179	29	scores	score	NNS
10_1101-2020_03_27_012757	179	30	(	(	-LRB-
10_1101-2020_03_27_012757	179	31	Fig	fig	NN
10_1101-2020_03_27_012757	179	32	6A	6a	NN
10_1101-2020_03_27_012757	179	33	,	,	,
10_1101-2020_03_27_012757	179	34	B	b	NN
10_1101-2020_03_27_012757	179	35	,	,	,
10_1101-2020_03_27_012757	179	36	E	e	NN
10_1101-2020_03_27_012757	179	37	)	)	-RRB-
10_1101-2020_03_27_012757	179	38	.	.	.
10_1101-2020_03_27_012757	180	1	391	391	CD
10_1101-2020_03_27_012757	180	2	Next	next	RB
10_1101-2020_03_27_012757	180	3	,	,	,
10_1101-2020_03_27_012757	180	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	180	5	explored	explore	VBD
10_1101-2020_03_27_012757	180	6	the	the	DT
10_1101-2020_03_27_012757	180	7	extent	extent	NN
10_1101-2020_03_27_012757	180	8	to	to	TO
10_1101-2020_03_27_012757	180	9	which	which	WDT
10_1101-2020_03_27_012757	180	10	genotype	genotype	NNP
10_1101-2020_03_27_012757	180	11	impacted	impact	VBN
10_1101-2020_03_27_012757	180	12	subtype	subtype	NN
10_1101-2020_03_27_012757	180	13	classification	classification	NN
10_1101-2020_03_27_012757	180	14	in	in	IN
10_1101-2020_03_27_012757	180	15	392	392	CD
10_1101-2020_03_27_012757	180	16	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	180	17	,	,	,
10_1101-2020_03_27_012757	180	18	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	180	19	,	,	,
10_1101-2020_03_27_012757	180	20	and	and	CC
10_1101-2020_03_27_012757	180	21	LUAD	luad	RB
10_1101-2020_03_27_012757	180	22	.	.	.
10_1101-2020_03_27_012757	181	1	Prg(cre/+)Pten(lox	Prg(cre/+)Pten(lox	NNP
10_1101-2020_03_27_012757	181	2	/	/	SYM
10_1101-2020_03_27_012757	181	3	lox	lox	NN
10_1101-2020_03_27_012757	181	4	)	)	-RRB-
10_1101-2020_03_27_012757	181	5	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	181	6	had	have	VBD
10_1101-2020_03_27_012757	181	7	a	a	DT
10_1101-2020_03_27_012757	181	8	mixed	mixed	JJ
10_1101-2020_03_27_012757	181	9	subtype	subtype	NN
10_1101-2020_03_27_012757	181	10	classification	classification	NN
10_1101-2020_03_27_012757	181	11	of	of	IN
10_1101-2020_03_27_012757	181	12	393	393	CD
10_1101-2020_03_27_012757	181	13	both	both	CC
10_1101-2020_03_27_012757	181	14	serous	serous	JJ
10_1101-2020_03_27_012757	181	15	and	and	CC
10_1101-2020_03_27_012757	181	16	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	181	17	,	,	,
10_1101-2020_03_27_012757	181	18	consistent	consistent	JJ
10_1101-2020_03_27_012757	181	19	with	with	IN
10_1101-2020_03_27_012757	181	20	the	the	DT
10_1101-2020_03_27_012757	181	21	fact	fact	NN
10_1101-2020_03_27_012757	181	22	that	that	IN
10_1101-2020_03_27_012757	181	23	Pten	Pten	NNP
10_1101-2020_03_27_012757	181	24	loss	loss	NN
10_1101-2020_03_27_012757	181	25	occurs	occur	VBZ
10_1101-2020_03_27_012757	181	26	in	in	IN
10_1101-2020_03_27_012757	181	27	both	both	DT
10_1101-2020_03_27_012757	181	28	subtypes	subtype	NNS
10_1101-2020_03_27_012757	181	29	394	394	CD
10_1101-2020_03_27_012757	181	30	(	(	-LRB-
10_1101-2020_03_27_012757	181	31	albeit	albeit	IN
10_1101-2020_03_27_012757	181	32	more	more	RBR
10_1101-2020_03_27_012757	181	33	frequently	frequently	RB
10_1101-2020_03_27_012757	181	34	in	in	IN
10_1101-2020_03_27_012757	181	35	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	181	36	)	)	-RRB-
10_1101-2020_03_27_012757	181	37	.	.	.
10_1101-2020_03_27_012757	182	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	182	2	also	also	RB
10_1101-2020_03_27_012757	182	3	analyzed	analyze	VBD
10_1101-2020_03_27_012757	182	4	Prg(cre/+)Pten(lox	Prg(cre/+)Pten(lox	NNP
10_1101-2020_03_27_012757	182	5	/	/	SYM
10_1101-2020_03_27_012757	182	6	lox)Csf3r-/-	lox)Csf3r-/-	NNS
10_1101-2020_03_27_012757	182	7	395	395	CD
10_1101-2020_03_27_012757	182	8	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	182	9	.	.	.
10_1101-2020_03_27_012757	183	1	Polymorphonuclear	polymorphonuclear	NN
10_1101-2020_03_27_012757	183	2	neutrophils	neutrophil	NNS
10_1101-2020_03_27_012757	183	3	(	(	-LRB-
10_1101-2020_03_27_012757	183	4	PMNs	PMNs	NNP
10_1101-2020_03_27_012757	183	5	)	)	-RRB-
10_1101-2020_03_27_012757	183	6	,	,	,
10_1101-2020_03_27_012757	183	7	which	which	WDT
10_1101-2020_03_27_012757	183	8	play	play	VBP
10_1101-2020_03_27_012757	183	9	anti	anti	JJ
10_1101-2020_03_27_012757	183	10	-	-	JJ
10_1101-2020_03_27_012757	183	11	tumor	tumor	JJ
10_1101-2020_03_27_012757	183	12	roles	role	NNS
10_1101-2020_03_27_012757	183	13	in	in	IN
10_1101-2020_03_27_012757	183	14	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	183	15	396	396	CD
10_1101-2020_03_27_012757	183	16	.CC	.CC	NFP
10_1101-2020_03_27_012757	183	17	-	-	HYPH
10_1101-2020_03_27_012757	183	18	BY	by	IN
10_1101-2020_03_27_012757	183	19	-	-	HYPH
10_1101-2020_03_27_012757	183	20	NC	NC	NNP
10_1101-2020_03_27_012757	183	21	-	-	HYPH
10_1101-2020_03_27_012757	183	22	ND	ND	NNP
10_1101-2020_03_27_012757	183	23	4.0	4.0	CD
10_1101-2020_03_27_012757	183	24	International	International	NNP
10_1101-2020_03_27_012757	183	25	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	183	26	under	under	IN
10_1101-2020_03_27_012757	183	27	a	a	DT
10_1101-2020_03_27_012757	183	28	(	(	-LRB-
10_1101-2020_03_27_012757	183	29	which	which	WDT
10_1101-2020_03_27_012757	183	30	was	be	VBD
10_1101-2020_03_27_012757	183	31	not	not	RB
10_1101-2020_03_27_012757	183	32	certified	certify	VBN
10_1101-2020_03_27_012757	183	33	by	by	IN
10_1101-2020_03_27_012757	183	34	peer	peer	NN
10_1101-2020_03_27_012757	183	35	review	review	NN
10_1101-2020_03_27_012757	183	36	)	)	-RRB-
10_1101-2020_03_27_012757	183	37	is	be	VBZ
10_1101-2020_03_27_012757	183	38	the	the	DT
10_1101-2020_03_27_012757	183	39	author	author	NN
10_1101-2020_03_27_012757	183	40	/	/	SYM
10_1101-2020_03_27_012757	183	41	funder	funder	NN
10_1101-2020_03_27_012757	183	42	,	,	,
10_1101-2020_03_27_012757	183	43	who	who	WP
10_1101-2020_03_27_012757	183	44	has	have	VBZ
10_1101-2020_03_27_012757	183	45	granted	grant	VBN
10_1101-2020_03_27_012757	183	46	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	183	47	a	a	DT
10_1101-2020_03_27_012757	183	48	license	license	NN
10_1101-2020_03_27_012757	183	49	to	to	TO
10_1101-2020_03_27_012757	183	50	display	display	VB
10_1101-2020_03_27_012757	183	51	the	the	DT
10_1101-2020_03_27_012757	183	52	preprint	preprint	NN
10_1101-2020_03_27_012757	183	53	in	in	IN
10_1101-2020_03_27_012757	183	54	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	183	55	.	.	.
10_1101-2020_03_27_012757	184	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	184	2	is	be	VBZ
10_1101-2020_03_27_012757	184	3	made	make	VBN
10_1101-2020_03_27_012757	184	4	The	the	DT
10_1101-2020_03_27_012757	184	5	copyright	copyright	NN
10_1101-2020_03_27_012757	184	6	holder	holder	NN
10_1101-2020_03_27_012757	184	7	for	for	IN
10_1101-2020_03_27_012757	184	8	this	this	DT
10_1101-2020_03_27_012757	184	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	184	10	version	version	NN
10_1101-2020_03_27_012757	184	11	posted	post	VBD
10_1101-2020_03_27_012757	184	12	January	January	NNP
10_1101-2020_03_27_012757	184	13	9	9	CD
10_1101-2020_03_27_012757	184	14	,	,	,
10_1101-2020_03_27_012757	184	15	2021	2021	CD
10_1101-2020_03_27_012757	184	16	.	.	.
10_1101-2020_03_27_012757	184	17	;	;	:
10_1101-2020_03_27_012757	184	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	184	19	:	:	:
10_1101-2020_03_27_012757	184	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	184	21	preprint	preprint	NN
10_1101-2020_03_27_012757	184	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	184	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	184	24	15	15	CD
10_1101-2020_03_27_012757	184	25	cancer	cancer	NN
10_1101-2020_03_27_012757	184	26	progression	progression	NN
10_1101-2020_03_27_012757	184	27	,	,	,
10_1101-2020_03_27_012757	184	28	are	be	VBP
10_1101-2020_03_27_012757	184	29	depleted	deplete	VBN
10_1101-2020_03_27_012757	184	30	in	in	IN
10_1101-2020_03_27_012757	184	31	these	these	DT
10_1101-2020_03_27_012757	184	32	animals	animal	NNS
10_1101-2020_03_27_012757	184	33	.	.	.
10_1101-2020_03_27_012757	185	1	Interestingly	interestingly	RB
10_1101-2020_03_27_012757	185	2	,	,	,
10_1101-2020_03_27_012757	185	3	Prg(cre/+)Pten(lox	Prg(cre/+)Pten(lox	NNP
10_1101-2020_03_27_012757	185	4	/	/	SYM
10_1101-2020_03_27_012757	185	5	lox)Csf3r-/-	lox)Csf3r-/-	NNS
10_1101-2020_03_27_012757	185	6	397	397	CD
10_1101-2020_03_27_012757	185	7	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	185	8	had	have	VBD
10_1101-2020_03_27_012757	185	9	a	a	DT
10_1101-2020_03_27_012757	185	10	serous	serous	JJ
10_1101-2020_03_27_012757	185	11	subtype	subtype	NN
10_1101-2020_03_27_012757	185	12	classification	classification	NN
10_1101-2020_03_27_012757	185	13	,	,	,
10_1101-2020_03_27_012757	185	14	which	which	WDT
10_1101-2020_03_27_012757	185	15	could	could	MD
10_1101-2020_03_27_012757	185	16	be	be	VB
10_1101-2020_03_27_012757	185	17	explained	explain	VBN
10_1101-2020_03_27_012757	185	18	by	by	IN
10_1101-2020_03_27_012757	185	19	differences	difference	NNS
10_1101-2020_03_27_012757	185	20	in	in	IN
10_1101-2020_03_27_012757	185	21	PMN	pmn	NN
10_1101-2020_03_27_012757	185	22	398	398	CD
10_1101-2020_03_27_012757	185	23	involvement	involvement	NN
10_1101-2020_03_27_012757	185	24	in	in	IN
10_1101-2020_03_27_012757	185	25	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	185	26	versus	versus	IN
10_1101-2020_03_27_012757	185	27	serous	serous	JJ
10_1101-2020_03_27_012757	185	28	uterine	uterine	JJ
10_1101-2020_03_27_012757	185	29	tumor	tumor	NN
10_1101-2020_03_27_012757	185	30	development	development	NN
10_1101-2020_03_27_012757	185	31	that	that	WDT
10_1101-2020_03_27_012757	185	32	are	be	VBP
10_1101-2020_03_27_012757	185	33	reflected	reflect	VBN
10_1101-2020_03_27_012757	185	34	in	in	IN
10_1101-2020_03_27_012757	185	35	the	the	DT
10_1101-2020_03_27_012757	185	36	399	399	CD
10_1101-2020_03_27_012757	185	37	respective	respective	JJ
10_1101-2020_03_27_012757	185	38	transcriptomes	transcriptome	NNS
10_1101-2020_03_27_012757	185	39	of	of	IN
10_1101-2020_03_27_012757	185	40	the	the	DT
10_1101-2020_03_27_012757	185	41	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	185	42	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	185	43	training	training	NN
10_1101-2020_03_27_012757	185	44	data	datum	NNS
10_1101-2020_03_27_012757	185	45	.	.	.
10_1101-2020_03_27_012757	186	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	186	2	note	note	VBP
10_1101-2020_03_27_012757	186	3	that	that	IN
10_1101-2020_03_27_012757	186	4	the	the	DT
10_1101-2020_03_27_012757	186	5	tumor	tumor	NN
10_1101-2020_03_27_012757	186	6	cells	cell	NNS
10_1101-2020_03_27_012757	186	7	were	be	VBD
10_1101-2020_03_27_012757	186	8	400	400	CD
10_1101-2020_03_27_012757	186	9	sorted	sort	VBN
10_1101-2020_03_27_012757	186	10	prior	prior	RB
10_1101-2020_03_27_012757	186	11	to	to	IN
10_1101-2020_03_27_012757	186	12	RNA	RNA	NNP
10_1101-2020_03_27_012757	186	13	-	-	HYPH
10_1101-2020_03_27_012757	186	14	seq	seq	NN
10_1101-2020_03_27_012757	186	15	and	and	CC
10_1101-2020_03_27_012757	186	16	thus	thus	RB
10_1101-2020_03_27_012757	186	17	the	the	DT
10_1101-2020_03_27_012757	186	18	shift	shift	NN
10_1101-2020_03_27_012757	186	19	in	in	IN
10_1101-2020_03_27_012757	186	20	subtype	subtype	NN
10_1101-2020_03_27_012757	186	21	classification	classification	NN
10_1101-2020_03_27_012757	186	22	is	be	VBZ
10_1101-2020_03_27_012757	186	23	not	not	RB
10_1101-2020_03_27_012757	186	24	due	due	JJ
10_1101-2020_03_27_012757	186	25	to	to	IN
10_1101-2020_03_27_012757	186	26	contamination	contamination	NN
10_1101-2020_03_27_012757	186	27	of	of	IN
10_1101-2020_03_27_012757	186	28	401	401	CD
10_1101-2020_03_27_012757	186	29	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	186	30	with	with	IN
10_1101-2020_03_27_012757	186	31	non	non	JJ
10_1101-2020_03_27_012757	186	32	-	-	JJ
10_1101-2020_03_27_012757	186	33	tumor	tumor	JJ
10_1101-2020_03_27_012757	186	34	components	component	NNS
10_1101-2020_03_27_012757	186	35	.	.	.
10_1101-2020_03_27_012757	187	1	In	in	IN
10_1101-2020_03_27_012757	187	2	short	short	JJ
10_1101-2020_03_27_012757	187	3	,	,	,
10_1101-2020_03_27_012757	187	4	this	this	DT
10_1101-2020_03_27_012757	187	5	analysis	analysis	NN
10_1101-2020_03_27_012757	187	6	supports	support	VBZ
10_1101-2020_03_27_012757	187	7	the	the	DT
10_1101-2020_03_27_012757	187	8	argument	argument	NN
10_1101-2020_03_27_012757	187	9	that	that	WDT
10_1101-2020_03_27_012757	187	10	tumor-402	tumor-402	JJ
10_1101-2020_03_27_012757	187	11	cell	cell	NN
10_1101-2020_03_27_012757	187	12	extrinsic	extrinsic	NN
10_1101-2020_03_27_012757	187	13	factors	factor	NNS
10_1101-2020_03_27_012757	187	14	,	,	,
10_1101-2020_03_27_012757	187	15	in	in	IN
10_1101-2020_03_27_012757	187	16	this	this	DT
10_1101-2020_03_27_012757	187	17	case	case	NN
10_1101-2020_03_27_012757	187	18	a	a	DT
10_1101-2020_03_27_012757	187	19	reduction	reduction	NN
10_1101-2020_03_27_012757	187	20	in	in	IN
10_1101-2020_03_27_012757	187	21	anti	anti	JJ
10_1101-2020_03_27_012757	187	22	-	-	JJ
10_1101-2020_03_27_012757	187	23	tumor	tumor	JJ
10_1101-2020_03_27_012757	187	24	PMNs	pmn	NNS
10_1101-2020_03_27_012757	187	25	,	,	,
10_1101-2020_03_27_012757	187	26	can	can	MD
10_1101-2020_03_27_012757	187	27	shift	shift	VB
10_1101-2020_03_27_012757	187	28	the	the	DT
10_1101-2020_03_27_012757	187	29	transcriptome	transcriptome	CD
10_1101-2020_03_27_012757	187	30	of	of	IN
10_1101-2020_03_27_012757	187	31	403	403	CD
10_1101-2020_03_27_012757	187	32	a	a	DT
10_1101-2020_03_27_012757	187	33	GEMM	GEMM	NNP
10_1101-2020_03_27_012757	187	34	so	so	IN
10_1101-2020_03_27_012757	187	35	that	that	IN
10_1101-2020_03_27_012757	187	36	it	-PRON-	PRP
10_1101-2020_03_27_012757	187	37	more	more	RBR
10_1101-2020_03_27_012757	187	38	closely	closely	RB
10_1101-2020_03_27_012757	187	39	resembles	resemble	VBZ
10_1101-2020_03_27_012757	187	40	a	a	DT
10_1101-2020_03_27_012757	187	41	serous	serous	JJ
10_1101-2020_03_27_012757	187	42	rather	rather	RB
10_1101-2020_03_27_012757	187	43	than	than	IN
10_1101-2020_03_27_012757	187	44	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	187	45	subtype	subtype	NN
10_1101-2020_03_27_012757	187	46	.	.	.
10_1101-2020_03_27_012757	188	1	404	404	CD
10_1101-2020_03_27_012757	188	2	The	the	DT
10_1101-2020_03_27_012757	188	3	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	188	4	GEMMs	gemm	VBZ
10_1101-2020_03_27_012757	188	5	that	that	IN
10_1101-2020_03_27_012757	188	6	we	-PRON-	PRP
10_1101-2020_03_27_012757	188	7	analyzed	analyze	VBD
10_1101-2020_03_27_012757	188	8	were	be	VBD
10_1101-2020_03_27_012757	188	9	Lkb1fl	Lkb1fl	NNP
10_1101-2020_03_27_012757	188	10	/	/	SYM
10_1101-2020_03_27_012757	188	11	fl	fl	NN
10_1101-2020_03_27_012757	188	12	and	and	CC
10_1101-2020_03_27_012757	188	13	they	-PRON-	PRP
10_1101-2020_03_27_012757	188	14	either	either	CC
10_1101-2020_03_27_012757	188	15	overexpressed	overexpresse	VBN
10_1101-2020_03_27_012757	188	16	of	of	IN
10_1101-2020_03_27_012757	188	17	405	405	CD
10_1101-2020_03_27_012757	188	18	Sox2	Sox2	NNPS
10_1101-2020_03_27_012757	188	19	(	(	-LRB-
10_1101-2020_03_27_012757	188	20	via	via	IN
10_1101-2020_03_27_012757	188	21	two	two	CD
10_1101-2020_03_27_012757	188	22	distinct	distinct	JJ
10_1101-2020_03_27_012757	188	23	mechanisms	mechanism	NNS
10_1101-2020_03_27_012757	188	24	)	)	-RRB-
10_1101-2020_03_27_012757	188	25	or	or	CC
10_1101-2020_03_27_012757	188	26	were	be	VBD
10_1101-2020_03_27_012757	188	27	also	also	RB
10_1101-2020_03_27_012757	188	28	Ptenfl	Ptenfl	NNP
10_1101-2020_03_27_012757	188	29	/	/	SYM
10_1101-2020_03_27_012757	188	30	fl	fl	NNP
10_1101-2020_03_27_012757	188	31	65	65	CD
10_1101-2020_03_27_012757	188	32	.	.	.
10_1101-2020_03_27_012757	189	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	189	2	note	note	VBP
10_1101-2020_03_27_012757	189	3	that	that	IN
10_1101-2020_03_27_012757	189	4	the	the	DT
10_1101-2020_03_27_012757	189	5	eight	eight	CD
10_1101-2020_03_27_012757	189	6	lenti	lenti	NN
10_1101-2020_03_27_012757	189	7	-	-	HYPH
10_1101-2020_03_27_012757	189	8	Sox2	sox2	NN
10_1101-2020_03_27_012757	189	9	-	-	HYPH
10_1101-2020_03_27_012757	189	10	406	406	CD
10_1101-2020_03_27_012757	189	11	Cre	Cre	NNP
10_1101-2020_03_27_012757	189	12	-	-	HYPH
10_1101-2020_03_27_012757	189	13	infected;Lkb1fl	infected;Lkb1fl	NNP
10_1101-2020_03_27_012757	189	14	/	/	SYM
10_1101-2020_03_27_012757	189	15	fl	fl	NN
10_1101-2020_03_27_012757	189	16	and	and	CC
10_1101-2020_03_27_012757	189	17	Rosa26LSL	Rosa26LSL	NNP
10_1101-2020_03_27_012757	189	18	-	-	HYPH
10_1101-2020_03_27_012757	189	19	Sox2-IRES	Sox2-IRES	NNP
10_1101-2020_03_27_012757	189	20	-	-	HYPH
10_1101-2020_03_27_012757	189	21	GFP;Lkb1fl	GFP;Lkb1fl	NNP
10_1101-2020_03_27_012757	189	22	/	/	SYM
10_1101-2020_03_27_012757	189	23	fl	fl	NN
10_1101-2020_03_27_012757	189	24	samples	sample	NNS
10_1101-2020_03_27_012757	189	25	that	that	WDT
10_1101-2020_03_27_012757	189	26	classified	classify	VBD
10_1101-2020_03_27_012757	189	27	as	as	IN
10_1101-2020_03_27_012757	189	28	407	407	CD
10_1101-2020_03_27_012757	189	29	'	'	``
10_1101-2020_03_27_012757	189	30	Unknown	unknown	JJ
10_1101-2020_03_27_012757	189	31	'	'	''
10_1101-2020_03_27_012757	189	32	had	have	VBD
10_1101-2020_03_27_012757	189	33	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	189	34	CCN	CCN	NNP
10_1101-2020_03_27_012757	189	35	scores	score	NNS
10_1101-2020_03_27_012757	189	36	only	only	RB
10_1101-2020_03_27_012757	189	37	modestly	modestly	RB
10_1101-2020_03_27_012757	189	38	lower	low	JJR
10_1101-2020_03_27_012757	189	39	than	than	IN
10_1101-2020_03_27_012757	189	40	the	the	DT
10_1101-2020_03_27_012757	189	41	decision	decision	NN
10_1101-2020_03_27_012757	189	42	threshold	threshold	NN
10_1101-2020_03_27_012757	189	43	(	(	-LRB-
10_1101-2020_03_27_012757	189	44	Fig	Fig	NNP
10_1101-2020_03_27_012757	189	45	6D	6d	NN
10_1101-2020_03_27_012757	189	46	)	)	-RRB-
10_1101-2020_03_27_012757	189	47	408	408	CD
10_1101-2020_03_27_012757	189	48	(	(	-LRB-
10_1101-2020_03_27_012757	189	49	mean	mean	VB
10_1101-2020_03_27_012757	189	50	CCN	CCN	NNP
10_1101-2020_03_27_012757	189	51	score	score	VBP
10_1101-2020_03_27_012757	189	52	=	=	SYM
10_1101-2020_03_27_012757	189	53	0.217	0.217	CD
10_1101-2020_03_27_012757	189	54	)	)	-RRB-
10_1101-2020_03_27_012757	189	55	.	.	.
10_1101-2020_03_27_012757	190	1	Thirteen	thirteen	CD
10_1101-2020_03_27_012757	190	2	out	out	IN
10_1101-2020_03_27_012757	190	3	of	of	IN
10_1101-2020_03_27_012757	190	4	the	the	DT
10_1101-2020_03_27_012757	190	5	17	17	CD
10_1101-2020_03_27_012757	190	6	of	of	IN
10_1101-2020_03_27_012757	190	7	the	the	DT
10_1101-2020_03_27_012757	190	8	Sox2	Sox2	NNPS
10_1101-2020_03_27_012757	190	9	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	190	10	classified	classify	VBD
10_1101-2020_03_27_012757	190	11	as	as	IN
10_1101-2020_03_27_012757	190	12	the	the	DT
10_1101-2020_03_27_012757	190	13	409	409	CD
10_1101-2020_03_27_012757	190	14	secretory	secretory	JJ
10_1101-2020_03_27_012757	190	15	subtype	subtype	NN
10_1101-2020_03_27_012757	190	16	of	of	IN
10_1101-2020_03_27_012757	190	17	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	190	18	.	.	.
10_1101-2020_03_27_012757	191	1	The	the	DT
10_1101-2020_03_27_012757	191	2	consistency	consistency	NN
10_1101-2020_03_27_012757	191	3	is	be	VBZ
10_1101-2020_03_27_012757	191	4	not	not	RB
10_1101-2020_03_27_012757	191	5	surprising	surprising	JJ
10_1101-2020_03_27_012757	191	6	given	give	VBN
10_1101-2020_03_27_012757	191	7	both	both	DT
10_1101-2020_03_27_012757	191	8	models	model	NNS
10_1101-2020_03_27_012757	191	9	overexpress	overexpres	VBD
10_1101-2020_03_27_012757	191	10	410	410	CD
10_1101-2020_03_27_012757	191	11	Sox2	Sox2	NNPS
10_1101-2020_03_27_012757	191	12	and	and	CC
10_1101-2020_03_27_012757	191	13	lose	lose	VB
10_1101-2020_03_27_012757	191	14	Lkb1	Lkb1	NNP
10_1101-2020_03_27_012757	191	15	.	.	.
10_1101-2020_03_27_012757	192	1	On	on	IN
10_1101-2020_03_27_012757	192	2	the	the	DT
10_1101-2020_03_27_012757	192	3	other	other	JJ
10_1101-2020_03_27_012757	192	4	hand	hand	NN
10_1101-2020_03_27_012757	192	5	,	,	,
10_1101-2020_03_27_012757	192	6	the	the	DT
10_1101-2020_03_27_012757	192	7	Lkb1fl	Lkb1fl	NNP
10_1101-2020_03_27_012757	192	8	/	/	SYM
10_1101-2020_03_27_012757	192	9	fl;Ptenfl	fl;Ptenfl	NNP
10_1101-2020_03_27_012757	192	10	/	/	SYM
10_1101-2020_03_27_012757	192	11	fl	fl	NN
10_1101-2020_03_27_012757	192	12	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	192	13	had	have	VBD
10_1101-2020_03_27_012757	192	14	substantially	substantially	RB
10_1101-2020_03_27_012757	192	15	lower	low	JJR
10_1101-2020_03_27_012757	192	16	411	411	CD
10_1101-2020_03_27_012757	192	17	general	general	JJ
10_1101-2020_03_27_012757	192	18	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	192	19	CCN	CCN	NNP
10_1101-2020_03_27_012757	192	20	scores	score	NNS
10_1101-2020_03_27_012757	192	21	and	and	CC
10_1101-2020_03_27_012757	192	22	our	-PRON-	PRP$
10_1101-2020_03_27_012757	192	23	subtype	subtype	NN
10_1101-2020_03_27_012757	192	24	classification	classification	NN
10_1101-2020_03_27_012757	192	25	indicated	indicate	VBD
10_1101-2020_03_27_012757	192	26	that	that	IN
10_1101-2020_03_27_012757	192	27	this	this	DT
10_1101-2020_03_27_012757	192	28	GEMM	GEMM	NNP
10_1101-2020_03_27_012757	192	29	was	be	VBD
10_1101-2020_03_27_012757	192	30	mostly	mostly	RB
10_1101-2020_03_27_012757	192	31	412	412	CD
10_1101-2020_03_27_012757	192	32	classified	classify	VBD
10_1101-2020_03_27_012757	192	33	as	as	IN
10_1101-2020_03_27_012757	192	34	'	'	``
10_1101-2020_03_27_012757	192	35	Unknown	unknown	JJ
10_1101-2020_03_27_012757	192	36	'	'	''
10_1101-2020_03_27_012757	192	37	,	,	,
10_1101-2020_03_27_012757	192	38	in	in	IN
10_1101-2020_03_27_012757	192	39	contrast	contrast	NN
10_1101-2020_03_27_012757	192	40	to	to	IN
10_1101-2020_03_27_012757	192	41	prior	prior	JJ
10_1101-2020_03_27_012757	192	42	reports	report	NNS
10_1101-2020_03_27_012757	192	43	suggesting	suggest	VBG
10_1101-2020_03_27_012757	192	44	that	that	IN
10_1101-2020_03_27_012757	192	45	it	-PRON-	PRP
10_1101-2020_03_27_012757	192	46	is	be	VBZ
10_1101-2020_03_27_012757	192	47	most	most	RBS
10_1101-2020_03_27_012757	192	48	similar	similar	JJ
10_1101-2020_03_27_012757	192	49	to	to	IN
10_1101-2020_03_27_012757	192	50	a	a	DT
10_1101-2020_03_27_012757	192	51	basal	basal	NN
10_1101-2020_03_27_012757	192	52	413	413	CD
10_1101-2020_03_27_012757	192	53	subtype68	subtype68	NN
10_1101-2020_03_27_012757	192	54	.	.	.
10_1101-2020_03_27_012757	193	1	None	none	NN
10_1101-2020_03_27_012757	193	2	of	of	IN
10_1101-2020_03_27_012757	193	3	the	the	DT
10_1101-2020_03_27_012757	193	4	three	three	CD
10_1101-2020_03_27_012757	193	5	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	193	6	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	193	7	have	have	VBP
10_1101-2020_03_27_012757	193	8	strong	strong	JJ
10_1101-2020_03_27_012757	193	9	classical	classical	JJ
10_1101-2020_03_27_012757	193	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	193	11	scores	score	NNS
10_1101-2020_03_27_012757	193	12	.	.	.
10_1101-2020_03_27_012757	194	1	Most	Most	JJS
10_1101-2020_03_27_012757	194	2	of	of	IN
10_1101-2020_03_27_012757	194	3	the	the	DT
10_1101-2020_03_27_012757	194	4	414	414	CD
10_1101-2020_03_27_012757	194	5	LUAD	luad	RB
10_1101-2020_03_27_012757	194	6	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	194	7	,	,	,
10_1101-2020_03_27_012757	194	8	which	which	WDT
10_1101-2020_03_27_012757	194	9	were	be	VBD
10_1101-2020_03_27_012757	194	10	generated	generate	VBN
10_1101-2020_03_27_012757	194	11	using	use	VBG
10_1101-2020_03_27_012757	194	12	various	various	JJ
10_1101-2020_03_27_012757	194	13	combinations	combination	NNS
10_1101-2020_03_27_012757	194	14	of	of	IN
10_1101-2020_03_27_012757	194	15	activating	activate	VBG
10_1101-2020_03_27_012757	194	16	Kras	Kras	NNP
10_1101-2020_03_27_012757	194	17	mutation	mutation	NN
10_1101-2020_03_27_012757	194	18	,	,	,
10_1101-2020_03_27_012757	194	19	415	415	CD
10_1101-2020_03_27_012757	194	20	loss	loss	NN
10_1101-2020_03_27_012757	194	21	of	of	IN
10_1101-2020_03_27_012757	194	22	Trp53	Trp53	NNP
10_1101-2020_03_27_012757	194	23	,	,	,
10_1101-2020_03_27_012757	194	24	and	and	CC
10_1101-2020_03_27_012757	194	25	loss	loss	NN
10_1101-2020_03_27_012757	194	26	of	of	IN
10_1101-2020_03_27_012757	194	27	Smarca4L59,65,67	Smarca4L59,65,67	NNP
10_1101-2020_03_27_012757	194	28	,	,	,
10_1101-2020_03_27_012757	194	29	were	be	VBD
10_1101-2020_03_27_012757	194	30	correctly	correctly	RB
10_1101-2020_03_27_012757	194	31	classified	classified	JJ
10_1101-2020_03_27_012757	194	32	(	(	-LRB-
10_1101-2020_03_27_012757	194	33	Fig	Fig	NNP
10_1101-2020_03_27_012757	194	34	6E	6e	NN
10_1101-2020_03_27_012757	194	35	)	)	-RRB-
10_1101-2020_03_27_012757	194	36	.	.	.
10_1101-2020_03_27_012757	195	1	Those	those	DT
10_1101-2020_03_27_012757	195	2	that	that	WDT
10_1101-2020_03_27_012757	195	3	were	be	VBD
10_1101-2020_03_27_012757	195	4	416	416	CD
10_1101-2020_03_27_012757	195	5	not	not	RB
10_1101-2020_03_27_012757	195	6	classified	classify	VBN
10_1101-2020_03_27_012757	195	7	have	have	VBP
10_1101-2020_03_27_012757	195	8	modestly	modestly	RB
10_1101-2020_03_27_012757	195	9	lower	low	JJR
10_1101-2020_03_27_012757	195	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	195	11	score	score	NN
10_1101-2020_03_27_012757	195	12	than	than	IN
10_1101-2020_03_27_012757	195	13	the	the	DT
10_1101-2020_03_27_012757	195	14	decision	decision	NN
10_1101-2020_03_27_012757	195	15	threshold	threshold	NN
10_1101-2020_03_27_012757	195	16	(	(	-LRB-
10_1101-2020_03_27_012757	195	17	mean	mean	VB
10_1101-2020_03_27_012757	195	18	CCN	CCN	NNP
10_1101-2020_03_27_012757	195	19	score	score	NN
10_1101-2020_03_27_012757	195	20	=	=	SYM
10_1101-2020_03_27_012757	195	21	417	417	CD
10_1101-2020_03_27_012757	195	22	0.214	0.214	CD
10_1101-2020_03_27_012757	195	23	)	)	-RRB-
10_1101-2020_03_27_012757	195	24	.	.	.
10_1101-2020_03_27_012757	196	1	There	there	EX
10_1101-2020_03_27_012757	196	2	were	be	VBD
10_1101-2020_03_27_012757	196	3	no	no	DT
10_1101-2020_03_27_012757	196	4	substantial	substantial	JJ
10_1101-2020_03_27_012757	196	5	differences	difference	NNS
10_1101-2020_03_27_012757	196	6	in	in	IN
10_1101-2020_03_27_012757	196	7	general	general	JJ
10_1101-2020_03_27_012757	196	8	or	or	CC
10_1101-2020_03_27_012757	196	9	subtype	subtype	NN
10_1101-2020_03_27_012757	196	10	classification	classification	NN
10_1101-2020_03_27_012757	196	11	across	across	IN
10_1101-2020_03_27_012757	196	12	driver	driver	NN
10_1101-2020_03_27_012757	196	13	418	418	CD
10_1101-2020_03_27_012757	196	14	genotypes	genotype	NNS
10_1101-2020_03_27_012757	196	15	.	.	.
10_1101-2020_03_27_012757	197	1	Although	although	IN
10_1101-2020_03_27_012757	197	2	the	the	DT
10_1101-2020_03_27_012757	197	3	sub	sub	NN
10_1101-2020_03_27_012757	197	4	-	-	HYPH
10_1101-2020_03_27_012757	197	5	type	type	NN
10_1101-2020_03_27_012757	197	6	of	of	IN
10_1101-2020_03_27_012757	197	7	all	all	DT
10_1101-2020_03_27_012757	197	8	LUAD	luad	RB
10_1101-2020_03_27_012757	197	9	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	197	10	was	be	VBD
10_1101-2020_03_27_012757	197	11	'	'	``
10_1101-2020_03_27_012757	197	12	Unknown	unknown	JJ
10_1101-2020_03_27_012757	197	13	'	'	''
10_1101-2020_03_27_012757	197	14	,	,	,
10_1101-2020_03_27_012757	197	15	the	the	DT
10_1101-2020_03_27_012757	197	16	subtypes	subtype	NNS
10_1101-2020_03_27_012757	197	17	tended	tend	VBD
10_1101-2020_03_27_012757	197	18	to	to	IN
10_1101-2020_03_27_012757	197	19	419	419	CD
10_1101-2020_03_27_012757	197	20	have	have	VB
10_1101-2020_03_27_012757	197	21	a	a	DT
10_1101-2020_03_27_012757	197	22	mixture	mixture	NN
10_1101-2020_03_27_012757	197	23	of	of	IN
10_1101-2020_03_27_012757	197	24	high	high	JJ
10_1101-2020_03_27_012757	197	25	CCN	CCN	NNP
10_1101-2020_03_27_012757	197	26	proximal	proximal	JJ
10_1101-2020_03_27_012757	197	27	proliferation	proliferation	NN
10_1101-2020_03_27_012757	197	28	,	,	,
10_1101-2020_03_27_012757	197	29	proximal	proximal	JJ
10_1101-2020_03_27_012757	197	30	inflammation	inflammation	NN
10_1101-2020_03_27_012757	197	31	and	and	CC
10_1101-2020_03_27_012757	197	32	TRU	tru	NN
10_1101-2020_03_27_012757	197	33	scores	score	NNS
10_1101-2020_03_27_012757	197	34	.	.	.
10_1101-2020_03_27_012757	198	1	420	420	CD
10_1101-2020_03_27_012757	198	2	Taken	take	VBN
10_1101-2020_03_27_012757	198	3	together	together	RB
10_1101-2020_03_27_012757	198	4	,	,	,
10_1101-2020_03_27_012757	198	5	this	this	DT
10_1101-2020_03_27_012757	198	6	analysis	analysis	NN
10_1101-2020_03_27_012757	198	7	suggests	suggest	VBZ
10_1101-2020_03_27_012757	198	8	that	that	IN
10_1101-2020_03_27_012757	198	9	there	there	EX
10_1101-2020_03_27_012757	198	10	is	be	VBZ
10_1101-2020_03_27_012757	198	11	a	a	DT
10_1101-2020_03_27_012757	198	12	degree	degree	NN
10_1101-2020_03_27_012757	198	13	of	of	IN
10_1101-2020_03_27_012757	198	14	similarity	similarity	NN
10_1101-2020_03_27_012757	198	15	,	,	,
10_1101-2020_03_27_012757	198	16	and	and	CC
10_1101-2020_03_27_012757	198	17	perhaps	perhaps	RB
10_1101-2020_03_27_012757	198	18	plasticity	plasticity	NN
10_1101-2020_03_27_012757	198	19	421	421	CD
10_1101-2020_03_27_012757	198	20	between	between	IN
10_1101-2020_03_27_012757	198	21	the	the	DT
10_1101-2020_03_27_012757	198	22	primitive	primitive	JJ
10_1101-2020_03_27_012757	198	23	and	and	CC
10_1101-2020_03_27_012757	198	24	secretory	secretory	JJ
10_1101-2020_03_27_012757	198	25	(	(	-LRB-
10_1101-2020_03_27_012757	198	26	but	but	CC
10_1101-2020_03_27_012757	198	27	not	not	RB
10_1101-2020_03_27_012757	198	28	basal	basal	JJ
10_1101-2020_03_27_012757	198	29	or	or	CC
10_1101-2020_03_27_012757	198	30	classical	classical	JJ
10_1101-2020_03_27_012757	198	31	)	)	-RRB-
10_1101-2020_03_27_012757	198	32	subtypes	subtype	NNS
10_1101-2020_03_27_012757	198	33	of	of	IN
10_1101-2020_03_27_012757	198	34	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	198	35	.	.	.
10_1101-2020_03_27_012757	199	1	On	on	IN
10_1101-2020_03_27_012757	199	2	the	the	DT
10_1101-2020_03_27_012757	199	3	other	other	JJ
10_1101-2020_03_27_012757	199	4	422	422	CD
10_1101-2020_03_27_012757	199	5	.CC	.CC	:
10_1101-2020_03_27_012757	199	6	-	-	HYPH
10_1101-2020_03_27_012757	199	7	BY	by	IN
10_1101-2020_03_27_012757	199	8	-	-	HYPH
10_1101-2020_03_27_012757	199	9	NC	NC	NNP
10_1101-2020_03_27_012757	199	10	-	-	HYPH
10_1101-2020_03_27_012757	199	11	ND	ND	NNP
10_1101-2020_03_27_012757	199	12	4.0	4.0	CD
10_1101-2020_03_27_012757	199	13	International	International	NNP
10_1101-2020_03_27_012757	199	14	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	199	15	under	under	IN
10_1101-2020_03_27_012757	199	16	a	a	DT
10_1101-2020_03_27_012757	199	17	(	(	-LRB-
10_1101-2020_03_27_012757	199	18	which	which	WDT
10_1101-2020_03_27_012757	199	19	was	be	VBD
10_1101-2020_03_27_012757	199	20	not	not	RB
10_1101-2020_03_27_012757	199	21	certified	certify	VBN
10_1101-2020_03_27_012757	199	22	by	by	IN
10_1101-2020_03_27_012757	199	23	peer	peer	NN
10_1101-2020_03_27_012757	199	24	review	review	NN
10_1101-2020_03_27_012757	199	25	)	)	-RRB-
10_1101-2020_03_27_012757	199	26	is	be	VBZ
10_1101-2020_03_27_012757	199	27	the	the	DT
10_1101-2020_03_27_012757	199	28	author	author	NN
10_1101-2020_03_27_012757	199	29	/	/	SYM
10_1101-2020_03_27_012757	199	30	funder	funder	NN
10_1101-2020_03_27_012757	199	31	,	,	,
10_1101-2020_03_27_012757	199	32	who	who	WP
10_1101-2020_03_27_012757	199	33	has	have	VBZ
10_1101-2020_03_27_012757	199	34	granted	grant	VBN
10_1101-2020_03_27_012757	199	35	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	199	36	a	a	DT
10_1101-2020_03_27_012757	199	37	license	license	NN
10_1101-2020_03_27_012757	199	38	to	to	TO
10_1101-2020_03_27_012757	199	39	display	display	VB
10_1101-2020_03_27_012757	199	40	the	the	DT
10_1101-2020_03_27_012757	199	41	preprint	preprint	NN
10_1101-2020_03_27_012757	199	42	in	in	IN
10_1101-2020_03_27_012757	199	43	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	199	44	.	.	.
10_1101-2020_03_27_012757	200	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	200	2	is	be	VBZ
10_1101-2020_03_27_012757	200	3	made	make	VBN
10_1101-2020_03_27_012757	200	4	The	the	DT
10_1101-2020_03_27_012757	200	5	copyright	copyright	NN
10_1101-2020_03_27_012757	200	6	holder	holder	NN
10_1101-2020_03_27_012757	200	7	for	for	IN
10_1101-2020_03_27_012757	200	8	this	this	DT
10_1101-2020_03_27_012757	200	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	200	10	version	version	NN
10_1101-2020_03_27_012757	200	11	posted	post	VBD
10_1101-2020_03_27_012757	200	12	January	January	NNP
10_1101-2020_03_27_012757	200	13	9	9	CD
10_1101-2020_03_27_012757	200	14	,	,	,
10_1101-2020_03_27_012757	200	15	2021	2021	CD
10_1101-2020_03_27_012757	200	16	.	.	.
10_1101-2020_03_27_012757	200	17	;	;	:
10_1101-2020_03_27_012757	200	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	200	19	:	:	:
10_1101-2020_03_27_012757	200	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	200	21	preprint	preprint	NN
10_1101-2020_03_27_012757	200	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	200	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	200	24	16	16	CD
10_1101-2020_03_27_012757	200	25	hand	hand	NN
10_1101-2020_03_27_012757	200	26	,	,	,
10_1101-2020_03_27_012757	200	27	while	while	IN
10_1101-2020_03_27_012757	200	28	the	the	DT
10_1101-2020_03_27_012757	200	29	LUAD	luad	RB
10_1101-2020_03_27_012757	200	30	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	200	31	classify	classify	VBP
10_1101-2020_03_27_012757	200	32	strongly	strongly	RB
10_1101-2020_03_27_012757	200	33	as	as	RB
10_1101-2020_03_27_012757	200	34	LUAD	luad	RB
10_1101-2020_03_27_012757	200	35	,	,	,
10_1101-2020_03_27_012757	200	36	they	-PRON-	PRP
10_1101-2020_03_27_012757	200	37	do	do	VBP
10_1101-2020_03_27_012757	200	38	not	not	RB
10_1101-2020_03_27_012757	200	39	have	have	VB
10_1101-2020_03_27_012757	200	40	strong	strong	JJ
10_1101-2020_03_27_012757	200	41	particular	particular	JJ
10_1101-2020_03_27_012757	200	42	423	423	CD
10_1101-2020_03_27_012757	200	43	subtype	subtype	NN
10_1101-2020_03_27_012757	200	44	classification	classification	NN
10_1101-2020_03_27_012757	200	45	--	--	:
10_1101-2020_03_27_012757	200	46	a	a	DT
10_1101-2020_03_27_012757	200	47	result	result	NN
10_1101-2020_03_27_012757	200	48	that	that	WDT
10_1101-2020_03_27_012757	200	49	does	do	VBZ
10_1101-2020_03_27_012757	200	50	not	not	RB
10_1101-2020_03_27_012757	200	51	vary	vary	VB
10_1101-2020_03_27_012757	200	52	by	by	IN
10_1101-2020_03_27_012757	200	53	genotype	genotype	NN
10_1101-2020_03_27_012757	200	54	.	.	.
10_1101-2020_03_27_012757	201	1	424	424	CD
10_1101-2020_03_27_012757	201	2	425	425	CD
10_1101-2020_03_27_012757	201	3	Evaluation	Evaluation	NNP
10_1101-2020_03_27_012757	201	4	of	of	IN
10_1101-2020_03_27_012757	201	5	Tumoroids	Tumoroids	NNP
10_1101-2020_03_27_012757	201	6	426	426	CD
10_1101-2020_03_27_012757	201	7	Lastly	lastly	RB
10_1101-2020_03_27_012757	201	8	,	,	,
10_1101-2020_03_27_012757	201	9	we	-PRON-	PRP
10_1101-2020_03_27_012757	201	10	used	use	VBD
10_1101-2020_03_27_012757	201	11	CCN	CCN	NNP
10_1101-2020_03_27_012757	201	12	to	to	TO
10_1101-2020_03_27_012757	201	13	assess	assess	VB
10_1101-2020_03_27_012757	201	14	a	a	DT
10_1101-2020_03_27_012757	201	15	relatively	relatively	RB
10_1101-2020_03_27_012757	201	16	novel	novel	JJ
10_1101-2020_03_27_012757	201	17	cancer	cancer	NN
10_1101-2020_03_27_012757	201	18	model	model	NN
10_1101-2020_03_27_012757	201	19	:	:	:
10_1101-2020_03_27_012757	201	20	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	201	21	.	.	.
10_1101-2020_03_27_012757	202	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	202	2	427	427	CD
10_1101-2020_03_27_012757	202	3	downloaded	download	VBN
10_1101-2020_03_27_012757	202	4	and	and	CC
10_1101-2020_03_27_012757	202	5	assessed	assess	VBN
10_1101-2020_03_27_012757	202	6	131	131	CD
10_1101-2020_03_27_012757	202	7	distinct	distinct	JJ
10_1101-2020_03_27_012757	202	8	tumoroid	tumoroid	NN
10_1101-2020_03_27_012757	202	9	expression	expression	NN
10_1101-2020_03_27_012757	202	10	profiles	profile	NNS
10_1101-2020_03_27_012757	202	11	spanning	span	VBG
10_1101-2020_03_27_012757	202	12	13	13	CD
10_1101-2020_03_27_012757	202	13	cancer	cancer	NN
10_1101-2020_03_27_012757	202	14	428	428	CD
10_1101-2020_03_27_012757	202	15	categories	category	NNS
10_1101-2020_03_27_012757	202	16	from	from	IN
10_1101-2020_03_27_012757	202	17	The	the	DT
10_1101-2020_03_27_012757	202	18	NCI	NCI	NNP
10_1101-2020_03_27_012757	202	19	Patient	Patient	NNP
10_1101-2020_03_27_012757	202	20	-	-	HYPH
10_1101-2020_03_27_012757	202	21	Derived	derive	VBN
10_1101-2020_03_27_012757	202	22	Models	Models	NNP
10_1101-2020_03_27_012757	202	23	Repository	Repository	NNP
10_1101-2020_03_27_012757	202	24	(	(	-LRB-
10_1101-2020_03_27_012757	202	25	PDMR)69	PDMR)69	NNP
10_1101-2020_03_27_012757	202	26	and	and	CC
10_1101-2020_03_27_012757	202	27	from	from	IN
10_1101-2020_03_27_012757	202	28	three	three	CD
10_1101-2020_03_27_012757	202	29	individual	individual	JJ
10_1101-2020_03_27_012757	202	30	429	429	CD
10_1101-2020_03_27_012757	202	31	studies70–72	studies70–72	NNS
10_1101-2020_03_27_012757	202	32	(	(	-LRB-
10_1101-2020_03_27_012757	202	33	Fig	fig	NN
10_1101-2020_03_27_012757	202	34	7A	7a	NN
10_1101-2020_03_27_012757	202	35	,	,	,
10_1101-2020_03_27_012757	202	36	Supp	Supp	NNP
10_1101-2020_03_27_012757	202	37	Tab	Tab	NNP
10_1101-2020_03_27_012757	202	38	7	7	CD
10_1101-2020_03_27_012757	202	39	)	)	-RRB-
10_1101-2020_03_27_012757	202	40	.	.	.
10_1101-2020_03_27_012757	203	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	203	2	note	note	VBP
10_1101-2020_03_27_012757	203	3	that	that	IN
10_1101-2020_03_27_012757	203	4	several	several	JJ
10_1101-2020_03_27_012757	203	5	categories	category	NNS
10_1101-2020_03_27_012757	203	6	have	have	VBP
10_1101-2020_03_27_012757	203	7	three	three	CD
10_1101-2020_03_27_012757	203	8	or	or	CC
10_1101-2020_03_27_012757	203	9	fewer	few	JJR
10_1101-2020_03_27_012757	203	10	samples	sample	NNS
10_1101-2020_03_27_012757	203	11	430	430	CD
10_1101-2020_03_27_012757	203	12	(	(	-LRB-
10_1101-2020_03_27_012757	203	13	BRCA	BRCA	NNP
10_1101-2020_03_27_012757	203	14	,	,	,
10_1101-2020_03_27_012757	203	15	CESC	CESC	NNP
10_1101-2020_03_27_012757	203	16	,	,	,
10_1101-2020_03_27_012757	203	17	KIRP	KIRP	NNP
10_1101-2020_03_27_012757	203	18	,	,	,
10_1101-2020_03_27_012757	203	19	OV	OV	NNP
10_1101-2020_03_27_012757	203	20	,	,	,
10_1101-2020_03_27_012757	203	21	LIHC	LIHC	NNP
10_1101-2020_03_27_012757	203	22	,	,	,
10_1101-2020_03_27_012757	203	23	and	and	CC
10_1101-2020_03_27_012757	203	24	BLCA	BLCA	NNP
10_1101-2020_03_27_012757	203	25	from	from	IN
10_1101-2020_03_27_012757	203	26	PDMR	PDMR	NNP
10_1101-2020_03_27_012757	203	27	)	)	-RRB-
10_1101-2020_03_27_012757	203	28	.	.	.
10_1101-2020_03_27_012757	204	1	Among	among	IN
10_1101-2020_03_27_012757	204	2	the	the	DT
10_1101-2020_03_27_012757	204	3	cancer	cancer	NN
10_1101-2020_03_27_012757	204	4	categories	category	NNS
10_1101-2020_03_27_012757	204	5	431	431	CD
10_1101-2020_03_27_012757	204	6	represented	represent	VBN
10_1101-2020_03_27_012757	204	7	by	by	IN
10_1101-2020_03_27_012757	204	8	more	more	JJR
10_1101-2020_03_27_012757	204	9	than	than	IN
10_1101-2020_03_27_012757	204	10	three	three	CD
10_1101-2020_03_27_012757	204	11	samples	sample	NNS
10_1101-2020_03_27_012757	204	12	,	,	,
10_1101-2020_03_27_012757	204	13	only	only	RB
10_1101-2020_03_27_012757	204	14	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	204	15	and	and	CC
10_1101-2020_03_27_012757	204	16	PAAD	PAAD	NNS
10_1101-2020_03_27_012757	204	17	have	have	VBP
10_1101-2020_03_27_012757	204	18	fewer	few	JJR
10_1101-2020_03_27_012757	204	19	than	than	IN
10_1101-2020_03_27_012757	204	20	50	50	CD
10_1101-2020_03_27_012757	204	21	%	%	NN
10_1101-2020_03_27_012757	204	22	classified	classify	VBD
10_1101-2020_03_27_012757	204	23	432	432	CD
10_1101-2020_03_27_012757	204	24	as	as	IN
10_1101-2020_03_27_012757	204	25	their	-PRON-	PRP$
10_1101-2020_03_27_012757	204	26	annotated	annotate	VBN
10_1101-2020_03_27_012757	204	27	label	label	NN
10_1101-2020_03_27_012757	204	28	(	(	-LRB-
10_1101-2020_03_27_012757	204	29	Fig	Fig	NNP
10_1101-2020_03_27_012757	204	30	7B	7b	NN
10_1101-2020_03_27_012757	204	31	)	)	-RRB-
10_1101-2020_03_27_012757	204	32	.	.	.
10_1101-2020_03_27_012757	205	1	In	in	IN
10_1101-2020_03_27_012757	205	2	contrast	contrast	NN
10_1101-2020_03_27_012757	205	3	to	to	IN
10_1101-2020_03_27_012757	205	4	GBM	GBM	NNP
10_1101-2020_03_27_012757	205	5	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	205	6	,	,	,
10_1101-2020_03_27_012757	205	7	all	all	DT
10_1101-2020_03_27_012757	205	8	three	three	CD
10_1101-2020_03_27_012757	205	9	induced	induce	VBN
10_1101-2020_03_27_012757	205	10	pluripotent	pluripotent	NN
10_1101-2020_03_27_012757	205	11	stem	stem	NN
10_1101-2020_03_27_012757	205	12	433	433	CD
10_1101-2020_03_27_012757	205	13	cell	cell	NN
10_1101-2020_03_27_012757	205	14	-	-	HYPH
10_1101-2020_03_27_012757	205	15	derived	derive	VBN
10_1101-2020_03_27_012757	205	16	GBM	GBM	NNP
10_1101-2020_03_27_012757	205	17	tumoroids72	tumoroids72	NN
10_1101-2020_03_27_012757	205	18	were	be	VBD
10_1101-2020_03_27_012757	205	19	classified	classify	VBN
10_1101-2020_03_27_012757	205	20	as	as	IN
10_1101-2020_03_27_012757	205	21	GBM	GBM	NNP
10_1101-2020_03_27_012757	205	22	with	with	IN
10_1101-2020_03_27_012757	205	23	high	high	JJ
10_1101-2020_03_27_012757	205	24	CCN	CCN	NNP
10_1101-2020_03_27_012757	205	25	scores	score	NNS
10_1101-2020_03_27_012757	205	26	(	(	-LRB-
10_1101-2020_03_27_012757	205	27	mean	mean	VB
10_1101-2020_03_27_012757	205	28	=	=	SYM
10_1101-2020_03_27_012757	205	29	0.53	0.53	CD
10_1101-2020_03_27_012757	205	30	)	)	-RRB-
10_1101-2020_03_27_012757	205	31	.	.	.
10_1101-2020_03_27_012757	206	1	To	to	IN
10_1101-2020_03_27_012757	206	2	434	434	CD
10_1101-2020_03_27_012757	206	3	further	further	RB
10_1101-2020_03_27_012757	206	4	characterize	characterize	VB
10_1101-2020_03_27_012757	206	5	the	the	DT
10_1101-2020_03_27_012757	206	6	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	206	7	,	,	,
10_1101-2020_03_27_012757	206	8	we	-PRON-	PRP
10_1101-2020_03_27_012757	206	9	performed	perform	VBD
10_1101-2020_03_27_012757	206	10	subtype	subtype	NN
10_1101-2020_03_27_012757	206	11	classification	classification	NN
10_1101-2020_03_27_012757	206	12	on	on	IN
10_1101-2020_03_27_012757	206	13	them	-PRON-	PRP
10_1101-2020_03_27_012757	206	14	(	(	-LRB-
10_1101-2020_03_27_012757	206	15	Supp	Supp	NNP
10_1101-2020_03_27_012757	206	16	Tab	Tab	NNP
10_1101-2020_03_27_012757	206	17	8)	8)	CD
10_1101-2020_03_27_012757	206	18	.	.	.
10_1101-2020_03_27_012757	207	1	435	435	CD
10_1101-2020_03_27_012757	207	2	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	207	3	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	207	4	from	from	IN
10_1101-2020_03_27_012757	207	5	PDMR	PDMR	NNP
10_1101-2020_03_27_012757	207	6	contains	contain	VBZ
10_1101-2020_03_27_012757	207	7	a	a	DT
10_1101-2020_03_27_012757	207	8	wide	wide	JJ
10_1101-2020_03_27_012757	207	9	range	range	NN
10_1101-2020_03_27_012757	207	10	of	of	IN
10_1101-2020_03_27_012757	207	11	subtypes	subtype	NNS
10_1101-2020_03_27_012757	207	12	with	with	IN
10_1101-2020_03_27_012757	207	13	two	two	CD
10_1101-2020_03_27_012757	207	14	endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	207	15	,	,	,
10_1101-2020_03_27_012757	207	16	two	two	CD
10_1101-2020_03_27_012757	207	17	436	436	CD
10_1101-2020_03_27_012757	207	18	serous	serous	JJ
10_1101-2020_03_27_012757	207	19	and	and	CC
10_1101-2020_03_27_012757	207	20	one	one	CD
10_1101-2020_03_27_012757	207	21	mixed	mix	VBN
10_1101-2020_03_27_012757	207	22	type	type	NN
10_1101-2020_03_27_012757	207	23	(	(	-LRB-
10_1101-2020_03_27_012757	207	24	Fig	Fig	NNP
10_1101-2020_03_27_012757	207	25	7C	7C	NNP
10_1101-2020_03_27_012757	207	26	)	)	-RRB-
10_1101-2020_03_27_012757	207	27	.	.	.
10_1101-2020_03_27_012757	208	1	On	on	IN
10_1101-2020_03_27_012757	208	2	the	the	DT
10_1101-2020_03_27_012757	208	3	other	other	JJ
10_1101-2020_03_27_012757	208	4	hand	hand	NN
10_1101-2020_03_27_012757	208	5	,	,	,
10_1101-2020_03_27_012757	208	6	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	208	7	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	208	8	appear	appear	VBP
10_1101-2020_03_27_012757	208	9	to	to	TO
10_1101-2020_03_27_012757	208	10	be	be	VB
10_1101-2020_03_27_012757	208	11	437	437	CD
10_1101-2020_03_27_012757	208	12	predominantly	predominantly	RB
10_1101-2020_03_27_012757	208	13	of	of	IN
10_1101-2020_03_27_012757	208	14	classical	classical	JJ
10_1101-2020_03_27_012757	208	15	subtypes	subtype	NNS
10_1101-2020_03_27_012757	208	16	with	with	IN
10_1101-2020_03_27_012757	208	17	one	one	CD
10_1101-2020_03_27_012757	208	18	tumoroid	tumoroid	NN
10_1101-2020_03_27_012757	208	19	classified	classify	VBD
10_1101-2020_03_27_012757	208	20	as	as	IN
10_1101-2020_03_27_012757	208	21	a	a	DT
10_1101-2020_03_27_012757	208	22	mix	mix	NN
10_1101-2020_03_27_012757	208	23	between	between	IN
10_1101-2020_03_27_012757	208	24	classical	classical	JJ
10_1101-2020_03_27_012757	208	25	and	and	CC
10_1101-2020_03_27_012757	208	26	438	438	CD
10_1101-2020_03_27_012757	208	27	primitive	primitive	JJ
10_1101-2020_03_27_012757	208	28	(	(	-LRB-
10_1101-2020_03_27_012757	208	29	Fig	fig	NN
10_1101-2020_03_27_012757	208	30	7D	7d	NN
10_1101-2020_03_27_012757	208	31	)	)	-RRB-
10_1101-2020_03_27_012757	208	32	.	.	.
10_1101-2020_03_27_012757	209	1	Lastly	lastly	RB
10_1101-2020_03_27_012757	209	2	,	,	,
10_1101-2020_03_27_012757	209	3	similar	similar	JJ
10_1101-2020_03_27_012757	209	4	to	to	IN
10_1101-2020_03_27_012757	209	5	the	the	DT
10_1101-2020_03_27_012757	209	6	CCL	CCL	NNP
10_1101-2020_03_27_012757	209	7	and	and	CC
10_1101-2020_03_27_012757	209	8	PDX	PDX	NNP
10_1101-2020_03_27_012757	209	9	counterparts	counterpart	NNS
10_1101-2020_03_27_012757	209	10	,	,	,
10_1101-2020_03_27_012757	209	11	LUAD	luad	RB
10_1101-2020_03_27_012757	209	12	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	209	13	are	be	VBP
10_1101-2020_03_27_012757	209	14	439	439	CD
10_1101-2020_03_27_012757	209	15	classified	classify	VBN
10_1101-2020_03_27_012757	209	16	as	as	IN
10_1101-2020_03_27_012757	209	17	proximal	proximal	JJ
10_1101-2020_03_27_012757	209	18	inflammatory	inflammatory	JJ
10_1101-2020_03_27_012757	209	19	and	and	CC
10_1101-2020_03_27_012757	209	20	proximal	proximal	JJ
10_1101-2020_03_27_012757	209	21	proliferation	proliferation	NN
10_1101-2020_03_27_012757	209	22	with	with	IN
10_1101-2020_03_27_012757	209	23	no	no	DT
10_1101-2020_03_27_012757	209	24	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	209	25	classified	classify	VBN
10_1101-2020_03_27_012757	209	26	as	as	IN
10_1101-2020_03_27_012757	209	27	440	440	CD
10_1101-2020_03_27_012757	209	28	TRU	tru	NN
10_1101-2020_03_27_012757	209	29	subtype	subtype	NN
10_1101-2020_03_27_012757	209	30	(	(	-LRB-
10_1101-2020_03_27_012757	209	31	Fig	fig	NN
10_1101-2020_03_27_012757	209	32	7E	7e	NN
10_1101-2020_03_27_012757	209	33	)	)	-RRB-
10_1101-2020_03_27_012757	209	34	.	.	.
10_1101-2020_03_27_012757	210	1	441	441	CD
10_1101-2020_03_27_012757	210	2	442	442	CD
10_1101-2020_03_27_012757	210	3	Comparison	Comparison	NNP
10_1101-2020_03_27_012757	210	4	of	of	IN
10_1101-2020_03_27_012757	210	5	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	210	6	,	,	,
10_1101-2020_03_27_012757	210	7	PDXs	pdx	NNS
10_1101-2020_03_27_012757	210	8	,	,	,
10_1101-2020_03_27_012757	210	9	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	210	10	and	and	CC
10_1101-2020_03_27_012757	210	11	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	210	12	443	443	CD
10_1101-2020_03_27_012757	210	13	Finally	finally	RB
10_1101-2020_03_27_012757	210	14	,	,	,
10_1101-2020_03_27_012757	210	15	we	-PRON-	PRP
10_1101-2020_03_27_012757	210	16	sought	seek	VBD
10_1101-2020_03_27_012757	210	17	to	to	TO
10_1101-2020_03_27_012757	210	18	estimate	estimate	VB
10_1101-2020_03_27_012757	210	19	the	the	DT
10_1101-2020_03_27_012757	210	20	comparative	comparative	JJ
10_1101-2020_03_27_012757	210	21	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	210	22	fidelity	fidelity	NN
10_1101-2020_03_27_012757	210	23	of	of	IN
10_1101-2020_03_27_012757	210	24	the	the	DT
10_1101-2020_03_27_012757	210	25	four	four	CD
10_1101-2020_03_27_012757	210	26	cancer	cancer	NN
10_1101-2020_03_27_012757	210	27	444	444	CD
10_1101-2020_03_27_012757	210	28	models	model	NNS
10_1101-2020_03_27_012757	210	29	modalities	modality	NNS
10_1101-2020_03_27_012757	210	30	.	.	.
10_1101-2020_03_27_012757	211	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	211	2	compared	compare	VBD
10_1101-2020_03_27_012757	211	3	the	the	DT
10_1101-2020_03_27_012757	211	4	general	general	JJ
10_1101-2020_03_27_012757	211	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	211	6	scores	score	NNS
10_1101-2020_03_27_012757	211	7	of	of	IN
10_1101-2020_03_27_012757	211	8	each	each	DT
10_1101-2020_03_27_012757	211	9	model	model	NN
10_1101-2020_03_27_012757	211	10	on	on	IN
10_1101-2020_03_27_012757	211	11	a	a	DT
10_1101-2020_03_27_012757	211	12	per	per	FW
10_1101-2020_03_27_012757	211	13	tumor	tumor	NN
10_1101-2020_03_27_012757	211	14	type	type	NN
10_1101-2020_03_27_012757	211	15	445	445	CD
10_1101-2020_03_27_012757	211	16	basis	basis	NN
10_1101-2020_03_27_012757	211	17	(	(	-LRB-
10_1101-2020_03_27_012757	211	18	Fig	fig	NN
10_1101-2020_03_27_012757	211	19	8)	8)	CD
10_1101-2020_03_27_012757	211	20	.	.	.
10_1101-2020_03_27_012757	212	1	In	in	IN
10_1101-2020_03_27_012757	212	2	the	the	DT
10_1101-2020_03_27_012757	212	3	case	case	NN
10_1101-2020_03_27_012757	212	4	of	of	IN
10_1101-2020_03_27_012757	212	5	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	212	6	,	,	,
10_1101-2020_03_27_012757	212	7	we	-PRON-	PRP
10_1101-2020_03_27_012757	212	8	used	use	VBD
10_1101-2020_03_27_012757	212	9	the	the	DT
10_1101-2020_03_27_012757	212	10	mean	mean	JJ
10_1101-2020_03_27_012757	212	11	classification	classification	NN
10_1101-2020_03_27_012757	212	12	score	score	NN
10_1101-2020_03_27_012757	212	13	of	of	IN
10_1101-2020_03_27_012757	212	14	all	all	DT
10_1101-2020_03_27_012757	212	15	samples	sample	NNS
10_1101-2020_03_27_012757	212	16	with	with	IN
10_1101-2020_03_27_012757	212	17	446	446	CD
10_1101-2020_03_27_012757	212	18	shared	shared	JJ
10_1101-2020_03_27_012757	212	19	genotypes	genotype	NNS
10_1101-2020_03_27_012757	212	20	.	.	.
10_1101-2020_03_27_012757	213	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	213	2	also	also	RB
10_1101-2020_03_27_012757	213	3	used	use	VBD
10_1101-2020_03_27_012757	213	4	mean	mean	VBP
10_1101-2020_03_27_012757	213	5	classification	classification	NN
10_1101-2020_03_27_012757	213	6	of	of	IN
10_1101-2020_03_27_012757	213	7	technical	technical	JJ
10_1101-2020_03_27_012757	213	8	replicates	replicate	NNS
10_1101-2020_03_27_012757	213	9	found	find	VBN
10_1101-2020_03_27_012757	213	10	in	in	IN
10_1101-2020_03_27_012757	213	11	LIHC	LIHC	NNP
10_1101-2020_03_27_012757	213	12	447	447	CD
10_1101-2020_03_27_012757	213	13	tumoroids70	tumoroids70	NN
10_1101-2020_03_27_012757	213	14	.	.	.
10_1101-2020_03_27_012757	214	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	214	2	evaluated	evaluate	VBD
10_1101-2020_03_27_012757	214	3	models	model	NNS
10_1101-2020_03_27_012757	214	4	based	base	VBN
10_1101-2020_03_27_012757	214	5	on	on	IN
10_1101-2020_03_27_012757	214	6	both	both	CC
10_1101-2020_03_27_012757	214	7	the	the	DT
10_1101-2020_03_27_012757	214	8	maximum	maximum	JJ
10_1101-2020_03_27_012757	214	9	CCN	CCN	NNP
10_1101-2020_03_27_012757	214	10	score	score	NN
10_1101-2020_03_27_012757	214	11	,	,	,
10_1101-2020_03_27_012757	214	12	as	as	IN
10_1101-2020_03_27_012757	214	13	this	this	DT
10_1101-2020_03_27_012757	214	14	represents	represent	VBZ
10_1101-2020_03_27_012757	214	15	448	448	CD
10_1101-2020_03_27_012757	214	16	.CC	.CC	:
10_1101-2020_03_27_012757	214	17	-	-	HYPH
10_1101-2020_03_27_012757	214	18	BY	by	IN
10_1101-2020_03_27_012757	214	19	-	-	HYPH
10_1101-2020_03_27_012757	214	20	NC	NC	NNP
10_1101-2020_03_27_012757	214	21	-	-	HYPH
10_1101-2020_03_27_012757	214	22	ND	ND	NNP
10_1101-2020_03_27_012757	214	23	4.0	4.0	CD
10_1101-2020_03_27_012757	214	24	International	International	NNP
10_1101-2020_03_27_012757	214	25	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	214	26	under	under	IN
10_1101-2020_03_27_012757	214	27	a	a	DT
10_1101-2020_03_27_012757	214	28	(	(	-LRB-
10_1101-2020_03_27_012757	214	29	which	which	WDT
10_1101-2020_03_27_012757	214	30	was	be	VBD
10_1101-2020_03_27_012757	214	31	not	not	RB
10_1101-2020_03_27_012757	214	32	certified	certify	VBN
10_1101-2020_03_27_012757	214	33	by	by	IN
10_1101-2020_03_27_012757	214	34	peer	peer	NN
10_1101-2020_03_27_012757	214	35	review	review	NN
10_1101-2020_03_27_012757	214	36	)	)	-RRB-
10_1101-2020_03_27_012757	214	37	is	be	VBZ
10_1101-2020_03_27_012757	214	38	the	the	DT
10_1101-2020_03_27_012757	214	39	author	author	NN
10_1101-2020_03_27_012757	214	40	/	/	SYM
10_1101-2020_03_27_012757	214	41	funder	funder	NN
10_1101-2020_03_27_012757	214	42	,	,	,
10_1101-2020_03_27_012757	214	43	who	who	WP
10_1101-2020_03_27_012757	214	44	has	have	VBZ
10_1101-2020_03_27_012757	214	45	granted	grant	VBN
10_1101-2020_03_27_012757	214	46	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	214	47	a	a	DT
10_1101-2020_03_27_012757	214	48	license	license	NN
10_1101-2020_03_27_012757	214	49	to	to	TO
10_1101-2020_03_27_012757	214	50	display	display	VB
10_1101-2020_03_27_012757	214	51	the	the	DT
10_1101-2020_03_27_012757	214	52	preprint	preprint	NN
10_1101-2020_03_27_012757	214	53	in	in	IN
10_1101-2020_03_27_012757	214	54	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	214	55	.	.	.
10_1101-2020_03_27_012757	215	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	215	2	is	be	VBZ
10_1101-2020_03_27_012757	215	3	made	make	VBN
10_1101-2020_03_27_012757	215	4	The	the	DT
10_1101-2020_03_27_012757	215	5	copyright	copyright	NN
10_1101-2020_03_27_012757	215	6	holder	holder	NN
10_1101-2020_03_27_012757	215	7	for	for	IN
10_1101-2020_03_27_012757	215	8	this	this	DT
10_1101-2020_03_27_012757	215	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	215	10	version	version	NN
10_1101-2020_03_27_012757	215	11	posted	post	VBD
10_1101-2020_03_27_012757	215	12	January	January	NNP
10_1101-2020_03_27_012757	215	13	9	9	CD
10_1101-2020_03_27_012757	215	14	,	,	,
10_1101-2020_03_27_012757	215	15	2021	2021	CD
10_1101-2020_03_27_012757	215	16	.	.	.
10_1101-2020_03_27_012757	215	17	;	;	:
10_1101-2020_03_27_012757	215	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	215	19	:	:	:
10_1101-2020_03_27_012757	215	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	215	21	preprint	preprint	NN
10_1101-2020_03_27_012757	215	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	215	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	215	24	17	17	CD
10_1101-2020_03_27_012757	215	25	the	the	DT
10_1101-2020_03_27_012757	215	26	potential	potential	NN
10_1101-2020_03_27_012757	215	27	for	for	IN
10_1101-2020_03_27_012757	215	28	a	a	DT
10_1101-2020_03_27_012757	215	29	model	model	NN
10_1101-2020_03_27_012757	215	30	class	class	NN
10_1101-2020_03_27_012757	215	31	,	,	,
10_1101-2020_03_27_012757	215	32	and	and	CC
10_1101-2020_03_27_012757	215	33	the	the	DT
10_1101-2020_03_27_012757	215	34	median	median	JJ
10_1101-2020_03_27_012757	215	35	CCN	CCN	NNP
10_1101-2020_03_27_012757	215	36	score	score	NN
10_1101-2020_03_27_012757	215	37	,	,	,
10_1101-2020_03_27_012757	215	38	as	as	IN
10_1101-2020_03_27_012757	215	39	this	this	DT
10_1101-2020_03_27_012757	215	40	indicates	indicate	VBZ
10_1101-2020_03_27_012757	215	41	the	the	DT
10_1101-2020_03_27_012757	215	42	current	current	JJ
10_1101-2020_03_27_012757	215	43	overall	overall	RB
10_1101-2020_03_27_012757	215	44	449	449	CD
10_1101-2020_03_27_012757	215	45	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	215	46	fidelity	fidelity	NN
10_1101-2020_03_27_012757	215	47	of	of	IN
10_1101-2020_03_27_012757	215	48	a	a	DT
10_1101-2020_03_27_012757	215	49	model	model	NN
10_1101-2020_03_27_012757	215	50	class	class	NN
10_1101-2020_03_27_012757	215	51	.	.	.
10_1101-2020_03_27_012757	216	1	PDXs	pdx	NNS
10_1101-2020_03_27_012757	216	2	achieved	achieve	VBD
10_1101-2020_03_27_012757	216	3	the	the	DT
10_1101-2020_03_27_012757	216	4	highest	high	JJS
10_1101-2020_03_27_012757	216	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	216	6	scores	score	NNS
10_1101-2020_03_27_012757	216	7	in	in	IN
10_1101-2020_03_27_012757	216	8	three	three	CD
10_1101-2020_03_27_012757	216	9	(	(	-LRB-
10_1101-2020_03_27_012757	216	10	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	216	11	,	,	,
10_1101-2020_03_27_012757	216	12	450	450	CD
10_1101-2020_03_27_012757	216	13	PAAD	PAAD	NNS
10_1101-2020_03_27_012757	216	14	,	,	,
10_1101-2020_03_27_012757	216	15	LUAD	luad	RB
10_1101-2020_03_27_012757	216	16	)	)	-RRB-
10_1101-2020_03_27_012757	216	17	out	out	IN
10_1101-2020_03_27_012757	216	18	of	of	IN
10_1101-2020_03_27_012757	216	19	the	the	DT
10_1101-2020_03_27_012757	216	20	five	five	CD
10_1101-2020_03_27_012757	216	21	cancer	cancer	NN
10_1101-2020_03_27_012757	216	22	categories	category	NNS
10_1101-2020_03_27_012757	216	23	in	in	IN
10_1101-2020_03_27_012757	216	24	which	which	WDT
10_1101-2020_03_27_012757	216	25	all	all	DT
10_1101-2020_03_27_012757	216	26	four	four	CD
10_1101-2020_03_27_012757	216	27	modalities	modality	NNS
10_1101-2020_03_27_012757	216	28	were	be	VBD
10_1101-2020_03_27_012757	216	29	available	available	JJ
10_1101-2020_03_27_012757	216	30	(	(	-LRB-
10_1101-2020_03_27_012757	216	31	Fig	fig	NN
10_1101-2020_03_27_012757	216	32	451	451	CD
10_1101-2020_03_27_012757	216	33	8)	8)	CD
10_1101-2020_03_27_012757	216	34	,	,	,
10_1101-2020_03_27_012757	216	35	despite	despite	IN
10_1101-2020_03_27_012757	216	36	having	have	VBG
10_1101-2020_03_27_012757	216	37	low	low	JJ
10_1101-2020_03_27_012757	216	38	median	median	JJ
10_1101-2020_03_27_012757	216	39	CCN	CCN	NNP
10_1101-2020_03_27_012757	216	40	scores	score	NNS
10_1101-2020_03_27_012757	216	41	.	.	.
10_1101-2020_03_27_012757	217	1	Notably	notably	RB
10_1101-2020_03_27_012757	217	2	,	,	,
10_1101-2020_03_27_012757	217	3	PDXs	pdx	NNS
10_1101-2020_03_27_012757	217	4	have	have	VBP
10_1101-2020_03_27_012757	217	5	a	a	DT
10_1101-2020_03_27_012757	217	6	median	median	JJ
10_1101-2020_03_27_012757	217	7	CCN	ccn	NN
10_1101-2020_03_27_012757	217	8	score	score	NN
10_1101-2020_03_27_012757	217	9	above	above	IN
10_1101-2020_03_27_012757	217	10	452	452	CD
10_1101-2020_03_27_012757	217	11	the	the	DT
10_1101-2020_03_27_012757	217	12	0.25	0.25	CD
10_1101-2020_03_27_012757	217	13	threshold	threshold	NN
10_1101-2020_03_27_012757	217	14	in	in	IN
10_1101-2020_03_27_012757	217	15	PAAD	PAAD	NNP
10_1101-2020_03_27_012757	217	16	while	while	IN
10_1101-2020_03_27_012757	217	17	none	none	NN
10_1101-2020_03_27_012757	217	18	of	of	IN
10_1101-2020_03_27_012757	217	19	the	the	DT
10_1101-2020_03_27_012757	217	20	other	other	JJ
10_1101-2020_03_27_012757	217	21	three	three	CD
10_1101-2020_03_27_012757	217	22	modalities	modality	NNS
10_1101-2020_03_27_012757	217	23	have	have	VBP
10_1101-2020_03_27_012757	217	24	any	any	DT
10_1101-2020_03_27_012757	217	25	samples	sample	NNS
10_1101-2020_03_27_012757	217	26	above	above	IN
10_1101-2020_03_27_012757	217	27	453	453	CD
10_1101-2020_03_27_012757	217	28	the	the	DT
10_1101-2020_03_27_012757	217	29	threshold	threshold	NN
10_1101-2020_03_27_012757	217	30	.	.	.
10_1101-2020_03_27_012757	218	1	In	in	IN
10_1101-2020_03_27_012757	218	2	LIHC	LIHC	NNP
10_1101-2020_03_27_012757	218	3	,	,	,
10_1101-2020_03_27_012757	218	4	the	the	DT
10_1101-2020_03_27_012757	218	5	highest	high	JJS
10_1101-2020_03_27_012757	218	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	218	7	score	score	NN
10_1101-2020_03_27_012757	218	8	for	for	IN
10_1101-2020_03_27_012757	218	9	PDX	PDX	NNP
10_1101-2020_03_27_012757	218	10	(	(	-LRB-
10_1101-2020_03_27_012757	218	11	0.9	0.9	CD
10_1101-2020_03_27_012757	218	12	)	)	-RRB-
10_1101-2020_03_27_012757	218	13	is	be	VBZ
10_1101-2020_03_27_012757	218	14	only	only	RB
10_1101-2020_03_27_012757	218	15	slightly	slightly	RB
10_1101-2020_03_27_012757	218	16	lower	low	JJR
10_1101-2020_03_27_012757	218	17	than	than	IN
10_1101-2020_03_27_012757	218	18	the	the	DT
10_1101-2020_03_27_012757	218	19	454	454	CD
10_1101-2020_03_27_012757	218	20	highest	high	JJS
10_1101-2020_03_27_012757	218	21	CCN	CCN	NNP
10_1101-2020_03_27_012757	218	22	score	score	NN
10_1101-2020_03_27_012757	218	23	for	for	IN
10_1101-2020_03_27_012757	218	24	tumoroid	tumoroid	NN
10_1101-2020_03_27_012757	218	25	(	(	-LRB-
10_1101-2020_03_27_012757	218	26	0.91	0.91	CD
10_1101-2020_03_27_012757	218	27	)	)	-RRB-
10_1101-2020_03_27_012757	218	28	.	.	.
10_1101-2020_03_27_012757	219	1	This	this	DT
10_1101-2020_03_27_012757	219	2	suggest	suggest	VBP
10_1101-2020_03_27_012757	219	3	that	that	IN
10_1101-2020_03_27_012757	219	4	certain	certain	JJ
10_1101-2020_03_27_012757	219	5	individual	individual	JJ
10_1101-2020_03_27_012757	219	6	PDXs	pdx	NNS
10_1101-2020_03_27_012757	219	7	most	most	RBS
10_1101-2020_03_27_012757	219	8	closely	closely	RB
10_1101-2020_03_27_012757	219	9	455	455	CD
10_1101-2020_03_27_012757	219	10	mimic	mimic	NN
10_1101-2020_03_27_012757	219	11	the	the	DT
10_1101-2020_03_27_012757	219	12	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	219	13	state	state	NN
10_1101-2020_03_27_012757	219	14	of	of	IN
10_1101-2020_03_27_012757	219	15	native	native	JJ
10_1101-2020_03_27_012757	219	16	patient	patient	JJ
10_1101-2020_03_27_012757	219	17	tumors	tumor	NNS
10_1101-2020_03_27_012757	219	18	despite	despite	IN
10_1101-2020_03_27_012757	219	19	a	a	DT
10_1101-2020_03_27_012757	219	20	portion	portion	NN
10_1101-2020_03_27_012757	219	21	of	of	IN
10_1101-2020_03_27_012757	219	22	the	the	DT
10_1101-2020_03_27_012757	219	23	PDXs	pdx	NNS
10_1101-2020_03_27_012757	219	24	having	have	VBG
10_1101-2020_03_27_012757	219	25	low	low	JJ
10_1101-2020_03_27_012757	219	26	456	456	CD
10_1101-2020_03_27_012757	219	27	CCN	ccn	NN
10_1101-2020_03_27_012757	219	28	scores	score	NNS
10_1101-2020_03_27_012757	219	29	.	.	.
10_1101-2020_03_27_012757	220	1	Similarly	similarly	RB
10_1101-2020_03_27_012757	220	2	,	,	,
10_1101-2020_03_27_012757	220	3	while	while	IN
10_1101-2020_03_27_012757	220	4	the	the	DT
10_1101-2020_03_27_012757	220	5	majority	majority	NN
10_1101-2020_03_27_012757	220	6	of	of	IN
10_1101-2020_03_27_012757	220	7	the	the	DT
10_1101-2020_03_27_012757	220	8	CCLs	ccl	NNS
10_1101-2020_03_27_012757	220	9	have	have	VBP
10_1101-2020_03_27_012757	220	10	low	low	JJ
10_1101-2020_03_27_012757	220	11	CCN	CCN	NNP
10_1101-2020_03_27_012757	220	12	scores	score	NNS
10_1101-2020_03_27_012757	220	13	,	,	,
10_1101-2020_03_27_012757	220	14	several	several	JJ
10_1101-2020_03_27_012757	220	15	lines	line	NNS
10_1101-2020_03_27_012757	220	16	457	457	CD
10_1101-2020_03_27_012757	220	17	achieve	achieve	VBP
10_1101-2020_03_27_012757	220	18	high	high	JJ
10_1101-2020_03_27_012757	220	19	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	220	20	fidelity	fidelity	NN
10_1101-2020_03_27_012757	220	21	in	in	IN
10_1101-2020_03_27_012757	220	22	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	220	23	,	,	,
10_1101-2020_03_27_012757	220	24	LUAD	LUAD	NNP
10_1101-2020_03_27_012757	220	25	and	and	CC
10_1101-2020_03_27_012757	220	26	LIHC	LIHC	NNP
10_1101-2020_03_27_012757	220	27	(	(	-LRB-
10_1101-2020_03_27_012757	220	28	Fig	Fig	NNP
10_1101-2020_03_27_012757	220	29	8)	8)	CD
10_1101-2020_03_27_012757	220	30	.	.	.
10_1101-2020_03_27_012757	221	1	Collectively	collectively	RB
10_1101-2020_03_27_012757	221	2	,	,	,
10_1101-2020_03_27_012757	221	3	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	221	4	and	and	CC
10_1101-2020_03_27_012757	221	5	458	458	CD
10_1101-2020_03_27_012757	221	6	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	221	7	had	have	VBD
10_1101-2020_03_27_012757	221	8	the	the	DT
10_1101-2020_03_27_012757	221	9	highest	high	JJS
10_1101-2020_03_27_012757	221	10	median	median	JJ
10_1101-2020_03_27_012757	221	11	CCN	CCN	NNP
10_1101-2020_03_27_012757	221	12	scores	score	NNS
10_1101-2020_03_27_012757	221	13	in	in	IN
10_1101-2020_03_27_012757	221	14	four	four	CD
10_1101-2020_03_27_012757	221	15	of	of	IN
10_1101-2020_03_27_012757	221	16	the	the	DT
10_1101-2020_03_27_012757	221	17	five	five	CD
10_1101-2020_03_27_012757	221	18	model	model	NN
10_1101-2020_03_27_012757	221	19	classes	class	NNS
10_1101-2020_03_27_012757	221	20	(	(	-LRB-
10_1101-2020_03_27_012757	221	21	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	221	22	and	and	CC
10_1101-2020_03_27_012757	221	23	459	459	CD
10_1101-2020_03_27_012757	221	24	LUAD	luad	RB
10_1101-2020_03_27_012757	221	25	for	for	IN
10_1101-2020_03_27_012757	221	26	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	221	27	and	and	CC
10_1101-2020_03_27_012757	221	28	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	221	29	and	and	CC
10_1101-2020_03_27_012757	221	30	LIHC	LIHC	NNP
10_1101-2020_03_27_012757	221	31	for	for	IN
10_1101-2020_03_27_012757	221	32	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	221	33	)	)	-RRB-
10_1101-2020_03_27_012757	221	34	.	.	.
10_1101-2020_03_27_012757	222	1	Notably	notably	RB
10_1101-2020_03_27_012757	222	2	,	,	,
10_1101-2020_03_27_012757	222	3	both	both	DT
10_1101-2020_03_27_012757	222	4	of	of	IN
10_1101-2020_03_27_012757	222	5	the	the	DT
10_1101-2020_03_27_012757	222	6	LIHC	LIHC	NNP
10_1101-2020_03_27_012757	222	7	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	222	8	460	460	CD
10_1101-2020_03_27_012757	222	9	achieved	achieve	VBD
10_1101-2020_03_27_012757	222	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	222	11	scores	score	NNS
10_1101-2020_03_27_012757	222	12	on	on	IN
10_1101-2020_03_27_012757	222	13	par	par	NN
10_1101-2020_03_27_012757	222	14	with	with	IN
10_1101-2020_03_27_012757	222	15	patient	patient	JJ
10_1101-2020_03_27_012757	222	16	tumors	tumor	NNS
10_1101-2020_03_27_012757	222	17	(	(	-LRB-
10_1101-2020_03_27_012757	222	18	Fig	fig	NN
10_1101-2020_03_27_012757	222	19	8)	8)	CD
10_1101-2020_03_27_012757	222	20	.	.	.
10_1101-2020_03_27_012757	223	1	In	in	IN
10_1101-2020_03_27_012757	223	2	brief	brief	NN
10_1101-2020_03_27_012757	223	3	,	,	,
10_1101-2020_03_27_012757	223	4	this	this	DT
10_1101-2020_03_27_012757	223	5	analysis	analysis	NN
10_1101-2020_03_27_012757	223	6	indicates	indicate	VBZ
10_1101-2020_03_27_012757	223	7	that	that	IN
10_1101-2020_03_27_012757	223	8	461	461	CD
10_1101-2020_03_27_012757	223	9	PDXs	pdx	NNS
10_1101-2020_03_27_012757	223	10	and	and	CC
10_1101-2020_03_27_012757	223	11	CCLs	ccl	NNS
10_1101-2020_03_27_012757	223	12	are	be	VBP
10_1101-2020_03_27_012757	223	13	heterogenous	heterogenous	JJ
10_1101-2020_03_27_012757	223	14	in	in	IN
10_1101-2020_03_27_012757	223	15	terms	term	NNS
10_1101-2020_03_27_012757	223	16	of	of	IN
10_1101-2020_03_27_012757	223	17	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	223	18	fidelity	fidelity	NN
10_1101-2020_03_27_012757	223	19	,	,	,
10_1101-2020_03_27_012757	223	20	with	with	IN
10_1101-2020_03_27_012757	223	21	a	a	DT
10_1101-2020_03_27_012757	223	22	portion	portion	NN
10_1101-2020_03_27_012757	223	23	of	of	IN
10_1101-2020_03_27_012757	223	24	the	the	DT
10_1101-2020_03_27_012757	223	25	462	462	CD
10_1101-2020_03_27_012757	223	26	models	model	NNS
10_1101-2020_03_27_012757	223	27	highly	highly	RB
10_1101-2020_03_27_012757	223	28	mimicking	mimic	VBG
10_1101-2020_03_27_012757	223	29	native	native	JJ
10_1101-2020_03_27_012757	223	30	tumors	tumor	NNS
10_1101-2020_03_27_012757	223	31	and	and	CC
10_1101-2020_03_27_012757	223	32	the	the	DT
10_1101-2020_03_27_012757	223	33	majority	majority	NN
10_1101-2020_03_27_012757	223	34	of	of	IN
10_1101-2020_03_27_012757	223	35	the	the	DT
10_1101-2020_03_27_012757	223	36	models	model	NNS
10_1101-2020_03_27_012757	223	37	having	have	VBG
10_1101-2020_03_27_012757	223	38	low	low	JJ
10_1101-2020_03_27_012757	223	39	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	223	40	463	463	CD
10_1101-2020_03_27_012757	223	41	fidelity	fidelity	NN
10_1101-2020_03_27_012757	223	42	(	(	-LRB-
10_1101-2020_03_27_012757	223	43	with	with	IN
10_1101-2020_03_27_012757	223	44	the	the	DT
10_1101-2020_03_27_012757	223	45	exception	exception	NN
10_1101-2020_03_27_012757	223	46	of	of	IN
10_1101-2020_03_27_012757	223	47	PAAD	PAAD	NNP
10_1101-2020_03_27_012757	223	48	for	for	IN
10_1101-2020_03_27_012757	223	49	PDXs	pdx	NNS
10_1101-2020_03_27_012757	223	50	)	)	-RRB-
10_1101-2020_03_27_012757	223	51	.	.	.
10_1101-2020_03_27_012757	224	1	On	on	IN
10_1101-2020_03_27_012757	224	2	the	the	DT
10_1101-2020_03_27_012757	224	3	other	other	JJ
10_1101-2020_03_27_012757	224	4	hand	hand	NN
10_1101-2020_03_27_012757	224	5	,	,	,
10_1101-2020_03_27_012757	224	6	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	224	7	and	and	CC
10_1101-2020_03_27_012757	224	8	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	224	9	464	464	CD
10_1101-2020_03_27_012757	224	10	displayed	display	VBD
10_1101-2020_03_27_012757	224	11	a	a	DT
10_1101-2020_03_27_012757	224	12	consistently	consistently	RB
10_1101-2020_03_27_012757	224	13	high	high	JJ
10_1101-2020_03_27_012757	224	14	fidelity	fidelity	NN
10_1101-2020_03_27_012757	224	15	across	across	IN
10_1101-2020_03_27_012757	224	16	different	different	JJ
10_1101-2020_03_27_012757	224	17	models	model	NNS
10_1101-2020_03_27_012757	224	18	.	.	.
10_1101-2020_03_27_012757	225	1	465	465	CD
10_1101-2020_03_27_012757	225	2	Because	because	IN
10_1101-2020_03_27_012757	225	3	the	the	DT
10_1101-2020_03_27_012757	225	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	225	5	score	score	NN
10_1101-2020_03_27_012757	225	6	is	be	VBZ
10_1101-2020_03_27_012757	225	7	based	base	VBN
10_1101-2020_03_27_012757	225	8	on	on	IN
10_1101-2020_03_27_012757	225	9	a	a	DT
10_1101-2020_03_27_012757	225	10	moderate	moderate	JJ
10_1101-2020_03_27_012757	225	11	number	number	NN
10_1101-2020_03_27_012757	225	12	of	of	IN
10_1101-2020_03_27_012757	225	13	gene	gene	NN
10_1101-2020_03_27_012757	225	14	features	feature	NNS
10_1101-2020_03_27_012757	225	15	(	(	-LRB-
10_1101-2020_03_27_012757	225	16	i.e.	i.e.	FW
10_1101-2020_03_27_012757	226	1	1,979	1,979	CD
10_1101-2020_03_27_012757	226	2	466	466	CD
10_1101-2020_03_27_012757	226	3	gene	gene	NN
10_1101-2020_03_27_012757	226	4	pairs	pair	NNS
10_1101-2020_03_27_012757	226	5	consisting	consist	VBG
10_1101-2020_03_27_012757	226	6	of	of	IN
10_1101-2020_03_27_012757	226	7	1,689	1,689	CD
10_1101-2020_03_27_012757	226	8	unique	unique	JJ
10_1101-2020_03_27_012757	226	9	genes	gene	NNS
10_1101-2020_03_27_012757	226	10	)	)	-RRB-
10_1101-2020_03_27_012757	226	11	relative	relative	JJ
10_1101-2020_03_27_012757	226	12	to	to	IN
10_1101-2020_03_27_012757	226	13	the	the	DT
10_1101-2020_03_27_012757	226	14	total	total	JJ
10_1101-2020_03_27_012757	226	15	number	number	NN
10_1101-2020_03_27_012757	226	16	of	of	IN
10_1101-2020_03_27_012757	226	17	protein	protein	NN
10_1101-2020_03_27_012757	226	18	-	-	HYPH
10_1101-2020_03_27_012757	226	19	coding	code	VBG
10_1101-2020_03_27_012757	226	20	467	467	CD
10_1101-2020_03_27_012757	226	21	genes	gene	NNS
10_1101-2020_03_27_012757	226	22	in	in	IN
10_1101-2020_03_27_012757	226	23	the	the	DT
10_1101-2020_03_27_012757	226	24	genome	genome	NN
10_1101-2020_03_27_012757	226	25	,	,	,
10_1101-2020_03_27_012757	226	26	it	-PRON-	PRP
10_1101-2020_03_27_012757	226	27	is	be	VBZ
10_1101-2020_03_27_012757	226	28	possible	possible	JJ
10_1101-2020_03_27_012757	226	29	that	that	IN
10_1101-2020_03_27_012757	226	30	a	a	DT
10_1101-2020_03_27_012757	226	31	cancer	cancer	NN
10_1101-2020_03_27_012757	226	32	model	model	NN
10_1101-2020_03_27_012757	226	33	with	with	IN
10_1101-2020_03_27_012757	226	34	a	a	DT
10_1101-2020_03_27_012757	226	35	high	high	JJ
10_1101-2020_03_27_012757	226	36	CCN	CCN	NNP
10_1101-2020_03_27_012757	226	37	score	score	NN
10_1101-2020_03_27_012757	226	38	might	may	MD
10_1101-2020_03_27_012757	226	39	not	not	RB
10_1101-2020_03_27_012757	226	40	have	have	VB
10_1101-2020_03_27_012757	226	41	a	a	DT
10_1101-2020_03_27_012757	226	42	468	468	CD
10_1101-2020_03_27_012757	226	43	high	high	JJ
10_1101-2020_03_27_012757	226	44	global	global	JJ
10_1101-2020_03_27_012757	226	45	similarity	similarity	NN
10_1101-2020_03_27_012757	226	46	to	to	IN
10_1101-2020_03_27_012757	226	47	a	a	DT
10_1101-2020_03_27_012757	226	48	naturally	naturally	RB
10_1101-2020_03_27_012757	226	49	occurring	occur	VBG
10_1101-2020_03_27_012757	226	50	tumor	tumor	NN
10_1101-2020_03_27_012757	226	51	.	.	.
10_1101-2020_03_27_012757	227	1	Therefore	therefore	RB
10_1101-2020_03_27_012757	227	2	,	,	,
10_1101-2020_03_27_012757	227	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	227	4	also	also	RB
10_1101-2020_03_27_012757	227	5	calculated	calculate	VBD
10_1101-2020_03_27_012757	227	6	the	the	DT
10_1101-2020_03_27_012757	227	7	GRN	GRN	NNP
10_1101-2020_03_27_012757	227	8	469	469	CD
10_1101-2020_03_27_012757	227	9	status	status	NN
10_1101-2020_03_27_012757	227	10	,	,	,
10_1101-2020_03_27_012757	227	11	a	a	DT
10_1101-2020_03_27_012757	227	12	metric	metric	NN
10_1101-2020_03_27_012757	227	13	of	of	IN
10_1101-2020_03_27_012757	227	14	the	the	DT
10_1101-2020_03_27_012757	227	15	extent	extent	NN
10_1101-2020_03_27_012757	227	16	to	to	TO
10_1101-2020_03_27_012757	227	17	which	which	WDT
10_1101-2020_03_27_012757	227	18	tumor	tumor	NN
10_1101-2020_03_27_012757	227	19	-	-	HYPH
10_1101-2020_03_27_012757	227	20	type	type	NN
10_1101-2020_03_27_012757	227	21	specific	specific	JJ
10_1101-2020_03_27_012757	227	22	gene	gene	NN
10_1101-2020_03_27_012757	227	23	regulatory	regulatory	JJ
10_1101-2020_03_27_012757	227	24	network	network	NN
10_1101-2020_03_27_012757	227	25	is	be	VBZ
10_1101-2020_03_27_012757	227	26	470	470	CD
10_1101-2020_03_27_012757	227	27	established21	established21	NNS
10_1101-2020_03_27_012757	227	28	,	,	,
10_1101-2020_03_27_012757	227	29	for	for	IN
10_1101-2020_03_27_012757	227	30	all	all	DT
10_1101-2020_03_27_012757	227	31	models	model	NNS
10_1101-2020_03_27_012757	227	32	(	(	-LRB-
10_1101-2020_03_27_012757	227	33	Supp	Supp	NNP
10_1101-2020_03_27_012757	227	34	Fig	Fig	NNP
10_1101-2020_03_27_012757	227	35	4	4	CD
10_1101-2020_03_27_012757	227	36	)	)	-RRB-
10_1101-2020_03_27_012757	227	37	.	.	.
10_1101-2020_03_27_012757	228	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	228	2	observed	observe	VBD
10_1101-2020_03_27_012757	228	3	high	high	JJ
10_1101-2020_03_27_012757	228	4	level	level	NN
10_1101-2020_03_27_012757	228	5	of	of	IN
10_1101-2020_03_27_012757	228	6	correlation	correlation	NN
10_1101-2020_03_27_012757	228	7	between	between	IN
10_1101-2020_03_27_012757	228	8	the	the	DT
10_1101-2020_03_27_012757	228	9	471	471	CD
10_1101-2020_03_27_012757	228	10	two	two	CD
10_1101-2020_03_27_012757	228	11	similarity	similarity	NN
10_1101-2020_03_27_012757	228	12	metrics	metric	NNS
10_1101-2020_03_27_012757	228	13	,	,	,
10_1101-2020_03_27_012757	228	14	which	which	WDT
10_1101-2020_03_27_012757	228	15	suggests	suggest	VBZ
10_1101-2020_03_27_012757	228	16	that	that	IN
10_1101-2020_03_27_012757	228	17	although	although	IN
10_1101-2020_03_27_012757	228	18	CCN	CCN	NNP
10_1101-2020_03_27_012757	228	19	classifies	classifie	NNS
10_1101-2020_03_27_012757	228	20	on	on	IN
10_1101-2020_03_27_012757	228	21	a	a	DT
10_1101-2020_03_27_012757	228	22	selected	select	VBN
10_1101-2020_03_27_012757	228	23	set	set	NN
10_1101-2020_03_27_012757	228	24	of	of	IN
10_1101-2020_03_27_012757	228	25	genes	gene	NNS
10_1101-2020_03_27_012757	228	26	,	,	,
10_1101-2020_03_27_012757	228	27	472	472	CD
10_1101-2020_03_27_012757	228	28	its	-PRON-	PRP$
10_1101-2020_03_27_012757	228	29	scores	score	NNS
10_1101-2020_03_27_012757	228	30	are	be	VBP
10_1101-2020_03_27_012757	228	31	highly	highly	RB
10_1101-2020_03_27_012757	228	32	correlated	correlate	VBN
10_1101-2020_03_27_012757	228	33	with	with	IN
10_1101-2020_03_27_012757	228	34	global	global	JJ
10_1101-2020_03_27_012757	228	35	assessment	assessment	NN
10_1101-2020_03_27_012757	228	36	of	of	IN
10_1101-2020_03_27_012757	228	37	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	228	38	similarity	similarity	NN
10_1101-2020_03_27_012757	228	39	.	.	.
10_1101-2020_03_27_012757	229	1	473	473	CD
10_1101-2020_03_27_012757	229	2	.CC	.CC	:
10_1101-2020_03_27_012757	229	3	-	-	HYPH
10_1101-2020_03_27_012757	229	4	BY	by	IN
10_1101-2020_03_27_012757	229	5	-	-	HYPH
10_1101-2020_03_27_012757	229	6	NC	NC	NNP
10_1101-2020_03_27_012757	229	7	-	-	HYPH
10_1101-2020_03_27_012757	229	8	ND	ND	NNP
10_1101-2020_03_27_012757	229	9	4.0	4.0	CD
10_1101-2020_03_27_012757	229	10	International	International	NNP
10_1101-2020_03_27_012757	229	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	229	12	under	under	IN
10_1101-2020_03_27_012757	229	13	a	a	DT
10_1101-2020_03_27_012757	229	14	(	(	-LRB-
10_1101-2020_03_27_012757	229	15	which	which	WDT
10_1101-2020_03_27_012757	229	16	was	be	VBD
10_1101-2020_03_27_012757	229	17	not	not	RB
10_1101-2020_03_27_012757	229	18	certified	certify	VBN
10_1101-2020_03_27_012757	229	19	by	by	IN
10_1101-2020_03_27_012757	229	20	peer	peer	NN
10_1101-2020_03_27_012757	229	21	review	review	NN
10_1101-2020_03_27_012757	229	22	)	)	-RRB-
10_1101-2020_03_27_012757	229	23	is	be	VBZ
10_1101-2020_03_27_012757	229	24	the	the	DT
10_1101-2020_03_27_012757	229	25	author	author	NN
10_1101-2020_03_27_012757	229	26	/	/	SYM
10_1101-2020_03_27_012757	229	27	funder	funder	NN
10_1101-2020_03_27_012757	229	28	,	,	,
10_1101-2020_03_27_012757	229	29	who	who	WP
10_1101-2020_03_27_012757	229	30	has	have	VBZ
10_1101-2020_03_27_012757	229	31	granted	grant	VBN
10_1101-2020_03_27_012757	229	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	229	33	a	a	DT
10_1101-2020_03_27_012757	229	34	license	license	NN
10_1101-2020_03_27_012757	229	35	to	to	TO
10_1101-2020_03_27_012757	229	36	display	display	VB
10_1101-2020_03_27_012757	229	37	the	the	DT
10_1101-2020_03_27_012757	229	38	preprint	preprint	NN
10_1101-2020_03_27_012757	229	39	in	in	IN
10_1101-2020_03_27_012757	229	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	229	41	.	.	.
10_1101-2020_03_27_012757	230	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	230	2	is	be	VBZ
10_1101-2020_03_27_012757	230	3	made	make	VBN
10_1101-2020_03_27_012757	230	4	The	the	DT
10_1101-2020_03_27_012757	230	5	copyright	copyright	NN
10_1101-2020_03_27_012757	230	6	holder	holder	NN
10_1101-2020_03_27_012757	230	7	for	for	IN
10_1101-2020_03_27_012757	230	8	this	this	DT
10_1101-2020_03_27_012757	230	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	230	10	version	version	NN
10_1101-2020_03_27_012757	230	11	posted	post	VBD
10_1101-2020_03_27_012757	230	12	January	January	NNP
10_1101-2020_03_27_012757	230	13	9	9	CD
10_1101-2020_03_27_012757	230	14	,	,	,
10_1101-2020_03_27_012757	230	15	2021	2021	CD
10_1101-2020_03_27_012757	230	16	.	.	.
10_1101-2020_03_27_012757	230	17	;	;	:
10_1101-2020_03_27_012757	230	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	230	19	:	:	:
10_1101-2020_03_27_012757	230	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	230	21	preprint	preprint	NN
10_1101-2020_03_27_012757	230	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	230	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	230	24	18	18	CD
10_1101-2020_03_27_012757	230	25	We	-PRON-	PRP
10_1101-2020_03_27_012757	230	26	also	also	RB
10_1101-2020_03_27_012757	230	27	sought	seek	VBD
10_1101-2020_03_27_012757	230	28	to	to	TO
10_1101-2020_03_27_012757	230	29	compare	compare	VB
10_1101-2020_03_27_012757	230	30	model	model	NN
10_1101-2020_03_27_012757	230	31	modalities	modality	NNS
10_1101-2020_03_27_012757	230	32	in	in	IN
10_1101-2020_03_27_012757	230	33	terms	term	NNS
10_1101-2020_03_27_012757	230	34	of	of	IN
10_1101-2020_03_27_012757	230	35	the	the	DT
10_1101-2020_03_27_012757	230	36	diversity	diversity	NN
10_1101-2020_03_27_012757	230	37	of	of	IN
10_1101-2020_03_27_012757	230	38	subtypes	subtype	NNS
10_1101-2020_03_27_012757	230	39	that	that	IN
10_1101-2020_03_27_012757	230	40	474	474	CD
10_1101-2020_03_27_012757	230	41	they	-PRON-	PRP
10_1101-2020_03_27_012757	230	42	represent	represent	VBP
10_1101-2020_03_27_012757	230	43	(	(	-LRB-
10_1101-2020_03_27_012757	230	44	Supp	Supp	NNP
10_1101-2020_03_27_012757	230	45	Fig	Fig	NNP
10_1101-2020_03_27_012757	230	46	5	5	CD
10_1101-2020_03_27_012757	230	47	)	)	-RRB-
10_1101-2020_03_27_012757	230	48	.	.	.
10_1101-2020_03_27_012757	231	1	As	as	IN
10_1101-2020_03_27_012757	231	2	a	a	DT
10_1101-2020_03_27_012757	231	3	reference	reference	NN
10_1101-2020_03_27_012757	231	4	,	,	,
10_1101-2020_03_27_012757	231	5	we	-PRON-	PRP
10_1101-2020_03_27_012757	231	6	also	also	RB
10_1101-2020_03_27_012757	231	7	included	include	VBD
10_1101-2020_03_27_012757	231	8	in	in	IN
10_1101-2020_03_27_012757	231	9	this	this	DT
10_1101-2020_03_27_012757	231	10	analysis	analysis	NN
10_1101-2020_03_27_012757	231	11	the	the	DT
10_1101-2020_03_27_012757	231	12	overall	overall	JJ
10_1101-2020_03_27_012757	231	13	475	475	CD
10_1101-2020_03_27_012757	231	14	subtype	subtype	NN
10_1101-2020_03_27_012757	231	15	incidence	incidence	NN
10_1101-2020_03_27_012757	231	16	,	,	,
10_1101-2020_03_27_012757	231	17	as	as	IN
10_1101-2020_03_27_012757	231	18	approximated	approximate	VBN
10_1101-2020_03_27_012757	231	19	by	by	IN
10_1101-2020_03_27_012757	231	20	incidence	incidence	NN
10_1101-2020_03_27_012757	231	21	in	in	IN
10_1101-2020_03_27_012757	231	22	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	231	23	.	.	.
10_1101-2020_03_27_012757	232	1	Replicates	replicate	NNS
10_1101-2020_03_27_012757	232	2	in	in	IN
10_1101-2020_03_27_012757	232	3	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	232	4	and	and	CC
10_1101-2020_03_27_012757	232	5	476	476	CD
10_1101-2020_03_27_012757	232	6	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	232	7	were	be	VBD
10_1101-2020_03_27_012757	232	8	averaged	average	VBN
10_1101-2020_03_27_012757	232	9	into	into	IN
10_1101-2020_03_27_012757	232	10	one	one	CD
10_1101-2020_03_27_012757	232	11	classification	classification	NN
10_1101-2020_03_27_012757	232	12	profile	profile	NN
10_1101-2020_03_27_012757	232	13	.	.	.
10_1101-2020_03_27_012757	233	1	In	in	IN
10_1101-2020_03_27_012757	233	2	models	model	NNS
10_1101-2020_03_27_012757	233	3	of	of	IN
10_1101-2020_03_27_012757	233	4	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	233	5	,	,	,
10_1101-2020_03_27_012757	233	6	there	there	EX
10_1101-2020_03_27_012757	233	7	is	be	VBZ
10_1101-2020_03_27_012757	233	8	a	a	DT
10_1101-2020_03_27_012757	233	9	notable	notable	JJ
10_1101-2020_03_27_012757	233	10	477	477	CD
10_1101-2020_03_27_012757	233	11	difference	difference	NN
10_1101-2020_03_27_012757	233	12	in	in	IN
10_1101-2020_03_27_012757	233	13	endometroid	endometroid	JJ
10_1101-2020_03_27_012757	233	14	incidence	incidence	NN
10_1101-2020_03_27_012757	233	15	,	,	,
10_1101-2020_03_27_012757	233	16	and	and	CC
10_1101-2020_03_27_012757	233	17	the	the	DT
10_1101-2020_03_27_012757	233	18	proportion	proportion	NN
10_1101-2020_03_27_012757	233	19	of	of	IN
10_1101-2020_03_27_012757	233	20	models	model	NNS
10_1101-2020_03_27_012757	233	21	classified	classify	VBN
10_1101-2020_03_27_012757	233	22	as	as	IN
10_1101-2020_03_27_012757	233	23	endometroid	endometroid	NNP
10_1101-2020_03_27_012757	233	24	,	,	,
10_1101-2020_03_27_012757	233	25	478	478	CD
10_1101-2020_03_27_012757	233	26	with	with	IN
10_1101-2020_03_27_012757	233	27	PDX	PDX	NNP
10_1101-2020_03_27_012757	233	28	and	and	CC
10_1101-2020_03_27_012757	233	29	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	233	30	having	have	VBG
10_1101-2020_03_27_012757	233	31	any	any	DT
10_1101-2020_03_27_012757	233	32	representatives	representative	NNS
10_1101-2020_03_27_012757	233	33	(	(	-LRB-
10_1101-2020_03_27_012757	233	34	Supp	Supp	NNP
10_1101-2020_03_27_012757	233	35	Fig	Fig	NNP
10_1101-2020_03_27_012757	233	36	5	5	CD
10_1101-2020_03_27_012757	233	37	)	)	-RRB-
10_1101-2020_03_27_012757	233	38	.	.	.
10_1101-2020_03_27_012757	234	1	All	all	DT
10_1101-2020_03_27_012757	234	2	of	of	IN
10_1101-2020_03_27_012757	234	3	the	the	DT
10_1101-2020_03_27_012757	234	4	CCL	CCL	NNP
10_1101-2020_03_27_012757	234	5	,	,	,
10_1101-2020_03_27_012757	234	6	GEMM	GEMM	NNP
10_1101-2020_03_27_012757	234	7	,	,	,
10_1101-2020_03_27_012757	234	8	and	and	CC
10_1101-2020_03_27_012757	234	9	479	479	CD
10_1101-2020_03_27_012757	234	10	tumoroid	tumoroid	NN
10_1101-2020_03_27_012757	234	11	models	model	NNS
10_1101-2020_03_27_012757	234	12	of	of	IN
10_1101-2020_03_27_012757	234	13	PAAD	PAAD	NNP
10_1101-2020_03_27_012757	234	14	have	have	VBP
10_1101-2020_03_27_012757	234	15	an	an	DT
10_1101-2020_03_27_012757	234	16	unknown	unknown	JJ
10_1101-2020_03_27_012757	234	17	subtype	subtype	NN
10_1101-2020_03_27_012757	234	18	classification	classification	NN
10_1101-2020_03_27_012757	234	19	and	and	CC
10_1101-2020_03_27_012757	234	20	no	no	DT
10_1101-2020_03_27_012757	234	21	correct	correct	JJ
10_1101-2020_03_27_012757	234	22	general	general	JJ
10_1101-2020_03_27_012757	234	23	480	480	CD
10_1101-2020_03_27_012757	234	24	classification	classification	NN
10_1101-2020_03_27_012757	234	25	.	.	.
10_1101-2020_03_27_012757	235	1	However	however	RB
10_1101-2020_03_27_012757	235	2	,	,	,
10_1101-2020_03_27_012757	235	3	the	the	DT
10_1101-2020_03_27_012757	235	4	majority	majority	NN
10_1101-2020_03_27_012757	235	5	of	of	IN
10_1101-2020_03_27_012757	235	6	PDXs	pdx	NNS
10_1101-2020_03_27_012757	235	7	are	be	VBP
10_1101-2020_03_27_012757	235	8	subtyped	subtyped	JJ
10_1101-2020_03_27_012757	235	9	as	as	IN
10_1101-2020_03_27_012757	235	10	either	either	CC
10_1101-2020_03_27_012757	235	11	a	a	DT
10_1101-2020_03_27_012757	235	12	mixture	mixture	NN
10_1101-2020_03_27_012757	235	13	of	of	IN
10_1101-2020_03_27_012757	235	14	basal	basal	NN
10_1101-2020_03_27_012757	235	15	and	and	CC
10_1101-2020_03_27_012757	235	16	481	481	CD
10_1101-2020_03_27_012757	235	17	classical	classical	JJ
10_1101-2020_03_27_012757	235	18	,	,	,
10_1101-2020_03_27_012757	235	19	or	or	CC
10_1101-2020_03_27_012757	235	20	classical	classical	JJ
10_1101-2020_03_27_012757	235	21	alone	alone	RB
10_1101-2020_03_27_012757	235	22	.	.	.
10_1101-2020_03_27_012757	236	1	LUAD	luad	RB
10_1101-2020_03_27_012757	236	2	have	have	VBP
10_1101-2020_03_27_012757	236	3	proximal	proximal	JJ
10_1101-2020_03_27_012757	236	4	inflammation	inflammation	NN
10_1101-2020_03_27_012757	236	5	and	and	CC
10_1101-2020_03_27_012757	236	6	proximal	proximal	JJ
10_1101-2020_03_27_012757	236	7	proliferation	proliferation	NN
10_1101-2020_03_27_012757	236	8	482	482	CD
10_1101-2020_03_27_012757	236	9	subtypes	subtype	NNS
10_1101-2020_03_27_012757	236	10	modelled	model	VBN
10_1101-2020_03_27_012757	236	11	by	by	IN
10_1101-2020_03_27_012757	236	12	CCLs	ccl	NNS
10_1101-2020_03_27_012757	236	13	and	and	CC
10_1101-2020_03_27_012757	236	14	PDX	PDX	NNP
10_1101-2020_03_27_012757	236	15	(	(	-LRB-
10_1101-2020_03_27_012757	236	16	Supp	Supp	NNP
10_1101-2020_03_27_012757	236	17	Fig	Fig	NNP
10_1101-2020_03_27_012757	236	18	5	5	CD
10_1101-2020_03_27_012757	236	19	)	)	-RRB-
10_1101-2020_03_27_012757	236	20	.	.	.
10_1101-2020_03_27_012757	237	1	Likewise	likewise	RB
10_1101-2020_03_27_012757	237	2	,	,	,
10_1101-2020_03_27_012757	237	3	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	237	4	have	have	VBP
10_1101-2020_03_27_012757	237	5	basal	basal	NN
10_1101-2020_03_27_012757	237	6	,	,	,
10_1101-2020_03_27_012757	237	7	classical	classical	JJ
10_1101-2020_03_27_012757	237	8	and	and	CC
10_1101-2020_03_27_012757	237	9	483	483	CD
10_1101-2020_03_27_012757	237	10	primitive	primitive	JJ
10_1101-2020_03_27_012757	237	11	subtypes	subtype	NNS
10_1101-2020_03_27_012757	237	12	modelled	model	VBN
10_1101-2020_03_27_012757	237	13	by	by	IN
10_1101-2020_03_27_012757	237	14	CCLs	ccl	NNS
10_1101-2020_03_27_012757	237	15	and	and	CC
10_1101-2020_03_27_012757	237	16	PDXs	pdx	NNS
10_1101-2020_03_27_012757	237	17	,	,	,
10_1101-2020_03_27_012757	237	18	and	and	CC
10_1101-2020_03_27_012757	237	19	secretory	secretory	JJ
10_1101-2020_03_27_012757	237	20	subtype	subtype	NN
10_1101-2020_03_27_012757	237	21	modelled	model	VBN
10_1101-2020_03_27_012757	237	22	by	by	IN
10_1101-2020_03_27_012757	237	23	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	237	24	484	484	CD
10_1101-2020_03_27_012757	237	25	exclusively	exclusively	RB
10_1101-2020_03_27_012757	237	26	(	(	-LRB-
10_1101-2020_03_27_012757	237	27	Supp	Supp	NNP
10_1101-2020_03_27_012757	237	28	Fig	Fig	NNP
10_1101-2020_03_27_012757	237	29	5	5	CD
10_1101-2020_03_27_012757	237	30	)	)	-RRB-
10_1101-2020_03_27_012757	237	31	.	.	.
10_1101-2020_03_27_012757	238	1	Taken	take	VBN
10_1101-2020_03_27_012757	238	2	together	together	RB
10_1101-2020_03_27_012757	238	3	,	,	,
10_1101-2020_03_27_012757	238	4	these	these	DT
10_1101-2020_03_27_012757	238	5	results	result	NNS
10_1101-2020_03_27_012757	238	6	demonstrate	demonstrate	VBP
10_1101-2020_03_27_012757	238	7	the	the	DT
10_1101-2020_03_27_012757	238	8	need	need	NN
10_1101-2020_03_27_012757	238	9	to	to	TO
10_1101-2020_03_27_012757	238	10	carefully	carefully	RB
10_1101-2020_03_27_012757	238	11	select	select	VB
10_1101-2020_03_27_012757	238	12	485	485	CD
10_1101-2020_03_27_012757	238	13	different	different	JJ
10_1101-2020_03_27_012757	238	14	model	model	NN
10_1101-2020_03_27_012757	238	15	systems	system	NNS
10_1101-2020_03_27_012757	238	16	to	to	IN
10_1101-2020_03_27_012757	238	17	more	more	RBR
10_1101-2020_03_27_012757	238	18	suitably	suitably	RB
10_1101-2020_03_27_012757	238	19	model	model	NN
10_1101-2020_03_27_012757	238	20	certain	certain	JJ
10_1101-2020_03_27_012757	238	21	cancer	cancer	NN
10_1101-2020_03_27_012757	238	22	subtypes	subtype	NNS
10_1101-2020_03_27_012757	238	23	.	.	.
10_1101-2020_03_27_012757	239	1	486	486	CD
10_1101-2020_03_27_012757	239	2	487	487	CD
10_1101-2020_03_27_012757	239	3	DISCUSSION	discussion	NN
10_1101-2020_03_27_012757	239	4	488	488	CD
10_1101-2020_03_27_012757	239	5	A	a	DT
10_1101-2020_03_27_012757	239	6	major	major	JJ
10_1101-2020_03_27_012757	239	7	goal	goal	NN
10_1101-2020_03_27_012757	239	8	in	in	IN
10_1101-2020_03_27_012757	239	9	the	the	DT
10_1101-2020_03_27_012757	239	10	field	field	NN
10_1101-2020_03_27_012757	239	11	of	of	IN
10_1101-2020_03_27_012757	239	12	cancer	cancer	NN
10_1101-2020_03_27_012757	239	13	biology	biology	NN
10_1101-2020_03_27_012757	239	14	is	be	VBZ
10_1101-2020_03_27_012757	239	15	to	to	TO
10_1101-2020_03_27_012757	239	16	develop	develop	VB
10_1101-2020_03_27_012757	239	17	models	model	NNS
10_1101-2020_03_27_012757	239	18	that	that	WDT
10_1101-2020_03_27_012757	239	19	mimic	mimic	VBP
10_1101-2020_03_27_012757	239	20	naturally	naturally	RB
10_1101-2020_03_27_012757	239	21	occurring	occur	VBG
10_1101-2020_03_27_012757	239	22	489	489	CD
10_1101-2020_03_27_012757	239	23	tumors	tumor	NNS
10_1101-2020_03_27_012757	239	24	with	with	IN
10_1101-2020_03_27_012757	239	25	enough	enough	JJ
10_1101-2020_03_27_012757	239	26	fidelity	fidelity	NN
10_1101-2020_03_27_012757	239	27	to	to	TO
10_1101-2020_03_27_012757	239	28	enable	enable	VB
10_1101-2020_03_27_012757	239	29	therapeutic	therapeutic	JJ
10_1101-2020_03_27_012757	239	30	discoveries	discovery	NNS
10_1101-2020_03_27_012757	239	31	.	.	.
10_1101-2020_03_27_012757	240	1	However	however	RB
10_1101-2020_03_27_012757	240	2	,	,	,
10_1101-2020_03_27_012757	240	3	methods	method	NNS
10_1101-2020_03_27_012757	240	4	to	to	TO
10_1101-2020_03_27_012757	240	5	measure	measure	VB
10_1101-2020_03_27_012757	240	6	490	490	CD
10_1101-2020_03_27_012757	240	7	the	the	DT
10_1101-2020_03_27_012757	240	8	extent	extent	NN
10_1101-2020_03_27_012757	240	9	to	to	TO
10_1101-2020_03_27_012757	240	10	which	which	WDT
10_1101-2020_03_27_012757	240	11	cancer	cancer	NN
10_1101-2020_03_27_012757	240	12	models	model	NNS
10_1101-2020_03_27_012757	240	13	resemble	resemble	VBP
10_1101-2020_03_27_012757	240	14	or	or	CC
10_1101-2020_03_27_012757	240	15	diverge	diverge	VBP
10_1101-2020_03_27_012757	240	16	from	from	IN
10_1101-2020_03_27_012757	240	17	native	native	JJ
10_1101-2020_03_27_012757	240	18	tumors	tumor	NNS
10_1101-2020_03_27_012757	240	19	are	be	VBP
10_1101-2020_03_27_012757	240	20	lacking	lack	VBG
10_1101-2020_03_27_012757	240	21	.	.	.
10_1101-2020_03_27_012757	241	1	This	this	DT
10_1101-2020_03_27_012757	241	2	is	be	VBZ
10_1101-2020_03_27_012757	241	3	491	491	CD
10_1101-2020_03_27_012757	241	4	especially	especially	RB
10_1101-2020_03_27_012757	241	5	problematic	problematic	JJ
10_1101-2020_03_27_012757	241	6	now	now	RB
10_1101-2020_03_27_012757	241	7	because	because	IN
10_1101-2020_03_27_012757	241	8	there	there	EX
10_1101-2020_03_27_012757	241	9	are	be	VBP
10_1101-2020_03_27_012757	241	10	many	many	JJ
10_1101-2020_03_27_012757	241	11	existing	exist	VBG
10_1101-2020_03_27_012757	241	12	models	model	NNS
10_1101-2020_03_27_012757	241	13	from	from	IN
10_1101-2020_03_27_012757	241	14	which	which	WDT
10_1101-2020_03_27_012757	241	15	to	to	TO
10_1101-2020_03_27_012757	241	16	choose	choose	VB
10_1101-2020_03_27_012757	241	17	,	,	,
10_1101-2020_03_27_012757	241	18	and	and	CC
10_1101-2020_03_27_012757	241	19	492	492	CD
10_1101-2020_03_27_012757	241	20	it	-PRON-	PRP
10_1101-2020_03_27_012757	241	21	has	have	VBZ
10_1101-2020_03_27_012757	241	22	become	become	VBN
10_1101-2020_03_27_012757	241	23	easier	easy	JJR
10_1101-2020_03_27_012757	241	24	to	to	TO
10_1101-2020_03_27_012757	241	25	generate	generate	VB
10_1101-2020_03_27_012757	241	26	new	new	JJ
10_1101-2020_03_27_012757	241	27	models	model	NNS
10_1101-2020_03_27_012757	241	28	.	.	.
10_1101-2020_03_27_012757	242	1	Here	here	RB
10_1101-2020_03_27_012757	242	2	,	,	,
10_1101-2020_03_27_012757	242	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	242	4	present	present	VBP
10_1101-2020_03_27_012757	242	5	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	242	6	(	(	-LRB-
10_1101-2020_03_27_012757	242	7	CCN	CCN	NNP
10_1101-2020_03_27_012757	242	8	)	)	-RRB-
10_1101-2020_03_27_012757	242	9	,	,	,
10_1101-2020_03_27_012757	242	10	a	a	DT
10_1101-2020_03_27_012757	242	11	493	493	CD
10_1101-2020_03_27_012757	242	12	computational	computational	JJ
10_1101-2020_03_27_012757	242	13	tool	tool	NN
10_1101-2020_03_27_012757	242	14	that	that	WDT
10_1101-2020_03_27_012757	242	15	measures	measure	VBZ
10_1101-2020_03_27_012757	242	16	the	the	DT
10_1101-2020_03_27_012757	242	17	similarity	similarity	NN
10_1101-2020_03_27_012757	242	18	of	of	IN
10_1101-2020_03_27_012757	242	19	cancer	cancer	NN
10_1101-2020_03_27_012757	242	20	models	model	NNS
10_1101-2020_03_27_012757	242	21	to	to	IN
10_1101-2020_03_27_012757	242	22	22	22	CD
10_1101-2020_03_27_012757	242	23	naturally	naturally	RB
10_1101-2020_03_27_012757	242	24	occurring	occur	VBG
10_1101-2020_03_27_012757	242	25	tumor	tumor	NN
10_1101-2020_03_27_012757	242	26	494	494	CD
10_1101-2020_03_27_012757	242	27	types	type	NNS
10_1101-2020_03_27_012757	242	28	and	and	CC
10_1101-2020_03_27_012757	242	29	36	36	CD
10_1101-2020_03_27_012757	242	30	subtypes	subtype	NNS
10_1101-2020_03_27_012757	242	31	.	.	.
10_1101-2020_03_27_012757	243	1	While	while	IN
10_1101-2020_03_27_012757	243	2	the	the	DT
10_1101-2020_03_27_012757	243	3	similarity	similarity	NN
10_1101-2020_03_27_012757	243	4	of	of	IN
10_1101-2020_03_27_012757	243	5	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	243	6	to	to	TO
10_1101-2020_03_27_012757	243	7	patient	patient	VB
10_1101-2020_03_27_012757	243	8	tumors	tumor	NNS
10_1101-2020_03_27_012757	243	9	has	have	VBZ
10_1101-2020_03_27_012757	243	10	already	already	RB
10_1101-2020_03_27_012757	243	11	been	be	VBN
10_1101-2020_03_27_012757	243	12	495	495	CD
10_1101-2020_03_27_012757	243	13	explored	explore	VBN
10_1101-2020_03_27_012757	243	14	in	in	IN
10_1101-2020_03_27_012757	243	15	previous	previous	JJ
10_1101-2020_03_27_012757	243	16	work	work	NN
10_1101-2020_03_27_012757	243	17	,	,	,
10_1101-2020_03_27_012757	243	18	our	-PRON-	PRP$
10_1101-2020_03_27_012757	243	19	tool	tool	NN
10_1101-2020_03_27_012757	243	20	introduces	introduce	VBZ
10_1101-2020_03_27_012757	243	21	the	the	DT
10_1101-2020_03_27_012757	243	22	capability	capability	NN
10_1101-2020_03_27_012757	243	23	to	to	TO
10_1101-2020_03_27_012757	243	24	assess	assess	VB
10_1101-2020_03_27_012757	243	25	the	the	DT
10_1101-2020_03_27_012757	243	26	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	243	27	fidelity	fidelity	NNP
10_1101-2020_03_27_012757	243	28	496	496	CD
10_1101-2020_03_27_012757	243	29	of	of	IN
10_1101-2020_03_27_012757	243	30	PDXs	pdx	NNS
10_1101-2020_03_27_012757	243	31	,	,	,
10_1101-2020_03_27_012757	243	32	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	243	33	,	,	,
10_1101-2020_03_27_012757	243	34	and	and	CC
10_1101-2020_03_27_012757	243	35	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	243	36	.	.	.
10_1101-2020_03_27_012757	244	1	Because	because	IN
10_1101-2020_03_27_012757	244	2	CCN	CCN	NNP
10_1101-2020_03_27_012757	244	3	is	be	VBZ
10_1101-2020_03_27_012757	244	4	platform-	platform-	NN
10_1101-2020_03_27_012757	244	5	and	and	CC
10_1101-2020_03_27_012757	244	6	species	species	NN
10_1101-2020_03_27_012757	244	7	-	-	HYPH
10_1101-2020_03_27_012757	244	8	agnostic	agnostic	RB
10_1101-2020_03_27_012757	244	9	,	,	,
10_1101-2020_03_27_012757	244	10	it	-PRON-	PRP
10_1101-2020_03_27_012757	244	11	497	497	CD
10_1101-2020_03_27_012757	244	12	represents	represent	VBZ
10_1101-2020_03_27_012757	244	13	a	a	DT
10_1101-2020_03_27_012757	244	14	consistent	consistent	JJ
10_1101-2020_03_27_012757	244	15	platform	platform	NN
10_1101-2020_03_27_012757	244	16	to	to	TO
10_1101-2020_03_27_012757	244	17	compare	compare	VB
10_1101-2020_03_27_012757	244	18	models	model	NNS
10_1101-2020_03_27_012757	244	19	across	across	IN
10_1101-2020_03_27_012757	244	20	modalities	modality	NNS
10_1101-2020_03_27_012757	244	21	including	include	VBG
10_1101-2020_03_27_012757	244	22	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	244	23	,	,	,
10_1101-2020_03_27_012757	244	24	PDXs	pdx	NNS
10_1101-2020_03_27_012757	244	25	,	,	,
10_1101-2020_03_27_012757	244	26	498	498	CD
10_1101-2020_03_27_012757	244	27	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	244	28	and	and	CC
10_1101-2020_03_27_012757	244	29	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	244	30	.	.	.
10_1101-2020_03_27_012757	245	1	Here	here	RB
10_1101-2020_03_27_012757	245	2	,	,	,
10_1101-2020_03_27_012757	245	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	245	4	applied	apply	VBD
10_1101-2020_03_27_012757	245	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	245	6	to	to	IN
10_1101-2020_03_27_012757	245	7	657	657	CD
10_1101-2020_03_27_012757	245	8	cancer	cancer	NN
10_1101-2020_03_27_012757	245	9	cell	cell	NN
10_1101-2020_03_27_012757	245	10	lines	line	NNS
10_1101-2020_03_27_012757	245	11	,	,	,
10_1101-2020_03_27_012757	245	12	415	415	CD
10_1101-2020_03_27_012757	245	13	patient	patient	NN
10_1101-2020_03_27_012757	245	14	derived	derive	VBD
10_1101-2020_03_27_012757	245	15	499	499	CD
10_1101-2020_03_27_012757	245	16	.CC	.CC	,
10_1101-2020_03_27_012757	245	17	-	-	:
10_1101-2020_03_27_012757	245	18	BY	by	IN
10_1101-2020_03_27_012757	245	19	-	-	HYPH
10_1101-2020_03_27_012757	245	20	NC	NC	NNP
10_1101-2020_03_27_012757	245	21	-	-	HYPH
10_1101-2020_03_27_012757	245	22	ND	ND	NNP
10_1101-2020_03_27_012757	245	23	4.0	4.0	CD
10_1101-2020_03_27_012757	245	24	International	International	NNP
10_1101-2020_03_27_012757	245	25	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	245	26	under	under	IN
10_1101-2020_03_27_012757	245	27	a	a	DT
10_1101-2020_03_27_012757	245	28	(	(	-LRB-
10_1101-2020_03_27_012757	245	29	which	which	WDT
10_1101-2020_03_27_012757	245	30	was	be	VBD
10_1101-2020_03_27_012757	245	31	not	not	RB
10_1101-2020_03_27_012757	245	32	certified	certify	VBN
10_1101-2020_03_27_012757	245	33	by	by	IN
10_1101-2020_03_27_012757	245	34	peer	peer	NN
10_1101-2020_03_27_012757	245	35	review	review	NN
10_1101-2020_03_27_012757	245	36	)	)	-RRB-
10_1101-2020_03_27_012757	245	37	is	be	VBZ
10_1101-2020_03_27_012757	245	38	the	the	DT
10_1101-2020_03_27_012757	245	39	author	author	NN
10_1101-2020_03_27_012757	245	40	/	/	SYM
10_1101-2020_03_27_012757	245	41	funder	funder	NN
10_1101-2020_03_27_012757	245	42	,	,	,
10_1101-2020_03_27_012757	245	43	who	who	WP
10_1101-2020_03_27_012757	245	44	has	have	VBZ
10_1101-2020_03_27_012757	245	45	granted	grant	VBN
10_1101-2020_03_27_012757	245	46	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	245	47	a	a	DT
10_1101-2020_03_27_012757	245	48	license	license	NN
10_1101-2020_03_27_012757	245	49	to	to	TO
10_1101-2020_03_27_012757	245	50	display	display	VB
10_1101-2020_03_27_012757	245	51	the	the	DT
10_1101-2020_03_27_012757	245	52	preprint	preprint	NN
10_1101-2020_03_27_012757	245	53	in	in	IN
10_1101-2020_03_27_012757	245	54	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	245	55	.	.	.
10_1101-2020_03_27_012757	246	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	246	2	is	be	VBZ
10_1101-2020_03_27_012757	246	3	made	make	VBN
10_1101-2020_03_27_012757	246	4	The	the	DT
10_1101-2020_03_27_012757	246	5	copyright	copyright	NN
10_1101-2020_03_27_012757	246	6	holder	holder	NN
10_1101-2020_03_27_012757	246	7	for	for	IN
10_1101-2020_03_27_012757	246	8	this	this	DT
10_1101-2020_03_27_012757	246	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	246	10	version	version	NN
10_1101-2020_03_27_012757	246	11	posted	post	VBD
10_1101-2020_03_27_012757	246	12	January	January	NNP
10_1101-2020_03_27_012757	246	13	9	9	CD
10_1101-2020_03_27_012757	246	14	,	,	,
10_1101-2020_03_27_012757	246	15	2021	2021	CD
10_1101-2020_03_27_012757	246	16	.	.	.
10_1101-2020_03_27_012757	246	17	;	;	:
10_1101-2020_03_27_012757	246	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	246	19	:	:	:
10_1101-2020_03_27_012757	246	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	246	21	preprint	preprint	NN
10_1101-2020_03_27_012757	246	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	246	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	246	24	19	19	CD
10_1101-2020_03_27_012757	246	25	xenografts	xenograft	NNS
10_1101-2020_03_27_012757	246	26	,	,	,
10_1101-2020_03_27_012757	246	27	26	26	CD
10_1101-2020_03_27_012757	246	28	distinct	distinct	JJ
10_1101-2020_03_27_012757	246	29	genetically	genetically	RB
10_1101-2020_03_27_012757	246	30	engineered	engineer	VBN
10_1101-2020_03_27_012757	246	31	mouse	mouse	NN
10_1101-2020_03_27_012757	246	32	models	model	NNS
10_1101-2020_03_27_012757	246	33	and	and	CC
10_1101-2020_03_27_012757	246	34	131	131	CD
10_1101-2020_03_27_012757	246	35	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	246	36	.	.	.
10_1101-2020_03_27_012757	247	1	Several	several	JJ
10_1101-2020_03_27_012757	247	2	500	500	CD
10_1101-2020_03_27_012757	247	3	insights	insight	NNS
10_1101-2020_03_27_012757	247	4	emerged	emerge	VBD
10_1101-2020_03_27_012757	247	5	from	from	IN
10_1101-2020_03_27_012757	247	6	our	-PRON-	PRP$
10_1101-2020_03_27_012757	247	7	computational	computational	JJ
10_1101-2020_03_27_012757	247	8	analyses	analysis	NNS
10_1101-2020_03_27_012757	247	9	that	that	WDT
10_1101-2020_03_27_012757	247	10	have	have	VBP
10_1101-2020_03_27_012757	247	11	implications	implication	NNS
10_1101-2020_03_27_012757	247	12	for	for	IN
10_1101-2020_03_27_012757	247	13	the	the	DT
10_1101-2020_03_27_012757	247	14	field	field	NN
10_1101-2020_03_27_012757	247	15	of	of	IN
10_1101-2020_03_27_012757	247	16	cancer	cancer	NN
10_1101-2020_03_27_012757	247	17	501	501	CD
10_1101-2020_03_27_012757	247	18	biology	biology	NN
10_1101-2020_03_27_012757	247	19	.	.	.
10_1101-2020_03_27_012757	248	1	502	502	CD
10_1101-2020_03_27_012757	248	2	First	first	RB
10_1101-2020_03_27_012757	248	3	,	,	,
10_1101-2020_03_27_012757	248	4	PDXs	pdx	NNS
10_1101-2020_03_27_012757	248	5	have	have	VBP
10_1101-2020_03_27_012757	248	6	the	the	DT
10_1101-2020_03_27_012757	248	7	greatest	great	JJS
10_1101-2020_03_27_012757	248	8	potential	potential	NN
10_1101-2020_03_27_012757	248	9	to	to	TO
10_1101-2020_03_27_012757	248	10	achieve	achieve	VB
10_1101-2020_03_27_012757	248	11	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	248	12	fidelity	fidelity	NN
10_1101-2020_03_27_012757	248	13	with	with	IN
10_1101-2020_03_27_012757	248	14	three	three	CD
10_1101-2020_03_27_012757	248	15	out	out	IN
10_1101-2020_03_27_012757	248	16	of	of	IN
10_1101-2020_03_27_012757	248	17	503	503	CD
10_1101-2020_03_27_012757	248	18	five	five	CD
10_1101-2020_03_27_012757	248	19	general	general	JJ
10_1101-2020_03_27_012757	248	20	tumor	tumor	NN
10_1101-2020_03_27_012757	248	21	types	type	NNS
10_1101-2020_03_27_012757	248	22	for	for	IN
10_1101-2020_03_27_012757	248	23	which	which	WDT
10_1101-2020_03_27_012757	248	24	data	datum	NNS
10_1101-2020_03_27_012757	248	25	from	from	IN
10_1101-2020_03_27_012757	248	26	all	all	DT
10_1101-2020_03_27_012757	248	27	modalities	modality	NNS
10_1101-2020_03_27_012757	248	28	was	be	VBD
10_1101-2020_03_27_012757	248	29	available	available	JJ
10_1101-2020_03_27_012757	248	30	,	,	,
10_1101-2020_03_27_012757	248	31	as	as	IN
10_1101-2020_03_27_012757	248	32	indicated	indicate	VBN
10_1101-2020_03_27_012757	248	33	by	by	IN
10_1101-2020_03_27_012757	248	34	the	the	DT
10_1101-2020_03_27_012757	248	35	504	504	CD
10_1101-2020_03_27_012757	248	36	high	high	JJ
10_1101-2020_03_27_012757	248	37	scores	score	NNS
10_1101-2020_03_27_012757	248	38	of	of	IN
10_1101-2020_03_27_012757	248	39	individual	individual	JJ
10_1101-2020_03_27_012757	248	40	PDXs	pdx	NNS
10_1101-2020_03_27_012757	248	41	.	.	.
10_1101-2020_03_27_012757	249	1	Notably	notably	RB
10_1101-2020_03_27_012757	249	2	PDXs	pdx	NNS
10_1101-2020_03_27_012757	249	3	are	be	VBP
10_1101-2020_03_27_012757	249	4	the	the	DT
10_1101-2020_03_27_012757	249	5	only	only	JJ
10_1101-2020_03_27_012757	249	6	modality	modality	NN
10_1101-2020_03_27_012757	249	7	with	with	IN
10_1101-2020_03_27_012757	249	8	samples	sample	NNS
10_1101-2020_03_27_012757	249	9	classified	classify	VBD
10_1101-2020_03_27_012757	249	10	as	as	IN
10_1101-2020_03_27_012757	249	11	505	505	CD
10_1101-2020_03_27_012757	249	12	PAAD	PAAD	NNS
10_1101-2020_03_27_012757	249	13	.	.	.
10_1101-2020_03_27_012757	250	1	At	at	IN
10_1101-2020_03_27_012757	250	2	the	the	DT
10_1101-2020_03_27_012757	250	3	same	same	JJ
10_1101-2020_03_27_012757	250	4	time	time	NN
10_1101-2020_03_27_012757	250	5	,	,	,
10_1101-2020_03_27_012757	250	6	the	the	DT
10_1101-2020_03_27_012757	250	7	median	median	JJ
10_1101-2020_03_27_012757	250	8	CCN	CCN	NNP
10_1101-2020_03_27_012757	250	9	scores	score	NNS
10_1101-2020_03_27_012757	250	10	of	of	IN
10_1101-2020_03_27_012757	250	11	PDXs	pdx	NNS
10_1101-2020_03_27_012757	250	12	were	be	VBD
10_1101-2020_03_27_012757	250	13	lower	low	JJR
10_1101-2020_03_27_012757	250	14	than	than	IN
10_1101-2020_03_27_012757	250	15	that	that	DT
10_1101-2020_03_27_012757	250	16	of	of	IN
10_1101-2020_03_27_012757	250	17	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	250	18	and	and	CC
10_1101-2020_03_27_012757	250	19	506	506	CD
10_1101-2020_03_27_012757	250	20	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	250	21	in	in	IN
10_1101-2020_03_27_012757	250	22	the	the	DT
10_1101-2020_03_27_012757	250	23	other	other	JJ
10_1101-2020_03_27_012757	250	24	four	four	CD
10_1101-2020_03_27_012757	250	25	tumor	tumor	NN
10_1101-2020_03_27_012757	250	26	types	type	NNS
10_1101-2020_03_27_012757	250	27	.	.	.
10_1101-2020_03_27_012757	251	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	251	2	is	be	VBZ
10_1101-2020_03_27_012757	251	3	unclear	unclear	JJ
10_1101-2020_03_27_012757	251	4	what	what	WP
10_1101-2020_03_27_012757	251	5	causes	cause	VBZ
10_1101-2020_03_27_012757	251	6	such	such	PDT
10_1101-2020_03_27_012757	251	7	a	a	DT
10_1101-2020_03_27_012757	251	8	wide	wide	JJ
10_1101-2020_03_27_012757	251	9	range	range	NN
10_1101-2020_03_27_012757	251	10	of	of	IN
10_1101-2020_03_27_012757	251	11	CCN	CCN	NNP
10_1101-2020_03_27_012757	251	12	507	507	CD
10_1101-2020_03_27_012757	251	13	scores	score	NNS
10_1101-2020_03_27_012757	251	14	within	within	IN
10_1101-2020_03_27_012757	251	15	PDXs	pdx	NNS
10_1101-2020_03_27_012757	251	16	.	.	.
10_1101-2020_03_27_012757	252	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	252	2	suspect	suspect	VBP
10_1101-2020_03_27_012757	252	3	that	that	IN
10_1101-2020_03_27_012757	252	4	some	some	DT
10_1101-2020_03_27_012757	252	5	PDXs	pdx	NNS
10_1101-2020_03_27_012757	252	6	might	may	MD
10_1101-2020_03_27_012757	252	7	have	have	VB
10_1101-2020_03_27_012757	252	8	undergone	undergo	VBN
10_1101-2020_03_27_012757	252	9	selective	selective	JJ
10_1101-2020_03_27_012757	252	10	pressures	pressure	NNS
10_1101-2020_03_27_012757	252	11	in	in	IN
10_1101-2020_03_27_012757	252	12	508	508	CD
10_1101-2020_03_27_012757	252	13	the	the	DT
10_1101-2020_03_27_012757	252	14	host	host	NN
10_1101-2020_03_27_012757	252	15	that	that	WDT
10_1101-2020_03_27_012757	252	16	distort	distort	VBP
10_1101-2020_03_27_012757	252	17	the	the	DT
10_1101-2020_03_27_012757	252	18	progression	progression	NN
10_1101-2020_03_27_012757	252	19	of	of	IN
10_1101-2020_03_27_012757	252	20	genomic	genomic	JJ
10_1101-2020_03_27_012757	252	21	alterations	alteration	NNS
10_1101-2020_03_27_012757	252	22	away	away	RB
10_1101-2020_03_27_012757	252	23	from	from	IN
10_1101-2020_03_27_012757	252	24	what	what	WP
10_1101-2020_03_27_012757	252	25	is	be	VBZ
10_1101-2020_03_27_012757	252	26	observed	observe	VBN
10_1101-2020_03_27_012757	252	27	in	in	IN
10_1101-2020_03_27_012757	252	28	509	509	CD
10_1101-2020_03_27_012757	252	29	natural	natural	JJ
10_1101-2020_03_27_012757	252	30	tumor73	tumor73	NN
10_1101-2020_03_27_012757	252	31	.	.	.
10_1101-2020_03_27_012757	253	1	Future	future	JJ
10_1101-2020_03_27_012757	253	2	work	work	NN
10_1101-2020_03_27_012757	253	3	to	to	TO
10_1101-2020_03_27_012757	253	4	understand	understand	VB
10_1101-2020_03_27_012757	253	5	this	this	DT
10_1101-2020_03_27_012757	253	6	heterogeneity	heterogeneity	NN
10_1101-2020_03_27_012757	253	7	is	be	VBZ
10_1101-2020_03_27_012757	253	8	important	important	JJ
10_1101-2020_03_27_012757	253	9	so	so	IN
10_1101-2020_03_27_012757	253	10	as	as	IN
10_1101-2020_03_27_012757	253	11	to	to	TO
10_1101-2020_03_27_012757	253	12	yield	yield	VB
10_1101-2020_03_27_012757	253	13	510	510	CD
10_1101-2020_03_27_012757	253	14	consistently	consistently	RB
10_1101-2020_03_27_012757	253	15	high	high	JJ
10_1101-2020_03_27_012757	253	16	fidelity	fidelity	NN
10_1101-2020_03_27_012757	253	17	PDXs	pdx	NNS
10_1101-2020_03_27_012757	253	18	,	,	,
10_1101-2020_03_27_012757	253	19	and	and	CC
10_1101-2020_03_27_012757	253	20	to	to	TO
10_1101-2020_03_27_012757	253	21	identify	identify	VB
10_1101-2020_03_27_012757	253	22	intrinsic	intrinsic	NN
10_1101-2020_03_27_012757	253	23	and	and	CC
10_1101-2020_03_27_012757	253	24	host	host	NN
10_1101-2020_03_27_012757	253	25	-	-	HYPH
10_1101-2020_03_27_012757	253	26	specific	specific	JJ
10_1101-2020_03_27_012757	253	27	factors	factor	NNS
10_1101-2020_03_27_012757	253	28	that	that	WDT
10_1101-2020_03_27_012757	253	29	so	so	RB
10_1101-2020_03_27_012757	253	30	511	511	CD
10_1101-2020_03_27_012757	253	31	powerfully	powerfully	RB
10_1101-2020_03_27_012757	253	32	shape	shape	VBP
10_1101-2020_03_27_012757	253	33	the	the	DT
10_1101-2020_03_27_012757	253	34	PDX	pdx	NN
10_1101-2020_03_27_012757	253	35	transcriptome	transcriptome	DT
10_1101-2020_03_27_012757	253	36	.	.	.
10_1101-2020_03_27_012757	254	1	512	512	CD
10_1101-2020_03_27_012757	254	2	Second	second	JJ
10_1101-2020_03_27_012757	254	3	,	,	,
10_1101-2020_03_27_012757	254	4	in	in	IN
10_1101-2020_03_27_012757	254	5	general	general	JJ
10_1101-2020_03_27_012757	254	6	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	254	7	and	and	CC
10_1101-2020_03_27_012757	254	8	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	254	9	have	have	VBP
10_1101-2020_03_27_012757	254	10	higher	high	JJR
10_1101-2020_03_27_012757	254	11	median	median	JJ
10_1101-2020_03_27_012757	254	12	CCN	CCN	NNP
10_1101-2020_03_27_012757	254	13	scores	score	NNS
10_1101-2020_03_27_012757	254	14	than	than	IN
10_1101-2020_03_27_012757	254	15	those	those	DT
10_1101-2020_03_27_012757	254	16	513	513	CD
10_1101-2020_03_27_012757	254	17	of	of	IN
10_1101-2020_03_27_012757	254	18	PDXs	pdx	NNS
10_1101-2020_03_27_012757	254	19	and	and	CC
10_1101-2020_03_27_012757	254	20	CCLs	ccl	NNS
10_1101-2020_03_27_012757	254	21	.	.	.
10_1101-2020_03_27_012757	255	1	This	this	DT
10_1101-2020_03_27_012757	255	2	is	be	VBZ
10_1101-2020_03_27_012757	255	3	also	also	RB
10_1101-2020_03_27_012757	255	4	consistent	consistent	JJ
10_1101-2020_03_27_012757	255	5	with	with	IN
10_1101-2020_03_27_012757	255	6	that	that	DT
10_1101-2020_03_27_012757	255	7	fact	fact	NN
10_1101-2020_03_27_012757	255	8	that	that	IN
10_1101-2020_03_27_012757	255	9	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	255	10	are	be	VBP
10_1101-2020_03_27_012757	255	11	typically	typically	RB
10_1101-2020_03_27_012757	255	12	derived	derive	VBN
10_1101-2020_03_27_012757	255	13	by	by	IN
10_1101-2020_03_27_012757	255	14	514	514	CD
10_1101-2020_03_27_012757	255	15	recapitulating	recapitulate	VBG
10_1101-2020_03_27_012757	255	16	well	well	RB
10_1101-2020_03_27_012757	255	17	-	-	HYPH
10_1101-2020_03_27_012757	255	18	defined	define	VBN
10_1101-2020_03_27_012757	255	19	driver	driver	NN
10_1101-2020_03_27_012757	255	20	mutations	mutation	NNS
10_1101-2020_03_27_012757	255	21	of	of	IN
10_1101-2020_03_27_012757	255	22	natural	natural	JJ
10_1101-2020_03_27_012757	255	23	tumors	tumor	NNS
10_1101-2020_03_27_012757	255	24	,	,	,
10_1101-2020_03_27_012757	255	25	and	and	CC
10_1101-2020_03_27_012757	255	26	thus	thus	RB
10_1101-2020_03_27_012757	255	27	this	this	DT
10_1101-2020_03_27_012757	255	28	observation	observation	NN
10_1101-2020_03_27_012757	255	29	515	515	CD
10_1101-2020_03_27_012757	255	30	corroborates	corroborate	NNS
10_1101-2020_03_27_012757	255	31	the	the	DT
10_1101-2020_03_27_012757	255	32	importance	importance	NN
10_1101-2020_03_27_012757	255	33	of	of	IN
10_1101-2020_03_27_012757	255	34	genetics	genetic	NNS
10_1101-2020_03_27_012757	255	35	in	in	IN
10_1101-2020_03_27_012757	255	36	the	the	DT
10_1101-2020_03_27_012757	255	37	etiology	etiology	NN
10_1101-2020_03_27_012757	255	38	of	of	IN
10_1101-2020_03_27_012757	255	39	cancer74	cancer74	NNP
10_1101-2020_03_27_012757	255	40	.	.	.
10_1101-2020_03_27_012757	256	1	Moreover	moreover	RB
10_1101-2020_03_27_012757	256	2	,	,	,
10_1101-2020_03_27_012757	256	3	in	in	IN
10_1101-2020_03_27_012757	256	4	contrast	contrast	NN
10_1101-2020_03_27_012757	256	5	to	to	IN
10_1101-2020_03_27_012757	256	6	516	516	CD
10_1101-2020_03_27_012757	256	7	most	most	JJS
10_1101-2020_03_27_012757	256	8	PDXs	pdx	NNS
10_1101-2020_03_27_012757	256	9	,	,	,
10_1101-2020_03_27_012757	256	10	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	256	11	are	be	VBP
10_1101-2020_03_27_012757	256	12	typically	typically	RB
10_1101-2020_03_27_012757	256	13	generated	generate	VBN
10_1101-2020_03_27_012757	256	14	in	in	IN
10_1101-2020_03_27_012757	256	15	immune	immune	JJ
10_1101-2020_03_27_012757	256	16	replete	replete	JJ
10_1101-2020_03_27_012757	256	17	hosts	host	NNS
10_1101-2020_03_27_012757	256	18	.	.	.
10_1101-2020_03_27_012757	257	1	Therefore	therefore	RB
10_1101-2020_03_27_012757	257	2	,	,	,
10_1101-2020_03_27_012757	257	3	the	the	DT
10_1101-2020_03_27_012757	257	4	higher	high	JJR
10_1101-2020_03_27_012757	257	5	517	517	CD
10_1101-2020_03_27_012757	257	6	overall	overall	JJ
10_1101-2020_03_27_012757	257	7	fidelity	fidelity	NN
10_1101-2020_03_27_012757	257	8	of	of	IN
10_1101-2020_03_27_012757	257	9	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	257	10	may	may	MD
10_1101-2020_03_27_012757	257	11	also	also	RB
10_1101-2020_03_27_012757	257	12	be	be	VB
10_1101-2020_03_27_012757	257	13	a	a	DT
10_1101-2020_03_27_012757	257	14	result	result	NN
10_1101-2020_03_27_012757	257	15	of	of	IN
10_1101-2020_03_27_012757	257	16	the	the	DT
10_1101-2020_03_27_012757	257	17	influence	influence	NN
10_1101-2020_03_27_012757	257	18	of	of	IN
10_1101-2020_03_27_012757	257	19	a	a	DT
10_1101-2020_03_27_012757	257	20	native	native	JJ
10_1101-2020_03_27_012757	257	21	immune	immune	JJ
10_1101-2020_03_27_012757	257	22	system	system	NN
10_1101-2020_03_27_012757	257	23	on	on	IN
10_1101-2020_03_27_012757	257	24	518	518	CD
10_1101-2020_03_27_012757	257	25	GEMM	GEMM	NNP
10_1101-2020_03_27_012757	257	26	tumors75	tumors75	VBD
10_1101-2020_03_27_012757	257	27	.	.	.
10_1101-2020_03_27_012757	258	1	The	the	DT
10_1101-2020_03_27_012757	258	2	high	high	JJ
10_1101-2020_03_27_012757	258	3	median	median	JJ
10_1101-2020_03_27_012757	258	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	258	5	scores	score	NNS
10_1101-2020_03_27_012757	258	6	of	of	IN
10_1101-2020_03_27_012757	258	7	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	258	8	can	can	MD
10_1101-2020_03_27_012757	258	9	be	be	VB
10_1101-2020_03_27_012757	258	10	attributed	attribute	VBN
10_1101-2020_03_27_012757	258	11	to	to	IN
10_1101-2020_03_27_012757	258	12	several	several	JJ
10_1101-2020_03_27_012757	258	13	factors	factor	NNS
10_1101-2020_03_27_012757	258	14	519	519	CD
10_1101-2020_03_27_012757	258	15	including	include	VBG
10_1101-2020_03_27_012757	258	16	the	the	DT
10_1101-2020_03_27_012757	258	17	increased	increase	VBN
10_1101-2020_03_27_012757	258	18	mechanical	mechanical	JJ
10_1101-2020_03_27_012757	258	19	stimuli	stimulus	NNS
10_1101-2020_03_27_012757	258	20	and	and	CC
10_1101-2020_03_27_012757	258	21	cell	cell	NN
10_1101-2020_03_27_012757	258	22	-	-	HYPH
10_1101-2020_03_27_012757	258	23	cell	cell	NN
10_1101-2020_03_27_012757	258	24	interactions	interaction	NNS
10_1101-2020_03_27_012757	258	25	that	that	WDT
10_1101-2020_03_27_012757	258	26	come	come	VBP
10_1101-2020_03_27_012757	258	27	from	from	IN
10_1101-2020_03_27_012757	258	28	3D	3D	NNP
10_1101-2020_03_27_012757	258	29	self-520	self-520	NNP
10_1101-2020_03_27_012757	258	30	organizing	organize	VBG
10_1101-2020_03_27_012757	258	31	cultures76,77	cultures76,77	NNP
10_1101-2020_03_27_012757	258	32	.	.	.
10_1101-2020_03_27_012757	259	1	521	521	CD
10_1101-2020_03_27_012757	259	2	Third	third	JJ
10_1101-2020_03_27_012757	259	3	,	,	,
10_1101-2020_03_27_012757	259	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	259	5	have	have	VBP
10_1101-2020_03_27_012757	259	6	found	find	VBN
10_1101-2020_03_27_012757	259	7	that	that	IN
10_1101-2020_03_27_012757	259	8	none	none	NN
10_1101-2020_03_27_012757	259	9	of	of	IN
10_1101-2020_03_27_012757	259	10	the	the	DT
10_1101-2020_03_27_012757	259	11	samples	sample	NNS
10_1101-2020_03_27_012757	259	12	that	that	WDT
10_1101-2020_03_27_012757	259	13	we	-PRON-	PRP
10_1101-2020_03_27_012757	259	14	evaluated	evaluate	VBD
10_1101-2020_03_27_012757	259	15	here	here	RB
10_1101-2020_03_27_012757	259	16	are	be	VBP
10_1101-2020_03_27_012757	259	17	522	522	CD
10_1101-2020_03_27_012757	259	18	transcriptionally	transcriptionally	RB
10_1101-2020_03_27_012757	259	19	adequate	adequate	JJ
10_1101-2020_03_27_012757	259	20	models	model	NNS
10_1101-2020_03_27_012757	259	21	of	of	IN
10_1101-2020_03_27_012757	259	22	ESCA	ESCA	NNP
10_1101-2020_03_27_012757	259	23	.	.	.
10_1101-2020_03_27_012757	260	1	This	this	DT
10_1101-2020_03_27_012757	260	2	may	may	MD
10_1101-2020_03_27_012757	260	3	be	be	VB
10_1101-2020_03_27_012757	260	4	due	due	IN
10_1101-2020_03_27_012757	260	5	to	to	IN
10_1101-2020_03_27_012757	260	6	an	an	DT
10_1101-2020_03_27_012757	260	7	inherent	inherent	JJ
10_1101-2020_03_27_012757	260	8	lability	lability	NN
10_1101-2020_03_27_012757	260	9	of	of	IN
10_1101-2020_03_27_012757	260	10	the	the	DT
10_1101-2020_03_27_012757	260	11	ESCA	ESCA	NNP
10_1101-2020_03_27_012757	260	12	523	523	CD
10_1101-2020_03_27_012757	260	13	transcriptome	transcriptome	VBP
10_1101-2020_03_27_012757	260	14	that	that	WDT
10_1101-2020_03_27_012757	260	15	is	be	VBZ
10_1101-2020_03_27_012757	260	16	often	often	RB
10_1101-2020_03_27_012757	260	17	preceded	precede	VBN
10_1101-2020_03_27_012757	260	18	by	by	IN
10_1101-2020_03_27_012757	260	19	a	a	DT
10_1101-2020_03_27_012757	260	20	metaplasia	metaplasia	NN
10_1101-2020_03_27_012757	260	21	that	that	WDT
10_1101-2020_03_27_012757	260	22	has	have	VBZ
10_1101-2020_03_27_012757	260	23	obscured	obscure	VBN
10_1101-2020_03_27_012757	260	24	determining	determine	VBG
10_1101-2020_03_27_012757	260	25	its	-PRON-	PRP$
10_1101-2020_03_27_012757	260	26	cell	cell	NN
10_1101-2020_03_27_012757	260	27	524	524	CD
10_1101-2020_03_27_012757	260	28	type(s	type(s	NNP
10_1101-2020_03_27_012757	260	29	)	)	-RRB-
10_1101-2020_03_27_012757	260	30	of	of	IN
10_1101-2020_03_27_012757	260	31	origin78	origin78	NNP
10_1101-2020_03_27_012757	260	32	.	.	.
10_1101-2020_03_27_012757	261	1	Therefore	therefore	RB
10_1101-2020_03_27_012757	261	2	,	,	,
10_1101-2020_03_27_012757	261	3	this	this	DT
10_1101-2020_03_27_012757	261	4	tumor	tumor	NN
10_1101-2020_03_27_012757	261	5	type	type	NN
10_1101-2020_03_27_012757	261	6	requires	require	VBZ
10_1101-2020_03_27_012757	261	7	further	further	JJ
10_1101-2020_03_27_012757	261	8	attention	attention	NN
10_1101-2020_03_27_012757	261	9	to	to	TO
10_1101-2020_03_27_012757	261	10	derive	derive	VB
10_1101-2020_03_27_012757	261	11	new	new	JJ
10_1101-2020_03_27_012757	261	12	models	model	NNS
10_1101-2020_03_27_012757	261	13	.	.	.
10_1101-2020_03_27_012757	262	1	525	525	CD
10_1101-2020_03_27_012757	262	2	.CC	.CC	:
10_1101-2020_03_27_012757	262	3	-	-	HYPH
10_1101-2020_03_27_012757	262	4	BY	by	IN
10_1101-2020_03_27_012757	262	5	-	-	HYPH
10_1101-2020_03_27_012757	262	6	NC	NC	NNP
10_1101-2020_03_27_012757	262	7	-	-	HYPH
10_1101-2020_03_27_012757	262	8	ND	ND	NNP
10_1101-2020_03_27_012757	262	9	4.0	4.0	CD
10_1101-2020_03_27_012757	262	10	International	International	NNP
10_1101-2020_03_27_012757	262	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	262	12	under	under	IN
10_1101-2020_03_27_012757	262	13	a	a	DT
10_1101-2020_03_27_012757	262	14	(	(	-LRB-
10_1101-2020_03_27_012757	262	15	which	which	WDT
10_1101-2020_03_27_012757	262	16	was	be	VBD
10_1101-2020_03_27_012757	262	17	not	not	RB
10_1101-2020_03_27_012757	262	18	certified	certify	VBN
10_1101-2020_03_27_012757	262	19	by	by	IN
10_1101-2020_03_27_012757	262	20	peer	peer	NN
10_1101-2020_03_27_012757	262	21	review	review	NN
10_1101-2020_03_27_012757	262	22	)	)	-RRB-
10_1101-2020_03_27_012757	262	23	is	be	VBZ
10_1101-2020_03_27_012757	262	24	the	the	DT
10_1101-2020_03_27_012757	262	25	author	author	NN
10_1101-2020_03_27_012757	262	26	/	/	SYM
10_1101-2020_03_27_012757	262	27	funder	funder	NN
10_1101-2020_03_27_012757	262	28	,	,	,
10_1101-2020_03_27_012757	262	29	who	who	WP
10_1101-2020_03_27_012757	262	30	has	have	VBZ
10_1101-2020_03_27_012757	262	31	granted	grant	VBN
10_1101-2020_03_27_012757	262	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	262	33	a	a	DT
10_1101-2020_03_27_012757	262	34	license	license	NN
10_1101-2020_03_27_012757	262	35	to	to	TO
10_1101-2020_03_27_012757	262	36	display	display	VB
10_1101-2020_03_27_012757	262	37	the	the	DT
10_1101-2020_03_27_012757	262	38	preprint	preprint	NN
10_1101-2020_03_27_012757	262	39	in	in	IN
10_1101-2020_03_27_012757	262	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	262	41	.	.	.
10_1101-2020_03_27_012757	263	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	263	2	is	be	VBZ
10_1101-2020_03_27_012757	263	3	made	make	VBN
10_1101-2020_03_27_012757	263	4	The	the	DT
10_1101-2020_03_27_012757	263	5	copyright	copyright	NN
10_1101-2020_03_27_012757	263	6	holder	holder	NN
10_1101-2020_03_27_012757	263	7	for	for	IN
10_1101-2020_03_27_012757	263	8	this	this	DT
10_1101-2020_03_27_012757	263	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	263	10	version	version	NN
10_1101-2020_03_27_012757	263	11	posted	post	VBD
10_1101-2020_03_27_012757	263	12	January	January	NNP
10_1101-2020_03_27_012757	263	13	9	9	CD
10_1101-2020_03_27_012757	263	14	,	,	,
10_1101-2020_03_27_012757	263	15	2021	2021	CD
10_1101-2020_03_27_012757	263	16	.	.	.
10_1101-2020_03_27_012757	263	17	;	;	:
10_1101-2020_03_27_012757	263	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	263	19	:	:	:
10_1101-2020_03_27_012757	263	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	263	21	preprint	preprint	NN
10_1101-2020_03_27_012757	263	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	263	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	RB
10_1101-2020_03_27_012757	263	24	20	20	CD
10_1101-2020_03_27_012757	263	25	Fourth	Fourth	NNP
10_1101-2020_03_27_012757	263	26	,	,	,
10_1101-2020_03_27_012757	263	27	we	-PRON-	PRP
10_1101-2020_03_27_012757	263	28	found	find	VBD
10_1101-2020_03_27_012757	263	29	that	that	IN
10_1101-2020_03_27_012757	263	30	in	in	IN
10_1101-2020_03_27_012757	263	31	several	several	JJ
10_1101-2020_03_27_012757	263	32	tumor	tumor	NN
10_1101-2020_03_27_012757	263	33	types	type	NNS
10_1101-2020_03_27_012757	263	34	,	,	,
10_1101-2020_03_27_012757	263	35	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	263	36	tend	tend	VBP
10_1101-2020_03_27_012757	263	37	to	to	TO
10_1101-2020_03_27_012757	263	38	reflect	reflect	VB
10_1101-2020_03_27_012757	263	39	mixtures	mixture	NNS
10_1101-2020_03_27_012757	263	40	of	of	IN
10_1101-2020_03_27_012757	263	41	526	526	CD
10_1101-2020_03_27_012757	263	42	subtypes	subtype	NNS
10_1101-2020_03_27_012757	263	43	rather	rather	RB
10_1101-2020_03_27_012757	263	44	than	than	IN
10_1101-2020_03_27_012757	263	45	conforming	conform	VBG
10_1101-2020_03_27_012757	263	46	strongly	strongly	RB
10_1101-2020_03_27_012757	263	47	to	to	IN
10_1101-2020_03_27_012757	263	48	single	single	JJ
10_1101-2020_03_27_012757	263	49	subtypes	subtype	NNS
10_1101-2020_03_27_012757	263	50	.	.	.
10_1101-2020_03_27_012757	264	1	The	the	DT
10_1101-2020_03_27_012757	264	2	reasons	reason	NNS
10_1101-2020_03_27_012757	264	3	for	for	IN
10_1101-2020_03_27_012757	264	4	this	this	DT
10_1101-2020_03_27_012757	264	5	are	be	VBP
10_1101-2020_03_27_012757	264	6	not	not	RB
10_1101-2020_03_27_012757	264	7	clear	clear	JJ
10_1101-2020_03_27_012757	264	8	527	527	CD
10_1101-2020_03_27_012757	264	9	but	but	CC
10_1101-2020_03_27_012757	264	10	it	-PRON-	PRP
10_1101-2020_03_27_012757	264	11	is	be	VBZ
10_1101-2020_03_27_012757	264	12	possible	possible	JJ
10_1101-2020_03_27_012757	264	13	that	that	IN
10_1101-2020_03_27_012757	264	14	in	in	IN
10_1101-2020_03_27_012757	264	15	the	the	DT
10_1101-2020_03_27_012757	264	16	cases	case	NNS
10_1101-2020_03_27_012757	264	17	that	that	WDT
10_1101-2020_03_27_012757	264	18	we	-PRON-	PRP
10_1101-2020_03_27_012757	264	19	examined	examine	VBD
10_1101-2020_03_27_012757	264	20	the	the	DT
10_1101-2020_03_27_012757	264	21	histologically	histologically	RB
10_1101-2020_03_27_012757	264	22	defined	define	VBN
10_1101-2020_03_27_012757	264	23	subtypes	subtype	NNS
10_1101-2020_03_27_012757	264	24	have	have	VBP
10_1101-2020_03_27_012757	264	25	a	a	DT
10_1101-2020_03_27_012757	264	26	528	528	CD
10_1101-2020_03_27_012757	264	27	degree	degree	NN
10_1101-2020_03_27_012757	264	28	of	of	IN
10_1101-2020_03_27_012757	264	29	plasticity	plasticity	NN
10_1101-2020_03_27_012757	264	30	that	that	WDT
10_1101-2020_03_27_012757	264	31	is	be	VBZ
10_1101-2020_03_27_012757	264	32	exacerbated	exacerbate	VBN
10_1101-2020_03_27_012757	264	33	in	in	IN
10_1101-2020_03_27_012757	264	34	the	the	DT
10_1101-2020_03_27_012757	264	35	murine	murine	NN
10_1101-2020_03_27_012757	264	36	host	host	NN
10_1101-2020_03_27_012757	264	37	environment	environment	NN
10_1101-2020_03_27_012757	264	38	.	.	.
10_1101-2020_03_27_012757	265	1	529	529	CD
10_1101-2020_03_27_012757	265	2	Lastly	lastly	RB
10_1101-2020_03_27_012757	265	3	,	,	,
10_1101-2020_03_27_012757	265	4	we	-PRON-	PRP
10_1101-2020_03_27_012757	265	5	recognize	recognize	VBP
10_1101-2020_03_27_012757	265	6	that	that	IN
10_1101-2020_03_27_012757	265	7	many	many	JJ
10_1101-2020_03_27_012757	265	8	CCLs	ccl	NNS
10_1101-2020_03_27_012757	265	9	are	be	VBP
10_1101-2020_03_27_012757	265	10	not	not	RB
10_1101-2020_03_27_012757	265	11	classified	classify	VBN
10_1101-2020_03_27_012757	265	12	as	as	IN
10_1101-2020_03_27_012757	265	13	their	-PRON-	PRP$
10_1101-2020_03_27_012757	265	14	annotated	annotate	VBN
10_1101-2020_03_27_012757	265	15	labels	label	NNS
10_1101-2020_03_27_012757	265	16	.	.	.
10_1101-2020_03_27_012757	266	1	While	while	IN
10_1101-2020_03_27_012757	266	2	530	530	CD
10_1101-2020_03_27_012757	266	3	we	-PRON-	PRP
10_1101-2020_03_27_012757	266	4	have	have	VBP
10_1101-2020_03_27_012757	266	5	suggested	suggest	VBN
10_1101-2020_03_27_012757	266	6	that	that	IN
10_1101-2020_03_27_012757	266	7	the	the	DT
10_1101-2020_03_27_012757	266	8	lack	lack	NN
10_1101-2020_03_27_012757	266	9	of	of	IN
10_1101-2020_03_27_012757	266	10	immune	immune	JJ
10_1101-2020_03_27_012757	266	11	component	component	NN
10_1101-2020_03_27_012757	266	12	is	be	VBZ
10_1101-2020_03_27_012757	266	13	not	not	RB
10_1101-2020_03_27_012757	266	14	a	a	DT
10_1101-2020_03_27_012757	266	15	major	major	JJ
10_1101-2020_03_27_012757	266	16	confounder	confounder	NN
10_1101-2020_03_27_012757	266	17	,	,	,
10_1101-2020_03_27_012757	266	18	we	-PRON-	PRP
10_1101-2020_03_27_012757	266	19	suspect	suspect	VBP
10_1101-2020_03_27_012757	266	20	531	531	CD
10_1101-2020_03_27_012757	266	21	that	that	IN
10_1101-2020_03_27_012757	266	22	the	the	DT
10_1101-2020_03_27_012757	266	23	CCLs	ccl	NNS
10_1101-2020_03_27_012757	266	24	could	could	MD
10_1101-2020_03_27_012757	266	25	undergo	undergo	VB
10_1101-2020_03_27_012757	266	26	genetic	genetic	JJ
10_1101-2020_03_27_012757	266	27	divergence	divergence	NN
10_1101-2020_03_27_012757	266	28	due	due	JJ
10_1101-2020_03_27_012757	266	29	to	to	IN
10_1101-2020_03_27_012757	266	30	high	high	JJ
10_1101-2020_03_27_012757	266	31	number	number	NN
10_1101-2020_03_27_012757	266	32	of	of	IN
10_1101-2020_03_27_012757	266	33	passages	passage	NNS
10_1101-2020_03_27_012757	266	34	,	,	,
10_1101-2020_03_27_012757	266	35	532	532	CD
10_1101-2020_03_27_012757	266	36	chemotherapy	chemotherapy	NN
10_1101-2020_03_27_012757	266	37	before	before	IN
10_1101-2020_03_27_012757	266	38	biopsy	biopsy	NN
10_1101-2020_03_27_012757	266	39	,	,	,
10_1101-2020_03_27_012757	266	40	culture	culture	NN
10_1101-2020_03_27_012757	266	41	condition	condition	NN
10_1101-2020_03_27_012757	266	42	and	and	CC
10_1101-2020_03_27_012757	266	43	genetic	genetic	JJ
10_1101-2020_03_27_012757	266	44	instability79–82	instability79–82	NNS
10_1101-2020_03_27_012757	266	45	,	,	,
10_1101-2020_03_27_012757	266	46	which	which	WDT
10_1101-2020_03_27_012757	266	47	could	could	MD
10_1101-2020_03_27_012757	266	48	all	all	DT
10_1101-2020_03_27_012757	266	49	be	be	VB
10_1101-2020_03_27_012757	266	50	533	533	CD
10_1101-2020_03_27_012757	266	51	factors	factor	NNS
10_1101-2020_03_27_012757	266	52	that	that	WDT
10_1101-2020_03_27_012757	266	53	drive	drive	VBP
10_1101-2020_03_27_012757	266	54	CCLs	ccl	NNS
10_1101-2020_03_27_012757	266	55	away	away	RB
10_1101-2020_03_27_012757	266	56	from	from	IN
10_1101-2020_03_27_012757	266	57	their	-PRON-	PRP$
10_1101-2020_03_27_012757	266	58	labelled	label	VBN
10_1101-2020_03_27_012757	266	59	tumors	tumor	NNS
10_1101-2020_03_27_012757	266	60	.	.	.
10_1101-2020_03_27_012757	267	1	534	534	CD
10_1101-2020_03_27_012757	267	2	Currently	currently	RB
10_1101-2020_03_27_012757	267	3	,	,	,
10_1101-2020_03_27_012757	267	4	there	there	EX
10_1101-2020_03_27_012757	267	5	are	be	VBP
10_1101-2020_03_27_012757	267	6	several	several	JJ
10_1101-2020_03_27_012757	267	7	limitations	limitation	NNS
10_1101-2020_03_27_012757	267	8	to	to	IN
10_1101-2020_03_27_012757	267	9	our	-PRON-	PRP$
10_1101-2020_03_27_012757	267	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	267	11	tool	tool	NN
10_1101-2020_03_27_012757	267	12	,	,	,
10_1101-2020_03_27_012757	267	13	and	and	CC
10_1101-2020_03_27_012757	267	14	caveats	caveat	NNS
10_1101-2020_03_27_012757	267	15	to	to	IN
10_1101-2020_03_27_012757	267	16	our	-PRON-	PRP$
10_1101-2020_03_27_012757	267	17	analyses	analysis	NNS
10_1101-2020_03_27_012757	267	18	535	535	CD
10_1101-2020_03_27_012757	267	19	which	which	WDT
10_1101-2020_03_27_012757	267	20	indicate	indicate	VBP
10_1101-2020_03_27_012757	267	21	areas	area	NNS
10_1101-2020_03_27_012757	267	22	for	for	IN
10_1101-2020_03_27_012757	267	23	future	future	JJ
10_1101-2020_03_27_012757	267	24	work	work	NN
10_1101-2020_03_27_012757	267	25	and	and	CC
10_1101-2020_03_27_012757	267	26	improvement	improvement	NN
10_1101-2020_03_27_012757	267	27	.	.	.
10_1101-2020_03_27_012757	268	1	First	first	RB
10_1101-2020_03_27_012757	268	2	,	,	,
10_1101-2020_03_27_012757	268	3	CCN	CCN	NNP
10_1101-2020_03_27_012757	268	4	is	be	VBZ
10_1101-2020_03_27_012757	268	5	based	base	VBN
10_1101-2020_03_27_012757	268	6	on	on	IN
10_1101-2020_03_27_012757	268	7	transcriptomic	transcriptomic	JJ
10_1101-2020_03_27_012757	268	8	536	536	CD
10_1101-2020_03_27_012757	268	9	data	datum	NNS
10_1101-2020_03_27_012757	268	10	but	but	CC
10_1101-2020_03_27_012757	268	11	other	other	JJ
10_1101-2020_03_27_012757	268	12	molecular	molecular	JJ
10_1101-2020_03_27_012757	268	13	readouts	readout	NNS
10_1101-2020_03_27_012757	268	14	of	of	IN
10_1101-2020_03_27_012757	268	15	tumor	tumor	NN
10_1101-2020_03_27_012757	268	16	state	state	NN
10_1101-2020_03_27_012757	268	17	,	,	,
10_1101-2020_03_27_012757	268	18	such	such	JJ
10_1101-2020_03_27_012757	268	19	as	as	IN
10_1101-2020_03_27_012757	268	20	profiles	profile	NNS
10_1101-2020_03_27_012757	268	21	of	of	IN
10_1101-2020_03_27_012757	268	22	the	the	DT
10_1101-2020_03_27_012757	268	23	proteome83	proteome83	NN
10_1101-2020_03_27_012757	268	24	,	,	,
10_1101-2020_03_27_012757	268	25	537	537	CD
10_1101-2020_03_27_012757	268	26	epigenome84	epigenome84	RB
10_1101-2020_03_27_012757	268	27	,	,	,
10_1101-2020_03_27_012757	268	28	non	non	JJ
10_1101-2020_03_27_012757	268	29	-	-	JJ
10_1101-2020_03_27_012757	268	30	coding	coding	JJ
10_1101-2020_03_27_012757	268	31	RNA	RNA	NNP
10_1101-2020_03_27_012757	268	32	-	-	HYPH
10_1101-2020_03_27_012757	268	33	ome84	ome84	NNP
10_1101-2020_03_27_012757	268	34	,	,	,
10_1101-2020_03_27_012757	268	35	and	and	CC
10_1101-2020_03_27_012757	268	36	genome74	genome74	NNP
10_1101-2020_03_27_012757	268	37	would	would	MD
10_1101-2020_03_27_012757	268	38	be	be	VB
10_1101-2020_03_27_012757	268	39	equally	equally	RB
10_1101-2020_03_27_012757	268	40	,	,	,
10_1101-2020_03_27_012757	268	41	if	if	IN
10_1101-2020_03_27_012757	268	42	not	not	RB
10_1101-2020_03_27_012757	268	43	more	more	RBR
10_1101-2020_03_27_012757	268	44	important	important	JJ
10_1101-2020_03_27_012757	268	45	,	,	,
10_1101-2020_03_27_012757	268	46	to	to	IN
10_1101-2020_03_27_012757	268	47	538	538	CD
10_1101-2020_03_27_012757	268	48	mimic	mimic	NN
10_1101-2020_03_27_012757	268	49	in	in	IN
10_1101-2020_03_27_012757	268	50	a	a	DT
10_1101-2020_03_27_012757	268	51	model	model	NN
10_1101-2020_03_27_012757	268	52	system	system	NN
10_1101-2020_03_27_012757	268	53	.	.	.
10_1101-2020_03_27_012757	269	1	Therefore	therefore	RB
10_1101-2020_03_27_012757	269	2	,	,	,
10_1101-2020_03_27_012757	269	3	it	-PRON-	PRP
10_1101-2020_03_27_012757	269	4	is	be	VBZ
10_1101-2020_03_27_012757	269	5	possible	possible	JJ
10_1101-2020_03_27_012757	269	6	that	that	IN
10_1101-2020_03_27_012757	269	7	some	some	DT
10_1101-2020_03_27_012757	269	8	models	model	NNS
10_1101-2020_03_27_012757	269	9	reflect	reflect	VBP
10_1101-2020_03_27_012757	269	10	tumor	tumor	NN
10_1101-2020_03_27_012757	269	11	behavior	behavior	NN
10_1101-2020_03_27_012757	269	12	well	well	RB
10_1101-2020_03_27_012757	269	13	,	,	,
10_1101-2020_03_27_012757	269	14	539	539	CD
10_1101-2020_03_27_012757	269	15	and	and	CC
10_1101-2020_03_27_012757	269	16	because	because	IN
10_1101-2020_03_27_012757	269	17	this	this	DT
10_1101-2020_03_27_012757	269	18	behavior	behavior	NN
10_1101-2020_03_27_012757	269	19	is	be	VBZ
10_1101-2020_03_27_012757	269	20	not	not	RB
10_1101-2020_03_27_012757	269	21	well	well	RB
10_1101-2020_03_27_012757	269	22	predicted	predict	VBN
10_1101-2020_03_27_012757	269	23	by	by	IN
10_1101-2020_03_27_012757	269	24	transcriptome	transcriptome	DT
10_1101-2020_03_27_012757	269	25	alone	alone	RB
10_1101-2020_03_27_012757	269	26	,	,	,
10_1101-2020_03_27_012757	269	27	these	these	DT
10_1101-2020_03_27_012757	269	28	models	model	NNS
10_1101-2020_03_27_012757	269	29	have	have	VBP
10_1101-2020_03_27_012757	269	30	540	540	CD
10_1101-2020_03_27_012757	269	31	lower	low	JJR
10_1101-2020_03_27_012757	269	32	CCN	CCN	NNP
10_1101-2020_03_27_012757	269	33	scores	score	NNS
10_1101-2020_03_27_012757	269	34	.	.	.
10_1101-2020_03_27_012757	270	1	To	to	TO
10_1101-2020_03_27_012757	270	2	both	both	DT
10_1101-2020_03_27_012757	270	3	measure	measure	VB
10_1101-2020_03_27_012757	270	4	the	the	DT
10_1101-2020_03_27_012757	270	5	extent	extent	NN
10_1101-2020_03_27_012757	270	6	that	that	IN
10_1101-2020_03_27_012757	270	7	such	such	JJ
10_1101-2020_03_27_012757	270	8	situations	situation	NNS
10_1101-2020_03_27_012757	270	9	exist	exist	VBP
10_1101-2020_03_27_012757	270	10	,	,	,
10_1101-2020_03_27_012757	270	11	and	and	CC
10_1101-2020_03_27_012757	270	12	to	to	TO
10_1101-2020_03_27_012757	270	13	correct	correct	VB
10_1101-2020_03_27_012757	270	14	for	for	IN
10_1101-2020_03_27_012757	270	15	541	541	CD
10_1101-2020_03_27_012757	270	16	them	-PRON-	PRP
10_1101-2020_03_27_012757	270	17	,	,	,
10_1101-2020_03_27_012757	270	18	we	-PRON-	PRP
10_1101-2020_03_27_012757	270	19	plan	plan	VBP
10_1101-2020_03_27_012757	270	20	in	in	IN
10_1101-2020_03_27_012757	270	21	the	the	DT
10_1101-2020_03_27_012757	270	22	future	future	NN
10_1101-2020_03_27_012757	270	23	to	to	TO
10_1101-2020_03_27_012757	270	24	incorporate	incorporate	VB
10_1101-2020_03_27_012757	270	25	other	other	JJ
10_1101-2020_03_27_012757	270	26	omic	omic	JJ
10_1101-2020_03_27_012757	270	27	data	datum	NNS
10_1101-2020_03_27_012757	270	28	into	into	IN
10_1101-2020_03_27_012757	270	29	CCN	CCN	NNP
10_1101-2020_03_27_012757	270	30	so	so	IN
10_1101-2020_03_27_012757	270	31	as	as	IN
10_1101-2020_03_27_012757	270	32	to	to	TO
10_1101-2020_03_27_012757	270	33	make	make	VB
10_1101-2020_03_27_012757	270	34	more	more	JJR
10_1101-2020_03_27_012757	270	35	542	542	CD
10_1101-2020_03_27_012757	270	36	accurate	accurate	JJ
10_1101-2020_03_27_012757	270	37	and	and	CC
10_1101-2020_03_27_012757	270	38	integrated	integrated	JJ
10_1101-2020_03_27_012757	270	39	model	model	NN
10_1101-2020_03_27_012757	270	40	evaluation	evaluation	NN
10_1101-2020_03_27_012757	270	41	possible	possible	JJ
10_1101-2020_03_27_012757	270	42	.	.	.
10_1101-2020_03_27_012757	271	1	As	as	IN
10_1101-2020_03_27_012757	271	2	a	a	DT
10_1101-2020_03_27_012757	271	3	first	first	JJ
10_1101-2020_03_27_012757	271	4	step	step	NN
10_1101-2020_03_27_012757	271	5	in	in	IN
10_1101-2020_03_27_012757	271	6	this	this	DT
10_1101-2020_03_27_012757	271	7	direction	direction	NN
10_1101-2020_03_27_012757	271	8	,	,	,
10_1101-2020_03_27_012757	271	9	we	-PRON-	PRP
10_1101-2020_03_27_012757	271	10	plan	plan	VBP
10_1101-2020_03_27_012757	271	11	to	to	IN
10_1101-2020_03_27_012757	271	12	543	543	CD
10_1101-2020_03_27_012757	271	13	incorporate	incorporate	JJ
10_1101-2020_03_27_012757	271	14	DNA	dna	NN
10_1101-2020_03_27_012757	271	15	methylation	methylation	NN
10_1101-2020_03_27_012757	271	16	and	and	CC
10_1101-2020_03_27_012757	271	17	genomic	genomic	JJ
10_1101-2020_03_27_012757	271	18	sequencing	sequencing	NN
10_1101-2020_03_27_012757	271	19	data	datum	NNS
10_1101-2020_03_27_012757	271	20	as	as	IN
10_1101-2020_03_27_012757	271	21	additional	additional	JJ
10_1101-2020_03_27_012757	271	22	features	feature	NNS
10_1101-2020_03_27_012757	271	23	for	for	IN
10_1101-2020_03_27_012757	271	24	our	-PRON-	PRP$
10_1101-2020_03_27_012757	271	25	544	544	CD
10_1101-2020_03_27_012757	271	26	Random	random	JJ
10_1101-2020_03_27_012757	271	27	forest	forest	NN
10_1101-2020_03_27_012757	271	28	classifier	classifier	NN
10_1101-2020_03_27_012757	271	29	as	as	IN
10_1101-2020_03_27_012757	271	30	this	this	DT
10_1101-2020_03_27_012757	271	31	data	data	NN
10_1101-2020_03_27_012757	271	32	is	be	VBZ
10_1101-2020_03_27_012757	271	33	becoming	become	VBG
10_1101-2020_03_27_012757	271	34	more	more	RBR
10_1101-2020_03_27_012757	271	35	readily	readily	RB
10_1101-2020_03_27_012757	271	36	available	available	JJ
10_1101-2020_03_27_012757	271	37	for	for	IN
10_1101-2020_03_27_012757	271	38	both	both	DT
10_1101-2020_03_27_012757	271	39	training	training	NN
10_1101-2020_03_27_012757	271	40	and	and	CC
10_1101-2020_03_27_012757	271	41	545	545	CD
10_1101-2020_03_27_012757	271	42	cancer	cancer	NN
10_1101-2020_03_27_012757	271	43	models	model	NNS
10_1101-2020_03_27_012757	271	44	.	.	.
10_1101-2020_03_27_012757	272	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	272	2	expect	expect	VBP
10_1101-2020_03_27_012757	272	3	that	that	IN
10_1101-2020_03_27_012757	272	4	this	this	DT
10_1101-2020_03_27_012757	272	5	will	will	MD
10_1101-2020_03_27_012757	272	6	allow	allow	VB
10_1101-2020_03_27_012757	272	7	us	-PRON-	PRP
10_1101-2020_03_27_012757	272	8	to	to	IN
10_1101-2020_03_27_012757	272	9	both	both	DT
10_1101-2020_03_27_012757	272	10	refine	refine	VB
10_1101-2020_03_27_012757	272	11	our	-PRON-	PRP$
10_1101-2020_03_27_012757	272	12	tumor	tumor	NN
10_1101-2020_03_27_012757	272	13	subtype	subtype	NN
10_1101-2020_03_27_012757	272	14	categories	category	NNS
10_1101-2020_03_27_012757	272	15	and	and	CC
10_1101-2020_03_27_012757	272	16	546	546	CD
10_1101-2020_03_27_012757	272	17	it	-PRON-	PRP
10_1101-2020_03_27_012757	272	18	will	will	MD
10_1101-2020_03_27_012757	272	19	enable	enable	VB
10_1101-2020_03_27_012757	272	20	more	more	RBR
10_1101-2020_03_27_012757	272	21	accurate	accurate	JJ
10_1101-2020_03_27_012757	272	22	predictions	prediction	NNS
10_1101-2020_03_27_012757	272	23	of	of	IN
10_1101-2020_03_27_012757	272	24	how	how	WRB
10_1101-2020_03_27_012757	272	25	models	model	NNS
10_1101-2020_03_27_012757	272	26	respond	respond	VBP
10_1101-2020_03_27_012757	272	27	to	to	IN
10_1101-2020_03_27_012757	272	28	perturbations	perturbation	NNS
10_1101-2020_03_27_012757	272	29	such	such	JJ
10_1101-2020_03_27_012757	272	30	as	as	IN
10_1101-2020_03_27_012757	272	31	drug	drug	NN
10_1101-2020_03_27_012757	272	32	547	547	CD
10_1101-2020_03_27_012757	272	33	treatment	treatment	NN
10_1101-2020_03_27_012757	272	34	.	.	.
10_1101-2020_03_27_012757	273	1	548	548	CD
10_1101-2020_03_27_012757	273	2	A	a	DT
10_1101-2020_03_27_012757	273	3	second	second	JJ
10_1101-2020_03_27_012757	273	4	limitation	limitation	NN
10_1101-2020_03_27_012757	273	5	is	be	VBZ
10_1101-2020_03_27_012757	273	6	that	that	IN
10_1101-2020_03_27_012757	273	7	in	in	IN
10_1101-2020_03_27_012757	273	8	the	the	DT
10_1101-2020_03_27_012757	273	9	cross	cross	JJ
10_1101-2020_03_27_012757	273	10	-	-	JJ
10_1101-2020_03_27_012757	273	11	species	species	JJ
10_1101-2020_03_27_012757	273	12	analysis	analysis	NN
10_1101-2020_03_27_012757	273	13	,	,	,
10_1101-2020_03_27_012757	273	14	CCN	CCN	NNP
10_1101-2020_03_27_012757	273	15	implicitly	implicitly	RB
10_1101-2020_03_27_012757	273	16	assumes	assume	VBZ
10_1101-2020_03_27_012757	273	17	that	that	IN
10_1101-2020_03_27_012757	273	18	549	549	CD
10_1101-2020_03_27_012757	273	19	homologs	homolog	NNS
10_1101-2020_03_27_012757	273	20	are	be	VBP
10_1101-2020_03_27_012757	273	21	functionally	functionally	RB
10_1101-2020_03_27_012757	273	22	equivalent	equivalent	JJ
10_1101-2020_03_27_012757	273	23	.	.	.
10_1101-2020_03_27_012757	274	1	The	the	DT
10_1101-2020_03_27_012757	274	2	extent	extent	NN
10_1101-2020_03_27_012757	274	3	to	to	TO
10_1101-2020_03_27_012757	274	4	which	which	WDT
10_1101-2020_03_27_012757	274	5	they	-PRON-	PRP
10_1101-2020_03_27_012757	274	6	are	be	VBP
10_1101-2020_03_27_012757	274	7	not	not	RB
10_1101-2020_03_27_012757	274	8	functionally	functionally	RB
10_1101-2020_03_27_012757	274	9	equivalent	equivalent	JJ
10_1101-2020_03_27_012757	274	10	550	550	CD
10_1101-2020_03_27_012757	274	11	determines	determine	NNS
10_1101-2020_03_27_012757	274	12	how	how	WRB
10_1101-2020_03_27_012757	274	13	confounded	confound	VBD
10_1101-2020_03_27_012757	274	14	the	the	DT
10_1101-2020_03_27_012757	274	15	CCN	CCN	NNP
10_1101-2020_03_27_012757	274	16	results	result	NNS
10_1101-2020_03_27_012757	274	17	will	will	MD
10_1101-2020_03_27_012757	274	18	be	be	VB
10_1101-2020_03_27_012757	274	19	.	.	.
10_1101-2020_03_27_012757	275	1	This	this	DT
10_1101-2020_03_27_012757	275	2	possibility	possibility	NN
10_1101-2020_03_27_012757	275	3	seems	seem	VBZ
10_1101-2020_03_27_012757	275	4	to	to	TO
10_1101-2020_03_27_012757	275	5	be	be	VB
10_1101-2020_03_27_012757	275	6	of	of	IN
10_1101-2020_03_27_012757	275	7	limited	limited	JJ
10_1101-2020_03_27_012757	275	8	551	551	CD
10_1101-2020_03_27_012757	275	9	.CC	.CC	:
10_1101-2020_03_27_012757	275	10	-	-	:
10_1101-2020_03_27_012757	275	11	BY	by	IN
10_1101-2020_03_27_012757	275	12	-	-	HYPH
10_1101-2020_03_27_012757	275	13	NC	NC	NNP
10_1101-2020_03_27_012757	275	14	-	-	HYPH
10_1101-2020_03_27_012757	275	15	ND	ND	NNP
10_1101-2020_03_27_012757	275	16	4.0	4.0	CD
10_1101-2020_03_27_012757	275	17	International	International	NNP
10_1101-2020_03_27_012757	275	18	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	275	19	under	under	IN
10_1101-2020_03_27_012757	275	20	a	a	DT
10_1101-2020_03_27_012757	275	21	(	(	-LRB-
10_1101-2020_03_27_012757	275	22	which	which	WDT
10_1101-2020_03_27_012757	275	23	was	be	VBD
10_1101-2020_03_27_012757	275	24	not	not	RB
10_1101-2020_03_27_012757	275	25	certified	certify	VBN
10_1101-2020_03_27_012757	275	26	by	by	IN
10_1101-2020_03_27_012757	275	27	peer	peer	NN
10_1101-2020_03_27_012757	275	28	review	review	NN
10_1101-2020_03_27_012757	275	29	)	)	-RRB-
10_1101-2020_03_27_012757	275	30	is	be	VBZ
10_1101-2020_03_27_012757	275	31	the	the	DT
10_1101-2020_03_27_012757	275	32	author	author	NN
10_1101-2020_03_27_012757	275	33	/	/	SYM
10_1101-2020_03_27_012757	275	34	funder	funder	NN
10_1101-2020_03_27_012757	275	35	,	,	,
10_1101-2020_03_27_012757	275	36	who	who	WP
10_1101-2020_03_27_012757	275	37	has	have	VBZ
10_1101-2020_03_27_012757	275	38	granted	grant	VBN
10_1101-2020_03_27_012757	275	39	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	275	40	a	a	DT
10_1101-2020_03_27_012757	275	41	license	license	NN
10_1101-2020_03_27_012757	275	42	to	to	TO
10_1101-2020_03_27_012757	275	43	display	display	VB
10_1101-2020_03_27_012757	275	44	the	the	DT
10_1101-2020_03_27_012757	275	45	preprint	preprint	NN
10_1101-2020_03_27_012757	275	46	in	in	IN
10_1101-2020_03_27_012757	275	47	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	275	48	.	.	.
10_1101-2020_03_27_012757	276	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	276	2	is	be	VBZ
10_1101-2020_03_27_012757	276	3	made	make	VBN
10_1101-2020_03_27_012757	276	4	The	the	DT
10_1101-2020_03_27_012757	276	5	copyright	copyright	NN
10_1101-2020_03_27_012757	276	6	holder	holder	NN
10_1101-2020_03_27_012757	276	7	for	for	IN
10_1101-2020_03_27_012757	276	8	this	this	DT
10_1101-2020_03_27_012757	276	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	276	10	version	version	NN
10_1101-2020_03_27_012757	276	11	posted	post	VBD
10_1101-2020_03_27_012757	276	12	January	January	NNP
10_1101-2020_03_27_012757	276	13	9	9	CD
10_1101-2020_03_27_012757	276	14	,	,	,
10_1101-2020_03_27_012757	276	15	2021	2021	CD
10_1101-2020_03_27_012757	276	16	.	.	.
10_1101-2020_03_27_012757	276	17	;	;	:
10_1101-2020_03_27_012757	276	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	276	19	:	:	:
10_1101-2020_03_27_012757	276	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	276	21	preprint	preprint	NN
10_1101-2020_03_27_012757	276	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	276	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	276	24	21	21	CD
10_1101-2020_03_27_012757	276	25	consequence	consequence	NN
10_1101-2020_03_27_012757	276	26	based	base	VBN
10_1101-2020_03_27_012757	276	27	on	on	IN
10_1101-2020_03_27_012757	276	28	the	the	DT
10_1101-2020_03_27_012757	276	29	high	high	JJ
10_1101-2020_03_27_012757	276	30	performance	performance	NN
10_1101-2020_03_27_012757	276	31	of	of	IN
10_1101-2020_03_27_012757	276	32	the	the	DT
10_1101-2020_03_27_012757	276	33	normal	normal	JJ
10_1101-2020_03_27_012757	276	34	tissue	tissue	NN
10_1101-2020_03_27_012757	276	35	cross	cross	NN
10_1101-2020_03_27_012757	276	36	-	-	JJ
10_1101-2020_03_27_012757	276	37	species	species	JJ
10_1101-2020_03_27_012757	276	38	classifier	classifier	NN
10_1101-2020_03_27_012757	276	39	and	and	CC
10_1101-2020_03_27_012757	276	40	552	552	CD
10_1101-2020_03_27_012757	276	41	based	base	VBN
10_1101-2020_03_27_012757	276	42	on	on	IN
10_1101-2020_03_27_012757	276	43	the	the	DT
10_1101-2020_03_27_012757	276	44	fact	fact	NN
10_1101-2020_03_27_012757	276	45	that	that	IN
10_1101-2020_03_27_012757	276	46	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	276	47	have	have	VBP
10_1101-2020_03_27_012757	276	48	the	the	DT
10_1101-2020_03_27_012757	276	49	highest	high	JJS
10_1101-2020_03_27_012757	276	50	median	median	JJ
10_1101-2020_03_27_012757	276	51	CCN	CCN	NNP
10_1101-2020_03_27_012757	276	52	scores	score	NNS
10_1101-2020_03_27_012757	276	53	(	(	-LRB-
10_1101-2020_03_27_012757	276	54	in	in	IN
10_1101-2020_03_27_012757	276	55	addition	addition	NN
10_1101-2020_03_27_012757	276	56	to	to	IN
10_1101-2020_03_27_012757	276	57	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	276	58	)	)	-RRB-
10_1101-2020_03_27_012757	276	59	.	.	.
10_1101-2020_03_27_012757	277	1	553	553	CD
10_1101-2020_03_27_012757	277	2	A	a	DT
10_1101-2020_03_27_012757	277	3	third	third	JJ
10_1101-2020_03_27_012757	277	4	caveat	caveat	NN
10_1101-2020_03_27_012757	277	5	to	to	IN
10_1101-2020_03_27_012757	277	6	our	-PRON-	PRP$
10_1101-2020_03_27_012757	277	7	analysis	analysis	NN
10_1101-2020_03_27_012757	277	8	is	be	VBZ
10_1101-2020_03_27_012757	277	9	that	that	IN
10_1101-2020_03_27_012757	277	10	there	there	EX
10_1101-2020_03_27_012757	277	11	were	be	VBD
10_1101-2020_03_27_012757	277	12	many	many	JJ
10_1101-2020_03_27_012757	277	13	fewer	few	JJR
10_1101-2020_03_27_012757	277	14	distinct	distinct	JJ
10_1101-2020_03_27_012757	277	15	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	277	16	and	and	CC
10_1101-2020_03_27_012757	277	17	554	554	CD
10_1101-2020_03_27_012757	277	18	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	277	19	than	than	IN
10_1101-2020_03_27_012757	277	20	CCLs	ccl	NNS
10_1101-2020_03_27_012757	277	21	and	and	CC
10_1101-2020_03_27_012757	277	22	PDXs	pdx	NNS
10_1101-2020_03_27_012757	277	23	.	.	.
10_1101-2020_03_27_012757	278	1	As	as	IN
10_1101-2020_03_27_012757	278	2	more	more	JJR
10_1101-2020_03_27_012757	278	3	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	278	4	profiles	profile	NNS
10_1101-2020_03_27_012757	278	5	for	for	IN
10_1101-2020_03_27_012757	278	6	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	278	7	and	and	CC
10_1101-2020_03_27_012757	278	8	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	278	9	555	555	CD
10_1101-2020_03_27_012757	278	10	emerge	emerge	NN
10_1101-2020_03_27_012757	278	11	,	,	,
10_1101-2020_03_27_012757	278	12	this	this	DT
10_1101-2020_03_27_012757	278	13	comparative	comparative	JJ
10_1101-2020_03_27_012757	278	14	analysis	analysis	NN
10_1101-2020_03_27_012757	278	15	should	should	MD
10_1101-2020_03_27_012757	278	16	be	be	VB
10_1101-2020_03_27_012757	278	17	revisited	revisit	VBN
10_1101-2020_03_27_012757	278	18	to	to	TO
10_1101-2020_03_27_012757	278	19	assess	assess	VB
10_1101-2020_03_27_012757	278	20	the	the	DT
10_1101-2020_03_27_012757	278	21	generality	generality	NN
10_1101-2020_03_27_012757	278	22	of	of	IN
10_1101-2020_03_27_012757	278	23	our	-PRON-	PRP$
10_1101-2020_03_27_012757	278	24	results	result	NNS
10_1101-2020_03_27_012757	278	25	.	.	.
10_1101-2020_03_27_012757	279	1	556	556	CD
10_1101-2020_03_27_012757	279	2	Finally	finally	RB
10_1101-2020_03_27_012757	279	3	,	,	,
10_1101-2020_03_27_012757	279	4	the	the	DT
10_1101-2020_03_27_012757	279	5	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	279	6	training	training	NN
10_1101-2020_03_27_012757	279	7	data	datum	NNS
10_1101-2020_03_27_012757	279	8	is	be	VBZ
10_1101-2020_03_27_012757	279	9	made	make	VBN
10_1101-2020_03_27_012757	279	10	up	up	RP
10_1101-2020_03_27_012757	279	11	of	of	IN
10_1101-2020_03_27_012757	279	12	RNA	RNA	NNP
10_1101-2020_03_27_012757	279	13	-	-	HYPH
10_1101-2020_03_27_012757	279	14	Seq	Seq	NNP
10_1101-2020_03_27_012757	279	15	from	from	IN
10_1101-2020_03_27_012757	279	16	bulk	bulk	JJ
10_1101-2020_03_27_012757	279	17	tumor	tumor	NN
10_1101-2020_03_27_012757	279	18	samples	sample	NNS
10_1101-2020_03_27_012757	279	19	,	,	,
10_1101-2020_03_27_012757	279	20	which	which	WDT
10_1101-2020_03_27_012757	279	21	557	557	CD
10_1101-2020_03_27_012757	279	22	necessarily	necessarily	RB
10_1101-2020_03_27_012757	279	23	includes	include	VBZ
10_1101-2020_03_27_012757	279	24	non	non	JJ
10_1101-2020_03_27_012757	279	25	-	-	JJ
10_1101-2020_03_27_012757	279	26	tumor	tumor	JJ
10_1101-2020_03_27_012757	279	27	cells	cell	NNS
10_1101-2020_03_27_012757	279	28	,	,	,
10_1101-2020_03_27_012757	279	29	whereas	whereas	IN
10_1101-2020_03_27_012757	279	30	the	the	DT
10_1101-2020_03_27_012757	279	31	CCLs	ccl	NNS
10_1101-2020_03_27_012757	279	32	are	be	VBP
10_1101-2020_03_27_012757	279	33	by	by	IN
10_1101-2020_03_27_012757	279	34	definition	definition	NN
10_1101-2020_03_27_012757	279	35	cell	cell	NN
10_1101-2020_03_27_012757	279	36	lines	line	NNS
10_1101-2020_03_27_012757	279	37	of	of	IN
10_1101-2020_03_27_012757	279	38	tumor	tumor	NN
10_1101-2020_03_27_012757	279	39	558	558	CD
10_1101-2020_03_27_012757	279	40	origin	origin	NN
10_1101-2020_03_27_012757	279	41	.	.	.
10_1101-2020_03_27_012757	280	1	Therefore	therefore	RB
10_1101-2020_03_27_012757	280	2	,	,	,
10_1101-2020_03_27_012757	280	3	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	280	4	theoretically	theoretically	RB
10_1101-2020_03_27_012757	280	5	could	could	MD
10_1101-2020_03_27_012757	280	6	have	have	VB
10_1101-2020_03_27_012757	280	7	artificially	artificially	RB
10_1101-2020_03_27_012757	280	8	low	low	JJ
10_1101-2020_03_27_012757	280	9	CCN	CCN	NNP
10_1101-2020_03_27_012757	280	10	scores	score	NNS
10_1101-2020_03_27_012757	280	11	due	due	IN
10_1101-2020_03_27_012757	280	12	to	to	IN
10_1101-2020_03_27_012757	280	13	the	the	DT
10_1101-2020_03_27_012757	280	14	presence	presence	NN
10_1101-2020_03_27_012757	280	15	559	559	CD
10_1101-2020_03_27_012757	280	16	of	of	IN
10_1101-2020_03_27_012757	280	17	non	non	JJ
10_1101-2020_03_27_012757	280	18	-	-	JJ
10_1101-2020_03_27_012757	280	19	tumor	tumor	JJ
10_1101-2020_03_27_012757	280	20	cells	cell	NNS
10_1101-2020_03_27_012757	280	21	in	in	IN
10_1101-2020_03_27_012757	280	22	the	the	DT
10_1101-2020_03_27_012757	280	23	training	training	NN
10_1101-2020_03_27_012757	280	24	data	datum	NNS
10_1101-2020_03_27_012757	280	25	.	.	.
10_1101-2020_03_27_012757	281	1	This	this	DT
10_1101-2020_03_27_012757	281	2	problem	problem	NN
10_1101-2020_03_27_012757	281	3	appears	appear	VBZ
10_1101-2020_03_27_012757	281	4	to	to	TO
10_1101-2020_03_27_012757	281	5	be	be	VB
10_1101-2020_03_27_012757	281	6	limited	limit	VBN
10_1101-2020_03_27_012757	281	7	as	as	IN
10_1101-2020_03_27_012757	281	8	we	-PRON-	PRP
10_1101-2020_03_27_012757	281	9	found	find	VBD
10_1101-2020_03_27_012757	281	10	no	no	DT
10_1101-2020_03_27_012757	281	11	560	560	CD
10_1101-2020_03_27_012757	281	12	correlation	correlation	NN
10_1101-2020_03_27_012757	281	13	between	between	IN
10_1101-2020_03_27_012757	281	14	tumor	tumor	NN
10_1101-2020_03_27_012757	281	15	purity	purity	NN
10_1101-2020_03_27_012757	281	16	and	and	CC
10_1101-2020_03_27_012757	281	17	CCN	CCN	NNP
10_1101-2020_03_27_012757	281	18	score	score	VBP
10_1101-2020_03_27_012757	281	19	in	in	IN
10_1101-2020_03_27_012757	281	20	the	the	DT
10_1101-2020_03_27_012757	281	21	CCLE	ccle	JJ
10_1101-2020_03_27_012757	281	22	samples	sample	NNS
10_1101-2020_03_27_012757	281	23	.	.	.
10_1101-2020_03_27_012757	282	1	However	however	RB
10_1101-2020_03_27_012757	282	2	,	,	,
10_1101-2020_03_27_012757	282	3	this	this	DT
10_1101-2020_03_27_012757	282	4	problem	problem	NN
10_1101-2020_03_27_012757	282	5	561	561	CD
10_1101-2020_03_27_012757	282	6	is	be	VBZ
10_1101-2020_03_27_012757	282	7	related	relate	VBN
10_1101-2020_03_27_012757	282	8	to	to	IN
10_1101-2020_03_27_012757	282	9	the	the	DT
10_1101-2020_03_27_012757	282	10	question	question	NN
10_1101-2020_03_27_012757	282	11	of	of	IN
10_1101-2020_03_27_012757	282	12	intra	intra	JJ
10_1101-2020_03_27_012757	282	13	-	-	JJ
10_1101-2020_03_27_012757	282	14	tumor	tumor	JJ
10_1101-2020_03_27_012757	282	15	heterogeneity	heterogeneity	NN
10_1101-2020_03_27_012757	282	16	.	.	.
10_1101-2020_03_27_012757	283	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	283	2	demonstrated	demonstrate	VBD
10_1101-2020_03_27_012757	283	3	the	the	DT
10_1101-2020_03_27_012757	283	4	feasibility	feasibility	NN
10_1101-2020_03_27_012757	283	5	of	of	IN
10_1101-2020_03_27_012757	283	6	using	use	VBG
10_1101-2020_03_27_012757	283	7	562	562	CD
10_1101-2020_03_27_012757	283	8	CCN	CCN	NNS
10_1101-2020_03_27_012757	283	9	and	and	CC
10_1101-2020_03_27_012757	283	10	single	single	JJ
10_1101-2020_03_27_012757	283	11	cell	cell	NN
10_1101-2020_03_27_012757	283	12	RNA	RNA	NNP
10_1101-2020_03_27_012757	283	13	-	-	HYPH
10_1101-2020_03_27_012757	283	14	seq	seq	NN
10_1101-2020_03_27_012757	283	15	data	datum	NNS
10_1101-2020_03_27_012757	283	16	to	to	TO
10_1101-2020_03_27_012757	283	17	refine	refine	VB
10_1101-2020_03_27_012757	283	18	the	the	DT
10_1101-2020_03_27_012757	283	19	evaluation	evaluation	NN
10_1101-2020_03_27_012757	283	20	of	of	IN
10_1101-2020_03_27_012757	283	21	cancer	cancer	NN
10_1101-2020_03_27_012757	283	22	cell	cell	NN
10_1101-2020_03_27_012757	283	23	lines	line	NNS
10_1101-2020_03_27_012757	283	24	contingent	contingent	JJ
10_1101-2020_03_27_012757	283	25	upon	upon	IN
10_1101-2020_03_27_012757	283	26	563	563	CD
10_1101-2020_03_27_012757	283	27	availability	availability	NN
10_1101-2020_03_27_012757	283	28	of	of	IN
10_1101-2020_03_27_012757	283	29	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	283	30	-	-	HYPH
10_1101-2020_03_27_012757	283	31	seq	seq	NN
10_1101-2020_03_27_012757	283	32	training	training	NN
10_1101-2020_03_27_012757	283	33	data	datum	NNS
10_1101-2020_03_27_012757	283	34	.	.	.
10_1101-2020_03_27_012757	284	1	As	as	IN
10_1101-2020_03_27_012757	284	2	more	more	JJR
10_1101-2020_03_27_012757	284	3	training	train	VBG
10_1101-2020_03_27_012757	284	4	single	single	JJ
10_1101-2020_03_27_012757	284	5	cell	cell	NN
10_1101-2020_03_27_012757	284	6	RNA	RNA	NNP
10_1101-2020_03_27_012757	284	7	-	-	HYPH
10_1101-2020_03_27_012757	284	8	seq	seq	NN
10_1101-2020_03_27_012757	284	9	data	datum	NNS
10_1101-2020_03_27_012757	284	10	accrues	accrue	NNS
10_1101-2020_03_27_012757	284	11	,	,	,
10_1101-2020_03_27_012757	284	12	CCN	CCN	NNP
10_1101-2020_03_27_012757	284	13	564	564	CD
10_1101-2020_03_27_012757	284	14	would	would	MD
10_1101-2020_03_27_012757	284	15	be	be	VB
10_1101-2020_03_27_012757	284	16	able	able	JJ
10_1101-2020_03_27_012757	284	17	to	to	TO
10_1101-2020_03_27_012757	284	18	not	not	RB
10_1101-2020_03_27_012757	284	19	only	only	RB
10_1101-2020_03_27_012757	284	20	evaluate	evaluate	VB
10_1101-2020_03_27_012757	284	21	models	model	NNS
10_1101-2020_03_27_012757	284	22	on	on	IN
10_1101-2020_03_27_012757	284	23	a	a	DT
10_1101-2020_03_27_012757	284	24	per	per	FW
10_1101-2020_03_27_012757	284	25	cell	cell	NN
10_1101-2020_03_27_012757	284	26	type	type	NN
10_1101-2020_03_27_012757	284	27	basis	basis	NN
10_1101-2020_03_27_012757	284	28	,	,	,
10_1101-2020_03_27_012757	284	29	but	but	CC
10_1101-2020_03_27_012757	284	30	also	also	RB
10_1101-2020_03_27_012757	284	31	based	base	VBN
10_1101-2020_03_27_012757	284	32	on	on	IN
10_1101-2020_03_27_012757	284	33	cellular	cellular	JJ
10_1101-2020_03_27_012757	284	34	565	565	CD
10_1101-2020_03_27_012757	284	35	composition	composition	NN
10_1101-2020_03_27_012757	284	36	.	.	.
10_1101-2020_03_27_012757	285	1	566	566	CD
10_1101-2020_03_27_012757	285	2	We	-PRON-	PRP
10_1101-2020_03_27_012757	285	3	have	have	VBP
10_1101-2020_03_27_012757	285	4	made	make	VBN
10_1101-2020_03_27_012757	285	5	the	the	DT
10_1101-2020_03_27_012757	285	6	results	result	NNS
10_1101-2020_03_27_012757	285	7	of	of	IN
10_1101-2020_03_27_012757	285	8	our	-PRON-	PRP$
10_1101-2020_03_27_012757	285	9	analyses	analysis	NNS
10_1101-2020_03_27_012757	285	10	available	available	JJ
10_1101-2020_03_27_012757	285	11	online	online	RB
10_1101-2020_03_27_012757	285	12	so	so	IN
10_1101-2020_03_27_012757	285	13	that	that	IN
10_1101-2020_03_27_012757	285	14	researchers	researcher	NNS
10_1101-2020_03_27_012757	285	15	can	can	MD
10_1101-2020_03_27_012757	285	16	567	567	CD
10_1101-2020_03_27_012757	285	17	easily	easily	RB
10_1101-2020_03_27_012757	285	18	explore	explore	VB
10_1101-2020_03_27_012757	285	19	the	the	DT
10_1101-2020_03_27_012757	285	20	performance	performance	NN
10_1101-2020_03_27_012757	285	21	of	of	IN
10_1101-2020_03_27_012757	285	22	selected	select	VBN
10_1101-2020_03_27_012757	285	23	models	model	NNS
10_1101-2020_03_27_012757	285	24	or	or	CC
10_1101-2020_03_27_012757	285	25	identify	identify	VB
10_1101-2020_03_27_012757	285	26	the	the	DT
10_1101-2020_03_27_012757	285	27	best	good	JJS
10_1101-2020_03_27_012757	285	28	models	model	NNS
10_1101-2020_03_27_012757	285	29	for	for	IN
10_1101-2020_03_27_012757	285	30	any	any	DT
10_1101-2020_03_27_012757	285	31	of	of	IN
10_1101-2020_03_27_012757	285	32	the	the	DT
10_1101-2020_03_27_012757	285	33	22	22	CD
10_1101-2020_03_27_012757	285	34	568	568	CD
10_1101-2020_03_27_012757	285	35	general	general	JJ
10_1101-2020_03_27_012757	285	36	tumor	tumor	NN
10_1101-2020_03_27_012757	285	37	types	type	NNS
10_1101-2020_03_27_012757	285	38	and	and	CC
10_1101-2020_03_27_012757	285	39	the	the	DT
10_1101-2020_03_27_012757	285	40	36	36	CD
10_1101-2020_03_27_012757	285	41	subtypes	subtype	NNS
10_1101-2020_03_27_012757	285	42	presented	present	VBN
10_1101-2020_03_27_012757	285	43	here	here	RB
10_1101-2020_03_27_012757	285	44	.	.	.
10_1101-2020_03_27_012757	286	1	To	to	TO
10_1101-2020_03_27_012757	286	2	ensure	ensure	VB
10_1101-2020_03_27_012757	286	3	that	that	IN
10_1101-2020_03_27_012757	286	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	286	5	is	be	VBZ
10_1101-2020_03_27_012757	286	6	widely	widely	RB
10_1101-2020_03_27_012757	286	7	569	569	CD
10_1101-2020_03_27_012757	286	8	available	available	JJ
10_1101-2020_03_27_012757	286	9	we	-PRON-	PRP
10_1101-2020_03_27_012757	286	10	have	have	VBP
10_1101-2020_03_27_012757	286	11	developed	develop	VBN
10_1101-2020_03_27_012757	286	12	a	a	DT
10_1101-2020_03_27_012757	286	13	free	free	JJ
10_1101-2020_03_27_012757	286	14	web	web	NN
10_1101-2020_03_27_012757	286	15	application	application	NN
10_1101-2020_03_27_012757	286	16	,	,	,
10_1101-2020_03_27_012757	286	17	which	which	WDT
10_1101-2020_03_27_012757	286	18	performs	perform	VBZ
10_1101-2020_03_27_012757	286	19	CCN	CCN	NNP
10_1101-2020_03_27_012757	286	20	analysis	analysis	NN
10_1101-2020_03_27_012757	286	21	on	on	IN
10_1101-2020_03_27_012757	286	22	user-570	user-570	NNP
10_1101-2020_03_27_012757	286	23	uploaded	uploaded	JJ
10_1101-2020_03_27_012757	286	24	data	datum	NNS
10_1101-2020_03_27_012757	286	25	and	and	CC
10_1101-2020_03_27_012757	286	26	allows	allow	VBZ
10_1101-2020_03_27_012757	286	27	for	for	IN
10_1101-2020_03_27_012757	286	28	direct	direct	JJ
10_1101-2020_03_27_012757	286	29	comparison	comparison	NN
10_1101-2020_03_27_012757	286	30	of	of	IN
10_1101-2020_03_27_012757	286	31	their	-PRON-	PRP$
10_1101-2020_03_27_012757	286	32	data	datum	NNS
10_1101-2020_03_27_012757	286	33	to	to	IN
10_1101-2020_03_27_012757	286	34	the	the	DT
10_1101-2020_03_27_012757	286	35	cancer	cancer	NN
10_1101-2020_03_27_012757	286	36	models	model	NNS
10_1101-2020_03_27_012757	286	37	evaluated	evaluate	VBD
10_1101-2020_03_27_012757	286	38	571	571	CD
10_1101-2020_03_27_012757	286	39	here	here	RB
10_1101-2020_03_27_012757	286	40	.	.	.
10_1101-2020_03_27_012757	287	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	287	2	have	have	VBP
10_1101-2020_03_27_012757	287	3	also	also	RB
10_1101-2020_03_27_012757	287	4	made	make	VBN
10_1101-2020_03_27_012757	287	5	the	the	DT
10_1101-2020_03_27_012757	287	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	287	7	code	code	NN
10_1101-2020_03_27_012757	287	8	freely	freely	RB
10_1101-2020_03_27_012757	287	9	available	available	JJ
10_1101-2020_03_27_012757	287	10	under	under	IN
10_1101-2020_03_27_012757	287	11	an	an	DT
10_1101-2020_03_27_012757	287	12	Open	open	JJ
10_1101-2020_03_27_012757	287	13	Source	source	NN
10_1101-2020_03_27_012757	287	14	license	license	NN
10_1101-2020_03_27_012757	287	15	and	and	CC
10_1101-2020_03_27_012757	287	16	as	as	IN
10_1101-2020_03_27_012757	287	17	572	572	CD
10_1101-2020_03_27_012757	287	18	an	an	DT
10_1101-2020_03_27_012757	287	19	easily	easily	RB
10_1101-2020_03_27_012757	287	20	installed	instal	VBN
10_1101-2020_03_27_012757	287	21	R	r	NN
10_1101-2020_03_27_012757	287	22	package	package	NN
10_1101-2020_03_27_012757	287	23	,	,	,
10_1101-2020_03_27_012757	287	24	and	and	CC
10_1101-2020_03_27_012757	287	25	we	-PRON-	PRP
10_1101-2020_03_27_012757	287	26	are	be	VBP
10_1101-2020_03_27_012757	287	27	actively	actively	RB
10_1101-2020_03_27_012757	287	28	supporting	support	VBG
10_1101-2020_03_27_012757	287	29	its	-PRON-	PRP$
10_1101-2020_03_27_012757	287	30	further	further	JJ
10_1101-2020_03_27_012757	287	31	development	development	NN
10_1101-2020_03_27_012757	287	32	.	.	.
10_1101-2020_03_27_012757	288	1	Included	include	VBN
10_1101-2020_03_27_012757	288	2	573	573	CD
10_1101-2020_03_27_012757	288	3	in	in	IN
10_1101-2020_03_27_012757	288	4	the	the	DT
10_1101-2020_03_27_012757	288	5	web	web	NN
10_1101-2020_03_27_012757	288	6	application	application	NN
10_1101-2020_03_27_012757	288	7	are	be	VBP
10_1101-2020_03_27_012757	288	8	instructions	instruction	NNS
10_1101-2020_03_27_012757	288	9	for	for	IN
10_1101-2020_03_27_012757	288	10	training	train	VBG
10_1101-2020_03_27_012757	288	11	CCN	CCN	NNP
10_1101-2020_03_27_012757	288	12	and	and	CC
10_1101-2020_03_27_012757	288	13	reproducing	reproduce	VBG
10_1101-2020_03_27_012757	288	14	our	-PRON-	PRP$
10_1101-2020_03_27_012757	288	15	analysis	analysis	NN
10_1101-2020_03_27_012757	288	16	.	.	.
10_1101-2020_03_27_012757	289	1	The	the	DT
10_1101-2020_03_27_012757	289	2	574	574	CD
10_1101-2020_03_27_012757	289	3	documentation	documentation	NN
10_1101-2020_03_27_012757	289	4	describes	describe	VBZ
10_1101-2020_03_27_012757	289	5	how	how	WRB
10_1101-2020_03_27_012757	289	6	to	to	TO
10_1101-2020_03_27_012757	289	7	analyze	analyze	VB
10_1101-2020_03_27_012757	289	8	models	model	NNS
10_1101-2020_03_27_012757	289	9	and	and	CC
10_1101-2020_03_27_012757	289	10	compare	compare	VB
10_1101-2020_03_27_012757	289	11	the	the	DT
10_1101-2020_03_27_012757	289	12	results	result	NNS
10_1101-2020_03_27_012757	289	13	to	to	IN
10_1101-2020_03_27_012757	289	14	the	the	DT
10_1101-2020_03_27_012757	289	15	panel	panel	NN
10_1101-2020_03_27_012757	289	16	of	of	IN
10_1101-2020_03_27_012757	289	17	575	575	CD
10_1101-2020_03_27_012757	289	18	models	model	NNS
10_1101-2020_03_27_012757	289	19	that	that	WDT
10_1101-2020_03_27_012757	289	20	we	-PRON-	PRP
10_1101-2020_03_27_012757	289	21	evaluated	evaluate	VBD
10_1101-2020_03_27_012757	289	22	here	here	RB
10_1101-2020_03_27_012757	289	23	,	,	,
10_1101-2020_03_27_012757	289	24	thereby	thereby	RB
10_1101-2020_03_27_012757	289	25	allowing	allow	VBG
10_1101-2020_03_27_012757	289	26	researchers	researcher	NNS
10_1101-2020_03_27_012757	289	27	to	to	TO
10_1101-2020_03_27_012757	289	28	immediately	immediately	RB
10_1101-2020_03_27_012757	289	29	compare	compare	VB
10_1101-2020_03_27_012757	289	30	their	-PRON-	PRP$
10_1101-2020_03_27_012757	289	31	576	576	CD
10_1101-2020_03_27_012757	289	32	models	model	NNS
10_1101-2020_03_27_012757	289	33	to	to	IN
10_1101-2020_03_27_012757	289	34	the	the	DT
10_1101-2020_03_27_012757	289	35	broader	broad	JJR
10_1101-2020_03_27_012757	289	36	field	field	NN
10_1101-2020_03_27_012757	289	37	in	in	IN
10_1101-2020_03_27_012757	289	38	a	a	DT
10_1101-2020_03_27_012757	289	39	comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	289	40	and	and	CC
10_1101-2020_03_27_012757	289	41	standard	standard	JJ
10_1101-2020_03_27_012757	289	42	fashion	fashion	NN
10_1101-2020_03_27_012757	289	43	.	.	.
10_1101-2020_03_27_012757	290	1	577	577	CD
10_1101-2020_03_27_012757	290	2	.CC	.CC	NFP
10_1101-2020_03_27_012757	290	3	-	-	:
10_1101-2020_03_27_012757	290	4	BY	by	IN
10_1101-2020_03_27_012757	290	5	-	-	HYPH
10_1101-2020_03_27_012757	290	6	NC	NC	NNP
10_1101-2020_03_27_012757	290	7	-	-	HYPH
10_1101-2020_03_27_012757	290	8	ND	ND	NNP
10_1101-2020_03_27_012757	290	9	4.0	4.0	CD
10_1101-2020_03_27_012757	290	10	International	International	NNP
10_1101-2020_03_27_012757	290	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	290	12	under	under	IN
10_1101-2020_03_27_012757	290	13	a	a	DT
10_1101-2020_03_27_012757	290	14	(	(	-LRB-
10_1101-2020_03_27_012757	290	15	which	which	WDT
10_1101-2020_03_27_012757	290	16	was	be	VBD
10_1101-2020_03_27_012757	290	17	not	not	RB
10_1101-2020_03_27_012757	290	18	certified	certify	VBN
10_1101-2020_03_27_012757	290	19	by	by	IN
10_1101-2020_03_27_012757	290	20	peer	peer	NN
10_1101-2020_03_27_012757	290	21	review	review	NN
10_1101-2020_03_27_012757	290	22	)	)	-RRB-
10_1101-2020_03_27_012757	290	23	is	be	VBZ
10_1101-2020_03_27_012757	290	24	the	the	DT
10_1101-2020_03_27_012757	290	25	author	author	NN
10_1101-2020_03_27_012757	290	26	/	/	SYM
10_1101-2020_03_27_012757	290	27	funder	funder	NN
10_1101-2020_03_27_012757	290	28	,	,	,
10_1101-2020_03_27_012757	290	29	who	who	WP
10_1101-2020_03_27_012757	290	30	has	have	VBZ
10_1101-2020_03_27_012757	290	31	granted	grant	VBN
10_1101-2020_03_27_012757	290	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	290	33	a	a	DT
10_1101-2020_03_27_012757	290	34	license	license	NN
10_1101-2020_03_27_012757	290	35	to	to	TO
10_1101-2020_03_27_012757	290	36	display	display	VB
10_1101-2020_03_27_012757	290	37	the	the	DT
10_1101-2020_03_27_012757	290	38	preprint	preprint	NN
10_1101-2020_03_27_012757	290	39	in	in	IN
10_1101-2020_03_27_012757	290	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	290	41	.	.	.
10_1101-2020_03_27_012757	291	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	291	2	is	be	VBZ
10_1101-2020_03_27_012757	291	3	made	make	VBN
10_1101-2020_03_27_012757	291	4	The	the	DT
10_1101-2020_03_27_012757	291	5	copyright	copyright	NN
10_1101-2020_03_27_012757	291	6	holder	holder	NN
10_1101-2020_03_27_012757	291	7	for	for	IN
10_1101-2020_03_27_012757	291	8	this	this	DT
10_1101-2020_03_27_012757	291	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	291	10	version	version	NN
10_1101-2020_03_27_012757	291	11	posted	post	VBD
10_1101-2020_03_27_012757	291	12	January	January	NNP
10_1101-2020_03_27_012757	291	13	9	9	CD
10_1101-2020_03_27_012757	291	14	,	,	,
10_1101-2020_03_27_012757	291	15	2021	2021	CD
10_1101-2020_03_27_012757	291	16	.	.	.
10_1101-2020_03_27_012757	291	17	;	;	:
10_1101-2020_03_27_012757	291	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	291	19	:	:	:
10_1101-2020_03_27_012757	291	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	291	21	preprint	preprint	NN
10_1101-2020_03_27_012757	291	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	291	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	291	24	22	22	CD
10_1101-2020_03_27_012757	291	25	578	578	CD
10_1101-2020_03_27_012757	291	26	Online	Online	NNP
10_1101-2020_03_27_012757	291	27	Methods	Methods	NNP
10_1101-2020_03_27_012757	291	28	579	579	CD
10_1101-2020_03_27_012757	291	29	Training	Training	NNP
10_1101-2020_03_27_012757	291	30	General	General	NNP
10_1101-2020_03_27_012757	291	31	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	291	32	Classifier	Classifier	NNP
10_1101-2020_03_27_012757	291	33	580	580	CD
10_1101-2020_03_27_012757	291	34	To	to	TO
10_1101-2020_03_27_012757	291	35	generate	generate	VB
10_1101-2020_03_27_012757	291	36	training	training	NN
10_1101-2020_03_27_012757	291	37	data	data	NN
10_1101-2020_03_27_012757	291	38	sets	set	NNS
10_1101-2020_03_27_012757	291	39	,	,	,
10_1101-2020_03_27_012757	291	40	we	-PRON-	PRP
10_1101-2020_03_27_012757	291	41	downloaded	download	VBD
10_1101-2020_03_27_012757	291	42	8,991	8,991	CD
10_1101-2020_03_27_012757	291	43	patient	patient	JJ
10_1101-2020_03_27_012757	291	44	tumor	tumor	NN
10_1101-2020_03_27_012757	291	45	RNA	RNA	NNP
10_1101-2020_03_27_012757	291	46	-	-	HYPH
10_1101-2020_03_27_012757	291	47	seq	seq	NN
10_1101-2020_03_27_012757	291	48	expression	expression	NN
10_1101-2020_03_27_012757	291	49	581	581	CD
10_1101-2020_03_27_012757	291	50	count	count	NN
10_1101-2020_03_27_012757	291	51	matrix	matrix	NN
10_1101-2020_03_27_012757	291	52	and	and	CC
10_1101-2020_03_27_012757	291	53	their	-PRON-	PRP$
10_1101-2020_03_27_012757	291	54	corresponding	corresponding	JJ
10_1101-2020_03_27_012757	291	55	sample	sample	NN
10_1101-2020_03_27_012757	291	56	table	table	NN
10_1101-2020_03_27_012757	291	57	across	across	IN
10_1101-2020_03_27_012757	291	58	22	22	CD
10_1101-2020_03_27_012757	291	59	different	different	JJ
10_1101-2020_03_27_012757	291	60	tumor	tumor	NN
10_1101-2020_03_27_012757	291	61	types	type	NNS
10_1101-2020_03_27_012757	291	62	from	from	IN
10_1101-2020_03_27_012757	291	63	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	291	64	582	582	CD
10_1101-2020_03_27_012757	291	65	using	use	VBG
10_1101-2020_03_27_012757	291	66	TCGAWorkflowData	TCGAWorkflowData	NNP
10_1101-2020_03_27_012757	291	67	,	,	,
10_1101-2020_03_27_012757	291	68	TCGAbiolinks85	tcgabiolinks85	NN
10_1101-2020_03_27_012757	291	69	and	and	CC
10_1101-2020_03_27_012757	291	70	SummarizedExperiment86	summarizedexperiment86	NN
10_1101-2020_03_27_012757	291	71	packages	package	NNS
10_1101-2020_03_27_012757	291	72	.	.	.
10_1101-2020_03_27_012757	292	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	292	2	used	use	VBD
10_1101-2020_03_27_012757	292	3	583	583	CD
10_1101-2020_03_27_012757	292	4	all	all	PDT
10_1101-2020_03_27_012757	292	5	the	the	DT
10_1101-2020_03_27_012757	292	6	patient	patient	JJ
10_1101-2020_03_27_012757	292	7	tumor	tumor	NN
10_1101-2020_03_27_012757	292	8	samples	sample	NNS
10_1101-2020_03_27_012757	292	9	for	for	IN
10_1101-2020_03_27_012757	292	10	training	train	VBG
10_1101-2020_03_27_012757	292	11	the	the	DT
10_1101-2020_03_27_012757	292	12	general	general	JJ
10_1101-2020_03_27_012757	292	13	CCN	CCN	NNP
10_1101-2020_03_27_012757	292	14	classifier	classifier	NN
10_1101-2020_03_27_012757	292	15	.	.	.
10_1101-2020_03_27_012757	293	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	293	2	limited	limit	VBD
10_1101-2020_03_27_012757	293	3	training	training	NN
10_1101-2020_03_27_012757	293	4	and	and	CC
10_1101-2020_03_27_012757	293	5	584	584	CD
10_1101-2020_03_27_012757	293	6	analysis	analysis	NN
10_1101-2020_03_27_012757	293	7	of	of	IN
10_1101-2020_03_27_012757	293	8	RNA	RNA	NNP
10_1101-2020_03_27_012757	293	9	-	-	HYPH
10_1101-2020_03_27_012757	293	10	seq	seq	NN
10_1101-2020_03_27_012757	293	11	data	datum	NNS
10_1101-2020_03_27_012757	293	12	to	to	IN
10_1101-2020_03_27_012757	293	13	the	the	DT
10_1101-2020_03_27_012757	293	14	13,142	13,142	CD
10_1101-2020_03_27_012757	293	15	genes	gene	NNS
10_1101-2020_03_27_012757	293	16	in	in	IN
10_1101-2020_03_27_012757	293	17	common	common	JJ
10_1101-2020_03_27_012757	293	18	between	between	IN
10_1101-2020_03_27_012757	293	19	the	the	DT
10_1101-2020_03_27_012757	293	20	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	293	21	dataset	dataset	NN
10_1101-2020_03_27_012757	293	22	and	and	CC
10_1101-2020_03_27_012757	293	23	all	all	DT
10_1101-2020_03_27_012757	293	24	585	585	CD
10_1101-2020_03_27_012757	293	25	the	the	DT
10_1101-2020_03_27_012757	293	26	query	query	NN
10_1101-2020_03_27_012757	293	27	samples	sample	NNS
10_1101-2020_03_27_012757	293	28	(	(	-LRB-
10_1101-2020_03_27_012757	293	29	CCLs	ccl	NNS
10_1101-2020_03_27_012757	293	30	,	,	,
10_1101-2020_03_27_012757	293	31	PDXs	pdx	NNS
10_1101-2020_03_27_012757	293	32	,	,	,
10_1101-2020_03_27_012757	293	33	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	293	34	,	,	,
10_1101-2020_03_27_012757	293	35	and	and	CC
10_1101-2020_03_27_012757	293	36	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	293	37	)	)	-RRB-
10_1101-2020_03_27_012757	293	38	.	.	.
10_1101-2020_03_27_012757	294	1	To	to	TO
10_1101-2020_03_27_012757	294	2	train	train	VB
10_1101-2020_03_27_012757	294	3	the	the	DT
10_1101-2020_03_27_012757	294	4	top	top	JJ
10_1101-2020_03_27_012757	294	5	pair	pair	NN
10_1101-2020_03_27_012757	294	6	Random	Random	NNP
10_1101-2020_03_27_012757	294	7	forest	forest	NN
10_1101-2020_03_27_012757	294	8	586	586	CD
10_1101-2020_03_27_012757	294	9	classifier	classifier	NN
10_1101-2020_03_27_012757	294	10	,	,	,
10_1101-2020_03_27_012757	294	11	we	-PRON-	PRP
10_1101-2020_03_27_012757	294	12	used	use	VBD
10_1101-2020_03_27_012757	294	13	a	a	DT
10_1101-2020_03_27_012757	294	14	method	method	NN
10_1101-2020_03_27_012757	294	15	similar	similar	JJ
10_1101-2020_03_27_012757	294	16	to	to	IN
10_1101-2020_03_27_012757	294	17	our	-PRON-	PRP$
10_1101-2020_03_27_012757	294	18	previous	previous	JJ
10_1101-2020_03_27_012757	294	19	method23	method23	NN
10_1101-2020_03_27_012757	294	20	.	.	.
10_1101-2020_03_27_012757	295	1	CCN	CCN	NNP
10_1101-2020_03_27_012757	295	2	first	first	RB
10_1101-2020_03_27_012757	295	3	normalized	normalize	VBD
10_1101-2020_03_27_012757	295	4	the	the	DT
10_1101-2020_03_27_012757	295	5	training	training	NN
10_1101-2020_03_27_012757	295	6	587	587	CD
10_1101-2020_03_27_012757	295	7	counts	count	NNS
10_1101-2020_03_27_012757	295	8	matrix	matrix	NN
10_1101-2020_03_27_012757	295	9	by	by	IN
10_1101-2020_03_27_012757	295	10	down	down	RB
10_1101-2020_03_27_012757	295	11	-	-	HYPH
10_1101-2020_03_27_012757	295	12	sampling	sample	VBG
10_1101-2020_03_27_012757	295	13	the	the	DT
10_1101-2020_03_27_012757	295	14	counts	count	NNS
10_1101-2020_03_27_012757	295	15	to	to	IN
10_1101-2020_03_27_012757	295	16	500,000	500,000	CD
10_1101-2020_03_27_012757	295	17	counts	count	NNS
10_1101-2020_03_27_012757	295	18	per	per	IN
10_1101-2020_03_27_012757	295	19	sample	sample	NN
10_1101-2020_03_27_012757	295	20	.	.	.
10_1101-2020_03_27_012757	296	1	To	to	IN
10_1101-2020_03_27_012757	296	2	significantly	significantly	RB
10_1101-2020_03_27_012757	296	3	588	588	CD
10_1101-2020_03_27_012757	296	4	reduce	reduce	VB
10_1101-2020_03_27_012757	296	5	the	the	DT
10_1101-2020_03_27_012757	296	6	execution	execution	NN
10_1101-2020_03_27_012757	296	7	time	time	NN
10_1101-2020_03_27_012757	296	8	and	and	CC
10_1101-2020_03_27_012757	296	9	memory	memory	NN
10_1101-2020_03_27_012757	296	10	of	of	IN
10_1101-2020_03_27_012757	296	11	generating	generate	VBG
10_1101-2020_03_27_012757	296	12	gene	gene	NN
10_1101-2020_03_27_012757	296	13	pairs	pair	NNS
10_1101-2020_03_27_012757	296	14	for	for	IN
10_1101-2020_03_27_012757	296	15	all	all	DT
10_1101-2020_03_27_012757	296	16	possible	possible	JJ
10_1101-2020_03_27_012757	296	17	genes	gene	NNS
10_1101-2020_03_27_012757	296	18	,	,	,
10_1101-2020_03_27_012757	296	19	CCN	CCN	NNP
10_1101-2020_03_27_012757	296	20	589	589	CD
10_1101-2020_03_27_012757	296	21	then	then	RB
10_1101-2020_03_27_012757	296	22	selected	select	VBD
10_1101-2020_03_27_012757	296	23	n	n	CC
10_1101-2020_03_27_012757	296	24	up	up	RB
10_1101-2020_03_27_012757	296	25	-	-	HYPH
10_1101-2020_03_27_012757	296	26	regulated	regulated	JJ
10_1101-2020_03_27_012757	296	27	genes	gene	NNS
10_1101-2020_03_27_012757	296	28	,	,	,
10_1101-2020_03_27_012757	296	29	n	n	CC
10_1101-2020_03_27_012757	296	30	down	down	RB
10_1101-2020_03_27_012757	296	31	-	-	HYPH
10_1101-2020_03_27_012757	296	32	regulated	regulated	JJ
10_1101-2020_03_27_012757	296	33	genes	gene	NNS
10_1101-2020_03_27_012757	296	34	and	and	CC
10_1101-2020_03_27_012757	296	35	n	n	RB
10_1101-2020_03_27_012757	296	36	least	least	JJS
10_1101-2020_03_27_012757	296	37	differentially	differentially	RB
10_1101-2020_03_27_012757	296	38	590	590	CD
10_1101-2020_03_27_012757	296	39	expressed	express	VBN
10_1101-2020_03_27_012757	296	40	genes	gene	NNS
10_1101-2020_03_27_012757	296	41	(	(	-LRB-
10_1101-2020_03_27_012757	296	42	CCN	CCN	NNP
10_1101-2020_03_27_012757	296	43	training	train	VBG
10_1101-2020_03_27_012757	296	44	parameter	parameter	NN
10_1101-2020_03_27_012757	296	45	nTopGenes	nTopGenes	NNP
10_1101-2020_03_27_012757	296	46	=	=	SYM
10_1101-2020_03_27_012757	296	47	n	n	NN
10_1101-2020_03_27_012757	296	48	)	)	-RRB-
10_1101-2020_03_27_012757	296	49	for	for	IN
10_1101-2020_03_27_012757	296	50	each	each	DT
10_1101-2020_03_27_012757	296	51	of	of	IN
10_1101-2020_03_27_012757	296	52	the	the	DT
10_1101-2020_03_27_012757	296	53	22	22	CD
10_1101-2020_03_27_012757	296	54	cancer	cancer	NN
10_1101-2020_03_27_012757	296	55	591	591	CD
10_1101-2020_03_27_012757	296	56	categories	category	NNS
10_1101-2020_03_27_012757	296	57	using	use	VBG
10_1101-2020_03_27_012757	296	58	template	template	NN
10_1101-2020_03_27_012757	296	59	matching87	matching87	NNP
10_1101-2020_03_27_012757	296	60	as	as	IN
10_1101-2020_03_27_012757	296	61	the	the	DT
10_1101-2020_03_27_012757	296	62	genes	gene	NNS
10_1101-2020_03_27_012757	296	63	to	to	TO
10_1101-2020_03_27_012757	296	64	generate	generate	VB
10_1101-2020_03_27_012757	296	65	top	top	JJ
10_1101-2020_03_27_012757	296	66	scoring	score	VBG
10_1101-2020_03_27_012757	296	67	gene	gene	NN
10_1101-2020_03_27_012757	296	68	pairs	pair	NNS
10_1101-2020_03_27_012757	296	69	.	.	.
10_1101-2020_03_27_012757	297	1	In	in	IN
10_1101-2020_03_27_012757	297	2	short	short	JJ
10_1101-2020_03_27_012757	297	3	,	,	,
10_1101-2020_03_27_012757	297	4	592	592	CD
10_1101-2020_03_27_012757	297	5	for	for	IN
10_1101-2020_03_27_012757	297	6	each	each	DT
10_1101-2020_03_27_012757	297	7	tumor	tumor	NN
10_1101-2020_03_27_012757	297	8	type	type	NN
10_1101-2020_03_27_012757	297	9	,	,	,
10_1101-2020_03_27_012757	297	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	297	11	defined	define	VBD
10_1101-2020_03_27_012757	297	12	a	a	DT
10_1101-2020_03_27_012757	297	13	template	template	NN
10_1101-2020_03_27_012757	297	14	vector	vector	NN
10_1101-2020_03_27_012757	297	15	that	that	WDT
10_1101-2020_03_27_012757	297	16	labelled	label	VBD
10_1101-2020_03_27_012757	297	17	the	the	DT
10_1101-2020_03_27_012757	297	18	training	training	NN
10_1101-2020_03_27_012757	297	19	tumor	tumor	NN
10_1101-2020_03_27_012757	297	20	samples	sample	NNS
10_1101-2020_03_27_012757	297	21	in	in	IN
10_1101-2020_03_27_012757	297	22	593	593	CD
10_1101-2020_03_27_012757	297	23	cancer	cancer	NN
10_1101-2020_03_27_012757	297	24	type	type	NN
10_1101-2020_03_27_012757	297	25	of	of	IN
10_1101-2020_03_27_012757	297	26	interest	interest	NN
10_1101-2020_03_27_012757	297	27	as	as	IN
10_1101-2020_03_27_012757	297	28	1	1	CD
10_1101-2020_03_27_012757	297	29	and	and	CC
10_1101-2020_03_27_012757	297	30	all	all	DT
10_1101-2020_03_27_012757	297	31	other	other	JJ
10_1101-2020_03_27_012757	297	32	tumor	tumor	NN
10_1101-2020_03_27_012757	297	33	samples	sample	NNS
10_1101-2020_03_27_012757	297	34	as	as	IN
10_1101-2020_03_27_012757	297	35	0	0	CD
10_1101-2020_03_27_012757	297	36	CCN	CCN	NNP
10_1101-2020_03_27_012757	297	37	then	then	RB
10_1101-2020_03_27_012757	297	38	calculated	calculate	VBD
10_1101-2020_03_27_012757	297	39	the	the	DT
10_1101-2020_03_27_012757	297	40	Pearson	Pearson	NNP
10_1101-2020_03_27_012757	297	41	594	594	CD
10_1101-2020_03_27_012757	297	42	correlation	correlation	NN
10_1101-2020_03_27_012757	297	43	coefficient	coefficient	NN
10_1101-2020_03_27_012757	297	44	between	between	IN
10_1101-2020_03_27_012757	297	45	template	template	NN
10_1101-2020_03_27_012757	297	46	vector	vector	NN
10_1101-2020_03_27_012757	297	47	and	and	CC
10_1101-2020_03_27_012757	297	48	gene	gene	NN
10_1101-2020_03_27_012757	297	49	expressions	expression	NNS
10_1101-2020_03_27_012757	297	50	for	for	IN
10_1101-2020_03_27_012757	297	51	all	all	DT
10_1101-2020_03_27_012757	297	52	genes	gene	NNS
10_1101-2020_03_27_012757	297	53	.	.	.
10_1101-2020_03_27_012757	298	1	The	the	DT
10_1101-2020_03_27_012757	298	2	genes	gene	NNS
10_1101-2020_03_27_012757	298	3	595	595	CD
10_1101-2020_03_27_012757	298	4	with	with	IN
10_1101-2020_03_27_012757	298	5	strong	strong	JJ
10_1101-2020_03_27_012757	298	6	match	match	NN
10_1101-2020_03_27_012757	298	7	to	to	TO
10_1101-2020_03_27_012757	298	8	template	template	VB
10_1101-2020_03_27_012757	298	9	as	as	IN
10_1101-2020_03_27_012757	298	10	either	either	CC
10_1101-2020_03_27_012757	298	11	upregulated	upregulate	VBN
10_1101-2020_03_27_012757	298	12	or	or	CC
10_1101-2020_03_27_012757	298	13	downregulated	downregulated	JJ
10_1101-2020_03_27_012757	298	14	had	have	VBD
10_1101-2020_03_27_012757	298	15	large	large	JJ
10_1101-2020_03_27_012757	298	16	absolute	absolute	JJ
10_1101-2020_03_27_012757	298	17	596	596	CD
10_1101-2020_03_27_012757	298	18	Pearson	Pearson	NNP
10_1101-2020_03_27_012757	298	19	correlation	correlation	NN
10_1101-2020_03_27_012757	298	20	coefficient	coefficient	NN
10_1101-2020_03_27_012757	298	21	.	.	.
10_1101-2020_03_27_012757	299	1	CCN	CCN	NNP
10_1101-2020_03_27_012757	299	2	chose	choose	VBD
10_1101-2020_03_27_012757	299	3	the	the	DT
10_1101-2020_03_27_012757	299	4	upregulated	upregulated	JJ
10_1101-2020_03_27_012757	299	5	,	,	,
10_1101-2020_03_27_012757	299	6	downregulated	downregulated	JJ
10_1101-2020_03_27_012757	299	7	and	and	CC
10_1101-2020_03_27_012757	299	8	least	least	JJS
10_1101-2020_03_27_012757	299	9	597	597	CD
10_1101-2020_03_27_012757	299	10	differentially	differentially	RB
10_1101-2020_03_27_012757	299	11	expressed	express	VBN
10_1101-2020_03_27_012757	299	12	genes	gene	NNS
10_1101-2020_03_27_012757	299	13	based	base	VBN
10_1101-2020_03_27_012757	299	14	on	on	IN
10_1101-2020_03_27_012757	299	15	the	the	DT
10_1101-2020_03_27_012757	299	16	magnitude	magnitude	NN
10_1101-2020_03_27_012757	299	17	of	of	IN
10_1101-2020_03_27_012757	299	18	Pearson	Pearson	NNP
10_1101-2020_03_27_012757	299	19	correlation	correlation	NN
10_1101-2020_03_27_012757	299	20	coefficient	coefficient	NN
10_1101-2020_03_27_012757	299	21	.	.	.
10_1101-2020_03_27_012757	300	1	598	598	CD
10_1101-2020_03_27_012757	300	2	After	after	IN
10_1101-2020_03_27_012757	300	3	CCN	CCN	NNP
10_1101-2020_03_27_012757	300	4	selected	select	VBD
10_1101-2020_03_27_012757	300	5	the	the	DT
10_1101-2020_03_27_012757	300	6	genes	gene	NNS
10_1101-2020_03_27_012757	300	7	for	for	IN
10_1101-2020_03_27_012757	300	8	each	each	DT
10_1101-2020_03_27_012757	300	9	cancer	cancer	NN
10_1101-2020_03_27_012757	300	10	type	type	NN
10_1101-2020_03_27_012757	300	11	,	,	,
10_1101-2020_03_27_012757	300	12	CCN	CCN	NNP
10_1101-2020_03_27_012757	300	13	generated	generate	VBD
10_1101-2020_03_27_012757	300	14	gene	gene	NN
10_1101-2020_03_27_012757	300	15	pairs	pair	NNS
10_1101-2020_03_27_012757	300	16	among	among	IN
10_1101-2020_03_27_012757	300	17	599	599	CD
10_1101-2020_03_27_012757	300	18	those	those	DT
10_1101-2020_03_27_012757	300	19	genes	gene	NNS
10_1101-2020_03_27_012757	300	20	.	.	.
10_1101-2020_03_27_012757	301	1	Gene	gene	NN
10_1101-2020_03_27_012757	301	2	pair	pair	NN
10_1101-2020_03_27_012757	301	3	transformation	transformation	NN
10_1101-2020_03_27_012757	301	4	was	be	VBD
10_1101-2020_03_27_012757	301	5	a	a	DT
10_1101-2020_03_27_012757	301	6	method	method	NN
10_1101-2020_03_27_012757	301	7	inspired	inspire	VBN
10_1101-2020_03_27_012757	301	8	by	by	IN
10_1101-2020_03_27_012757	301	9	the	the	DT
10_1101-2020_03_27_012757	301	10	top	top	RB
10_1101-2020_03_27_012757	301	11	-	-	HYPH
10_1101-2020_03_27_012757	301	12	scoring	score	VBG
10_1101-2020_03_27_012757	301	13	pair	pair	NN
10_1101-2020_03_27_012757	301	14	classifier88	classifier88	NNP
10_1101-2020_03_27_012757	301	15	600	600	CD
10_1101-2020_03_27_012757	301	16	to	to	TO
10_1101-2020_03_27_012757	301	17	allow	allow	VB
10_1101-2020_03_27_012757	301	18	compatibility	compatibility	NN
10_1101-2020_03_27_012757	301	19	of	of	IN
10_1101-2020_03_27_012757	301	20	classifier	classifier	NN
10_1101-2020_03_27_012757	301	21	with	with	IN
10_1101-2020_03_27_012757	301	22	query	query	NNP
10_1101-2020_03_27_012757	301	23	expression	expression	NN
10_1101-2020_03_27_012757	301	24	profiles	profile	NNS
10_1101-2020_03_27_012757	301	25	that	that	WDT
10_1101-2020_03_27_012757	301	26	were	be	VBD
10_1101-2020_03_27_012757	301	27	collected	collect	VBN
10_1101-2020_03_27_012757	301	28	through	through	IN
10_1101-2020_03_27_012757	301	29	601	601	CD
10_1101-2020_03_27_012757	301	30	different	different	JJ
10_1101-2020_03_27_012757	301	31	platforms	platform	NNS
10_1101-2020_03_27_012757	301	32	(	(	-LRB-
10_1101-2020_03_27_012757	301	33	e.g.	e.g.	RB
10_1101-2020_03_27_012757	302	1	microarray	microarray	JJ
10_1101-2020_03_27_012757	302	2	query	query	NNP
10_1101-2020_03_27_012757	302	3	data	datum	NNS
10_1101-2020_03_27_012757	302	4	applied	apply	VBN
10_1101-2020_03_27_012757	302	5	to	to	IN
10_1101-2020_03_27_012757	302	6	RNA	RNA	NNP
10_1101-2020_03_27_012757	302	7	-	-	HYPH
10_1101-2020_03_27_012757	302	8	seq	seq	NN
10_1101-2020_03_27_012757	302	9	training	training	NN
10_1101-2020_03_27_012757	302	10	data	datum	NNS
10_1101-2020_03_27_012757	302	11	)	)	-RRB-
10_1101-2020_03_27_012757	302	12	.	.	.
10_1101-2020_03_27_012757	303	1	In	in	IN
10_1101-2020_03_27_012757	303	2	brief	brief	NN
10_1101-2020_03_27_012757	303	3	,	,	,
10_1101-2020_03_27_012757	303	4	the	the	DT
10_1101-2020_03_27_012757	303	5	602	602	CD
10_1101-2020_03_27_012757	303	6	gene	gene	NN
10_1101-2020_03_27_012757	303	7	pair	pair	NN
10_1101-2020_03_27_012757	303	8	transformation	transformation	NN
10_1101-2020_03_27_012757	303	9	compares	compare	VBZ
10_1101-2020_03_27_012757	303	10	2	2	CD
10_1101-2020_03_27_012757	303	11	genes	gene	NNS
10_1101-2020_03_27_012757	303	12	within	within	IN
10_1101-2020_03_27_012757	303	13	an	an	DT
10_1101-2020_03_27_012757	303	14	expression	expression	NN
10_1101-2020_03_27_012757	303	15	sample	sample	NN
10_1101-2020_03_27_012757	303	16	and	and	CC
10_1101-2020_03_27_012757	303	17	encodes	encode	VBZ
10_1101-2020_03_27_012757	303	18	the	the	DT
10_1101-2020_03_27_012757	303	19	603	603	CD
10_1101-2020_03_27_012757	303	20	.CC	.CC	:
10_1101-2020_03_27_012757	303	21	-	-	HYPH
10_1101-2020_03_27_012757	303	22	BY	by	IN
10_1101-2020_03_27_012757	303	23	-	-	HYPH
10_1101-2020_03_27_012757	303	24	NC	NC	NNP
10_1101-2020_03_27_012757	303	25	-	-	HYPH
10_1101-2020_03_27_012757	303	26	ND	ND	NNP
10_1101-2020_03_27_012757	303	27	4.0	4.0	CD
10_1101-2020_03_27_012757	303	28	International	International	NNP
10_1101-2020_03_27_012757	303	29	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	303	30	under	under	IN
10_1101-2020_03_27_012757	303	31	a	a	DT
10_1101-2020_03_27_012757	303	32	(	(	-LRB-
10_1101-2020_03_27_012757	303	33	which	which	WDT
10_1101-2020_03_27_012757	303	34	was	be	VBD
10_1101-2020_03_27_012757	303	35	not	not	RB
10_1101-2020_03_27_012757	303	36	certified	certify	VBN
10_1101-2020_03_27_012757	303	37	by	by	IN
10_1101-2020_03_27_012757	303	38	peer	peer	NN
10_1101-2020_03_27_012757	303	39	review	review	NN
10_1101-2020_03_27_012757	303	40	)	)	-RRB-
10_1101-2020_03_27_012757	303	41	is	be	VBZ
10_1101-2020_03_27_012757	303	42	the	the	DT
10_1101-2020_03_27_012757	303	43	author	author	NN
10_1101-2020_03_27_012757	303	44	/	/	SYM
10_1101-2020_03_27_012757	303	45	funder	funder	NN
10_1101-2020_03_27_012757	303	46	,	,	,
10_1101-2020_03_27_012757	303	47	who	who	WP
10_1101-2020_03_27_012757	303	48	has	have	VBZ
10_1101-2020_03_27_012757	303	49	granted	grant	VBN
10_1101-2020_03_27_012757	303	50	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	303	51	a	a	DT
10_1101-2020_03_27_012757	303	52	license	license	NN
10_1101-2020_03_27_012757	303	53	to	to	TO
10_1101-2020_03_27_012757	303	54	display	display	VB
10_1101-2020_03_27_012757	303	55	the	the	DT
10_1101-2020_03_27_012757	303	56	preprint	preprint	NN
10_1101-2020_03_27_012757	303	57	in	in	IN
10_1101-2020_03_27_012757	303	58	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	303	59	.	.	.
10_1101-2020_03_27_012757	304	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	304	2	is	be	VBZ
10_1101-2020_03_27_012757	304	3	made	make	VBN
10_1101-2020_03_27_012757	304	4	The	the	DT
10_1101-2020_03_27_012757	304	5	copyright	copyright	NN
10_1101-2020_03_27_012757	304	6	holder	holder	NN
10_1101-2020_03_27_012757	304	7	for	for	IN
10_1101-2020_03_27_012757	304	8	this	this	DT
10_1101-2020_03_27_012757	304	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	304	10	version	version	NN
10_1101-2020_03_27_012757	304	11	posted	post	VBD
10_1101-2020_03_27_012757	304	12	January	January	NNP
10_1101-2020_03_27_012757	304	13	9	9	CD
10_1101-2020_03_27_012757	304	14	,	,	,
10_1101-2020_03_27_012757	304	15	2021	2021	CD
10_1101-2020_03_27_012757	304	16	.	.	.
10_1101-2020_03_27_012757	304	17	;	;	:
10_1101-2020_03_27_012757	304	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	304	19	:	:	:
10_1101-2020_03_27_012757	304	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	304	21	preprint	preprint	NN
10_1101-2020_03_27_012757	304	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	304	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	304	24	23	23	CD
10_1101-2020_03_27_012757	304	25	“	"	``
10_1101-2020_03_27_012757	304	26	gene1_gene2	gene1_gene2	NNP
10_1101-2020_03_27_012757	304	27	”	"	''
10_1101-2020_03_27_012757	304	28	gene	gene	NN
10_1101-2020_03_27_012757	304	29	-	-	HYPH
10_1101-2020_03_27_012757	304	30	pair	pair	NN
10_1101-2020_03_27_012757	304	31	as	as	IN
10_1101-2020_03_27_012757	304	32	1	1	CD
10_1101-2020_03_27_012757	304	33	if	if	IN
10_1101-2020_03_27_012757	304	34	the	the	DT
10_1101-2020_03_27_012757	304	35	first	first	JJ
10_1101-2020_03_27_012757	304	36	gene	gene	NN
10_1101-2020_03_27_012757	304	37	has	have	VBZ
10_1101-2020_03_27_012757	304	38	higher	high	JJR
10_1101-2020_03_27_012757	304	39	expression	expression	NN
10_1101-2020_03_27_012757	304	40	than	than	IN
10_1101-2020_03_27_012757	304	41	the	the	DT
10_1101-2020_03_27_012757	304	42	second	second	JJ
10_1101-2020_03_27_012757	304	43	gene	gene	NN
10_1101-2020_03_27_012757	304	44	.	.	.
10_1101-2020_03_27_012757	305	1	604	604	CD
10_1101-2020_03_27_012757	305	2	Otherwise	otherwise	RB
10_1101-2020_03_27_012757	305	3	,	,	,
10_1101-2020_03_27_012757	305	4	gene	gene	NN
10_1101-2020_03_27_012757	305	5	pair	pair	NN
10_1101-2020_03_27_012757	305	6	transformation	transformation	NN
10_1101-2020_03_27_012757	305	7	would	would	MD
10_1101-2020_03_27_012757	305	8	encode	encode	VB
10_1101-2020_03_27_012757	305	9	the	the	DT
10_1101-2020_03_27_012757	305	10	gene	gene	NN
10_1101-2020_03_27_012757	305	11	-	-	HYPH
10_1101-2020_03_27_012757	305	12	pair	pair	NN
10_1101-2020_03_27_012757	305	13	as	as	IN
10_1101-2020_03_27_012757	305	14	0	0	CD
10_1101-2020_03_27_012757	305	15	.	.	.
10_1101-2020_03_27_012757	306	1	Using	use	VBG
10_1101-2020_03_27_012757	306	2	all	all	PDT
10_1101-2020_03_27_012757	306	3	the	the	DT
10_1101-2020_03_27_012757	306	4	gene	gene	NN
10_1101-2020_03_27_012757	306	5	pair	pair	NN
10_1101-2020_03_27_012757	306	6	605	605	CD
10_1101-2020_03_27_012757	306	7	combinations	combination	NNS
10_1101-2020_03_27_012757	306	8	generated	generate	VBN
10_1101-2020_03_27_012757	306	9	through	through	IN
10_1101-2020_03_27_012757	306	10	the	the	DT
10_1101-2020_03_27_012757	306	11	gene	gene	NN
10_1101-2020_03_27_012757	306	12	sets	set	NNS
10_1101-2020_03_27_012757	306	13	per	per	IN
10_1101-2020_03_27_012757	306	14	cancer	cancer	NN
10_1101-2020_03_27_012757	306	15	type	type	NN
10_1101-2020_03_27_012757	306	16	,	,	,
10_1101-2020_03_27_012757	306	17	CCN	CCN	NNP
10_1101-2020_03_27_012757	306	18	then	then	RB
10_1101-2020_03_27_012757	306	19	selected	select	VBD
10_1101-2020_03_27_012757	306	20	top	top	JJ
10_1101-2020_03_27_012757	306	21	m	m	NNP
10_1101-2020_03_27_012757	306	22	606	606	CD
10_1101-2020_03_27_012757	306	23	discriminative	discriminative	JJ
10_1101-2020_03_27_012757	306	24	gene	gene	NN
10_1101-2020_03_27_012757	306	25	pairs	pair	NNS
10_1101-2020_03_27_012757	306	26	(	(	-LRB-
10_1101-2020_03_27_012757	306	27	CCN	CCN	NNP
10_1101-2020_03_27_012757	306	28	training	training	NN
10_1101-2020_03_27_012757	306	29	parameter	parameter	NN
10_1101-2020_03_27_012757	306	30	nTopGenePairs	nTopGenePairs	NNP
10_1101-2020_03_27_012757	306	31	=	=	SYM
10_1101-2020_03_27_012757	306	32	m	m	NN
10_1101-2020_03_27_012757	306	33	)	)	-RRB-
10_1101-2020_03_27_012757	306	34	for	for	IN
10_1101-2020_03_27_012757	306	35	each	each	DT
10_1101-2020_03_27_012757	306	36	category	category	NN
10_1101-2020_03_27_012757	306	37	using	use	VBG
10_1101-2020_03_27_012757	306	38	607	607	CD
10_1101-2020_03_27_012757	306	39	template	template	NN
10_1101-2020_03_27_012757	306	40	matching	matching	NN
10_1101-2020_03_27_012757	306	41	(	(	-LRB-
10_1101-2020_03_27_012757	306	42	with	with	IN
10_1101-2020_03_27_012757	306	43	large	large	JJ
10_1101-2020_03_27_012757	306	44	absolute	absolute	JJ
10_1101-2020_03_27_012757	306	45	Pearson	Pearson	NNP
10_1101-2020_03_27_012757	306	46	correlation	correlation	NN
10_1101-2020_03_27_012757	306	47	coefficient	coefficient	NN
10_1101-2020_03_27_012757	306	48	)	)	-RRB-
10_1101-2020_03_27_012757	306	49	described	describe	VBN
10_1101-2020_03_27_012757	306	50	above	above	RB
10_1101-2020_03_27_012757	306	51	.	.	.
10_1101-2020_03_27_012757	307	1	To	to	IN
10_1101-2020_03_27_012757	307	2	608	608	CD
10_1101-2020_03_27_012757	307	3	prevent	prevent	VB
10_1101-2020_03_27_012757	307	4	any	any	DT
10_1101-2020_03_27_012757	307	5	single	single	JJ
10_1101-2020_03_27_012757	307	6	gene	gene	NN
10_1101-2020_03_27_012757	307	7	from	from	IN
10_1101-2020_03_27_012757	307	8	dominating	dominate	VBG
10_1101-2020_03_27_012757	307	9	the	the	DT
10_1101-2020_03_27_012757	307	10	gene	gene	NN
10_1101-2020_03_27_012757	307	11	pair	pair	NN
10_1101-2020_03_27_012757	307	12	list	list	NN
10_1101-2020_03_27_012757	307	13	,	,	,
10_1101-2020_03_27_012757	307	14	we	-PRON-	PRP
10_1101-2020_03_27_012757	307	15	allowed	allow	VBD
10_1101-2020_03_27_012757	307	16	each	each	DT
10_1101-2020_03_27_012757	307	17	gene	gene	NN
10_1101-2020_03_27_012757	307	18	to	to	TO
10_1101-2020_03_27_012757	307	19	appear	appear	VB
10_1101-2020_03_27_012757	307	20	at	at	IN
10_1101-2020_03_27_012757	307	21	609	609	CD
10_1101-2020_03_27_012757	307	22	maximum	maximum	NN
10_1101-2020_03_27_012757	307	23	of	of	IN
10_1101-2020_03_27_012757	307	24	three	three	CD
10_1101-2020_03_27_012757	307	25	times	time	NNS
10_1101-2020_03_27_012757	307	26	among	among	IN
10_1101-2020_03_27_012757	307	27	the	the	DT
10_1101-2020_03_27_012757	307	28	gene	gene	NN
10_1101-2020_03_27_012757	307	29	pairs	pair	NNS
10_1101-2020_03_27_012757	307	30	selected	select	VBN
10_1101-2020_03_27_012757	307	31	as	as	IN
10_1101-2020_03_27_012757	307	32	features	feature	NNS
10_1101-2020_03_27_012757	307	33	per	per	IN
10_1101-2020_03_27_012757	307	34	cancer	cancer	NN
10_1101-2020_03_27_012757	307	35	type	type	NN
10_1101-2020_03_27_012757	307	36	.	.	.
10_1101-2020_03_27_012757	308	1	610	610	CD
10_1101-2020_03_27_012757	308	2	After	after	IN
10_1101-2020_03_27_012757	308	3	the	the	DT
10_1101-2020_03_27_012757	308	4	top	top	JJ
10_1101-2020_03_27_012757	308	5	discriminative	discriminative	JJ
10_1101-2020_03_27_012757	308	6	gene	gene	NN
10_1101-2020_03_27_012757	308	7	pairs	pair	NNS
10_1101-2020_03_27_012757	308	8	were	be	VBD
10_1101-2020_03_27_012757	308	9	selected	select	VBN
10_1101-2020_03_27_012757	308	10	for	for	IN
10_1101-2020_03_27_012757	308	11	each	each	DT
10_1101-2020_03_27_012757	308	12	cancer	cancer	NN
10_1101-2020_03_27_012757	308	13	category	category	NN
10_1101-2020_03_27_012757	308	14	,	,	,
10_1101-2020_03_27_012757	308	15	CCN	CCN	NNP
10_1101-2020_03_27_012757	308	16	611	611	CD
10_1101-2020_03_27_012757	308	17	grouped	group	VBD
10_1101-2020_03_27_012757	308	18	all	all	PDT
10_1101-2020_03_27_012757	308	19	the	the	DT
10_1101-2020_03_27_012757	308	20	gene	gene	NN
10_1101-2020_03_27_012757	308	21	pairs	pair	NNS
10_1101-2020_03_27_012757	308	22	together	together	RB
10_1101-2020_03_27_012757	308	23	and	and	CC
10_1101-2020_03_27_012757	308	24	gene	gene	NN
10_1101-2020_03_27_012757	308	25	pair	pair	NN
10_1101-2020_03_27_012757	308	26	transformed	transform	VBD
10_1101-2020_03_27_012757	308	27	the	the	DT
10_1101-2020_03_27_012757	308	28	training	training	NN
10_1101-2020_03_27_012757	308	29	samples	sample	NNS
10_1101-2020_03_27_012757	308	30	into	into	IN
10_1101-2020_03_27_012757	308	31	a	a	DT
10_1101-2020_03_27_012757	308	32	binary	binary	JJ
10_1101-2020_03_27_012757	308	33	612	612	CD
10_1101-2020_03_27_012757	308	34	matrix	matrix	NN
10_1101-2020_03_27_012757	308	35	with	with	IN
10_1101-2020_03_27_012757	308	36	all	all	PDT
10_1101-2020_03_27_012757	308	37	the	the	DT
10_1101-2020_03_27_012757	308	38	discriminative	discriminative	JJ
10_1101-2020_03_27_012757	308	39	gene	gene	NN
10_1101-2020_03_27_012757	308	40	pairs	pair	NNS
10_1101-2020_03_27_012757	308	41	as	as	IN
10_1101-2020_03_27_012757	308	42	row	row	NN
10_1101-2020_03_27_012757	308	43	names	name	NNS
10_1101-2020_03_27_012757	308	44	and	and	CC
10_1101-2020_03_27_012757	308	45	all	all	PDT
10_1101-2020_03_27_012757	308	46	the	the	DT
10_1101-2020_03_27_012757	308	47	training	training	NN
10_1101-2020_03_27_012757	308	48	samples	sample	NNS
10_1101-2020_03_27_012757	308	49	as	as	IN
10_1101-2020_03_27_012757	308	50	613	613	CD
10_1101-2020_03_27_012757	308	51	column	column	NN
10_1101-2020_03_27_012757	308	52	names	name	NNS
10_1101-2020_03_27_012757	308	53	.	.	.
10_1101-2020_03_27_012757	309	1	Using	use	VBG
10_1101-2020_03_27_012757	309	2	the	the	DT
10_1101-2020_03_27_012757	309	3	binary	binary	JJ
10_1101-2020_03_27_012757	309	4	gene	gene	NN
10_1101-2020_03_27_012757	309	5	pair	pair	NN
10_1101-2020_03_27_012757	309	6	matrix	matrix	NNP
10_1101-2020_03_27_012757	309	7	,	,	,
10_1101-2020_03_27_012757	309	8	CCN	CCN	NNP
10_1101-2020_03_27_012757	309	9	randomly	randomly	RB
10_1101-2020_03_27_012757	309	10	shuffled	shuffle	VBD
10_1101-2020_03_27_012757	309	11	the	the	DT
10_1101-2020_03_27_012757	309	12	binary	binary	JJ
10_1101-2020_03_27_012757	309	13	values	value	NNS
10_1101-2020_03_27_012757	309	14	614	614	CD
10_1101-2020_03_27_012757	309	15	across	across	IN
10_1101-2020_03_27_012757	309	16	rows	row	NNS
10_1101-2020_03_27_012757	309	17	then	then	RB
10_1101-2020_03_27_012757	309	18	across	across	IN
10_1101-2020_03_27_012757	309	19	columns	column	NNS
10_1101-2020_03_27_012757	309	20	to	to	TO
10_1101-2020_03_27_012757	309	21	generate	generate	VB
10_1101-2020_03_27_012757	309	22	random	random	JJ
10_1101-2020_03_27_012757	309	23	profiles	profile	NNS
10_1101-2020_03_27_012757	309	24	that	that	WDT
10_1101-2020_03_27_012757	309	25	should	should	MD
10_1101-2020_03_27_012757	309	26	not	not	RB
10_1101-2020_03_27_012757	309	27	resemble	resemble	VB
10_1101-2020_03_27_012757	309	28	training	train	VBG
10_1101-2020_03_27_012757	309	29	615	615	CD
10_1101-2020_03_27_012757	309	30	data	datum	NNS
10_1101-2020_03_27_012757	309	31	from	from	IN
10_1101-2020_03_27_012757	309	32	any	any	DT
10_1101-2020_03_27_012757	309	33	of	of	IN
10_1101-2020_03_27_012757	309	34	the	the	DT
10_1101-2020_03_27_012757	309	35	cancer	cancer	NN
10_1101-2020_03_27_012757	309	36	categories	category	NNS
10_1101-2020_03_27_012757	309	37	.	.	.
10_1101-2020_03_27_012757	310	1	CCN	CCN	NNP
10_1101-2020_03_27_012757	310	2	then	then	RB
10_1101-2020_03_27_012757	310	3	sampled	sample	VBD
10_1101-2020_03_27_012757	310	4	70	70	CD
10_1101-2020_03_27_012757	310	5	random	random	JJ
10_1101-2020_03_27_012757	310	6	profiles	profile	NNS
10_1101-2020_03_27_012757	310	7	,	,	,
10_1101-2020_03_27_012757	310	8	annotated	annotate	VBD
10_1101-2020_03_27_012757	310	9	them	-PRON-	PRP
10_1101-2020_03_27_012757	310	10	616	616	CD
10_1101-2020_03_27_012757	310	11	as	as	IN
10_1101-2020_03_27_012757	310	12	“	"	``
10_1101-2020_03_27_012757	310	13	Unknown	unknown	JJ
10_1101-2020_03_27_012757	310	14	”	"	''
10_1101-2020_03_27_012757	310	15	and	and	CC
10_1101-2020_03_27_012757	310	16	used	use	VBD
10_1101-2020_03_27_012757	310	17	them	-PRON-	PRP
10_1101-2020_03_27_012757	310	18	as	as	IN
10_1101-2020_03_27_012757	310	19	training	training	NN
10_1101-2020_03_27_012757	310	20	data	datum	NNS
10_1101-2020_03_27_012757	310	21	for	for	IN
10_1101-2020_03_27_012757	310	22	the	the	DT
10_1101-2020_03_27_012757	310	23	“	"	``
10_1101-2020_03_27_012757	310	24	Unknown	unknown	JJ
10_1101-2020_03_27_012757	310	25	”	"	''
10_1101-2020_03_27_012757	310	26	category	category	NN
10_1101-2020_03_27_012757	310	27	.	.	.
10_1101-2020_03_27_012757	311	1	Using	use	VBG
10_1101-2020_03_27_012757	311	2	gene	gene	NN
10_1101-2020_03_27_012757	311	3	pair	pair	NN
10_1101-2020_03_27_012757	311	4	617	617	CD
10_1101-2020_03_27_012757	311	5	binary	binary	JJ
10_1101-2020_03_27_012757	311	6	training	training	NN
10_1101-2020_03_27_012757	311	7	matrix	matrix	NN
10_1101-2020_03_27_012757	311	8	,	,	,
10_1101-2020_03_27_012757	311	9	CCN	CCN	NNP
10_1101-2020_03_27_012757	311	10	constructed	construct	VBD
10_1101-2020_03_27_012757	311	11	a	a	DT
10_1101-2020_03_27_012757	311	12	multi	multi	JJ
10_1101-2020_03_27_012757	311	13	-	-	JJ
10_1101-2020_03_27_012757	311	14	class	class	JJ
10_1101-2020_03_27_012757	311	15	Random	Random	NNP
10_1101-2020_03_27_012757	311	16	Forest	Forest	NNP
10_1101-2020_03_27_012757	311	17	classifier	classifier	NN
10_1101-2020_03_27_012757	311	18	of	of	IN
10_1101-2020_03_27_012757	311	19	2000	2000	CD
10_1101-2020_03_27_012757	311	20	trees	tree	NNS
10_1101-2020_03_27_012757	311	21	618	618	CD
10_1101-2020_03_27_012757	311	22	and	and	CC
10_1101-2020_03_27_012757	311	23	used	use	VBD
10_1101-2020_03_27_012757	311	24	stratified	stratify	VBN
10_1101-2020_03_27_012757	311	25	sampling	sampling	NN
10_1101-2020_03_27_012757	311	26	of	of	IN
10_1101-2020_03_27_012757	311	27	60	60	CD
10_1101-2020_03_27_012757	311	28	sample	sample	NN
10_1101-2020_03_27_012757	311	29	size	size	NN
10_1101-2020_03_27_012757	311	30	to	to	TO
10_1101-2020_03_27_012757	311	31	ensure	ensure	VB
10_1101-2020_03_27_012757	311	32	balance	balance	NN
10_1101-2020_03_27_012757	311	33	of	of	IN
10_1101-2020_03_27_012757	311	34	training	training	NN
10_1101-2020_03_27_012757	311	35	data	datum	NNS
10_1101-2020_03_27_012757	311	36	in	in	IN
10_1101-2020_03_27_012757	311	37	constructing	construct	VBG
10_1101-2020_03_27_012757	311	38	619	619	CD
10_1101-2020_03_27_012757	311	39	the	the	DT
10_1101-2020_03_27_012757	311	40	decision	decision	NN
10_1101-2020_03_27_012757	311	41	trees	tree	NNS
10_1101-2020_03_27_012757	311	42	.	.	.
10_1101-2020_03_27_012757	312	1	620	620	CD
10_1101-2020_03_27_012757	312	2	To	to	TO
10_1101-2020_03_27_012757	312	3	identify	identify	VB
10_1101-2020_03_27_012757	312	4	the	the	DT
10_1101-2020_03_27_012757	312	5	best	good	JJS
10_1101-2020_03_27_012757	312	6	set	set	NN
10_1101-2020_03_27_012757	312	7	of	of	IN
10_1101-2020_03_27_012757	312	8	genes	gene	NNS
10_1101-2020_03_27_012757	312	9	and	and	CC
10_1101-2020_03_27_012757	312	10	gene	gene	NN
10_1101-2020_03_27_012757	312	11	-	-	HYPH
10_1101-2020_03_27_012757	312	12	pair	pair	NN
10_1101-2020_03_27_012757	312	13	parameters	parameter	NNS
10_1101-2020_03_27_012757	312	14	(	(	-LRB-
10_1101-2020_03_27_012757	312	15	n	n	NNP
10_1101-2020_03_27_012757	312	16	and	and	CC
10_1101-2020_03_27_012757	312	17	m	m	NNP
10_1101-2020_03_27_012757	312	18	)	)	-RRB-
10_1101-2020_03_27_012757	312	19	,	,	,
10_1101-2020_03_27_012757	312	20	we	-PRON-	PRP
10_1101-2020_03_27_012757	312	21	used	use	VBD
10_1101-2020_03_27_012757	312	22	a	a	DT
10_1101-2020_03_27_012757	312	23	grid-621	grid-621	JJ
10_1101-2020_03_27_012757	312	24	search	search	NN
10_1101-2020_03_27_012757	312	25	cross	cross	NN
10_1101-2020_03_27_012757	312	26	-	-	JJ
10_1101-2020_03_27_012757	312	27	validation89	validation89	NNP
10_1101-2020_03_27_012757	312	28	strategy	strategy	NN
10_1101-2020_03_27_012757	312	29	with	with	IN
10_1101-2020_03_27_012757	312	30	5	5	CD
10_1101-2020_03_27_012757	312	31	cross	cross	NN
10_1101-2020_03_27_012757	312	32	-	-	NNS
10_1101-2020_03_27_012757	312	33	validations	validation	NNS
10_1101-2020_03_27_012757	312	34	at	at	IN
10_1101-2020_03_27_012757	312	35	each	each	DT
10_1101-2020_03_27_012757	312	36	parameter	parameter	NN
10_1101-2020_03_27_012757	312	37	set	set	NN
10_1101-2020_03_27_012757	312	38	.	.	.
10_1101-2020_03_27_012757	313	1	The	the	DT
10_1101-2020_03_27_012757	313	2	specific	specific	JJ
10_1101-2020_03_27_012757	313	3	622	622	CD
10_1101-2020_03_27_012757	313	4	parameters	parameter	NNS
10_1101-2020_03_27_012757	313	5	for	for	IN
10_1101-2020_03_27_012757	313	6	the	the	DT
10_1101-2020_03_27_012757	313	7	final	final	JJ
10_1101-2020_03_27_012757	313	8	CCN	CCN	NNP
10_1101-2020_03_27_012757	313	9	classifier	classifier	NN
10_1101-2020_03_27_012757	313	10	using	use	VBG
10_1101-2020_03_27_012757	313	11	the	the	DT
10_1101-2020_03_27_012757	313	12	function	function	NN
10_1101-2020_03_27_012757	313	13	“	"	``
10_1101-2020_03_27_012757	313	14	broadClass_train	broadclass_train	NN
10_1101-2020_03_27_012757	313	15	”	"	''
10_1101-2020_03_27_012757	313	16	in	in	IN
10_1101-2020_03_27_012757	313	17	the	the	DT
10_1101-2020_03_27_012757	313	18	package	package	NN
10_1101-2020_03_27_012757	313	19	623	623	CD
10_1101-2020_03_27_012757	313	20	cancerCellNet	cancerCellNet	NNS
10_1101-2020_03_27_012757	313	21	are	be	VBP
10_1101-2020_03_27_012757	313	22	in	in	IN
10_1101-2020_03_27_012757	313	23	Supp	Supp	NNP
10_1101-2020_03_27_012757	313	24	Tab	Tab	NNP
10_1101-2020_03_27_012757	313	25	9	9	CD
10_1101-2020_03_27_012757	313	26	.	.	.
10_1101-2020_03_27_012757	314	1	The	the	DT
10_1101-2020_03_27_012757	314	2	gene	gene	NN
10_1101-2020_03_27_012757	314	3	-	-	HYPH
10_1101-2020_03_27_012757	314	4	pairs	pair	NNS
10_1101-2020_03_27_012757	314	5	are	be	VBP
10_1101-2020_03_27_012757	314	6	in	in	IN
10_1101-2020_03_27_012757	314	7	Supp	Supp	NNP
10_1101-2020_03_27_012757	314	8	Tab	Tab	NNP
10_1101-2020_03_27_012757	314	9	10	10	CD
10_1101-2020_03_27_012757	314	10	.	.	.
10_1101-2020_03_27_012757	315	1	624	624	CD
10_1101-2020_03_27_012757	315	2	625	625	CD
10_1101-2020_03_27_012757	315	3	Validating	Validating	NNP
10_1101-2020_03_27_012757	315	4	General	general	JJ
10_1101-2020_03_27_012757	315	5	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	315	6	Classifier	Classifier	NNP
10_1101-2020_03_27_012757	315	7	626	626	CD
10_1101-2020_03_27_012757	315	8	Two	two	CD
10_1101-2020_03_27_012757	315	9	thirds	third	NNS
10_1101-2020_03_27_012757	315	10	of	of	IN
10_1101-2020_03_27_012757	315	11	patient	patient	JJ
10_1101-2020_03_27_012757	315	12	tumor	tumor	NN
10_1101-2020_03_27_012757	315	13	data	datum	NNS
10_1101-2020_03_27_012757	315	14	from	from	IN
10_1101-2020_03_27_012757	315	15	each	each	DT
10_1101-2020_03_27_012757	315	16	cancer	cancer	NN
10_1101-2020_03_27_012757	315	17	type	type	NN
10_1101-2020_03_27_012757	315	18	were	be	VBD
10_1101-2020_03_27_012757	315	19	randomly	randomly	RB
10_1101-2020_03_27_012757	315	20	sampled	sample	VBN
10_1101-2020_03_27_012757	315	21	as	as	IN
10_1101-2020_03_27_012757	315	22	627	627	CD
10_1101-2020_03_27_012757	315	23	training	training	NN
10_1101-2020_03_27_012757	315	24	data	datum	NNS
10_1101-2020_03_27_012757	315	25	to	to	TO
10_1101-2020_03_27_012757	315	26	construct	construct	VB
10_1101-2020_03_27_012757	315	27	a	a	DT
10_1101-2020_03_27_012757	315	28	CCN	ccn	NN
10_1101-2020_03_27_012757	315	29	classifier	classifier	NN
10_1101-2020_03_27_012757	315	30	.	.	.
10_1101-2020_03_27_012757	316	1	Based	base	VBN
10_1101-2020_03_27_012757	316	2	on	on	IN
10_1101-2020_03_27_012757	316	3	the	the	DT
10_1101-2020_03_27_012757	316	4	training	training	NN
10_1101-2020_03_27_012757	316	5	data	datum	NNS
10_1101-2020_03_27_012757	316	6	,	,	,
10_1101-2020_03_27_012757	316	7	CCN	CCN	NNP
10_1101-2020_03_27_012757	316	8	selected	select	VBD
10_1101-2020_03_27_012757	316	9	the	the	DT
10_1101-2020_03_27_012757	316	10	628	628	CD
10_1101-2020_03_27_012757	316	11	classification	classification	NN
10_1101-2020_03_27_012757	316	12	genes	gene	NNS
10_1101-2020_03_27_012757	316	13	and	and	CC
10_1101-2020_03_27_012757	316	14	gene	gene	NN
10_1101-2020_03_27_012757	316	15	-	-	HYPH
10_1101-2020_03_27_012757	316	16	pairs	pair	NNS
10_1101-2020_03_27_012757	316	17	and	and	CC
10_1101-2020_03_27_012757	316	18	trained	train	VBD
10_1101-2020_03_27_012757	316	19	a	a	DT
10_1101-2020_03_27_012757	316	20	classifier	classifier	NN
10_1101-2020_03_27_012757	316	21	.	.	.
10_1101-2020_03_27_012757	317	1	After	after	IN
10_1101-2020_03_27_012757	317	2	the	the	DT
10_1101-2020_03_27_012757	317	3	classifier	classifier	NN
10_1101-2020_03_27_012757	317	4	was	be	VBD
10_1101-2020_03_27_012757	317	5	built	build	VBN
10_1101-2020_03_27_012757	317	6	,	,	,
10_1101-2020_03_27_012757	317	7	35	35	CD
10_1101-2020_03_27_012757	317	8	629	629	CD
10_1101-2020_03_27_012757	317	9	.CC	.CC	:
10_1101-2020_03_27_012757	317	10	-	-	HYPH
10_1101-2020_03_27_012757	317	11	BY	by	IN
10_1101-2020_03_27_012757	317	12	-	-	HYPH
10_1101-2020_03_27_012757	317	13	NC	NC	NNP
10_1101-2020_03_27_012757	317	14	-	-	HYPH
10_1101-2020_03_27_012757	317	15	ND	ND	NNP
10_1101-2020_03_27_012757	317	16	4.0	4.0	CD
10_1101-2020_03_27_012757	317	17	International	International	NNP
10_1101-2020_03_27_012757	317	18	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	317	19	under	under	IN
10_1101-2020_03_27_012757	317	20	a	a	DT
10_1101-2020_03_27_012757	317	21	(	(	-LRB-
10_1101-2020_03_27_012757	317	22	which	which	WDT
10_1101-2020_03_27_012757	317	23	was	be	VBD
10_1101-2020_03_27_012757	317	24	not	not	RB
10_1101-2020_03_27_012757	317	25	certified	certify	VBN
10_1101-2020_03_27_012757	317	26	by	by	IN
10_1101-2020_03_27_012757	317	27	peer	peer	NN
10_1101-2020_03_27_012757	317	28	review	review	NN
10_1101-2020_03_27_012757	317	29	)	)	-RRB-
10_1101-2020_03_27_012757	317	30	is	be	VBZ
10_1101-2020_03_27_012757	317	31	the	the	DT
10_1101-2020_03_27_012757	317	32	author	author	NN
10_1101-2020_03_27_012757	317	33	/	/	SYM
10_1101-2020_03_27_012757	317	34	funder	funder	NN
10_1101-2020_03_27_012757	317	35	,	,	,
10_1101-2020_03_27_012757	317	36	who	who	WP
10_1101-2020_03_27_012757	317	37	has	have	VBZ
10_1101-2020_03_27_012757	317	38	granted	grant	VBN
10_1101-2020_03_27_012757	317	39	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	317	40	a	a	DT
10_1101-2020_03_27_012757	317	41	license	license	NN
10_1101-2020_03_27_012757	317	42	to	to	TO
10_1101-2020_03_27_012757	317	43	display	display	VB
10_1101-2020_03_27_012757	317	44	the	the	DT
10_1101-2020_03_27_012757	317	45	preprint	preprint	NN
10_1101-2020_03_27_012757	317	46	in	in	IN
10_1101-2020_03_27_012757	317	47	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	317	48	.	.	.
10_1101-2020_03_27_012757	318	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	318	2	is	be	VBZ
10_1101-2020_03_27_012757	318	3	made	make	VBN
10_1101-2020_03_27_012757	318	4	The	the	DT
10_1101-2020_03_27_012757	318	5	copyright	copyright	NN
10_1101-2020_03_27_012757	318	6	holder	holder	NN
10_1101-2020_03_27_012757	318	7	for	for	IN
10_1101-2020_03_27_012757	318	8	this	this	DT
10_1101-2020_03_27_012757	318	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	318	10	version	version	NN
10_1101-2020_03_27_012757	318	11	posted	post	VBD
10_1101-2020_03_27_012757	318	12	January	January	NNP
10_1101-2020_03_27_012757	318	13	9	9	CD
10_1101-2020_03_27_012757	318	14	,	,	,
10_1101-2020_03_27_012757	318	15	2021	2021	CD
10_1101-2020_03_27_012757	318	16	.	.	.
10_1101-2020_03_27_012757	318	17	;	;	:
10_1101-2020_03_27_012757	318	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	318	19	:	:	:
10_1101-2020_03_27_012757	318	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	318	21	preprint	preprint	NN
10_1101-2020_03_27_012757	318	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	318	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	RB
10_1101-2020_03_27_012757	318	24	24	24	CD
10_1101-2020_03_27_012757	318	25	held	hold	VBN
10_1101-2020_03_27_012757	318	26	-	-	HYPH
10_1101-2020_03_27_012757	318	27	out	out	RP
10_1101-2020_03_27_012757	318	28	samples	sample	NNS
10_1101-2020_03_27_012757	318	29	from	from	IN
10_1101-2020_03_27_012757	318	30	each	each	DT
10_1101-2020_03_27_012757	318	31	cancer	cancer	NN
10_1101-2020_03_27_012757	318	32	category	category	NN
10_1101-2020_03_27_012757	318	33	were	be	VBD
10_1101-2020_03_27_012757	318	34	sampled	sample	VBN
10_1101-2020_03_27_012757	318	35	and	and	CC
10_1101-2020_03_27_012757	318	36	40	40	CD
10_1101-2020_03_27_012757	318	37	“	"	``
10_1101-2020_03_27_012757	318	38	Unknown	unknown	JJ
10_1101-2020_03_27_012757	318	39	”	"	''
10_1101-2020_03_27_012757	318	40	profiles	profile	NNS
10_1101-2020_03_27_012757	318	41	were	be	VBD
10_1101-2020_03_27_012757	318	42	630	630	CD
10_1101-2020_03_27_012757	318	43	generated	generate	VBN
10_1101-2020_03_27_012757	318	44	for	for	IN
10_1101-2020_03_27_012757	318	45	validation	validation	NN
10_1101-2020_03_27_012757	318	46	.	.	.
10_1101-2020_03_27_012757	319	1	The	the	DT
10_1101-2020_03_27_012757	319	2	process	process	NN
10_1101-2020_03_27_012757	319	3	of	of	IN
10_1101-2020_03_27_012757	319	4	randomly	randomly	RB
10_1101-2020_03_27_012757	319	5	sampling	sample	VBG
10_1101-2020_03_27_012757	319	6	training	training	NN
10_1101-2020_03_27_012757	319	7	set	set	VBN
10_1101-2020_03_27_012757	319	8	from	from	IN
10_1101-2020_03_27_012757	319	9	2/3	2/3	CD
10_1101-2020_03_27_012757	319	10	of	of	IN
10_1101-2020_03_27_012757	319	11	all	all	DT
10_1101-2020_03_27_012757	319	12	patient	patient	JJ
10_1101-2020_03_27_012757	319	13	631	631	CD
10_1101-2020_03_27_012757	319	14	tumor	tumor	NN
10_1101-2020_03_27_012757	319	15	data	datum	NNS
10_1101-2020_03_27_012757	319	16	,	,	,
10_1101-2020_03_27_012757	319	17	selecting	select	VBG
10_1101-2020_03_27_012757	319	18	features	feature	NNS
10_1101-2020_03_27_012757	319	19	based	base	VBN
10_1101-2020_03_27_012757	319	20	on	on	IN
10_1101-2020_03_27_012757	319	21	the	the	DT
10_1101-2020_03_27_012757	319	22	training	training	NN
10_1101-2020_03_27_012757	319	23	set	set	NN
10_1101-2020_03_27_012757	319	24	,	,	,
10_1101-2020_03_27_012757	319	25	training	train	VBG
10_1101-2020_03_27_012757	319	26	classifier	classifier	NN
10_1101-2020_03_27_012757	319	27	and	and	CC
10_1101-2020_03_27_012757	319	28	validating	validating	NN
10_1101-2020_03_27_012757	319	29	was	be	VBD
10_1101-2020_03_27_012757	319	30	632	632	CD
10_1101-2020_03_27_012757	319	31	repeated	repeat	VBN
10_1101-2020_03_27_012757	319	32	50	50	CD
10_1101-2020_03_27_012757	319	33	times	time	NNS
10_1101-2020_03_27_012757	319	34	to	to	TO
10_1101-2020_03_27_012757	319	35	have	have	VB
10_1101-2020_03_27_012757	319	36	a	a	DT
10_1101-2020_03_27_012757	319	37	more	more	RBR
10_1101-2020_03_27_012757	319	38	comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	319	39	assessment	assessment	NN
10_1101-2020_03_27_012757	319	40	of	of	IN
10_1101-2020_03_27_012757	319	41	the	the	DT
10_1101-2020_03_27_012757	319	42	classifier	classifier	NN
10_1101-2020_03_27_012757	319	43	trained	train	VBN
10_1101-2020_03_27_012757	319	44	with	with	IN
10_1101-2020_03_27_012757	319	45	the	the	DT
10_1101-2020_03_27_012757	319	46	633	633	CD
10_1101-2020_03_27_012757	319	47	optimal	optimal	JJ
10_1101-2020_03_27_012757	319	48	parameter	parameter	NN
10_1101-2020_03_27_012757	319	49	set	set	NN
10_1101-2020_03_27_012757	319	50	.	.	.
10_1101-2020_03_27_012757	320	1	To	to	TO
10_1101-2020_03_27_012757	320	2	test	test	VB
10_1101-2020_03_27_012757	320	3	the	the	DT
10_1101-2020_03_27_012757	320	4	performance	performance	NN
10_1101-2020_03_27_012757	320	5	of	of	IN
10_1101-2020_03_27_012757	320	6	final	final	JJ
10_1101-2020_03_27_012757	320	7	CCN	CCN	NNP
10_1101-2020_03_27_012757	320	8	on	on	IN
10_1101-2020_03_27_012757	320	9	independent	independent	JJ
10_1101-2020_03_27_012757	320	10	testing	testing	NN
10_1101-2020_03_27_012757	320	11	data	datum	NNS
10_1101-2020_03_27_012757	320	12	,	,	,
10_1101-2020_03_27_012757	320	13	we	-PRON-	PRP
10_1101-2020_03_27_012757	320	14	634	634	CD
10_1101-2020_03_27_012757	320	15	applied	apply	VBD
10_1101-2020_03_27_012757	320	16	it	-PRON-	PRP
10_1101-2020_03_27_012757	320	17	to	to	IN
10_1101-2020_03_27_012757	320	18	725	725	CD
10_1101-2020_03_27_012757	320	19	profiles	profile	NNS
10_1101-2020_03_27_012757	320	20	from	from	IN
10_1101-2020_03_27_012757	320	21	ICGC	ICGC	NNP
10_1101-2020_03_27_012757	320	22	spanning	span	VBG
10_1101-2020_03_27_012757	320	23	6	6	CD
10_1101-2020_03_27_012757	320	24	projects	project	NNS
10_1101-2020_03_27_012757	320	25	that	that	WDT
10_1101-2020_03_27_012757	320	26	do	do	VBP
10_1101-2020_03_27_012757	320	27	not	not	RB
10_1101-2020_03_27_012757	320	28	overlap	overlap	VB
10_1101-2020_03_27_012757	320	29	with	with	IN
10_1101-2020_03_27_012757	320	30	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	320	31	(	(	-LRB-
10_1101-2020_03_27_012757	320	32	BRCA-635	BRCA-635	NNP
10_1101-2020_03_27_012757	320	33	KR	KR	NNP
10_1101-2020_03_27_012757	320	34	,	,	,
10_1101-2020_03_27_012757	320	35	LIRI	LIRI	NNP
10_1101-2020_03_27_012757	320	36	-	-	HYPH
10_1101-2020_03_27_012757	320	37	JP	JP	NNP
10_1101-2020_03_27_012757	320	38	,	,	,
10_1101-2020_03_27_012757	320	39	OV	OV	NNP
10_1101-2020_03_27_012757	320	40	-	-	HYPH
10_1101-2020_03_27_012757	320	41	AU	AU	NNP
10_1101-2020_03_27_012757	320	42	,	,	,
10_1101-2020_03_27_012757	320	43	PACA	PACA	NNP
10_1101-2020_03_27_012757	320	44	-	-	HYPH
10_1101-2020_03_27_012757	320	45	AU	AU	NNP
10_1101-2020_03_27_012757	320	46	,	,	,
10_1101-2020_03_27_012757	320	47	PACA	PACA	NNP
10_1101-2020_03_27_012757	320	48	-	-	HYPH
10_1101-2020_03_27_012757	320	49	CA	CA	NNP
10_1101-2020_03_27_012757	320	50	,	,	,
10_1101-2020_03_27_012757	320	51	PRAD	PRAD	NNP
10_1101-2020_03_27_012757	320	52	-	-	HYPH
10_1101-2020_03_27_012757	320	53	FR	FR	NNP
10_1101-2020_03_27_012757	320	54	)	)	-RRB-
10_1101-2020_03_27_012757	320	55	.	.	.
10_1101-2020_03_27_012757	321	1	636	636	CD
10_1101-2020_03_27_012757	321	2	637	637	CD
10_1101-2020_03_27_012757	321	3	Selecting	Selecting	NNP
10_1101-2020_03_27_012757	321	4	Decision	decision	NN
10_1101-2020_03_27_012757	321	5	Thresholds	Thresholds	NNP
10_1101-2020_03_27_012757	321	6	638	638	CD
10_1101-2020_03_27_012757	321	7	Our	-PRON-	PRP$
10_1101-2020_03_27_012757	321	8	strategy	strategy	NN
10_1101-2020_03_27_012757	321	9	for	for	IN
10_1101-2020_03_27_012757	321	10	selecting	select	VBG
10_1101-2020_03_27_012757	321	11	a	a	DT
10_1101-2020_03_27_012757	321	12	decision	decision	NN
10_1101-2020_03_27_012757	321	13	threshold	threshold	NN
10_1101-2020_03_27_012757	321	14	was	be	VBD
10_1101-2020_03_27_012757	321	15	to	to	TO
10_1101-2020_03_27_012757	321	16	find	find	VB
10_1101-2020_03_27_012757	321	17	the	the	DT
10_1101-2020_03_27_012757	321	18	value	value	NN
10_1101-2020_03_27_012757	321	19	that	that	WDT
10_1101-2020_03_27_012757	321	20	maximizes	maximize	VBZ
10_1101-2020_03_27_012757	321	21	the	the	DT
10_1101-2020_03_27_012757	321	22	639	639	CD
10_1101-2020_03_27_012757	321	23	average	average	JJ
10_1101-2020_03_27_012757	321	24	Macro	Macro	NNP
10_1101-2020_03_27_012757	321	25	F1	F1	NNP
10_1101-2020_03_27_012757	321	26	measure90	measure90	NNS
10_1101-2020_03_27_012757	321	27	for	for	IN
10_1101-2020_03_27_012757	321	28	each	each	DT
10_1101-2020_03_27_012757	321	29	of	of	IN
10_1101-2020_03_27_012757	321	30	the	the	DT
10_1101-2020_03_27_012757	321	31	50	50	CD
10_1101-2020_03_27_012757	321	32	cross	cros	NNS
10_1101-2020_03_27_012757	321	33	-	-	NNS
10_1101-2020_03_27_012757	321	34	validations	validation	NNS
10_1101-2020_03_27_012757	321	35	that	that	WDT
10_1101-2020_03_27_012757	321	36	were	be	VBD
10_1101-2020_03_27_012757	321	37	performed	perform	VBN
10_1101-2020_03_27_012757	321	38	with	with	IN
10_1101-2020_03_27_012757	321	39	the	the	DT
10_1101-2020_03_27_012757	321	40	640	640	CD
10_1101-2020_03_27_012757	321	41	optimal	optimal	JJ
10_1101-2020_03_27_012757	321	42	parameter	parameter	NN
10_1101-2020_03_27_012757	321	43	set	set	NN
10_1101-2020_03_27_012757	321	44	,	,	,
10_1101-2020_03_27_012757	321	45	testing	test	VBG
10_1101-2020_03_27_012757	321	46	thresholds	threshold	NNS
10_1101-2020_03_27_012757	321	47	between	between	IN
10_1101-2020_03_27_012757	321	48	0	0	CD
10_1101-2020_03_27_012757	321	49	and	and	CC
10_1101-2020_03_27_012757	321	50	1	1	CD
10_1101-2020_03_27_012757	321	51	with	with	IN
10_1101-2020_03_27_012757	321	52	a	a	DT
10_1101-2020_03_27_012757	321	53	0.01	0.01	CD
10_1101-2020_03_27_012757	321	54	increment	increment	NN
10_1101-2020_03_27_012757	321	55	.	.	.
10_1101-2020_03_27_012757	322	1	The	the	DT
10_1101-2020_03_27_012757	322	2	F1	f1	NN
10_1101-2020_03_27_012757	322	3	641	641	CD
10_1101-2020_03_27_012757	322	4	measure	measure	NN
10_1101-2020_03_27_012757	322	5	is	be	VBZ
10_1101-2020_03_27_012757	322	6	defined	define	VBN
10_1101-2020_03_27_012757	322	7	as	as	IN
10_1101-2020_03_27_012757	322	8	:	:	:
10_1101-2020_03_27_012757	322	9	642	642	CD
10_1101-2020_03_27_012757	322	10	𝑀𝑎𝑐𝑟𝑜	𝑀𝑎𝑐𝑟𝑜	NNP
10_1101-2020_03_27_012757	322	11	𝐹1	𝐹1	NNP
10_1101-2020_03_27_012757	322	12	=	=	NNS
10_1101-2020_03_27_012757	322	13	2	2	CD
10_1101-2020_03_27_012757	322	14	×	×	NN
10_1101-2020_03_27_012757	322	15	𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛	𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛	NN
10_1101-2020_03_27_012757	322	16	×	×	NNP
10_1101-2020_03_27_012757	322	17	𝑟𝑒𝑐𝑎𝑙𝑙	𝑟𝑒𝑐𝑎𝑙𝑙	NNP
10_1101-2020_03_27_012757	322	18	𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛	𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛	NNP
10_1101-2020_03_27_012757	322	19	+	+	CC
10_1101-2020_03_27_012757	322	20	𝑟𝑒𝑐𝑎𝑙𝑙	𝑟𝑒𝑐𝑎𝑙𝑙	NNP
10_1101-2020_03_27_012757	322	21	643	643	CD
10_1101-2020_03_27_012757	322	22	We	-PRON-	PRP
10_1101-2020_03_27_012757	322	23	selected	select	VBD
10_1101-2020_03_27_012757	322	24	the	the	DT
10_1101-2020_03_27_012757	322	25	most	most	RBS
10_1101-2020_03_27_012757	322	26	commonly	commonly	RB
10_1101-2020_03_27_012757	322	27	occurring	occur	VBG
10_1101-2020_03_27_012757	322	28	threshold	threshold	NN
10_1101-2020_03_27_012757	322	29	above	above	IN
10_1101-2020_03_27_012757	322	30	0.2	0.2	CD
10_1101-2020_03_27_012757	322	31	that	that	WDT
10_1101-2020_03_27_012757	322	32	maximized	maximize	VBD
10_1101-2020_03_27_012757	322	33	the	the	DT
10_1101-2020_03_27_012757	322	34	average	average	JJ
10_1101-2020_03_27_012757	322	35	644	644	CD
10_1101-2020_03_27_012757	322	36	Macro	Macro	NNP
10_1101-2020_03_27_012757	322	37	F1	F1	NNP
10_1101-2020_03_27_012757	322	38	measure	measure	NN
10_1101-2020_03_27_012757	322	39	across	across	IN
10_1101-2020_03_27_012757	322	40	the	the	DT
10_1101-2020_03_27_012757	322	41	50	50	CD
10_1101-2020_03_27_012757	322	42	cross	cros	NNS
10_1101-2020_03_27_012757	322	43	-	-	NNS
10_1101-2020_03_27_012757	322	44	validations	validation	NNS
10_1101-2020_03_27_012757	322	45	as	as	IN
10_1101-2020_03_27_012757	322	46	the	the	DT
10_1101-2020_03_27_012757	322	47	decision	decision	NN
10_1101-2020_03_27_012757	322	48	threshold	threshold	NN
10_1101-2020_03_27_012757	322	49	for	for	IN
10_1101-2020_03_27_012757	322	50	the	the	DT
10_1101-2020_03_27_012757	322	51	final	final	JJ
10_1101-2020_03_27_012757	322	52	645	645	CD
10_1101-2020_03_27_012757	322	53	classifier	classifier	NN
10_1101-2020_03_27_012757	322	54	(	(	-LRB-
10_1101-2020_03_27_012757	322	55	threshold	threshold	NN
10_1101-2020_03_27_012757	322	56	=	=	SYM
10_1101-2020_03_27_012757	322	57	0.25	0.25	CD
10_1101-2020_03_27_012757	322	58	)	)	-RRB-
10_1101-2020_03_27_012757	322	59	.	.	.
10_1101-2020_03_27_012757	323	1	The	the	DT
10_1101-2020_03_27_012757	323	2	same	same	JJ
10_1101-2020_03_27_012757	323	3	approach	approach	NN
10_1101-2020_03_27_012757	323	4	was	be	VBD
10_1101-2020_03_27_012757	323	5	applied	apply	VBN
10_1101-2020_03_27_012757	323	6	for	for	IN
10_1101-2020_03_27_012757	323	7	the	the	DT
10_1101-2020_03_27_012757	323	8	subtype	subtype	NN
10_1101-2020_03_27_012757	323	9	classifiers	classifier	NNS
10_1101-2020_03_27_012757	323	10	.	.	.
10_1101-2020_03_27_012757	324	1	The	the	DT
10_1101-2020_03_27_012757	324	2	646	646	CD
10_1101-2020_03_27_012757	324	3	thresholds	threshold	NNS
10_1101-2020_03_27_012757	324	4	and	and	CC
10_1101-2020_03_27_012757	324	5	the	the	DT
10_1101-2020_03_27_012757	324	6	corresponding	corresponding	JJ
10_1101-2020_03_27_012757	324	7	average	average	JJ
10_1101-2020_03_27_012757	324	8	precision	precision	NN
10_1101-2020_03_27_012757	324	9	,	,	,
10_1101-2020_03_27_012757	324	10	recall	recall	NN
10_1101-2020_03_27_012757	324	11	and	and	CC
10_1101-2020_03_27_012757	324	12	F1	f1	NN
10_1101-2020_03_27_012757	324	13	measures	measure	NNS
10_1101-2020_03_27_012757	324	14	are	be	VBP
10_1101-2020_03_27_012757	324	15	recorded	record	VBN
10_1101-2020_03_27_012757	324	16	in	in	IN
10_1101-2020_03_27_012757	324	17	647	647	CD
10_1101-2020_03_27_012757	324	18	(	(	-LRB-
10_1101-2020_03_27_012757	324	19	Supp	Supp	NNP
10_1101-2020_03_27_012757	324	20	Tab	Tab	NNP
10_1101-2020_03_27_012757	324	21	11	11	CD
10_1101-2020_03_27_012757	324	22	)	)	-RRB-
10_1101-2020_03_27_012757	324	23	.	.	.
10_1101-2020_03_27_012757	325	1	648	648	CD
10_1101-2020_03_27_012757	325	2	649	649	CD
10_1101-2020_03_27_012757	325	3	Classifying	Classifying	NNP
10_1101-2020_03_27_012757	325	4	Query	Query	NNP
10_1101-2020_03_27_012757	325	5	Data	Data	NNP
10_1101-2020_03_27_012757	325	6	into	into	IN
10_1101-2020_03_27_012757	325	7	General	General	NNP
10_1101-2020_03_27_012757	325	8	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	325	9	Categories	Categories	NNPS
10_1101-2020_03_27_012757	325	10	650	650	CD
10_1101-2020_03_27_012757	325	11	We	-PRON-	PRP
10_1101-2020_03_27_012757	325	12	downloaded	download	VBD
10_1101-2020_03_27_012757	325	13	the	the	DT
10_1101-2020_03_27_012757	325	14	RNA	RNA	NNP
10_1101-2020_03_27_012757	325	15	-	-	HYPH
10_1101-2020_03_27_012757	325	16	seq	seq	NN
10_1101-2020_03_27_012757	325	17	cancer	cancer	NN
10_1101-2020_03_27_012757	325	18	cell	cell	NN
10_1101-2020_03_27_012757	325	19	lines	line	NNS
10_1101-2020_03_27_012757	325	20	expression	expression	NN
10_1101-2020_03_27_012757	325	21	profiles	profile	NNS
10_1101-2020_03_27_012757	325	22	and	and	CC
10_1101-2020_03_27_012757	325	23	sample	sample	NN
10_1101-2020_03_27_012757	325	24	table	table	NN
10_1101-2020_03_27_012757	325	25	651	651	CD
10_1101-2020_03_27_012757	325	26	from	from	IN
10_1101-2020_03_27_012757	325	27	(	(	-LRB-
10_1101-2020_03_27_012757	325	28	https://portals.broadinstitute.org/ccle/data	https://portals.broadinstitute.org/ccle/data	NNP
10_1101-2020_03_27_012757	325	29	)	)	-RRB-
10_1101-2020_03_27_012757	325	30	,	,	,
10_1101-2020_03_27_012757	325	31	and	and	CC
10_1101-2020_03_27_012757	325	32	microarray	microarray	JJ
10_1101-2020_03_27_012757	325	33	cancer	cancer	NN
10_1101-2020_03_27_012757	325	34	cell	cell	NN
10_1101-2020_03_27_012757	325	35	lines	line	NNS
10_1101-2020_03_27_012757	325	36	expression	expression	VBP
10_1101-2020_03_27_012757	325	37	652	652	CD
10_1101-2020_03_27_012757	325	38	profiles	profile	NNS
10_1101-2020_03_27_012757	325	39	and	and	CC
10_1101-2020_03_27_012757	325	40	sample	sample	NN
10_1101-2020_03_27_012757	325	41	table	table	NN
10_1101-2020_03_27_012757	325	42	from	from	IN
10_1101-2020_03_27_012757	325	43	Barretina	Barretina	NNP
10_1101-2020_03_27_012757	325	44	et	et	NNP
10_1101-2020_03_27_012757	325	45	al	al	NNP
10_1101-2020_03_27_012757	325	46	37	37	CD
10_1101-2020_03_27_012757	325	47	.	.	.
10_1101-2020_03_27_012757	326	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	326	2	extracted	extract	VBD
10_1101-2020_03_27_012757	326	3	two	two	CD
10_1101-2020_03_27_012757	326	4	WT	WT	NNP
10_1101-2020_03_27_012757	326	5	control	control	NN
10_1101-2020_03_27_012757	326	6	NCCIT	NCCIT	NNP
10_1101-2020_03_27_012757	326	7	RNA	RNA	NNP
10_1101-2020_03_27_012757	326	8	-	-	HYPH
10_1101-2020_03_27_012757	326	9	seq	seq	NN
10_1101-2020_03_27_012757	326	10	653	653	CD
10_1101-2020_03_27_012757	326	11	expression	expression	NN
10_1101-2020_03_27_012757	326	12	profiles	profile	NNS
10_1101-2020_03_27_012757	326	13	from	from	IN
10_1101-2020_03_27_012757	326	14	Grow	Grow	NNP
10_1101-2020_03_27_012757	326	15	et	et	FW
10_1101-2020_03_27_012757	326	16	al91	al91	NNP
10_1101-2020_03_27_012757	326	17	.	.	.
10_1101-2020_03_27_012757	327	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	327	2	received	receive	VBD
10_1101-2020_03_27_012757	327	3	PDX	pdx	NN
10_1101-2020_03_27_012757	327	4	expression	expression	NN
10_1101-2020_03_27_012757	327	5	estimates	estimate	VBZ
10_1101-2020_03_27_012757	327	6	and	and	CC
10_1101-2020_03_27_012757	327	7	sample	sample	VBP
10_1101-2020_03_27_012757	327	8	654	654	CD
10_1101-2020_03_27_012757	327	9	.CC	.CC	,
10_1101-2020_03_27_012757	327	10	-	-	HYPH
10_1101-2020_03_27_012757	327	11	BY	by	IN
10_1101-2020_03_27_012757	327	12	-	-	HYPH
10_1101-2020_03_27_012757	327	13	NC	NC	NNP
10_1101-2020_03_27_012757	327	14	-	-	HYPH
10_1101-2020_03_27_012757	327	15	ND	ND	NNP
10_1101-2020_03_27_012757	327	16	4.0	4.0	CD
10_1101-2020_03_27_012757	327	17	International	International	NNP
10_1101-2020_03_27_012757	327	18	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	327	19	under	under	IN
10_1101-2020_03_27_012757	327	20	a	a	DT
10_1101-2020_03_27_012757	327	21	(	(	-LRB-
10_1101-2020_03_27_012757	327	22	which	which	WDT
10_1101-2020_03_27_012757	327	23	was	be	VBD
10_1101-2020_03_27_012757	327	24	not	not	RB
10_1101-2020_03_27_012757	327	25	certified	certify	VBN
10_1101-2020_03_27_012757	327	26	by	by	IN
10_1101-2020_03_27_012757	327	27	peer	peer	NN
10_1101-2020_03_27_012757	327	28	review	review	NN
10_1101-2020_03_27_012757	327	29	)	)	-RRB-
10_1101-2020_03_27_012757	327	30	is	be	VBZ
10_1101-2020_03_27_012757	327	31	the	the	DT
10_1101-2020_03_27_012757	327	32	author	author	NN
10_1101-2020_03_27_012757	327	33	/	/	SYM
10_1101-2020_03_27_012757	327	34	funder	funder	NN
10_1101-2020_03_27_012757	327	35	,	,	,
10_1101-2020_03_27_012757	327	36	who	who	WP
10_1101-2020_03_27_012757	327	37	has	have	VBZ
10_1101-2020_03_27_012757	327	38	granted	grant	VBN
10_1101-2020_03_27_012757	327	39	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	327	40	a	a	DT
10_1101-2020_03_27_012757	327	41	license	license	NN
10_1101-2020_03_27_012757	327	42	to	to	TO
10_1101-2020_03_27_012757	327	43	display	display	VB
10_1101-2020_03_27_012757	327	44	the	the	DT
10_1101-2020_03_27_012757	327	45	preprint	preprint	NN
10_1101-2020_03_27_012757	327	46	in	in	IN
10_1101-2020_03_27_012757	327	47	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	327	48	.	.	.
10_1101-2020_03_27_012757	328	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	328	2	is	be	VBZ
10_1101-2020_03_27_012757	328	3	made	make	VBN
10_1101-2020_03_27_012757	328	4	The	the	DT
10_1101-2020_03_27_012757	328	5	copyright	copyright	NN
10_1101-2020_03_27_012757	328	6	holder	holder	NN
10_1101-2020_03_27_012757	328	7	for	for	IN
10_1101-2020_03_27_012757	328	8	this	this	DT
10_1101-2020_03_27_012757	328	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	328	10	version	version	NN
10_1101-2020_03_27_012757	328	11	posted	post	VBD
10_1101-2020_03_27_012757	328	12	January	January	NNP
10_1101-2020_03_27_012757	328	13	9	9	CD
10_1101-2020_03_27_012757	328	14	,	,	,
10_1101-2020_03_27_012757	328	15	2021	2021	CD
10_1101-2020_03_27_012757	328	16	.	.	.
10_1101-2020_03_27_012757	328	17	;	;	:
10_1101-2020_03_27_012757	328	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	328	19	:	:	:
10_1101-2020_03_27_012757	328	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	328	21	preprint	preprint	NN
10_1101-2020_03_27_012757	328	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	328	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	328	24	25	25	CD
10_1101-2020_03_27_012757	328	25	annotations	annotation	NNS
10_1101-2020_03_27_012757	328	26	from	from	IN
10_1101-2020_03_27_012757	328	27	the	the	DT
10_1101-2020_03_27_012757	328	28	authors	author	NNS
10_1101-2020_03_27_012757	328	29	of	of	IN
10_1101-2020_03_27_012757	328	30	Gao	Gao	NNP
10_1101-2020_03_27_012757	328	31	et	et	NNP
10_1101-2020_03_27_012757	328	32	al	al	NNP
10_1101-2020_03_27_012757	328	33	20	20	CD
10_1101-2020_03_27_012757	328	34	.	.	.
10_1101-2020_03_27_012757	329	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	329	2	gathered	gather	VBD
10_1101-2020_03_27_012757	329	3	GEMM	GEMM	NNP
10_1101-2020_03_27_012757	329	4	expression	expression	NN
10_1101-2020_03_27_012757	329	5	profiles	profile	NNS
10_1101-2020_03_27_012757	329	6	from	from	IN
10_1101-2020_03_27_012757	329	7	nine	nine	CD
10_1101-2020_03_27_012757	329	8	655	655	CD
10_1101-2020_03_27_012757	329	9	different	different	JJ
10_1101-2020_03_27_012757	329	10	studies59–67	studies59–67	NN
10_1101-2020_03_27_012757	329	11	.	.	.
10_1101-2020_03_27_012757	330	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	330	2	downloaded	download	VBD
10_1101-2020_03_27_012757	330	3	tumoroid	tumoroid	NN
10_1101-2020_03_27_012757	330	4	expression	expression	NN
10_1101-2020_03_27_012757	330	5	profiles	profile	NNS
10_1101-2020_03_27_012757	330	6	from	from	IN
10_1101-2020_03_27_012757	330	7	The	the	DT
10_1101-2020_03_27_012757	330	8	NCI	NCI	NNP
10_1101-2020_03_27_012757	330	9	Patient-656	Patient-656	NNP
10_1101-2020_03_27_012757	330	10	Derived	Derived	NNP
10_1101-2020_03_27_012757	330	11	Models	Models	NNP
10_1101-2020_03_27_012757	330	12	Repository	Repository	NNP
10_1101-2020_03_27_012757	330	13	(	(	-LRB-
10_1101-2020_03_27_012757	330	14	PDMR)69	PDMR)69	NNP
10_1101-2020_03_27_012757	330	15	and	and	CC
10_1101-2020_03_27_012757	330	16	from	from	IN
10_1101-2020_03_27_012757	330	17	three	three	CD
10_1101-2020_03_27_012757	330	18	individual	individual	JJ
10_1101-2020_03_27_012757	330	19	studies70–72	studies70–72	NNS
10_1101-2020_03_27_012757	330	20	.	.	.
10_1101-2020_03_27_012757	331	1	To	to	TO
10_1101-2020_03_27_012757	331	2	use	use	VB
10_1101-2020_03_27_012757	331	3	CCN	CCN	NNP
10_1101-2020_03_27_012757	331	4	657	657	CD
10_1101-2020_03_27_012757	331	5	classifier	classifier	NN
10_1101-2020_03_27_012757	331	6	on	on	IN
10_1101-2020_03_27_012757	331	7	GEMM	GEMM	NNP
10_1101-2020_03_27_012757	331	8	data	datum	NNS
10_1101-2020_03_27_012757	331	9	,	,	,
10_1101-2020_03_27_012757	331	10	the	the	DT
10_1101-2020_03_27_012757	331	11	mouse	mouse	NN
10_1101-2020_03_27_012757	331	12	genes	gene	NNS
10_1101-2020_03_27_012757	331	13	from	from	IN
10_1101-2020_03_27_012757	331	14	GEMM	GEMM	NNP
10_1101-2020_03_27_012757	331	15	expression	expression	NN
10_1101-2020_03_27_012757	331	16	profiles	profile	NNS
10_1101-2020_03_27_012757	331	17	were	be	VBD
10_1101-2020_03_27_012757	331	18	converted	convert	VBN
10_1101-2020_03_27_012757	331	19	into	into	IN
10_1101-2020_03_27_012757	331	20	658	658	CD
10_1101-2020_03_27_012757	331	21	their	-PRON-	PRP$
10_1101-2020_03_27_012757	331	22	human	human	JJ
10_1101-2020_03_27_012757	331	23	homologs	homolog	NNS
10_1101-2020_03_27_012757	331	24	.	.	.
10_1101-2020_03_27_012757	332	1	The	the	DT
10_1101-2020_03_27_012757	332	2	query	query	NN
10_1101-2020_03_27_012757	332	3	samples	sample	NNS
10_1101-2020_03_27_012757	332	4	were	be	VBD
10_1101-2020_03_27_012757	332	5	classified	classify	VBN
10_1101-2020_03_27_012757	332	6	using	use	VBG
10_1101-2020_03_27_012757	332	7	the	the	DT
10_1101-2020_03_27_012757	332	8	final	final	JJ
10_1101-2020_03_27_012757	332	9	CCN	ccn	NN
10_1101-2020_03_27_012757	332	10	classifier	classifier	NN
10_1101-2020_03_27_012757	332	11	.	.	.
10_1101-2020_03_27_012757	333	1	Each	each	DT
10_1101-2020_03_27_012757	333	2	659	659	CD
10_1101-2020_03_27_012757	333	3	query	query	NN
10_1101-2020_03_27_012757	333	4	classification	classification	NN
10_1101-2020_03_27_012757	333	5	profile	profile	NN
10_1101-2020_03_27_012757	333	6	was	be	VBD
10_1101-2020_03_27_012757	333	7	labelled	label	VBN
10_1101-2020_03_27_012757	333	8	as	as	IN
10_1101-2020_03_27_012757	333	9	one	one	CD
10_1101-2020_03_27_012757	333	10	of	of	IN
10_1101-2020_03_27_012757	333	11	the	the	DT
10_1101-2020_03_27_012757	333	12	four	four	CD
10_1101-2020_03_27_012757	333	13	classification	classification	NN
10_1101-2020_03_27_012757	333	14	categories	category	NNS
10_1101-2020_03_27_012757	333	15	:	:	:
10_1101-2020_03_27_012757	333	16	“	"	``
10_1101-2020_03_27_012757	333	17	correct	correct	JJ
10_1101-2020_03_27_012757	333	18	”	"	''
10_1101-2020_03_27_012757	333	19	,	,	,
10_1101-2020_03_27_012757	333	20	660	660	CD
10_1101-2020_03_27_012757	333	21	“	"	``
10_1101-2020_03_27_012757	333	22	mixed	mixed	JJ
10_1101-2020_03_27_012757	333	23	”	"	''
10_1101-2020_03_27_012757	333	24	,	,	,
10_1101-2020_03_27_012757	333	25	“	"	``
10_1101-2020_03_27_012757	333	26	none	none	NN
10_1101-2020_03_27_012757	333	27	”	"	''
10_1101-2020_03_27_012757	333	28	and	and	CC
10_1101-2020_03_27_012757	333	29	“	"	``
10_1101-2020_03_27_012757	333	30	other	other	JJ
10_1101-2020_03_27_012757	333	31	”	"	''
10_1101-2020_03_27_012757	333	32	based	base	VBN
10_1101-2020_03_27_012757	333	33	on	on	IN
10_1101-2020_03_27_012757	333	34	classification	classification	NN
10_1101-2020_03_27_012757	333	35	profiles	profile	NNS
10_1101-2020_03_27_012757	333	36	.	.	.
10_1101-2020_03_27_012757	334	1	If	if	IN
10_1101-2020_03_27_012757	334	2	a	a	DT
10_1101-2020_03_27_012757	334	3	sample	sample	NN
10_1101-2020_03_27_012757	334	4	has	have	VBZ
10_1101-2020_03_27_012757	334	5	a	a	DT
10_1101-2020_03_27_012757	334	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	334	7	score	score	NN
10_1101-2020_03_27_012757	334	8	higher	higher	RBR
10_1101-2020_03_27_012757	334	9	661	661	CD
10_1101-2020_03_27_012757	334	10	than	than	IN
10_1101-2020_03_27_012757	334	11	the	the	DT
10_1101-2020_03_27_012757	334	12	decision	decision	NN
10_1101-2020_03_27_012757	334	13	threshold	threshold	NN
10_1101-2020_03_27_012757	334	14	in	in	IN
10_1101-2020_03_27_012757	334	15	the	the	DT
10_1101-2020_03_27_012757	334	16	labelled	label	VBN
10_1101-2020_03_27_012757	334	17	cancer	cancer	NN
10_1101-2020_03_27_012757	334	18	category	category	NN
10_1101-2020_03_27_012757	334	19	,	,	,
10_1101-2020_03_27_012757	334	20	we	-PRON-	PRP
10_1101-2020_03_27_012757	334	21	assigned	assign	VBD
10_1101-2020_03_27_012757	334	22	that	that	IN
10_1101-2020_03_27_012757	334	23	as	as	IN
10_1101-2020_03_27_012757	334	24	“	"	``
10_1101-2020_03_27_012757	334	25	correct	correct	JJ
10_1101-2020_03_27_012757	334	26	”	"	''
10_1101-2020_03_27_012757	334	27	.	.	.
10_1101-2020_03_27_012757	335	1	If	if	IN
10_1101-2020_03_27_012757	335	2	a	a	DT
10_1101-2020_03_27_012757	335	3	662	662	CD
10_1101-2020_03_27_012757	335	4	sample	sample	NN
10_1101-2020_03_27_012757	335	5	has	have	VBZ
10_1101-2020_03_27_012757	335	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	335	7	score	score	VB
10_1101-2020_03_27_012757	335	8	higher	high	JJR
10_1101-2020_03_27_012757	335	9	than	than	IN
10_1101-2020_03_27_012757	335	10	the	the	DT
10_1101-2020_03_27_012757	335	11	decision	decision	NN
10_1101-2020_03_27_012757	335	12	threshold	threshold	NN
10_1101-2020_03_27_012757	335	13	in	in	IN
10_1101-2020_03_27_012757	335	14	labelled	label	VBN
10_1101-2020_03_27_012757	335	15	cancer	cancer	NN
10_1101-2020_03_27_012757	335	16	category	category	NN
10_1101-2020_03_27_012757	335	17	and	and	CC
10_1101-2020_03_27_012757	335	18	in	in	IN
10_1101-2020_03_27_012757	335	19	663	663	CD
10_1101-2020_03_27_012757	335	20	other	other	JJ
10_1101-2020_03_27_012757	335	21	cancer	cancer	NN
10_1101-2020_03_27_012757	335	22	categories	category	NNS
10_1101-2020_03_27_012757	335	23	,	,	,
10_1101-2020_03_27_012757	335	24	we	-PRON-	PRP
10_1101-2020_03_27_012757	335	25	assigned	assign	VBD
10_1101-2020_03_27_012757	335	26	that	that	IN
10_1101-2020_03_27_012757	335	27	as	as	IN
10_1101-2020_03_27_012757	335	28	“	"	``
10_1101-2020_03_27_012757	335	29	mixed	mixed	JJ
10_1101-2020_03_27_012757	335	30	”	"	''
10_1101-2020_03_27_012757	335	31	.	.	.
10_1101-2020_03_27_012757	336	1	If	if	IN
10_1101-2020_03_27_012757	336	2	a	a	DT
10_1101-2020_03_27_012757	336	3	sample	sample	NN
10_1101-2020_03_27_012757	336	4	has	have	VBZ
10_1101-2020_03_27_012757	336	5	no	no	DT
10_1101-2020_03_27_012757	336	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	336	7	score	score	NN
10_1101-2020_03_27_012757	336	8	higher	high	JJR
10_1101-2020_03_27_012757	336	9	664	664	CD
10_1101-2020_03_27_012757	336	10	than	than	IN
10_1101-2020_03_27_012757	336	11	the	the	DT
10_1101-2020_03_27_012757	336	12	decision	decision	NN
10_1101-2020_03_27_012757	336	13	threshold	threshold	NN
10_1101-2020_03_27_012757	336	14	in	in	IN
10_1101-2020_03_27_012757	336	15	any	any	DT
10_1101-2020_03_27_012757	336	16	cancer	cancer	NN
10_1101-2020_03_27_012757	336	17	category	category	NN
10_1101-2020_03_27_012757	336	18	or	or	CC
10_1101-2020_03_27_012757	336	19	has	have	VBZ
10_1101-2020_03_27_012757	336	20	the	the	DT
10_1101-2020_03_27_012757	336	21	highest	high	JJS
10_1101-2020_03_27_012757	336	22	CCN	CCN	NNP
10_1101-2020_03_27_012757	336	23	score	score	NN
10_1101-2020_03_27_012757	336	24	in	in	IN
10_1101-2020_03_27_012757	336	25	‘	'	``
10_1101-2020_03_27_012757	336	26	Unknown	Unknown	NNP
10_1101-2020_03_27_012757	336	27	’	'	''
10_1101-2020_03_27_012757	336	28	665	665	CD
10_1101-2020_03_27_012757	336	29	category	category	NN
10_1101-2020_03_27_012757	336	30	,	,	,
10_1101-2020_03_27_012757	336	31	then	then	RB
10_1101-2020_03_27_012757	336	32	we	-PRON-	PRP
10_1101-2020_03_27_012757	336	33	assigned	assign	VBD
10_1101-2020_03_27_012757	336	34	it	-PRON-	PRP
10_1101-2020_03_27_012757	336	35	as	as	IN
10_1101-2020_03_27_012757	336	36	“	"	``
10_1101-2020_03_27_012757	336	37	none	none	NN
10_1101-2020_03_27_012757	336	38	”	"	''
10_1101-2020_03_27_012757	336	39	.	.	.
10_1101-2020_03_27_012757	337	1	If	if	IN
10_1101-2020_03_27_012757	337	2	a	a	DT
10_1101-2020_03_27_012757	337	3	sample	sample	NN
10_1101-2020_03_27_012757	337	4	has	have	VBZ
10_1101-2020_03_27_012757	337	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	337	6	score	score	VB
10_1101-2020_03_27_012757	337	7	higher	high	JJR
10_1101-2020_03_27_012757	337	8	than	than	IN
10_1101-2020_03_27_012757	337	9	the	the	DT
10_1101-2020_03_27_012757	337	10	decision	decision	NN
10_1101-2020_03_27_012757	337	11	666	666	CD
10_1101-2020_03_27_012757	337	12	threshold	threshold	NN
10_1101-2020_03_27_012757	337	13	in	in	IN
10_1101-2020_03_27_012757	337	14	a	a	DT
10_1101-2020_03_27_012757	337	15	cancer	cancer	NN
10_1101-2020_03_27_012757	337	16	category	category	NN
10_1101-2020_03_27_012757	337	17	or	or	CC
10_1101-2020_03_27_012757	337	18	categories	category	NNS
10_1101-2020_03_27_012757	337	19	not	not	RB
10_1101-2020_03_27_012757	337	20	including	include	VBG
10_1101-2020_03_27_012757	337	21	the	the	DT
10_1101-2020_03_27_012757	337	22	labelled	label	VBN
10_1101-2020_03_27_012757	337	23	cancer	cancer	NN
10_1101-2020_03_27_012757	337	24	category	category	NN
10_1101-2020_03_27_012757	337	25	,	,	,
10_1101-2020_03_27_012757	337	26	we	-PRON-	PRP
10_1101-2020_03_27_012757	337	27	667	667	CD
10_1101-2020_03_27_012757	337	28	assigned	assign	VBD
10_1101-2020_03_27_012757	337	29	it	-PRON-	PRP
10_1101-2020_03_27_012757	337	30	as	as	IN
10_1101-2020_03_27_012757	337	31	”	"	``
10_1101-2020_03_27_012757	337	32	other	other	JJ
10_1101-2020_03_27_012757	337	33	”	"	''
10_1101-2020_03_27_012757	337	34	.	.	.
10_1101-2020_03_27_012757	338	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	338	2	analyzed	analyze	VBD
10_1101-2020_03_27_012757	338	3	and	and	CC
10_1101-2020_03_27_012757	338	4	visualized	visualize	VBD
10_1101-2020_03_27_012757	338	5	the	the	DT
10_1101-2020_03_27_012757	338	6	results	result	NNS
10_1101-2020_03_27_012757	338	7	using	use	VBG
10_1101-2020_03_27_012757	338	8	R	r	NN
10_1101-2020_03_27_012757	338	9	and	and	CC
10_1101-2020_03_27_012757	338	10	R	r	NN
10_1101-2020_03_27_012757	338	11	packages	package	NNS
10_1101-2020_03_27_012757	338	12	668	668	CD
10_1101-2020_03_27_012757	338	13	pheatmap92	pheatmap92	NNPS
10_1101-2020_03_27_012757	338	14	and	and	CC
10_1101-2020_03_27_012757	338	15	ggplot293	ggplot293	NNP
10_1101-2020_03_27_012757	338	16	.	.	.
10_1101-2020_03_27_012757	339	1	669	669	CD
10_1101-2020_03_27_012757	339	2	670	670	CD
10_1101-2020_03_27_012757	339	3	Cross	Cross	NNP
10_1101-2020_03_27_012757	339	4	-	-	NNP
10_1101-2020_03_27_012757	339	5	Species	Species	NNP
10_1101-2020_03_27_012757	339	6	Assessment	Assessment	NNP
10_1101-2020_03_27_012757	339	7	671	671	CD
10_1101-2020_03_27_012757	339	8	To	to	TO
10_1101-2020_03_27_012757	339	9	assess	assess	VB
10_1101-2020_03_27_012757	339	10	the	the	DT
10_1101-2020_03_27_012757	339	11	performance	performance	NN
10_1101-2020_03_27_012757	339	12	of	of	IN
10_1101-2020_03_27_012757	339	13	cross	cross	JJ
10_1101-2020_03_27_012757	339	14	-	-	JJ
10_1101-2020_03_27_012757	339	15	species	species	JJ
10_1101-2020_03_27_012757	339	16	classification	classification	NN
10_1101-2020_03_27_012757	339	17	,	,	,
10_1101-2020_03_27_012757	339	18	we	-PRON-	PRP
10_1101-2020_03_27_012757	339	19	downloaded	download	VBD
10_1101-2020_03_27_012757	339	20	1003	1003	CD
10_1101-2020_03_27_012757	339	21	672	672	CD
10_1101-2020_03_27_012757	339	22	labelled	label	VBD
10_1101-2020_03_27_012757	339	23	human	human	JJ
10_1101-2020_03_27_012757	339	24	tissue	tissue	NN
10_1101-2020_03_27_012757	339	25	/	/	SYM
10_1101-2020_03_27_012757	339	26	cell	cell	NN
10_1101-2020_03_27_012757	339	27	type	type	NN
10_1101-2020_03_27_012757	339	28	and	and	CC
10_1101-2020_03_27_012757	339	29	1993	1993	CD
10_1101-2020_03_27_012757	339	30	labelled	label	VBN
10_1101-2020_03_27_012757	339	31	mouse	mouse	NN
10_1101-2020_03_27_012757	339	32	tissue	tissue	NN
10_1101-2020_03_27_012757	339	33	/	/	SYM
10_1101-2020_03_27_012757	339	34	cell	cell	NN
10_1101-2020_03_27_012757	339	35	type	type	NN
10_1101-2020_03_27_012757	339	36	RNA	RNA	NNP
10_1101-2020_03_27_012757	339	37	-	-	HYPH
10_1101-2020_03_27_012757	339	38	seq	seq	NN
10_1101-2020_03_27_012757	339	39	expression	expression	NN
10_1101-2020_03_27_012757	339	40	673	673	CD
10_1101-2020_03_27_012757	339	41	profiles	profile	NNS
10_1101-2020_03_27_012757	339	42	from	from	IN
10_1101-2020_03_27_012757	339	43	Github	Github	NNP
10_1101-2020_03_27_012757	339	44	(	(	-LRB-
10_1101-2020_03_27_012757	339	45	https://github.com/pcahan1/CellNet	https://github.com/pcahan1/CellNet	NNP
10_1101-2020_03_27_012757	339	46	)	)	-RRB-
10_1101-2020_03_27_012757	339	47	.	.	.
10_1101-2020_03_27_012757	340	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	340	2	first	first	RB
10_1101-2020_03_27_012757	340	3	converted	convert	VBD
10_1101-2020_03_27_012757	340	4	the	the	DT
10_1101-2020_03_27_012757	340	5	mouse	mouse	NN
10_1101-2020_03_27_012757	340	6	genes	gene	VBZ
10_1101-2020_03_27_012757	340	7	674	674	CD
10_1101-2020_03_27_012757	340	8	into	into	IN
10_1101-2020_03_27_012757	340	9	human	human	JJ
10_1101-2020_03_27_012757	340	10	homologous	homologous	JJ
10_1101-2020_03_27_012757	340	11	genes	gene	NNS
10_1101-2020_03_27_012757	340	12	.	.	.
10_1101-2020_03_27_012757	341	1	Then	then	RB
10_1101-2020_03_27_012757	341	2	we	-PRON-	PRP
10_1101-2020_03_27_012757	341	3	found	find	VBD
10_1101-2020_03_27_012757	341	4	the	the	DT
10_1101-2020_03_27_012757	341	5	intersecting	intersect	VBG
10_1101-2020_03_27_012757	341	6	genes	gene	NNS
10_1101-2020_03_27_012757	341	7	between	between	IN
10_1101-2020_03_27_012757	341	8	mouse	mouse	NN
10_1101-2020_03_27_012757	341	9	675	675	CD
10_1101-2020_03_27_012757	341	10	tissue	tissue	NN
10_1101-2020_03_27_012757	341	11	/	/	SYM
10_1101-2020_03_27_012757	341	12	cell	cell	NN
10_1101-2020_03_27_012757	341	13	expression	expression	NN
10_1101-2020_03_27_012757	341	14	profiles	profile	NNS
10_1101-2020_03_27_012757	341	15	and	and	CC
10_1101-2020_03_27_012757	341	16	human	human	JJ
10_1101-2020_03_27_012757	341	17	tissue	tissue	NN
10_1101-2020_03_27_012757	341	18	/	/	SYM
10_1101-2020_03_27_012757	341	19	cell	cell	NN
10_1101-2020_03_27_012757	341	20	expression	expression	NN
10_1101-2020_03_27_012757	341	21	profiles	profile	NNS
10_1101-2020_03_27_012757	341	22	.	.	.
10_1101-2020_03_27_012757	342	1	Limiting	limit	VBG
10_1101-2020_03_27_012757	342	2	the	the	DT
10_1101-2020_03_27_012757	342	3	input	input	NN
10_1101-2020_03_27_012757	342	4	of	of	IN
10_1101-2020_03_27_012757	342	5	676	676	CD
10_1101-2020_03_27_012757	342	6	human	human	JJ
10_1101-2020_03_27_012757	342	7	tissue	tissue	NN
10_1101-2020_03_27_012757	342	8	RNA	RNA	NNP
10_1101-2020_03_27_012757	342	9	-	-	HYPH
10_1101-2020_03_27_012757	342	10	seq	seq	NN
10_1101-2020_03_27_012757	342	11	profiles	profile	NNS
10_1101-2020_03_27_012757	342	12	to	to	IN
10_1101-2020_03_27_012757	342	13	the	the	DT
10_1101-2020_03_27_012757	342	14	intersecting	intersect	VBG
10_1101-2020_03_27_012757	342	15	genes	gene	NNS
10_1101-2020_03_27_012757	342	16	,	,	,
10_1101-2020_03_27_012757	342	17	we	-PRON-	PRP
10_1101-2020_03_27_012757	342	18	trained	train	VBD
10_1101-2020_03_27_012757	342	19	a	a	DT
10_1101-2020_03_27_012757	342	20	CCN	CCN	NNP
10_1101-2020_03_27_012757	342	21	classifier	classifier	NN
10_1101-2020_03_27_012757	342	22	with	with	IN
10_1101-2020_03_27_012757	342	23	all	all	DT
10_1101-2020_03_27_012757	342	24	677	677	CD
10_1101-2020_03_27_012757	342	25	the	the	DT
10_1101-2020_03_27_012757	342	26	human	human	JJ
10_1101-2020_03_27_012757	342	27	tissue	tissue	NN
10_1101-2020_03_27_012757	342	28	/	/	SYM
10_1101-2020_03_27_012757	342	29	cell	cell	NN
10_1101-2020_03_27_012757	342	30	expression	expression	NN
10_1101-2020_03_27_012757	342	31	profiles	profile	NNS
10_1101-2020_03_27_012757	342	32	.	.	.
10_1101-2020_03_27_012757	343	1	The	the	DT
10_1101-2020_03_27_012757	343	2	parameters	parameter	NNS
10_1101-2020_03_27_012757	343	3	used	use	VBD
10_1101-2020_03_27_012757	343	4	for	for	IN
10_1101-2020_03_27_012757	343	5	the	the	DT
10_1101-2020_03_27_012757	343	6	function	function	NN
10_1101-2020_03_27_012757	343	7	678	678	CD
10_1101-2020_03_27_012757	343	8	“	"	``
10_1101-2020_03_27_012757	343	9	broadClass_train	broadclass_train	NN
10_1101-2020_03_27_012757	343	10	”	"	''
10_1101-2020_03_27_012757	343	11	in	in	IN
10_1101-2020_03_27_012757	343	12	the	the	DT
10_1101-2020_03_27_012757	343	13	package	package	NN
10_1101-2020_03_27_012757	343	14	cancerCellNet	cancerCellNet	NNS
10_1101-2020_03_27_012757	343	15	are	be	VBP
10_1101-2020_03_27_012757	343	16	in	in	IN
10_1101-2020_03_27_012757	343	17	Supp	Supp	NNP
10_1101-2020_03_27_012757	343	18	Tab	Tab	NNP
10_1101-2020_03_27_012757	343	19	9	9	CD
10_1101-2020_03_27_012757	343	20	.	.	.
10_1101-2020_03_27_012757	344	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	344	2	randomly	randomly	RB
10_1101-2020_03_27_012757	344	3	sampled	sample	VBD
10_1101-2020_03_27_012757	344	4	75	75	CD
10_1101-2020_03_27_012757	344	5	679	679	CD
10_1101-2020_03_27_012757	344	6	.CC	.CC	NFP
10_1101-2020_03_27_012757	344	7	-	-	HYPH
10_1101-2020_03_27_012757	344	8	BY	by	IN
10_1101-2020_03_27_012757	344	9	-	-	HYPH
10_1101-2020_03_27_012757	344	10	NC	NC	NNP
10_1101-2020_03_27_012757	344	11	-	-	HYPH
10_1101-2020_03_27_012757	344	12	ND	ND	NNP
10_1101-2020_03_27_012757	344	13	4.0	4.0	CD
10_1101-2020_03_27_012757	344	14	International	International	NNP
10_1101-2020_03_27_012757	344	15	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	344	16	under	under	IN
10_1101-2020_03_27_012757	344	17	a	a	DT
10_1101-2020_03_27_012757	344	18	(	(	-LRB-
10_1101-2020_03_27_012757	344	19	which	which	WDT
10_1101-2020_03_27_012757	344	20	was	be	VBD
10_1101-2020_03_27_012757	344	21	not	not	RB
10_1101-2020_03_27_012757	344	22	certified	certify	VBN
10_1101-2020_03_27_012757	344	23	by	by	IN
10_1101-2020_03_27_012757	344	24	peer	peer	NN
10_1101-2020_03_27_012757	344	25	review	review	NN
10_1101-2020_03_27_012757	344	26	)	)	-RRB-
10_1101-2020_03_27_012757	344	27	is	be	VBZ
10_1101-2020_03_27_012757	344	28	the	the	DT
10_1101-2020_03_27_012757	344	29	author	author	NN
10_1101-2020_03_27_012757	344	30	/	/	SYM
10_1101-2020_03_27_012757	344	31	funder	funder	NN
10_1101-2020_03_27_012757	344	32	,	,	,
10_1101-2020_03_27_012757	344	33	who	who	WP
10_1101-2020_03_27_012757	344	34	has	have	VBZ
10_1101-2020_03_27_012757	344	35	granted	grant	VBN
10_1101-2020_03_27_012757	344	36	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	344	37	a	a	DT
10_1101-2020_03_27_012757	344	38	license	license	NN
10_1101-2020_03_27_012757	344	39	to	to	TO
10_1101-2020_03_27_012757	344	40	display	display	VB
10_1101-2020_03_27_012757	344	41	the	the	DT
10_1101-2020_03_27_012757	344	42	preprint	preprint	NN
10_1101-2020_03_27_012757	344	43	in	in	IN
10_1101-2020_03_27_012757	344	44	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	344	45	.	.	.
10_1101-2020_03_27_012757	345	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	345	2	is	be	VBZ
10_1101-2020_03_27_012757	345	3	made	make	VBN
10_1101-2020_03_27_012757	345	4	The	the	DT
10_1101-2020_03_27_012757	345	5	copyright	copyright	NN
10_1101-2020_03_27_012757	345	6	holder	holder	NN
10_1101-2020_03_27_012757	345	7	for	for	IN
10_1101-2020_03_27_012757	345	8	this	this	DT
10_1101-2020_03_27_012757	345	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	345	10	version	version	NN
10_1101-2020_03_27_012757	345	11	posted	post	VBD
10_1101-2020_03_27_012757	345	12	January	January	NNP
10_1101-2020_03_27_012757	345	13	9	9	CD
10_1101-2020_03_27_012757	345	14	,	,	,
10_1101-2020_03_27_012757	345	15	2021	2021	CD
10_1101-2020_03_27_012757	345	16	.	.	.
10_1101-2020_03_27_012757	345	17	;	;	:
10_1101-2020_03_27_012757	345	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	345	19	:	:	:
10_1101-2020_03_27_012757	345	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	345	21	preprint	preprint	NN
10_1101-2020_03_27_012757	345	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	345	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	345	24	26	26	CD
10_1101-2020_03_27_012757	345	25	samples	sample	NNS
10_1101-2020_03_27_012757	345	26	from	from	IN
10_1101-2020_03_27_012757	345	27	each	each	DT
10_1101-2020_03_27_012757	345	28	tissue	tissue	NN
10_1101-2020_03_27_012757	345	29	category	category	NN
10_1101-2020_03_27_012757	345	30	in	in	IN
10_1101-2020_03_27_012757	345	31	mouse	mouse	NN
10_1101-2020_03_27_012757	345	32	tissue	tissue	NN
10_1101-2020_03_27_012757	345	33	/	/	SYM
10_1101-2020_03_27_012757	345	34	cell	cell	NN
10_1101-2020_03_27_012757	345	35	data	datum	NNS
10_1101-2020_03_27_012757	345	36	and	and	CC
10_1101-2020_03_27_012757	345	37	applied	apply	VBD
10_1101-2020_03_27_012757	345	38	the	the	DT
10_1101-2020_03_27_012757	345	39	classifier	classifier	NN
10_1101-2020_03_27_012757	345	40	on	on	IN
10_1101-2020_03_27_012757	345	41	those	those	DT
10_1101-2020_03_27_012757	345	42	680	680	CD
10_1101-2020_03_27_012757	345	43	samples	sample	NNS
10_1101-2020_03_27_012757	345	44	to	to	TO
10_1101-2020_03_27_012757	345	45	assess	assess	VB
10_1101-2020_03_27_012757	345	46	performance	performance	NN
10_1101-2020_03_27_012757	345	47	.	.	.
10_1101-2020_03_27_012757	346	1	681	681	CD
10_1101-2020_03_27_012757	346	2	682	682	CD
10_1101-2020_03_27_012757	346	3	Cross	Cross	NNP
10_1101-2020_03_27_012757	346	4	-	-	NNP
10_1101-2020_03_27_012757	346	5	Technology	Technology	NNP
10_1101-2020_03_27_012757	346	6	Assessment	Assessment	NNP
10_1101-2020_03_27_012757	346	7	683	683	CD
10_1101-2020_03_27_012757	346	8	To	to	TO
10_1101-2020_03_27_012757	346	9	assess	assess	VB
10_1101-2020_03_27_012757	346	10	the	the	DT
10_1101-2020_03_27_012757	346	11	performance	performance	NN
10_1101-2020_03_27_012757	346	12	of	of	IN
10_1101-2020_03_27_012757	346	13	CCN	CCN	NNP
10_1101-2020_03_27_012757	346	14	in	in	IN
10_1101-2020_03_27_012757	346	15	applications	application	NNS
10_1101-2020_03_27_012757	346	16	to	to	IN
10_1101-2020_03_27_012757	346	17	microarray	microarray	JJ
10_1101-2020_03_27_012757	346	18	data	datum	NNS
10_1101-2020_03_27_012757	346	19	,	,	,
10_1101-2020_03_27_012757	346	20	we	-PRON-	PRP
10_1101-2020_03_27_012757	346	21	gathered	gather	VBD
10_1101-2020_03_27_012757	346	22	684	684	CD
10_1101-2020_03_27_012757	346	23	6,219	6,219	CD
10_1101-2020_03_27_012757	346	24	patient	patient	JJ
10_1101-2020_03_27_012757	346	25	tumor	tumor	NN
10_1101-2020_03_27_012757	346	26	microarray	microarray	NN
10_1101-2020_03_27_012757	346	27	profiles	profile	NNS
10_1101-2020_03_27_012757	346	28	across	across	IN
10_1101-2020_03_27_012757	346	29	12	12	CD
10_1101-2020_03_27_012757	346	30	different	different	JJ
10_1101-2020_03_27_012757	346	31	cancer	cancer	NN
10_1101-2020_03_27_012757	346	32	types	type	NNS
10_1101-2020_03_27_012757	346	33	from	from	IN
10_1101-2020_03_27_012757	346	34	more	more	JJR
10_1101-2020_03_27_012757	346	35	than	than	IN
10_1101-2020_03_27_012757	346	36	100	100	CD
10_1101-2020_03_27_012757	346	37	685	685	CD
10_1101-2020_03_27_012757	346	38	different	different	JJ
10_1101-2020_03_27_012757	346	39	projects	project	NNS
10_1101-2020_03_27_012757	346	40	(	(	-LRB-
10_1101-2020_03_27_012757	346	41	Supp	Supp	NNP
10_1101-2020_03_27_012757	346	42	Tab	Tab	NNP
10_1101-2020_03_27_012757	346	43	12	12	CD
10_1101-2020_03_27_012757	346	44	)	)	-RRB-
10_1101-2020_03_27_012757	346	45	.	.	.
10_1101-2020_03_27_012757	347	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	347	2	found	find	VBD
10_1101-2020_03_27_012757	347	3	the	the	DT
10_1101-2020_03_27_012757	347	4	intersecting	intersect	VBG
10_1101-2020_03_27_012757	347	5	genes	gene	NNS
10_1101-2020_03_27_012757	347	6	between	between	IN
10_1101-2020_03_27_012757	347	7	the	the	DT
10_1101-2020_03_27_012757	347	8	microarray	microarray	JJ
10_1101-2020_03_27_012757	347	9	686	686	CD
10_1101-2020_03_27_012757	347	10	profiles	profile	NNS
10_1101-2020_03_27_012757	347	11	and	and	CC
10_1101-2020_03_27_012757	347	12	TCGA	tcga	NN
10_1101-2020_03_27_012757	347	13	patient	patient	NN
10_1101-2020_03_27_012757	347	14	RNA	RNA	NNP
10_1101-2020_03_27_012757	347	15	-	-	HYPH
10_1101-2020_03_27_012757	347	16	seq	seq	NN
10_1101-2020_03_27_012757	347	17	profiles	profile	NNS
10_1101-2020_03_27_012757	347	18	.	.	.
10_1101-2020_03_27_012757	348	1	Limiting	limit	VBG
10_1101-2020_03_27_012757	348	2	the	the	DT
10_1101-2020_03_27_012757	348	3	input	input	NN
10_1101-2020_03_27_012757	348	4	of	of	IN
10_1101-2020_03_27_012757	348	5	RNA	RNA	NNP
10_1101-2020_03_27_012757	348	6	-	-	HYPH
10_1101-2020_03_27_012757	348	7	seq	seq	NN
10_1101-2020_03_27_012757	348	8	profiles	profile	NNS
10_1101-2020_03_27_012757	348	9	to	to	IN
10_1101-2020_03_27_012757	348	10	the	the	DT
10_1101-2020_03_27_012757	348	11	687	687	CD
10_1101-2020_03_27_012757	348	12	intersecting	intersect	VBG
10_1101-2020_03_27_012757	348	13	genes	gene	NNS
10_1101-2020_03_27_012757	348	14	,	,	,
10_1101-2020_03_27_012757	348	15	we	-PRON-	PRP
10_1101-2020_03_27_012757	348	16	created	create	VBD
10_1101-2020_03_27_012757	348	17	a	a	DT
10_1101-2020_03_27_012757	348	18	CCN	ccn	NN
10_1101-2020_03_27_012757	348	19	classifier	classifier	NN
10_1101-2020_03_27_012757	348	20	with	with	IN
10_1101-2020_03_27_012757	348	21	all	all	PDT
10_1101-2020_03_27_012757	348	22	the	the	DT
10_1101-2020_03_27_012757	348	23	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	348	24	patient	patient	NN
10_1101-2020_03_27_012757	348	25	profiles	profile	NNS
10_1101-2020_03_27_012757	348	26	using	use	VBG
10_1101-2020_03_27_012757	348	27	688	688	CD
10_1101-2020_03_27_012757	348	28	parameters	parameter	NNS
10_1101-2020_03_27_012757	348	29	for	for	IN
10_1101-2020_03_27_012757	348	30	the	the	DT
10_1101-2020_03_27_012757	348	31	function	function	NN
10_1101-2020_03_27_012757	348	32	“	"	``
10_1101-2020_03_27_012757	348	33	broadClass_train	broadclass_train	NN
10_1101-2020_03_27_012757	348	34	”	"	''
10_1101-2020_03_27_012757	348	35	listed	list	VBN
10_1101-2020_03_27_012757	348	36	in	in	IN
10_1101-2020_03_27_012757	348	37	Supp	Supp	NNP
10_1101-2020_03_27_012757	348	38	Tab	Tab	NNP
10_1101-2020_03_27_012757	348	39	9	9	CD
10_1101-2020_03_27_012757	348	40	.	.	.
10_1101-2020_03_27_012757	349	1	After	after	IN
10_1101-2020_03_27_012757	349	2	the	the	DT
10_1101-2020_03_27_012757	349	3	microarray	microarray	JJ
10_1101-2020_03_27_012757	349	4	689	689	CD
10_1101-2020_03_27_012757	349	5	specific	specific	JJ
10_1101-2020_03_27_012757	349	6	classifier	classifier	NN
10_1101-2020_03_27_012757	349	7	was	be	VBD
10_1101-2020_03_27_012757	349	8	trained	train	VBN
10_1101-2020_03_27_012757	349	9	,	,	,
10_1101-2020_03_27_012757	349	10	we	-PRON-	PRP
10_1101-2020_03_27_012757	349	11	randomly	randomly	RB
10_1101-2020_03_27_012757	349	12	sampled	sample	VBD
10_1101-2020_03_27_012757	349	13	60	60	CD
10_1101-2020_03_27_012757	349	14	microarray	microarray	JJ
10_1101-2020_03_27_012757	349	15	patient	patient	NN
10_1101-2020_03_27_012757	349	16	samples	sample	NNS
10_1101-2020_03_27_012757	349	17	from	from	IN
10_1101-2020_03_27_012757	349	18	each	each	DT
10_1101-2020_03_27_012757	349	19	690	690	CD
10_1101-2020_03_27_012757	349	20	cancer	cancer	NN
10_1101-2020_03_27_012757	349	21	category	category	NN
10_1101-2020_03_27_012757	349	22	and	and	CC
10_1101-2020_03_27_012757	349	23	applied	applied	JJ
10_1101-2020_03_27_012757	349	24	CCN	CCN	NNP
10_1101-2020_03_27_012757	349	25	classifier	classifier	NN
10_1101-2020_03_27_012757	349	26	on	on	IN
10_1101-2020_03_27_012757	349	27	them	-PRON-	PRP
10_1101-2020_03_27_012757	349	28	as	as	IN
10_1101-2020_03_27_012757	349	29	assessment	assessment	NN
10_1101-2020_03_27_012757	349	30	of	of	IN
10_1101-2020_03_27_012757	349	31	the	the	DT
10_1101-2020_03_27_012757	349	32	cross	cross	JJ
10_1101-2020_03_27_012757	349	33	-	-	NN
10_1101-2020_03_27_012757	349	34	technology	technology	NN
10_1101-2020_03_27_012757	349	35	691	691	CD
10_1101-2020_03_27_012757	349	36	performance	performance	NN
10_1101-2020_03_27_012757	349	37	in	in	IN
10_1101-2020_03_27_012757	349	38	Supp	Supp	NNP
10_1101-2020_03_27_012757	349	39	Fig	Fig	NNP
10_1101-2020_03_27_012757	349	40	2A.	2a.	CD
10_1101-2020_03_27_012757	350	1	The	the	DT
10_1101-2020_03_27_012757	350	2	same	same	JJ
10_1101-2020_03_27_012757	350	3	CCN	ccn	NN
10_1101-2020_03_27_012757	350	4	classifier	classifier	NN
10_1101-2020_03_27_012757	350	5	was	be	VBD
10_1101-2020_03_27_012757	350	6	used	use	VBN
10_1101-2020_03_27_012757	350	7	to	to	TO
10_1101-2020_03_27_012757	350	8	assess	assess	VB
10_1101-2020_03_27_012757	350	9	microarray	microarray	NNP
10_1101-2020_03_27_012757	350	10	CCL	CCL	NNP
10_1101-2020_03_27_012757	350	11	692	692	CD
10_1101-2020_03_27_012757	350	12	samples	sample	NNS
10_1101-2020_03_27_012757	350	13	Supp	Supp	NNP
10_1101-2020_03_27_012757	350	14	Fig	Fig	NNP
10_1101-2020_03_27_012757	350	15	2B.	2b.	CD
10_1101-2020_03_27_012757	351	1	693	693	CD
10_1101-2020_03_27_012757	351	2	694	694	CD
10_1101-2020_03_27_012757	351	3	Training	training	NN
10_1101-2020_03_27_012757	351	4	and	and	CC
10_1101-2020_03_27_012757	351	5	validating	validate	VBG
10_1101-2020_03_27_012757	351	6	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	351	7	-	-	HYPH
10_1101-2020_03_27_012757	351	8	seq	seq	NN
10_1101-2020_03_27_012757	351	9	Classifier	Classifier	NNP
10_1101-2020_03_27_012757	351	10	695	695	CD
10_1101-2020_03_27_012757	351	11	We	-PRON-	PRP
10_1101-2020_03_27_012757	351	12	extracted	extract	VBD
10_1101-2020_03_27_012757	351	13	labelled	label	VBN
10_1101-2020_03_27_012757	351	14	human	human	JJ
10_1101-2020_03_27_012757	351	15	melanoma	melanoma	NNP
10_1101-2020_03_27_012757	351	16	and	and	CC
10_1101-2020_03_27_012757	351	17	glioblastoma	glioblastoma	NNP
10_1101-2020_03_27_012757	351	18	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	351	19	-	-	HYPH
10_1101-2020_03_27_012757	351	20	seq	seq	NN
10_1101-2020_03_27_012757	351	21	expression	expression	NN
10_1101-2020_03_27_012757	351	22	696	696	CD
10_1101-2020_03_27_012757	351	23	profiles40,41	profiles40,41	NNS
10_1101-2020_03_27_012757	351	24	,	,	,
10_1101-2020_03_27_012757	351	25	and	and	CC
10_1101-2020_03_27_012757	351	26	compiled	compile	VBD
10_1101-2020_03_27_012757	351	27	the	the	DT
10_1101-2020_03_27_012757	351	28	two	two	CD
10_1101-2020_03_27_012757	351	29	datasets	dataset	NNS
10_1101-2020_03_27_012757	351	30	excluding	exclude	VBG
10_1101-2020_03_27_012757	351	31	3	3	CD
10_1101-2020_03_27_012757	351	32	cell	cell	NN
10_1101-2020_03_27_012757	351	33	types	type	NNS
10_1101-2020_03_27_012757	351	34	T.CD4	t.cd4	JJ
10_1101-2020_03_27_012757	351	35	,	,	,
10_1101-2020_03_27_012757	351	36	T.CD8	T.CD8	NNP
10_1101-2020_03_27_012757	351	37	and	and	CC
10_1101-2020_03_27_012757	351	38	Myeloid	Myeloid	NNP
10_1101-2020_03_27_012757	351	39	697	697	CD
10_1101-2020_03_27_012757	351	40	due	due	IN
10_1101-2020_03_27_012757	351	41	to	to	IN
10_1101-2020_03_27_012757	351	42	low	low	JJ
10_1101-2020_03_27_012757	351	43	number	number	NN
10_1101-2020_03_27_012757	351	44	of	of	IN
10_1101-2020_03_27_012757	351	45	cells	cell	NNS
10_1101-2020_03_27_012757	351	46	for	for	IN
10_1101-2020_03_27_012757	351	47	training	training	NN
10_1101-2020_03_27_012757	351	48	.	.	.
10_1101-2020_03_27_012757	352	1	60	60	CD
10_1101-2020_03_27_012757	352	2	cells	cell	NNS
10_1101-2020_03_27_012757	352	3	from	from	IN
10_1101-2020_03_27_012757	352	4	each	each	DT
10_1101-2020_03_27_012757	352	5	of	of	IN
10_1101-2020_03_27_012757	352	6	the	the	DT
10_1101-2020_03_27_012757	352	7	11	11	CD
10_1101-2020_03_27_012757	352	8	cell	cell	NN
10_1101-2020_03_27_012757	352	9	types	type	NNS
10_1101-2020_03_27_012757	352	10	were	be	VBD
10_1101-2020_03_27_012757	352	11	sampled	sample	VBN
10_1101-2020_03_27_012757	352	12	for	for	IN
10_1101-2020_03_27_012757	352	13	698	698	CD
10_1101-2020_03_27_012757	352	14	training	training	NN
10_1101-2020_03_27_012757	352	15	a	a	DT
10_1101-2020_03_27_012757	352	16	scRNA	scrna	CD
10_1101-2020_03_27_012757	352	17	-	-	HYPH
10_1101-2020_03_27_012757	352	18	seq	seq	NN
10_1101-2020_03_27_012757	352	19	classifier	classifier	NN
10_1101-2020_03_27_012757	352	20	.	.	.
10_1101-2020_03_27_012757	353	1	The	the	DT
10_1101-2020_03_27_012757	353	2	parameters	parameter	NNS
10_1101-2020_03_27_012757	353	3	for	for	IN
10_1101-2020_03_27_012757	353	4	training	train	VBG
10_1101-2020_03_27_012757	353	5	a	a	DT
10_1101-2020_03_27_012757	353	6	general	general	JJ
10_1101-2020_03_27_012757	353	7	scRNA	scrna	JJ
10_1101-2020_03_27_012757	353	8	-	-	HYPH
10_1101-2020_03_27_012757	353	9	seq	seq	NN
10_1101-2020_03_27_012757	353	10	classifier	classifier	NN
10_1101-2020_03_27_012757	353	11	699	699	CD
10_1101-2020_03_27_012757	353	12	using	use	VBG
10_1101-2020_03_27_012757	353	13	the	the	DT
10_1101-2020_03_27_012757	353	14	function	function	NN
10_1101-2020_03_27_012757	353	15	“	"	``
10_1101-2020_03_27_012757	353	16	broadClass_train	broadclass_train	NN
10_1101-2020_03_27_012757	353	17	”	"	''
10_1101-2020_03_27_012757	353	18	are	be	VBP
10_1101-2020_03_27_012757	353	19	in	in	IN
10_1101-2020_03_27_012757	353	20	Supp	Supp	NNP
10_1101-2020_03_27_012757	353	21	Tab	Tab	NNP
10_1101-2020_03_27_012757	353	22	9	9	CD
10_1101-2020_03_27_012757	353	23	.	.	.
10_1101-2020_03_27_012757	354	1	25	25	CD
10_1101-2020_03_27_012757	354	2	cells	cell	NNS
10_1101-2020_03_27_012757	354	3	from	from	IN
10_1101-2020_03_27_012757	354	4	each	each	DT
10_1101-2020_03_27_012757	354	5	of	of	IN
10_1101-2020_03_27_012757	354	6	the	the	DT
10_1101-2020_03_27_012757	354	7	11	11	CD
10_1101-2020_03_27_012757	354	8	cell	cell	NN
10_1101-2020_03_27_012757	354	9	types	type	NNS
10_1101-2020_03_27_012757	354	10	700	700	CD
10_1101-2020_03_27_012757	354	11	from	from	IN
10_1101-2020_03_27_012757	354	12	the	the	DT
10_1101-2020_03_27_012757	354	13	held	hold	VBN
10_1101-2020_03_27_012757	354	14	-	-	HYPH
10_1101-2020_03_27_012757	354	15	out	out	RP
10_1101-2020_03_27_012757	354	16	data	datum	NNS
10_1101-2020_03_27_012757	354	17	were	be	VBD
10_1101-2020_03_27_012757	354	18	selected	select	VBN
10_1101-2020_03_27_012757	354	19	to	to	TO
10_1101-2020_03_27_012757	354	20	assess	assess	VB
10_1101-2020_03_27_012757	354	21	the	the	DT
10_1101-2020_03_27_012757	354	22	single	single	JJ
10_1101-2020_03_27_012757	354	23	cell	cell	NN
10_1101-2020_03_27_012757	354	24	classifier	classifier	NN
10_1101-2020_03_27_012757	354	25	.	.	.
10_1101-2020_03_27_012757	355	1	Using	use	VBG
10_1101-2020_03_27_012757	355	2	maximization	maximization	NN
10_1101-2020_03_27_012757	355	3	of	of	IN
10_1101-2020_03_27_012757	355	4	701	701	CD
10_1101-2020_03_27_012757	355	5	average	average	JJ
10_1101-2020_03_27_012757	355	6	Macro	Macro	NNP
10_1101-2020_03_27_012757	355	7	F1	F1	NNP
10_1101-2020_03_27_012757	355	8	measure	measure	NN
10_1101-2020_03_27_012757	355	9	,	,	,
10_1101-2020_03_27_012757	355	10	we	-PRON-	PRP
10_1101-2020_03_27_012757	355	11	selected	select	VBD
10_1101-2020_03_27_012757	355	12	the	the	DT
10_1101-2020_03_27_012757	355	13	decision	decision	NN
10_1101-2020_03_27_012757	355	14	threshold	threshold	NN
10_1101-2020_03_27_012757	355	15	of	of	IN
10_1101-2020_03_27_012757	355	16	0.255	0.255	CD
10_1101-2020_03_27_012757	355	17	.	.	.
10_1101-2020_03_27_012757	356	1	The	the	DT
10_1101-2020_03_27_012757	356	2	gene	gene	NN
10_1101-2020_03_27_012757	356	3	-	-	HYPH
10_1101-2020_03_27_012757	356	4	pairs	pair	NNS
10_1101-2020_03_27_012757	356	5	that	that	WDT
10_1101-2020_03_27_012757	356	6	702	702	CD
10_1101-2020_03_27_012757	356	7	were	be	VBD
10_1101-2020_03_27_012757	356	8	selected	select	VBN
10_1101-2020_03_27_012757	356	9	to	to	TO
10_1101-2020_03_27_012757	356	10	construct	construct	VB
10_1101-2020_03_27_012757	356	11	the	the	DT
10_1101-2020_03_27_012757	356	12	classifier	classifier	NN
10_1101-2020_03_27_012757	356	13	are	be	VBP
10_1101-2020_03_27_012757	356	14	in	in	IN
10_1101-2020_03_27_012757	356	15	Supp	Supp	NNP
10_1101-2020_03_27_012757	356	16	Tab	Tab	NNP
10_1101-2020_03_27_012757	356	17	10	10	CD
10_1101-2020_03_27_012757	356	18	.	.	.
10_1101-2020_03_27_012757	357	1	To	to	TO
10_1101-2020_03_27_012757	357	2	assess	assess	VB
10_1101-2020_03_27_012757	357	3	the	the	DT
10_1101-2020_03_27_012757	357	4	cross	cross	NN
10_1101-2020_03_27_012757	357	5	-	-	NN
10_1101-2020_03_27_012757	357	6	technology	technology	NN
10_1101-2020_03_27_012757	357	7	703	703	CD
10_1101-2020_03_27_012757	357	8	capability	capability	NN
10_1101-2020_03_27_012757	357	9	of	of	IN
10_1101-2020_03_27_012757	357	10	applying	apply	VBG
10_1101-2020_03_27_012757	357	11	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	357	12	-	-	HYPH
10_1101-2020_03_27_012757	357	13	seq	seq	NN
10_1101-2020_03_27_012757	357	14	classifier	classifier	NN
10_1101-2020_03_27_012757	357	15	to	to	TO
10_1101-2020_03_27_012757	357	16	bulk	bulk	NNP
10_1101-2020_03_27_012757	357	17	RNA	RNA	NNP
10_1101-2020_03_27_012757	357	18	-	-	HYPH
10_1101-2020_03_27_012757	357	19	seq	seq	NN
10_1101-2020_03_27_012757	357	20	,	,	,
10_1101-2020_03_27_012757	357	21	we	-PRON-	PRP
10_1101-2020_03_27_012757	357	22	downloaded	download	VBD
10_1101-2020_03_27_012757	357	23	305	305	CD
10_1101-2020_03_27_012757	357	24	expression	expression	NN
10_1101-2020_03_27_012757	357	25	704	704	CD
10_1101-2020_03_27_012757	357	26	.CC	.CC	,
10_1101-2020_03_27_012757	357	27	-	-	HYPH
10_1101-2020_03_27_012757	357	28	BY	by	IN
10_1101-2020_03_27_012757	357	29	-	-	HYPH
10_1101-2020_03_27_012757	357	30	NC	NC	NNP
10_1101-2020_03_27_012757	357	31	-	-	HYPH
10_1101-2020_03_27_012757	357	32	ND	ND	NNP
10_1101-2020_03_27_012757	357	33	4.0	4.0	CD
10_1101-2020_03_27_012757	357	34	International	International	NNP
10_1101-2020_03_27_012757	357	35	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	357	36	under	under	IN
10_1101-2020_03_27_012757	357	37	a	a	DT
10_1101-2020_03_27_012757	357	38	(	(	-LRB-
10_1101-2020_03_27_012757	357	39	which	which	WDT
10_1101-2020_03_27_012757	357	40	was	be	VBD
10_1101-2020_03_27_012757	357	41	not	not	RB
10_1101-2020_03_27_012757	357	42	certified	certify	VBN
10_1101-2020_03_27_012757	357	43	by	by	IN
10_1101-2020_03_27_012757	357	44	peer	peer	NN
10_1101-2020_03_27_012757	357	45	review	review	NN
10_1101-2020_03_27_012757	357	46	)	)	-RRB-
10_1101-2020_03_27_012757	357	47	is	be	VBZ
10_1101-2020_03_27_012757	357	48	the	the	DT
10_1101-2020_03_27_012757	357	49	author	author	NN
10_1101-2020_03_27_012757	357	50	/	/	SYM
10_1101-2020_03_27_012757	357	51	funder	funder	NN
10_1101-2020_03_27_012757	357	52	,	,	,
10_1101-2020_03_27_012757	357	53	who	who	WP
10_1101-2020_03_27_012757	357	54	has	have	VBZ
10_1101-2020_03_27_012757	357	55	granted	grant	VBN
10_1101-2020_03_27_012757	357	56	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	357	57	a	a	DT
10_1101-2020_03_27_012757	357	58	license	license	NN
10_1101-2020_03_27_012757	357	59	to	to	TO
10_1101-2020_03_27_012757	357	60	display	display	VB
10_1101-2020_03_27_012757	357	61	the	the	DT
10_1101-2020_03_27_012757	357	62	preprint	preprint	NN
10_1101-2020_03_27_012757	357	63	in	in	IN
10_1101-2020_03_27_012757	357	64	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	357	65	.	.	.
10_1101-2020_03_27_012757	358	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	358	2	is	be	VBZ
10_1101-2020_03_27_012757	358	3	made	make	VBN
10_1101-2020_03_27_012757	358	4	The	the	DT
10_1101-2020_03_27_012757	358	5	copyright	copyright	NN
10_1101-2020_03_27_012757	358	6	holder	holder	NN
10_1101-2020_03_27_012757	358	7	for	for	IN
10_1101-2020_03_27_012757	358	8	this	this	DT
10_1101-2020_03_27_012757	358	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	358	10	version	version	NN
10_1101-2020_03_27_012757	358	11	posted	post	VBD
10_1101-2020_03_27_012757	358	12	January	January	NNP
10_1101-2020_03_27_012757	358	13	9	9	CD
10_1101-2020_03_27_012757	358	14	,	,	,
10_1101-2020_03_27_012757	358	15	2021	2021	CD
10_1101-2020_03_27_012757	358	16	.	.	.
10_1101-2020_03_27_012757	358	17	;	;	:
10_1101-2020_03_27_012757	358	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	358	19	:	:	:
10_1101-2020_03_27_012757	358	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	358	21	preprint	preprint	NN
10_1101-2020_03_27_012757	358	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	358	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	358	24	27	27	CD
10_1101-2020_03_27_012757	358	25	profiles	profile	NNS
10_1101-2020_03_27_012757	358	26	spanning	span	VBG
10_1101-2020_03_27_012757	358	27	4	4	CD
10_1101-2020_03_27_012757	358	28	purified	purify	VBN
10_1101-2020_03_27_012757	358	29	cell	cell	NN
10_1101-2020_03_27_012757	358	30	types	type	NNS
10_1101-2020_03_27_012757	358	31	(	(	-LRB-
10_1101-2020_03_27_012757	358	32	B	b	NN
10_1101-2020_03_27_012757	358	33	cells	cell	NNS
10_1101-2020_03_27_012757	358	34	,	,	,
10_1101-2020_03_27_012757	358	35	endothelial	endothelial	JJ
10_1101-2020_03_27_012757	358	36	cells	cell	NNS
10_1101-2020_03_27_012757	358	37	,	,	,
10_1101-2020_03_27_012757	358	38	monocyte	monocyte	NN
10_1101-2020_03_27_012757	358	39	/	/	SYM
10_1101-2020_03_27_012757	358	40	macrophage	macrophage	NN
10_1101-2020_03_27_012757	358	41	,	,	,
10_1101-2020_03_27_012757	358	42	705	705	CD
10_1101-2020_03_27_012757	358	43	fibroblast	fibroblast	NN
10_1101-2020_03_27_012757	358	44	)	)	-RRB-
10_1101-2020_03_27_012757	358	45	from	from	IN
10_1101-2020_03_27_012757	358	46	https://github.com/pcahan1/CellNet	https://github.com/pcahan1/CellNet	NNP
10_1101-2020_03_27_012757	358	47	.	.	.
10_1101-2020_03_27_012757	359	1	706	706	CD
10_1101-2020_03_27_012757	359	2	707	707	CD
10_1101-2020_03_27_012757	359	3	Training	Training	NNP
10_1101-2020_03_27_012757	359	4	Subtype	Subtype	NNP
10_1101-2020_03_27_012757	359	5	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	359	6	708	708	CD
10_1101-2020_03_27_012757	359	7	We	-PRON-	PRP
10_1101-2020_03_27_012757	359	8	found	find	VBD
10_1101-2020_03_27_012757	359	9	11	11	CD
10_1101-2020_03_27_012757	359	10	cancer	cancer	NN
10_1101-2020_03_27_012757	359	11	types	type	NNS
10_1101-2020_03_27_012757	359	12	(	(	-LRB-
10_1101-2020_03_27_012757	359	13	BRCA	BRCA	NNP
10_1101-2020_03_27_012757	359	14	,	,	,
10_1101-2020_03_27_012757	359	15	COAD	COAD	NNP
10_1101-2020_03_27_012757	359	16	,	,	,
10_1101-2020_03_27_012757	359	17	ESCA	ESCA	NNP
10_1101-2020_03_27_012757	359	18	,	,	,
10_1101-2020_03_27_012757	359	19	HNSC	HNSC	NNP
10_1101-2020_03_27_012757	359	20	,	,	,
10_1101-2020_03_27_012757	359	21	KIRC	KIRC	NNP
10_1101-2020_03_27_012757	359	22	,	,	,
10_1101-2020_03_27_012757	359	23	LGG	LGG	NNP
10_1101-2020_03_27_012757	359	24	,	,	,
10_1101-2020_03_27_012757	359	25	PAAD	PAAD	NNP
10_1101-2020_03_27_012757	359	26	,	,	,
10_1101-2020_03_27_012757	359	27	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	359	28	,	,	,
10_1101-2020_03_27_012757	359	29	709	709	CD
10_1101-2020_03_27_012757	359	30	STAD	stad	NN
10_1101-2020_03_27_012757	359	31	,	,	,
10_1101-2020_03_27_012757	359	32	LUAD	luad	RB
10_1101-2020_03_27_012757	359	33	,	,	,
10_1101-2020_03_27_012757	359	34	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	359	35	)	)	-RRB-
10_1101-2020_03_27_012757	359	36	which	which	WDT
10_1101-2020_03_27_012757	359	37	have	have	VBP
10_1101-2020_03_27_012757	359	38	meaningful	meaningful	JJ
10_1101-2020_03_27_012757	359	39	subtypes	subtype	NNS
10_1101-2020_03_27_012757	359	40	based	base	VBN
10_1101-2020_03_27_012757	359	41	on	on	IN
10_1101-2020_03_27_012757	359	42	either	either	DT
10_1101-2020_03_27_012757	359	43	histology	histology	NN
10_1101-2020_03_27_012757	359	44	or	or	CC
10_1101-2020_03_27_012757	359	45	molecular	molecular	NNP
10_1101-2020_03_27_012757	359	46	710	710	CD
10_1101-2020_03_27_012757	359	47	profile	profile	NN
10_1101-2020_03_27_012757	359	48	and	and	CC
10_1101-2020_03_27_012757	359	49	have	have	VB
10_1101-2020_03_27_012757	359	50	sufficient	sufficient	JJ
10_1101-2020_03_27_012757	359	51	samples	sample	NNS
10_1101-2020_03_27_012757	359	52	to	to	TO
10_1101-2020_03_27_012757	359	53	train	train	VB
10_1101-2020_03_27_012757	359	54	a	a	DT
10_1101-2020_03_27_012757	359	55	subtype	subtype	NN
10_1101-2020_03_27_012757	359	56	classifier	classifier	NN
10_1101-2020_03_27_012757	359	57	with	with	IN
10_1101-2020_03_27_012757	359	58	high	high	JJ
10_1101-2020_03_27_012757	359	59	AUPR	AUPR	NNP
10_1101-2020_03_27_012757	359	60	.	.	.
10_1101-2020_03_27_012757	360	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	360	2	also	also	RB
10_1101-2020_03_27_012757	360	3	711	711	CD
10_1101-2020_03_27_012757	360	4	included	include	VBD
10_1101-2020_03_27_012757	360	5	normal	normal	JJ
10_1101-2020_03_27_012757	360	6	tissues	tissue	NNS
10_1101-2020_03_27_012757	360	7	samples	sample	NNS
10_1101-2020_03_27_012757	360	8	from	from	IN
10_1101-2020_03_27_012757	360	9	BRCA	BRCA	NNP
10_1101-2020_03_27_012757	360	10	,	,	,
10_1101-2020_03_27_012757	360	11	COAD	COAD	NNP
10_1101-2020_03_27_012757	360	12	,	,	,
10_1101-2020_03_27_012757	360	13	HNSC	HNSC	NNP
10_1101-2020_03_27_012757	360	14	,	,	,
10_1101-2020_03_27_012757	360	15	KIRC	KIRC	NNP
10_1101-2020_03_27_012757	360	16	,	,	,
10_1101-2020_03_27_012757	360	17	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	360	18	to	to	TO
10_1101-2020_03_27_012757	360	19	create	create	VB
10_1101-2020_03_27_012757	360	20	a	a	DT
10_1101-2020_03_27_012757	360	21	normal	normal	JJ
10_1101-2020_03_27_012757	360	22	712	712	CD
10_1101-2020_03_27_012757	360	23	tissue	tissue	NN
10_1101-2020_03_27_012757	360	24	category	category	NN
10_1101-2020_03_27_012757	360	25	in	in	IN
10_1101-2020_03_27_012757	360	26	the	the	DT
10_1101-2020_03_27_012757	360	27	construction	construction	NN
10_1101-2020_03_27_012757	360	28	of	of	IN
10_1101-2020_03_27_012757	360	29	their	-PRON-	PRP$
10_1101-2020_03_27_012757	360	30	subtype	subtype	NN
10_1101-2020_03_27_012757	360	31	classifiers	classifier	NNS
10_1101-2020_03_27_012757	360	32	.	.	.
10_1101-2020_03_27_012757	361	1	Training	training	NN
10_1101-2020_03_27_012757	361	2	samples	sample	NNS
10_1101-2020_03_27_012757	361	3	were	be	VBD
10_1101-2020_03_27_012757	361	4	either	either	CC
10_1101-2020_03_27_012757	361	5	713	713	CD
10_1101-2020_03_27_012757	361	6	labelled	label	VBN
10_1101-2020_03_27_012757	361	7	as	as	IN
10_1101-2020_03_27_012757	361	8	a	a	DT
10_1101-2020_03_27_012757	361	9	cancer	cancer	NN
10_1101-2020_03_27_012757	361	10	subtype	subtype	NN
10_1101-2020_03_27_012757	361	11	for	for	IN
10_1101-2020_03_27_012757	361	12	the	the	DT
10_1101-2020_03_27_012757	361	13	cancer	cancer	NN
10_1101-2020_03_27_012757	361	14	of	of	IN
10_1101-2020_03_27_012757	361	15	interest	interest	NN
10_1101-2020_03_27_012757	361	16	or	or	CC
10_1101-2020_03_27_012757	361	17	as	as	IN
10_1101-2020_03_27_012757	361	18	“	"	``
10_1101-2020_03_27_012757	361	19	Unknown	unknown	JJ
10_1101-2020_03_27_012757	361	20	”	"	''
10_1101-2020_03_27_012757	361	21	if	if	IN
10_1101-2020_03_27_012757	361	22	they	-PRON-	PRP
10_1101-2020_03_27_012757	361	23	belong	belong	VBP
10_1101-2020_03_27_012757	361	24	to	to	IN
10_1101-2020_03_27_012757	361	25	other	other	JJ
10_1101-2020_03_27_012757	361	26	714	714	CD
10_1101-2020_03_27_012757	361	27	cancer	cancer	NN
10_1101-2020_03_27_012757	361	28	types	type	NNS
10_1101-2020_03_27_012757	361	29	.	.	.
10_1101-2020_03_27_012757	362	1	Similar	similar	JJ
10_1101-2020_03_27_012757	362	2	to	to	IN
10_1101-2020_03_27_012757	362	3	general	general	JJ
10_1101-2020_03_27_012757	362	4	classifier	classifier	NN
10_1101-2020_03_27_012757	362	5	training	training	NN
10_1101-2020_03_27_012757	362	6	,	,	,
10_1101-2020_03_27_012757	362	7	CCN	CCN	NNP
10_1101-2020_03_27_012757	362	8	performed	perform	VBD
10_1101-2020_03_27_012757	362	9	gene	gene	NN
10_1101-2020_03_27_012757	362	10	pair	pair	NN
10_1101-2020_03_27_012757	362	11	transformation	transformation	NN
10_1101-2020_03_27_012757	362	12	and	and	CC
10_1101-2020_03_27_012757	362	13	715	715	CD
10_1101-2020_03_27_012757	362	14	selected	select	VBD
10_1101-2020_03_27_012757	362	15	the	the	DT
10_1101-2020_03_27_012757	362	16	most	most	RBS
10_1101-2020_03_27_012757	362	17	discriminate	discriminate	NN
10_1101-2020_03_27_012757	362	18	gene	gene	NN
10_1101-2020_03_27_012757	362	19	pairs	pair	NNS
10_1101-2020_03_27_012757	362	20	for	for	IN
10_1101-2020_03_27_012757	362	21	each	each	DT
10_1101-2020_03_27_012757	362	22	cancer	cancer	NN
10_1101-2020_03_27_012757	362	23	subtype	subtype	NN
10_1101-2020_03_27_012757	362	24	.	.	.
10_1101-2020_03_27_012757	363	1	In	in	IN
10_1101-2020_03_27_012757	363	2	addition	addition	NN
10_1101-2020_03_27_012757	363	3	to	to	IN
10_1101-2020_03_27_012757	363	4	the	the	DT
10_1101-2020_03_27_012757	363	5	gene	gene	NN
10_1101-2020_03_27_012757	363	6	pairs	pairs	NNP
10_1101-2020_03_27_012757	363	7	716	716	CD
10_1101-2020_03_27_012757	363	8	selected	select	VBN
10_1101-2020_03_27_012757	363	9	to	to	TO
10_1101-2020_03_27_012757	363	10	discriminate	discriminate	VB
10_1101-2020_03_27_012757	363	11	cancer	cancer	NN
10_1101-2020_03_27_012757	363	12	subtypes	subtype	NNS
10_1101-2020_03_27_012757	363	13	,	,	,
10_1101-2020_03_27_012757	363	14	CCN	CCN	NNP
10_1101-2020_03_27_012757	363	15	also	also	RB
10_1101-2020_03_27_012757	363	16	performed	perform	VBD
10_1101-2020_03_27_012757	363	17	general	general	JJ
10_1101-2020_03_27_012757	363	18	classification	classification	NN
10_1101-2020_03_27_012757	363	19	of	of	IN
10_1101-2020_03_27_012757	363	20	all	all	DT
10_1101-2020_03_27_012757	363	21	717	717	CD
10_1101-2020_03_27_012757	363	22	training	training	NN
10_1101-2020_03_27_012757	363	23	data	datum	NNS
10_1101-2020_03_27_012757	363	24	and	and	CC
10_1101-2020_03_27_012757	363	25	appended	append	VBD
10_1101-2020_03_27_012757	363	26	the	the	DT
10_1101-2020_03_27_012757	363	27	classification	classification	NN
10_1101-2020_03_27_012757	363	28	profiles	profile	NNS
10_1101-2020_03_27_012757	363	29	of	of	IN
10_1101-2020_03_27_012757	363	30	training	train	VBG
10_1101-2020_03_27_012757	363	31	data	datum	NNS
10_1101-2020_03_27_012757	363	32	with	with	IN
10_1101-2020_03_27_012757	363	33	gene	gene	NN
10_1101-2020_03_27_012757	363	34	pair	pair	NN
10_1101-2020_03_27_012757	363	35	binary	binary	NNP
10_1101-2020_03_27_012757	363	36	718	718	CD
10_1101-2020_03_27_012757	363	37	matrix	matrix	NN
10_1101-2020_03_27_012757	363	38	as	as	IN
10_1101-2020_03_27_012757	363	39	additional	additional	JJ
10_1101-2020_03_27_012757	363	40	features	feature	NNS
10_1101-2020_03_27_012757	363	41	.	.	.
10_1101-2020_03_27_012757	364	1	The	the	DT
10_1101-2020_03_27_012757	364	2	reason	reason	NN
10_1101-2020_03_27_012757	364	3	behind	behind	IN
10_1101-2020_03_27_012757	364	4	using	use	VBG
10_1101-2020_03_27_012757	364	5	general	general	JJ
10_1101-2020_03_27_012757	364	6	classification	classification	NN
10_1101-2020_03_27_012757	364	7	profile	profile	NN
10_1101-2020_03_27_012757	364	8	as	as	IN
10_1101-2020_03_27_012757	364	9	additional	additional	JJ
10_1101-2020_03_27_012757	364	10	719	719	CD
10_1101-2020_03_27_012757	364	11	features	feature	NNS
10_1101-2020_03_27_012757	364	12	is	be	VBZ
10_1101-2020_03_27_012757	364	13	that	that	IN
10_1101-2020_03_27_012757	364	14	many	many	JJ
10_1101-2020_03_27_012757	364	15	general	general	JJ
10_1101-2020_03_27_012757	364	16	cancer	cancer	NN
10_1101-2020_03_27_012757	364	17	types	type	NNS
10_1101-2020_03_27_012757	364	18	may	may	MD
10_1101-2020_03_27_012757	364	19	share	share	VB
10_1101-2020_03_27_012757	364	20	similar	similar	JJ
10_1101-2020_03_27_012757	364	21	subtypes	subtype	NNS
10_1101-2020_03_27_012757	364	22	,	,	,
10_1101-2020_03_27_012757	364	23	and	and	CC
10_1101-2020_03_27_012757	364	24	general	general	JJ
10_1101-2020_03_27_012757	364	25	720	720	CD
10_1101-2020_03_27_012757	364	26	classification	classification	NN
10_1101-2020_03_27_012757	364	27	profile	profile	NN
10_1101-2020_03_27_012757	364	28	could	could	MD
10_1101-2020_03_27_012757	364	29	be	be	VB
10_1101-2020_03_27_012757	364	30	important	important	JJ
10_1101-2020_03_27_012757	364	31	features	feature	NNS
10_1101-2020_03_27_012757	364	32	to	to	TO
10_1101-2020_03_27_012757	364	33	discriminate	discriminate	VB
10_1101-2020_03_27_012757	364	34	the	the	DT
10_1101-2020_03_27_012757	364	35	general	general	JJ
10_1101-2020_03_27_012757	364	36	cancer	cancer	NN
10_1101-2020_03_27_012757	364	37	type	type	NN
10_1101-2020_03_27_012757	364	38	of	of	IN
10_1101-2020_03_27_012757	364	39	721	721	CD
10_1101-2020_03_27_012757	364	40	interest	interest	NN
10_1101-2020_03_27_012757	364	41	from	from	IN
10_1101-2020_03_27_012757	364	42	other	other	JJ
10_1101-2020_03_27_012757	364	43	cancer	cancer	NN
10_1101-2020_03_27_012757	364	44	types	type	NNS
10_1101-2020_03_27_012757	364	45	before	before	IN
10_1101-2020_03_27_012757	364	46	performing	perform	VBG
10_1101-2020_03_27_012757	364	47	finer	fine	JJR
10_1101-2020_03_27_012757	364	48	subtype	subtype	NN
10_1101-2020_03_27_012757	364	49	classification	classification	NN
10_1101-2020_03_27_012757	364	50	.	.	.
10_1101-2020_03_27_012757	365	1	The	the	DT
10_1101-2020_03_27_012757	365	2	specific	specific	JJ
10_1101-2020_03_27_012757	365	3	722	722	CD
10_1101-2020_03_27_012757	365	4	parameters	parameter	NNS
10_1101-2020_03_27_012757	365	5	used	use	VBN
10_1101-2020_03_27_012757	365	6	to	to	TO
10_1101-2020_03_27_012757	365	7	train	train	VB
10_1101-2020_03_27_012757	365	8	individual	individual	JJ
10_1101-2020_03_27_012757	365	9	subtype	subtype	NN
10_1101-2020_03_27_012757	365	10	classifiers	classifier	NNS
10_1101-2020_03_27_012757	365	11	using	use	VBG
10_1101-2020_03_27_012757	365	12	“	"	``
10_1101-2020_03_27_012757	365	13	subClass_train	subClass_train	,
10_1101-2020_03_27_012757	365	14	”	"	''
10_1101-2020_03_27_012757	365	15	function	function	NN
10_1101-2020_03_27_012757	365	16	of	of	IN
10_1101-2020_03_27_012757	365	17	723	723	CD
10_1101-2020_03_27_012757	365	18	CancerCellNet	cancercellnet	JJ
10_1101-2020_03_27_012757	365	19	package	package	NN
10_1101-2020_03_27_012757	365	20	can	can	MD
10_1101-2020_03_27_012757	365	21	be	be	VB
10_1101-2020_03_27_012757	365	22	found	find	VBN
10_1101-2020_03_27_012757	365	23	in	in	IN
10_1101-2020_03_27_012757	365	24	Supp	Supp	NNP
10_1101-2020_03_27_012757	365	25	Tab	Tab	NNP
10_1101-2020_03_27_012757	365	26	9	9	CD
10_1101-2020_03_27_012757	365	27	and	and	CC
10_1101-2020_03_27_012757	365	28	the	the	DT
10_1101-2020_03_27_012757	365	29	gene	gene	NN
10_1101-2020_03_27_012757	365	30	pairs	pair	NNS
10_1101-2020_03_27_012757	365	31	are	be	VBP
10_1101-2020_03_27_012757	365	32	in	in	IN
10_1101-2020_03_27_012757	365	33	Supp	Supp	NNP
10_1101-2020_03_27_012757	365	34	Tab	Tab	NNP
10_1101-2020_03_27_012757	365	35	10	10	CD
10_1101-2020_03_27_012757	365	36	.	.	.
10_1101-2020_03_27_012757	366	1	724	724	CD
10_1101-2020_03_27_012757	366	2	725	725	CD
10_1101-2020_03_27_012757	366	3	Validating	Validating	NNP
10_1101-2020_03_27_012757	366	4	Subtype	Subtype	NNP
10_1101-2020_03_27_012757	366	5	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	366	6	726	726	CD
10_1101-2020_03_27_012757	366	7	Similar	Similar	NNP
10_1101-2020_03_27_012757	366	8	to	to	IN
10_1101-2020_03_27_012757	366	9	validating	validate	VBG
10_1101-2020_03_27_012757	366	10	general	general	JJ
10_1101-2020_03_27_012757	366	11	class	class	NN
10_1101-2020_03_27_012757	366	12	classifier	classifier	NN
10_1101-2020_03_27_012757	366	13	,	,	,
10_1101-2020_03_27_012757	366	14	we	-PRON-	PRP
10_1101-2020_03_27_012757	366	15	randomly	randomly	RB
10_1101-2020_03_27_012757	366	16	sampled	sample	VBD
10_1101-2020_03_27_012757	366	17	2/3	2/3	CD
10_1101-2020_03_27_012757	366	18	of	of	IN
10_1101-2020_03_27_012757	366	19	all	all	DT
10_1101-2020_03_27_012757	366	20	samples	sample	NNS
10_1101-2020_03_27_012757	366	21	in	in	IN
10_1101-2020_03_27_012757	366	22	727	727	CD
10_1101-2020_03_27_012757	366	23	each	each	DT
10_1101-2020_03_27_012757	366	24	cancer	cancer	NN
10_1101-2020_03_27_012757	366	25	subtype	subtype	NN
10_1101-2020_03_27_012757	366	26	as	as	IN
10_1101-2020_03_27_012757	366	27	training	training	NN
10_1101-2020_03_27_012757	366	28	data	datum	NNS
10_1101-2020_03_27_012757	366	29	and	and	CC
10_1101-2020_03_27_012757	366	30	sampled	sample	VBD
10_1101-2020_03_27_012757	366	31	an	an	DT
10_1101-2020_03_27_012757	366	32	equal	equal	JJ
10_1101-2020_03_27_012757	366	33	amount	amount	NN
10_1101-2020_03_27_012757	366	34	across	across	IN
10_1101-2020_03_27_012757	366	35	subtypes	subtype	NNS
10_1101-2020_03_27_012757	366	36	in	in	IN
10_1101-2020_03_27_012757	366	37	the	the	DT
10_1101-2020_03_27_012757	366	38	1/3	1/3	CD
10_1101-2020_03_27_012757	366	39	728	728	CD
10_1101-2020_03_27_012757	366	40	held	hold	VBN
10_1101-2020_03_27_012757	366	41	-	-	HYPH
10_1101-2020_03_27_012757	366	42	out	out	RP
10_1101-2020_03_27_012757	366	43	data	datum	NNS
10_1101-2020_03_27_012757	366	44	for	for	IN
10_1101-2020_03_27_012757	366	45	assessing	assess	VBG
10_1101-2020_03_27_012757	366	46	subtype	subtype	NN
10_1101-2020_03_27_012757	366	47	classifiers	classifier	NNS
10_1101-2020_03_27_012757	366	48	.	.	.
10_1101-2020_03_27_012757	367	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	367	2	repeated	repeat	VBD
10_1101-2020_03_27_012757	367	3	the	the	DT
10_1101-2020_03_27_012757	367	4	process	process	NN
10_1101-2020_03_27_012757	367	5	20	20	CD
10_1101-2020_03_27_012757	367	6	times	time	NNS
10_1101-2020_03_27_012757	367	7	for	for	IN
10_1101-2020_03_27_012757	367	8	more	more	JJR
10_1101-2020_03_27_012757	367	9	729	729	CD
10_1101-2020_03_27_012757	367	10	comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	367	11	assessment	assessment	NN
10_1101-2020_03_27_012757	367	12	of	of	IN
10_1101-2020_03_27_012757	367	13	subtype	subtype	NN
10_1101-2020_03_27_012757	367	14	classifiers	classifier	NNS
10_1101-2020_03_27_012757	367	15	.	.	.
10_1101-2020_03_27_012757	368	1	730	730	CD
10_1101-2020_03_27_012757	368	2	.CC	.CC	:
10_1101-2020_03_27_012757	368	3	-	-	HYPH
10_1101-2020_03_27_012757	368	4	BY	by	IN
10_1101-2020_03_27_012757	368	5	-	-	HYPH
10_1101-2020_03_27_012757	368	6	NC	NC	NNP
10_1101-2020_03_27_012757	368	7	-	-	HYPH
10_1101-2020_03_27_012757	368	8	ND	ND	NNP
10_1101-2020_03_27_012757	368	9	4.0	4.0	CD
10_1101-2020_03_27_012757	368	10	International	International	NNP
10_1101-2020_03_27_012757	368	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	368	12	under	under	IN
10_1101-2020_03_27_012757	368	13	a	a	DT
10_1101-2020_03_27_012757	368	14	(	(	-LRB-
10_1101-2020_03_27_012757	368	15	which	which	WDT
10_1101-2020_03_27_012757	368	16	was	be	VBD
10_1101-2020_03_27_012757	368	17	not	not	RB
10_1101-2020_03_27_012757	368	18	certified	certify	VBN
10_1101-2020_03_27_012757	368	19	by	by	IN
10_1101-2020_03_27_012757	368	20	peer	peer	NN
10_1101-2020_03_27_012757	368	21	review	review	NN
10_1101-2020_03_27_012757	368	22	)	)	-RRB-
10_1101-2020_03_27_012757	368	23	is	be	VBZ
10_1101-2020_03_27_012757	368	24	the	the	DT
10_1101-2020_03_27_012757	368	25	author	author	NN
10_1101-2020_03_27_012757	368	26	/	/	SYM
10_1101-2020_03_27_012757	368	27	funder	funder	NN
10_1101-2020_03_27_012757	368	28	,	,	,
10_1101-2020_03_27_012757	368	29	who	who	WP
10_1101-2020_03_27_012757	368	30	has	have	VBZ
10_1101-2020_03_27_012757	368	31	granted	grant	VBN
10_1101-2020_03_27_012757	368	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	368	33	a	a	DT
10_1101-2020_03_27_012757	368	34	license	license	NN
10_1101-2020_03_27_012757	368	35	to	to	TO
10_1101-2020_03_27_012757	368	36	display	display	VB
10_1101-2020_03_27_012757	368	37	the	the	DT
10_1101-2020_03_27_012757	368	38	preprint	preprint	NN
10_1101-2020_03_27_012757	368	39	in	in	IN
10_1101-2020_03_27_012757	368	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	368	41	.	.	.
10_1101-2020_03_27_012757	369	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	369	2	is	be	VBZ
10_1101-2020_03_27_012757	369	3	made	make	VBN
10_1101-2020_03_27_012757	369	4	The	the	DT
10_1101-2020_03_27_012757	369	5	copyright	copyright	NN
10_1101-2020_03_27_012757	369	6	holder	holder	NN
10_1101-2020_03_27_012757	369	7	for	for	IN
10_1101-2020_03_27_012757	369	8	this	this	DT
10_1101-2020_03_27_012757	369	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	369	10	version	version	NN
10_1101-2020_03_27_012757	369	11	posted	post	VBD
10_1101-2020_03_27_012757	369	12	January	January	NNP
10_1101-2020_03_27_012757	369	13	9	9	CD
10_1101-2020_03_27_012757	369	14	,	,	,
10_1101-2020_03_27_012757	369	15	2021	2021	CD
10_1101-2020_03_27_012757	369	16	.	.	.
10_1101-2020_03_27_012757	369	17	;	;	:
10_1101-2020_03_27_012757	369	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	369	19	:	:	:
10_1101-2020_03_27_012757	369	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	369	21	preprint	preprint	NN
10_1101-2020_03_27_012757	369	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	369	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	369	24	28	28	CD
10_1101-2020_03_27_012757	369	25	Classifying	classify	VBG
10_1101-2020_03_27_012757	369	26	Query	Query	NNP
10_1101-2020_03_27_012757	369	27	Data	Data	NNP
10_1101-2020_03_27_012757	369	28	into	into	IN
10_1101-2020_03_27_012757	369	29	Subtypes	subtype	NNS
10_1101-2020_03_27_012757	369	30	731	731	CD
10_1101-2020_03_27_012757	369	31	We	-PRON-	PRP
10_1101-2020_03_27_012757	369	32	assigned	assign	VBD
10_1101-2020_03_27_012757	369	33	subtype	subtype	NN
10_1101-2020_03_27_012757	369	34	to	to	IN
10_1101-2020_03_27_012757	369	35	query	query	NN
10_1101-2020_03_27_012757	369	36	sample	sample	VB
10_1101-2020_03_27_012757	369	37	if	if	IN
10_1101-2020_03_27_012757	369	38	the	the	DT
10_1101-2020_03_27_012757	369	39	query	query	NN
10_1101-2020_03_27_012757	369	40	sample	sample	NN
10_1101-2020_03_27_012757	369	41	has	have	VBZ
10_1101-2020_03_27_012757	369	42	CCN	CCN	NNP
10_1101-2020_03_27_012757	369	43	score	score	VB
10_1101-2020_03_27_012757	369	44	higher	high	JJR
10_1101-2020_03_27_012757	369	45	than	than	IN
10_1101-2020_03_27_012757	369	46	732	732	CD
10_1101-2020_03_27_012757	369	47	the	the	DT
10_1101-2020_03_27_012757	369	48	decision	decision	NN
10_1101-2020_03_27_012757	369	49	threshold	threshold	NN
10_1101-2020_03_27_012757	369	50	.	.	.
10_1101-2020_03_27_012757	370	1	The	the	DT
10_1101-2020_03_27_012757	370	2	table	table	NN
10_1101-2020_03_27_012757	370	3	of	of	IN
10_1101-2020_03_27_012757	370	4	decision	decision	NN
10_1101-2020_03_27_012757	370	5	threshold	threshold	NN
10_1101-2020_03_27_012757	370	6	for	for	IN
10_1101-2020_03_27_012757	370	7	subtype	subtype	NN
10_1101-2020_03_27_012757	370	8	classifiers	classifier	NNS
10_1101-2020_03_27_012757	370	9	are	be	VBP
10_1101-2020_03_27_012757	370	10	in	in	IN
10_1101-2020_03_27_012757	370	11	Supp	Supp	NNP
10_1101-2020_03_27_012757	370	12	Tab	Tab	NNP
10_1101-2020_03_27_012757	370	13	733	733	CD
10_1101-2020_03_27_012757	370	14	11	11	CD
10_1101-2020_03_27_012757	370	15	.	.	.
10_1101-2020_03_27_012757	371	1	If	if	IN
10_1101-2020_03_27_012757	371	2	no	no	DT
10_1101-2020_03_27_012757	371	3	CCN	CCN	NNP
10_1101-2020_03_27_012757	371	4	scores	score	NNS
10_1101-2020_03_27_012757	371	5	exceed	exceed	VBP
10_1101-2020_03_27_012757	371	6	the	the	DT
10_1101-2020_03_27_012757	371	7	decision	decision	NN
10_1101-2020_03_27_012757	371	8	threshold	threshold	NN
10_1101-2020_03_27_012757	371	9	in	in	IN
10_1101-2020_03_27_012757	371	10	any	any	DT
10_1101-2020_03_27_012757	371	11	subtype	subtype	NN
10_1101-2020_03_27_012757	371	12	or	or	CC
10_1101-2020_03_27_012757	371	13	if	if	IN
10_1101-2020_03_27_012757	371	14	the	the	DT
10_1101-2020_03_27_012757	371	15	highest	high	JJS
10_1101-2020_03_27_012757	371	16	CCN	CCN	NNP
10_1101-2020_03_27_012757	371	17	score	score	NN
10_1101-2020_03_27_012757	371	18	734	734	CD
10_1101-2020_03_27_012757	371	19	is	be	VBZ
10_1101-2020_03_27_012757	371	20	in	in	IN
10_1101-2020_03_27_012757	371	21	‘	'	``
10_1101-2020_03_27_012757	371	22	Unknown	unknown	JJ
10_1101-2020_03_27_012757	371	23	’	'	''
10_1101-2020_03_27_012757	371	24	category	category	NN
10_1101-2020_03_27_012757	371	25	,	,	,
10_1101-2020_03_27_012757	371	26	then	then	RB
10_1101-2020_03_27_012757	371	27	we	-PRON-	PRP
10_1101-2020_03_27_012757	371	28	assigned	assign	VBD
10_1101-2020_03_27_012757	371	29	that	that	DT
10_1101-2020_03_27_012757	371	30	sample	sample	NN
10_1101-2020_03_27_012757	371	31	as	as	IN
10_1101-2020_03_27_012757	371	32	‘	'	``
10_1101-2020_03_27_012757	371	33	Unknown	unknown	JJ
10_1101-2020_03_27_012757	371	34	’	'	''
10_1101-2020_03_27_012757	371	35	.	.	.
10_1101-2020_03_27_012757	372	1	Analysis	analysis	NN
10_1101-2020_03_27_012757	372	2	was	be	VBD
10_1101-2020_03_27_012757	372	3	performed	perform	VBN
10_1101-2020_03_27_012757	372	4	735	735	CD
10_1101-2020_03_27_012757	372	5	in	in	IN
10_1101-2020_03_27_012757	372	6	R	r	NN
10_1101-2020_03_27_012757	372	7	and	and	CC
10_1101-2020_03_27_012757	372	8	visualizations	visualization	NNS
10_1101-2020_03_27_012757	372	9	were	be	VBD
10_1101-2020_03_27_012757	372	10	generated	generate	VBN
10_1101-2020_03_27_012757	372	11	with	with	IN
10_1101-2020_03_27_012757	372	12	the	the	DT
10_1101-2020_03_27_012757	372	13	ComplexHeatmap	ComplexHeatmap	NNP
10_1101-2020_03_27_012757	372	14	package94	package94	NN
10_1101-2020_03_27_012757	372	15	.	.	.
10_1101-2020_03_27_012757	373	1	736	736	CD
10_1101-2020_03_27_012757	373	2	737	737	CD
10_1101-2020_03_27_012757	373	3	Cells	cell	NNS
10_1101-2020_03_27_012757	373	4	culture	culture	NN
10_1101-2020_03_27_012757	373	5	,	,	,
10_1101-2020_03_27_012757	373	6	Immunohistochemistry	Immunohistochemistry	NNP
10_1101-2020_03_27_012757	373	7	and	and	CC
10_1101-2020_03_27_012757	373	8	histomorphometry	histomorphometry	NN
10_1101-2020_03_27_012757	373	9	738	738	CD
10_1101-2020_03_27_012757	373	10	Caov-4	Caov-4	NNP
10_1101-2020_03_27_012757	373	11	(	(	-LRB-
10_1101-2020_03_27_012757	373	12	ATCC	ATCC	NNP
10_1101-2020_03_27_012757	373	13	®	®	NNPS
10_1101-2020_03_27_012757	373	14	HTB-76	htb-76	CD
10_1101-2020_03_27_012757	373	15	™	™	CD
10_1101-2020_03_27_012757	373	16	)	)	-RRB-
10_1101-2020_03_27_012757	373	17	,	,	,
10_1101-2020_03_27_012757	373	18	SK	SK	NNP
10_1101-2020_03_27_012757	373	19	-	-	HYPH
10_1101-2020_03_27_012757	373	20	OV-3(ATCC	OV-3(ATCC	NNP
10_1101-2020_03_27_012757	373	21	®	®	NNPS
10_1101-2020_03_27_012757	373	22	HTB-77	HTB-77	NNP
10_1101-2020_03_27_012757	373	23	™	™	CD
10_1101-2020_03_27_012757	373	24	)	)	-RRB-
10_1101-2020_03_27_012757	373	25	,	,	,
10_1101-2020_03_27_012757	373	26	RT4	RT4	NNP
10_1101-2020_03_27_012757	373	27	(	(	-LRB-
10_1101-2020_03_27_012757	373	28	ATCC	ATCC	NNP
10_1101-2020_03_27_012757	373	29	®	®	NNPS
10_1101-2020_03_27_012757	373	30	HTB-2	HTB-2	NNP
10_1101-2020_03_27_012757	373	31	™	™	CD
10_1101-2020_03_27_012757	373	32	)	)	-RRB-
10_1101-2020_03_27_012757	373	33	,	,	,
10_1101-2020_03_27_012757	373	34	and	and	CC
10_1101-2020_03_27_012757	373	35	739	739	CD
10_1101-2020_03_27_012757	373	36	NCCIT(ATCC	NCCIT(ATCC	NNP
10_1101-2020_03_27_012757	373	37	®	®	NNP
10_1101-2020_03_27_012757	373	38	CRL-2073	CRL-2073	NNP
10_1101-2020_03_27_012757	373	39	™	™	CD
10_1101-2020_03_27_012757	373	40	)	)	-RRB-
10_1101-2020_03_27_012757	373	41	cell	cell	NN
10_1101-2020_03_27_012757	373	42	lines	line	NNS
10_1101-2020_03_27_012757	373	43	were	be	VBD
10_1101-2020_03_27_012757	373	44	purchased	purchase	VBN
10_1101-2020_03_27_012757	373	45	from	from	IN
10_1101-2020_03_27_012757	373	46	ATCC	ATCC	NNP
10_1101-2020_03_27_012757	373	47	.	.	.
10_1101-2020_03_27_012757	374	1	HEC-59	HEC-59	NNP
10_1101-2020_03_27_012757	374	2	(	(	-LRB-
10_1101-2020_03_27_012757	374	3	C0026001	C0026001	NNP
10_1101-2020_03_27_012757	374	4	)	)	-RRB-
10_1101-2020_03_27_012757	374	5	and	and	CC
10_1101-2020_03_27_012757	374	6	740	740	CD
10_1101-2020_03_27_012757	374	7	A2780	a2780	NN
10_1101-2020_03_27_012757	374	8	(	(	-LRB-
10_1101-2020_03_27_012757	374	9	93112519	93112519	CD
10_1101-2020_03_27_012757	374	10	-	-	SYM
10_1101-2020_03_27_012757	374	11	1VL	1vl	CD
10_1101-2020_03_27_012757	374	12	)	)	-RRB-
10_1101-2020_03_27_012757	374	13	were	be	VBD
10_1101-2020_03_27_012757	374	14	obtained	obtain	VBN
10_1101-2020_03_27_012757	374	15	from	from	IN
10_1101-2020_03_27_012757	374	16	Addexbio	Addexbio	NNP
10_1101-2020_03_27_012757	374	17	Technologies	Technologies	NNPS
10_1101-2020_03_27_012757	374	18	and	and	CC
10_1101-2020_03_27_012757	374	19	Sigma	Sigma	NNP
10_1101-2020_03_27_012757	374	20	-	-	HYPH
10_1101-2020_03_27_012757	374	21	Aldrich	Aldrich	NNP
10_1101-2020_03_27_012757	374	22	.	.	.
10_1101-2020_03_27_012757	375	1	Vcap	Vcap	NNP
10_1101-2020_03_27_012757	375	2	741	741	CD
10_1101-2020_03_27_012757	375	3	and	and	CC
10_1101-2020_03_27_012757	375	4	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	375	5	.	.	.
10_1101-2020_03_27_012757	376	1	SK	SK	NNP
10_1101-2020_03_27_012757	376	2	-	-	HYPH
10_1101-2020_03_27_012757	376	3	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	376	4	,	,	,
10_1101-2020_03_27_012757	376	5	Vcap	Vcap	NNP
10_1101-2020_03_27_012757	376	6	,	,	,
10_1101-2020_03_27_012757	376	7	and	and	CC
10_1101-2020_03_27_012757	376	8	RT4	RT4	NNP
10_1101-2020_03_27_012757	376	9	were	be	VBD
10_1101-2020_03_27_012757	376	10	cultured	culture	VBN
10_1101-2020_03_27_012757	376	11	in	in	IN
10_1101-2020_03_27_012757	376	12	Dulbecco	Dulbecco	NNP
10_1101-2020_03_27_012757	376	13	's	's	POS
10_1101-2020_03_27_012757	376	14	Modified	Modified	NNP
10_1101-2020_03_27_012757	376	15	Eagle	Eagle	NNP
10_1101-2020_03_27_012757	376	16	Medium	Medium	NNP
10_1101-2020_03_27_012757	376	17	742	742	CD
10_1101-2020_03_27_012757	376	18	(	(	-LRB-
10_1101-2020_03_27_012757	376	19	DMEM	DMEM	NNS
10_1101-2020_03_27_012757	376	20	,	,	,
10_1101-2020_03_27_012757	376	21	high	high	JJ
10_1101-2020_03_27_012757	376	22	glucose	glucose	NN
10_1101-2020_03_27_012757	376	23	,	,	,
10_1101-2020_03_27_012757	376	24	11960069	11960069	CD
10_1101-2020_03_27_012757	376	25	,	,	,
10_1101-2020_03_27_012757	376	26	Gibco	Gibco	NNP
10_1101-2020_03_27_012757	376	27	)	)	-RRB-
10_1101-2020_03_27_012757	376	28	with	with	IN
10_1101-2020_03_27_012757	376	29	1	1	CD
10_1101-2020_03_27_012757	376	30	%	%	NN
10_1101-2020_03_27_012757	376	31	Penicillin	Penicillin	NNP
10_1101-2020_03_27_012757	376	32	-	-	HYPH
10_1101-2020_03_27_012757	376	33	Streptomycin	Streptomycin	NNP
10_1101-2020_03_27_012757	376	34	-	-	HYPH
10_1101-2020_03_27_012757	376	35	Glutamine	Glutamine	NNP
10_1101-2020_03_27_012757	376	36	(	(	-LRB-
10_1101-2020_03_27_012757	376	37	743	743	CD
10_1101-2020_03_27_012757	376	38	10378016	10378016	CD
10_1101-2020_03_27_012757	376	39	,	,	,
10_1101-2020_03_27_012757	376	40	Life	Life	NNP
10_1101-2020_03_27_012757	376	41	Technologies	Technologies	NNP
10_1101-2020_03_27_012757	376	42	)	)	-RRB-
10_1101-2020_03_27_012757	376	43	;	;	:
10_1101-2020_03_27_012757	376	44	Caov-4	Caov-4	NNP
10_1101-2020_03_27_012757	376	45	,	,	,
10_1101-2020_03_27_012757	376	46	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	376	47	,	,	,
10_1101-2020_03_27_012757	376	48	NCCIT	NCCIT	NNP
10_1101-2020_03_27_012757	376	49	,	,	,
10_1101-2020_03_27_012757	376	50	and	and	CC
10_1101-2020_03_27_012757	376	51	A2780	A2780	NNP
10_1101-2020_03_27_012757	376	52	were	be	VBD
10_1101-2020_03_27_012757	376	53	cultured	culture	VBN
10_1101-2020_03_27_012757	376	54	using	use	VBG
10_1101-2020_03_27_012757	376	55	RPMI-744	RPMI-744	NNP
10_1101-2020_03_27_012757	376	56	1640	1640	CD
10_1101-2020_03_27_012757	376	57	medium	medium	NN
10_1101-2020_03_27_012757	376	58	(	(	-LRB-
10_1101-2020_03_27_012757	376	59	11875093	11875093	CD
10_1101-2020_03_27_012757	376	60	,	,	,
10_1101-2020_03_27_012757	376	61	Gibco	Gibco	NNP
10_1101-2020_03_27_012757	376	62	)	)	-RRB-
10_1101-2020_03_27_012757	376	63	while	while	IN
10_1101-2020_03_27_012757	376	64	HEC-59	HEC-59	NNP
10_1101-2020_03_27_012757	376	65	was	be	VBD
10_1101-2020_03_27_012757	376	66	in	in	IN
10_1101-2020_03_27_012757	376	67	Iscove	Iscove	NNP
10_1101-2020_03_27_012757	376	68	's	's	POS
10_1101-2020_03_27_012757	376	69	Modified	Modified	NNP
10_1101-2020_03_27_012757	376	70	Dulbecco	Dulbecco	NNP
10_1101-2020_03_27_012757	376	71	's	's	POS
10_1101-2020_03_27_012757	376	72	Medium	Medium	NNP
10_1101-2020_03_27_012757	376	73	745	745	CD
10_1101-2020_03_27_012757	376	74	(	(	-LRB-
10_1101-2020_03_27_012757	376	75	IMDM	IMDM	NNP
10_1101-2020_03_27_012757	376	76	,	,	,
10_1101-2020_03_27_012757	376	77	12440053	12440053	CD
10_1101-2020_03_27_012757	376	78	,	,	,
10_1101-2020_03_27_012757	376	79	Gibco	Gibco	NNP
10_1101-2020_03_27_012757	376	80	)	)	-RRB-
10_1101-2020_03_27_012757	376	81	.	.	.
10_1101-2020_03_27_012757	377	1	Both	both	DT
10_1101-2020_03_27_012757	377	2	media	medium	NNS
10_1101-2020_03_27_012757	377	3	were	be	VBD
10_1101-2020_03_27_012757	377	4	supplemented	supplement	VBN
10_1101-2020_03_27_012757	377	5	with	with	IN
10_1101-2020_03_27_012757	377	6	1	1	CD
10_1101-2020_03_27_012757	377	7	%	%	NN
10_1101-2020_03_27_012757	377	8	Penicillin	Penicillin	NNP
10_1101-2020_03_27_012757	377	9	-	-	HYPH
10_1101-2020_03_27_012757	377	10	Streptomycin	Streptomycin	NNP
10_1101-2020_03_27_012757	377	11	746	746	CD
10_1101-2020_03_27_012757	377	12	(	(	-LRB-
10_1101-2020_03_27_012757	377	13	15140122	15140122	CD
10_1101-2020_03_27_012757	377	14	,	,	,
10_1101-2020_03_27_012757	377	15	Gibco	Gibco	NNP
10_1101-2020_03_27_012757	377	16	)	)	-RRB-
10_1101-2020_03_27_012757	377	17	.	.	.
10_1101-2020_03_27_012757	378	1	All	all	DT
10_1101-2020_03_27_012757	378	2	medium	medium	NN
10_1101-2020_03_27_012757	378	3	included	include	VBD
10_1101-2020_03_27_012757	378	4	10	10	CD
10_1101-2020_03_27_012757	378	5	%	%	NN
10_1101-2020_03_27_012757	378	6	Fetal	Fetal	NNP
10_1101-2020_03_27_012757	378	7	Bovine	Bovine	NNP
10_1101-2020_03_27_012757	378	8	Serum	Serum	NNP
10_1101-2020_03_27_012757	378	9	(	(	-LRB-
10_1101-2020_03_27_012757	378	10	FBS	FBS	NNP
10_1101-2020_03_27_012757	378	11	)	)	-RRB-
10_1101-2020_03_27_012757	378	12	.	.	.
10_1101-2020_03_27_012757	379	1	747	747	CD
10_1101-2020_03_27_012757	379	2	Cells	cell	NNS
10_1101-2020_03_27_012757	379	3	cultured	culture	VBD
10_1101-2020_03_27_012757	379	4	in	in	IN
10_1101-2020_03_27_012757	379	5	48-well	48-well	CD
10_1101-2020_03_27_012757	379	6	plate	plate	NN
10_1101-2020_03_27_012757	379	7	were	be	VBD
10_1101-2020_03_27_012757	379	8	washed	wash	VBN
10_1101-2020_03_27_012757	379	9	twice	twice	RB
10_1101-2020_03_27_012757	379	10	with	with	IN
10_1101-2020_03_27_012757	379	11	PBS	PBS	NNP
10_1101-2020_03_27_012757	379	12	and	and	CC
10_1101-2020_03_27_012757	379	13	fixed	fix	VBN
10_1101-2020_03_27_012757	379	14	in	in	IN
10_1101-2020_03_27_012757	379	15	10	10	CD
10_1101-2020_03_27_012757	379	16	%	%	NN
10_1101-2020_03_27_012757	379	17	buffered	buffer	VBN
10_1101-2020_03_27_012757	379	18	748	748	CD
10_1101-2020_03_27_012757	379	19	formalin	formalin	NN
10_1101-2020_03_27_012757	379	20	for	for	IN
10_1101-2020_03_27_012757	379	21	24	24	CD
10_1101-2020_03_27_012757	379	22	 	 	_SP
10_1101-2020_03_27_012757	379	23	hrs	hrs	VBP
10_1101-2020_03_27_012757	379	24	at	at	IN
10_1101-2020_03_27_012757	379	25	4	4	CD
10_1101-2020_03_27_012757	379	26	°	°	NNS
10_1101-2020_03_27_012757	379	27	C	C	NNP
10_1101-2020_03_27_012757	379	28	.	.	.
10_1101-2020_03_27_012757	380	1	Immunostaining	Immunostaining	NNP
10_1101-2020_03_27_012757	380	2	was	be	VBD
10_1101-2020_03_27_012757	380	3	performed	perform	VBN
10_1101-2020_03_27_012757	380	4	using	use	VBG
10_1101-2020_03_27_012757	380	5	a	a	DT
10_1101-2020_03_27_012757	380	6	standard	standard	JJ
10_1101-2020_03_27_012757	380	7	protocol	protocol	NN
10_1101-2020_03_27_012757	380	8	.	.	.
10_1101-2020_03_27_012757	381	1	Cells	cell	NNS
10_1101-2020_03_27_012757	381	2	749	749	CD
10_1101-2020_03_27_012757	381	3	were	be	VBD
10_1101-2020_03_27_012757	381	4	incubated	incubate	VBN
10_1101-2020_03_27_012757	381	5	with	with	IN
10_1101-2020_03_27_012757	381	6	primary	primary	JJ
10_1101-2020_03_27_012757	381	7	antibodies	antibody	NNS
10_1101-2020_03_27_012757	381	8	to	to	IN
10_1101-2020_03_27_012757	381	9	goat	goat	NNP
10_1101-2020_03_27_012757	381	10	HOXB6	HOXB6	.
10_1101-2020_03_27_012757	381	11	(	(	-LRB-
10_1101-2020_03_27_012757	381	12	10	10	CD
10_1101-2020_03_27_012757	381	13	µg	µg	CD
10_1101-2020_03_27_012757	381	14	/	/	SYM
10_1101-2020_03_27_012757	381	15	mL	mL	NNP
10_1101-2020_03_27_012757	381	16	,	,	,
10_1101-2020_03_27_012757	381	17	PA5	PA5	NNP
10_1101-2020_03_27_012757	381	18	-	-	HYPH
10_1101-2020_03_27_012757	381	19	37867	37867	CD
10_1101-2020_03_27_012757	381	20	,	,	,
10_1101-2020_03_27_012757	381	21	Invitrogen	Invitrogen	NNP
10_1101-2020_03_27_012757	381	22	)	)	-RRB-
10_1101-2020_03_27_012757	381	23	,	,	,
10_1101-2020_03_27_012757	381	24	750	750	CD
10_1101-2020_03_27_012757	381	25	mouse	mouse	NN
10_1101-2020_03_27_012757	381	26	WT1(10	WT1(10	NNP
10_1101-2020_03_27_012757	381	27	µg	µg	NNP
10_1101-2020_03_27_012757	381	28	/	/	SYM
10_1101-2020_03_27_012757	381	29	mL	mL	NNP
10_1101-2020_03_27_012757	381	30	,	,	,
10_1101-2020_03_27_012757	381	31	MA1	MA1	NNP
10_1101-2020_03_27_012757	381	32	-	-	HYPH
10_1101-2020_03_27_012757	381	33	46028	46028	CD
10_1101-2020_03_27_012757	381	34	,	,	,
10_1101-2020_03_27_012757	381	35	Invitrogen	Invitrogen	NNP
10_1101-2020_03_27_012757	381	36	)	)	-RRB-
10_1101-2020_03_27_012757	381	37	,	,	,
10_1101-2020_03_27_012757	381	38	rabbit	rabbit	NN
10_1101-2020_03_27_012757	381	39	PPARG	PPARG	NNP
10_1101-2020_03_27_012757	381	40	(	(	-LRB-
10_1101-2020_03_27_012757	381	41	1:50	1:50	CD
10_1101-2020_03_27_012757	381	42	,	,	,
10_1101-2020_03_27_012757	381	43	ABN1445	ABN1445	NNP
10_1101-2020_03_27_012757	381	44	,	,	,
10_1101-2020_03_27_012757	381	45	Millipore	Millipore	NNP
10_1101-2020_03_27_012757	381	46	)	)	-RRB-
10_1101-2020_03_27_012757	381	47	,	,	,
10_1101-2020_03_27_012757	381	48	751	751	CD
10_1101-2020_03_27_012757	381	49	mouse	mouse	NN
10_1101-2020_03_27_012757	381	50	FOLH1(10	folh1(10	NN
10_1101-2020_03_27_012757	381	51	µg	µg	.
10_1101-2020_03_27_012757	381	52	/	/	SYM
10_1101-2020_03_27_012757	381	53	mL	mL	NNP
10_1101-2020_03_27_012757	381	54	,	,	,
10_1101-2020_03_27_012757	381	55	UM570025	UM570025	NNP
10_1101-2020_03_27_012757	381	56	,	,	,
10_1101-2020_03_27_012757	381	57	Origene	Origene	NNP
10_1101-2020_03_27_012757	381	58	)	)	-RRB-
10_1101-2020_03_27_012757	381	59	,	,	,
10_1101-2020_03_27_012757	381	60	and	and	CC
10_1101-2020_03_27_012757	381	61	rabbit	rabbit	NN
10_1101-2020_03_27_012757	381	62	LIN28A	lin28a	CD
10_1101-2020_03_27_012757	381	63	(	(	-LRB-
10_1101-2020_03_27_012757	381	64	1:50	1:50	CD
10_1101-2020_03_27_012757	381	65	,	,	,
10_1101-2020_03_27_012757	381	66	#	#	$
10_1101-2020_03_27_012757	381	67	3978	3978	CD
10_1101-2020_03_27_012757	381	68	,	,	,
10_1101-2020_03_27_012757	381	69	Cell	Cell	NNP
10_1101-2020_03_27_012757	381	70	Signaling	Signaling	NNP
10_1101-2020_03_27_012757	381	71	)	)	-RRB-
10_1101-2020_03_27_012757	381	72	752	752	CD
10_1101-2020_03_27_012757	381	73	in	in	IN
10_1101-2020_03_27_012757	381	74	Antibody	Antibody	NNP
10_1101-2020_03_27_012757	381	75	Diluent	Diluent	NNP
10_1101-2020_03_27_012757	381	76	(	(	-LRB-
10_1101-2020_03_27_012757	381	77	S080981	S080981	NNP
10_1101-2020_03_27_012757	381	78	-	-	HYPH
10_1101-2020_03_27_012757	381	79	2	2	CD
10_1101-2020_03_27_012757	381	80	,	,	,
10_1101-2020_03_27_012757	381	81	DAKO	DAKO	NNP
10_1101-2020_03_27_012757	381	82	)	)	-RRB-
10_1101-2020_03_27_012757	381	83	,	,	,
10_1101-2020_03_27_012757	381	84	at	at	IN
10_1101-2020_03_27_012757	381	85	4	4	CD
10_1101-2020_03_27_012757	381	86	 	 	_SP
10_1101-2020_03_27_012757	381	87	°	°	,
10_1101-2020_03_27_012757	381	88	C	C	NNP
10_1101-2020_03_27_012757	381	89	overnight	overnight	RB
10_1101-2020_03_27_012757	381	90	followed	follow	VBD
10_1101-2020_03_27_012757	381	91	with	with	IN
10_1101-2020_03_27_012757	381	92	three	three	CD
10_1101-2020_03_27_012757	381	93	5	5	CD
10_1101-2020_03_27_012757	381	94	min	min	NN
10_1101-2020_03_27_012757	381	95	washes	wash	NNS
10_1101-2020_03_27_012757	381	96	in	in	IN
10_1101-2020_03_27_012757	381	97	753	753	CD
10_1101-2020_03_27_012757	381	98	TBST	TBST	NNP
10_1101-2020_03_27_012757	381	99	.	.	.
10_1101-2020_03_27_012757	382	1	The	the	DT
10_1101-2020_03_27_012757	382	2	slides	slide	NNS
10_1101-2020_03_27_012757	382	3	were	be	VBD
10_1101-2020_03_27_012757	382	4	then	then	RB
10_1101-2020_03_27_012757	382	5	incubated	incubate	VBN
10_1101-2020_03_27_012757	382	6	with	with	IN
10_1101-2020_03_27_012757	382	7	secondary	secondary	JJ
10_1101-2020_03_27_012757	382	8	antibodies	antibody	NNS
10_1101-2020_03_27_012757	382	9	conjugated	conjugate	VBN
10_1101-2020_03_27_012757	382	10	with	with	IN
10_1101-2020_03_27_012757	382	11	fluorescence	fluorescence	NN
10_1101-2020_03_27_012757	382	12	754	754	CD
10_1101-2020_03_27_012757	382	13	at	at	IN
10_1101-2020_03_27_012757	382	14	room	room	NN
10_1101-2020_03_27_012757	382	15	temperature	temperature	NN
10_1101-2020_03_27_012757	382	16	for	for	IN
10_1101-2020_03_27_012757	382	17	1	1	CD
10_1101-2020_03_27_012757	382	18	 	 	_SP
10_1101-2020_03_27_012757	382	19	h	h	NN
10_1101-2020_03_27_012757	382	20	while	while	IN
10_1101-2020_03_27_012757	382	21	avoiding	avoid	VBG
10_1101-2020_03_27_012757	382	22	light	light	NN
10_1101-2020_03_27_012757	382	23	followed	follow	VBN
10_1101-2020_03_27_012757	382	24	with	with	IN
10_1101-2020_03_27_012757	382	25	three	three	CD
10_1101-2020_03_27_012757	382	26	5	5	CD
10_1101-2020_03_27_012757	382	27	min	min	NN
10_1101-2020_03_27_012757	382	28	washes	wash	NNS
10_1101-2020_03_27_012757	382	29	in	in	IN
10_1101-2020_03_27_012757	382	30	TBST	TBST	NNP
10_1101-2020_03_27_012757	382	31	and	and	CC
10_1101-2020_03_27_012757	382	32	755	755	CD
10_1101-2020_03_27_012757	382	33	.CC	.CC	:
10_1101-2020_03_27_012757	382	34	-	-	HYPH
10_1101-2020_03_27_012757	382	35	BY	by	IN
10_1101-2020_03_27_012757	382	36	-	-	HYPH
10_1101-2020_03_27_012757	382	37	NC	NC	NNP
10_1101-2020_03_27_012757	382	38	-	-	HYPH
10_1101-2020_03_27_012757	382	39	ND	ND	NNP
10_1101-2020_03_27_012757	382	40	4.0	4.0	CD
10_1101-2020_03_27_012757	382	41	International	International	NNP
10_1101-2020_03_27_012757	382	42	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	382	43	under	under	IN
10_1101-2020_03_27_012757	382	44	a	a	DT
10_1101-2020_03_27_012757	382	45	(	(	-LRB-
10_1101-2020_03_27_012757	382	46	which	which	WDT
10_1101-2020_03_27_012757	382	47	was	be	VBD
10_1101-2020_03_27_012757	382	48	not	not	RB
10_1101-2020_03_27_012757	382	49	certified	certify	VBN
10_1101-2020_03_27_012757	382	50	by	by	IN
10_1101-2020_03_27_012757	382	51	peer	peer	NN
10_1101-2020_03_27_012757	382	52	review	review	NN
10_1101-2020_03_27_012757	382	53	)	)	-RRB-
10_1101-2020_03_27_012757	382	54	is	be	VBZ
10_1101-2020_03_27_012757	382	55	the	the	DT
10_1101-2020_03_27_012757	382	56	author	author	NN
10_1101-2020_03_27_012757	382	57	/	/	SYM
10_1101-2020_03_27_012757	382	58	funder	funder	NN
10_1101-2020_03_27_012757	382	59	,	,	,
10_1101-2020_03_27_012757	382	60	who	who	WP
10_1101-2020_03_27_012757	382	61	has	have	VBZ
10_1101-2020_03_27_012757	382	62	granted	grant	VBN
10_1101-2020_03_27_012757	382	63	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	382	64	a	a	DT
10_1101-2020_03_27_012757	382	65	license	license	NN
10_1101-2020_03_27_012757	382	66	to	to	TO
10_1101-2020_03_27_012757	382	67	display	display	VB
10_1101-2020_03_27_012757	382	68	the	the	DT
10_1101-2020_03_27_012757	382	69	preprint	preprint	NN
10_1101-2020_03_27_012757	382	70	in	in	IN
10_1101-2020_03_27_012757	382	71	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	382	72	.	.	.
10_1101-2020_03_27_012757	383	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	383	2	is	be	VBZ
10_1101-2020_03_27_012757	383	3	made	make	VBN
10_1101-2020_03_27_012757	383	4	The	the	DT
10_1101-2020_03_27_012757	383	5	copyright	copyright	NN
10_1101-2020_03_27_012757	383	6	holder	holder	NN
10_1101-2020_03_27_012757	383	7	for	for	IN
10_1101-2020_03_27_012757	383	8	this	this	DT
10_1101-2020_03_27_012757	383	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	383	10	version	version	NN
10_1101-2020_03_27_012757	383	11	posted	post	VBD
10_1101-2020_03_27_012757	383	12	January	January	NNP
10_1101-2020_03_27_012757	383	13	9	9	CD
10_1101-2020_03_27_012757	383	14	,	,	,
10_1101-2020_03_27_012757	383	15	2021	2021	CD
10_1101-2020_03_27_012757	383	16	.	.	.
10_1101-2020_03_27_012757	383	17	;	;	:
10_1101-2020_03_27_012757	383	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	383	19	:	:	:
10_1101-2020_03_27_012757	383	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	383	21	preprint	preprint	NN
10_1101-2020_03_27_012757	383	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	383	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	383	24	29	29	CD
10_1101-2020_03_27_012757	383	25	nuclear	nuclear	NN
10_1101-2020_03_27_012757	383	26	stained	stain	VBN
10_1101-2020_03_27_012757	383	27	with	with	IN
10_1101-2020_03_27_012757	383	28	mounting	mount	VBG
10_1101-2020_03_27_012757	383	29	medium	medium	NN
10_1101-2020_03_27_012757	383	30	containing	contain	VBG
10_1101-2020_03_27_012757	383	31	DAPI	dapi	NN
10_1101-2020_03_27_012757	383	32	.	.	.
10_1101-2020_03_27_012757	384	1	Images	image	NNS
10_1101-2020_03_27_012757	384	2	were	be	VBD
10_1101-2020_03_27_012757	384	3	captured	capture	VBN
10_1101-2020_03_27_012757	384	4	by	by	IN
10_1101-2020_03_27_012757	384	5	Nikon	Nikon	NNP
10_1101-2020_03_27_012757	384	6	756	756	CD
10_1101-2020_03_27_012757	384	7	EcLipse	EcLipse	NNP
10_1101-2020_03_27_012757	384	8	Ti	Ti	NNP
10_1101-2020_03_27_012757	384	9	-	-	HYPH
10_1101-2020_03_27_012757	384	10	S	S	NNP
10_1101-2020_03_27_012757	384	11	,	,	,
10_1101-2020_03_27_012757	384	12	DS	DS	NNP
10_1101-2020_03_27_012757	384	13	-	-	HYPH
10_1101-2020_03_27_012757	384	14	U3	U3	NNP
10_1101-2020_03_27_012757	384	15	and	and	CC
10_1101-2020_03_27_012757	384	16	DS	DS	NNP
10_1101-2020_03_27_012757	384	17	-	-	HYPH
10_1101-2020_03_27_012757	384	18	Qi2	Qi2	NNP
10_1101-2020_03_27_012757	384	19	.	.	.
10_1101-2020_03_27_012757	385	1	757	757	CD
10_1101-2020_03_27_012757	385	2	Histomorphometry	Histomorphometry	NNP
10_1101-2020_03_27_012757	385	3	was	be	VBD
10_1101-2020_03_27_012757	385	4	performed	perform	VBN
10_1101-2020_03_27_012757	385	5	using	use	VBG
10_1101-2020_03_27_012757	385	6	ImageJ	ImageJ	NNP
10_1101-2020_03_27_012757	385	7	(	(	-LRB-
10_1101-2020_03_27_012757	385	8	Version	Version	NNP
10_1101-2020_03_27_012757	385	9	2.0.0-rc-69/1.52i	2.0.0-rc-69/1.52i	NNP
10_1101-2020_03_27_012757	385	10	)	)	-RRB-
10_1101-2020_03_27_012757	385	11	.	.	.
10_1101-2020_03_27_012757	386	1	%	%	NN
10_1101-2020_03_27_012757	386	2	758	758	CD
10_1101-2020_03_27_012757	386	3	N.positive	n.positive	JJ
10_1101-2020_03_27_012757	386	4	cells	cell	NNS
10_1101-2020_03_27_012757	386	5	was	be	VBD
10_1101-2020_03_27_012757	386	6	calculated	calculate	VBN
10_1101-2020_03_27_012757	386	7	by	by	IN
10_1101-2020_03_27_012757	386	8	the	the	DT
10_1101-2020_03_27_012757	386	9	percentage	percentage	NN
10_1101-2020_03_27_012757	386	10	of	of	IN
10_1101-2020_03_27_012757	386	11	the	the	DT
10_1101-2020_03_27_012757	386	12	number	number	NN
10_1101-2020_03_27_012757	386	13	of	of	IN
10_1101-2020_03_27_012757	386	14	positive	positive	JJ
10_1101-2020_03_27_012757	386	15	stained	stain	VBN
10_1101-2020_03_27_012757	386	16	cells	cell	NNS
10_1101-2020_03_27_012757	386	17	divided	divide	VBD
10_1101-2020_03_27_012757	386	18	759	759	CD
10_1101-2020_03_27_012757	386	19	by	by	IN
10_1101-2020_03_27_012757	386	20	the	the	DT
10_1101-2020_03_27_012757	386	21	number	number	NN
10_1101-2020_03_27_012757	386	22	of	of	IN
10_1101-2020_03_27_012757	386	23	DAPI	dapi	NN
10_1101-2020_03_27_012757	386	24	-	-	HYPH
10_1101-2020_03_27_012757	386	25	positive	positive	JJ
10_1101-2020_03_27_012757	386	26	nucleus	nucleus	NN
10_1101-2020_03_27_012757	386	27	within	within	IN
10_1101-2020_03_27_012757	386	28	three	three	CD
10_1101-2020_03_27_012757	386	29	of	of	IN
10_1101-2020_03_27_012757	386	30	randomly	randomly	RB
10_1101-2020_03_27_012757	386	31	chosen	choose	VBN
10_1101-2020_03_27_012757	386	32	areas	area	NNS
10_1101-2020_03_27_012757	386	33	.	.	.
10_1101-2020_03_27_012757	387	1	The	the	DT
10_1101-2020_03_27_012757	387	2	data	datum	NNS
10_1101-2020_03_27_012757	387	3	were	be	VBD
10_1101-2020_03_27_012757	387	4	760	760	CD
10_1101-2020_03_27_012757	387	5	expressed	express	VBN
10_1101-2020_03_27_012757	387	6	as	as	IN
10_1101-2020_03_27_012757	387	7	means	mean	VBZ
10_1101-2020_03_27_012757	387	8	±	±	NNP
10_1101-2020_03_27_012757	387	9	SD	sd	NN
10_1101-2020_03_27_012757	387	10	.	.	.
10_1101-2020_03_27_012757	388	1	761	761	CD
10_1101-2020_03_27_012757	388	2	762	762	CD
10_1101-2020_03_27_012757	388	3	Tumor	Tumor	NNP
10_1101-2020_03_27_012757	388	4	Purity	Purity	NNP
10_1101-2020_03_27_012757	388	5	Analysis	Analysis	NNP
10_1101-2020_03_27_012757	388	6	763	763	CD
10_1101-2020_03_27_012757	388	7	We	-PRON-	PRP
10_1101-2020_03_27_012757	388	8	used	use	VBD
10_1101-2020_03_27_012757	388	9	the	the	DT
10_1101-2020_03_27_012757	388	10	R	r	NN
10_1101-2020_03_27_012757	388	11	package	package	NN
10_1101-2020_03_27_012757	388	12	ESTIMATE95	ESTIMATE95	NNS
10_1101-2020_03_27_012757	388	13	to	to	TO
10_1101-2020_03_27_012757	388	14	calculate	calculate	VB
10_1101-2020_03_27_012757	388	15	the	the	DT
10_1101-2020_03_27_012757	388	16	ESTIMATE	estimate	NN
10_1101-2020_03_27_012757	388	17	scores	score	NNS
10_1101-2020_03_27_012757	388	18	from	from	IN
10_1101-2020_03_27_012757	388	19	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	388	20	764	764	CD
10_1101-2020_03_27_012757	388	21	tumor	tumor	NN
10_1101-2020_03_27_012757	388	22	expression	expression	NN
10_1101-2020_03_27_012757	388	23	profiles	profile	NNS
10_1101-2020_03_27_012757	388	24	that	that	WDT
10_1101-2020_03_27_012757	388	25	we	-PRON-	PRP
10_1101-2020_03_27_012757	388	26	used	use	VBD
10_1101-2020_03_27_012757	388	27	as	as	IN
10_1101-2020_03_27_012757	388	28	training	training	NN
10_1101-2020_03_27_012757	388	29	data	datum	NNS
10_1101-2020_03_27_012757	388	30	for	for	IN
10_1101-2020_03_27_012757	388	31	CCN	CCN	NNP
10_1101-2020_03_27_012757	388	32	classifier	classifier	NN
10_1101-2020_03_27_012757	388	33	.	.	.
10_1101-2020_03_27_012757	389	1	To	to	TO
10_1101-2020_03_27_012757	389	2	calculate	calculate	VB
10_1101-2020_03_27_012757	389	3	tumor	tumor	NN
10_1101-2020_03_27_012757	389	4	765	765	CD
10_1101-2020_03_27_012757	389	5	purity	purity	NN
10_1101-2020_03_27_012757	389	6	we	-PRON-	PRP
10_1101-2020_03_27_012757	389	7	used	use	VBD
10_1101-2020_03_27_012757	389	8	the	the	DT
10_1101-2020_03_27_012757	389	9	equation	equation	NN
10_1101-2020_03_27_012757	389	10	described	describe	VBN
10_1101-2020_03_27_012757	389	11	in	in	IN
10_1101-2020_03_27_012757	389	12	YoshiHara	YoshiHara	NNP
10_1101-2020_03_27_012757	389	13	et	et	FW
10_1101-2020_03_27_012757	389	14	al	al	NNP
10_1101-2020_03_27_012757	389	15	.	.	NNP
10_1101-2020_03_27_012757	389	16	,	,	,
10_1101-2020_03_27_012757	389	17	201395	201395	CD
10_1101-2020_03_27_012757	389	18	:	:	:
10_1101-2020_03_27_012757	389	19	766	766	CD
10_1101-2020_03_27_012757	389	20	Tumour	Tumour	NNP
10_1101-2020_03_27_012757	389	21	purity	purity	NN
10_1101-2020_03_27_012757	389	22	=	=	SYM
10_1101-2020_03_27_012757	389	23	cos	cos	NNP
10_1101-2020_03_27_012757	389	24	(	(	-LRB-
10_1101-2020_03_27_012757	389	25	0.6049872018	0.6049872018	CD
10_1101-2020_03_27_012757	389	26	+	+	SYM
10_1101-2020_03_27_012757	389	27	0.0001467884	0.0001467884	CD
10_1101-2020_03_27_012757	389	28	×	×	NN
10_1101-2020_03_27_012757	389	29	ESTIMATE	estimate	NN
10_1101-2020_03_27_012757	389	30	score	score	NN
10_1101-2020_03_27_012757	389	31	)	)	-RRB-
10_1101-2020_03_27_012757	389	32	767	767	CD
10_1101-2020_03_27_012757	389	33	768	768	CD
10_1101-2020_03_27_012757	389	34	Extracting	Extracting	NNP
10_1101-2020_03_27_012757	389	35	Citation	citation	NN
10_1101-2020_03_27_012757	389	36	Counts	count	VBZ
10_1101-2020_03_27_012757	389	37	769	769	CD
10_1101-2020_03_27_012757	389	38	We	-PRON-	PRP
10_1101-2020_03_27_012757	389	39	used	use	VBD
10_1101-2020_03_27_012757	389	40	the	the	DT
10_1101-2020_03_27_012757	389	41	R	r	NN
10_1101-2020_03_27_012757	389	42	package	package	NN
10_1101-2020_03_27_012757	389	43	RISmed96	RISmed96	NNP
10_1101-2020_03_27_012757	389	44	to	to	TO
10_1101-2020_03_27_012757	389	45	extract	extract	VB
10_1101-2020_03_27_012757	389	46	the	the	DT
10_1101-2020_03_27_012757	389	47	number	number	NN
10_1101-2020_03_27_012757	389	48	of	of	IN
10_1101-2020_03_27_012757	389	49	citations	citation	NNS
10_1101-2020_03_27_012757	389	50	for	for	IN
10_1101-2020_03_27_012757	389	51	each	each	DT
10_1101-2020_03_27_012757	389	52	cell	cell	NN
10_1101-2020_03_27_012757	389	53	line	line	NN
10_1101-2020_03_27_012757	389	54	770	770	CD
10_1101-2020_03_27_012757	389	55	through	through	IN
10_1101-2020_03_27_012757	389	56	query	query	NN
10_1101-2020_03_27_012757	389	57	search	search	NN
10_1101-2020_03_27_012757	389	58	of	of	IN
10_1101-2020_03_27_012757	389	59	“	"	``
10_1101-2020_03_27_012757	389	60	cell	cell	NN
10_1101-2020_03_27_012757	389	61	line	line	NN
10_1101-2020_03_27_012757	389	62	name[Text	name[text	IN
10_1101-2020_03_27_012757	389	63	Word	Word	NNP
10_1101-2020_03_27_012757	389	64	]	]	-RRB-
10_1101-2020_03_27_012757	389	65	AND	and	CC
10_1101-2020_03_27_012757	389	66	cancer[Text	cancer[Text	NNP
10_1101-2020_03_27_012757	389	67	Word	Word	NNP
10_1101-2020_03_27_012757	389	68	]	]	-RRB-
10_1101-2020_03_27_012757	389	69	”	"	''
10_1101-2020_03_27_012757	389	70	on	on	IN
10_1101-2020_03_27_012757	389	71	PubMed	PubMed	NNP
10_1101-2020_03_27_012757	389	72	.	.	.
10_1101-2020_03_27_012757	390	1	The	the	DT
10_1101-2020_03_27_012757	390	2	771	771	CD
10_1101-2020_03_27_012757	390	3	citation	citation	NN
10_1101-2020_03_27_012757	390	4	counts	count	NNS
10_1101-2020_03_27_012757	390	5	were	be	VBD
10_1101-2020_03_27_012757	390	6	normalized	normalize	VBN
10_1101-2020_03_27_012757	390	7	by	by	IN
10_1101-2020_03_27_012757	390	8	dividing	divide	VBG
10_1101-2020_03_27_012757	390	9	the	the	DT
10_1101-2020_03_27_012757	390	10	citation	citation	NN
10_1101-2020_03_27_012757	390	11	counts	count	NNS
10_1101-2020_03_27_012757	390	12	with	with	IN
10_1101-2020_03_27_012757	390	13	the	the	DT
10_1101-2020_03_27_012757	390	14	number	number	NN
10_1101-2020_03_27_012757	390	15	of	of	IN
10_1101-2020_03_27_012757	390	16	years	year	NNS
10_1101-2020_03_27_012757	390	17	since	since	IN
10_1101-2020_03_27_012757	390	18	772	772	CD
10_1101-2020_03_27_012757	390	19	first	first	JJ
10_1101-2020_03_27_012757	390	20	documented	document	VBN
10_1101-2020_03_27_012757	390	21	.	.	.
10_1101-2020_03_27_012757	391	1	773	773	CD
10_1101-2020_03_27_012757	391	2	𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑	𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑	NNS
10_1101-2020_03_27_012757	391	3	𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛	𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛	VBP
10_1101-2020_03_27_012757	391	4	𝑐𝑜𝑢𝑛𝑡𝑠	𝑐𝑜𝑢𝑛𝑡𝑠	NNP
10_1101-2020_03_27_012757	391	5	=	=	SYM
10_1101-2020_03_27_012757	391	6	𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛	𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛	VB
10_1101-2020_03_27_012757	391	7	𝑐𝑜𝑢𝑛𝑡𝑠	𝑐𝑜𝑢𝑛𝑡𝑠	NNP
10_1101-2020_03_27_012757	391	8	#	#	NNP
10_1101-2020_03_27_012757	391	9	𝑦𝑒𝑎𝑟𝑠	𝑦𝑒𝑎𝑟𝑠	NNP
10_1101-2020_03_27_012757	391	10	𝑠𝑖𝑛𝑐𝑒	𝑠𝑖𝑛𝑐𝑒	NNP
10_1101-2020_03_27_012757	391	11	𝑓𝑖𝑟𝑠𝑡	𝑓𝑖𝑟𝑠𝑡	NNP
10_1101-2020_03_27_012757	391	12	𝑑𝑜𝑐𝑢𝑚𝑒𝑛𝑡𝑒𝑑	𝑑𝑜𝑐𝑢𝑚𝑒𝑛𝑡𝑒𝑑	NNP
10_1101-2020_03_27_012757	391	13	774	774	CD
10_1101-2020_03_27_012757	391	14	775	775	CD
10_1101-2020_03_27_012757	391	15	GRN	GRN	NNP
10_1101-2020_03_27_012757	391	16	construction	construction	NN
10_1101-2020_03_27_012757	391	17	and	and	CC
10_1101-2020_03_27_012757	391	18	GRN	GRN	NNP
10_1101-2020_03_27_012757	391	19	Status	Status	NNP
10_1101-2020_03_27_012757	391	20	776	776	CD
10_1101-2020_03_27_012757	391	21	GRN	GRN	NNP
10_1101-2020_03_27_012757	391	22	construction	construction	NN
10_1101-2020_03_27_012757	391	23	was	be	VBD
10_1101-2020_03_27_012757	391	24	extended	extend	VBN
10_1101-2020_03_27_012757	391	25	from	from	IN
10_1101-2020_03_27_012757	391	26	our	-PRON-	PRP$
10_1101-2020_03_27_012757	391	27	previous	previous	JJ
10_1101-2020_03_27_012757	391	28	method21	method21	CD
10_1101-2020_03_27_012757	391	29	.	.	.
10_1101-2020_03_27_012757	392	1	80	80	CD
10_1101-2020_03_27_012757	392	2	samples	sample	NNS
10_1101-2020_03_27_012757	392	3	per	per	IN
10_1101-2020_03_27_012757	392	4	cancer	cancer	NN
10_1101-2020_03_27_012757	392	5	777	777	CD
10_1101-2020_03_27_012757	392	6	type	type	NN
10_1101-2020_03_27_012757	392	7	were	be	VBD
10_1101-2020_03_27_012757	392	8	randomly	randomly	RB
10_1101-2020_03_27_012757	392	9	sampled	sample	VBN
10_1101-2020_03_27_012757	392	10	and	and	CC
10_1101-2020_03_27_012757	392	11	normalized	normalize	VBN
10_1101-2020_03_27_012757	392	12	through	through	IN
10_1101-2020_03_27_012757	392	13	down	down	RB
10_1101-2020_03_27_012757	392	14	sampling	sampling	NN
10_1101-2020_03_27_012757	392	15	as	as	IN
10_1101-2020_03_27_012757	392	16	training	training	NN
10_1101-2020_03_27_012757	392	17	data	datum	NNS
10_1101-2020_03_27_012757	392	18	for	for	IN
10_1101-2020_03_27_012757	392	19	the	the	DT
10_1101-2020_03_27_012757	392	20	778	778	CD
10_1101-2020_03_27_012757	392	21	CLR	CLR	NNP
10_1101-2020_03_27_012757	392	22	GRN	GRN	NNP
10_1101-2020_03_27_012757	392	23	construction	construction	NN
10_1101-2020_03_27_012757	392	24	algorithm	algorithm	NN
10_1101-2020_03_27_012757	392	25	.	.	.
10_1101-2020_03_27_012757	393	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	393	2	type	type	NN
10_1101-2020_03_27_012757	393	3	specific	specific	JJ
10_1101-2020_03_27_012757	393	4	GRNs	grn	NNS
10_1101-2020_03_27_012757	393	5	were	be	VBD
10_1101-2020_03_27_012757	393	6	identified	identify	VBN
10_1101-2020_03_27_012757	393	7	by	by	IN
10_1101-2020_03_27_012757	393	8	determining	determine	VBG
10_1101-2020_03_27_012757	393	9	the	the	DT
10_1101-2020_03_27_012757	393	10	779	779	CD
10_1101-2020_03_27_012757	393	11	.CC	.CC	:
10_1101-2020_03_27_012757	393	12	-	-	HYPH
10_1101-2020_03_27_012757	393	13	BY	by	IN
10_1101-2020_03_27_012757	393	14	-	-	HYPH
10_1101-2020_03_27_012757	393	15	NC	NC	NNP
10_1101-2020_03_27_012757	393	16	-	-	HYPH
10_1101-2020_03_27_012757	393	17	ND	ND	NNP
10_1101-2020_03_27_012757	393	18	4.0	4.0	CD
10_1101-2020_03_27_012757	393	19	International	International	NNP
10_1101-2020_03_27_012757	393	20	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	393	21	under	under	IN
10_1101-2020_03_27_012757	393	22	a	a	DT
10_1101-2020_03_27_012757	393	23	(	(	-LRB-
10_1101-2020_03_27_012757	393	24	which	which	WDT
10_1101-2020_03_27_012757	393	25	was	be	VBD
10_1101-2020_03_27_012757	393	26	not	not	RB
10_1101-2020_03_27_012757	393	27	certified	certify	VBN
10_1101-2020_03_27_012757	393	28	by	by	IN
10_1101-2020_03_27_012757	393	29	peer	peer	NN
10_1101-2020_03_27_012757	393	30	review	review	NN
10_1101-2020_03_27_012757	393	31	)	)	-RRB-
10_1101-2020_03_27_012757	393	32	is	be	VBZ
10_1101-2020_03_27_012757	393	33	the	the	DT
10_1101-2020_03_27_012757	393	34	author	author	NN
10_1101-2020_03_27_012757	393	35	/	/	SYM
10_1101-2020_03_27_012757	393	36	funder	funder	NN
10_1101-2020_03_27_012757	393	37	,	,	,
10_1101-2020_03_27_012757	393	38	who	who	WP
10_1101-2020_03_27_012757	393	39	has	have	VBZ
10_1101-2020_03_27_012757	393	40	granted	grant	VBN
10_1101-2020_03_27_012757	393	41	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	393	42	a	a	DT
10_1101-2020_03_27_012757	393	43	license	license	NN
10_1101-2020_03_27_012757	393	44	to	to	TO
10_1101-2020_03_27_012757	393	45	display	display	VB
10_1101-2020_03_27_012757	393	46	the	the	DT
10_1101-2020_03_27_012757	393	47	preprint	preprint	NN
10_1101-2020_03_27_012757	393	48	in	in	IN
10_1101-2020_03_27_012757	393	49	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	393	50	.	.	.
10_1101-2020_03_27_012757	394	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	394	2	is	be	VBZ
10_1101-2020_03_27_012757	394	3	made	make	VBN
10_1101-2020_03_27_012757	394	4	The	the	DT
10_1101-2020_03_27_012757	394	5	copyright	copyright	NN
10_1101-2020_03_27_012757	394	6	holder	holder	NN
10_1101-2020_03_27_012757	394	7	for	for	IN
10_1101-2020_03_27_012757	394	8	this	this	DT
10_1101-2020_03_27_012757	394	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	394	10	version	version	NN
10_1101-2020_03_27_012757	394	11	posted	post	VBD
10_1101-2020_03_27_012757	394	12	January	January	NNP
10_1101-2020_03_27_012757	394	13	9	9	CD
10_1101-2020_03_27_012757	394	14	,	,	,
10_1101-2020_03_27_012757	394	15	2021	2021	CD
10_1101-2020_03_27_012757	394	16	.	.	.
10_1101-2020_03_27_012757	394	17	;	;	:
10_1101-2020_03_27_012757	394	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	394	19	:	:	:
10_1101-2020_03_27_012757	394	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	394	21	preprint	preprint	NN
10_1101-2020_03_27_012757	394	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	394	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	RB
10_1101-2020_03_27_012757	394	24	30	30	CD
10_1101-2020_03_27_012757	394	25	differentially	differentially	RB
10_1101-2020_03_27_012757	394	26	expressed	express	VBD
10_1101-2020_03_27_012757	394	27	genes	gene	NNS
10_1101-2020_03_27_012757	394	28	per	per	IN
10_1101-2020_03_27_012757	394	29	each	each	DT
10_1101-2020_03_27_012757	394	30	cancer	cancer	NN
10_1101-2020_03_27_012757	394	31	type	type	NN
10_1101-2020_03_27_012757	394	32	and	and	CC
10_1101-2020_03_27_012757	394	33	extracting	extract	VBG
10_1101-2020_03_27_012757	394	34	the	the	DT
10_1101-2020_03_27_012757	394	35	subnetwork	subnetwork	NN
10_1101-2020_03_27_012757	394	36	using	use	VBG
10_1101-2020_03_27_012757	394	37	those	those	DT
10_1101-2020_03_27_012757	394	38	780	780	CD
10_1101-2020_03_27_012757	394	39	genes	gene	NNS
10_1101-2020_03_27_012757	394	40	.	.	.
10_1101-2020_03_27_012757	395	1	781	781	CD
10_1101-2020_03_27_012757	395	2	To	to	TO
10_1101-2020_03_27_012757	395	3	extend	extend	VB
10_1101-2020_03_27_012757	395	4	the	the	DT
10_1101-2020_03_27_012757	395	5	original	original	JJ
10_1101-2020_03_27_012757	395	6	GRN	GRN	NNP
10_1101-2020_03_27_012757	395	7	status	status	NN
10_1101-2020_03_27_012757	395	8	algorithm21	algorithm21	VBN
10_1101-2020_03_27_012757	395	9	across	across	IN
10_1101-2020_03_27_012757	395	10	different	different	JJ
10_1101-2020_03_27_012757	395	11	platforms	platform	NNS
10_1101-2020_03_27_012757	395	12	and	and	CC
10_1101-2020_03_27_012757	395	13	species	specie	NNS
10_1101-2020_03_27_012757	395	14	,	,	,
10_1101-2020_03_27_012757	395	15	we	-PRON-	PRP
10_1101-2020_03_27_012757	395	16	782	782	CD
10_1101-2020_03_27_012757	395	17	devised	devise	VBD
10_1101-2020_03_27_012757	395	18	a	a	DT
10_1101-2020_03_27_012757	395	19	rank	rank	NN
10_1101-2020_03_27_012757	395	20	-	-	HYPH
10_1101-2020_03_27_012757	395	21	based	base	VBN
10_1101-2020_03_27_012757	395	22	GRN	GRN	NNP
10_1101-2020_03_27_012757	395	23	status	status	NN
10_1101-2020_03_27_012757	395	24	algorithm	algorithm	NNP
10_1101-2020_03_27_012757	395	25	.	.	.
10_1101-2020_03_27_012757	396	1	Like	like	IN
10_1101-2020_03_27_012757	396	2	the	the	DT
10_1101-2020_03_27_012757	396	3	original	original	JJ
10_1101-2020_03_27_012757	396	4	GRN	GRN	NNP
10_1101-2020_03_27_012757	396	5	status	status	NN
10_1101-2020_03_27_012757	396	6	,	,	,
10_1101-2020_03_27_012757	396	7	rank	rank	NN
10_1101-2020_03_27_012757	396	8	based	base	VBN
10_1101-2020_03_27_012757	396	9	GRN	GRN	NNP
10_1101-2020_03_27_012757	396	10	783	783	CD
10_1101-2020_03_27_012757	396	11	status	status	NN
10_1101-2020_03_27_012757	396	12	is	be	VBZ
10_1101-2020_03_27_012757	396	13	a	a	DT
10_1101-2020_03_27_012757	396	14	metric	metric	NN
10_1101-2020_03_27_012757	396	15	of	of	IN
10_1101-2020_03_27_012757	396	16	assessing	assess	VBG
10_1101-2020_03_27_012757	396	17	the	the	DT
10_1101-2020_03_27_012757	396	18	similarity	similarity	NN
10_1101-2020_03_27_012757	396	19	of	of	IN
10_1101-2020_03_27_012757	396	20	cancer	cancer	NN
10_1101-2020_03_27_012757	396	21	type	type	NN
10_1101-2020_03_27_012757	396	22	specific	specific	JJ
10_1101-2020_03_27_012757	396	23	GRN	GRN	NNP
10_1101-2020_03_27_012757	396	24	between	between	IN
10_1101-2020_03_27_012757	396	25	training	train	VBG
10_1101-2020_03_27_012757	396	26	data	datum	NNS
10_1101-2020_03_27_012757	396	27	784	784	CD
10_1101-2020_03_27_012757	396	28	in	in	IN
10_1101-2020_03_27_012757	396	29	the	the	DT
10_1101-2020_03_27_012757	396	30	cancer	cancer	NN
10_1101-2020_03_27_012757	396	31	type	type	NN
10_1101-2020_03_27_012757	396	32	of	of	IN
10_1101-2020_03_27_012757	396	33	interest	interest	NN
10_1101-2020_03_27_012757	396	34	and	and	CC
10_1101-2020_03_27_012757	396	35	query	query	NN
10_1101-2020_03_27_012757	396	36	samples	sample	NNS
10_1101-2020_03_27_012757	396	37	.	.	.
10_1101-2020_03_27_012757	397	1	Hence	hence	RB
10_1101-2020_03_27_012757	397	2	,	,	,
10_1101-2020_03_27_012757	397	3	high	high	JJ
10_1101-2020_03_27_012757	397	4	GRN	GRN	NNP
10_1101-2020_03_27_012757	397	5	status	status	NN
10_1101-2020_03_27_012757	397	6	represents	represent	VBZ
10_1101-2020_03_27_012757	397	7	high	high	JJ
10_1101-2020_03_27_012757	397	8	level	level	NN
10_1101-2020_03_27_012757	397	9	785	785	CD
10_1101-2020_03_27_012757	397	10	of	of	IN
10_1101-2020_03_27_012757	397	11	establishment	establishment	NN
10_1101-2020_03_27_012757	397	12	or	or	CC
10_1101-2020_03_27_012757	397	13	similarity	similarity	NN
10_1101-2020_03_27_012757	397	14	of	of	IN
10_1101-2020_03_27_012757	397	15	the	the	DT
10_1101-2020_03_27_012757	397	16	cancer	cancer	NN
10_1101-2020_03_27_012757	397	17	specific	specific	JJ
10_1101-2020_03_27_012757	397	18	GRN	GRN	NNP
10_1101-2020_03_27_012757	397	19	in	in	IN
10_1101-2020_03_27_012757	397	20	the	the	DT
10_1101-2020_03_27_012757	397	21	query	query	NN
10_1101-2020_03_27_012757	397	22	sample	sample	NN
10_1101-2020_03_27_012757	397	23	compared	compare	VBN
10_1101-2020_03_27_012757	397	24	to	to	IN
10_1101-2020_03_27_012757	397	25	those	those	DT
10_1101-2020_03_27_012757	397	26	786	786	CD
10_1101-2020_03_27_012757	397	27	of	of	IN
10_1101-2020_03_27_012757	397	28	the	the	DT
10_1101-2020_03_27_012757	397	29	training	training	NN
10_1101-2020_03_27_012757	397	30	data	datum	NNS
10_1101-2020_03_27_012757	397	31	.	.	.
10_1101-2020_03_27_012757	398	1	The	the	DT
10_1101-2020_03_27_012757	398	2	expression	expression	NN
10_1101-2020_03_27_012757	398	3	profiles	profile	NNS
10_1101-2020_03_27_012757	398	4	of	of	IN
10_1101-2020_03_27_012757	398	5	training	train	VBG
10_1101-2020_03_27_012757	398	6	data	datum	NNS
10_1101-2020_03_27_012757	398	7	and	and	CC
10_1101-2020_03_27_012757	398	8	query	query	NN
10_1101-2020_03_27_012757	398	9	data	datum	NNS
10_1101-2020_03_27_012757	398	10	were	be	VBD
10_1101-2020_03_27_012757	398	11	transformed	transform	VBN
10_1101-2020_03_27_012757	398	12	787	787	CD
10_1101-2020_03_27_012757	398	13	into	into	IN
10_1101-2020_03_27_012757	398	14	rank	rank	NN
10_1101-2020_03_27_012757	398	15	expression	expression	NN
10_1101-2020_03_27_012757	398	16	profiles	profile	NNS
10_1101-2020_03_27_012757	398	17	by	by	IN
10_1101-2020_03_27_012757	398	18	replacing	replace	VBG
10_1101-2020_03_27_012757	398	19	the	the	DT
10_1101-2020_03_27_012757	398	20	expression	expression	NN
10_1101-2020_03_27_012757	398	21	values	value	NNS
10_1101-2020_03_27_012757	398	22	with	with	IN
10_1101-2020_03_27_012757	398	23	the	the	DT
10_1101-2020_03_27_012757	398	24	rank	rank	NN
10_1101-2020_03_27_012757	398	25	of	of	IN
10_1101-2020_03_27_012757	398	26	the	the	DT
10_1101-2020_03_27_012757	398	27	expression	expression	NN
10_1101-2020_03_27_012757	398	28	788	788	CD
10_1101-2020_03_27_012757	398	29	values	value	NNS
10_1101-2020_03_27_012757	398	30	within	within	IN
10_1101-2020_03_27_012757	398	31	a	a	DT
10_1101-2020_03_27_012757	398	32	sample	sample	NN
10_1101-2020_03_27_012757	398	33	(	(	-LRB-
10_1101-2020_03_27_012757	398	34	highest	high	JJS
10_1101-2020_03_27_012757	398	35	expressed	express	VBN
10_1101-2020_03_27_012757	398	36	gene	gene	NN
10_1101-2020_03_27_012757	398	37	would	would	MD
10_1101-2020_03_27_012757	398	38	have	have	VB
10_1101-2020_03_27_012757	398	39	the	the	DT
10_1101-2020_03_27_012757	398	40	highest	high	JJS
10_1101-2020_03_27_012757	398	41	rank	rank	NN
10_1101-2020_03_27_012757	398	42	and	and	CC
10_1101-2020_03_27_012757	398	43	lowest	low	JJS
10_1101-2020_03_27_012757	398	44	789	789	CD
10_1101-2020_03_27_012757	398	45	expressed	express	VBN
10_1101-2020_03_27_012757	398	46	genes	gene	NNS
10_1101-2020_03_27_012757	398	47	would	would	MD
10_1101-2020_03_27_012757	398	48	have	have	VB
10_1101-2020_03_27_012757	398	49	a	a	DT
10_1101-2020_03_27_012757	398	50	rank	rank	NN
10_1101-2020_03_27_012757	398	51	of	of	IN
10_1101-2020_03_27_012757	398	52	1	1	CD
10_1101-2020_03_27_012757	398	53	)	)	-RRB-
10_1101-2020_03_27_012757	398	54	.	.	.
10_1101-2020_03_27_012757	399	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	399	2	type	type	NN
10_1101-2020_03_27_012757	399	3	specific	specific	JJ
10_1101-2020_03_27_012757	399	4	mean	mean	JJ
10_1101-2020_03_27_012757	399	5	and	and	CC
10_1101-2020_03_27_012757	399	6	standard	standard	JJ
10_1101-2020_03_27_012757	399	7	deviation	deviation	NN
10_1101-2020_03_27_012757	399	8	of	of	IN
10_1101-2020_03_27_012757	399	9	790	790	CD
10_1101-2020_03_27_012757	399	10	every	every	DT
10_1101-2020_03_27_012757	399	11	gene	gene	NN
10_1101-2020_03_27_012757	399	12	’s	’s	POS
10_1101-2020_03_27_012757	399	13	rank	rank	NN
10_1101-2020_03_27_012757	399	14	expression	expression	NN
10_1101-2020_03_27_012757	399	15	were	be	VBD
10_1101-2020_03_27_012757	399	16	learned	learn	VBN
10_1101-2020_03_27_012757	399	17	from	from	IN
10_1101-2020_03_27_012757	399	18	training	training	NN
10_1101-2020_03_27_012757	399	19	data	datum	NNS
10_1101-2020_03_27_012757	399	20	.	.	.
10_1101-2020_03_27_012757	400	1	The	the	DT
10_1101-2020_03_27_012757	400	2	modified	modified	JJ
10_1101-2020_03_27_012757	400	3	Z	z	NN
10_1101-2020_03_27_012757	400	4	-	-	HYPH
10_1101-2020_03_27_012757	400	5	score	score	NN
10_1101-2020_03_27_012757	400	6	values	value	NNS
10_1101-2020_03_27_012757	400	7	for	for	IN
10_1101-2020_03_27_012757	400	8	791	791	CD
10_1101-2020_03_27_012757	400	9	genes	gene	NNS
10_1101-2020_03_27_012757	400	10	within	within	IN
10_1101-2020_03_27_012757	400	11	cancer	cancer	NN
10_1101-2020_03_27_012757	400	12	type	type	NN
10_1101-2020_03_27_012757	400	13	specific	specific	JJ
10_1101-2020_03_27_012757	400	14	GRN	GRN	NNP
10_1101-2020_03_27_012757	400	15	were	be	VBD
10_1101-2020_03_27_012757	400	16	calculated	calculate	VBN
10_1101-2020_03_27_012757	400	17	for	for	IN
10_1101-2020_03_27_012757	400	18	query	query	NNP
10_1101-2020_03_27_012757	400	19	sample	sample	NNP
10_1101-2020_03_27_012757	400	20	’s	’s	POS
10_1101-2020_03_27_012757	400	21	rank	rank	NNP
10_1101-2020_03_27_012757	400	22	expression	expression	NN
10_1101-2020_03_27_012757	400	23	792	792	CD
10_1101-2020_03_27_012757	400	24	profiles	profile	NNS
10_1101-2020_03_27_012757	400	25	to	to	TO
10_1101-2020_03_27_012757	400	26	quantify	quantify	VB
10_1101-2020_03_27_012757	400	27	how	how	WRB
10_1101-2020_03_27_012757	400	28	dissimilar	dissimilar	JJ
10_1101-2020_03_27_012757	400	29	the	the	DT
10_1101-2020_03_27_012757	400	30	expression	expression	NN
10_1101-2020_03_27_012757	400	31	values	value	NNS
10_1101-2020_03_27_012757	400	32	of	of	IN
10_1101-2020_03_27_012757	400	33	genes	gene	NNS
10_1101-2020_03_27_012757	400	34	in	in	IN
10_1101-2020_03_27_012757	400	35	query	query	NNP
10_1101-2020_03_27_012757	400	36	sample	sample	NN
10_1101-2020_03_27_012757	400	37	’s	’s	POS
10_1101-2020_03_27_012757	400	38	cancer	cancer	NN
10_1101-2020_03_27_012757	400	39	type	type	NN
10_1101-2020_03_27_012757	400	40	793	793	CD
10_1101-2020_03_27_012757	400	41	specific	specific	JJ
10_1101-2020_03_27_012757	400	42	GRN	GRN	NNP
10_1101-2020_03_27_012757	400	43	compared	compare	VBN
10_1101-2020_03_27_012757	400	44	to	to	IN
10_1101-2020_03_27_012757	400	45	those	those	DT
10_1101-2020_03_27_012757	400	46	of	of	IN
10_1101-2020_03_27_012757	400	47	the	the	DT
10_1101-2020_03_27_012757	400	48	reference	reference	NN
10_1101-2020_03_27_012757	400	49	training	training	NN
10_1101-2020_03_27_012757	400	50	data	datum	NNS
10_1101-2020_03_27_012757	400	51	:	:	:
10_1101-2020_03_27_012757	400	52	794	794	CD
10_1101-2020_03_27_012757	400	53	𝑍𝑠𝑐𝑜𝑟𝑒(𝑔𝑒𝑛𝑒	𝑍𝑠𝑐𝑜𝑟𝑒(𝑔𝑒𝑛𝑒	CD
10_1101-2020_03_27_012757	400	54	𝑖)XYZ	𝑖)XYZ	NNS
10_1101-2020_03_27_012757	400	55	=	=	SYM
10_1101-2020_03_27_012757	400	56	[	[	-LRB-
10_1101-2020_03_27_012757	400	57	0	0	CD
10_1101-2020_03_27_012757	400	58	,	,	,
10_1101-2020_03_27_012757	400	59	𝑖𝑓	𝑖𝑓	NNP
10_1101-2020_03_27_012757	400	60	𝑍𝑠𝑐𝑜𝑟𝑒	𝑍𝑠𝑐𝑜𝑟𝑒	NNP
10_1101-2020_03_27_012757	400	61	𝑖𝑠	𝑖𝑠	XX
10_1101-2020_03_27_012757	400	62	𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒	𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒	NNP
10_1101-2020_03_27_012757	400	63	𝑎𝑛𝑑	𝑎𝑛𝑑	NNP
10_1101-2020_03_27_012757	400	64	𝑡ℎ𝑒	𝑡ℎ𝑒	NNP
10_1101-2020_03_27_012757	400	65	𝑔𝑒𝑛𝑒	𝑔𝑒𝑛𝑒	NNP
10_1101-2020_03_27_012757	400	66	𝑖𝑠	𝑖𝑠	NNP
10_1101-2020_03_27_012757	400	67	𝑓𝑜𝑢𝑛𝑑	𝑓𝑜𝑢𝑛𝑑	NNP
10_1101-2020_03_27_012757	400	68	𝑡𝑜	𝑡𝑜	NNP
10_1101-2020_03_27_012757	400	69	𝑏𝑒	𝑏𝑒	NNP
10_1101-2020_03_27_012757	400	70	𝑢𝑝𝑟𝑒𝑔𝑢𝑙𝑎𝑡𝑒𝑑	𝑢𝑝𝑟𝑒𝑔𝑢𝑙𝑎𝑡𝑒𝑑	NNP
10_1101-2020_03_27_012757	400	71	0	0	CD
10_1101-2020_03_27_012757	400	72	,	,	,
10_1101-2020_03_27_012757	400	73	𝑖𝑓	𝑖𝑓	NNP
10_1101-2020_03_27_012757	400	74	𝑍𝑠𝑐𝑜𝑟𝑒	𝑍𝑠𝑐𝑜𝑟𝑒	NNP
10_1101-2020_03_27_012757	400	75	𝑖𝑠	𝑖𝑠	IN
10_1101-2020_03_27_012757	400	76	𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒	𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒	NNP
10_1101-2020_03_27_012757	400	77	𝑎𝑛𝑑	𝑎𝑛𝑑	NNP
10_1101-2020_03_27_012757	400	78	𝑡ℎ𝑒	𝑡ℎ𝑒	NNP
10_1101-2020_03_27_012757	400	79	𝑔𝑒𝑛𝑒	𝑔𝑒𝑛𝑒	NNP
10_1101-2020_03_27_012757	400	80	𝑖𝑠	𝑖𝑠	NNP
10_1101-2020_03_27_012757	400	81	𝑓𝑜𝑢𝑛𝑑	𝑓𝑜𝑢𝑛𝑑	NNP
10_1101-2020_03_27_012757	400	82	𝑡𝑜	𝑡𝑜	NNP
10_1101-2020_03_27_012757	400	83	𝑏𝑒	𝑏𝑒	NNP
10_1101-2020_03_27_012757	400	84	𝑑𝑜𝑤𝑛𝑟𝑒𝑔𝑢𝑙𝑎𝑡𝑒𝑑	𝑑𝑜𝑤𝑛𝑟𝑒𝑔𝑢𝑙𝑎𝑡𝑒𝑑	NNP
10_1101-2020_03_27_012757	400	85	𝑎𝑏𝑠(𝑍𝑠𝑐𝑜𝑟𝑒	𝑎𝑏𝑠(𝑍𝑠𝑐𝑜𝑟𝑒	NNP
10_1101-2020_03_27_012757	400	86	)	)	-RRB-
10_1101-2020_03_27_012757	400	87	,	,	,
10_1101-2020_03_27_012757	400	88	𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒	𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒	VB
10_1101-2020_03_27_012757	400	89	795	795	CD
10_1101-2020_03_27_012757	400	90	If	if	IN
10_1101-2020_03_27_012757	400	91	a	a	DT
10_1101-2020_03_27_012757	400	92	gene	gene	NN
10_1101-2020_03_27_012757	400	93	in	in	IN
10_1101-2020_03_27_012757	400	94	the	the	DT
10_1101-2020_03_27_012757	400	95	cancer	cancer	NN
10_1101-2020_03_27_012757	400	96	type	type	NN
10_1101-2020_03_27_012757	400	97	specific	specific	JJ
10_1101-2020_03_27_012757	400	98	GRN	GRN	NNP
10_1101-2020_03_27_012757	400	99	is	be	VBZ
10_1101-2020_03_27_012757	400	100	found	find	VBN
10_1101-2020_03_27_012757	400	101	to	to	TO
10_1101-2020_03_27_012757	400	102	be	be	VB
10_1101-2020_03_27_012757	400	103	upregulated	upregulate	VBN
10_1101-2020_03_27_012757	400	104	in	in	IN
10_1101-2020_03_27_012757	400	105	the	the	DT
10_1101-2020_03_27_012757	400	106	specific	specific	JJ
10_1101-2020_03_27_012757	400	107	796	796	CD
10_1101-2020_03_27_012757	400	108	cancer	cancer	NN
10_1101-2020_03_27_012757	400	109	type	type	NN
10_1101-2020_03_27_012757	400	110	relative	relative	JJ
10_1101-2020_03_27_012757	400	111	to	to	IN
10_1101-2020_03_27_012757	400	112	other	other	JJ
10_1101-2020_03_27_012757	400	113	cancer	cancer	NN
10_1101-2020_03_27_012757	400	114	types	type	NNS
10_1101-2020_03_27_012757	400	115	,	,	,
10_1101-2020_03_27_012757	400	116	then	then	RB
10_1101-2020_03_27_012757	400	117	we	-PRON-	PRP
10_1101-2020_03_27_012757	400	118	would	would	MD
10_1101-2020_03_27_012757	400	119	consider	consider	VB
10_1101-2020_03_27_012757	400	120	query	query	NNP
10_1101-2020_03_27_012757	400	121	sample	sample	NNP
10_1101-2020_03_27_012757	400	122	’s	’s	POS
10_1101-2020_03_27_012757	400	123	gene	gene	NN
10_1101-2020_03_27_012757	400	124	to	to	TO
10_1101-2020_03_27_012757	400	125	be	be	VB
10_1101-2020_03_27_012757	400	126	797	797	CD
10_1101-2020_03_27_012757	400	127	similar	similar	JJ
10_1101-2020_03_27_012757	400	128	if	if	IN
10_1101-2020_03_27_012757	400	129	the	the	DT
10_1101-2020_03_27_012757	400	130	ranking	ranking	NN
10_1101-2020_03_27_012757	400	131	of	of	IN
10_1101-2020_03_27_012757	400	132	the	the	DT
10_1101-2020_03_27_012757	400	133	query	query	NN
10_1101-2020_03_27_012757	400	134	sample	sample	NN
10_1101-2020_03_27_012757	400	135	’s	’s	NNP
10_1101-2020_03_27_012757	400	136	gene	gene	NN
10_1101-2020_03_27_012757	400	137	is	be	VBZ
10_1101-2020_03_27_012757	400	138	equal	equal	JJ
10_1101-2020_03_27_012757	400	139	to	to	IN
10_1101-2020_03_27_012757	400	140	or	or	CC
10_1101-2020_03_27_012757	400	141	greater	great	JJR
10_1101-2020_03_27_012757	400	142	than	than	IN
10_1101-2020_03_27_012757	400	143	the	the	DT
10_1101-2020_03_27_012757	400	144	mean	mean	NN
10_1101-2020_03_27_012757	400	145	ranking	ranking	NN
10_1101-2020_03_27_012757	400	146	of	of	IN
10_1101-2020_03_27_012757	400	147	798	798	CD
10_1101-2020_03_27_012757	400	148	the	the	DT
10_1101-2020_03_27_012757	400	149	gene	gene	NN
10_1101-2020_03_27_012757	400	150	in	in	IN
10_1101-2020_03_27_012757	400	151	training	training	NN
10_1101-2020_03_27_012757	400	152	sample	sample	NN
10_1101-2020_03_27_012757	400	153	.	.	.
10_1101-2020_03_27_012757	401	1	As	as	IN
10_1101-2020_03_27_012757	401	2	a	a	DT
10_1101-2020_03_27_012757	401	3	result	result	NN
10_1101-2020_03_27_012757	401	4	of	of	IN
10_1101-2020_03_27_012757	401	5	similarity	similarity	NN
10_1101-2020_03_27_012757	401	6	,	,	,
10_1101-2020_03_27_012757	401	7	we	-PRON-	PRP
10_1101-2020_03_27_012757	401	8	assign	assign	VBP
10_1101-2020_03_27_012757	401	9	that	that	DT
10_1101-2020_03_27_012757	401	10	gene	gene	NN
10_1101-2020_03_27_012757	401	11	of	of	IN
10_1101-2020_03_27_012757	401	12	a	a	DT
10_1101-2020_03_27_012757	401	13	Z	z	NN
10_1101-2020_03_27_012757	401	14	-	-	HYPH
10_1101-2020_03_27_012757	401	15	score	score	NN
10_1101-2020_03_27_012757	401	16	of	of	IN
10_1101-2020_03_27_012757	401	17	0	0	CD
10_1101-2020_03_27_012757	401	18	.	.	.
10_1101-2020_03_27_012757	402	1	The	the	DT
10_1101-2020_03_27_012757	402	2	799	799	CD
10_1101-2020_03_27_012757	402	3	same	same	JJ
10_1101-2020_03_27_012757	402	4	principle	principle	NN
10_1101-2020_03_27_012757	402	5	applies	apply	VBZ
10_1101-2020_03_27_012757	402	6	to	to	IN
10_1101-2020_03_27_012757	402	7	cases	case	NNS
10_1101-2020_03_27_012757	402	8	where	where	WRB
10_1101-2020_03_27_012757	402	9	the	the	DT
10_1101-2020_03_27_012757	402	10	gene	gene	NN
10_1101-2020_03_27_012757	402	11	is	be	VBZ
10_1101-2020_03_27_012757	402	12	downregulated	downregulate	VBN
10_1101-2020_03_27_012757	402	13	in	in	IN
10_1101-2020_03_27_012757	402	14	cancer	cancer	NN
10_1101-2020_03_27_012757	402	15	specific	specific	JJ
10_1101-2020_03_27_012757	402	16	subnetwork	subnetwork	NN
10_1101-2020_03_27_012757	402	17	.	.	.
10_1101-2020_03_27_012757	403	1	800	800	CD
10_1101-2020_03_27_012757	403	2	GRN	GRN	NNP
10_1101-2020_03_27_012757	403	3	status	status	NN
10_1101-2020_03_27_012757	403	4	for	for	IN
10_1101-2020_03_27_012757	403	5	query	query	NN
10_1101-2020_03_27_012757	403	6	sample	sample	NN
10_1101-2020_03_27_012757	403	7	is	be	VBZ
10_1101-2020_03_27_012757	403	8	calculated	calculate	VBN
10_1101-2020_03_27_012757	403	9	as	as	IN
10_1101-2020_03_27_012757	403	10	the	the	DT
10_1101-2020_03_27_012757	403	11	weighted	weighted	JJ
10_1101-2020_03_27_012757	403	12	mean	mean	NN
10_1101-2020_03_27_012757	403	13	of	of	IN
10_1101-2020_03_27_012757	403	14	the	the	DT
10_1101-2020_03_27_012757	403	15	801	801	CD
10_1101-2020_03_27_012757	403	16	(	(	-LRB-
10_1101-2020_03_27_012757	403	17	1000	1000	CD
10_1101-2020_03_27_012757	403	18	−	−	NNP
10_1101-2020_03_27_012757	403	19	𝑍𝑠𝑐𝑜𝑟𝑒(𝑔𝑒𝑛𝑒	𝑍𝑠𝑐𝑜𝑟𝑒(𝑔𝑒𝑛𝑒	CD
10_1101-2020_03_27_012757	403	20	𝑖)XYZ	𝑖)XYZ	NNP
10_1101-2020_03_27_012757	403	21	)	)	-RRB-
10_1101-2020_03_27_012757	403	22	across	across	IN
10_1101-2020_03_27_012757	403	23	genes	gene	NNS
10_1101-2020_03_27_012757	403	24	in	in	IN
10_1101-2020_03_27_012757	403	25	cancer	cancer	NN
10_1101-2020_03_27_012757	403	26	type	type	NN
10_1101-2020_03_27_012757	403	27	specific	specific	JJ
10_1101-2020_03_27_012757	403	28	GRN	GRN	NNP
10_1101-2020_03_27_012757	403	29	.	.	.
10_1101-2020_03_27_012757	404	1	1000	1000	CD
10_1101-2020_03_27_012757	404	2	is	be	VBZ
10_1101-2020_03_27_012757	404	3	an	an	DT
10_1101-2020_03_27_012757	404	4	arbitrary	arbitrary	JJ
10_1101-2020_03_27_012757	404	5	802	802	CD
10_1101-2020_03_27_012757	404	6	.CC	.CC	:
10_1101-2020_03_27_012757	404	7	-	-	HYPH
10_1101-2020_03_27_012757	404	8	BY	by	IN
10_1101-2020_03_27_012757	404	9	-	-	HYPH
10_1101-2020_03_27_012757	404	10	NC	NC	NNP
10_1101-2020_03_27_012757	404	11	-	-	HYPH
10_1101-2020_03_27_012757	404	12	ND	ND	NNP
10_1101-2020_03_27_012757	404	13	4.0	4.0	CD
10_1101-2020_03_27_012757	404	14	International	International	NNP
10_1101-2020_03_27_012757	404	15	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	404	16	under	under	IN
10_1101-2020_03_27_012757	404	17	a	a	DT
10_1101-2020_03_27_012757	404	18	(	(	-LRB-
10_1101-2020_03_27_012757	404	19	which	which	WDT
10_1101-2020_03_27_012757	404	20	was	be	VBD
10_1101-2020_03_27_012757	404	21	not	not	RB
10_1101-2020_03_27_012757	404	22	certified	certify	VBN
10_1101-2020_03_27_012757	404	23	by	by	IN
10_1101-2020_03_27_012757	404	24	peer	peer	NN
10_1101-2020_03_27_012757	404	25	review	review	NN
10_1101-2020_03_27_012757	404	26	)	)	-RRB-
10_1101-2020_03_27_012757	404	27	is	be	VBZ
10_1101-2020_03_27_012757	404	28	the	the	DT
10_1101-2020_03_27_012757	404	29	author	author	NN
10_1101-2020_03_27_012757	404	30	/	/	SYM
10_1101-2020_03_27_012757	404	31	funder	funder	NN
10_1101-2020_03_27_012757	404	32	,	,	,
10_1101-2020_03_27_012757	404	33	who	who	WP
10_1101-2020_03_27_012757	404	34	has	have	VBZ
10_1101-2020_03_27_012757	404	35	granted	grant	VBN
10_1101-2020_03_27_012757	404	36	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	404	37	a	a	DT
10_1101-2020_03_27_012757	404	38	license	license	NN
10_1101-2020_03_27_012757	404	39	to	to	TO
10_1101-2020_03_27_012757	404	40	display	display	VB
10_1101-2020_03_27_012757	404	41	the	the	DT
10_1101-2020_03_27_012757	404	42	preprint	preprint	NN
10_1101-2020_03_27_012757	404	43	in	in	IN
10_1101-2020_03_27_012757	404	44	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	404	45	.	.	.
10_1101-2020_03_27_012757	405	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	405	2	is	be	VBZ
10_1101-2020_03_27_012757	405	3	made	make	VBN
10_1101-2020_03_27_012757	405	4	The	the	DT
10_1101-2020_03_27_012757	405	5	copyright	copyright	NN
10_1101-2020_03_27_012757	405	6	holder	holder	NN
10_1101-2020_03_27_012757	405	7	for	for	IN
10_1101-2020_03_27_012757	405	8	this	this	DT
10_1101-2020_03_27_012757	405	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	405	10	version	version	NN
10_1101-2020_03_27_012757	405	11	posted	post	VBD
10_1101-2020_03_27_012757	405	12	January	January	NNP
10_1101-2020_03_27_012757	405	13	9	9	CD
10_1101-2020_03_27_012757	405	14	,	,	,
10_1101-2020_03_27_012757	405	15	2021	2021	CD
10_1101-2020_03_27_012757	405	16	.	.	.
10_1101-2020_03_27_012757	405	17	;	;	:
10_1101-2020_03_27_012757	405	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	405	19	:	:	:
10_1101-2020_03_27_012757	405	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	405	21	preprint	preprint	NN
10_1101-2020_03_27_012757	405	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	405	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	RB
10_1101-2020_03_27_012757	405	24	31	31	CD
10_1101-2020_03_27_012757	405	25	large	large	JJ
10_1101-2020_03_27_012757	405	26	number	number	NN
10_1101-2020_03_27_012757	405	27	,	,	,
10_1101-2020_03_27_012757	405	28	and	and	CC
10_1101-2020_03_27_012757	405	29	larger	large	JJR
10_1101-2020_03_27_012757	405	30	dissimilarity	dissimilarity	NN
10_1101-2020_03_27_012757	405	31	between	between	IN
10_1101-2020_03_27_012757	405	32	query	query	NN
10_1101-2020_03_27_012757	405	33	’s	’s	POS
10_1101-2020_03_27_012757	405	34	cancer	cancer	NN
10_1101-2020_03_27_012757	405	35	type	type	NN
10_1101-2020_03_27_012757	405	36	specific	specific	JJ
10_1101-2020_03_27_012757	405	37	GRN	GRN	NNP
10_1101-2020_03_27_012757	405	38	indicate	indicate	VBP
10_1101-2020_03_27_012757	405	39	high	high	JJ
10_1101-2020_03_27_012757	405	40	803	803	CD
10_1101-2020_03_27_012757	405	41	Z	z	NN
10_1101-2020_03_27_012757	405	42	-	-	HYPH
10_1101-2020_03_27_012757	405	43	scores	score	NNS
10_1101-2020_03_27_012757	405	44	for	for	IN
10_1101-2020_03_27_012757	405	45	the	the	DT
10_1101-2020_03_27_012757	405	46	GRN	GRN	NNP
10_1101-2020_03_27_012757	405	47	genes	gene	NNS
10_1101-2020_03_27_012757	405	48	and	and	CC
10_1101-2020_03_27_012757	405	49	low	low	JJ
10_1101-2020_03_27_012757	405	50	GRN	GRN	NNP
10_1101-2020_03_27_012757	405	51	status	status	NN
10_1101-2020_03_27_012757	405	52	.	.	.
10_1101-2020_03_27_012757	406	1	804	804	CD
10_1101-2020_03_27_012757	406	2	𝑅𝐺𝑆	𝑅𝐺𝑆	NNP
10_1101-2020_03_27_012757	406	3	=	=	SYM
10_1101-2020_03_27_012757	406	4	e(1000	e(1000	CD
10_1101-2020_03_27_012757	406	5	−	−	NNP
10_1101-2020_03_27_012757	406	6	𝑍𝑠𝑐𝑜𝑟𝑒(𝑔𝑒𝑛𝑒	𝑍𝑠𝑐𝑜𝑟𝑒(𝑔𝑒𝑛𝑒	NNP
10_1101-2020_03_27_012757	406	7	𝑖)XYZ)𝑤𝑒𝑖𝑔ℎ𝑡fghg	𝑖)xyz)𝑤𝑒𝑖𝑔ℎ𝑡fghg	NN
10_1101-2020_03_27_012757	406	8	i	i	NN
10_1101-2020_03_27_012757	406	9	h	h	NN
10_1101-2020_03_27_012757	406	10	ijk	ijk	VBP
10_1101-2020_03_27_012757	406	11	805	805	CD
10_1101-2020_03_27_012757	406	12	𝐺𝑅𝑁	𝐺𝑅𝑁	NNP
10_1101-2020_03_27_012757	406	13	𝑆𝑡𝑎𝑡𝑢𝑠	𝑆𝑡𝑎𝑡𝑢𝑠	NNP
10_1101-2020_03_27_012757	406	14	=	=	SYM
10_1101-2020_03_27_012757	406	15	𝑅𝐺𝑆	𝑅𝐺𝑆	NNP
10_1101-2020_03_27_012757	406	16	∑	∑	.
10_1101-2020_03_27_012757	406	17	𝑤𝑒𝑖𝑔ℎ𝑡fghg	𝑤𝑒𝑖𝑔ℎ𝑡fghg	NNP
10_1101-2020_03_27_012757	406	18	ihijk	ihijk	NNP
10_1101-2020_03_27_012757	406	19	806	806	CD
10_1101-2020_03_27_012757	406	20	The	the	DT
10_1101-2020_03_27_012757	406	21	weight	weight	NN
10_1101-2020_03_27_012757	406	22	of	of	IN
10_1101-2020_03_27_012757	406	23	individual	individual	JJ
10_1101-2020_03_27_012757	406	24	genes	gene	NNS
10_1101-2020_03_27_012757	406	25	in	in	IN
10_1101-2020_03_27_012757	406	26	the	the	DT
10_1101-2020_03_27_012757	406	27	cancer	cancer	NN
10_1101-2020_03_27_012757	406	28	specific	specific	JJ
10_1101-2020_03_27_012757	406	29	network	network	NN
10_1101-2020_03_27_012757	406	30	is	be	VBZ
10_1101-2020_03_27_012757	406	31	determined	determine	VBN
10_1101-2020_03_27_012757	406	32	by	by	IN
10_1101-2020_03_27_012757	406	33	the	the	DT
10_1101-2020_03_27_012757	406	34	807	807	CD
10_1101-2020_03_27_012757	406	35	importance	importance	NN
10_1101-2020_03_27_012757	406	36	of	of	IN
10_1101-2020_03_27_012757	406	37	the	the	DT
10_1101-2020_03_27_012757	406	38	gene	gene	NN
10_1101-2020_03_27_012757	406	39	in	in	IN
10_1101-2020_03_27_012757	406	40	the	the	DT
10_1101-2020_03_27_012757	406	41	Random	Random	NNP
10_1101-2020_03_27_012757	406	42	Forest	Forest	NNP
10_1101-2020_03_27_012757	406	43	classifier	classifier	NN
10_1101-2020_03_27_012757	406	44	.	.	.
10_1101-2020_03_27_012757	407	1	Finally	finally	RB
10_1101-2020_03_27_012757	407	2	,	,	,
10_1101-2020_03_27_012757	407	3	the	the	DT
10_1101-2020_03_27_012757	407	4	GRN	GRN	NNP
10_1101-2020_03_27_012757	407	5	status	status	NN
10_1101-2020_03_27_012757	407	6	gets	get	VBZ
10_1101-2020_03_27_012757	407	7	normalized	normalized	JJ
10_1101-2020_03_27_012757	407	8	808	808	CD
10_1101-2020_03_27_012757	407	9	with	with	IN
10_1101-2020_03_27_012757	407	10	respect	respect	NN
10_1101-2020_03_27_012757	407	11	to	to	IN
10_1101-2020_03_27_012757	407	12	the	the	DT
10_1101-2020_03_27_012757	407	13	GRN	GRN	NNP
10_1101-2020_03_27_012757	407	14	status	status	NN
10_1101-2020_03_27_012757	407	15	of	of	IN
10_1101-2020_03_27_012757	407	16	the	the	DT
10_1101-2020_03_27_012757	407	17	cancer	cancer	NN
10_1101-2020_03_27_012757	407	18	type	type	NN
10_1101-2020_03_27_012757	407	19	of	of	IN
10_1101-2020_03_27_012757	407	20	interest	interest	NN
10_1101-2020_03_27_012757	407	21	and	and	CC
10_1101-2020_03_27_012757	407	22	the	the	DT
10_1101-2020_03_27_012757	407	23	cancer	cancer	NN
10_1101-2020_03_27_012757	407	24	type	type	NN
10_1101-2020_03_27_012757	407	25	with	with	IN
10_1101-2020_03_27_012757	407	26	the	the	DT
10_1101-2020_03_27_012757	407	27	lowest	low	JJS
10_1101-2020_03_27_012757	407	28	809	809	CD
10_1101-2020_03_27_012757	407	29	mean	mean	NN
10_1101-2020_03_27_012757	407	30	GRN	GRN	NNP
10_1101-2020_03_27_012757	407	31	status	status	NN
10_1101-2020_03_27_012757	407	32	.	.	.
10_1101-2020_03_27_012757	408	1	810	810	CD
10_1101-2020_03_27_012757	408	2	𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑	𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑	NNS
10_1101-2020_03_27_012757	408	3	𝐺𝑅𝑁	𝐺𝑅𝑁	RB
10_1101-2020_03_27_012757	408	4	𝑠𝑡𝑎𝑡𝑢𝑠	𝑠𝑡𝑎𝑡𝑢𝑠	NNS
10_1101-2020_03_27_012757	408	5	=	=	-RRB-
10_1101-2020_03_27_012757	408	6	𝐺𝑅𝑁	𝐺𝑅𝑁	RB
10_1101-2020_03_27_012757	408	7	𝑠𝑡𝑎𝑡𝑢𝑠	𝑠𝑡𝑎𝑡𝑢𝑠	NN
10_1101-2020_03_27_012757	408	8	mngop	mngop	NN
10_1101-2020_03_27_012757	408	9	−	−	NNP
10_1101-2020_03_27_012757	408	10	𝑎𝑣𝑔(𝐺𝑅𝑁	𝑎𝑣𝑔(𝐺𝑅𝑁	,
10_1101-2020_03_27_012757	408	11	𝑠𝑡𝑎𝑡𝑢𝑠	𝑠𝑡𝑎𝑡𝑢𝑠	JJ
10_1101-2020_03_27_012757	408	12	Xih	Xih	NNP
10_1101-2020_03_27_012757	408	13	qrhqgo	qrhqgo	NN
10_1101-2020_03_27_012757	408	14	)	)	-RRB-
10_1101-2020_03_27_012757	408	15	𝑎𝑣𝑔(𝐺𝑅𝑁	𝑎𝑣𝑔(𝐺𝑅𝑁	,
10_1101-2020_03_27_012757	408	16	𝑠𝑡𝑎𝑡𝑢𝑠qrhqgo	𝑠𝑡𝑎𝑡𝑢𝑠qrhqgo	JJ
10_1101-2020_03_27_012757	408	17	sptg	sptg	NN
10_1101-2020_03_27_012757	408	18	ihsgogus	ihsgogus	JJ
10_1101-2020_03_27_012757	408	19	)	)	-RRB-
10_1101-2020_03_27_012757	408	20	811	811	CD
10_1101-2020_03_27_012757	408	21	Where	where	WRB
10_1101-2020_03_27_012757	408	22	“	"	``
10_1101-2020_03_27_012757	408	23	min	min	NNP
10_1101-2020_03_27_012757	408	24	cancer	cancer	NNP
10_1101-2020_03_27_012757	408	25	”	"	''
10_1101-2020_03_27_012757	408	26	represents	represent	VBZ
10_1101-2020_03_27_012757	408	27	the	the	DT
10_1101-2020_03_27_012757	408	28	cancer	cancer	NN
10_1101-2020_03_27_012757	408	29	type	type	NN
10_1101-2020_03_27_012757	408	30	where	where	WRB
10_1101-2020_03_27_012757	408	31	its	-PRON-	PRP$
10_1101-2020_03_27_012757	408	32	training	training	NN
10_1101-2020_03_27_012757	408	33	data	datum	NNS
10_1101-2020_03_27_012757	408	34	have	have	VBP
10_1101-2020_03_27_012757	408	35	the	the	DT
10_1101-2020_03_27_012757	408	36	lowest	low	JJS
10_1101-2020_03_27_012757	408	37	812	812	CD
10_1101-2020_03_27_012757	408	38	mean	mean	JJ
10_1101-2020_03_27_012757	408	39	GRN	GRN	NNP
10_1101-2020_03_27_012757	408	40	status	status	NN
10_1101-2020_03_27_012757	408	41	in	in	IN
10_1101-2020_03_27_012757	408	42	the	the	DT
10_1101-2020_03_27_012757	408	43	cancer	cancer	NN
10_1101-2020_03_27_012757	408	44	type	type	NN
10_1101-2020_03_27_012757	408	45	of	of	IN
10_1101-2020_03_27_012757	408	46	interest	interest	NN
10_1101-2020_03_27_012757	408	47	,	,	,
10_1101-2020_03_27_012757	408	48	and	and	CC
10_1101-2020_03_27_012757	408	49	𝑎𝑣𝑔(𝐺𝑅𝑁	𝑎𝑣𝑔(𝐺𝑅𝑁	CD
10_1101-2020_03_27_012757	408	50	𝑠𝑡𝑎𝑡𝑢𝑠	𝑠𝑡𝑎𝑡𝑢𝑠	JJ
10_1101-2020_03_27_012757	408	51	Xih	Xih	NNP
10_1101-2020_03_27_012757	408	52	qrhqgo	qrhqgo	NN
10_1101-2020_03_27_012757	408	53	)	)	-RRB-
10_1101-2020_03_27_012757	408	54	represents	represent	VBZ
10_1101-2020_03_27_012757	408	55	the	the	DT
10_1101-2020_03_27_012757	408	56	813	813	CD
10_1101-2020_03_27_012757	408	57	lowest	low	JJS
10_1101-2020_03_27_012757	408	58	average	average	JJ
10_1101-2020_03_27_012757	408	59	GRN	GRN	NNP
10_1101-2020_03_27_012757	408	60	status	status	NN
10_1101-2020_03_27_012757	408	61	in	in	IN
10_1101-2020_03_27_012757	408	62	the	the	DT
10_1101-2020_03_27_012757	408	63	cancer	cancer	NN
10_1101-2020_03_27_012757	408	64	type	type	NN
10_1101-2020_03_27_012757	408	65	of	of	IN
10_1101-2020_03_27_012757	408	66	interest	interest	NN
10_1101-2020_03_27_012757	408	67	.	.	.
10_1101-2020_03_27_012757	409	1	𝑎𝑣𝑔(𝐺𝑅𝑁	𝑎𝑣𝑔(𝐺𝑅𝑁	``
10_1101-2020_03_27_012757	409	2	𝑠𝑡𝑎𝑡𝑢𝑠qrhqgo	𝑠𝑡𝑎𝑡𝑢𝑠qrhqgo	JJ
10_1101-2020_03_27_012757	409	3	sptg	sptg	NN
10_1101-2020_03_27_012757	409	4	ihsgogus	ihsgogus	JJ
10_1101-2020_03_27_012757	409	5	)	)	-RRB-
10_1101-2020_03_27_012757	409	6	814	814	CD
10_1101-2020_03_27_012757	409	7	represents	represent	VBZ
10_1101-2020_03_27_012757	409	8	average	average	JJ
10_1101-2020_03_27_012757	409	9	GRN	GRN	NNP
10_1101-2020_03_27_012757	409	10	status	status	NN
10_1101-2020_03_27_012757	409	11	of	of	IN
10_1101-2020_03_27_012757	409	12	the	the	DT
10_1101-2020_03_27_012757	409	13	cancer	cancer	NN
10_1101-2020_03_27_012757	409	14	type	type	NN
10_1101-2020_03_27_012757	409	15	of	of	IN
10_1101-2020_03_27_012757	409	16	interest	interest	NN
10_1101-2020_03_27_012757	409	17	in	in	IN
10_1101-2020_03_27_012757	409	18	the	the	DT
10_1101-2020_03_27_012757	409	19	training	training	NN
10_1101-2020_03_27_012757	409	20	data	datum	NNS
10_1101-2020_03_27_012757	409	21	.	.	.
10_1101-2020_03_27_012757	410	1	815	815	CD
10_1101-2020_03_27_012757	410	2	816	816	CD
10_1101-2020_03_27_012757	410	3	Code	code	NN
10_1101-2020_03_27_012757	410	4	availability	availability	NN
10_1101-2020_03_27_012757	410	5	817	817	CD
10_1101-2020_03_27_012757	410	6	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	410	7	code	code	NN
10_1101-2020_03_27_012757	410	8	and	and	CC
10_1101-2020_03_27_012757	410	9	documentation	documentation	NN
10_1101-2020_03_27_012757	410	10	is	be	VBZ
10_1101-2020_03_27_012757	410	11	available	available	JJ
10_1101-2020_03_27_012757	410	12	at	at	IN
10_1101-2020_03_27_012757	410	13	GitHub	GitHub	NNP
10_1101-2020_03_27_012757	410	14	:	:	:
10_1101-2020_03_27_012757	410	15	818	818	CD
10_1101-2020_03_27_012757	410	16	https://github.com/pcahan1/cancerCellNet	https://github.com/pcahan1/cancerCellNet	NNS
10_1101-2020_03_27_012757	410	17	819	819	CD
10_1101-2020_03_27_012757	410	18	820	820	CD
10_1101-2020_03_27_012757	410	19	Acknowledgements	acknowledgement	NNS
10_1101-2020_03_27_012757	410	20	821	821	CD
10_1101-2020_03_27_012757	410	21	This	this	DT
10_1101-2020_03_27_012757	410	22	work	work	NN
10_1101-2020_03_27_012757	410	23	was	be	VBD
10_1101-2020_03_27_012757	410	24	supported	support	VBN
10_1101-2020_03_27_012757	410	25	by	by	IN
10_1101-2020_03_27_012757	410	26	the	the	DT
10_1101-2020_03_27_012757	410	27	National	National	NNP
10_1101-2020_03_27_012757	410	28	Institutes	Institutes	NNPS
10_1101-2020_03_27_012757	410	29	of	of	IN
10_1101-2020_03_27_012757	410	30	Health	Health	NNP
10_1101-2020_03_27_012757	410	31	NCI	NCI	NNP
10_1101-2020_03_27_012757	410	32	Ovarian	Ovarian	NNP
10_1101-2020_03_27_012757	410	33	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	410	34	SPORE	SPORE	NNP
10_1101-2020_03_27_012757	410	35	822	822	CD
10_1101-2020_03_27_012757	410	36	P50CA228991	p50ca228991	NN
10_1101-2020_03_27_012757	410	37	via	via	IN
10_1101-2020_03_27_012757	410	38	a	a	DT
10_1101-2020_03_27_012757	410	39	Development	Development	NNP
10_1101-2020_03_27_012757	410	40	Research	Research	NNP
10_1101-2020_03_27_012757	410	41	Program	Program	NNP
10_1101-2020_03_27_012757	410	42	award	award	NN
10_1101-2020_03_27_012757	410	43	to	to	IN
10_1101-2020_03_27_012757	410	44	PC	PC	NNP
10_1101-2020_03_27_012757	410	45	.	.	.
10_1101-2020_03_27_012757	411	1	FWH	FWH	NNP
10_1101-2020_03_27_012757	411	2	was	be	VBD
10_1101-2020_03_27_012757	411	3	supported	support	VBN
10_1101-2020_03_27_012757	411	4	by	by	IN
10_1101-2020_03_27_012757	411	5	a	a	DT
10_1101-2020_03_27_012757	411	6	823	823	CD
10_1101-2020_03_27_012757	411	7	Prostate	Prostate	NNP
10_1101-2020_03_27_012757	411	8	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	411	9	Foundation	Foundation	NNP
10_1101-2020_03_27_012757	411	10	Young	Young	NNP
10_1101-2020_03_27_012757	411	11	Investigator	Investigator	NNP
10_1101-2020_03_27_012757	411	12	Award	Award	NNP
10_1101-2020_03_27_012757	411	13	,	,	,
10_1101-2020_03_27_012757	411	14	Department	Department	NNP
10_1101-2020_03_27_012757	411	15	of	of	IN
10_1101-2020_03_27_012757	411	16	Defense	Defense	NNP
10_1101-2020_03_27_012757	411	17	W81XWH-17	W81XWH-17	NNP
10_1101-2020_03_27_012757	411	18	-	-	HYPH
10_1101-2020_03_27_012757	411	19	824	824	CD
10_1101-2020_03_27_012757	411	20	PCRP	pcrp	NN
10_1101-2020_03_27_012757	411	21	-	-	HYPH
10_1101-2020_03_27_012757	411	22	HD	HD	NNP
10_1101-2020_03_27_012757	411	23	(	(	-LRB-
10_1101-2020_03_27_012757	411	24	F.W.H.	F.W.H.	NNP
10_1101-2020_03_27_012757	412	1	)	)	-RRB-
10_1101-2020_03_27_012757	412	2	,	,	,
10_1101-2020_03_27_012757	412	3	the	the	DT
10_1101-2020_03_27_012757	412	4	National	National	NNP
10_1101-2020_03_27_012757	412	5	Institutes	Institutes	NNPS
10_1101-2020_03_27_012757	412	6	of	of	IN
10_1101-2020_03_27_012757	412	7	Health	Health	NNP
10_1101-2020_03_27_012757	412	8	/	/	SYM
10_1101-2020_03_27_012757	412	9	National	National	NNP
10_1101-2020_03_27_012757	412	10	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	412	11	Institute	Institute	NNP
10_1101-2020_03_27_012757	412	12	P20	P20	NNP
10_1101-2020_03_27_012757	412	13	CA233255	CA233255	NNP
10_1101-2020_03_27_012757	412	14	-	-	HYPH
10_1101-2020_03_27_012757	412	15	825	825	CD
10_1101-2020_03_27_012757	412	16	.CC	.CC	:
10_1101-2020_03_27_012757	412	17	-	-	HYPH
10_1101-2020_03_27_012757	412	18	BY	by	IN
10_1101-2020_03_27_012757	412	19	-	-	HYPH
10_1101-2020_03_27_012757	412	20	NC	NC	NNP
10_1101-2020_03_27_012757	412	21	-	-	HYPH
10_1101-2020_03_27_012757	412	22	ND	ND	NNP
10_1101-2020_03_27_012757	412	23	4.0	4.0	CD
10_1101-2020_03_27_012757	412	24	International	International	NNP
10_1101-2020_03_27_012757	412	25	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	412	26	under	under	IN
10_1101-2020_03_27_012757	412	27	a	a	DT
10_1101-2020_03_27_012757	412	28	(	(	-LRB-
10_1101-2020_03_27_012757	412	29	which	which	WDT
10_1101-2020_03_27_012757	412	30	was	be	VBD
10_1101-2020_03_27_012757	412	31	not	not	RB
10_1101-2020_03_27_012757	412	32	certified	certify	VBN
10_1101-2020_03_27_012757	412	33	by	by	IN
10_1101-2020_03_27_012757	412	34	peer	peer	NN
10_1101-2020_03_27_012757	412	35	review	review	NN
10_1101-2020_03_27_012757	412	36	)	)	-RRB-
10_1101-2020_03_27_012757	412	37	is	be	VBZ
10_1101-2020_03_27_012757	412	38	the	the	DT
10_1101-2020_03_27_012757	412	39	author	author	NN
10_1101-2020_03_27_012757	412	40	/	/	SYM
10_1101-2020_03_27_012757	412	41	funder	funder	NN
10_1101-2020_03_27_012757	412	42	,	,	,
10_1101-2020_03_27_012757	412	43	who	who	WP
10_1101-2020_03_27_012757	412	44	has	have	VBZ
10_1101-2020_03_27_012757	412	45	granted	grant	VBN
10_1101-2020_03_27_012757	412	46	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	412	47	a	a	DT
10_1101-2020_03_27_012757	412	48	license	license	NN
10_1101-2020_03_27_012757	412	49	to	to	TO
10_1101-2020_03_27_012757	412	50	display	display	VB
10_1101-2020_03_27_012757	412	51	the	the	DT
10_1101-2020_03_27_012757	412	52	preprint	preprint	NN
10_1101-2020_03_27_012757	412	53	in	in	IN
10_1101-2020_03_27_012757	412	54	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	412	55	.	.	.
10_1101-2020_03_27_012757	413	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	413	2	is	be	VBZ
10_1101-2020_03_27_012757	413	3	made	make	VBN
10_1101-2020_03_27_012757	413	4	The	the	DT
10_1101-2020_03_27_012757	413	5	copyright	copyright	NN
10_1101-2020_03_27_012757	413	6	holder	holder	NN
10_1101-2020_03_27_012757	413	7	for	for	IN
10_1101-2020_03_27_012757	413	8	this	this	DT
10_1101-2020_03_27_012757	413	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	413	10	version	version	NN
10_1101-2020_03_27_012757	413	11	posted	post	VBD
10_1101-2020_03_27_012757	413	12	January	January	NNP
10_1101-2020_03_27_012757	413	13	9	9	CD
10_1101-2020_03_27_012757	413	14	,	,	,
10_1101-2020_03_27_012757	413	15	2021	2021	CD
10_1101-2020_03_27_012757	413	16	.	.	.
10_1101-2020_03_27_012757	413	17	;	;	:
10_1101-2020_03_27_012757	413	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	413	19	:	:	:
10_1101-2020_03_27_012757	413	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	413	21	preprint	preprint	NN
10_1101-2020_03_27_012757	413	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	413	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	413	24	32	32	CD
10_1101-2020_03_27_012757	413	25	01	01	CD
10_1101-2020_03_27_012757	413	26	(	(	-LRB-
10_1101-2020_03_27_012757	413	27	F.W.H.	F.W.H.	NNP
10_1101-2020_03_27_012757	413	28	)	)	-RRB-
10_1101-2020_03_27_012757	414	1	U19	U19	NNP
10_1101-2020_03_27_012757	414	2	CA214253	CA214253	.
10_1101-2020_03_27_012757	414	3	(	(	-LRB-
10_1101-2020_03_27_012757	414	4	F.W.H.	F.W.H.	NNP
10_1101-2020_03_27_012757	414	5	)	)	-RRB-
10_1101-2020_03_27_012757	414	6	.	.	.
10_1101-2020_03_27_012757	415	1	We	-PRON-	PRP
10_1101-2020_03_27_012757	415	2	would	would	MD
10_1101-2020_03_27_012757	415	3	like	like	VB
10_1101-2020_03_27_012757	415	4	to	to	TO
10_1101-2020_03_27_012757	415	5	thank	thank	VB
10_1101-2020_03_27_012757	415	6	John	John	NNP
10_1101-2020_03_27_012757	415	7	Powers	Powers	NNP
10_1101-2020_03_27_012757	415	8	,	,	,
10_1101-2020_03_27_012757	415	9	Hao	Hao	NNP
10_1101-2020_03_27_012757	415	10	Zhu	Zhu	NNP
10_1101-2020_03_27_012757	415	11	,	,	,
10_1101-2020_03_27_012757	415	12	Tian	Tian	NNP
10_1101-2020_03_27_012757	415	13	-	-	HYPH
10_1101-2020_03_27_012757	415	14	Li	Li	NNP
10_1101-2020_03_27_012757	415	15	826	826	CD
10_1101-2020_03_27_012757	415	16	Wang	Wang	NNP
10_1101-2020_03_27_012757	415	17	,	,	,
10_1101-2020_03_27_012757	415	18	Charles	Charles	NNP
10_1101-2020_03_27_012757	415	19	Eberhart	Eberhart	NNP
10_1101-2020_03_27_012757	415	20	,	,	,
10_1101-2020_03_27_012757	415	21	and	and	CC
10_1101-2020_03_27_012757	415	22	Kaloyan	Kaloyan	NNP
10_1101-2020_03_27_012757	415	23	Tsanov	Tsanov	NNP
10_1101-2020_03_27_012757	415	24	for	for	IN
10_1101-2020_03_27_012757	415	25	comments	comment	NNS
10_1101-2020_03_27_012757	415	26	on	on	IN
10_1101-2020_03_27_012757	415	27	the	the	DT
10_1101-2020_03_27_012757	415	28	manuscript	manuscript	NN
10_1101-2020_03_27_012757	415	29	and	and	CC
10_1101-2020_03_27_012757	415	30	helpful	helpful	JJ
10_1101-2020_03_27_012757	415	31	827	827	CD
10_1101-2020_03_27_012757	415	32	discussions	discussion	NNS
10_1101-2020_03_27_012757	415	33	.	.	.
10_1101-2020_03_27_012757	416	1	Some	some	DT
10_1101-2020_03_27_012757	416	2	figures	figure	NNS
10_1101-2020_03_27_012757	416	3	were	be	VBD
10_1101-2020_03_27_012757	416	4	created	create	VBN
10_1101-2020_03_27_012757	416	5	in	in	IN
10_1101-2020_03_27_012757	416	6	part	part	NN
10_1101-2020_03_27_012757	416	7	with	with	IN
10_1101-2020_03_27_012757	416	8	Biorender.com	Biorender.com	NNP
10_1101-2020_03_27_012757	416	9	.	.	.
10_1101-2020_03_27_012757	417	1	828	828	CD
10_1101-2020_03_27_012757	417	2	829	829	CD
10_1101-2020_03_27_012757	417	3	FIGURE	figure	NN
10_1101-2020_03_27_012757	417	4	LEGENDS	legend	NNS
10_1101-2020_03_27_012757	417	5	830	830	CD
10_1101-2020_03_27_012757	417	6	Fig	fig	NN
10_1101-2020_03_27_012757	417	7	.	.	.
10_1101-2020_03_27_012757	418	1	1	1	CD
10_1101-2020_03_27_012757	418	2	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	418	3	(	(	-LRB-
10_1101-2020_03_27_012757	418	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	418	5	)	)	-RRB-
10_1101-2020_03_27_012757	418	6	workflow	workflow	NN
10_1101-2020_03_27_012757	418	7	,	,	,
10_1101-2020_03_27_012757	418	8	training	training	NN
10_1101-2020_03_27_012757	418	9	,	,	,
10_1101-2020_03_27_012757	418	10	and	and	CC
10_1101-2020_03_27_012757	418	11	performance	performance	NN
10_1101-2020_03_27_012757	418	12	.	.	.
10_1101-2020_03_27_012757	419	1	(	(	-LRB-
10_1101-2020_03_27_012757	419	2	A	a	DT
10_1101-2020_03_27_012757	419	3	)	)	-RRB-
10_1101-2020_03_27_012757	419	4	Schematic	schematic	JJ
10_1101-2020_03_27_012757	419	5	of	of	IN
10_1101-2020_03_27_012757	419	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	419	7	831	831	CD
10_1101-2020_03_27_012757	419	8	usage	usage	NN
10_1101-2020_03_27_012757	419	9	.	.	.
10_1101-2020_03_27_012757	420	1	CCN	CCN	NNP
10_1101-2020_03_27_012757	420	2	was	be	VBD
10_1101-2020_03_27_012757	420	3	designed	design	VBN
10_1101-2020_03_27_012757	420	4	to	to	TO
10_1101-2020_03_27_012757	420	5	assess	assess	VB
10_1101-2020_03_27_012757	420	6	and	and	CC
10_1101-2020_03_27_012757	420	7	compare	compare	VB
10_1101-2020_03_27_012757	420	8	the	the	DT
10_1101-2020_03_27_012757	420	9	expression	expression	NN
10_1101-2020_03_27_012757	420	10	profiles	profile	NNS
10_1101-2020_03_27_012757	420	11	of	of	IN
10_1101-2020_03_27_012757	420	12	cancer	cancer	NN
10_1101-2020_03_27_012757	420	13	models	model	NNS
10_1101-2020_03_27_012757	420	14	832	832	CD
10_1101-2020_03_27_012757	420	15	such	such	JJ
10_1101-2020_03_27_012757	420	16	as	as	IN
10_1101-2020_03_27_012757	420	17	CCLs	ccl	NNS
10_1101-2020_03_27_012757	420	18	,	,	,
10_1101-2020_03_27_012757	420	19	PDXs	pdx	NNS
10_1101-2020_03_27_012757	420	20	,	,	,
10_1101-2020_03_27_012757	420	21	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	420	22	,	,	,
10_1101-2020_03_27_012757	420	23	and	and	CC
10_1101-2020_03_27_012757	420	24	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	420	25	with	with	IN
10_1101-2020_03_27_012757	420	26	native	native	JJ
10_1101-2020_03_27_012757	420	27	patient	patient	JJ
10_1101-2020_03_27_012757	420	28	tumors	tumor	NNS
10_1101-2020_03_27_012757	420	29	.	.	.
10_1101-2020_03_27_012757	421	1	To	to	TO
10_1101-2020_03_27_012757	421	2	use	use	VB
10_1101-2020_03_27_012757	421	3	trained	train	VBN
10_1101-2020_03_27_012757	421	4	833	833	CD
10_1101-2020_03_27_012757	421	5	classifier	classifier	NN
10_1101-2020_03_27_012757	421	6	,	,	,
10_1101-2020_03_27_012757	421	7	CCN	CCN	NNP
10_1101-2020_03_27_012757	421	8	inputs	input	VBZ
10_1101-2020_03_27_012757	421	9	the	the	DT
10_1101-2020_03_27_012757	421	10	query	query	NN
10_1101-2020_03_27_012757	421	11	samples	sample	NNS
10_1101-2020_03_27_012757	421	12	(	(	-LRB-
10_1101-2020_03_27_012757	421	13	e.g.	e.g.	RB
10_1101-2020_03_27_012757	422	1	expression	expression	NN
10_1101-2020_03_27_012757	422	2	profiles	profile	NNS
10_1101-2020_03_27_012757	422	3	from	from	IN
10_1101-2020_03_27_012757	422	4	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	422	5	,	,	,
10_1101-2020_03_27_012757	422	6	PDXs	pdx	NNS
10_1101-2020_03_27_012757	422	7	,	,	,
10_1101-2020_03_27_012757	422	8	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	422	9	,	,	,
10_1101-2020_03_27_012757	422	10	834	834	CD
10_1101-2020_03_27_012757	422	11	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	422	12	)	)	-RRB-
10_1101-2020_03_27_012757	422	13	and	and	CC
10_1101-2020_03_27_012757	422	14	generates	generate	VBZ
10_1101-2020_03_27_012757	422	15	a	a	DT
10_1101-2020_03_27_012757	422	16	classification	classification	NN
10_1101-2020_03_27_012757	422	17	profile	profile	NN
10_1101-2020_03_27_012757	422	18	for	for	IN
10_1101-2020_03_27_012757	422	19	the	the	DT
10_1101-2020_03_27_012757	422	20	query	query	NN
10_1101-2020_03_27_012757	422	21	samples	sample	NNS
10_1101-2020_03_27_012757	422	22	.	.	.
10_1101-2020_03_27_012757	423	1	The	the	DT
10_1101-2020_03_27_012757	423	2	column	column	NN
10_1101-2020_03_27_012757	423	3	names	name	NNS
10_1101-2020_03_27_012757	423	4	of	of	IN
10_1101-2020_03_27_012757	423	5	835	835	CD
10_1101-2020_03_27_012757	423	6	the	the	DT
10_1101-2020_03_27_012757	423	7	classification	classification	NN
10_1101-2020_03_27_012757	423	8	heatmap	heatmap	NN
10_1101-2020_03_27_012757	423	9	represent	represent	VBP
10_1101-2020_03_27_012757	423	10	sample	sample	NN
10_1101-2020_03_27_012757	423	11	annotation	annotation	NN
10_1101-2020_03_27_012757	423	12	and	and	CC
10_1101-2020_03_27_012757	423	13	the	the	DT
10_1101-2020_03_27_012757	423	14	row	row	NN
10_1101-2020_03_27_012757	423	15	names	name	NNS
10_1101-2020_03_27_012757	423	16	of	of	IN
10_1101-2020_03_27_012757	423	17	the	the	DT
10_1101-2020_03_27_012757	423	18	classification	classification	NN
10_1101-2020_03_27_012757	423	19	836	836	CD
10_1101-2020_03_27_012757	423	20	heatmap	heatmap	NNP
10_1101-2020_03_27_012757	423	21	represent	represent	VBP
10_1101-2020_03_27_012757	423	22	different	different	JJ
10_1101-2020_03_27_012757	423	23	cancer	cancer	NN
10_1101-2020_03_27_012757	423	24	types	type	NNS
10_1101-2020_03_27_012757	423	25	.	.	.
10_1101-2020_03_27_012757	424	1	Each	each	DT
10_1101-2020_03_27_012757	424	2	grid	grid	NN
10_1101-2020_03_27_012757	424	3	is	be	VBZ
10_1101-2020_03_27_012757	424	4	colored	color	VBN
10_1101-2020_03_27_012757	424	5	from	from	IN
10_1101-2020_03_27_012757	424	6	black	black	JJ
10_1101-2020_03_27_012757	424	7	to	to	IN
10_1101-2020_03_27_012757	424	8	yellow	yellow	JJ
10_1101-2020_03_27_012757	424	9	representing	represent	VBG
10_1101-2020_03_27_012757	424	10	837	837	CD
10_1101-2020_03_27_012757	424	11	the	the	DT
10_1101-2020_03_27_012757	424	12	lowest	low	JJS
10_1101-2020_03_27_012757	424	13	classification	classification	NN
10_1101-2020_03_27_012757	424	14	score	score	NN
10_1101-2020_03_27_012757	424	15	(	(	-LRB-
10_1101-2020_03_27_012757	424	16	e.g.	e.g.	RB
10_1101-2020_03_27_012757	425	1	0	0	LS
10_1101-2020_03_27_012757	425	2	)	)	-RRB-
10_1101-2020_03_27_012757	425	3	to	to	IN
10_1101-2020_03_27_012757	425	4	highest	high	JJS
10_1101-2020_03_27_012757	425	5	classification	classification	NN
10_1101-2020_03_27_012757	425	6	score	score	NN
10_1101-2020_03_27_012757	425	7	(	(	-LRB-
10_1101-2020_03_27_012757	425	8	e.g.	e.g.	RB
10_1101-2020_03_27_012757	426	1	1	1	LS
10_1101-2020_03_27_012757	426	2	)	)	-RRB-
10_1101-2020_03_27_012757	426	3	.	.	.
10_1101-2020_03_27_012757	427	1	(	(	-LRB-
10_1101-2020_03_27_012757	427	2	B	b	NN
10_1101-2020_03_27_012757	427	3	)	)	-RRB-
10_1101-2020_03_27_012757	427	4	Schematic	Schematic	NNP
10_1101-2020_03_27_012757	427	5	of	of	IN
10_1101-2020_03_27_012757	427	6	838	838	CD
10_1101-2020_03_27_012757	427	7	CCN	CCN	NNP
10_1101-2020_03_27_012757	427	8	training	training	NN
10_1101-2020_03_27_012757	427	9	process	process	NN
10_1101-2020_03_27_012757	427	10	.	.	.
10_1101-2020_03_27_012757	428	1	CCN	CCN	NNP
10_1101-2020_03_27_012757	428	2	uses	use	VBZ
10_1101-2020_03_27_012757	428	3	patient	patient	JJ
10_1101-2020_03_27_012757	428	4	tumor	tumor	NN
10_1101-2020_03_27_012757	428	5	expression	expression	NN
10_1101-2020_03_27_012757	428	6	profiles	profile	NNS
10_1101-2020_03_27_012757	428	7	of	of	IN
10_1101-2020_03_27_012757	428	8	22	22	CD
10_1101-2020_03_27_012757	428	9	different	different	JJ
10_1101-2020_03_27_012757	428	10	cancer	cancer	NN
10_1101-2020_03_27_012757	428	11	types	type	NNS
10_1101-2020_03_27_012757	428	12	839	839	CD
10_1101-2020_03_27_012757	428	13	from	from	IN
10_1101-2020_03_27_012757	428	14	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	428	15	as	as	IN
10_1101-2020_03_27_012757	428	16	training	training	NN
10_1101-2020_03_27_012757	428	17	data	datum	NNS
10_1101-2020_03_27_012757	428	18	.	.	.
10_1101-2020_03_27_012757	429	1	First	first	RB
10_1101-2020_03_27_012757	429	2	,	,	,
10_1101-2020_03_27_012757	429	3	CCN	CCN	NNP
10_1101-2020_03_27_012757	429	4	identifies	identifie	NNS
10_1101-2020_03_27_012757	429	5	n	n	CC
10_1101-2020_03_27_012757	429	6	genes	gene	NNS
10_1101-2020_03_27_012757	429	7	that	that	WDT
10_1101-2020_03_27_012757	429	8	are	be	VBP
10_1101-2020_03_27_012757	429	9	upregulated	upregulate	VBN
10_1101-2020_03_27_012757	429	10	,	,	,
10_1101-2020_03_27_012757	429	11	n	n	CC
10_1101-2020_03_27_012757	429	12	that	that	WDT
10_1101-2020_03_27_012757	429	13	are	be	VBP
10_1101-2020_03_27_012757	429	14	840	840	CD
10_1101-2020_03_27_012757	429	15	downregulated	downregulate	VBN
10_1101-2020_03_27_012757	429	16	,	,	,
10_1101-2020_03_27_012757	429	17	and	and	CC
10_1101-2020_03_27_012757	429	18	n	n	IN
10_1101-2020_03_27_012757	429	19	that	that	WDT
10_1101-2020_03_27_012757	429	20	are	be	VBP
10_1101-2020_03_27_012757	429	21	relatively	relatively	RB
10_1101-2020_03_27_012757	429	22	invariant	invariant	JJ
10_1101-2020_03_27_012757	429	23	in	in	IN
10_1101-2020_03_27_012757	429	24	each	each	DT
10_1101-2020_03_27_012757	429	25	tumor	tumor	NN
10_1101-2020_03_27_012757	429	26	type	type	NN
10_1101-2020_03_27_012757	429	27	versus	versus	IN
10_1101-2020_03_27_012757	429	28	all	all	DT
10_1101-2020_03_27_012757	429	29	of	of	IN
10_1101-2020_03_27_012757	429	30	the	the	DT
10_1101-2020_03_27_012757	429	31	others	other	NNS
10_1101-2020_03_27_012757	429	32	.	.	.
10_1101-2020_03_27_012757	430	1	841	841	CD
10_1101-2020_03_27_012757	430	2	Then	then	RB
10_1101-2020_03_27_012757	430	3	,	,	,
10_1101-2020_03_27_012757	430	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	430	5	performs	perform	VBZ
10_1101-2020_03_27_012757	430	6	a	a	DT
10_1101-2020_03_27_012757	430	7	pair	pair	NN
10_1101-2020_03_27_012757	430	8	transform	transform	NN
10_1101-2020_03_27_012757	430	9	on	on	IN
10_1101-2020_03_27_012757	430	10	these	these	DT
10_1101-2020_03_27_012757	430	11	genes	gene	NNS
10_1101-2020_03_27_012757	430	12	and	and	CC
10_1101-2020_03_27_012757	430	13	subsequently	subsequently	RB
10_1101-2020_03_27_012757	430	14	selects	select	VBZ
10_1101-2020_03_27_012757	430	15	the	the	DT
10_1101-2020_03_27_012757	430	16	most	most	JJS
10_1101-2020_03_27_012757	430	17	842	842	CD
10_1101-2020_03_27_012757	430	18	discriminative	discriminative	JJ
10_1101-2020_03_27_012757	430	19	set	set	NN
10_1101-2020_03_27_012757	430	20	of	of	IN
10_1101-2020_03_27_012757	430	21	m	m	NN
10_1101-2020_03_27_012757	430	22	gene	gene	NN
10_1101-2020_03_27_012757	430	23	pairs	pair	NNS
10_1101-2020_03_27_012757	430	24	for	for	IN
10_1101-2020_03_27_012757	430	25	each	each	DT
10_1101-2020_03_27_012757	430	26	cancer	cancer	NN
10_1101-2020_03_27_012757	430	27	type	type	NN
10_1101-2020_03_27_012757	430	28	as	as	IN
10_1101-2020_03_27_012757	430	29	features	feature	NNS
10_1101-2020_03_27_012757	430	30	(	(	-LRB-
10_1101-2020_03_27_012757	430	31	or	or	CC
10_1101-2020_03_27_012757	430	32	predictors	predictor	NNS
10_1101-2020_03_27_012757	430	33	)	)	-RRB-
10_1101-2020_03_27_012757	430	34	for	for	IN
10_1101-2020_03_27_012757	430	35	the	the	DT
10_1101-2020_03_27_012757	430	36	843	843	CD
10_1101-2020_03_27_012757	430	37	Random	random	JJ
10_1101-2020_03_27_012757	430	38	forest	forest	NN
10_1101-2020_03_27_012757	430	39	classifier	classifier	NN
10_1101-2020_03_27_012757	430	40	.	.	.
10_1101-2020_03_27_012757	431	1	Lastly	lastly	RB
10_1101-2020_03_27_012757	431	2	,	,	,
10_1101-2020_03_27_012757	431	3	CCN	CCN	NNP
10_1101-2020_03_27_012757	431	4	trains	train	VBZ
10_1101-2020_03_27_012757	431	5	a	a	DT
10_1101-2020_03_27_012757	431	6	multi	multi	JJ
10_1101-2020_03_27_012757	431	7	-	-	JJ
10_1101-2020_03_27_012757	431	8	class	class	JJ
10_1101-2020_03_27_012757	431	9	Random	Random	NNP
10_1101-2020_03_27_012757	431	10	Forest	Forest	NNP
10_1101-2020_03_27_012757	431	11	classifier	classifier	NN
10_1101-2020_03_27_012757	431	12	using	use	VBG
10_1101-2020_03_27_012757	431	13	gene-844	gene-844	NNP
10_1101-2020_03_27_012757	431	14	pair	pair	NN
10_1101-2020_03_27_012757	431	15	transformed	transform	VBD
10_1101-2020_03_27_012757	431	16	training	training	NN
10_1101-2020_03_27_012757	431	17	data	datum	NNS
10_1101-2020_03_27_012757	431	18	.	.	.
10_1101-2020_03_27_012757	432	1	(	(	-LRB-
10_1101-2020_03_27_012757	432	2	C	C	NNP
10_1101-2020_03_27_012757	432	3	)	)	-RRB-
10_1101-2020_03_27_012757	432	4	Parameter	parameter	NN
10_1101-2020_03_27_012757	432	5	optimization	optimization	NN
10_1101-2020_03_27_012757	432	6	strategy	strategy	NN
10_1101-2020_03_27_012757	432	7	.	.	.
10_1101-2020_03_27_012757	433	1	5	5	CD
10_1101-2020_03_27_012757	433	2	cross	cross	NN
10_1101-2020_03_27_012757	433	3	-	-	NNS
10_1101-2020_03_27_012757	433	4	validations	validation	NNS
10_1101-2020_03_27_012757	433	5	of	of	IN
10_1101-2020_03_27_012757	433	6	each	each	DT
10_1101-2020_03_27_012757	433	7	845	845	CD
10_1101-2020_03_27_012757	433	8	parameter	parameter	NN
10_1101-2020_03_27_012757	433	9	set	set	VBN
10_1101-2020_03_27_012757	433	10	in	in	IN
10_1101-2020_03_27_012757	433	11	which	which	WDT
10_1101-2020_03_27_012757	433	12	2/3	2/3	CD
10_1101-2020_03_27_012757	433	13	of	of	IN
10_1101-2020_03_27_012757	433	14	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	433	15	data	datum	NNS
10_1101-2020_03_27_012757	433	16	was	be	VBD
10_1101-2020_03_27_012757	433	17	used	use	VBN
10_1101-2020_03_27_012757	433	18	to	to	TO
10_1101-2020_03_27_012757	433	19	train	train	VB
10_1101-2020_03_27_012757	433	20	and	and	CC
10_1101-2020_03_27_012757	433	21	1/3	1/3	CD
10_1101-2020_03_27_012757	433	22	to	to	TO
10_1101-2020_03_27_012757	433	23	validate	validate	VB
10_1101-2020_03_27_012757	433	24	was	be	VBD
10_1101-2020_03_27_012757	433	25	used	use	VBN
10_1101-2020_03_27_012757	433	26	search	search	NN
10_1101-2020_03_27_012757	433	27	846	846	CD
10_1101-2020_03_27_012757	433	28	for	for	IN
10_1101-2020_03_27_012757	433	29	the	the	DT
10_1101-2020_03_27_012757	433	30	values	value	NNS
10_1101-2020_03_27_012757	433	31	of	of	IN
10_1101-2020_03_27_012757	433	32	n	n	NN
10_1101-2020_03_27_012757	433	33	and	and	CC
10_1101-2020_03_27_012757	433	34	m	m	NNP
10_1101-2020_03_27_012757	433	35	that	that	WDT
10_1101-2020_03_27_012757	433	36	maximized	maximize	VBD
10_1101-2020_03_27_012757	433	37	performance	performance	NN
10_1101-2020_03_27_012757	433	38	of	of	IN
10_1101-2020_03_27_012757	433	39	the	the	DT
10_1101-2020_03_27_012757	433	40	classifier	classifier	NN
10_1101-2020_03_27_012757	433	41	as	as	IN
10_1101-2020_03_27_012757	433	42	measured	measure	VBN
10_1101-2020_03_27_012757	433	43	by	by	IN
10_1101-2020_03_27_012757	433	44	area	area	NN
10_1101-2020_03_27_012757	433	45	847	847	CD
10_1101-2020_03_27_012757	433	46	under	under	IN
10_1101-2020_03_27_012757	433	47	the	the	DT
10_1101-2020_03_27_012757	433	48	precision	precision	NN
10_1101-2020_03_27_012757	433	49	recall	recall	NN
10_1101-2020_03_27_012757	433	50	curve	curve	NN
10_1101-2020_03_27_012757	433	51	(	(	-LRB-
10_1101-2020_03_27_012757	433	52	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	433	53	)	)	-RRB-
10_1101-2020_03_27_012757	433	54	.	.	.
10_1101-2020_03_27_012757	434	1	(	(	-LRB-
10_1101-2020_03_27_012757	434	2	D	d	NN
10_1101-2020_03_27_012757	434	3	)	)	-RRB-
10_1101-2020_03_27_012757	434	4	Mean	mean	JJ
10_1101-2020_03_27_012757	434	5	and	and	CC
10_1101-2020_03_27_012757	434	6	standard	standard	JJ
10_1101-2020_03_27_012757	434	7	deviation	deviation	NN
10_1101-2020_03_27_012757	434	8	of	of	IN
10_1101-2020_03_27_012757	434	9	classifiers	classifier	NNS
10_1101-2020_03_27_012757	434	10	based	base	VBD
10_1101-2020_03_27_012757	434	11	848	848	CD
10_1101-2020_03_27_012757	434	12	on	on	IN
10_1101-2020_03_27_012757	434	13	50	50	CD
10_1101-2020_03_27_012757	434	14	cross	cross	NN
10_1101-2020_03_27_012757	434	15	-	-	NNS
10_1101-2020_03_27_012757	434	16	validations	validation	NNS
10_1101-2020_03_27_012757	434	17	with	with	IN
10_1101-2020_03_27_012757	434	18	the	the	DT
10_1101-2020_03_27_012757	434	19	optimal	optimal	JJ
10_1101-2020_03_27_012757	434	20	parameter	parameter	NN
10_1101-2020_03_27_012757	434	21	set	set	NN
10_1101-2020_03_27_012757	434	22	.	.	.
10_1101-2020_03_27_012757	435	1	(	(	-LRB-
10_1101-2020_03_27_012757	435	2	E	e	NN
10_1101-2020_03_27_012757	435	3	)	)	-RRB-
10_1101-2020_03_27_012757	435	4	AUPRC	AUPRC	NNS
10_1101-2020_03_27_012757	435	5	of	of	IN
10_1101-2020_03_27_012757	435	6	the	the	DT
10_1101-2020_03_27_012757	435	7	final	final	JJ
10_1101-2020_03_27_012757	435	8	CCN	CCN	NNP
10_1101-2020_03_27_012757	435	9	classifier	classifier	NN
10_1101-2020_03_27_012757	435	10	849	849	CD
10_1101-2020_03_27_012757	435	11	when	when	WRB
10_1101-2020_03_27_012757	435	12	applied	apply	VBN
10_1101-2020_03_27_012757	435	13	to	to	IN
10_1101-2020_03_27_012757	435	14	independent	independent	JJ
10_1101-2020_03_27_012757	435	15	patient	patient	JJ
10_1101-2020_03_27_012757	435	16	tumor	tumor	NN
10_1101-2020_03_27_012757	435	17	data	datum	NNS
10_1101-2020_03_27_012757	435	18	from	from	IN
10_1101-2020_03_27_012757	435	19	ICGC	ICGC	NNP
10_1101-2020_03_27_012757	435	20	.	.	.
10_1101-2020_03_27_012757	436	1	850	850	CD
10_1101-2020_03_27_012757	436	2	851	851	CD
10_1101-2020_03_27_012757	436	3	.CC	.cc	SYM
10_1101-2020_03_27_012757	436	4	-	-	HYPH
10_1101-2020_03_27_012757	436	5	BY	by	IN
10_1101-2020_03_27_012757	436	6	-	-	HYPH
10_1101-2020_03_27_012757	436	7	NC	NC	NNP
10_1101-2020_03_27_012757	436	8	-	-	HYPH
10_1101-2020_03_27_012757	436	9	ND	ND	NNP
10_1101-2020_03_27_012757	436	10	4.0	4.0	CD
10_1101-2020_03_27_012757	436	11	International	International	NNP
10_1101-2020_03_27_012757	436	12	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	436	13	under	under	IN
10_1101-2020_03_27_012757	436	14	a	a	DT
10_1101-2020_03_27_012757	436	15	(	(	-LRB-
10_1101-2020_03_27_012757	436	16	which	which	WDT
10_1101-2020_03_27_012757	436	17	was	be	VBD
10_1101-2020_03_27_012757	436	18	not	not	RB
10_1101-2020_03_27_012757	436	19	certified	certify	VBN
10_1101-2020_03_27_012757	436	20	by	by	IN
10_1101-2020_03_27_012757	436	21	peer	peer	NN
10_1101-2020_03_27_012757	436	22	review	review	NN
10_1101-2020_03_27_012757	436	23	)	)	-RRB-
10_1101-2020_03_27_012757	436	24	is	be	VBZ
10_1101-2020_03_27_012757	436	25	the	the	DT
10_1101-2020_03_27_012757	436	26	author	author	NN
10_1101-2020_03_27_012757	436	27	/	/	SYM
10_1101-2020_03_27_012757	436	28	funder	funder	NN
10_1101-2020_03_27_012757	436	29	,	,	,
10_1101-2020_03_27_012757	436	30	who	who	WP
10_1101-2020_03_27_012757	436	31	has	have	VBZ
10_1101-2020_03_27_012757	436	32	granted	grant	VBN
10_1101-2020_03_27_012757	436	33	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	436	34	a	a	DT
10_1101-2020_03_27_012757	436	35	license	license	NN
10_1101-2020_03_27_012757	436	36	to	to	TO
10_1101-2020_03_27_012757	436	37	display	display	VB
10_1101-2020_03_27_012757	436	38	the	the	DT
10_1101-2020_03_27_012757	436	39	preprint	preprint	NN
10_1101-2020_03_27_012757	436	40	in	in	IN
10_1101-2020_03_27_012757	436	41	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	436	42	.	.	.
10_1101-2020_03_27_012757	437	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	437	2	is	be	VBZ
10_1101-2020_03_27_012757	437	3	made	make	VBN
10_1101-2020_03_27_012757	437	4	The	the	DT
10_1101-2020_03_27_012757	437	5	copyright	copyright	NN
10_1101-2020_03_27_012757	437	6	holder	holder	NN
10_1101-2020_03_27_012757	437	7	for	for	IN
10_1101-2020_03_27_012757	437	8	this	this	DT
10_1101-2020_03_27_012757	437	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	437	10	version	version	NN
10_1101-2020_03_27_012757	437	11	posted	post	VBD
10_1101-2020_03_27_012757	437	12	January	January	NNP
10_1101-2020_03_27_012757	437	13	9	9	CD
10_1101-2020_03_27_012757	437	14	,	,	,
10_1101-2020_03_27_012757	437	15	2021	2021	CD
10_1101-2020_03_27_012757	437	16	.	.	.
10_1101-2020_03_27_012757	437	17	;	;	:
10_1101-2020_03_27_012757	437	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	437	19	:	:	:
10_1101-2020_03_27_012757	437	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	437	21	preprint	preprint	NN
10_1101-2020_03_27_012757	437	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	437	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	437	24	33	33	CD
10_1101-2020_03_27_012757	437	25	Fig	fig	NN
10_1101-2020_03_27_012757	437	26	.	.	.
10_1101-2020_03_27_012757	438	1	2	2	CD
10_1101-2020_03_27_012757	438	2	Evaluation	evaluation	NN
10_1101-2020_03_27_012757	438	3	of	of	IN
10_1101-2020_03_27_012757	438	4	cancer	cancer	NN
10_1101-2020_03_27_012757	438	5	cell	cell	NN
10_1101-2020_03_27_012757	438	6	lines	line	NNS
10_1101-2020_03_27_012757	438	7	.	.	.
10_1101-2020_03_27_012757	439	1	(	(	-LRB-
10_1101-2020_03_27_012757	439	2	A	a	DT
10_1101-2020_03_27_012757	439	3	)	)	-RRB-
10_1101-2020_03_27_012757	439	4	General	general	JJ
10_1101-2020_03_27_012757	439	5	classification	classification	NN
10_1101-2020_03_27_012757	439	6	heatmap	heatmap	NN
10_1101-2020_03_27_012757	439	7	of	of	IN
10_1101-2020_03_27_012757	439	8	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	439	9	extracted	extract	VBD
10_1101-2020_03_27_012757	439	10	852	852	CD
10_1101-2020_03_27_012757	439	11	from	from	IN
10_1101-2020_03_27_012757	439	12	CCLE	CCLE	NNP
10_1101-2020_03_27_012757	439	13	.	.	.
10_1101-2020_03_27_012757	440	1	Column	column	NN
10_1101-2020_03_27_012757	440	2	annotations	annotation	NNS
10_1101-2020_03_27_012757	440	3	of	of	IN
10_1101-2020_03_27_012757	440	4	the	the	DT
10_1101-2020_03_27_012757	440	5	heatmap	heatmap	NNP
10_1101-2020_03_27_012757	440	6	represent	represent	VBP
10_1101-2020_03_27_012757	440	7	the	the	DT
10_1101-2020_03_27_012757	440	8	labelled	label	VBN
10_1101-2020_03_27_012757	440	9	cancer	cancer	NN
10_1101-2020_03_27_012757	440	10	category	category	NN
10_1101-2020_03_27_012757	440	11	of	of	IN
10_1101-2020_03_27_012757	440	12	the	the	DT
10_1101-2020_03_27_012757	440	13	853	853	CD
10_1101-2020_03_27_012757	440	14	CCLs	ccl	NNS
10_1101-2020_03_27_012757	440	15	given	give	VBN
10_1101-2020_03_27_012757	440	16	by	by	IN
10_1101-2020_03_27_012757	440	17	CCLE	ccle	NN
10_1101-2020_03_27_012757	440	18	and	and	CC
10_1101-2020_03_27_012757	440	19	the	the	DT
10_1101-2020_03_27_012757	440	20	row	row	NN
10_1101-2020_03_27_012757	440	21	names	name	NNS
10_1101-2020_03_27_012757	440	22	of	of	IN
10_1101-2020_03_27_012757	440	23	the	the	DT
10_1101-2020_03_27_012757	440	24	heatmap	heatmap	NNP
10_1101-2020_03_27_012757	440	25	represent	represent	VBP
10_1101-2020_03_27_012757	440	26	different	different	JJ
10_1101-2020_03_27_012757	440	27	cancer	cancer	NN
10_1101-2020_03_27_012757	440	28	categories	category	NNS
10_1101-2020_03_27_012757	440	29	.	.	.
10_1101-2020_03_27_012757	441	1	854	854	CD
10_1101-2020_03_27_012757	441	2	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	441	3	’	’	POS
10_1101-2020_03_27_012757	441	4	general	general	JJ
10_1101-2020_03_27_012757	441	5	classification	classification	NN
10_1101-2020_03_27_012757	441	6	profiles	profile	NNS
10_1101-2020_03_27_012757	441	7	are	be	VBP
10_1101-2020_03_27_012757	441	8	categorized	categorize	VBN
10_1101-2020_03_27_012757	441	9	into	into	IN
10_1101-2020_03_27_012757	441	10	4	4	CD
10_1101-2020_03_27_012757	441	11	categories	category	NNS
10_1101-2020_03_27_012757	441	12	:	:	:
10_1101-2020_03_27_012757	441	13	correct	correct	JJ
10_1101-2020_03_27_012757	441	14	(	(	-LRB-
10_1101-2020_03_27_012757	441	15	red	red	NNP
10_1101-2020_03_27_012757	441	16	)	)	-RRB-
10_1101-2020_03_27_012757	441	17	,	,	,
10_1101-2020_03_27_012757	441	18	correct	correct	VB
10_1101-2020_03_27_012757	441	19	855	855	CD
10_1101-2020_03_27_012757	441	20	mixed	mixed	JJ
10_1101-2020_03_27_012757	441	21	(	(	-LRB-
10_1101-2020_03_27_012757	441	22	pink	pink	JJ
10_1101-2020_03_27_012757	441	23	)	)	-RRB-
10_1101-2020_03_27_012757	441	24	,	,	,
10_1101-2020_03_27_012757	441	25	no	no	DT
10_1101-2020_03_27_012757	441	26	classification	classification	NN
10_1101-2020_03_27_012757	441	27	(	(	-LRB-
10_1101-2020_03_27_012757	441	28	light	light	JJ
10_1101-2020_03_27_012757	441	29	green	green	NN
10_1101-2020_03_27_012757	441	30	)	)	-RRB-
10_1101-2020_03_27_012757	441	31	and	and	CC
10_1101-2020_03_27_012757	441	32	other	other	JJ
10_1101-2020_03_27_012757	441	33	classification	classification	NN
10_1101-2020_03_27_012757	441	34	(	(	-LRB-
10_1101-2020_03_27_012757	441	35	dark	dark	JJ
10_1101-2020_03_27_012757	441	36	green	green	NN
10_1101-2020_03_27_012757	441	37	)	)	-RRB-
10_1101-2020_03_27_012757	441	38	based	base	VBN
10_1101-2020_03_27_012757	441	39	on	on	IN
10_1101-2020_03_27_012757	441	40	the	the	DT
10_1101-2020_03_27_012757	441	41	856	856	CD
10_1101-2020_03_27_012757	441	42	decision	decision	NN
10_1101-2020_03_27_012757	441	43	threshold	threshold	NN
10_1101-2020_03_27_012757	441	44	of	of	IN
10_1101-2020_03_27_012757	441	45	0.25	0.25	CD
10_1101-2020_03_27_012757	441	46	.	.	.
10_1101-2020_03_27_012757	442	1	(	(	-LRB-
10_1101-2020_03_27_012757	442	2	B	b	NN
10_1101-2020_03_27_012757	442	3	)	)	-RRB-
10_1101-2020_03_27_012757	442	4	Bar	bar	VB
10_1101-2020_03_27_012757	442	5	plot	plot	NN
10_1101-2020_03_27_012757	442	6	represents	represent	VBZ
10_1101-2020_03_27_012757	442	7	the	the	DT
10_1101-2020_03_27_012757	442	8	proportion	proportion	NN
10_1101-2020_03_27_012757	442	9	of	of	IN
10_1101-2020_03_27_012757	442	10	each	each	DT
10_1101-2020_03_27_012757	442	11	classification	classification	NN
10_1101-2020_03_27_012757	442	12	category	category	NN
10_1101-2020_03_27_012757	442	13	857	857	CD
10_1101-2020_03_27_012757	442	14	in	in	IN
10_1101-2020_03_27_012757	442	15	CCLs	ccl	NNS
10_1101-2020_03_27_012757	442	16	across	across	IN
10_1101-2020_03_27_012757	442	17	cancer	cancer	NN
10_1101-2020_03_27_012757	442	18	types	type	NNS
10_1101-2020_03_27_012757	442	19	ordered	order	VBN
10_1101-2020_03_27_012757	442	20	from	from	IN
10_1101-2020_03_27_012757	442	21	the	the	DT
10_1101-2020_03_27_012757	442	22	cancer	cancer	NN
10_1101-2020_03_27_012757	442	23	types	type	NNS
10_1101-2020_03_27_012757	442	24	with	with	IN
10_1101-2020_03_27_012757	442	25	the	the	DT
10_1101-2020_03_27_012757	442	26	highest	high	JJS
10_1101-2020_03_27_012757	442	27	proportion	proportion	NN
10_1101-2020_03_27_012757	442	28	of	of	IN
10_1101-2020_03_27_012757	442	29	858	858	CD
10_1101-2020_03_27_012757	442	30	correct	correct	JJ
10_1101-2020_03_27_012757	442	31	and	and	CC
10_1101-2020_03_27_012757	442	32	correct	correct	JJ
10_1101-2020_03_27_012757	442	33	mixed	mixed	JJ
10_1101-2020_03_27_012757	442	34	CCLs	ccl	NNS
10_1101-2020_03_27_012757	442	35	to	to	IN
10_1101-2020_03_27_012757	442	36	lowest	low	JJS
10_1101-2020_03_27_012757	442	37	proportion	proportion	NN
10_1101-2020_03_27_012757	442	38	.	.	.
10_1101-2020_03_27_012757	443	1	(	(	-LRB-
10_1101-2020_03_27_012757	443	2	C	C	NNP
10_1101-2020_03_27_012757	443	3	)	)	-RRB-
10_1101-2020_03_27_012757	443	4	Comparison	comparison	NN
10_1101-2020_03_27_012757	443	5	between	between	IN
10_1101-2020_03_27_012757	443	6	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	443	7	general	general	JJ
10_1101-2020_03_27_012757	443	8	859	859	CD
10_1101-2020_03_27_012757	443	9	CCN	ccn	NN
10_1101-2020_03_27_012757	443	10	scores	score	NNS
10_1101-2020_03_27_012757	443	11	from	from	IN
10_1101-2020_03_27_012757	443	12	bulk	bulk	JJ
10_1101-2020_03_27_012757	443	13	RNA	RNA	NNP
10_1101-2020_03_27_012757	443	14	-	-	HYPH
10_1101-2020_03_27_012757	443	15	seq	seq	NN
10_1101-2020_03_27_012757	443	16	classifier	classifier	NN
10_1101-2020_03_27_012757	443	17	and	and	CC
10_1101-2020_03_27_012757	443	18	SKCM	skcm	VB
10_1101-2020_03_27_012757	443	19	malignant	malignant	JJ
10_1101-2020_03_27_012757	443	20	CCN	CCN	NNP
10_1101-2020_03_27_012757	443	21	scores	score	NNS
10_1101-2020_03_27_012757	443	22	from	from	IN
10_1101-2020_03_27_012757	443	23	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	443	24	-	-	HYPH
10_1101-2020_03_27_012757	443	25	seq	seq	NN
10_1101-2020_03_27_012757	443	26	860	860	CD
10_1101-2020_03_27_012757	443	27	classifier	classifier	NN
10_1101-2020_03_27_012757	443	28	for	for	IN
10_1101-2020_03_27_012757	443	29	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	443	30	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	443	31	.	.	.
10_1101-2020_03_27_012757	444	1	(	(	-LRB-
10_1101-2020_03_27_012757	444	2	D	d	NN
10_1101-2020_03_27_012757	444	3	)	)	-RRB-
10_1101-2020_03_27_012757	444	4	Comparison	comparison	NN
10_1101-2020_03_27_012757	444	5	between	between	IN
10_1101-2020_03_27_012757	444	6	SARC	SARC	NNP
10_1101-2020_03_27_012757	444	7	general	general	JJ
10_1101-2020_03_27_012757	444	8	CCN	CCN	NNP
10_1101-2020_03_27_012757	444	9	scores	score	NNS
10_1101-2020_03_27_012757	444	10	from	from	IN
10_1101-2020_03_27_012757	444	11	bulk	bulk	NNP
10_1101-2020_03_27_012757	444	12	RNA-861	RNA-861	NNP
10_1101-2020_03_27_012757	444	13	seq	seq	NN
10_1101-2020_03_27_012757	444	14	classifier	classifier	NN
10_1101-2020_03_27_012757	444	15	and	and	CC
10_1101-2020_03_27_012757	444	16	CAF	CAF	NNP
10_1101-2020_03_27_012757	444	17	CCN	CCN	NNP
10_1101-2020_03_27_012757	444	18	scores	score	NNS
10_1101-2020_03_27_012757	444	19	from	from	IN
10_1101-2020_03_27_012757	444	20	scRNA	scrna	CD
10_1101-2020_03_27_012757	444	21	-	-	HYPH
10_1101-2020_03_27_012757	444	22	seq	seq	NN
10_1101-2020_03_27_012757	444	23	classifier	classifier	NN
10_1101-2020_03_27_012757	444	24	for	for	IN
10_1101-2020_03_27_012757	444	25	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	444	26	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	444	27	.	.	.
10_1101-2020_03_27_012757	445	1	(	(	-LRB-
10_1101-2020_03_27_012757	445	2	E	e	NN
10_1101-2020_03_27_012757	445	3	)	)	-RRB-
10_1101-2020_03_27_012757	445	4	Comparison	comparison	NN
10_1101-2020_03_27_012757	445	5	862	862	CD
10_1101-2020_03_27_012757	445	6	between	between	IN
10_1101-2020_03_27_012757	445	7	GBM	GBM	NNP
10_1101-2020_03_27_012757	445	8	general	general	JJ
10_1101-2020_03_27_012757	445	9	CCN	CCN	NNP
10_1101-2020_03_27_012757	445	10	scores	score	NNS
10_1101-2020_03_27_012757	445	11	from	from	IN
10_1101-2020_03_27_012757	445	12	bulk	bulk	JJ
10_1101-2020_03_27_012757	445	13	RNA	RNA	NNP
10_1101-2020_03_27_012757	445	14	-	-	HYPH
10_1101-2020_03_27_012757	445	15	seq	seq	NN
10_1101-2020_03_27_012757	445	16	classifier	classifier	NN
10_1101-2020_03_27_012757	445	17	and	and	CC
10_1101-2020_03_27_012757	445	18	GBM	GBM	NNP
10_1101-2020_03_27_012757	445	19	neoplastic	neoplastic	JJ
10_1101-2020_03_27_012757	445	20	CCN	CCN	NNP
10_1101-2020_03_27_012757	445	21	863	863	CD
10_1101-2020_03_27_012757	445	22	scores	score	NNS
10_1101-2020_03_27_012757	445	23	from	from	IN
10_1101-2020_03_27_012757	445	24	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	445	25	-	-	HYPH
10_1101-2020_03_27_012757	445	26	seq	seq	NN
10_1101-2020_03_27_012757	445	27	classifier	classifier	NN
10_1101-2020_03_27_012757	445	28	for	for	IN
10_1101-2020_03_27_012757	445	29	GBM	GBM	NNP
10_1101-2020_03_27_012757	445	30	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	445	31	.	.	.
10_1101-2020_03_27_012757	446	1	(	(	-LRB-
10_1101-2020_03_27_012757	446	2	F	F	NNP
10_1101-2020_03_27_012757	446	3	)	)	-RRB-
10_1101-2020_03_27_012757	446	4	Comparison	comparison	NN
10_1101-2020_03_27_012757	446	5	between	between	IN
10_1101-2020_03_27_012757	446	6	SARC	SARC	NNP
10_1101-2020_03_27_012757	446	7	general	general	NN
10_1101-2020_03_27_012757	446	8	CCN	CCN	NNP
10_1101-2020_03_27_012757	446	9	864	864	CD
10_1101-2020_03_27_012757	446	10	scores	score	NNS
10_1101-2020_03_27_012757	446	11	and	and	CC
10_1101-2020_03_27_012757	446	12	CAF	CAF	NNP
10_1101-2020_03_27_012757	446	13	CCN	CCN	NNP
10_1101-2020_03_27_012757	446	14	scores	score	NNS
10_1101-2020_03_27_012757	446	15	from	from	IN
10_1101-2020_03_27_012757	446	16	scRNA	scrna	CD
10_1101-2020_03_27_012757	446	17	-	-	HYPH
10_1101-2020_03_27_012757	446	18	seq	seq	NN
10_1101-2020_03_27_012757	446	19	classifier	classifier	NN
10_1101-2020_03_27_012757	446	20	for	for	IN
10_1101-2020_03_27_012757	446	21	GBM	GBM	NNP
10_1101-2020_03_27_012757	446	22	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	446	23	.	.	.
10_1101-2020_03_27_012757	447	1	The	the	DT
10_1101-2020_03_27_012757	447	2	green	green	JJ
10_1101-2020_03_27_012757	447	3	lines	line	NNS
10_1101-2020_03_27_012757	447	4	865	865	CD
10_1101-2020_03_27_012757	447	5	indicate	indicate	VBP
10_1101-2020_03_27_012757	447	6	the	the	DT
10_1101-2020_03_27_012757	447	7	decision	decision	NN
10_1101-2020_03_27_012757	447	8	threshold	threshold	NN
10_1101-2020_03_27_012757	447	9	for	for	IN
10_1101-2020_03_27_012757	447	10	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	447	11	-	-	HYPH
10_1101-2020_03_27_012757	447	12	seq	seq	NN
10_1101-2020_03_27_012757	447	13	classifier	classifier	NN
10_1101-2020_03_27_012757	447	14	and	and	CC
10_1101-2020_03_27_012757	447	15	general	general	JJ
10_1101-2020_03_27_012757	447	16	classifier	classifier	NNP
10_1101-2020_03_27_012757	447	17	.	.	.
10_1101-2020_03_27_012757	448	1	866	866	CD
10_1101-2020_03_27_012757	448	2	867	867	CD
10_1101-2020_03_27_012757	448	3	Fig	Fig	NNP
10_1101-2020_03_27_012757	448	4	.	.	.
10_1101-2020_03_27_012757	449	1	3	3	CD
10_1101-2020_03_27_012757	449	2	Immunofluorescence	Immunofluorescence	NNP
10_1101-2020_03_27_012757	449	3	of	of	IN
10_1101-2020_03_27_012757	449	4	selected	select	VBN
10_1101-2020_03_27_012757	449	5	cell	cell	NN
10_1101-2020_03_27_012757	449	6	lines	line	NNS
10_1101-2020_03_27_012757	449	7	.	.	.
10_1101-2020_03_27_012757	450	1	(	(	-LRB-
10_1101-2020_03_27_012757	450	2	A	a	NN
10_1101-2020_03_27_012757	450	3	)	)	-RRB-
10_1101-2020_03_27_012757	450	4	Classification	classification	NN
10_1101-2020_03_27_012757	450	5	profiles	profile	NNS
10_1101-2020_03_27_012757	450	6	(	(	-LRB-
10_1101-2020_03_27_012757	450	7	left	left	RB
10_1101-2020_03_27_012757	450	8	)	)	-RRB-
10_1101-2020_03_27_012757	450	9	and	and	CC
10_1101-2020_03_27_012757	450	10	IF	if	IN
10_1101-2020_03_27_012757	450	11	868	868	CD
10_1101-2020_03_27_012757	450	12	expression	expression	NN
10_1101-2020_03_27_012757	450	13	(	(	-LRB-
10_1101-2020_03_27_012757	450	14	middle	middle	JJ
10_1101-2020_03_27_012757	450	15	)	)	-RRB-
10_1101-2020_03_27_012757	450	16	of	of	IN
10_1101-2020_03_27_012757	450	17	Caov-4	Caov-4	NNP
10_1101-2020_03_27_012757	450	18	(	(	-LRB-
10_1101-2020_03_27_012757	450	19	OV	OV	NNP
10_1101-2020_03_27_012757	450	20	positive	positive	JJ
10_1101-2020_03_27_012757	450	21	control	control	NN
10_1101-2020_03_27_012757	450	22	)	)	-RRB-
10_1101-2020_03_27_012757	450	23	,	,	,
10_1101-2020_03_27_012757	450	24	HEC-59	HEC-59	NNP
10_1101-2020_03_27_012757	450	25	(	(	-LRB-
10_1101-2020_03_27_012757	450	26	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	450	27	positive	positive	JJ
10_1101-2020_03_27_012757	450	28	control	control	NN
10_1101-2020_03_27_012757	450	29	)	)	-RRB-
10_1101-2020_03_27_012757	450	30	and	and	CC
10_1101-2020_03_27_012757	450	31	SK-869	SK-869	NNP
10_1101-2020_03_27_012757	450	32	OV-3	OV-3	NNP
10_1101-2020_03_27_012757	450	33	for	for	IN
10_1101-2020_03_27_012757	450	34	WT1	WT1	NNP
10_1101-2020_03_27_012757	450	35	(	(	-LRB-
10_1101-2020_03_27_012757	450	36	OV	OV	NNP
10_1101-2020_03_27_012757	450	37	biomarker	biomarker	NN
10_1101-2020_03_27_012757	450	38	)	)	-RRB-
10_1101-2020_03_27_012757	450	39	and	and	CC
10_1101-2020_03_27_012757	450	40	HOXB6	HOXB6	NNS
10_1101-2020_03_27_012757	450	41	(	(	-LRB-
10_1101-2020_03_27_012757	450	42	uterine	uterine	NNP
10_1101-2020_03_27_012757	450	43	biomarker	biomarker	NN
10_1101-2020_03_27_012757	450	44	)	)	-RRB-
10_1101-2020_03_27_012757	450	45	.	.	.
10_1101-2020_03_27_012757	451	1	The	the	DT
10_1101-2020_03_27_012757	451	2	bar	bar	NN
10_1101-2020_03_27_012757	451	3	plots	plot	NNS
10_1101-2020_03_27_012757	451	4	quantify	quantify	VBP
10_1101-2020_03_27_012757	451	5	the	the	DT
10_1101-2020_03_27_012757	451	6	870	870	CD
10_1101-2020_03_27_012757	451	7	average	average	JJ
10_1101-2020_03_27_012757	451	8	percentage	percentage	NN
10_1101-2020_03_27_012757	451	9	of	of	IN
10_1101-2020_03_27_012757	451	10	positive	positive	JJ
10_1101-2020_03_27_012757	451	11	cells	cell	NNS
10_1101-2020_03_27_012757	451	12	for	for	IN
10_1101-2020_03_27_012757	451	13	WT1	WT1	NNP
10_1101-2020_03_27_012757	451	14	(	(	-LRB-
10_1101-2020_03_27_012757	451	15	top	top	JJ
10_1101-2020_03_27_012757	451	16	-	-	HYPH
10_1101-2020_03_27_012757	451	17	right	right	NN
10_1101-2020_03_27_012757	451	18	)	)	-RRB-
10_1101-2020_03_27_012757	451	19	and	and	CC
10_1101-2020_03_27_012757	451	20	HOXB6	HOXB6	NNS
10_1101-2020_03_27_012757	451	21	(	(	-LRB-
10_1101-2020_03_27_012757	451	22	bottom	bottom	JJ
10_1101-2020_03_27_012757	451	23	-	-	HYPH
10_1101-2020_03_27_012757	451	24	right	right	JJ
10_1101-2020_03_27_012757	451	25	)	)	-RRB-
10_1101-2020_03_27_012757	451	26	.	.	.
10_1101-2020_03_27_012757	452	1	(	(	-LRB-
10_1101-2020_03_27_012757	452	2	B	b	NN
10_1101-2020_03_27_012757	452	3	)	)	-RRB-
10_1101-2020_03_27_012757	452	4	871	871	CD
10_1101-2020_03_27_012757	452	5	Classification	classification	NN
10_1101-2020_03_27_012757	452	6	profiles	profile	NNS
10_1101-2020_03_27_012757	452	7	(	(	-LRB-
10_1101-2020_03_27_012757	452	8	left	left	RB
10_1101-2020_03_27_012757	452	9	)	)	-RRB-
10_1101-2020_03_27_012757	452	10	and	and	CC
10_1101-2020_03_27_012757	452	11	IF	if	IN
10_1101-2020_03_27_012757	452	12	expression	expression	NN
10_1101-2020_03_27_012757	452	13	(	(	-LRB-
10_1101-2020_03_27_012757	452	14	middle	middle	NN
10_1101-2020_03_27_012757	452	15	)	)	-RRB-
10_1101-2020_03_27_012757	452	16	of	of	IN
10_1101-2020_03_27_012757	452	17	Caov-4	Caov-4	NNP
10_1101-2020_03_27_012757	452	18	,	,	,
10_1101-2020_03_27_012757	452	19	NCCIT	NCCIT	NNP
10_1101-2020_03_27_012757	452	20	(	(	-LRB-
10_1101-2020_03_27_012757	452	21	germ	germ	NNP
10_1101-2020_03_27_012757	452	22	cell	cell	NN
10_1101-2020_03_27_012757	452	23	tumor	tumor	NN
10_1101-2020_03_27_012757	452	24	872	872	CD
10_1101-2020_03_27_012757	452	25	positive	positive	JJ
10_1101-2020_03_27_012757	452	26	control	control	NN
10_1101-2020_03_27_012757	452	27	)	)	-RRB-
10_1101-2020_03_27_012757	452	28	and	and	CC
10_1101-2020_03_27_012757	452	29	A2780	A2780	NNP
10_1101-2020_03_27_012757	452	30	for	for	IN
10_1101-2020_03_27_012757	452	31	WT1	WT1	NNP
10_1101-2020_03_27_012757	452	32	and	and	CC
10_1101-2020_03_27_012757	452	33	LIN28A	LIN28A	NNP
10_1101-2020_03_27_012757	452	34	(	(	-LRB-
10_1101-2020_03_27_012757	452	35	germ	germ	NNP
10_1101-2020_03_27_012757	452	36	cell	cell	NN
10_1101-2020_03_27_012757	452	37	tumor	tumor	NN
10_1101-2020_03_27_012757	452	38	biomarker	biomarker	NN
10_1101-2020_03_27_012757	452	39	)	)	-RRB-
10_1101-2020_03_27_012757	452	40	.	.	.
10_1101-2020_03_27_012757	453	1	Classification	classification	NN
10_1101-2020_03_27_012757	453	2	of	of	IN
10_1101-2020_03_27_012757	453	3	873	873	CD
10_1101-2020_03_27_012757	453	4	NCCIT	NCCIT	NNP
10_1101-2020_03_27_012757	453	5	were	be	VBD
10_1101-2020_03_27_012757	453	6	performed	perform	VBN
10_1101-2020_03_27_012757	453	7	using	use	VBG
10_1101-2020_03_27_012757	453	8	RNA	RNA	NNP
10_1101-2020_03_27_012757	453	9	-	-	HYPH
10_1101-2020_03_27_012757	453	10	seq	seq	NN
10_1101-2020_03_27_012757	453	11	profiles	profile	NNS
10_1101-2020_03_27_012757	453	12	of	of	IN
10_1101-2020_03_27_012757	453	13	WT	WT	NNP
10_1101-2020_03_27_012757	453	14	control	control	NN
10_1101-2020_03_27_012757	453	15	NCCIT	NCCIT	NNP
10_1101-2020_03_27_012757	453	16	duplicate	duplicate	VBP
10_1101-2020_03_27_012757	453	17	from	from	IN
10_1101-2020_03_27_012757	453	18	Grow	Grow	NNP
10_1101-2020_03_27_012757	453	19	et	et	NNP
10_1101-2020_03_27_012757	453	20	874	874	CD
10_1101-2020_03_27_012757	453	21	al91	al91	NNP
10_1101-2020_03_27_012757	453	22	.	.	.
10_1101-2020_03_27_012757	454	1	The	the	DT
10_1101-2020_03_27_012757	454	2	bar	bar	NN
10_1101-2020_03_27_012757	454	3	plots	plot	NNS
10_1101-2020_03_27_012757	454	4	quantify	quantify	VBP
10_1101-2020_03_27_012757	454	5	the	the	DT
10_1101-2020_03_27_012757	454	6	average	average	JJ
10_1101-2020_03_27_012757	454	7	percentage	percentage	NN
10_1101-2020_03_27_012757	454	8	of	of	IN
10_1101-2020_03_27_012757	454	9	positive	positive	JJ
10_1101-2020_03_27_012757	454	10	cells	cell	NNS
10_1101-2020_03_27_012757	454	11	for	for	IN
10_1101-2020_03_27_012757	454	12	WT1	WT1	NNP
10_1101-2020_03_27_012757	454	13	(	(	-LRB-
10_1101-2020_03_27_012757	454	14	top	top	JJ
10_1101-2020_03_27_012757	454	15	-	-	HYPH
10_1101-2020_03_27_012757	454	16	right	right	NN
10_1101-2020_03_27_012757	454	17	)	)	-RRB-
10_1101-2020_03_27_012757	454	18	and	and	CC
10_1101-2020_03_27_012757	454	19	875	875	CD
10_1101-2020_03_27_012757	454	20	LIN28A	lin28a	CD
10_1101-2020_03_27_012757	454	21	(	(	-LRB-
10_1101-2020_03_27_012757	454	22	bottom	bottom	NN
10_1101-2020_03_27_012757	454	23	-	-	HYPH
10_1101-2020_03_27_012757	454	24	right	right	JJ
10_1101-2020_03_27_012757	454	25	)	)	-RRB-
10_1101-2020_03_27_012757	454	26	.	.	.
10_1101-2020_03_27_012757	455	1	(	(	-LRB-
10_1101-2020_03_27_012757	455	2	C	c	NN
10_1101-2020_03_27_012757	455	3	)	)	-RRB-
10_1101-2020_03_27_012757	455	4	Classification	classification	NN
10_1101-2020_03_27_012757	455	5	profiles	profile	NNS
10_1101-2020_03_27_012757	455	6	(	(	-LRB-
10_1101-2020_03_27_012757	455	7	left	left	RB
10_1101-2020_03_27_012757	455	8	)	)	-RRB-
10_1101-2020_03_27_012757	455	9	and	and	CC
10_1101-2020_03_27_012757	455	10	IF	if	IN
10_1101-2020_03_27_012757	455	11	expression	expression	NN
10_1101-2020_03_27_012757	455	12	(	(	-LRB-
10_1101-2020_03_27_012757	455	13	middle	middle	JJ
10_1101-2020_03_27_012757	455	14	)	)	-RRB-
10_1101-2020_03_27_012757	455	15	of	of	IN
10_1101-2020_03_27_012757	455	16	Vcap	Vcap	NNP
10_1101-2020_03_27_012757	455	17	876	876	CD
10_1101-2020_03_27_012757	455	18	(	(	-LRB-
10_1101-2020_03_27_012757	455	19	PRAD	PRAD	NNP
10_1101-2020_03_27_012757	455	20	positive	positive	JJ
10_1101-2020_03_27_012757	455	21	control	control	NN
10_1101-2020_03_27_012757	455	22	)	)	-RRB-
10_1101-2020_03_27_012757	455	23	,	,	,
10_1101-2020_03_27_012757	455	24	RT4	RT4	NNP
10_1101-2020_03_27_012757	455	25	(	(	-LRB-
10_1101-2020_03_27_012757	455	26	BLCA	BLCA	NNP
10_1101-2020_03_27_012757	455	27	positive	positive	JJ
10_1101-2020_03_27_012757	455	28	control	control	NN
10_1101-2020_03_27_012757	455	29	)	)	-RRB-
10_1101-2020_03_27_012757	455	30	and	and	CC
10_1101-2020_03_27_012757	455	31	PC-3	PC-3	NNP
10_1101-2020_03_27_012757	455	32	for	for	IN
10_1101-2020_03_27_012757	455	33	FOLH1	FOLH1	NNP
10_1101-2020_03_27_012757	455	34	(	(	-LRB-
10_1101-2020_03_27_012757	455	35	prostate	prostate	NN
10_1101-2020_03_27_012757	455	36	biomarker	biomarker	NNP
10_1101-2020_03_27_012757	455	37	)	)	-RRB-
10_1101-2020_03_27_012757	455	38	877	877	CD
10_1101-2020_03_27_012757	455	39	.CC	.CC	,
10_1101-2020_03_27_012757	455	40	-	-	HYPH
10_1101-2020_03_27_012757	455	41	BY	by	IN
10_1101-2020_03_27_012757	455	42	-	-	HYPH
10_1101-2020_03_27_012757	455	43	NC	NC	NNP
10_1101-2020_03_27_012757	455	44	-	-	HYPH
10_1101-2020_03_27_012757	455	45	ND	ND	NNP
10_1101-2020_03_27_012757	455	46	4.0	4.0	CD
10_1101-2020_03_27_012757	455	47	International	International	NNP
10_1101-2020_03_27_012757	455	48	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	455	49	under	under	IN
10_1101-2020_03_27_012757	455	50	a	a	DT
10_1101-2020_03_27_012757	455	51	(	(	-LRB-
10_1101-2020_03_27_012757	455	52	which	which	WDT
10_1101-2020_03_27_012757	455	53	was	be	VBD
10_1101-2020_03_27_012757	455	54	not	not	RB
10_1101-2020_03_27_012757	455	55	certified	certify	VBN
10_1101-2020_03_27_012757	455	56	by	by	IN
10_1101-2020_03_27_012757	455	57	peer	peer	NN
10_1101-2020_03_27_012757	455	58	review	review	NN
10_1101-2020_03_27_012757	455	59	)	)	-RRB-
10_1101-2020_03_27_012757	455	60	is	be	VBZ
10_1101-2020_03_27_012757	455	61	the	the	DT
10_1101-2020_03_27_012757	455	62	author	author	NN
10_1101-2020_03_27_012757	455	63	/	/	SYM
10_1101-2020_03_27_012757	455	64	funder	funder	NN
10_1101-2020_03_27_012757	455	65	,	,	,
10_1101-2020_03_27_012757	455	66	who	who	WP
10_1101-2020_03_27_012757	455	67	has	have	VBZ
10_1101-2020_03_27_012757	455	68	granted	grant	VBN
10_1101-2020_03_27_012757	455	69	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	455	70	a	a	DT
10_1101-2020_03_27_012757	455	71	license	license	NN
10_1101-2020_03_27_012757	455	72	to	to	TO
10_1101-2020_03_27_012757	455	73	display	display	VB
10_1101-2020_03_27_012757	455	74	the	the	DT
10_1101-2020_03_27_012757	455	75	preprint	preprint	NN
10_1101-2020_03_27_012757	455	76	in	in	IN
10_1101-2020_03_27_012757	455	77	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	455	78	.	.	.
10_1101-2020_03_27_012757	456	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	456	2	is	be	VBZ
10_1101-2020_03_27_012757	456	3	made	make	VBN
10_1101-2020_03_27_012757	456	4	The	the	DT
10_1101-2020_03_27_012757	456	5	copyright	copyright	NN
10_1101-2020_03_27_012757	456	6	holder	holder	NN
10_1101-2020_03_27_012757	456	7	for	for	IN
10_1101-2020_03_27_012757	456	8	this	this	DT
10_1101-2020_03_27_012757	456	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	456	10	version	version	NN
10_1101-2020_03_27_012757	456	11	posted	post	VBD
10_1101-2020_03_27_012757	456	12	January	January	NNP
10_1101-2020_03_27_012757	456	13	9	9	CD
10_1101-2020_03_27_012757	456	14	,	,	,
10_1101-2020_03_27_012757	456	15	2021	2021	CD
10_1101-2020_03_27_012757	456	16	.	.	.
10_1101-2020_03_27_012757	456	17	;	;	:
10_1101-2020_03_27_012757	456	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	456	19	:	:	:
10_1101-2020_03_27_012757	456	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	456	21	preprint	preprint	NN
10_1101-2020_03_27_012757	456	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	456	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	456	24	34	34	CD
10_1101-2020_03_27_012757	456	25	and	and	CC
10_1101-2020_03_27_012757	456	26	PPARG	PPARG	NNP
10_1101-2020_03_27_012757	456	27	(	(	-LRB-
10_1101-2020_03_27_012757	456	28	urothelial	urothelial	JJ
10_1101-2020_03_27_012757	456	29	biomarker	biomarker	NN
10_1101-2020_03_27_012757	456	30	)	)	-RRB-
10_1101-2020_03_27_012757	456	31	.	.	.
10_1101-2020_03_27_012757	457	1	The	the	DT
10_1101-2020_03_27_012757	457	2	bar	bar	NN
10_1101-2020_03_27_012757	457	3	plots	plot	NNS
10_1101-2020_03_27_012757	457	4	quantify	quantify	VBP
10_1101-2020_03_27_012757	457	5	the	the	DT
10_1101-2020_03_27_012757	457	6	average	average	JJ
10_1101-2020_03_27_012757	457	7	percentage	percentage	NN
10_1101-2020_03_27_012757	457	8	of	of	IN
10_1101-2020_03_27_012757	457	9	positive	positive	JJ
10_1101-2020_03_27_012757	457	10	878	878	CD
10_1101-2020_03_27_012757	457	11	cells	cell	NNS
10_1101-2020_03_27_012757	457	12	for	for	IN
10_1101-2020_03_27_012757	457	13	FOLH1	FOLH1	NNS
10_1101-2020_03_27_012757	457	14	(	(	-LRB-
10_1101-2020_03_27_012757	457	15	top	top	JJ
10_1101-2020_03_27_012757	457	16	-	-	HYPH
10_1101-2020_03_27_012757	457	17	right	right	NN
10_1101-2020_03_27_012757	457	18	)	)	-RRB-
10_1101-2020_03_27_012757	457	19	and	and	CC
10_1101-2020_03_27_012757	457	20	PPARG	PPARG	NNP
10_1101-2020_03_27_012757	457	21	(	(	-LRB-
10_1101-2020_03_27_012757	457	22	bottom	bottom	JJ
10_1101-2020_03_27_012757	457	23	-	-	HYPH
10_1101-2020_03_27_012757	457	24	right	right	JJ
10_1101-2020_03_27_012757	457	25	)	)	-RRB-
10_1101-2020_03_27_012757	457	26	.	.	.
10_1101-2020_03_27_012757	458	1	879	879	CD
10_1101-2020_03_27_012757	458	2	880	880	CD
10_1101-2020_03_27_012757	458	3	Fig	fig	NN
10_1101-2020_03_27_012757	458	4	.	.	.
10_1101-2020_03_27_012757	459	1	4	4	CD
10_1101-2020_03_27_012757	459	2	Subtype	subtype	NN
10_1101-2020_03_27_012757	459	3	classification	classification	NN
10_1101-2020_03_27_012757	459	4	of	of	IN
10_1101-2020_03_27_012757	459	5	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	459	6	and	and	CC
10_1101-2020_03_27_012757	459	7	CCL	CCL	NNP
10_1101-2020_03_27_012757	459	8	prevalence	prevalence	NN
10_1101-2020_03_27_012757	459	9	.	.	.
10_1101-2020_03_27_012757	460	1	The	the	DT
10_1101-2020_03_27_012757	460	2	heatmap	heatmap	NNP
10_1101-2020_03_27_012757	460	3	visualizations	visualization	VBZ
10_1101-2020_03_27_012757	460	4	881	881	CD
10_1101-2020_03_27_012757	460	5	represent	represent	NN
10_1101-2020_03_27_012757	460	6	subtype	subtype	NN
10_1101-2020_03_27_012757	460	7	classification	classification	NN
10_1101-2020_03_27_012757	460	8	of	of	IN
10_1101-2020_03_27_012757	460	9	(	(	-LRB-
10_1101-2020_03_27_012757	460	10	A	a	NN
10_1101-2020_03_27_012757	460	11	)	)	-RRB-
10_1101-2020_03_27_012757	460	12	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	460	13	CCLs	ccl	NNS
10_1101-2020_03_27_012757	460	14	,	,	,
10_1101-2020_03_27_012757	460	15	(	(	-LRB-
10_1101-2020_03_27_012757	460	16	B	b	NN
10_1101-2020_03_27_012757	460	17	)	)	-RRB-
10_1101-2020_03_27_012757	460	18	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	460	19	CCLs	ccl	NNS
10_1101-2020_03_27_012757	460	20	and	and	CC
10_1101-2020_03_27_012757	460	21	(	(	-LRB-
10_1101-2020_03_27_012757	460	22	C	C	NNP
10_1101-2020_03_27_012757	460	23	)	)	-RRB-
10_1101-2020_03_27_012757	460	24	LUAD	luad	RB
10_1101-2020_03_27_012757	460	25	CCLs	ccl	NNS
10_1101-2020_03_27_012757	460	26	.	.	.
10_1101-2020_03_27_012757	461	1	Only	only	RB
10_1101-2020_03_27_012757	461	2	882	882	CD
10_1101-2020_03_27_012757	461	3	samples	sample	NNS
10_1101-2020_03_27_012757	461	4	with	with	IN
10_1101-2020_03_27_012757	461	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	461	6	scores	score	NNS
10_1101-2020_03_27_012757	461	7	>	>	XX
10_1101-2020_03_27_012757	461	8	0.1	0.1	CD
10_1101-2020_03_27_012757	461	9	in	in	IN
10_1101-2020_03_27_012757	461	10	their	-PRON-	PRP$
10_1101-2020_03_27_012757	461	11	nominal	nominal	JJ
10_1101-2020_03_27_012757	461	12	tumor	tumor	NN
10_1101-2020_03_27_012757	461	13	type	type	NN
10_1101-2020_03_27_012757	461	14	are	be	VBP
10_1101-2020_03_27_012757	461	15	displayed	display	VBN
10_1101-2020_03_27_012757	461	16	.	.	.
10_1101-2020_03_27_012757	462	1	(	(	-LRB-
10_1101-2020_03_27_012757	462	2	D	d	NN
10_1101-2020_03_27_012757	462	3	)	)	-RRB-
10_1101-2020_03_27_012757	462	4	Comparison	comparison	NN
10_1101-2020_03_27_012757	462	5	of	of	IN
10_1101-2020_03_27_012757	462	6	883	883	CD
10_1101-2020_03_27_012757	462	7	normalized	normalized	JJ
10_1101-2020_03_27_012757	462	8	citation	citation	NN
10_1101-2020_03_27_012757	462	9	counts	count	NNS
10_1101-2020_03_27_012757	462	10	and	and	CC
10_1101-2020_03_27_012757	462	11	general	general	JJ
10_1101-2020_03_27_012757	462	12	CCN	CCN	NNP
10_1101-2020_03_27_012757	462	13	classification	classification	NN
10_1101-2020_03_27_012757	462	14	scores	score	NNS
10_1101-2020_03_27_012757	462	15	of	of	IN
10_1101-2020_03_27_012757	462	16	CCLs	ccl	NNS
10_1101-2020_03_27_012757	462	17	.	.	.
10_1101-2020_03_27_012757	463	1	Labelled	label	VBN
10_1101-2020_03_27_012757	463	2	cell	cell	NN
10_1101-2020_03_27_012757	463	3	lines	line	NNS
10_1101-2020_03_27_012757	463	4	884	884	CD
10_1101-2020_03_27_012757	463	5	either	either	CC
10_1101-2020_03_27_012757	463	6	have	have	VBP
10_1101-2020_03_27_012757	463	7	the	the	DT
10_1101-2020_03_27_012757	463	8	highest	high	JJS
10_1101-2020_03_27_012757	463	9	CCN	CCN	NNP
10_1101-2020_03_27_012757	463	10	classification	classification	NN
10_1101-2020_03_27_012757	463	11	score	score	NN
10_1101-2020_03_27_012757	463	12	in	in	IN
10_1101-2020_03_27_012757	463	13	their	-PRON-	PRP$
10_1101-2020_03_27_012757	463	14	labelled	label	VBN
10_1101-2020_03_27_012757	463	15	cancer	cancer	NN
10_1101-2020_03_27_012757	463	16	category	category	NN
10_1101-2020_03_27_012757	463	17	or	or	CC
10_1101-2020_03_27_012757	463	18	highest	high	JJS
10_1101-2020_03_27_012757	463	19	885	885	CD
10_1101-2020_03_27_012757	463	20	normalized	normalized	JJ
10_1101-2020_03_27_012757	463	21	citation	citation	NN
10_1101-2020_03_27_012757	463	22	count	count	NN
10_1101-2020_03_27_012757	463	23	.	.	.
10_1101-2020_03_27_012757	464	1	Each	each	DT
10_1101-2020_03_27_012757	464	2	citation	citation	NN
10_1101-2020_03_27_012757	464	3	count	count	NN
10_1101-2020_03_27_012757	464	4	was	be	VBD
10_1101-2020_03_27_012757	464	5	normalized	normalize	VBN
10_1101-2020_03_27_012757	464	6	by	by	IN
10_1101-2020_03_27_012757	464	7	number	number	NN
10_1101-2020_03_27_012757	464	8	of	of	IN
10_1101-2020_03_27_012757	464	9	years	year	NNS
10_1101-2020_03_27_012757	464	10	since	since	IN
10_1101-2020_03_27_012757	464	11	first	first	RB
10_1101-2020_03_27_012757	464	12	886	886	CD
10_1101-2020_03_27_012757	464	13	documented	document	VBN
10_1101-2020_03_27_012757	464	14	on	on	IN
10_1101-2020_03_27_012757	464	15	PubMed	PubMed	NNP
10_1101-2020_03_27_012757	464	16	.	.	.
10_1101-2020_03_27_012757	465	1	887	887	CD
10_1101-2020_03_27_012757	465	2	888	888	CD
10_1101-2020_03_27_012757	465	3	Fig	fig	NN
10_1101-2020_03_27_012757	465	4	.	.	.
10_1101-2020_03_27_012757	466	1	5	5	CD
10_1101-2020_03_27_012757	466	2	Evaluation	evaluation	NN
10_1101-2020_03_27_012757	466	3	of	of	IN
10_1101-2020_03_27_012757	466	4	patient	patient	JJ
10_1101-2020_03_27_012757	466	5	derived	derive	VBN
10_1101-2020_03_27_012757	466	6	xenografts	xenograft	NNS
10_1101-2020_03_27_012757	466	7	.	.	.
10_1101-2020_03_27_012757	467	1	(	(	-LRB-
10_1101-2020_03_27_012757	467	2	A	a	DT
10_1101-2020_03_27_012757	467	3	)	)	-RRB-
10_1101-2020_03_27_012757	467	4	General	General	NNP
10_1101-2020_03_27_012757	467	5	classification	classification	NN
10_1101-2020_03_27_012757	467	6	heatmap	heatmap	NN
10_1101-2020_03_27_012757	467	7	of	of	IN
10_1101-2020_03_27_012757	467	8	PDXs	PDXs	NNP
10_1101-2020_03_27_012757	467	9	.	.	.
10_1101-2020_03_27_012757	468	1	889	889	CD
10_1101-2020_03_27_012757	468	2	Column	column	NN
10_1101-2020_03_27_012757	468	3	annotations	annotation	NNS
10_1101-2020_03_27_012757	468	4	represent	represent	VBP
10_1101-2020_03_27_012757	468	5	annotated	annotate	VBN
10_1101-2020_03_27_012757	468	6	cancer	cancer	NN
10_1101-2020_03_27_012757	468	7	type	type	NN
10_1101-2020_03_27_012757	468	8	of	of	IN
10_1101-2020_03_27_012757	468	9	the	the	DT
10_1101-2020_03_27_012757	468	10	PDXs	pdx	NNS
10_1101-2020_03_27_012757	468	11	,	,	,
10_1101-2020_03_27_012757	468	12	and	and	CC
10_1101-2020_03_27_012757	468	13	row	row	NN
10_1101-2020_03_27_012757	468	14	names	name	NNS
10_1101-2020_03_27_012757	468	15	represent	represent	VBP
10_1101-2020_03_27_012757	468	16	890	890	CD
10_1101-2020_03_27_012757	468	17	cancer	cancer	NN
10_1101-2020_03_27_012757	468	18	categories	category	NNS
10_1101-2020_03_27_012757	468	19	.	.	.
10_1101-2020_03_27_012757	469	1	(	(	-LRB-
10_1101-2020_03_27_012757	469	2	B	b	NN
10_1101-2020_03_27_012757	469	3	)	)	-RRB-
10_1101-2020_03_27_012757	469	4	Proportion	proportion	NN
10_1101-2020_03_27_012757	469	5	of	of	IN
10_1101-2020_03_27_012757	469	6	classification	classification	NN
10_1101-2020_03_27_012757	469	7	categories	category	NNS
10_1101-2020_03_27_012757	469	8	in	in	IN
10_1101-2020_03_27_012757	469	9	PDXs	pdx	NNS
10_1101-2020_03_27_012757	469	10	across	across	IN
10_1101-2020_03_27_012757	469	11	cancer	cancer	NN
10_1101-2020_03_27_012757	469	12	types	type	NNS
10_1101-2020_03_27_012757	469	13	is	be	VBZ
10_1101-2020_03_27_012757	469	14	891	891	CD
10_1101-2020_03_27_012757	469	15	visualized	visualize	VBN
10_1101-2020_03_27_012757	469	16	in	in	IN
10_1101-2020_03_27_012757	469	17	the	the	DT
10_1101-2020_03_27_012757	469	18	bar	bar	NN
10_1101-2020_03_27_012757	469	19	plot	plot	NN
10_1101-2020_03_27_012757	469	20	and	and	CC
10_1101-2020_03_27_012757	469	21	ordered	order	VBN
10_1101-2020_03_27_012757	469	22	from	from	IN
10_1101-2020_03_27_012757	469	23	the	the	DT
10_1101-2020_03_27_012757	469	24	cancer	cancer	NN
10_1101-2020_03_27_012757	469	25	type	type	NN
10_1101-2020_03_27_012757	469	26	with	with	IN
10_1101-2020_03_27_012757	469	27	highest	high	JJS
10_1101-2020_03_27_012757	469	28	proportion	proportion	NN
10_1101-2020_03_27_012757	469	29	of	of	IN
10_1101-2020_03_27_012757	469	30	correct	correct	JJ
10_1101-2020_03_27_012757	469	31	and	and	CC
10_1101-2020_03_27_012757	469	32	892	892	CD
10_1101-2020_03_27_012757	469	33	mixed	mixed	JJ
10_1101-2020_03_27_012757	469	34	correct	correct	JJ
10_1101-2020_03_27_012757	469	35	classified	classify	VBN
10_1101-2020_03_27_012757	469	36	PDXs	pdx	NNS
10_1101-2020_03_27_012757	469	37	to	to	IN
10_1101-2020_03_27_012757	469	38	the	the	DT
10_1101-2020_03_27_012757	469	39	lowest	low	JJS
10_1101-2020_03_27_012757	469	40	.	.	.
10_1101-2020_03_27_012757	470	1	Subtype	subtype	NN
10_1101-2020_03_27_012757	470	2	classification	classification	NN
10_1101-2020_03_27_012757	470	3	heatmaps	heatmap	NNS
10_1101-2020_03_27_012757	470	4	of	of	IN
10_1101-2020_03_27_012757	470	5	(	(	-LRB-
10_1101-2020_03_27_012757	470	6	C	C	NNP
10_1101-2020_03_27_012757	470	7	)	)	-RRB-
10_1101-2020_03_27_012757	470	8	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	470	9	893	893	CD
10_1101-2020_03_27_012757	470	10	PDXs	pdx	NNS
10_1101-2020_03_27_012757	470	11	,	,	,
10_1101-2020_03_27_012757	470	12	(	(	-LRB-
10_1101-2020_03_27_012757	470	13	D	d	NN
10_1101-2020_03_27_012757	470	14	)	)	-RRB-
10_1101-2020_03_27_012757	470	15	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	470	16	PDXs	pdx	NNS
10_1101-2020_03_27_012757	470	17	and	and	CC
10_1101-2020_03_27_012757	470	18	(	(	-LRB-
10_1101-2020_03_27_012757	470	19	E	e	NN
10_1101-2020_03_27_012757	470	20	)	)	-RRB-
10_1101-2020_03_27_012757	470	21	LUAD	luad	JJ
10_1101-2020_03_27_012757	470	22	PDXs	pdx	NNS
10_1101-2020_03_27_012757	470	23	.	.	.
10_1101-2020_03_27_012757	471	1	Only	only	RB
10_1101-2020_03_27_012757	471	2	samples	sample	NNS
10_1101-2020_03_27_012757	471	3	with	with	IN
10_1101-2020_03_27_012757	471	4	CCN	CCN	NNP
10_1101-2020_03_27_012757	471	5	scores	score	NNS
10_1101-2020_03_27_012757	471	6	>	>	XX
10_1101-2020_03_27_012757	471	7	0.1	0.1	CD
10_1101-2020_03_27_012757	471	8	in	in	IN
10_1101-2020_03_27_012757	471	9	their	-PRON-	PRP$
10_1101-2020_03_27_012757	471	10	894	894	CD
10_1101-2020_03_27_012757	471	11	nominal	nominal	JJ
10_1101-2020_03_27_012757	471	12	tumor	tumor	NN
10_1101-2020_03_27_012757	471	13	type	type	NN
10_1101-2020_03_27_012757	471	14	are	be	VBP
10_1101-2020_03_27_012757	471	15	displayed	display	VBN
10_1101-2020_03_27_012757	471	16	.	.	.
10_1101-2020_03_27_012757	472	1	895	895	CD
10_1101-2020_03_27_012757	472	2	896	896	CD
10_1101-2020_03_27_012757	472	3	Fig	fig	NN
10_1101-2020_03_27_012757	472	4	.	.	.
10_1101-2020_03_27_012757	473	1	6	6	CD
10_1101-2020_03_27_012757	473	2	Evaluation	Evaluation	NNP
10_1101-2020_03_27_012757	473	3	of	of	IN
10_1101-2020_03_27_012757	473	4	genetically	genetically	RB
10_1101-2020_03_27_012757	473	5	engineered	engineer	VBN
10_1101-2020_03_27_012757	473	6	mouse	mouse	NN
10_1101-2020_03_27_012757	473	7	models	model	NNS
10_1101-2020_03_27_012757	473	8	.	.	.
10_1101-2020_03_27_012757	474	1	(	(	-LRB-
10_1101-2020_03_27_012757	474	2	A	a	DT
10_1101-2020_03_27_012757	474	3	)	)	-RRB-
10_1101-2020_03_27_012757	474	4	General	General	NNP
10_1101-2020_03_27_012757	474	5	classification	classification	NN
10_1101-2020_03_27_012757	474	6	897	897	CD
10_1101-2020_03_27_012757	474	7	heatmap	heatmap	NN
10_1101-2020_03_27_012757	474	8	of	of	IN
10_1101-2020_03_27_012757	474	9	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	474	10	.	.	.
10_1101-2020_03_27_012757	475	1	Column	column	NN
10_1101-2020_03_27_012757	475	2	annotations	annotation	NNS
10_1101-2020_03_27_012757	475	3	represent	represent	VBP
10_1101-2020_03_27_012757	475	4	annotated	annotate	VBN
10_1101-2020_03_27_012757	475	5	cancer	cancer	NN
10_1101-2020_03_27_012757	475	6	type	type	NN
10_1101-2020_03_27_012757	475	7	of	of	IN
10_1101-2020_03_27_012757	475	8	the	the	DT
10_1101-2020_03_27_012757	475	9	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	475	10	,	,	,
10_1101-2020_03_27_012757	475	11	and	and	CC
10_1101-2020_03_27_012757	475	12	898	898	CD
10_1101-2020_03_27_012757	475	13	row	row	NN
10_1101-2020_03_27_012757	475	14	names	name	NNS
10_1101-2020_03_27_012757	475	15	represent	represent	VBP
10_1101-2020_03_27_012757	475	16	cancer	cancer	NN
10_1101-2020_03_27_012757	475	17	categories	category	NNS
10_1101-2020_03_27_012757	475	18	.	.	.
10_1101-2020_03_27_012757	476	1	(	(	-LRB-
10_1101-2020_03_27_012757	476	2	B	b	NN
10_1101-2020_03_27_012757	476	3	)	)	-RRB-
10_1101-2020_03_27_012757	476	4	Proportion	proportion	NN
10_1101-2020_03_27_012757	476	5	of	of	IN
10_1101-2020_03_27_012757	476	6	classification	classification	NN
10_1101-2020_03_27_012757	476	7	categories	category	NNS
10_1101-2020_03_27_012757	476	8	in	in	IN
10_1101-2020_03_27_012757	476	9	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	476	10	899	899	CD
10_1101-2020_03_27_012757	476	11	across	across	IN
10_1101-2020_03_27_012757	476	12	cancer	cancer	NN
10_1101-2020_03_27_012757	476	13	types	type	NNS
10_1101-2020_03_27_012757	476	14	is	be	VBZ
10_1101-2020_03_27_012757	476	15	visualized	visualize	VBN
10_1101-2020_03_27_012757	476	16	in	in	IN
10_1101-2020_03_27_012757	476	17	the	the	DT
10_1101-2020_03_27_012757	476	18	bar	bar	NN
10_1101-2020_03_27_012757	476	19	plot	plot	NN
10_1101-2020_03_27_012757	476	20	and	and	CC
10_1101-2020_03_27_012757	476	21	ordered	order	VBN
10_1101-2020_03_27_012757	476	22	from	from	IN
10_1101-2020_03_27_012757	476	23	the	the	DT
10_1101-2020_03_27_012757	476	24	cancer	cancer	NN
10_1101-2020_03_27_012757	476	25	type	type	NN
10_1101-2020_03_27_012757	476	26	with	with	IN
10_1101-2020_03_27_012757	476	27	highest	high	JJS
10_1101-2020_03_27_012757	476	28	900	900	CD
10_1101-2020_03_27_012757	476	29	proportion	proportion	NN
10_1101-2020_03_27_012757	476	30	of	of	IN
10_1101-2020_03_27_012757	476	31	correct	correct	JJ
10_1101-2020_03_27_012757	476	32	and	and	CC
10_1101-2020_03_27_012757	476	33	mixed	mixed	JJ
10_1101-2020_03_27_012757	476	34	correct	correct	JJ
10_1101-2020_03_27_012757	476	35	classified	classify	VBD
10_1101-2020_03_27_012757	476	36	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	476	37	to	to	IN
10_1101-2020_03_27_012757	476	38	the	the	DT
10_1101-2020_03_27_012757	476	39	lowest	low	JJS
10_1101-2020_03_27_012757	476	40	.	.	.
10_1101-2020_03_27_012757	477	1	Subtype	subtype	NN
10_1101-2020_03_27_012757	477	2	classification	classification	NN
10_1101-2020_03_27_012757	477	3	901	901	CD
10_1101-2020_03_27_012757	477	4	heatmap	heatmap	NN
10_1101-2020_03_27_012757	477	5	of	of	IN
10_1101-2020_03_27_012757	477	6	(	(	-LRB-
10_1101-2020_03_27_012757	477	7	C	C	NNP
10_1101-2020_03_27_012757	477	8	)	)	-RRB-
10_1101-2020_03_27_012757	477	9	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	477	10	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	477	11	,	,	,
10_1101-2020_03_27_012757	477	12	(	(	-LRB-
10_1101-2020_03_27_012757	477	13	D	d	NN
10_1101-2020_03_27_012757	477	14	)	)	-RRB-
10_1101-2020_03_27_012757	477	15	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	477	16	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	477	17	and	and	CC
10_1101-2020_03_27_012757	477	18	(	(	-LRB-
10_1101-2020_03_27_012757	477	19	E	e	NN
10_1101-2020_03_27_012757	477	20	)	)	-RRB-
10_1101-2020_03_27_012757	477	21	LUAD	luad	RB
10_1101-2020_03_27_012757	477	22	GEMMs	gemm	NNS
10_1101-2020_03_27_012757	477	23	.	.	.
10_1101-2020_03_27_012757	478	1	Only	only	RB
10_1101-2020_03_27_012757	478	2	samples	sample	NNS
10_1101-2020_03_27_012757	478	3	with	with	IN
10_1101-2020_03_27_012757	478	4	902	902	CD
10_1101-2020_03_27_012757	478	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	478	6	scores	score	NNS
10_1101-2020_03_27_012757	478	7	>	>	XX
10_1101-2020_03_27_012757	478	8	0.1	0.1	CD
10_1101-2020_03_27_012757	478	9	in	in	IN
10_1101-2020_03_27_012757	478	10	their	-PRON-	PRP$
10_1101-2020_03_27_012757	478	11	nominal	nominal	JJ
10_1101-2020_03_27_012757	478	12	tumor	tumor	NN
10_1101-2020_03_27_012757	478	13	type	type	NN
10_1101-2020_03_27_012757	478	14	are	be	VBP
10_1101-2020_03_27_012757	478	15	displayed	display	VBN
10_1101-2020_03_27_012757	478	16	.	.	.
10_1101-2020_03_27_012757	479	1	903	903	CD
10_1101-2020_03_27_012757	479	2	.CC	.CC	:
10_1101-2020_03_27_012757	479	3	-	-	HYPH
10_1101-2020_03_27_012757	479	4	BY	by	IN
10_1101-2020_03_27_012757	479	5	-	-	HYPH
10_1101-2020_03_27_012757	479	6	NC	NC	NNP
10_1101-2020_03_27_012757	479	7	-	-	HYPH
10_1101-2020_03_27_012757	479	8	ND	ND	NNP
10_1101-2020_03_27_012757	479	9	4.0	4.0	CD
10_1101-2020_03_27_012757	479	10	International	International	NNP
10_1101-2020_03_27_012757	479	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	479	12	under	under	IN
10_1101-2020_03_27_012757	479	13	a	a	DT
10_1101-2020_03_27_012757	479	14	(	(	-LRB-
10_1101-2020_03_27_012757	479	15	which	which	WDT
10_1101-2020_03_27_012757	479	16	was	be	VBD
10_1101-2020_03_27_012757	479	17	not	not	RB
10_1101-2020_03_27_012757	479	18	certified	certify	VBN
10_1101-2020_03_27_012757	479	19	by	by	IN
10_1101-2020_03_27_012757	479	20	peer	peer	NN
10_1101-2020_03_27_012757	479	21	review	review	NN
10_1101-2020_03_27_012757	479	22	)	)	-RRB-
10_1101-2020_03_27_012757	479	23	is	be	VBZ
10_1101-2020_03_27_012757	479	24	the	the	DT
10_1101-2020_03_27_012757	479	25	author	author	NN
10_1101-2020_03_27_012757	479	26	/	/	SYM
10_1101-2020_03_27_012757	479	27	funder	funder	NN
10_1101-2020_03_27_012757	479	28	,	,	,
10_1101-2020_03_27_012757	479	29	who	who	WP
10_1101-2020_03_27_012757	479	30	has	have	VBZ
10_1101-2020_03_27_012757	479	31	granted	grant	VBN
10_1101-2020_03_27_012757	479	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	479	33	a	a	DT
10_1101-2020_03_27_012757	479	34	license	license	NN
10_1101-2020_03_27_012757	479	35	to	to	TO
10_1101-2020_03_27_012757	479	36	display	display	VB
10_1101-2020_03_27_012757	479	37	the	the	DT
10_1101-2020_03_27_012757	479	38	preprint	preprint	NN
10_1101-2020_03_27_012757	479	39	in	in	IN
10_1101-2020_03_27_012757	479	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	479	41	.	.	.
10_1101-2020_03_27_012757	480	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	480	2	is	be	VBZ
10_1101-2020_03_27_012757	480	3	made	make	VBN
10_1101-2020_03_27_012757	480	4	The	the	DT
10_1101-2020_03_27_012757	480	5	copyright	copyright	NN
10_1101-2020_03_27_012757	480	6	holder	holder	NN
10_1101-2020_03_27_012757	480	7	for	for	IN
10_1101-2020_03_27_012757	480	8	this	this	DT
10_1101-2020_03_27_012757	480	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	480	10	version	version	NN
10_1101-2020_03_27_012757	480	11	posted	post	VBD
10_1101-2020_03_27_012757	480	12	January	January	NNP
10_1101-2020_03_27_012757	480	13	9	9	CD
10_1101-2020_03_27_012757	480	14	,	,	,
10_1101-2020_03_27_012757	480	15	2021	2021	CD
10_1101-2020_03_27_012757	480	16	.	.	.
10_1101-2020_03_27_012757	480	17	;	;	:
10_1101-2020_03_27_012757	480	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	480	19	:	:	:
10_1101-2020_03_27_012757	480	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	480	21	preprint	preprint	NN
10_1101-2020_03_27_012757	480	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	480	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	480	24	35	35	CD
10_1101-2020_03_27_012757	480	25	904	904	CD
10_1101-2020_03_27_012757	480	26	Fig	fig	NN
10_1101-2020_03_27_012757	480	27	.	.	.
10_1101-2020_03_27_012757	481	1	7	7	CD
10_1101-2020_03_27_012757	481	2	Evaluation	evaluation	NN
10_1101-2020_03_27_012757	481	3	of	of	IN
10_1101-2020_03_27_012757	481	4	tumoroid	tumoroid	NN
10_1101-2020_03_27_012757	481	5	models	model	NNS
10_1101-2020_03_27_012757	481	6	.	.	.
10_1101-2020_03_27_012757	482	1	(	(	-LRB-
10_1101-2020_03_27_012757	482	2	A	a	DT
10_1101-2020_03_27_012757	482	3	)	)	-RRB-
10_1101-2020_03_27_012757	482	4	General	General	NNP
10_1101-2020_03_27_012757	482	5	classification	classification	NN
10_1101-2020_03_27_012757	482	6	heatmap	heatmap	NN
10_1101-2020_03_27_012757	482	7	of	of	IN
10_1101-2020_03_27_012757	482	8	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	482	9	.	.	.
10_1101-2020_03_27_012757	483	1	905	905	CD
10_1101-2020_03_27_012757	483	2	Column	column	NN
10_1101-2020_03_27_012757	483	3	annotations	annotation	NNS
10_1101-2020_03_27_012757	483	4	represent	represent	VBP
10_1101-2020_03_27_012757	483	5	annotated	annotate	VBN
10_1101-2020_03_27_012757	483	6	cancer	cancer	NN
10_1101-2020_03_27_012757	483	7	type	type	NN
10_1101-2020_03_27_012757	483	8	of	of	IN
10_1101-2020_03_27_012757	483	9	the	the	DT
10_1101-2020_03_27_012757	483	10	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	483	11	,	,	,
10_1101-2020_03_27_012757	483	12	and	and	CC
10_1101-2020_03_27_012757	483	13	row	row	NN
10_1101-2020_03_27_012757	483	14	names	name	NNS
10_1101-2020_03_27_012757	483	15	906	906	CD
10_1101-2020_03_27_012757	483	16	represent	represent	NN
10_1101-2020_03_27_012757	483	17	cancer	cancer	NN
10_1101-2020_03_27_012757	483	18	categories	category	NNS
10_1101-2020_03_27_012757	483	19	.	.	.
10_1101-2020_03_27_012757	484	1	(	(	-LRB-
10_1101-2020_03_27_012757	484	2	B	b	NN
10_1101-2020_03_27_012757	484	3	)	)	-RRB-
10_1101-2020_03_27_012757	484	4	Proportion	proportion	NN
10_1101-2020_03_27_012757	484	5	of	of	IN
10_1101-2020_03_27_012757	484	6	classification	classification	NN
10_1101-2020_03_27_012757	484	7	categories	category	NNS
10_1101-2020_03_27_012757	484	8	in	in	IN
10_1101-2020_03_27_012757	484	9	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	484	10	across	across	IN
10_1101-2020_03_27_012757	484	11	907	907	CD
10_1101-2020_03_27_012757	484	12	cancer	cancer	NN
10_1101-2020_03_27_012757	484	13	types	type	NNS
10_1101-2020_03_27_012757	484	14	is	be	VBZ
10_1101-2020_03_27_012757	484	15	visualized	visualize	VBN
10_1101-2020_03_27_012757	484	16	in	in	IN
10_1101-2020_03_27_012757	484	17	the	the	DT
10_1101-2020_03_27_012757	484	18	bar	bar	NN
10_1101-2020_03_27_012757	484	19	plot	plot	NN
10_1101-2020_03_27_012757	484	20	and	and	CC
10_1101-2020_03_27_012757	484	21	ordered	order	VBN
10_1101-2020_03_27_012757	484	22	from	from	IN
10_1101-2020_03_27_012757	484	23	the	the	DT
10_1101-2020_03_27_012757	484	24	cancer	cancer	NN
10_1101-2020_03_27_012757	484	25	type	type	NN
10_1101-2020_03_27_012757	484	26	with	with	IN
10_1101-2020_03_27_012757	484	27	highest	high	JJS
10_1101-2020_03_27_012757	484	28	908	908	CD
10_1101-2020_03_27_012757	484	29	proportion	proportion	NN
10_1101-2020_03_27_012757	484	30	of	of	IN
10_1101-2020_03_27_012757	484	31	correct	correct	JJ
10_1101-2020_03_27_012757	484	32	and	and	CC
10_1101-2020_03_27_012757	484	33	mixed	mixed	JJ
10_1101-2020_03_27_012757	484	34	correct	correct	JJ
10_1101-2020_03_27_012757	484	35	classified	classified	JJ
10_1101-2020_03_27_012757	484	36	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	484	37	to	to	IN
10_1101-2020_03_27_012757	484	38	the	the	DT
10_1101-2020_03_27_012757	484	39	lowest	low	JJS
10_1101-2020_03_27_012757	484	40	.	.	.
10_1101-2020_03_27_012757	485	1	Subtype	subtype	NN
10_1101-2020_03_27_012757	485	2	classification	classification	NN
10_1101-2020_03_27_012757	485	3	909	909	CD
10_1101-2020_03_27_012757	485	4	heatmap	heatmap	NN
10_1101-2020_03_27_012757	485	5	of	of	IN
10_1101-2020_03_27_012757	485	6	(	(	-LRB-
10_1101-2020_03_27_012757	485	7	C	C	NNP
10_1101-2020_03_27_012757	485	8	)	)	-RRB-
10_1101-2020_03_27_012757	485	9	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	485	10	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	485	11	,	,	,
10_1101-2020_03_27_012757	485	12	(	(	-LRB-
10_1101-2020_03_27_012757	485	13	D	d	NN
10_1101-2020_03_27_012757	485	14	)	)	-RRB-
10_1101-2020_03_27_012757	485	15	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	485	16	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	485	17	and	and	CC
10_1101-2020_03_27_012757	485	18	(	(	-LRB-
10_1101-2020_03_27_012757	485	19	E	e	NN
10_1101-2020_03_27_012757	485	20	)	)	-RRB-
10_1101-2020_03_27_012757	485	21	LUAD	luad	RB
10_1101-2020_03_27_012757	485	22	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	485	23	.	.	.
10_1101-2020_03_27_012757	486	1	Only	only	RB
10_1101-2020_03_27_012757	486	2	samples	sample	NNS
10_1101-2020_03_27_012757	486	3	910	910	CD
10_1101-2020_03_27_012757	486	4	with	with	IN
10_1101-2020_03_27_012757	486	5	CCN	CCN	NNP
10_1101-2020_03_27_012757	486	6	scores	score	NNS
10_1101-2020_03_27_012757	486	7	>	>	XX
10_1101-2020_03_27_012757	486	8	0.1	0.1	CD
10_1101-2020_03_27_012757	486	9	in	in	IN
10_1101-2020_03_27_012757	486	10	their	-PRON-	PRP$
10_1101-2020_03_27_012757	486	11	nominal	nominal	JJ
10_1101-2020_03_27_012757	486	12	tumor	tumor	NN
10_1101-2020_03_27_012757	486	13	type	type	NN
10_1101-2020_03_27_012757	486	14	are	be	VBP
10_1101-2020_03_27_012757	486	15	displayed	display	VBN
10_1101-2020_03_27_012757	486	16	.	.	.
10_1101-2020_03_27_012757	487	1	911	911	CD
10_1101-2020_03_27_012757	487	2	912	912	CD
10_1101-2020_03_27_012757	487	3	Fig	fig	NN
10_1101-2020_03_27_012757	487	4	.	.	.
10_1101-2020_03_27_012757	488	1	8	8	CD
10_1101-2020_03_27_012757	488	2	Comparison	Comparison	NNP
10_1101-2020_03_27_012757	488	3	of	of	IN
10_1101-2020_03_27_012757	488	4	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	488	5	,	,	,
10_1101-2020_03_27_012757	488	6	PDXs	pdx	NNS
10_1101-2020_03_27_012757	488	7	,	,	,
10_1101-2020_03_27_012757	488	8	and	and	CC
10_1101-2020_03_27_012757	488	9	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	488	10	.	.	.
10_1101-2020_03_27_012757	489	1	Box	Box	NNP
10_1101-2020_03_27_012757	489	2	-	-	HYPH
10_1101-2020_03_27_012757	489	3	and	and	CC
10_1101-2020_03_27_012757	489	4	-	-	HYPH
10_1101-2020_03_27_012757	489	5	whiskers	whisker	NNS
10_1101-2020_03_27_012757	489	6	plot	plot	NN
10_1101-2020_03_27_012757	489	7	comparing	compare	VBG
10_1101-2020_03_27_012757	489	8	general	general	JJ
10_1101-2020_03_27_012757	489	9	913	913	CD
10_1101-2020_03_27_012757	489	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	489	11	scores	score	NNS
10_1101-2020_03_27_012757	489	12	across	across	IN
10_1101-2020_03_27_012757	489	13	CCLs	ccl	NNS
10_1101-2020_03_27_012757	489	14	,	,	,
10_1101-2020_03_27_012757	489	15	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	489	16	,	,	,
10_1101-2020_03_27_012757	489	17	PDXs	pdx	NNS
10_1101-2020_03_27_012757	489	18	of	of	IN
10_1101-2020_03_27_012757	489	19	five	five	CD
10_1101-2020_03_27_012757	489	20	general	general	JJ
10_1101-2020_03_27_012757	489	21	tumor	tumor	NN
10_1101-2020_03_27_012757	489	22	types	type	NNS
10_1101-2020_03_27_012757	489	23	(	(	-LRB-
10_1101-2020_03_27_012757	489	24	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	489	25	,	,	,
10_1101-2020_03_27_012757	489	26	PAAD	PAAD	NNP
10_1101-2020_03_27_012757	489	27	,	,	,
10_1101-2020_03_27_012757	489	28	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	489	29	,	,	,
10_1101-2020_03_27_012757	489	30	914	914	CD
10_1101-2020_03_27_012757	489	31	LUAD	luad	RB
10_1101-2020_03_27_012757	489	32	,	,	,
10_1101-2020_03_27_012757	489	33	LIHC	LIHC	NNP
10_1101-2020_03_27_012757	489	34	)	)	-RRB-
10_1101-2020_03_27_012757	489	35	.	.	.
10_1101-2020_03_27_012757	490	1	915	915	CD
10_1101-2020_03_27_012757	490	2	916	916	CD
10_1101-2020_03_27_012757	490	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	490	4	Information	information	NN
10_1101-2020_03_27_012757	490	5	917	917	CD
10_1101-2020_03_27_012757	490	6	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	490	7	Figure	figure	NN
10_1101-2020_03_27_012757	490	8	1	1	CD
10_1101-2020_03_27_012757	490	9	Assessment	Assessment	NNP
10_1101-2020_03_27_012757	490	10	of	of	IN
10_1101-2020_03_27_012757	490	11	CCN	CCN	NNP
10_1101-2020_03_27_012757	490	12	general	general	JJ
10_1101-2020_03_27_012757	490	13	classifier	classifier	NN
10_1101-2020_03_27_012757	490	14	and	and	CC
10_1101-2020_03_27_012757	490	15	subtype	subtype	NN
10_1101-2020_03_27_012757	490	16	classifier	classifier	NN
10_1101-2020_03_27_012757	490	17	.	.	.
10_1101-2020_03_27_012757	491	1	(	(	-LRB-
10_1101-2020_03_27_012757	491	2	A	a	DT
10_1101-2020_03_27_012757	491	3	)	)	-RRB-
10_1101-2020_03_27_012757	491	4	918	918	CD
10_1101-2020_03_27_012757	491	5	Mean	Mean	NNP
10_1101-2020_03_27_012757	491	6	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	491	7	of	of	IN
10_1101-2020_03_27_012757	491	8	repeated	repeat	VBN
10_1101-2020_03_27_012757	491	9	grid	grid	NN
10_1101-2020_03_27_012757	491	10	-	-	HYPH
10_1101-2020_03_27_012757	491	11	search	search	NN
10_1101-2020_03_27_012757	491	12	cross	cross	NN
10_1101-2020_03_27_012757	491	13	-	-	NN
10_1101-2020_03_27_012757	491	14	validation	validation	NN
10_1101-2020_03_27_012757	491	15	for	for	IN
10_1101-2020_03_27_012757	491	16	each	each	DT
10_1101-2020_03_27_012757	491	17	parameter	parameter	NN
10_1101-2020_03_27_012757	491	18	grid	grid	NN
10_1101-2020_03_27_012757	491	19	.	.	.
10_1101-2020_03_27_012757	492	1	(	(	-LRB-
10_1101-2020_03_27_012757	492	2	B	b	NN
10_1101-2020_03_27_012757	492	3	)	)	-RRB-
10_1101-2020_03_27_012757	492	4	Mean	Mean	NNP
10_1101-2020_03_27_012757	492	5	and	and	CC
10_1101-2020_03_27_012757	492	6	919	919	CD
10_1101-2020_03_27_012757	492	7	range	range	NN
10_1101-2020_03_27_012757	492	8	of	of	IN
10_1101-2020_03_27_012757	492	9	CCN	CCN	NNP
10_1101-2020_03_27_012757	492	10	classifier	classifier	NN
10_1101-2020_03_27_012757	492	11	’s	’s	NN
10_1101-2020_03_27_012757	492	12	PR	pr	NN
10_1101-2020_03_27_012757	492	13	curves	curve	NNS
10_1101-2020_03_27_012757	492	14	from	from	IN
10_1101-2020_03_27_012757	492	15	50	50	CD
10_1101-2020_03_27_012757	492	16	cross	cross	NN
10_1101-2020_03_27_012757	492	17	validations	validation	NNS
10_1101-2020_03_27_012757	492	18	based	base	VBN
10_1101-2020_03_27_012757	492	19	on	on	IN
10_1101-2020_03_27_012757	492	20	the	the	DT
10_1101-2020_03_27_012757	492	21	optimal	optimal	JJ
10_1101-2020_03_27_012757	492	22	feature	feature	NN
10_1101-2020_03_27_012757	492	23	920	920	CD
10_1101-2020_03_27_012757	492	24	selection	selection	NN
10_1101-2020_03_27_012757	492	25	parameters	parameter	NNS
10_1101-2020_03_27_012757	492	26	n	n	NN
10_1101-2020_03_27_012757	492	27	and	and	CC
10_1101-2020_03_27_012757	492	28	m.	m.	NN
10_1101-2020_03_27_012757	492	29	(	(	-LRB-
10_1101-2020_03_27_012757	492	30	C	C	NNP
10_1101-2020_03_27_012757	492	31	)	)	-RRB-
10_1101-2020_03_27_012757	492	32	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	492	33	of	of	IN
10_1101-2020_03_27_012757	492	34	CCN	CCN	NNP
10_1101-2020_03_27_012757	492	35	human	human	JJ
10_1101-2020_03_27_012757	492	36	tissue	tissue	NN
10_1101-2020_03_27_012757	492	37	classifier	classifier	NN
10_1101-2020_03_27_012757	492	38	when	when	WRB
10_1101-2020_03_27_012757	492	39	applied	apply	VBN
10_1101-2020_03_27_012757	492	40	to	to	IN
10_1101-2020_03_27_012757	492	41	921	921	CD
10_1101-2020_03_27_012757	492	42	mouse	mouse	NN
10_1101-2020_03_27_012757	492	43	tissue	tissue	NN
10_1101-2020_03_27_012757	492	44	data	datum	NNS
10_1101-2020_03_27_012757	492	45	.	.	.
10_1101-2020_03_27_012757	493	1	(	(	-LRB-
10_1101-2020_03_27_012757	493	2	D	d	NN
10_1101-2020_03_27_012757	493	3	)	)	-RRB-
10_1101-2020_03_27_012757	493	4	The	the	DT
10_1101-2020_03_27_012757	493	5	schematic	schematic	NN
10_1101-2020_03_27_012757	493	6	of	of	IN
10_1101-2020_03_27_012757	493	7	training	train	VBG
10_1101-2020_03_27_012757	493	8	a	a	DT
10_1101-2020_03_27_012757	493	9	subtype	subtype	NN
10_1101-2020_03_27_012757	493	10	classifier	classifier	NN
10_1101-2020_03_27_012757	493	11	in	in	IN
10_1101-2020_03_27_012757	493	12	CCN	CCN	NNP
10_1101-2020_03_27_012757	493	13	.	.	.
10_1101-2020_03_27_012757	494	1	CCN	CCN	NNP
10_1101-2020_03_27_012757	494	2	uses	use	VBZ
10_1101-2020_03_27_012757	494	3	patient	patient	JJ
10_1101-2020_03_27_012757	494	4	922	922	CD
10_1101-2020_03_27_012757	494	5	tumor	tumor	NN
10_1101-2020_03_27_012757	494	6	expression	expression	NN
10_1101-2020_03_27_012757	494	7	profiles	profile	NNS
10_1101-2020_03_27_012757	494	8	from	from	IN
10_1101-2020_03_27_012757	494	9	cancer	cancer	NN
10_1101-2020_03_27_012757	494	10	of	of	IN
10_1101-2020_03_27_012757	494	11	interest	interest	NN
10_1101-2020_03_27_012757	494	12	as	as	IN
10_1101-2020_03_27_012757	494	13	training	training	NN
10_1101-2020_03_27_012757	494	14	data	datum	NNS
10_1101-2020_03_27_012757	494	15	.	.	.
10_1101-2020_03_27_012757	495	1	CCN	CCN	NNP
10_1101-2020_03_27_012757	495	2	performs	perform	VBZ
10_1101-2020_03_27_012757	495	3	gene	gene	NN
10_1101-2020_03_27_012757	495	4	-	-	HYPH
10_1101-2020_03_27_012757	495	5	pair	pair	VB
10_1101-2020_03_27_012757	495	6	923	923	CD
10_1101-2020_03_27_012757	495	7	transformation	transformation	NN
10_1101-2020_03_27_012757	495	8	and	and	CC
10_1101-2020_03_27_012757	495	9	selects	select	VBZ
10_1101-2020_03_27_012757	495	10	the	the	DT
10_1101-2020_03_27_012757	495	11	most	most	RBS
10_1101-2020_03_27_012757	495	12	discriminative	discriminative	JJ
10_1101-2020_03_27_012757	495	13	gene	gene	NN
10_1101-2020_03_27_012757	495	14	pairs	pair	NNS
10_1101-2020_03_27_012757	495	15	among	among	IN
10_1101-2020_03_27_012757	495	16	the	the	DT
10_1101-2020_03_27_012757	495	17	cancer	cancer	NN
10_1101-2020_03_27_012757	495	18	subtypes	subtype	NNS
10_1101-2020_03_27_012757	495	19	from	from	IN
10_1101-2020_03_27_012757	495	20	924	924	CD
10_1101-2020_03_27_012757	495	21	training	training	NN
10_1101-2020_03_27_012757	495	22	data	datum	NNS
10_1101-2020_03_27_012757	495	23	as	as	IN
10_1101-2020_03_27_012757	495	24	features	feature	NNS
10_1101-2020_03_27_012757	495	25	.	.	.
10_1101-2020_03_27_012757	496	1	CCN	CCN	NNP
10_1101-2020_03_27_012757	496	2	then	then	RB
10_1101-2020_03_27_012757	496	3	applies	apply	VBZ
10_1101-2020_03_27_012757	496	4	the	the	DT
10_1101-2020_03_27_012757	496	5	general	general	JJ
10_1101-2020_03_27_012757	496	6	classification	classification	NN
10_1101-2020_03_27_012757	496	7	on	on	IN
10_1101-2020_03_27_012757	496	8	training	train	VBG
10_1101-2020_03_27_012757	496	9	data	datum	NNS
10_1101-2020_03_27_012757	496	10	and	and	CC
10_1101-2020_03_27_012757	496	11	uses	use	VBZ
10_1101-2020_03_27_012757	496	12	925	925	CD
10_1101-2020_03_27_012757	496	13	the	the	DT
10_1101-2020_03_27_012757	496	14	general	general	JJ
10_1101-2020_03_27_012757	496	15	classification	classification	NN
10_1101-2020_03_27_012757	496	16	profile	profile	NN
10_1101-2020_03_27_012757	496	17	as	as	IN
10_1101-2020_03_27_012757	496	18	features	feature	VBZ
10_1101-2020_03_27_012757	496	19	in	in	IN
10_1101-2020_03_27_012757	496	20	addition	addition	NN
10_1101-2020_03_27_012757	496	21	to	to	TO
10_1101-2020_03_27_012757	496	22	gene	gene	VB
10_1101-2020_03_27_012757	496	23	pairs	pair	NNS
10_1101-2020_03_27_012757	496	24	for	for	IN
10_1101-2020_03_27_012757	496	25	training	train	VBG
10_1101-2020_03_27_012757	496	26	a	a	DT
10_1101-2020_03_27_012757	496	27	Random	Random	NNP
10_1101-2020_03_27_012757	496	28	926	926	CD
10_1101-2020_03_27_012757	496	29	Forest	Forest	NNP
10_1101-2020_03_27_012757	496	30	classifier	classifier	NN
10_1101-2020_03_27_012757	496	31	.	.	.
10_1101-2020_03_27_012757	497	1	The	the	DT
10_1101-2020_03_27_012757	497	2	weight	weight	NN
10_1101-2020_03_27_012757	497	3	of	of	IN
10_1101-2020_03_27_012757	497	4	the	the	DT
10_1101-2020_03_27_012757	497	5	general	general	JJ
10_1101-2020_03_27_012757	497	6	classification	classification	NN
10_1101-2020_03_27_012757	497	7	profiles	profile	NNS
10_1101-2020_03_27_012757	497	8	as	as	IN
10_1101-2020_03_27_012757	497	9	features	feature	NNS
10_1101-2020_03_27_012757	497	10	can	can	MD
10_1101-2020_03_27_012757	497	11	be	be	VB
10_1101-2020_03_27_012757	497	12	tuned	tune	VBN
10_1101-2020_03_27_012757	497	13	to	to	IN
10_1101-2020_03_27_012757	497	14	927	927	CD
10_1101-2020_03_27_012757	497	15	improve	improve	VB
10_1101-2020_03_27_012757	497	16	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	497	17	.	.	.
10_1101-2020_03_27_012757	498	1	(	(	-LRB-
10_1101-2020_03_27_012757	498	2	E	e	NN
10_1101-2020_03_27_012757	498	3	)	)	-RRB-
10_1101-2020_03_27_012757	498	4	The	the	DT
10_1101-2020_03_27_012757	498	5	mean	mean	JJ
10_1101-2020_03_27_012757	498	6	and	and	CC
10_1101-2020_03_27_012757	498	7	standard	standard	JJ
10_1101-2020_03_27_012757	498	8	deviation	deviation	NN
10_1101-2020_03_27_012757	498	9	of	of	IN
10_1101-2020_03_27_012757	498	10	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	498	11	for	for	IN
10_1101-2020_03_27_012757	498	12	11	11	CD
10_1101-2020_03_27_012757	498	13	subtype	subtype	NN
10_1101-2020_03_27_012757	498	14	classifiers	classifier	NNS
10_1101-2020_03_27_012757	498	15	928	928	CD
10_1101-2020_03_27_012757	498	16	based	base	VBN
10_1101-2020_03_27_012757	498	17	on	on	IN
10_1101-2020_03_27_012757	498	18	20	20	CD
10_1101-2020_03_27_012757	498	19	iterations	iteration	NNS
10_1101-2020_03_27_012757	498	20	of	of	IN
10_1101-2020_03_27_012757	498	21	random	random	JJ
10_1101-2020_03_27_012757	498	22	sampling	sampling	NN
10_1101-2020_03_27_012757	498	23	of	of	IN
10_1101-2020_03_27_012757	498	24	training	training	NN
10_1101-2020_03_27_012757	498	25	and	and	CC
10_1101-2020_03_27_012757	498	26	held	hold	VBN
10_1101-2020_03_27_012757	498	27	-	-	HYPH
10_1101-2020_03_27_012757	498	28	out	out	RP
10_1101-2020_03_27_012757	498	29	data	data	NN
10_1101-2020_03_27_012757	498	30	,	,	,
10_1101-2020_03_27_012757	498	31	training	training	NN
10_1101-2020_03_27_012757	498	32	subtype	subtype	NN
10_1101-2020_03_27_012757	498	33	929	929	CD
10_1101-2020_03_27_012757	498	34	.CC	.CC	,
10_1101-2020_03_27_012757	498	35	-	-	HYPH
10_1101-2020_03_27_012757	498	36	BY	by	IN
10_1101-2020_03_27_012757	498	37	-	-	HYPH
10_1101-2020_03_27_012757	498	38	NC	NC	NNP
10_1101-2020_03_27_012757	498	39	-	-	HYPH
10_1101-2020_03_27_012757	498	40	ND	ND	NNP
10_1101-2020_03_27_012757	498	41	4.0	4.0	CD
10_1101-2020_03_27_012757	498	42	International	International	NNP
10_1101-2020_03_27_012757	498	43	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	498	44	under	under	IN
10_1101-2020_03_27_012757	498	45	a	a	DT
10_1101-2020_03_27_012757	498	46	(	(	-LRB-
10_1101-2020_03_27_012757	498	47	which	which	WDT
10_1101-2020_03_27_012757	498	48	was	be	VBD
10_1101-2020_03_27_012757	498	49	not	not	RB
10_1101-2020_03_27_012757	498	50	certified	certify	VBN
10_1101-2020_03_27_012757	498	51	by	by	IN
10_1101-2020_03_27_012757	498	52	peer	peer	NN
10_1101-2020_03_27_012757	498	53	review	review	NN
10_1101-2020_03_27_012757	498	54	)	)	-RRB-
10_1101-2020_03_27_012757	498	55	is	be	VBZ
10_1101-2020_03_27_012757	498	56	the	the	DT
10_1101-2020_03_27_012757	498	57	author	author	NN
10_1101-2020_03_27_012757	498	58	/	/	SYM
10_1101-2020_03_27_012757	498	59	funder	funder	NN
10_1101-2020_03_27_012757	498	60	,	,	,
10_1101-2020_03_27_012757	498	61	who	who	WP
10_1101-2020_03_27_012757	498	62	has	have	VBZ
10_1101-2020_03_27_012757	498	63	granted	grant	VBN
10_1101-2020_03_27_012757	498	64	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	498	65	a	a	DT
10_1101-2020_03_27_012757	498	66	license	license	NN
10_1101-2020_03_27_012757	498	67	to	to	TO
10_1101-2020_03_27_012757	498	68	display	display	VB
10_1101-2020_03_27_012757	498	69	the	the	DT
10_1101-2020_03_27_012757	498	70	preprint	preprint	NN
10_1101-2020_03_27_012757	498	71	in	in	IN
10_1101-2020_03_27_012757	498	72	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	498	73	.	.	.
10_1101-2020_03_27_012757	499	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	499	2	is	be	VBZ
10_1101-2020_03_27_012757	499	3	made	make	VBN
10_1101-2020_03_27_012757	499	4	The	the	DT
10_1101-2020_03_27_012757	499	5	copyright	copyright	NN
10_1101-2020_03_27_012757	499	6	holder	holder	NN
10_1101-2020_03_27_012757	499	7	for	for	IN
10_1101-2020_03_27_012757	499	8	this	this	DT
10_1101-2020_03_27_012757	499	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	499	10	version	version	NN
10_1101-2020_03_27_012757	499	11	posted	post	VBD
10_1101-2020_03_27_012757	499	12	January	January	NNP
10_1101-2020_03_27_012757	499	13	9	9	CD
10_1101-2020_03_27_012757	499	14	,	,	,
10_1101-2020_03_27_012757	499	15	2021	2021	CD
10_1101-2020_03_27_012757	499	16	.	.	.
10_1101-2020_03_27_012757	499	17	;	;	:
10_1101-2020_03_27_012757	499	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	499	19	:	:	:
10_1101-2020_03_27_012757	499	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	499	21	preprint	preprint	NN
10_1101-2020_03_27_012757	499	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	499	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	499	24	36	36	CD
10_1101-2020_03_27_012757	499	25	classifier	classifier	NN
10_1101-2020_03_27_012757	499	26	using	use	VBG
10_1101-2020_03_27_012757	499	27	training	training	NN
10_1101-2020_03_27_012757	499	28	data	datum	NNS
10_1101-2020_03_27_012757	499	29	,	,	,
10_1101-2020_03_27_012757	499	30	classification	classification	NN
10_1101-2020_03_27_012757	499	31	of	of	IN
10_1101-2020_03_27_012757	499	32	held	hold	VBN
10_1101-2020_03_27_012757	499	33	-	-	HYPH
10_1101-2020_03_27_012757	499	34	out	out	RP
10_1101-2020_03_27_012757	499	35	data	data	NN
10_1101-2020_03_27_012757	499	36	,	,	,
10_1101-2020_03_27_012757	499	37	and	and	CC
10_1101-2020_03_27_012757	499	38	calculation	calculation	NN
10_1101-2020_03_27_012757	499	39	of	of	IN
10_1101-2020_03_27_012757	499	40	recall	recall	NN
10_1101-2020_03_27_012757	499	41	and	and	CC
10_1101-2020_03_27_012757	499	42	930	930	CD
10_1101-2020_03_27_012757	499	43	precision	precision	NN
10_1101-2020_03_27_012757	499	44	.	.	.
10_1101-2020_03_27_012757	500	1	931	931	CD
10_1101-2020_03_27_012757	500	2	932	932	CD
10_1101-2020_03_27_012757	500	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	500	4	Figure	figure	NN
10_1101-2020_03_27_012757	500	5	2	2	CD
10_1101-2020_03_27_012757	500	6	Further	further	JJ
10_1101-2020_03_27_012757	500	7	validation	validation	NN
10_1101-2020_03_27_012757	500	8	of	of	IN
10_1101-2020_03_27_012757	500	9	CCN	ccn	NN
10_1101-2020_03_27_012757	500	10	and	and	CC
10_1101-2020_03_27_012757	500	11	classification	classification	NN
10_1101-2020_03_27_012757	500	12	results	result	NNS
10_1101-2020_03_27_012757	500	13	.	.	.
10_1101-2020_03_27_012757	501	1	To	to	TO
10_1101-2020_03_27_012757	501	2	validate	validate	VB
10_1101-2020_03_27_012757	501	3	the	the	DT
10_1101-2020_03_27_012757	501	4	933	933	CD
10_1101-2020_03_27_012757	501	5	cross	cross	JJ
10_1101-2020_03_27_012757	501	6	-	-	JJ
10_1101-2020_03_27_012757	501	7	platform	platform	JJ
10_1101-2020_03_27_012757	501	8	classification	classification	NN
10_1101-2020_03_27_012757	501	9	performance	performance	NN
10_1101-2020_03_27_012757	501	10	of	of	IN
10_1101-2020_03_27_012757	501	11	CCN	CCN	NNP
10_1101-2020_03_27_012757	501	12	,	,	,
10_1101-2020_03_27_012757	501	13	a	a	DT
10_1101-2020_03_27_012757	501	14	new	new	JJ
10_1101-2020_03_27_012757	501	15	classifier	classifier	NN
10_1101-2020_03_27_012757	501	16	specifically	specifically	RB
10_1101-2020_03_27_012757	501	17	trained	train	VBN
10_1101-2020_03_27_012757	501	18	to	to	TO
10_1101-2020_03_27_012757	501	19	classify	classify	VB
10_1101-2020_03_27_012757	501	20	934	934	CD
10_1101-2020_03_27_012757	501	21	microarray	microarray	JJ
10_1101-2020_03_27_012757	501	22	data	datum	NNS
10_1101-2020_03_27_012757	501	23	was	be	VBD
10_1101-2020_03_27_012757	501	24	trained	train	VBN
10_1101-2020_03_27_012757	501	25	using	use	VBG
10_1101-2020_03_27_012757	501	26	RNA	RNA	NNP
10_1101-2020_03_27_012757	501	27	-	-	HYPH
10_1101-2020_03_27_012757	501	28	seq	seq	NN
10_1101-2020_03_27_012757	501	29	data	datum	NNS
10_1101-2020_03_27_012757	501	30	from	from	IN
10_1101-2020_03_27_012757	501	31	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	501	32	as	as	IN
10_1101-2020_03_27_012757	501	33	training	training	NN
10_1101-2020_03_27_012757	501	34	data	datum	NNS
10_1101-2020_03_27_012757	501	35	and	and	CC
10_1101-2020_03_27_012757	501	36	intersecting	intersect	VBG
10_1101-2020_03_27_012757	501	37	935	935	CD
10_1101-2020_03_27_012757	501	38	genes	gene	NNS
10_1101-2020_03_27_012757	501	39	between	between	IN
10_1101-2020_03_27_012757	501	40	RNA	RNA	NNP
10_1101-2020_03_27_012757	501	41	-	-	HYPH
10_1101-2020_03_27_012757	501	42	seq	seq	NN
10_1101-2020_03_27_012757	501	43	data	datum	NNS
10_1101-2020_03_27_012757	501	44	and	and	CC
10_1101-2020_03_27_012757	501	45	microarray	microarray	JJ
10_1101-2020_03_27_012757	501	46	data	datum	NNS
10_1101-2020_03_27_012757	501	47	.	.	.
10_1101-2020_03_27_012757	502	1	(	(	-LRB-
10_1101-2020_03_27_012757	502	2	A	a	NN
10_1101-2020_03_27_012757	502	3	)	)	-RRB-
10_1101-2020_03_27_012757	502	4	AUPRC	AUPRC	NNS
10_1101-2020_03_27_012757	502	5	of	of	IN
10_1101-2020_03_27_012757	502	6	CCN	CCN	NNP
10_1101-2020_03_27_012757	502	7	classifier	classifier	NN
10_1101-2020_03_27_012757	502	8	when	when	WRB
10_1101-2020_03_27_012757	502	9	applied	apply	VBD
10_1101-2020_03_27_012757	502	10	936	936	CD
10_1101-2020_03_27_012757	502	11	to	to	IN
10_1101-2020_03_27_012757	502	12	tumor	tumor	NN
10_1101-2020_03_27_012757	502	13	profiles	profile	NNS
10_1101-2020_03_27_012757	502	14	assayed	assay	VBN
10_1101-2020_03_27_012757	502	15	on	on	IN
10_1101-2020_03_27_012757	502	16	microarrays	microarray	NNS
10_1101-2020_03_27_012757	502	17	.	.	.
10_1101-2020_03_27_012757	503	1	(	(	-LRB-
10_1101-2020_03_27_012757	503	2	B	b	NN
10_1101-2020_03_27_012757	503	3	)	)	-RRB-
10_1101-2020_03_27_012757	503	4	Classification	classification	NN
10_1101-2020_03_27_012757	503	5	heatmap	heatmap	NN
10_1101-2020_03_27_012757	503	6	of	of	IN
10_1101-2020_03_27_012757	503	7	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	503	8	using	use	VBG
10_1101-2020_03_27_012757	503	9	microarray	microarray	JJ
10_1101-2020_03_27_012757	503	10	937	937	CD
10_1101-2020_03_27_012757	503	11	expression	expression	NN
10_1101-2020_03_27_012757	503	12	data	datum	NNS
10_1101-2020_03_27_012757	503	13	.	.	.
10_1101-2020_03_27_012757	504	1	(	(	-LRB-
10_1101-2020_03_27_012757	504	2	C	C	NNP
10_1101-2020_03_27_012757	504	3	)	)	-RRB-
10_1101-2020_03_27_012757	504	4	Pearson	Pearson	NNP
10_1101-2020_03_27_012757	504	5	correlation	correlation	NN
10_1101-2020_03_27_012757	504	6	between	between	IN
10_1101-2020_03_27_012757	504	7	CCN	CCN	NNP
10_1101-2020_03_27_012757	504	8	scores	score	NNS
10_1101-2020_03_27_012757	504	9	of	of	IN
10_1101-2020_03_27_012757	504	10	CCLE	ccle	JJ
10_1101-2020_03_27_012757	504	11	lines	line	NNS
10_1101-2020_03_27_012757	504	12	generated	generate	VBN
10_1101-2020_03_27_012757	504	13	from	from	IN
10_1101-2020_03_27_012757	504	14	938	938	CD
10_1101-2020_03_27_012757	504	15	RNA	RNA	NNP
10_1101-2020_03_27_012757	504	16	-	-	HYPH
10_1101-2020_03_27_012757	504	17	seq	seq	NN
10_1101-2020_03_27_012757	504	18	data	datum	NNS
10_1101-2020_03_27_012757	504	19	and	and	CC
10_1101-2020_03_27_012757	504	20	microarray	microarray	JJ
10_1101-2020_03_27_012757	504	21	data	datum	NNS
10_1101-2020_03_27_012757	504	22	.	.	.
10_1101-2020_03_27_012757	505	1	(	(	-LRB-
10_1101-2020_03_27_012757	505	2	D	d	NN
10_1101-2020_03_27_012757	505	3	)	)	-RRB-
10_1101-2020_03_27_012757	505	4	Comparison	comparison	NN
10_1101-2020_03_27_012757	505	5	between	between	IN
10_1101-2020_03_27_012757	505	6	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	505	7	’	’	POS
10_1101-2020_03_27_012757	505	8	CCN	CCN	NNP
10_1101-2020_03_27_012757	505	9	scores	score	NNS
10_1101-2020_03_27_012757	505	10	and	and	CC
10_1101-2020_03_27_012757	505	11	the	the	DT
10_1101-2020_03_27_012757	505	12	939	939	CD
10_1101-2020_03_27_012757	505	13	similarity	similarity	NN
10_1101-2020_03_27_012757	505	14	metric	metric	NN
10_1101-2020_03_27_012757	505	15	from	from	IN
10_1101-2020_03_27_012757	505	16	Yu	Yu	NNP
10_1101-2020_03_27_012757	505	17	et	et	NNP
10_1101-2020_03_27_012757	505	18	al15	al15	NNP
10_1101-2020_03_27_012757	505	19	,	,	,
10_1101-2020_03_27_012757	505	20	median	median	JJ
10_1101-2020_03_27_012757	505	21	correlations	correlation	NNS
10_1101-2020_03_27_012757	505	22	of	of	IN
10_1101-2020_03_27_012757	505	23	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	505	24	profiles	profile	NNS
10_1101-2020_03_27_012757	505	25	between	between	IN
10_1101-2020_03_27_012757	505	26	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	505	27	940	940	CD
10_1101-2020_03_27_012757	505	28	and	and	CC
10_1101-2020_03_27_012757	505	29	TCGA	tcga	NN
10_1101-2020_03_27_012757	505	30	tumors	tumor	NNS
10_1101-2020_03_27_012757	505	31	from	from	IN
10_1101-2020_03_27_012757	505	32	CCLs	CCLs	NNP
10_1101-2020_03_27_012757	505	33	’	’	POS
10_1101-2020_03_27_012757	505	34	labelled	label	VBN
10_1101-2020_03_27_012757	505	35	cancer	cancer	NN
10_1101-2020_03_27_012757	505	36	category	category	NN
10_1101-2020_03_27_012757	505	37	.	.	.
10_1101-2020_03_27_012757	506	1	(	(	-LRB-
10_1101-2020_03_27_012757	506	2	E	e	NN
10_1101-2020_03_27_012757	506	3	)	)	-RRB-
10_1101-2020_03_27_012757	506	4	Comparison	comparison	NN
10_1101-2020_03_27_012757	506	5	of	of	IN
10_1101-2020_03_27_012757	506	6	mean	mean	JJ
10_1101-2020_03_27_012757	506	7	tumor	tumor	NN
10_1101-2020_03_27_012757	506	8	purity	purity	NN
10_1101-2020_03_27_012757	506	9	941	941	CD
10_1101-2020_03_27_012757	506	10	of	of	IN
10_1101-2020_03_27_012757	506	11	training	train	VBG
10_1101-2020_03_27_012757	506	12	data	datum	NNS
10_1101-2020_03_27_012757	506	13	and	and	CC
10_1101-2020_03_27_012757	506	14	mean	mean	VB
10_1101-2020_03_27_012757	506	15	CCN	CCN	NNP
10_1101-2020_03_27_012757	506	16	scores	score	NNS
10_1101-2020_03_27_012757	506	17	of	of	IN
10_1101-2020_03_27_012757	506	18	CCLs	ccl	NNS
10_1101-2020_03_27_012757	506	19	for	for	IN
10_1101-2020_03_27_012757	506	20	each	each	DT
10_1101-2020_03_27_012757	506	21	cancer	cancer	NN
10_1101-2020_03_27_012757	506	22	category	category	NN
10_1101-2020_03_27_012757	506	23	.	.	.
10_1101-2020_03_27_012757	507	1	942	942	CD
10_1101-2020_03_27_012757	507	2	943	943	CD
10_1101-2020_03_27_012757	507	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	507	4	Figure	figure	NN
10_1101-2020_03_27_012757	507	5	3	3	CD
10_1101-2020_03_27_012757	507	6	Single	single	JJ
10_1101-2020_03_27_012757	507	7	-	-	HYPH
10_1101-2020_03_27_012757	507	8	cell	cell	NN
10_1101-2020_03_27_012757	507	9	classification	classification	NN
10_1101-2020_03_27_012757	507	10	of	of	IN
10_1101-2020_03_27_012757	507	11	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	507	12	and	and	CC
10_1101-2020_03_27_012757	507	13	GBM	GBM	NNP
10_1101-2020_03_27_012757	507	14	cell	cell	NN
10_1101-2020_03_27_012757	507	15	lines	line	NNS
10_1101-2020_03_27_012757	507	16	.	.	.
10_1101-2020_03_27_012757	508	1	(	(	-LRB-
10_1101-2020_03_27_012757	508	2	A	a	NN
10_1101-2020_03_27_012757	508	3	)	)	-RRB-
10_1101-2020_03_27_012757	508	4	AUPRC	AUPRC	NNS
10_1101-2020_03_27_012757	508	5	of	of	IN
10_1101-2020_03_27_012757	508	6	944	944	CD
10_1101-2020_03_27_012757	508	7	the	the	DT
10_1101-2020_03_27_012757	508	8	single	single	JJ
10_1101-2020_03_27_012757	508	9	-	-	HYPH
10_1101-2020_03_27_012757	508	10	cell	cell	NN
10_1101-2020_03_27_012757	508	11	classifier	classifier	NN
10_1101-2020_03_27_012757	508	12	when	when	WRB
10_1101-2020_03_27_012757	508	13	applied	apply	VBN
10_1101-2020_03_27_012757	508	14	to	to	IN
10_1101-2020_03_27_012757	508	15	scRNA	scRNA	NNP
10_1101-2020_03_27_012757	508	16	-	-	HYPH
10_1101-2020_03_27_012757	508	17	seq	seq	NN
10_1101-2020_03_27_012757	508	18	held	hold	VBN
10_1101-2020_03_27_012757	508	19	-	-	HYPH
10_1101-2020_03_27_012757	508	20	out	out	RP
10_1101-2020_03_27_012757	508	21	data	datum	NNS
10_1101-2020_03_27_012757	508	22	.	.	.
10_1101-2020_03_27_012757	509	1	(	(	-LRB-
10_1101-2020_03_27_012757	509	2	B	b	NN
10_1101-2020_03_27_012757	509	3	)	)	-RRB-
10_1101-2020_03_27_012757	509	4	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	509	5	of	of	IN
10_1101-2020_03_27_012757	509	6	the	the	DT
10_1101-2020_03_27_012757	509	7	scRNA-945	scrna-945	NN
10_1101-2020_03_27_012757	509	8	seq	seq	NN
10_1101-2020_03_27_012757	509	9	classifier	classifier	NN
10_1101-2020_03_27_012757	509	10	when	when	WRB
10_1101-2020_03_27_012757	509	11	applied	apply	VBN
10_1101-2020_03_27_012757	509	12	to	to	IN
10_1101-2020_03_27_012757	509	13	purified	purify	VBN
10_1101-2020_03_27_012757	509	14	bulk	bulk	NNP
10_1101-2020_03_27_012757	509	15	RNA	RNA	NNP
10_1101-2020_03_27_012757	509	16	samples	sample	NNS
10_1101-2020_03_27_012757	509	17	.	.	.
10_1101-2020_03_27_012757	510	1	(	(	-LRB-
10_1101-2020_03_27_012757	510	2	C	C	NNP
10_1101-2020_03_27_012757	510	3	)	)	-RRB-
10_1101-2020_03_27_012757	510	4	Single	single	JJ
10_1101-2020_03_27_012757	510	5	-	-	HYPH
10_1101-2020_03_27_012757	510	6	cell	cell	NN
10_1101-2020_03_27_012757	510	7	classification	classification	NN
10_1101-2020_03_27_012757	510	8	of	of	IN
10_1101-2020_03_27_012757	510	9	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	510	10	946	946	CD
10_1101-2020_03_27_012757	510	11	CCLs	ccl	NNS
10_1101-2020_03_27_012757	510	12	.	.	.
10_1101-2020_03_27_012757	511	1	Red	red	JJ
10_1101-2020_03_27_012757	511	2	bar	bar	NN
10_1101-2020_03_27_012757	511	3	-	-	HYPH
10_1101-2020_03_27_012757	511	4	plot	plot	NN
10_1101-2020_03_27_012757	511	5	(	(	-LRB-
10_1101-2020_03_27_012757	511	6	top	top	NN
10_1101-2020_03_27_012757	511	7	)	)	-RRB-
10_1101-2020_03_27_012757	511	8	represents	represent	VBZ
10_1101-2020_03_27_012757	511	9	general	general	JJ
10_1101-2020_03_27_012757	511	10	CCN	CCN	NNP
10_1101-2020_03_27_012757	511	11	scores	score	NNS
10_1101-2020_03_27_012757	511	12	in	in	IN
10_1101-2020_03_27_012757	511	13	SARC	SARC	NNP
10_1101-2020_03_27_012757	511	14	and	and	CC
10_1101-2020_03_27_012757	511	15	blue	blue	JJ
10_1101-2020_03_27_012757	511	16	bar	bar	NN
10_1101-2020_03_27_012757	511	17	-	-	HYPH
10_1101-2020_03_27_012757	511	18	plot	plot	NN
10_1101-2020_03_27_012757	511	19	(	(	-LRB-
10_1101-2020_03_27_012757	511	20	bottom	bottom	NN
10_1101-2020_03_27_012757	511	21	)	)	-RRB-
10_1101-2020_03_27_012757	511	22	947	947	CD
10_1101-2020_03_27_012757	511	23	represents	represent	VBZ
10_1101-2020_03_27_012757	511	24	general	general	JJ
10_1101-2020_03_27_012757	511	25	CCN	CCN	NNP
10_1101-2020_03_27_012757	511	26	scores	score	NNS
10_1101-2020_03_27_012757	511	27	in	in	IN
10_1101-2020_03_27_012757	511	28	SKCM	SKCM	NNP
10_1101-2020_03_27_012757	511	29	.	.	.
10_1101-2020_03_27_012757	512	1	(	(	-LRB-
10_1101-2020_03_27_012757	512	2	D	d	NN
10_1101-2020_03_27_012757	512	3	)	)	-RRB-
10_1101-2020_03_27_012757	512	4	Single	single	JJ
10_1101-2020_03_27_012757	512	5	-	-	HYPH
10_1101-2020_03_27_012757	512	6	cell	cell	NN
10_1101-2020_03_27_012757	512	7	classification	classification	NN
10_1101-2020_03_27_012757	512	8	of	of	IN
10_1101-2020_03_27_012757	512	9	GBM	GBM	NNP
10_1101-2020_03_27_012757	512	10	CCLs	CCLs	NNPS
10_1101-2020_03_27_012757	512	11	.	.	.
10_1101-2020_03_27_012757	513	1	Red	red	JJ
10_1101-2020_03_27_012757	513	2	bar-948	bar-948	NNP
10_1101-2020_03_27_012757	513	3	plot	plot	NN
10_1101-2020_03_27_012757	513	4	(	(	-LRB-
10_1101-2020_03_27_012757	513	5	top	top	NN
10_1101-2020_03_27_012757	513	6	)	)	-RRB-
10_1101-2020_03_27_012757	513	7	represents	represent	VBZ
10_1101-2020_03_27_012757	513	8	general	general	JJ
10_1101-2020_03_27_012757	513	9	CCN	CCN	NNP
10_1101-2020_03_27_012757	513	10	scores	score	NNS
10_1101-2020_03_27_012757	513	11	in	in	IN
10_1101-2020_03_27_012757	513	12	SARC	SARC	NNP
10_1101-2020_03_27_012757	513	13	and	and	CC
10_1101-2020_03_27_012757	513	14	yellow	yellow	JJ
10_1101-2020_03_27_012757	513	15	bar	bar	NN
10_1101-2020_03_27_012757	513	16	-	-	HYPH
10_1101-2020_03_27_012757	513	17	plot	plot	NN
10_1101-2020_03_27_012757	513	18	(	(	-LRB-
10_1101-2020_03_27_012757	513	19	bottom	bottom	NN
10_1101-2020_03_27_012757	513	20	)	)	-RRB-
10_1101-2020_03_27_012757	513	21	represents	represent	VBZ
10_1101-2020_03_27_012757	513	22	949	949	CD
10_1101-2020_03_27_012757	513	23	general	general	JJ
10_1101-2020_03_27_012757	513	24	CCN	CCN	NNP
10_1101-2020_03_27_012757	513	25	scores	score	NNS
10_1101-2020_03_27_012757	513	26	in	in	IN
10_1101-2020_03_27_012757	513	27	GBM	GBM	NNP
10_1101-2020_03_27_012757	513	28	.	.	.
10_1101-2020_03_27_012757	514	1	950	950	CD
10_1101-2020_03_27_012757	514	2	951	951	CD
10_1101-2020_03_27_012757	514	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	514	4	Figure	figure	NN
10_1101-2020_03_27_012757	514	5	4	4	CD
10_1101-2020_03_27_012757	514	6	Correlation	correlation	NN
10_1101-2020_03_27_012757	514	7	between	between	IN
10_1101-2020_03_27_012757	514	8	cancer	cancer	NN
10_1101-2020_03_27_012757	514	9	type	type	NN
10_1101-2020_03_27_012757	514	10	specific	specific	JJ
10_1101-2020_03_27_012757	514	11	network	network	NN
10_1101-2020_03_27_012757	514	12	GRN	GRN	NNP
10_1101-2020_03_27_012757	514	13	status	status	NN
10_1101-2020_03_27_012757	514	14	and	and	CC
10_1101-2020_03_27_012757	514	15	952	952	CD
10_1101-2020_03_27_012757	514	16	general	general	JJ
10_1101-2020_03_27_012757	514	17	CCN	CCN	NNP
10_1101-2020_03_27_012757	514	18	scores	score	NNS
10_1101-2020_03_27_012757	514	19	.	.	.
10_1101-2020_03_27_012757	515	1	953	953	CD
10_1101-2020_03_27_012757	515	2	954	954	CD
10_1101-2020_03_27_012757	515	3	955	955	CD
10_1101-2020_03_27_012757	515	4	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	515	5	Figure	figure	NN
10_1101-2020_03_27_012757	515	6	5	5	CD
10_1101-2020_03_27_012757	515	7	Proportion	proportion	NN
10_1101-2020_03_27_012757	515	8	of	of	IN
10_1101-2020_03_27_012757	515	9	cancer	cancer	NN
10_1101-2020_03_27_012757	515	10	subtypes	subtype	NNS
10_1101-2020_03_27_012757	515	11	in	in	IN
10_1101-2020_03_27_012757	515	12	different	different	JJ
10_1101-2020_03_27_012757	515	13	cancer	cancer	NN
10_1101-2020_03_27_012757	515	14	models	model	NNS
10_1101-2020_03_27_012757	515	15	and	and	CC
10_1101-2020_03_27_012757	515	16	TCGA	tcga	NN
10_1101-2020_03_27_012757	515	17	956	956	CD
10_1101-2020_03_27_012757	515	18	tumor	tumor	NN
10_1101-2020_03_27_012757	515	19	data	datum	NNS
10_1101-2020_03_27_012757	515	20	across	across	IN
10_1101-2020_03_27_012757	515	21	11	11	CD
10_1101-2020_03_27_012757	515	22	general	general	JJ
10_1101-2020_03_27_012757	515	23	cancer	cancer	NN
10_1101-2020_03_27_012757	515	24	types	type	NNS
10_1101-2020_03_27_012757	515	25	.	.	.
10_1101-2020_03_27_012757	516	1	957	957	CD
10_1101-2020_03_27_012757	516	2	958	958	CD
10_1101-2020_03_27_012757	516	3	.CC	.CC	:
10_1101-2020_03_27_012757	516	4	-	-	HYPH
10_1101-2020_03_27_012757	516	5	BY	by	IN
10_1101-2020_03_27_012757	516	6	-	-	HYPH
10_1101-2020_03_27_012757	516	7	NC	NC	NNP
10_1101-2020_03_27_012757	516	8	-	-	HYPH
10_1101-2020_03_27_012757	516	9	ND	ND	NNP
10_1101-2020_03_27_012757	516	10	4.0	4.0	CD
10_1101-2020_03_27_012757	516	11	International	International	NNP
10_1101-2020_03_27_012757	516	12	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	516	13	under	under	IN
10_1101-2020_03_27_012757	516	14	a	a	DT
10_1101-2020_03_27_012757	516	15	(	(	-LRB-
10_1101-2020_03_27_012757	516	16	which	which	WDT
10_1101-2020_03_27_012757	516	17	was	be	VBD
10_1101-2020_03_27_012757	516	18	not	not	RB
10_1101-2020_03_27_012757	516	19	certified	certify	VBN
10_1101-2020_03_27_012757	516	20	by	by	IN
10_1101-2020_03_27_012757	516	21	peer	peer	NN
10_1101-2020_03_27_012757	516	22	review	review	NN
10_1101-2020_03_27_012757	516	23	)	)	-RRB-
10_1101-2020_03_27_012757	516	24	is	be	VBZ
10_1101-2020_03_27_012757	516	25	the	the	DT
10_1101-2020_03_27_012757	516	26	author	author	NN
10_1101-2020_03_27_012757	516	27	/	/	SYM
10_1101-2020_03_27_012757	516	28	funder	funder	NN
10_1101-2020_03_27_012757	516	29	,	,	,
10_1101-2020_03_27_012757	516	30	who	who	WP
10_1101-2020_03_27_012757	516	31	has	have	VBZ
10_1101-2020_03_27_012757	516	32	granted	grant	VBN
10_1101-2020_03_27_012757	516	33	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	516	34	a	a	DT
10_1101-2020_03_27_012757	516	35	license	license	NN
10_1101-2020_03_27_012757	516	36	to	to	TO
10_1101-2020_03_27_012757	516	37	display	display	VB
10_1101-2020_03_27_012757	516	38	the	the	DT
10_1101-2020_03_27_012757	516	39	preprint	preprint	NN
10_1101-2020_03_27_012757	516	40	in	in	IN
10_1101-2020_03_27_012757	516	41	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	516	42	.	.	.
10_1101-2020_03_27_012757	517	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	517	2	is	be	VBZ
10_1101-2020_03_27_012757	517	3	made	make	VBN
10_1101-2020_03_27_012757	517	4	The	the	DT
10_1101-2020_03_27_012757	517	5	copyright	copyright	NN
10_1101-2020_03_27_012757	517	6	holder	holder	NN
10_1101-2020_03_27_012757	517	7	for	for	IN
10_1101-2020_03_27_012757	517	8	this	this	DT
10_1101-2020_03_27_012757	517	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	517	10	version	version	NN
10_1101-2020_03_27_012757	517	11	posted	post	VBD
10_1101-2020_03_27_012757	517	12	January	January	NNP
10_1101-2020_03_27_012757	517	13	9	9	CD
10_1101-2020_03_27_012757	517	14	,	,	,
10_1101-2020_03_27_012757	517	15	2021	2021	CD
10_1101-2020_03_27_012757	517	16	.	.	.
10_1101-2020_03_27_012757	517	17	;	;	:
10_1101-2020_03_27_012757	517	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	517	19	:	:	:
10_1101-2020_03_27_012757	517	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	517	21	preprint	preprint	NN
10_1101-2020_03_27_012757	517	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	517	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	517	24	37	37	CD
10_1101-2020_03_27_012757	517	25	959	959	CD
10_1101-2020_03_27_012757	517	26	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	517	27	Table	table	NN
10_1101-2020_03_27_012757	517	28	1	1	CD
10_1101-2020_03_27_012757	517	29	General	general	JJ
10_1101-2020_03_27_012757	517	30	classification	classification	NN
10_1101-2020_03_27_012757	517	31	profiles	profile	NNS
10_1101-2020_03_27_012757	517	32	of	of	IN
10_1101-2020_03_27_012757	517	33	CCLs	ccl	NNS
10_1101-2020_03_27_012757	517	34	.	.	.
10_1101-2020_03_27_012757	518	1	960	960	CD
10_1101-2020_03_27_012757	518	2	961	961	CD
10_1101-2020_03_27_012757	518	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	518	4	Table	table	NN
10_1101-2020_03_27_012757	518	5	2	2	NNP
10_1101-2020_03_27_012757	518	6	Subtype	Subtype	NNP
10_1101-2020_03_27_012757	518	7	classification	classification	NN
10_1101-2020_03_27_012757	518	8	profiles	profile	NNS
10_1101-2020_03_27_012757	518	9	of	of	IN
10_1101-2020_03_27_012757	518	10	CCLs	ccl	NNS
10_1101-2020_03_27_012757	518	11	.	.	.
10_1101-2020_03_27_012757	519	1	962	962	CD
10_1101-2020_03_27_012757	519	2	963	963	CD
10_1101-2020_03_27_012757	519	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	519	4	Table	table	NN
10_1101-2020_03_27_012757	519	5	3	3	CD
10_1101-2020_03_27_012757	519	6	General	general	JJ
10_1101-2020_03_27_012757	519	7	classification	classification	NN
10_1101-2020_03_27_012757	519	8	profiles	profile	NNS
10_1101-2020_03_27_012757	519	9	of	of	IN
10_1101-2020_03_27_012757	519	10	PDXs	pdx	NNS
10_1101-2020_03_27_012757	519	11	.	.	.
10_1101-2020_03_27_012757	520	1	964	964	CD
10_1101-2020_03_27_012757	520	2	965	965	CD
10_1101-2020_03_27_012757	520	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	520	4	Table	table	NN
10_1101-2020_03_27_012757	520	5	4	4	CD
10_1101-2020_03_27_012757	520	6	Subtype	Subtype	NNP
10_1101-2020_03_27_012757	520	7	classification	classification	NN
10_1101-2020_03_27_012757	520	8	profiles	profile	NNS
10_1101-2020_03_27_012757	520	9	of	of	IN
10_1101-2020_03_27_012757	520	10	PDXs	pdx	NNS
10_1101-2020_03_27_012757	520	11	.	.	.
10_1101-2020_03_27_012757	521	1	966	966	CD
10_1101-2020_03_27_012757	521	2	967	967	CD
10_1101-2020_03_27_012757	521	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	521	4	Table	table	NN
10_1101-2020_03_27_012757	521	5	5	5	CD
10_1101-2020_03_27_012757	521	6	General	general	JJ
10_1101-2020_03_27_012757	521	7	classification	classification	NN
10_1101-2020_03_27_012757	521	8	profiles	profile	NNS
10_1101-2020_03_27_012757	521	9	of	of	IN
10_1101-2020_03_27_012757	521	10	GEMMs	GEMMs	NNP
10_1101-2020_03_27_012757	521	11	968	968	CD
10_1101-2020_03_27_012757	521	12	969	969	CD
10_1101-2020_03_27_012757	521	13	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	521	14	Table	table	NN
10_1101-2020_03_27_012757	521	15	6	6	CD
10_1101-2020_03_27_012757	521	16	Subtype	Subtype	NNP
10_1101-2020_03_27_012757	521	17	classification	classification	NN
10_1101-2020_03_27_012757	521	18	profiles	profile	NNS
10_1101-2020_03_27_012757	521	19	of	of	IN
10_1101-2020_03_27_012757	521	20	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	521	21	.	.	.
10_1101-2020_03_27_012757	522	1	970	970	CD
10_1101-2020_03_27_012757	522	2	971	971	CD
10_1101-2020_03_27_012757	522	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	522	4	Table	table	NN
10_1101-2020_03_27_012757	522	5	7	7	CD
10_1101-2020_03_27_012757	522	6	General	General	NNP
10_1101-2020_03_27_012757	522	7	classification	classification	NN
10_1101-2020_03_27_012757	522	8	profiles	profile	NNS
10_1101-2020_03_27_012757	522	9	of	of	IN
10_1101-2020_03_27_012757	522	10	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	522	11	.	.	.
10_1101-2020_03_27_012757	523	1	972	972	CD
10_1101-2020_03_27_012757	523	2	973	973	CD
10_1101-2020_03_27_012757	523	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	523	4	Table	Table	NNP
10_1101-2020_03_27_012757	523	5	8	8	CD
10_1101-2020_03_27_012757	523	6	Subtype	Subtype	NNP
10_1101-2020_03_27_012757	523	7	classification	classification	NN
10_1101-2020_03_27_012757	523	8	profiles	profile	NNS
10_1101-2020_03_27_012757	523	9	of	of	IN
10_1101-2020_03_27_012757	523	10	tumoroids	tumoroid	NNS
10_1101-2020_03_27_012757	523	11	.	.	.
10_1101-2020_03_27_012757	524	1	974	974	CD
10_1101-2020_03_27_012757	524	2	975	975	CD
10_1101-2020_03_27_012757	524	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	524	4	Table	table	NN
10_1101-2020_03_27_012757	524	5	9	9	CD
10_1101-2020_03_27_012757	524	6	Specific	specific	JJ
10_1101-2020_03_27_012757	524	7	parameters	parameter	NNS
10_1101-2020_03_27_012757	524	8	used	use	VBN
10_1101-2020_03_27_012757	524	9	for	for	IN
10_1101-2020_03_27_012757	524	10	training	training	NN
10_1101-2020_03_27_012757	524	11	of	of	IN
10_1101-2020_03_27_012757	524	12	all	all	DT
10_1101-2020_03_27_012757	524	13	classifiers	classifier	NNS
10_1101-2020_03_27_012757	524	14	.	.	.
10_1101-2020_03_27_012757	525	1	976	976	CD
10_1101-2020_03_27_012757	525	2	977	977	CD
10_1101-2020_03_27_012757	525	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	525	4	Table	table	NN
10_1101-2020_03_27_012757	525	5	10	10	CD
10_1101-2020_03_27_012757	525	6	Gene	Gene	NNP
10_1101-2020_03_27_012757	525	7	-	-	HYPH
10_1101-2020_03_27_012757	525	8	pairs	pairs	NNP
10_1101-2020_03_27_012757	525	9	selected	select	VBN
10_1101-2020_03_27_012757	525	10	for	for	IN
10_1101-2020_03_27_012757	525	11	final	final	JJ
10_1101-2020_03_27_012757	525	12	training	training	NN
10_1101-2020_03_27_012757	525	13	of	of	IN
10_1101-2020_03_27_012757	525	14	CCN	CCN	NNP
10_1101-2020_03_27_012757	525	15	general	general	JJ
10_1101-2020_03_27_012757	525	16	,	,	,
10_1101-2020_03_27_012757	525	17	subtype	subtype	NN
10_1101-2020_03_27_012757	525	18	978	978	CD
10_1101-2020_03_27_012757	525	19	classifiers	classifier	NNS
10_1101-2020_03_27_012757	525	20	and	and	CC
10_1101-2020_03_27_012757	525	21	single	single	JJ
10_1101-2020_03_27_012757	525	22	-	-	HYPH
10_1101-2020_03_27_012757	525	23	cell	cell	NN
10_1101-2020_03_27_012757	525	24	classifier	classifier	NN
10_1101-2020_03_27_012757	525	25	.	.	.
10_1101-2020_03_27_012757	526	1	979	979	CD
10_1101-2020_03_27_012757	526	2	980	980	CD
10_1101-2020_03_27_012757	526	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	526	4	Table	table	NN
10_1101-2020_03_27_012757	526	5	11	11	CD
10_1101-2020_03_27_012757	526	6	Decision	Decision	NNP
10_1101-2020_03_27_012757	526	7	thresholds	threshold	NNS
10_1101-2020_03_27_012757	526	8	and	and	CC
10_1101-2020_03_27_012757	526	9	the	the	DT
10_1101-2020_03_27_012757	526	10	corresponding	corresponding	JJ
10_1101-2020_03_27_012757	526	11	precision	precision	NN
10_1101-2020_03_27_012757	526	12	and	and	CC
10_1101-2020_03_27_012757	526	13	recall	recall	NN
10_1101-2020_03_27_012757	526	14	for	for	IN
10_1101-2020_03_27_012757	526	15	981	981	CD
10_1101-2020_03_27_012757	526	16	the	the	DT
10_1101-2020_03_27_012757	526	17	general	general	JJ
10_1101-2020_03_27_012757	526	18	classifier	classifier	NN
10_1101-2020_03_27_012757	526	19	and	and	CC
10_1101-2020_03_27_012757	526	20	subtype	subtype	NN
10_1101-2020_03_27_012757	526	21	classifier	classifier	NN
10_1101-2020_03_27_012757	526	22	.	.	.
10_1101-2020_03_27_012757	527	1	982	982	CD
10_1101-2020_03_27_012757	527	2	983	983	CD
10_1101-2020_03_27_012757	527	3	Supplementary	Supplementary	NNP
10_1101-2020_03_27_012757	527	4	Table	table	NN
10_1101-2020_03_27_012757	527	5	12	12	CD
10_1101-2020_03_27_012757	527	6	Accessions	accession	NNS
10_1101-2020_03_27_012757	527	7	of	of	IN
10_1101-2020_03_27_012757	527	8	tumor	tumor	NN
10_1101-2020_03_27_012757	527	9	microarray	microarray	JJ
10_1101-2020_03_27_012757	527	10	data	datum	NNS
10_1101-2020_03_27_012757	527	11	used	use	VBN
10_1101-2020_03_27_012757	527	12	in	in	IN
10_1101-2020_03_27_012757	527	13	validation	validation	NN
10_1101-2020_03_27_012757	527	14	.	.	.
10_1101-2020_03_27_012757	528	1	984	984	CD
10_1101-2020_03_27_012757	528	2	985	985	CD
10_1101-2020_03_27_012757	528	3	986	986	CD
10_1101-2020_03_27_012757	528	4	REFERENCES	reference	NNS
10_1101-2020_03_27_012757	528	5	987	987	CD
10_1101-2020_03_27_012757	528	6	1	1	CD
10_1101-2020_03_27_012757	528	7	.	.	.
10_1101-2020_03_27_012757	529	1	Sharma	Sharma	NNP
10_1101-2020_03_27_012757	529	2	,	,	,
10_1101-2020_03_27_012757	529	3	S.	S.	NNP
10_1101-2020_03_27_012757	529	4	V.	V.	NNP
10_1101-2020_03_27_012757	529	5	,	,	,
10_1101-2020_03_27_012757	529	6	Haber	Haber	NNP
10_1101-2020_03_27_012757	529	7	,	,	,
10_1101-2020_03_27_012757	529	8	D.	D.	NNP
10_1101-2020_03_27_012757	529	9	A.	A.	NNP
10_1101-2020_03_27_012757	530	1	&	&	CC
10_1101-2020_03_27_012757	530	2	Settleman	Settleman	NNP
10_1101-2020_03_27_012757	530	3	,	,	,
10_1101-2020_03_27_012757	530	4	J.	J.	NNP
10_1101-2020_03_27_012757	531	1	Cell	cell	NN
10_1101-2020_03_27_012757	531	2	line	line	NN
10_1101-2020_03_27_012757	531	3	-	-	HYPH
10_1101-2020_03_27_012757	531	4	based	base	VBN
10_1101-2020_03_27_012757	531	5	platforms	platform	NNS
10_1101-2020_03_27_012757	531	6	to	to	TO
10_1101-2020_03_27_012757	531	7	evaluate	evaluate	VB
10_1101-2020_03_27_012757	531	8	988	988	CD
10_1101-2020_03_27_012757	531	9	the	the	DT
10_1101-2020_03_27_012757	531	10	therapeutic	therapeutic	JJ
10_1101-2020_03_27_012757	531	11	efficacy	efficacy	NN
10_1101-2020_03_27_012757	531	12	of	of	IN
10_1101-2020_03_27_012757	531	13	candidate	candidate	NN
10_1101-2020_03_27_012757	531	14	anticancer	anticancer	NN
10_1101-2020_03_27_012757	531	15	agents	agent	NNS
10_1101-2020_03_27_012757	531	16	.	.	.
10_1101-2020_03_27_012757	532	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	532	2	.	.	.
10_1101-2020_03_27_012757	533	1	Rev.	Rev.	NNP
10_1101-2020_03_27_012757	534	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	534	2	10	10	CD
10_1101-2020_03_27_012757	534	3	,	,	,
10_1101-2020_03_27_012757	534	4	241–989	241–989	CD
10_1101-2020_03_27_012757	534	5	253	253	CD
10_1101-2020_03_27_012757	534	6	(	(	-LRB-
10_1101-2020_03_27_012757	534	7	2010	2010	CD
10_1101-2020_03_27_012757	534	8	)	)	-RRB-
10_1101-2020_03_27_012757	534	9	.	.	.
10_1101-2020_03_27_012757	535	1	990	990	CD
10_1101-2020_03_27_012757	535	2	2	2	CD
10_1101-2020_03_27_012757	535	3	.	.	.
10_1101-2020_03_27_012757	536	1	Kersten	Kersten	NNP
10_1101-2020_03_27_012757	536	2	,	,	,
10_1101-2020_03_27_012757	536	3	K.	K.	NNP
10_1101-2020_03_27_012757	536	4	,	,	,
10_1101-2020_03_27_012757	536	5	de	de	NNP
10_1101-2020_03_27_012757	536	6	Visser	Visser	NNP
10_1101-2020_03_27_012757	536	7	,	,	,
10_1101-2020_03_27_012757	536	8	K.	K.	NNP
10_1101-2020_03_27_012757	536	9	E.	E.	NNP
10_1101-2020_03_27_012757	536	10	,	,	,
10_1101-2020_03_27_012757	536	11	van	van	NNP
10_1101-2020_03_27_012757	536	12	Miltenburg	Miltenburg	NNP
10_1101-2020_03_27_012757	536	13	,	,	,
10_1101-2020_03_27_012757	536	14	M.	M.	NNP
10_1101-2020_03_27_012757	536	15	H.	H.	NNP
10_1101-2020_03_27_012757	536	16	&	&	CC
10_1101-2020_03_27_012757	536	17	Jonkers	Jonkers	NNP
10_1101-2020_03_27_012757	536	18	,	,	,
10_1101-2020_03_27_012757	536	19	J.	J.	NNP
10_1101-2020_03_27_012757	537	1	Genetically	genetically	RB
10_1101-2020_03_27_012757	537	2	991	991	CD
10_1101-2020_03_27_012757	537	3	engineered	engineer	VBN
10_1101-2020_03_27_012757	537	4	mouse	mouse	NN
10_1101-2020_03_27_012757	537	5	models	model	NNS
10_1101-2020_03_27_012757	537	6	in	in	IN
10_1101-2020_03_27_012757	537	7	oncology	oncology	NN
10_1101-2020_03_27_012757	537	8	research	research	NN
10_1101-2020_03_27_012757	537	9	and	and	CC
10_1101-2020_03_27_012757	537	10	cancer	cancer	NN
10_1101-2020_03_27_012757	537	11	medicine	medicine	NN
10_1101-2020_03_27_012757	537	12	.	.	.
10_1101-2020_03_27_012757	538	1	EMBO	EMBO	NNP
10_1101-2020_03_27_012757	538	2	Mol	Mol	NNP
10_1101-2020_03_27_012757	538	3	.	.	.
10_1101-2020_03_27_012757	539	1	992	992	CD
10_1101-2020_03_27_012757	539	2	Med	Med	NNP
10_1101-2020_03_27_012757	539	3	.	.	.
10_1101-2020_03_27_012757	540	1	9	9	CD
10_1101-2020_03_27_012757	540	2	,	,	,
10_1101-2020_03_27_012757	540	3	137–153	137–153	CD
10_1101-2020_03_27_012757	540	4	(	(	-LRB-
10_1101-2020_03_27_012757	540	5	2017	2017	CD
10_1101-2020_03_27_012757	540	6	)	)	-RRB-
10_1101-2020_03_27_012757	540	7	.	.	.
10_1101-2020_03_27_012757	541	1	993	993	CD
10_1101-2020_03_27_012757	541	2	3	3	CD
10_1101-2020_03_27_012757	541	3	.	.	.
10_1101-2020_03_27_012757	542	1	Hidalgo	Hidalgo	NNP
10_1101-2020_03_27_012757	542	2	,	,	,
10_1101-2020_03_27_012757	542	3	M.	M.	NNP
10_1101-2020_03_27_012757	542	4	et	et	NNP
10_1101-2020_03_27_012757	542	5	al	al	NNP
10_1101-2020_03_27_012757	542	6	.	.	.
10_1101-2020_03_27_012757	543	1	Patient	patient	NN
10_1101-2020_03_27_012757	543	2	-	-	HYPH
10_1101-2020_03_27_012757	543	3	derived	derive	VBN
10_1101-2020_03_27_012757	543	4	xenograft	xenograft	NN
10_1101-2020_03_27_012757	543	5	models	model	NNS
10_1101-2020_03_27_012757	543	6	:	:	:
10_1101-2020_03_27_012757	543	7	an	an	DT
10_1101-2020_03_27_012757	543	8	emerging	emerge	VBG
10_1101-2020_03_27_012757	543	9	platform	platform	NN
10_1101-2020_03_27_012757	543	10	for	for	IN
10_1101-2020_03_27_012757	543	11	994	994	CD
10_1101-2020_03_27_012757	543	12	translational	translational	JJ
10_1101-2020_03_27_012757	543	13	cancer	cancer	NN
10_1101-2020_03_27_012757	543	14	research	research	NN
10_1101-2020_03_27_012757	543	15	.	.	.
10_1101-2020_03_27_012757	544	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	544	2	Discov	Discov	NNP
10_1101-2020_03_27_012757	544	3	.	.	.
10_1101-2020_03_27_012757	545	1	4	4	LS
10_1101-2020_03_27_012757	545	2	,	,	,
10_1101-2020_03_27_012757	545	3	998–1013	998–1013	CD
10_1101-2020_03_27_012757	545	4	(	(	-LRB-
10_1101-2020_03_27_012757	545	5	2014	2014	CD
10_1101-2020_03_27_012757	545	6	)	)	-RRB-
10_1101-2020_03_27_012757	545	7	.	.	.
10_1101-2020_03_27_012757	546	1	995	995	CD
10_1101-2020_03_27_012757	546	2	4	4	CD
10_1101-2020_03_27_012757	546	3	.	.	.
10_1101-2020_03_27_012757	547	1	Drost	drost	UH
10_1101-2020_03_27_012757	547	2	,	,	,
10_1101-2020_03_27_012757	547	3	J.	J.	NNP
10_1101-2020_03_27_012757	548	1	&	&	CC
10_1101-2020_03_27_012757	548	2	Clevers	Clevers	NNP
10_1101-2020_03_27_012757	548	3	,	,	,
10_1101-2020_03_27_012757	548	4	H.	H.	NNP
10_1101-2020_03_27_012757	548	5	Organoids	Organoids	NNP
10_1101-2020_03_27_012757	548	6	in	in	IN
10_1101-2020_03_27_012757	548	7	cancer	cancer	NN
10_1101-2020_03_27_012757	548	8	research	research	NN
10_1101-2020_03_27_012757	548	9	.	.	.
10_1101-2020_03_27_012757	549	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	549	2	.	.	.
10_1101-2020_03_27_012757	550	1	Rev.	Rev.	NNP
10_1101-2020_03_27_012757	551	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	551	2	18	18	CD
10_1101-2020_03_27_012757	551	3	,	,	,
10_1101-2020_03_27_012757	551	4	407–996	407–996	CD
10_1101-2020_03_27_012757	551	5	418	418	CD
10_1101-2020_03_27_012757	551	6	(	(	-LRB-
10_1101-2020_03_27_012757	551	7	2018	2018	CD
10_1101-2020_03_27_012757	551	8	)	)	-RRB-
10_1101-2020_03_27_012757	551	9	.	.	.
10_1101-2020_03_27_012757	552	1	997	997	CD
10_1101-2020_03_27_012757	552	2	5	5	CD
10_1101-2020_03_27_012757	552	3	.	.	.
10_1101-2020_03_27_012757	553	1	Klijn	Klijn	NNP
10_1101-2020_03_27_012757	553	2	,	,	,
10_1101-2020_03_27_012757	553	3	C.	C.	NNP
10_1101-2020_03_27_012757	553	4	et	et	NNP
10_1101-2020_03_27_012757	553	5	al	al	NNP
10_1101-2020_03_27_012757	553	6	.	.	.
10_1101-2020_03_27_012757	554	1	A	a	DT
10_1101-2020_03_27_012757	554	2	comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	554	3	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	554	4	portrait	portrait	NN
10_1101-2020_03_27_012757	554	5	of	of	IN
10_1101-2020_03_27_012757	554	6	human	human	JJ
10_1101-2020_03_27_012757	554	7	cancer	cancer	NN
10_1101-2020_03_27_012757	554	8	cell	cell	NN
10_1101-2020_03_27_012757	554	9	lines	line	NNS
10_1101-2020_03_27_012757	554	10	.	.	.
10_1101-2020_03_27_012757	555	1	998	998	CD
10_1101-2020_03_27_012757	555	2	Nat	Nat	NNP
10_1101-2020_03_27_012757	555	3	.	.	.
10_1101-2020_03_27_012757	556	1	Biotechnol	Biotechnol	NNS
10_1101-2020_03_27_012757	556	2	.	.	.
10_1101-2020_03_27_012757	557	1	33	33	CD
10_1101-2020_03_27_012757	557	2	,	,	,
10_1101-2020_03_27_012757	557	3	306–312	306–312	CD
10_1101-2020_03_27_012757	557	4	(	(	-LRB-
10_1101-2020_03_27_012757	557	5	2015	2015	CD
10_1101-2020_03_27_012757	557	6	)	)	-RRB-
10_1101-2020_03_27_012757	557	7	.	.	.
10_1101-2020_03_27_012757	558	1	999	999	CD
10_1101-2020_03_27_012757	558	2	6	6	CD
10_1101-2020_03_27_012757	558	3	.	.	.
10_1101-2020_03_27_012757	559	1	Koren	Koren	NNP
10_1101-2020_03_27_012757	559	2	,	,	,
10_1101-2020_03_27_012757	559	3	S.	S.	NNP
10_1101-2020_03_27_012757	559	4	et	et	NNP
10_1101-2020_03_27_012757	559	5	al	al	NNP
10_1101-2020_03_27_012757	559	6	.	.	.
10_1101-2020_03_27_012757	560	1	PIK3CA(H1047R	PIK3CA(H1047R	NNP
10_1101-2020_03_27_012757	560	2	)	)	-RRB-
10_1101-2020_03_27_012757	560	3	induces	induce	VBZ
10_1101-2020_03_27_012757	560	4	multipotency	multipotency	NNP
10_1101-2020_03_27_012757	560	5	and	and	CC
10_1101-2020_03_27_012757	560	6	multi	multi	JJ
10_1101-2020_03_27_012757	560	7	-	-	JJ
10_1101-2020_03_27_012757	560	8	lineage	lineage	JJ
10_1101-2020_03_27_012757	560	9	mammary	mammary	JJ
10_1101-2020_03_27_012757	560	10	1000	1000	CD
10_1101-2020_03_27_012757	560	11	tumours	tumour	NNS
10_1101-2020_03_27_012757	560	12	.	.	.
10_1101-2020_03_27_012757	561	1	Nature	nature	NN
10_1101-2020_03_27_012757	561	2	525	525	CD
10_1101-2020_03_27_012757	561	3	,	,	,
10_1101-2020_03_27_012757	561	4	114–118	114–118	CD
10_1101-2020_03_27_012757	561	5	(	(	-LRB-
10_1101-2020_03_27_012757	561	6	2015	2015	CD
10_1101-2020_03_27_012757	561	7	)	)	-RRB-
10_1101-2020_03_27_012757	561	8	.	.	.
10_1101-2020_03_27_012757	562	1	1001	1001	CD
10_1101-2020_03_27_012757	562	2	7	7	CD
10_1101-2020_03_27_012757	562	3	.	.	.
10_1101-2020_03_27_012757	563	1	DeRose	DeRose	NNP
10_1101-2020_03_27_012757	563	2	,	,	,
10_1101-2020_03_27_012757	563	3	Y.	Y.	NNP
10_1101-2020_03_27_012757	563	4	S.	S.	NNP
10_1101-2020_03_27_012757	563	5	et	et	NNP
10_1101-2020_03_27_012757	563	6	al	al	NNP
10_1101-2020_03_27_012757	563	7	.	.	.
10_1101-2020_03_27_012757	564	1	Tumor	tumor	NN
10_1101-2020_03_27_012757	564	2	grafts	graft	NNS
10_1101-2020_03_27_012757	564	3	derived	derive	VBN
10_1101-2020_03_27_012757	564	4	from	from	IN
10_1101-2020_03_27_012757	564	5	women	woman	NNS
10_1101-2020_03_27_012757	564	6	with	with	IN
10_1101-2020_03_27_012757	564	7	breast	breast	NN
10_1101-2020_03_27_012757	564	8	cancer	cancer	NN
10_1101-2020_03_27_012757	564	9	1002	1002	CD
10_1101-2020_03_27_012757	564	10	authentically	authentically	RB
10_1101-2020_03_27_012757	564	11	reflect	reflect	VBP
10_1101-2020_03_27_012757	564	12	tumor	tumor	NN
10_1101-2020_03_27_012757	564	13	pathology	pathology	NN
10_1101-2020_03_27_012757	564	14	,	,	,
10_1101-2020_03_27_012757	564	15	growth	growth	NN
10_1101-2020_03_27_012757	564	16	,	,	,
10_1101-2020_03_27_012757	564	17	metastasis	metastasis	NN
10_1101-2020_03_27_012757	564	18	and	and	CC
10_1101-2020_03_27_012757	564	19	disease	disease	NN
10_1101-2020_03_27_012757	564	20	outcomes	outcome	NNS
10_1101-2020_03_27_012757	564	21	.	.	.
10_1101-2020_03_27_012757	565	1	1003	1003	CD
10_1101-2020_03_27_012757	565	2	Nat	Nat	NNP
10_1101-2020_03_27_012757	565	3	.	.	.
10_1101-2020_03_27_012757	566	1	Med	Med	NNP
10_1101-2020_03_27_012757	566	2	.	.	.
10_1101-2020_03_27_012757	567	1	17	17	CD
10_1101-2020_03_27_012757	567	2	,	,	,
10_1101-2020_03_27_012757	567	3	1514–1520	1514–1520	CD
10_1101-2020_03_27_012757	567	4	(	(	-LRB-
10_1101-2020_03_27_012757	567	5	2011	2011	CD
10_1101-2020_03_27_012757	567	6	)	)	-RRB-
10_1101-2020_03_27_012757	567	7	.	.	.
10_1101-2020_03_27_012757	568	1	1004	1004	CD
10_1101-2020_03_27_012757	568	2	.CC	.CC	:
10_1101-2020_03_27_012757	568	3	-	-	:
10_1101-2020_03_27_012757	568	4	BY	by	IN
10_1101-2020_03_27_012757	568	5	-	-	HYPH
10_1101-2020_03_27_012757	568	6	NC	NC	NNP
10_1101-2020_03_27_012757	568	7	-	-	HYPH
10_1101-2020_03_27_012757	568	8	ND	ND	NNP
10_1101-2020_03_27_012757	568	9	4.0	4.0	CD
10_1101-2020_03_27_012757	568	10	International	International	NNP
10_1101-2020_03_27_012757	568	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	568	12	under	under	IN
10_1101-2020_03_27_012757	568	13	a	a	DT
10_1101-2020_03_27_012757	568	14	(	(	-LRB-
10_1101-2020_03_27_012757	568	15	which	which	WDT
10_1101-2020_03_27_012757	568	16	was	be	VBD
10_1101-2020_03_27_012757	568	17	not	not	RB
10_1101-2020_03_27_012757	568	18	certified	certify	VBN
10_1101-2020_03_27_012757	568	19	by	by	IN
10_1101-2020_03_27_012757	568	20	peer	peer	NN
10_1101-2020_03_27_012757	568	21	review	review	NN
10_1101-2020_03_27_012757	568	22	)	)	-RRB-
10_1101-2020_03_27_012757	568	23	is	be	VBZ
10_1101-2020_03_27_012757	568	24	the	the	DT
10_1101-2020_03_27_012757	568	25	author	author	NN
10_1101-2020_03_27_012757	568	26	/	/	SYM
10_1101-2020_03_27_012757	568	27	funder	funder	NN
10_1101-2020_03_27_012757	568	28	,	,	,
10_1101-2020_03_27_012757	568	29	who	who	WP
10_1101-2020_03_27_012757	568	30	has	have	VBZ
10_1101-2020_03_27_012757	568	31	granted	grant	VBN
10_1101-2020_03_27_012757	568	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	568	33	a	a	DT
10_1101-2020_03_27_012757	568	34	license	license	NN
10_1101-2020_03_27_012757	568	35	to	to	TO
10_1101-2020_03_27_012757	568	36	display	display	VB
10_1101-2020_03_27_012757	568	37	the	the	DT
10_1101-2020_03_27_012757	568	38	preprint	preprint	NN
10_1101-2020_03_27_012757	568	39	in	in	IN
10_1101-2020_03_27_012757	568	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	568	41	.	.	.
10_1101-2020_03_27_012757	569	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	569	2	is	be	VBZ
10_1101-2020_03_27_012757	569	3	made	make	VBN
10_1101-2020_03_27_012757	569	4	The	the	DT
10_1101-2020_03_27_012757	569	5	copyright	copyright	NN
10_1101-2020_03_27_012757	569	6	holder	holder	NN
10_1101-2020_03_27_012757	569	7	for	for	IN
10_1101-2020_03_27_012757	569	8	this	this	DT
10_1101-2020_03_27_012757	569	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	569	10	version	version	NN
10_1101-2020_03_27_012757	569	11	posted	post	VBD
10_1101-2020_03_27_012757	569	12	January	January	NNP
10_1101-2020_03_27_012757	569	13	9	9	CD
10_1101-2020_03_27_012757	569	14	,	,	,
10_1101-2020_03_27_012757	569	15	2021	2021	CD
10_1101-2020_03_27_012757	569	16	.	.	.
10_1101-2020_03_27_012757	569	17	;	;	:
10_1101-2020_03_27_012757	569	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	569	19	:	:	:
10_1101-2020_03_27_012757	569	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	569	21	preprint	preprint	NN
10_1101-2020_03_27_012757	569	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	569	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	569	24	38	38	CD
10_1101-2020_03_27_012757	569	25	8	8	CD
10_1101-2020_03_27_012757	569	26	.	.	.
10_1101-2020_03_27_012757	570	1	Sharpless	Sharpless	NNP
10_1101-2020_03_27_012757	570	2	,	,	,
10_1101-2020_03_27_012757	570	3	N.	N.	NNP
10_1101-2020_03_27_012757	570	4	E.	E.	NNP
10_1101-2020_03_27_012757	570	5	&	&	CC
10_1101-2020_03_27_012757	570	6	Depinho	Depinho	NNP
10_1101-2020_03_27_012757	570	7	,	,	,
10_1101-2020_03_27_012757	570	8	R.	R.	NNP
10_1101-2020_03_27_012757	570	9	A.	A.	NNP
10_1101-2020_03_27_012757	571	1	The	the	DT
10_1101-2020_03_27_012757	571	2	mighty	mighty	JJ
10_1101-2020_03_27_012757	571	3	mouse	mouse	NN
10_1101-2020_03_27_012757	571	4	:	:	:
10_1101-2020_03_27_012757	571	5	genetically	genetically	RB
10_1101-2020_03_27_012757	571	6	engineered	engineer	VBN
10_1101-2020_03_27_012757	571	7	1005	1005	CD
10_1101-2020_03_27_012757	571	8	mouse	mouse	NN
10_1101-2020_03_27_012757	571	9	models	model	NNS
10_1101-2020_03_27_012757	571	10	in	in	IN
10_1101-2020_03_27_012757	571	11	cancer	cancer	NN
10_1101-2020_03_27_012757	571	12	drug	drug	NN
10_1101-2020_03_27_012757	571	13	development	development	NN
10_1101-2020_03_27_012757	571	14	.	.	.
10_1101-2020_03_27_012757	572	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	572	2	.	.	.
10_1101-2020_03_27_012757	573	1	Rev.	Rev.	NNP
10_1101-2020_03_27_012757	574	1	Drug	Drug	NNP
10_1101-2020_03_27_012757	574	2	Discov	Discov	NNP
10_1101-2020_03_27_012757	574	3	.	.	.
10_1101-2020_03_27_012757	575	1	5	5	CD
10_1101-2020_03_27_012757	575	2	,	,	,
10_1101-2020_03_27_012757	575	3	741–754	741–754	CD
10_1101-2020_03_27_012757	575	4	1006	1006	CD
10_1101-2020_03_27_012757	575	5	(	(	-LRB-
10_1101-2020_03_27_012757	575	6	2006	2006	CD
10_1101-2020_03_27_012757	575	7	)	)	-RRB-
10_1101-2020_03_27_012757	575	8	.	.	.
10_1101-2020_03_27_012757	576	1	1007	1007	CD
10_1101-2020_03_27_012757	576	2	9	9	CD
10_1101-2020_03_27_012757	576	3	.	.	.
10_1101-2020_03_27_012757	577	1	Mouradov	Mouradov	NNP
10_1101-2020_03_27_012757	577	2	,	,	,
10_1101-2020_03_27_012757	577	3	D.	D.	NNP
10_1101-2020_03_27_012757	577	4	et	et	NNP
10_1101-2020_03_27_012757	577	5	al	al	NNP
10_1101-2020_03_27_012757	577	6	.	.	.
10_1101-2020_03_27_012757	578	1	Colorectal	colorectal	JJ
10_1101-2020_03_27_012757	578	2	cancer	cancer	NN
10_1101-2020_03_27_012757	578	3	cell	cell	NN
10_1101-2020_03_27_012757	578	4	lines	line	NNS
10_1101-2020_03_27_012757	578	5	are	be	VBP
10_1101-2020_03_27_012757	578	6	representative	representative	JJ
10_1101-2020_03_27_012757	578	7	models	model	NNS
10_1101-2020_03_27_012757	578	8	of	of	IN
10_1101-2020_03_27_012757	578	9	the	the	DT
10_1101-2020_03_27_012757	578	10	1008	1008	CD
10_1101-2020_03_27_012757	578	11	main	main	JJ
10_1101-2020_03_27_012757	578	12	molecular	molecular	JJ
10_1101-2020_03_27_012757	578	13	subtypes	subtype	NNS
10_1101-2020_03_27_012757	578	14	of	of	IN
10_1101-2020_03_27_012757	578	15	primary	primary	JJ
10_1101-2020_03_27_012757	578	16	cancer	cancer	NN
10_1101-2020_03_27_012757	578	17	.	.	.
10_1101-2020_03_27_012757	579	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	579	2	Res	Res	NNP
10_1101-2020_03_27_012757	579	3	.	.	.
10_1101-2020_03_27_012757	580	1	74	74	CD
10_1101-2020_03_27_012757	580	2	,	,	,
10_1101-2020_03_27_012757	580	3	3238–3247	3238–3247	CD
10_1101-2020_03_27_012757	580	4	(	(	-LRB-
10_1101-2020_03_27_012757	580	5	2014	2014	CD
10_1101-2020_03_27_012757	580	6	)	)	-RRB-
10_1101-2020_03_27_012757	580	7	.	.	.
10_1101-2020_03_27_012757	581	1	1009	1009	CD
10_1101-2020_03_27_012757	581	2	10	10	CD
10_1101-2020_03_27_012757	581	3	.	.	.
10_1101-2020_03_27_012757	582	1	Stuckelberger	Stuckelberger	NNP
10_1101-2020_03_27_012757	582	2	,	,	,
10_1101-2020_03_27_012757	582	3	S.	S.	NNP
10_1101-2020_03_27_012757	582	4	&	&	CC
10_1101-2020_03_27_012757	582	5	Drapkin	Drapkin	NNP
10_1101-2020_03_27_012757	582	6	,	,	,
10_1101-2020_03_27_012757	582	7	R.	R.	NNP
10_1101-2020_03_27_012757	582	8	Precious	Precious	NNP
10_1101-2020_03_27_012757	582	9	GEMMs	GEMMs	NNPS
10_1101-2020_03_27_012757	582	10	:	:	:
10_1101-2020_03_27_012757	582	11	emergence	emergence	NN
10_1101-2020_03_27_012757	582	12	of	of	IN
10_1101-2020_03_27_012757	582	13	faithful	faithful	JJ
10_1101-2020_03_27_012757	582	14	models	model	NNS
10_1101-2020_03_27_012757	582	15	for	for	IN
10_1101-2020_03_27_012757	582	16	1010	1010	CD
10_1101-2020_03_27_012757	582	17	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	582	18	cancer	cancer	NN
10_1101-2020_03_27_012757	582	19	research	research	NN
10_1101-2020_03_27_012757	582	20	.	.	.
10_1101-2020_03_27_012757	583	1	J.	J.	NNP
10_1101-2020_03_27_012757	583	2	Pathol	Pathol	NNP
10_1101-2020_03_27_012757	583	3	.	.	.
10_1101-2020_03_27_012757	584	1	245	245	CD
10_1101-2020_03_27_012757	584	2	,	,	,
10_1101-2020_03_27_012757	584	3	129–131	129–131	CD
10_1101-2020_03_27_012757	584	4	(	(	-LRB-
10_1101-2020_03_27_012757	584	5	2018	2018	CD
10_1101-2020_03_27_012757	584	6	)	)	-RRB-
10_1101-2020_03_27_012757	584	7	.	.	.
10_1101-2020_03_27_012757	585	1	1011	1011	CD
10_1101-2020_03_27_012757	585	2	11	11	CD
10_1101-2020_03_27_012757	585	3	.	.	.
10_1101-2020_03_27_012757	586	1	Domcke	Domcke	NNP
10_1101-2020_03_27_012757	586	2	,	,	,
10_1101-2020_03_27_012757	586	3	S.	S.	NNP
10_1101-2020_03_27_012757	586	4	,	,	,
10_1101-2020_03_27_012757	586	5	Sinha	Sinha	NNP
10_1101-2020_03_27_012757	586	6	,	,	,
10_1101-2020_03_27_012757	586	7	R.	R.	NNP
10_1101-2020_03_27_012757	586	8	,	,	,
10_1101-2020_03_27_012757	586	9	Levine	Levine	NNP
10_1101-2020_03_27_012757	586	10	,	,	,
10_1101-2020_03_27_012757	586	11	D.	D.	NNP
10_1101-2020_03_27_012757	586	12	A.	A.	NNP
10_1101-2020_03_27_012757	586	13	,	,	,
10_1101-2020_03_27_012757	586	14	Sander	Sander	NNP
10_1101-2020_03_27_012757	586	15	,	,	,
10_1101-2020_03_27_012757	586	16	C.	C.	NNP
10_1101-2020_03_27_012757	586	17	&	&	CC
10_1101-2020_03_27_012757	586	18	Schultz	Schultz	NNP
10_1101-2020_03_27_012757	586	19	,	,	,
10_1101-2020_03_27_012757	586	20	N.	N.	NNP
10_1101-2020_03_27_012757	586	21	Evaluating	evaluate	VBG
10_1101-2020_03_27_012757	586	22	cell	cell	NN
10_1101-2020_03_27_012757	586	23	lines	line	NNS
10_1101-2020_03_27_012757	586	24	1012	1012	CD
10_1101-2020_03_27_012757	586	25	as	as	IN
10_1101-2020_03_27_012757	586	26	tumour	tumour	NN
10_1101-2020_03_27_012757	586	27	models	model	NNS
10_1101-2020_03_27_012757	586	28	by	by	IN
10_1101-2020_03_27_012757	586	29	comparison	comparison	NN
10_1101-2020_03_27_012757	586	30	of	of	IN
10_1101-2020_03_27_012757	586	31	genomic	genomic	NNP
10_1101-2020_03_27_012757	586	32	profiles	profile	NNS
10_1101-2020_03_27_012757	586	33	.	.	.
10_1101-2020_03_27_012757	587	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	587	2	.	.	.
10_1101-2020_03_27_012757	588	1	Commun	Commun	VBN
10_1101-2020_03_27_012757	588	2	.	.	.
10_1101-2020_03_27_012757	589	1	4	4	CD
10_1101-2020_03_27_012757	589	2	,	,	,
10_1101-2020_03_27_012757	589	3	2126	2126	CD
10_1101-2020_03_27_012757	589	4	1013	1013	CD
10_1101-2020_03_27_012757	589	5	(	(	-LRB-
10_1101-2020_03_27_012757	589	6	2013	2013	CD
10_1101-2020_03_27_012757	589	7	)	)	-RRB-
10_1101-2020_03_27_012757	589	8	.	.	.
10_1101-2020_03_27_012757	590	1	1014	1014	CD
10_1101-2020_03_27_012757	590	2	12	12	CD
10_1101-2020_03_27_012757	590	3	.	.	.
10_1101-2020_03_27_012757	591	1	Jiang	Jiang	NNP
10_1101-2020_03_27_012757	591	2	,	,	,
10_1101-2020_03_27_012757	591	3	G.	G.	NNP
10_1101-2020_03_27_012757	591	4	et	et	NNP
10_1101-2020_03_27_012757	591	5	al	al	NNP
10_1101-2020_03_27_012757	591	6	.	.	.
10_1101-2020_03_27_012757	592	1	Comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	592	2	comparison	comparison	NN
10_1101-2020_03_27_012757	592	3	of	of	IN
10_1101-2020_03_27_012757	592	4	molecular	molecular	JJ
10_1101-2020_03_27_012757	592	5	portraits	portrait	NNS
10_1101-2020_03_27_012757	592	6	between	between	IN
10_1101-2020_03_27_012757	592	7	cell	cell	NN
10_1101-2020_03_27_012757	592	8	lines	line	NNS
10_1101-2020_03_27_012757	592	9	1015	1015	CD
10_1101-2020_03_27_012757	592	10	and	and	CC
10_1101-2020_03_27_012757	592	11	tumors	tumor	NNS
10_1101-2020_03_27_012757	592	12	in	in	IN
10_1101-2020_03_27_012757	592	13	breast	breast	NN
10_1101-2020_03_27_012757	592	14	cancer	cancer	NN
10_1101-2020_03_27_012757	592	15	.	.	.
10_1101-2020_03_27_012757	593	1	BMC	BMC	NNP
10_1101-2020_03_27_012757	593	2	Genomics	Genomics	NNP
10_1101-2020_03_27_012757	593	3	17	17	CD
10_1101-2020_03_27_012757	593	4	Suppl	Suppl	NNP
10_1101-2020_03_27_012757	593	5	7	7	CD
10_1101-2020_03_27_012757	593	6	,	,	,
10_1101-2020_03_27_012757	593	7	525	525	CD
10_1101-2020_03_27_012757	593	8	(	(	-LRB-
10_1101-2020_03_27_012757	593	9	2016	2016	CD
10_1101-2020_03_27_012757	593	10	)	)	-RRB-
10_1101-2020_03_27_012757	593	11	.	.	.
10_1101-2020_03_27_012757	594	1	1016	1016	CD
10_1101-2020_03_27_012757	594	2	13	13	CD
10_1101-2020_03_27_012757	594	3	.	.	.
10_1101-2020_03_27_012757	595	1	Chen	Chen	NNP
10_1101-2020_03_27_012757	595	2	,	,	,
10_1101-2020_03_27_012757	595	3	B.	B.	NNP
10_1101-2020_03_27_012757	595	4	,	,	,
10_1101-2020_03_27_012757	595	5	Sirota	Sirota	NNP
10_1101-2020_03_27_012757	595	6	,	,	,
10_1101-2020_03_27_012757	595	7	M.	M.	NNP
10_1101-2020_03_27_012757	595	8	,	,	,
10_1101-2020_03_27_012757	595	9	Fan	Fan	NNP
10_1101-2020_03_27_012757	595	10	-	-	HYPH
10_1101-2020_03_27_012757	595	11	Minogue	Minogue	NNP
10_1101-2020_03_27_012757	595	12	,	,	,
10_1101-2020_03_27_012757	595	13	H.	H.	NNP
10_1101-2020_03_27_012757	595	14	,	,	,
10_1101-2020_03_27_012757	595	15	Hadley	Hadley	NNP
10_1101-2020_03_27_012757	595	16	,	,	,
10_1101-2020_03_27_012757	595	17	D.	D.	NNP
10_1101-2020_03_27_012757	595	18	&	&	CC
10_1101-2020_03_27_012757	595	19	Butte	Butte	NNP
10_1101-2020_03_27_012757	595	20	,	,	,
10_1101-2020_03_27_012757	595	21	A.	a.	NN
10_1101-2020_03_27_012757	595	22	J.	J.	NNP
10_1101-2020_03_27_012757	596	1	Relating	relate	VBG
10_1101-2020_03_27_012757	596	2	1017	1017	CD
10_1101-2020_03_27_012757	596	3	hepatocellular	hepatocellular	JJ
10_1101-2020_03_27_012757	596	4	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	596	5	tumor	tumor	NN
10_1101-2020_03_27_012757	596	6	samples	sample	NNS
10_1101-2020_03_27_012757	596	7	and	and	CC
10_1101-2020_03_27_012757	596	8	cell	cell	NN
10_1101-2020_03_27_012757	596	9	lines	line	NNS
10_1101-2020_03_27_012757	596	10	using	use	VBG
10_1101-2020_03_27_012757	596	11	gene	gene	NN
10_1101-2020_03_27_012757	596	12	expression	expression	NN
10_1101-2020_03_27_012757	596	13	data	datum	NNS
10_1101-2020_03_27_012757	596	14	1018	1018	CD
10_1101-2020_03_27_012757	596	15	in	in	IN
10_1101-2020_03_27_012757	596	16	translational	translational	JJ
10_1101-2020_03_27_012757	596	17	research	research	NN
10_1101-2020_03_27_012757	596	18	.	.	.
10_1101-2020_03_27_012757	597	1	BMC	BMC	NNP
10_1101-2020_03_27_012757	597	2	Med	Med	NNP
10_1101-2020_03_27_012757	597	3	.	.	.
10_1101-2020_03_27_012757	598	1	Genomics	genomic	NNS
10_1101-2020_03_27_012757	598	2	8	8	CD
10_1101-2020_03_27_012757	598	3	Suppl	suppl	NN
10_1101-2020_03_27_012757	598	4	2	2	CD
10_1101-2020_03_27_012757	598	5	,	,	,
10_1101-2020_03_27_012757	598	6	S5	s5	NN
10_1101-2020_03_27_012757	598	7	(	(	-LRB-
10_1101-2020_03_27_012757	598	8	2015	2015	CD
10_1101-2020_03_27_012757	598	9	)	)	-RRB-
10_1101-2020_03_27_012757	598	10	.	.	.
10_1101-2020_03_27_012757	599	1	1019	1019	CD
10_1101-2020_03_27_012757	599	2	14	14	CD
10_1101-2020_03_27_012757	599	3	.	.	.
10_1101-2020_03_27_012757	600	1	Vincent	Vincent	NNP
10_1101-2020_03_27_012757	600	2	,	,	,
10_1101-2020_03_27_012757	600	3	K.	K.	NNP
10_1101-2020_03_27_012757	600	4	M.	M.	NNP
10_1101-2020_03_27_012757	600	5	,	,	,
10_1101-2020_03_27_012757	600	6	Findlay	Findlay	NNP
10_1101-2020_03_27_012757	600	7	,	,	,
10_1101-2020_03_27_012757	600	8	S.	S.	NNP
10_1101-2020_03_27_012757	600	9	D.	D.	NNP
10_1101-2020_03_27_012757	600	10	&	&	CC
10_1101-2020_03_27_012757	600	11	Postovit	Postovit	NNP
10_1101-2020_03_27_012757	600	12	,	,	,
10_1101-2020_03_27_012757	600	13	L.	L.	NNP
10_1101-2020_03_27_012757	600	14	M.	M.	NNP
10_1101-2020_03_27_012757	600	15	Assessing	Assessing	NNP
10_1101-2020_03_27_012757	600	16	breast	breast	NN
10_1101-2020_03_27_012757	600	17	cancer	cancer	NN
10_1101-2020_03_27_012757	600	18	cell	cell	NN
10_1101-2020_03_27_012757	600	19	lines	line	NNS
10_1101-2020_03_27_012757	600	20	as	as	IN
10_1101-2020_03_27_012757	600	21	1020	1020	CD
10_1101-2020_03_27_012757	600	22	tumour	tumour	NN
10_1101-2020_03_27_012757	600	23	models	model	NNS
10_1101-2020_03_27_012757	600	24	by	by	IN
10_1101-2020_03_27_012757	600	25	comparison	comparison	NN
10_1101-2020_03_27_012757	600	26	of	of	IN
10_1101-2020_03_27_012757	600	27	mRNA	mRNA	NNP
10_1101-2020_03_27_012757	600	28	expression	expression	NNP
10_1101-2020_03_27_012757	600	29	profiles	profile	NNS
10_1101-2020_03_27_012757	600	30	.	.	.
10_1101-2020_03_27_012757	601	1	Breast	Breast	NNP
10_1101-2020_03_27_012757	601	2	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	601	3	Res	Res	NNP
10_1101-2020_03_27_012757	601	4	.	.	.
10_1101-2020_03_27_012757	602	1	1021	1021	CD
10_1101-2020_03_27_012757	602	2	17	17	CD
10_1101-2020_03_27_012757	602	3	,	,	,
10_1101-2020_03_27_012757	602	4	114	114	CD
10_1101-2020_03_27_012757	602	5	(	(	-LRB-
10_1101-2020_03_27_012757	602	6	2015	2015	CD
10_1101-2020_03_27_012757	602	7	)	)	-RRB-
10_1101-2020_03_27_012757	602	8	.	.	.
10_1101-2020_03_27_012757	603	1	1022	1022	CD
10_1101-2020_03_27_012757	603	2	15	15	CD
10_1101-2020_03_27_012757	603	3	.	.	.
10_1101-2020_03_27_012757	604	1	Yu	Yu	NNP
10_1101-2020_03_27_012757	604	2	,	,	,
10_1101-2020_03_27_012757	604	3	K.	K.	NNP
10_1101-2020_03_27_012757	604	4	et	et	NNP
10_1101-2020_03_27_012757	604	5	al	al	NNP
10_1101-2020_03_27_012757	604	6	.	.	.
10_1101-2020_03_27_012757	605	1	Comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	605	2	transcriptomic	transcriptomic	JJ
10_1101-2020_03_27_012757	605	3	analysis	analysis	NN
10_1101-2020_03_27_012757	605	4	of	of	IN
10_1101-2020_03_27_012757	605	5	cell	cell	NN
10_1101-2020_03_27_012757	605	6	lines	line	NNS
10_1101-2020_03_27_012757	605	7	as	as	IN
10_1101-2020_03_27_012757	605	8	models	model	NNS
10_1101-2020_03_27_012757	605	9	of	of	IN
10_1101-2020_03_27_012757	605	10	1023	1023	CD
10_1101-2020_03_27_012757	605	11	primary	primary	JJ
10_1101-2020_03_27_012757	605	12	tumors	tumor	NNS
10_1101-2020_03_27_012757	605	13	across	across	IN
10_1101-2020_03_27_012757	605	14	22	22	CD
10_1101-2020_03_27_012757	605	15	tumor	tumor	NN
10_1101-2020_03_27_012757	605	16	types	type	NNS
10_1101-2020_03_27_012757	605	17	.	.	.
10_1101-2020_03_27_012757	606	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	606	2	.	.	.
10_1101-2020_03_27_012757	607	1	Commun	Commun	VBN
10_1101-2020_03_27_012757	607	2	.	.	.
10_1101-2020_03_27_012757	608	1	10	10	CD
10_1101-2020_03_27_012757	608	2	,	,	,
10_1101-2020_03_27_012757	608	3	3574	3574	CD
10_1101-2020_03_27_012757	608	4	(	(	-LRB-
10_1101-2020_03_27_012757	608	5	2019	2019	CD
10_1101-2020_03_27_012757	608	6	)	)	-RRB-
10_1101-2020_03_27_012757	608	7	.	.	.
10_1101-2020_03_27_012757	609	1	1024	1024	CD
10_1101-2020_03_27_012757	609	2	16	16	CD
10_1101-2020_03_27_012757	609	3	.	.	.
10_1101-2020_03_27_012757	610	1	Najgebauer	Najgebauer	NNP
10_1101-2020_03_27_012757	610	2	,	,	,
10_1101-2020_03_27_012757	610	3	H.	H.	NNP
10_1101-2020_03_27_012757	610	4	et	et	NNP
10_1101-2020_03_27_012757	610	5	al	al	NNP
10_1101-2020_03_27_012757	610	6	.	.	.
10_1101-2020_03_27_012757	611	1	CELLector	cellector	NN
10_1101-2020_03_27_012757	611	2	:	:	:
10_1101-2020_03_27_012757	611	3	Genomics	Genomics	NNP
10_1101-2020_03_27_012757	611	4	-	-	HYPH
10_1101-2020_03_27_012757	611	5	Guided	guide	VBN
10_1101-2020_03_27_012757	611	6	Selection	Selection	NNP
10_1101-2020_03_27_012757	611	7	of	of	IN
10_1101-2020_03_27_012757	611	8	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	611	9	In	in	IN
10_1101-2020_03_27_012757	611	10	Vitro	Vitro	NNP
10_1101-2020_03_27_012757	611	11	1025	1025	CD
10_1101-2020_03_27_012757	611	12	Models	model	NNS
10_1101-2020_03_27_012757	611	13	.	.	.
10_1101-2020_03_27_012757	612	1	Cell	Cell	NNP
10_1101-2020_03_27_012757	612	2	Syst	Syst	NNP
10_1101-2020_03_27_012757	612	3	.	.	.
10_1101-2020_03_27_012757	613	1	10	10	CD
10_1101-2020_03_27_012757	613	2	,	,	,
10_1101-2020_03_27_012757	613	3	424–432.e6	424–432.e6	CD
10_1101-2020_03_27_012757	613	4	(	(	-LRB-
10_1101-2020_03_27_012757	613	5	2020	2020	CD
10_1101-2020_03_27_012757	613	6	)	)	-RRB-
10_1101-2020_03_27_012757	613	7	.	.	.
10_1101-2020_03_27_012757	614	1	1026	1026	CD
10_1101-2020_03_27_012757	614	2	17	17	CD
10_1101-2020_03_27_012757	614	3	.	.	.
10_1101-2020_03_27_012757	615	1	Salvadores	Salvadores	NNP
10_1101-2020_03_27_012757	615	2	,	,	,
10_1101-2020_03_27_012757	615	3	M.	M.	NNP
10_1101-2020_03_27_012757	615	4	,	,	,
10_1101-2020_03_27_012757	615	5	Fuster	Fuster	NNP
10_1101-2020_03_27_012757	615	6	-	-	HYPH
10_1101-2020_03_27_012757	615	7	Tormo	Tormo	NNP
10_1101-2020_03_27_012757	615	8	,	,	,
10_1101-2020_03_27_012757	615	9	F.	F.	NNP
10_1101-2020_03_27_012757	615	10	&	&	CC
10_1101-2020_03_27_012757	615	11	Supek	Supek	NNP
10_1101-2020_03_27_012757	615	12	,	,	,
10_1101-2020_03_27_012757	615	13	F.	F.	NNP
10_1101-2020_03_27_012757	615	14	Matching	Matching	NNP
10_1101-2020_03_27_012757	615	15	cell	cell	NN
10_1101-2020_03_27_012757	615	16	lines	line	NNS
10_1101-2020_03_27_012757	615	17	with	with	IN
10_1101-2020_03_27_012757	615	18	cancer	cancer	NN
10_1101-2020_03_27_012757	615	19	type	type	NN
10_1101-2020_03_27_012757	615	20	1027	1027	CD
10_1101-2020_03_27_012757	615	21	and	and	CC
10_1101-2020_03_27_012757	615	22	subtype	subtype	NN
10_1101-2020_03_27_012757	615	23	of	of	IN
10_1101-2020_03_27_012757	615	24	origin	origin	NN
10_1101-2020_03_27_012757	615	25	via	via	IN
10_1101-2020_03_27_012757	615	26	mutational	mutational	JJ
10_1101-2020_03_27_012757	615	27	,	,	,
10_1101-2020_03_27_012757	615	28	epigenomic	epigenomic	JJ
10_1101-2020_03_27_012757	615	29	,	,	,
10_1101-2020_03_27_012757	615	30	and	and	CC
10_1101-2020_03_27_012757	615	31	transcriptomic	transcriptomic	JJ
10_1101-2020_03_27_012757	615	32	patterns	pattern	NNS
10_1101-2020_03_27_012757	615	33	.	.	.
10_1101-2020_03_27_012757	616	1	Sci	Sci	NNP
10_1101-2020_03_27_012757	616	2	.	.	.
10_1101-2020_03_27_012757	617	1	1028	1028	CD
10_1101-2020_03_27_012757	617	2	Adv	Adv	NNP
10_1101-2020_03_27_012757	617	3	.	.	.
10_1101-2020_03_27_012757	618	1	6	6	CD
10_1101-2020_03_27_012757	618	2	,	,	,
10_1101-2020_03_27_012757	618	3	(	(	-LRB-
10_1101-2020_03_27_012757	618	4	2020	2020	CD
10_1101-2020_03_27_012757	618	5	)	)	-RRB-
10_1101-2020_03_27_012757	618	6	.	.	.
10_1101-2020_03_27_012757	619	1	1029	1029	CD
10_1101-2020_03_27_012757	619	2	18	18	CD
10_1101-2020_03_27_012757	619	3	.	.	.
10_1101-2020_03_27_012757	620	1	Guernet	Guernet	NNP
10_1101-2020_03_27_012757	620	2	,	,	,
10_1101-2020_03_27_012757	620	3	A.	a.	NN
10_1101-2020_03_27_012757	621	1	&	&	CC
10_1101-2020_03_27_012757	621	2	Grumolato	Grumolato	NNP
10_1101-2020_03_27_012757	621	3	,	,	,
10_1101-2020_03_27_012757	621	4	L.	L.	NNP
10_1101-2020_03_27_012757	621	5	CRISPR	CRISPR	NNP
10_1101-2020_03_27_012757	621	6	/	/	SYM
10_1101-2020_03_27_012757	621	7	Cas9	Cas9	NNP
10_1101-2020_03_27_012757	621	8	editing	editing	NN
10_1101-2020_03_27_012757	621	9	of	of	IN
10_1101-2020_03_27_012757	621	10	the	the	DT
10_1101-2020_03_27_012757	621	11	genome	genome	NN
10_1101-2020_03_27_012757	621	12	for	for	IN
10_1101-2020_03_27_012757	621	13	cancer	cancer	NN
10_1101-2020_03_27_012757	621	14	1030	1030	CD
10_1101-2020_03_27_012757	621	15	modeling	modeling	NN
10_1101-2020_03_27_012757	621	16	.	.	.
10_1101-2020_03_27_012757	622	1	Methods	Methods	NNP
10_1101-2020_03_27_012757	622	2	121	121	CD
10_1101-2020_03_27_012757	622	3	-	-	SYM
10_1101-2020_03_27_012757	622	4	122	122	CD
10_1101-2020_03_27_012757	622	5	,	,	,
10_1101-2020_03_27_012757	622	6	130–137	130–137	CD
10_1101-2020_03_27_012757	622	7	(	(	-LRB-
10_1101-2020_03_27_012757	622	8	2017	2017	CD
10_1101-2020_03_27_012757	622	9	)	)	-RRB-
10_1101-2020_03_27_012757	622	10	.	.	.
10_1101-2020_03_27_012757	623	1	1031	1031	CD
10_1101-2020_03_27_012757	623	2	19	19	CD
10_1101-2020_03_27_012757	623	3	.	.	.
10_1101-2020_03_27_012757	624	1	Gargiulo	Gargiulo	NNP
10_1101-2020_03_27_012757	624	2	,	,	,
10_1101-2020_03_27_012757	624	3	G.	G.	NNP
10_1101-2020_03_27_012757	624	4	Next	Next	NNP
10_1101-2020_03_27_012757	624	5	-	-	HYPH
10_1101-2020_03_27_012757	624	6	Generation	Generation	NNP
10_1101-2020_03_27_012757	624	7	in	in	IN
10_1101-2020_03_27_012757	624	8	vivo	vivo	NN
10_1101-2020_03_27_012757	624	9	Modeling	Modeling	NNP
10_1101-2020_03_27_012757	624	10	of	of	IN
10_1101-2020_03_27_012757	624	11	Human	Human	NNP
10_1101-2020_03_27_012757	624	12	Cancers	Cancers	NNPS
10_1101-2020_03_27_012757	624	13	.	.	.
10_1101-2020_03_27_012757	625	1	Front	front	NN
10_1101-2020_03_27_012757	625	2	.	.	.
10_1101-2020_03_27_012757	626	1	Oncol	Oncol	NNP
10_1101-2020_03_27_012757	626	2	.	.	.
10_1101-2020_03_27_012757	627	1	8	8	CD
10_1101-2020_03_27_012757	627	2	,	,	,
10_1101-2020_03_27_012757	627	3	1032	1032	CD
10_1101-2020_03_27_012757	627	4	429	429	CD
10_1101-2020_03_27_012757	627	5	(	(	-LRB-
10_1101-2020_03_27_012757	627	6	2018	2018	CD
10_1101-2020_03_27_012757	627	7	)	)	-RRB-
10_1101-2020_03_27_012757	627	8	.	.	.
10_1101-2020_03_27_012757	628	1	1033	1033	CD
10_1101-2020_03_27_012757	628	2	20	20	CD
10_1101-2020_03_27_012757	628	3	.	.	.
10_1101-2020_03_27_012757	629	1	Gao	Gao	NNP
10_1101-2020_03_27_012757	629	2	,	,	,
10_1101-2020_03_27_012757	629	3	H.	H.	NNP
10_1101-2020_03_27_012757	629	4	et	et	NNP
10_1101-2020_03_27_012757	629	5	al	al	NNP
10_1101-2020_03_27_012757	629	6	.	.	.
10_1101-2020_03_27_012757	630	1	High	high	JJ
10_1101-2020_03_27_012757	630	2	-	-	HYPH
10_1101-2020_03_27_012757	630	3	throughput	throughput	NN
10_1101-2020_03_27_012757	630	4	screening	screening	NN
10_1101-2020_03_27_012757	630	5	using	use	VBG
10_1101-2020_03_27_012757	630	6	patient	patient	NN
10_1101-2020_03_27_012757	630	7	-	-	HYPH
10_1101-2020_03_27_012757	630	8	derived	derive	VBN
10_1101-2020_03_27_012757	630	9	tumor	tumor	NN
10_1101-2020_03_27_012757	630	10	xenografts	xenograft	NNS
10_1101-2020_03_27_012757	630	11	to	to	IN
10_1101-2020_03_27_012757	630	12	1034	1034	CD
10_1101-2020_03_27_012757	630	13	predict	predict	VB
10_1101-2020_03_27_012757	630	14	clinical	clinical	JJ
10_1101-2020_03_27_012757	630	15	trial	trial	NN
10_1101-2020_03_27_012757	630	16	drug	drug	NN
10_1101-2020_03_27_012757	630	17	response	response	NN
10_1101-2020_03_27_012757	630	18	.	.	.
10_1101-2020_03_27_012757	631	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	631	2	.	.	.
10_1101-2020_03_27_012757	632	1	Med	Med	NNP
10_1101-2020_03_27_012757	632	2	.	.	.
10_1101-2020_03_27_012757	633	1	21	21	CD
10_1101-2020_03_27_012757	633	2	,	,	,
10_1101-2020_03_27_012757	633	3	1318–1325	1318–1325	CD
10_1101-2020_03_27_012757	633	4	(	(	-LRB-
10_1101-2020_03_27_012757	633	5	2015	2015	CD
10_1101-2020_03_27_012757	633	6	)	)	-RRB-
10_1101-2020_03_27_012757	633	7	.	.	.
10_1101-2020_03_27_012757	634	1	1035	1035	CD
10_1101-2020_03_27_012757	634	2	21	21	CD
10_1101-2020_03_27_012757	634	3	.	.	.
10_1101-2020_03_27_012757	635	1	Cahan	Cahan	NNP
10_1101-2020_03_27_012757	635	2	,	,	,
10_1101-2020_03_27_012757	635	3	P.	P.	NNP
10_1101-2020_03_27_012757	635	4	et	et	NNP
10_1101-2020_03_27_012757	635	5	al	al	NNP
10_1101-2020_03_27_012757	635	6	.	.	.
10_1101-2020_03_27_012757	636	1	CellNet	CellNet	NNP
10_1101-2020_03_27_012757	636	2	:	:	:
10_1101-2020_03_27_012757	636	3	network	network	NN
10_1101-2020_03_27_012757	636	4	biology	biology	NN
10_1101-2020_03_27_012757	636	5	applied	apply	VBD
10_1101-2020_03_27_012757	636	6	to	to	TO
10_1101-2020_03_27_012757	636	7	stem	stem	VB
10_1101-2020_03_27_012757	636	8	cell	cell	NN
10_1101-2020_03_27_012757	636	9	engineering	engineering	NN
10_1101-2020_03_27_012757	636	10	.	.	.
10_1101-2020_03_27_012757	637	1	Cell	cell	NN
10_1101-2020_03_27_012757	637	2	158	158	CD
10_1101-2020_03_27_012757	637	3	,	,	,
10_1101-2020_03_27_012757	637	4	1036	1036	CD
10_1101-2020_03_27_012757	637	5	903–915	903–915	CD
10_1101-2020_03_27_012757	637	6	(	(	-LRB-
10_1101-2020_03_27_012757	637	7	2014	2014	CD
10_1101-2020_03_27_012757	637	8	)	)	-RRB-
10_1101-2020_03_27_012757	637	9	.	.	.
10_1101-2020_03_27_012757	638	1	1037	1037	CD
10_1101-2020_03_27_012757	638	2	22	22	CD
10_1101-2020_03_27_012757	638	3	.	.	.
10_1101-2020_03_27_012757	639	1	Radley	Radley	NNP
10_1101-2020_03_27_012757	639	2	,	,	,
10_1101-2020_03_27_012757	639	3	A.	A.	NNP
10_1101-2020_03_27_012757	639	4	H.	H.	NNP
10_1101-2020_03_27_012757	639	5	et	et	NNP
10_1101-2020_03_27_012757	639	6	al	al	NNP
10_1101-2020_03_27_012757	639	7	.	.	.
10_1101-2020_03_27_012757	640	1	Assessment	assessment	NN
10_1101-2020_03_27_012757	640	2	of	of	IN
10_1101-2020_03_27_012757	640	3	engineered	engineered	JJ
10_1101-2020_03_27_012757	640	4	cells	cell	NNS
10_1101-2020_03_27_012757	640	5	using	use	VBG
10_1101-2020_03_27_012757	640	6	CellNet	CellNet	NNP
10_1101-2020_03_27_012757	640	7	and	and	CC
10_1101-2020_03_27_012757	640	8	RNA	RNA	NNP
10_1101-2020_03_27_012757	640	9	-	-	HYPH
10_1101-2020_03_27_012757	640	10	seq	seq	NNP
10_1101-2020_03_27_012757	640	11	.	.	.
10_1101-2020_03_27_012757	641	1	1038	1038	CD
10_1101-2020_03_27_012757	641	2	Nat	Nat	NNP
10_1101-2020_03_27_012757	641	3	.	.	.
10_1101-2020_03_27_012757	642	1	Protoc	Protoc	NNP
10_1101-2020_03_27_012757	642	2	.	.	.
10_1101-2020_03_27_012757	643	1	12	12	CD
10_1101-2020_03_27_012757	643	2	,	,	,
10_1101-2020_03_27_012757	643	3	1089–1102	1089–1102	CD
10_1101-2020_03_27_012757	643	4	(	(	-LRB-
10_1101-2020_03_27_012757	643	5	2017	2017	CD
10_1101-2020_03_27_012757	643	6	)	)	-RRB-
10_1101-2020_03_27_012757	643	7	.	.	.
10_1101-2020_03_27_012757	644	1	1039	1039	CD
10_1101-2020_03_27_012757	644	2	23	23	CD
10_1101-2020_03_27_012757	644	3	.	.	.
10_1101-2020_03_27_012757	645	1	Tan	Tan	NNP
10_1101-2020_03_27_012757	645	2	,	,	,
10_1101-2020_03_27_012757	645	3	Y.	Y.	NNP
10_1101-2020_03_27_012757	646	1	&	&	CC
10_1101-2020_03_27_012757	646	2	Cahan	Cahan	NNP
10_1101-2020_03_27_012757	646	3	,	,	,
10_1101-2020_03_27_012757	646	4	P.	P.	NNP
10_1101-2020_03_27_012757	646	5	SingleCellNet	singlecellnet	XX
10_1101-2020_03_27_012757	646	6	:	:	:
10_1101-2020_03_27_012757	646	7	A	a	DT
10_1101-2020_03_27_012757	646	8	Computational	Computational	NNP
10_1101-2020_03_27_012757	646	9	Tool	Tool	NNP
10_1101-2020_03_27_012757	646	10	to	to	TO
10_1101-2020_03_27_012757	646	11	Classify	classify	VB
10_1101-2020_03_27_012757	646	12	Single	single	JJ
10_1101-2020_03_27_012757	646	13	Cell	cell	NN
10_1101-2020_03_27_012757	646	14	1040	1040	CD
10_1101-2020_03_27_012757	646	15	RNA	RNA	NNP
10_1101-2020_03_27_012757	646	16	-	-	HYPH
10_1101-2020_03_27_012757	646	17	Seq	Seq	NNP
10_1101-2020_03_27_012757	646	18	Data	Data	NNPS
10_1101-2020_03_27_012757	646	19	Across	Across	NNP
10_1101-2020_03_27_012757	646	20	Platforms	Platforms	NNPS
10_1101-2020_03_27_012757	646	21	and	and	CC
10_1101-2020_03_27_012757	646	22	Across	Across	NNP
10_1101-2020_03_27_012757	646	23	Species	Species	NNPS
10_1101-2020_03_27_012757	646	24	.	.	.
10_1101-2020_03_27_012757	647	1	Cell	Cell	NNP
10_1101-2020_03_27_012757	647	2	Syst	Syst	NNP
10_1101-2020_03_27_012757	647	3	.	.	.
10_1101-2020_03_27_012757	648	1	9	9	CD
10_1101-2020_03_27_012757	648	2	,	,	,
10_1101-2020_03_27_012757	648	3	207–213.e2	207–213.e2	NNS
10_1101-2020_03_27_012757	648	4	1041	1041	CD
10_1101-2020_03_27_012757	648	5	(	(	-LRB-
10_1101-2020_03_27_012757	648	6	2019	2019	CD
10_1101-2020_03_27_012757	648	7	)	)	-RRB-
10_1101-2020_03_27_012757	648	8	.	.	.
10_1101-2020_03_27_012757	649	1	1042	1042	CD
10_1101-2020_03_27_012757	649	2	24	24	CD
10_1101-2020_03_27_012757	649	3	.	.	.
10_1101-2020_03_27_012757	650	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	650	2	Genome	Genome	NNP
10_1101-2020_03_27_012757	650	3	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	650	4	Network	Network	NNP
10_1101-2020_03_27_012757	650	5	.	.	.
10_1101-2020_03_27_012757	651	1	Comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	651	2	molecular	molecular	JJ
10_1101-2020_03_27_012757	651	3	characterization	characterization	NN
10_1101-2020_03_27_012757	651	4	of	of	IN
10_1101-2020_03_27_012757	651	5	1043	1043	CD
10_1101-2020_03_27_012757	651	6	human	human	JJ
10_1101-2020_03_27_012757	651	7	colon	colon	NN
10_1101-2020_03_27_012757	651	8	and	and	CC
10_1101-2020_03_27_012757	651	9	rectal	rectal	JJ
10_1101-2020_03_27_012757	651	10	cancer	cancer	NN
10_1101-2020_03_27_012757	651	11	.	.	.
10_1101-2020_03_27_012757	652	1	Nature	nature	NN
10_1101-2020_03_27_012757	652	2	487	487	CD
10_1101-2020_03_27_012757	652	3	,	,	,
10_1101-2020_03_27_012757	652	4	330–337	330–337	CD
10_1101-2020_03_27_012757	652	5	(	(	-LRB-
10_1101-2020_03_27_012757	652	6	2012	2012	CD
10_1101-2020_03_27_012757	652	7	)	)	-RRB-
10_1101-2020_03_27_012757	652	8	.	.	.
10_1101-2020_03_27_012757	653	1	1044	1044	CD
10_1101-2020_03_27_012757	653	2	25	25	CD
10_1101-2020_03_27_012757	653	3	.	.	.
10_1101-2020_03_27_012757	654	1	Zhang	Zhang	NNP
10_1101-2020_03_27_012757	654	2	,	,	,
10_1101-2020_03_27_012757	654	3	J.	J.	NNP
10_1101-2020_03_27_012757	654	4	et	et	NNP
10_1101-2020_03_27_012757	654	5	al	al	NNP
10_1101-2020_03_27_012757	654	6	.	.	.
10_1101-2020_03_27_012757	655	1	International	International	NNP
10_1101-2020_03_27_012757	655	2	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	655	3	Genome	Genome	NNP
10_1101-2020_03_27_012757	655	4	Consortium	Consortium	NNP
10_1101-2020_03_27_012757	655	5	Data	Data	NNP
10_1101-2020_03_27_012757	655	6	Portal	Portal	NNP
10_1101-2020_03_27_012757	655	7	--	--	:
10_1101-2020_03_27_012757	655	8	a	a	DT
10_1101-2020_03_27_012757	655	9	one	one	CD
10_1101-2020_03_27_012757	655	10	-	-	HYPH
10_1101-2020_03_27_012757	655	11	stop	stop	NN
10_1101-2020_03_27_012757	655	12	1045	1045	CD
10_1101-2020_03_27_012757	655	13	shop	shop	NN
10_1101-2020_03_27_012757	655	14	for	for	IN
10_1101-2020_03_27_012757	655	15	cancer	cancer	NN
10_1101-2020_03_27_012757	655	16	genomics	genomic	NNS
10_1101-2020_03_27_012757	655	17	data	datum	NNS
10_1101-2020_03_27_012757	655	18	.	.	.
10_1101-2020_03_27_012757	656	1	Database	Database	NNP
10_1101-2020_03_27_012757	656	2	(	(	-LRB-
10_1101-2020_03_27_012757	656	3	Oxford	Oxford	NNP
10_1101-2020_03_27_012757	656	4	)	)	-RRB-
10_1101-2020_03_27_012757	656	5	2011	2011	CD
10_1101-2020_03_27_012757	656	6	,	,	,
10_1101-2020_03_27_012757	656	7	bar026	bar026	NFP
10_1101-2020_03_27_012757	656	8	(	(	-LRB-
10_1101-2020_03_27_012757	656	9	2011	2011	CD
10_1101-2020_03_27_012757	656	10	)	)	-RRB-
10_1101-2020_03_27_012757	656	11	.	.	.
10_1101-2020_03_27_012757	657	1	1046	1046	CD
10_1101-2020_03_27_012757	657	2	26	26	CD
10_1101-2020_03_27_012757	657	3	.	.	.
10_1101-2020_03_27_012757	658	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	658	2	Genome	Genome	NNP
10_1101-2020_03_27_012757	658	3	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	658	4	Network	Network	NNP
10_1101-2020_03_27_012757	658	5	.	.	.
10_1101-2020_03_27_012757	659	1	Comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	659	2	molecular	molecular	JJ
10_1101-2020_03_27_012757	659	3	portraits	portrait	NNS
10_1101-2020_03_27_012757	659	4	of	of	IN
10_1101-2020_03_27_012757	659	5	human	human	JJ
10_1101-2020_03_27_012757	659	6	1047	1047	CD
10_1101-2020_03_27_012757	659	7	breast	breast	NN
10_1101-2020_03_27_012757	659	8	tumours	tumour	NNS
10_1101-2020_03_27_012757	659	9	.	.	.
10_1101-2020_03_27_012757	660	1	Nature	nature	NN
10_1101-2020_03_27_012757	660	2	490	490	CD
10_1101-2020_03_27_012757	660	3	,	,	,
10_1101-2020_03_27_012757	660	4	61–70	61–70	CD
10_1101-2020_03_27_012757	660	5	(	(	-LRB-
10_1101-2020_03_27_012757	660	6	2012	2012	CD
10_1101-2020_03_27_012757	660	7	)	)	-RRB-
10_1101-2020_03_27_012757	660	8	.	.	.
10_1101-2020_03_27_012757	661	1	1048	1048	CD
10_1101-2020_03_27_012757	661	2	27	27	CD
10_1101-2020_03_27_012757	661	3	.	.	.
10_1101-2020_03_27_012757	662	1	Parker	Parker	NNP
10_1101-2020_03_27_012757	662	2	,	,	,
10_1101-2020_03_27_012757	662	3	J.	J.	NNP
10_1101-2020_03_27_012757	662	4	S.	S.	NNP
10_1101-2020_03_27_012757	662	5	et	et	NNP
10_1101-2020_03_27_012757	662	6	al	al	NNP
10_1101-2020_03_27_012757	662	7	.	.	.
10_1101-2020_03_27_012757	663	1	Supervised	supervise	VBN
10_1101-2020_03_27_012757	663	2	risk	risk	NN
10_1101-2020_03_27_012757	663	3	predictor	predictor	NN
10_1101-2020_03_27_012757	663	4	of	of	IN
10_1101-2020_03_27_012757	663	5	breast	breast	NN
10_1101-2020_03_27_012757	663	6	cancer	cancer	NN
10_1101-2020_03_27_012757	663	7	based	base	VBN
10_1101-2020_03_27_012757	663	8	on	on	IN
10_1101-2020_03_27_012757	663	9	intrinsic	intrinsic	JJ
10_1101-2020_03_27_012757	663	10	1049	1049	CD
10_1101-2020_03_27_012757	663	11	subtypes	subtype	NNS
10_1101-2020_03_27_012757	663	12	.	.	.
10_1101-2020_03_27_012757	664	1	J.	J.	NNP
10_1101-2020_03_27_012757	664	2	Clin	Clin	NNP
10_1101-2020_03_27_012757	664	3	.	.	.
10_1101-2020_03_27_012757	665	1	Oncol	Oncol	NNP
10_1101-2020_03_27_012757	665	2	.	.	.
10_1101-2020_03_27_012757	666	1	27	27	CD
10_1101-2020_03_27_012757	666	2	,	,	,
10_1101-2020_03_27_012757	666	3	1160–1167	1160–1167	CD
10_1101-2020_03_27_012757	666	4	(	(	-LRB-
10_1101-2020_03_27_012757	666	5	2009	2009	CD
10_1101-2020_03_27_012757	666	6	)	)	-RRB-
10_1101-2020_03_27_012757	666	7	.	.	.
10_1101-2020_03_27_012757	667	1	1050	1050	CD
10_1101-2020_03_27_012757	667	2	.CC	.CC	:
10_1101-2020_03_27_012757	667	3	-	-	:
10_1101-2020_03_27_012757	667	4	BY	by	IN
10_1101-2020_03_27_012757	667	5	-	-	HYPH
10_1101-2020_03_27_012757	667	6	NC	NC	NNP
10_1101-2020_03_27_012757	667	7	-	-	HYPH
10_1101-2020_03_27_012757	667	8	ND	ND	NNP
10_1101-2020_03_27_012757	667	9	4.0	4.0	CD
10_1101-2020_03_27_012757	667	10	International	International	NNP
10_1101-2020_03_27_012757	667	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	667	12	under	under	IN
10_1101-2020_03_27_012757	667	13	a	a	DT
10_1101-2020_03_27_012757	667	14	(	(	-LRB-
10_1101-2020_03_27_012757	667	15	which	which	WDT
10_1101-2020_03_27_012757	667	16	was	be	VBD
10_1101-2020_03_27_012757	667	17	not	not	RB
10_1101-2020_03_27_012757	667	18	certified	certify	VBN
10_1101-2020_03_27_012757	667	19	by	by	IN
10_1101-2020_03_27_012757	667	20	peer	peer	NN
10_1101-2020_03_27_012757	667	21	review	review	NN
10_1101-2020_03_27_012757	667	22	)	)	-RRB-
10_1101-2020_03_27_012757	667	23	is	be	VBZ
10_1101-2020_03_27_012757	667	24	the	the	DT
10_1101-2020_03_27_012757	667	25	author	author	NN
10_1101-2020_03_27_012757	667	26	/	/	SYM
10_1101-2020_03_27_012757	667	27	funder	funder	NN
10_1101-2020_03_27_012757	667	28	,	,	,
10_1101-2020_03_27_012757	667	29	who	who	WP
10_1101-2020_03_27_012757	667	30	has	have	VBZ
10_1101-2020_03_27_012757	667	31	granted	grant	VBN
10_1101-2020_03_27_012757	667	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	667	33	a	a	DT
10_1101-2020_03_27_012757	667	34	license	license	NN
10_1101-2020_03_27_012757	667	35	to	to	TO
10_1101-2020_03_27_012757	667	36	display	display	VB
10_1101-2020_03_27_012757	667	37	the	the	DT
10_1101-2020_03_27_012757	667	38	preprint	preprint	NN
10_1101-2020_03_27_012757	667	39	in	in	IN
10_1101-2020_03_27_012757	667	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	667	41	.	.	.
10_1101-2020_03_27_012757	668	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	668	2	is	be	VBZ
10_1101-2020_03_27_012757	668	3	made	make	VBN
10_1101-2020_03_27_012757	668	4	The	the	DT
10_1101-2020_03_27_012757	668	5	copyright	copyright	NN
10_1101-2020_03_27_012757	668	6	holder	holder	NN
10_1101-2020_03_27_012757	668	7	for	for	IN
10_1101-2020_03_27_012757	668	8	this	this	DT
10_1101-2020_03_27_012757	668	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	668	10	version	version	NN
10_1101-2020_03_27_012757	668	11	posted	post	VBD
10_1101-2020_03_27_012757	668	12	January	January	NNP
10_1101-2020_03_27_012757	668	13	9	9	CD
10_1101-2020_03_27_012757	668	14	,	,	,
10_1101-2020_03_27_012757	668	15	2021	2021	CD
10_1101-2020_03_27_012757	668	16	.	.	.
10_1101-2020_03_27_012757	668	17	;	;	:
10_1101-2020_03_27_012757	668	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	668	19	:	:	:
10_1101-2020_03_27_012757	668	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	668	21	preprint	preprint	NN
10_1101-2020_03_27_012757	668	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	668	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	668	24	39	39	CD
10_1101-2020_03_27_012757	668	25	28	28	CD
10_1101-2020_03_27_012757	668	26	.	.	.
10_1101-2020_03_27_012757	669	1	Wilkerson	Wilkerson	NNP
10_1101-2020_03_27_012757	669	2	,	,	,
10_1101-2020_03_27_012757	669	3	M.	M.	NNP
10_1101-2020_03_27_012757	669	4	D.	D.	NNP
10_1101-2020_03_27_012757	669	5	et	et	NNP
10_1101-2020_03_27_012757	669	6	al	al	NNP
10_1101-2020_03_27_012757	669	7	.	.	.
10_1101-2020_03_27_012757	670	1	Lung	Lung	NNP
10_1101-2020_03_27_012757	670	2	squamous	squamous	JJ
10_1101-2020_03_27_012757	670	3	cell	cell	NN
10_1101-2020_03_27_012757	670	4	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	670	5	mRNA	mRNA	NNP
10_1101-2020_03_27_012757	670	6	expression	expression	NNP
10_1101-2020_03_27_012757	670	7	subtypes	subtype	NNS
10_1101-2020_03_27_012757	670	8	1051	1051	CD
10_1101-2020_03_27_012757	670	9	are	be	VBP
10_1101-2020_03_27_012757	670	10	reproducible	reproducible	JJ
10_1101-2020_03_27_012757	670	11	,	,	,
10_1101-2020_03_27_012757	670	12	clinically	clinically	RB
10_1101-2020_03_27_012757	670	13	important	important	JJ
10_1101-2020_03_27_012757	670	14	,	,	,
10_1101-2020_03_27_012757	670	15	and	and	CC
10_1101-2020_03_27_012757	670	16	correspond	correspond	VB
10_1101-2020_03_27_012757	670	17	to	to	IN
10_1101-2020_03_27_012757	670	18	normal	normal	JJ
10_1101-2020_03_27_012757	670	19	cell	cell	NN
10_1101-2020_03_27_012757	670	20	types	type	NNS
10_1101-2020_03_27_012757	670	21	.	.	.
10_1101-2020_03_27_012757	671	1	Clin	Clin	NNP
10_1101-2020_03_27_012757	671	2	.	.	.
10_1101-2020_03_27_012757	672	1	1052	1052	CD
10_1101-2020_03_27_012757	672	2	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	672	3	Res	Res	NNP
10_1101-2020_03_27_012757	672	4	.	.	.
10_1101-2020_03_27_012757	673	1	16	16	CD
10_1101-2020_03_27_012757	673	2	,	,	,
10_1101-2020_03_27_012757	673	3	4864–4875	4864–4875	CD
10_1101-2020_03_27_012757	673	4	(	(	-LRB-
10_1101-2020_03_27_012757	673	5	2010	2010	CD
10_1101-2020_03_27_012757	673	6	)	)	-RRB-
10_1101-2020_03_27_012757	673	7	.	.	.
10_1101-2020_03_27_012757	674	1	1053	1053	CD
10_1101-2020_03_27_012757	674	2	29	29	CD
10_1101-2020_03_27_012757	674	3	.	.	.
10_1101-2020_03_27_012757	675	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	675	2	Genome	Genome	NNP
10_1101-2020_03_27_012757	675	3	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	675	4	Research	Research	NNP
10_1101-2020_03_27_012757	675	5	Network	Network	NNP
10_1101-2020_03_27_012757	675	6	.	.	.
10_1101-2020_03_27_012757	676	1	Electronic	electronic	JJ
10_1101-2020_03_27_012757	676	2	address	address	NN
10_1101-2020_03_27_012757	676	3	:	:	:
10_1101-2020_03_27_012757	676	4	1054	1054	CD
10_1101-2020_03_27_012757	676	5	andrew_aguirre@dfci.harvard.edu	andrew_aguirre@dfci.harvard.edu	NNP
10_1101-2020_03_27_012757	676	6	&	&	CC
10_1101-2020_03_27_012757	676	7	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	676	8	Genome	Genome	NNP
10_1101-2020_03_27_012757	676	9	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	676	10	Research	Research	NNP
10_1101-2020_03_27_012757	676	11	Network	Network	NNP
10_1101-2020_03_27_012757	676	12	.	.	.
10_1101-2020_03_27_012757	677	1	1055	1055	CD
10_1101-2020_03_27_012757	677	2	Integrated	integrated	JJ
10_1101-2020_03_27_012757	677	3	genomic	genomic	JJ
10_1101-2020_03_27_012757	677	4	characterization	characterization	NN
10_1101-2020_03_27_012757	677	5	of	of	IN
10_1101-2020_03_27_012757	677	6	pancreatic	pancreatic	JJ
10_1101-2020_03_27_012757	677	7	ductal	ductal	JJ
10_1101-2020_03_27_012757	677	8	adenocarcinoma	adenocarcinoma	NN
10_1101-2020_03_27_012757	677	9	.	.	.
10_1101-2020_03_27_012757	678	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	678	2	1056	1056	CD
10_1101-2020_03_27_012757	678	3	Cell	Cell	NNP
10_1101-2020_03_27_012757	678	4	32	32	CD
10_1101-2020_03_27_012757	678	5	,	,	,
10_1101-2020_03_27_012757	678	6	185–203.e13	185–203.e13	CD
10_1101-2020_03_27_012757	678	7	(	(	-LRB-
10_1101-2020_03_27_012757	678	8	2017	2017	CD
10_1101-2020_03_27_012757	678	9	)	)	-RRB-
10_1101-2020_03_27_012757	678	10	.	.	.
10_1101-2020_03_27_012757	679	1	1057	1057	CD
10_1101-2020_03_27_012757	679	2	30	30	CD
10_1101-2020_03_27_012757	679	3	.	.	.
10_1101-2020_03_27_012757	680	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	680	2	Genome	Genome	NNP
10_1101-2020_03_27_012757	680	3	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	680	4	Research	Research	NNP
10_1101-2020_03_27_012757	680	5	Network	Network	NNP
10_1101-2020_03_27_012757	680	6	et	et	NNP
10_1101-2020_03_27_012757	680	7	al	al	NNP
10_1101-2020_03_27_012757	680	8	.	.	.
10_1101-2020_03_27_012757	681	1	Integrated	integrate	VBN
10_1101-2020_03_27_012757	681	2	genomic	genomic	JJ
10_1101-2020_03_27_012757	681	3	characterization	characterization	NN
10_1101-2020_03_27_012757	681	4	1058	1058	CD
10_1101-2020_03_27_012757	681	5	of	of	IN
10_1101-2020_03_27_012757	681	6	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	681	7	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	681	8	.	.	.
10_1101-2020_03_27_012757	682	1	Nature	nature	NN
10_1101-2020_03_27_012757	682	2	497	497	CD
10_1101-2020_03_27_012757	682	3	,	,	,
10_1101-2020_03_27_012757	682	4	67–73	67–73	CD
10_1101-2020_03_27_012757	682	5	(	(	-LRB-
10_1101-2020_03_27_012757	682	6	2013	2013	CD
10_1101-2020_03_27_012757	682	7	)	)	-RRB-
10_1101-2020_03_27_012757	682	8	.	.	.
10_1101-2020_03_27_012757	683	1	1059	1059	CD
10_1101-2020_03_27_012757	683	2	31	31	CD
10_1101-2020_03_27_012757	683	3	.	.	.
10_1101-2020_03_27_012757	684	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	684	2	Genome	Genome	NNP
10_1101-2020_03_27_012757	684	3	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	684	4	Research	Research	NNP
10_1101-2020_03_27_012757	684	5	Network	Network	NNP
10_1101-2020_03_27_012757	684	6	et	et	NNP
10_1101-2020_03_27_012757	684	7	al	al	NNP
10_1101-2020_03_27_012757	684	8	.	.	.
10_1101-2020_03_27_012757	685	1	Integrated	integrate	VBN
10_1101-2020_03_27_012757	685	2	genomic	genomic	JJ
10_1101-2020_03_27_012757	685	3	characterization	characterization	NN
10_1101-2020_03_27_012757	685	4	1060	1060	CD
10_1101-2020_03_27_012757	685	5	of	of	IN
10_1101-2020_03_27_012757	685	6	oesophageal	oesophageal	JJ
10_1101-2020_03_27_012757	685	7	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	685	8	.	.	.
10_1101-2020_03_27_012757	686	1	Nature	nature	NN
10_1101-2020_03_27_012757	686	2	541	541	CD
10_1101-2020_03_27_012757	686	3	,	,	,
10_1101-2020_03_27_012757	686	4	169–175	169–175	CD
10_1101-2020_03_27_012757	686	5	(	(	-LRB-
10_1101-2020_03_27_012757	686	6	2017	2017	CD
10_1101-2020_03_27_012757	686	7	)	)	-RRB-
10_1101-2020_03_27_012757	686	8	.	.	.
10_1101-2020_03_27_012757	687	1	1061	1061	CD
10_1101-2020_03_27_012757	687	2	32	32	CD
10_1101-2020_03_27_012757	687	3	.	.	.
10_1101-2020_03_27_012757	688	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	688	2	Genome	Genome	NNP
10_1101-2020_03_27_012757	688	3	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	688	4	Network	Network	NNP
10_1101-2020_03_27_012757	688	5	.	.	.
10_1101-2020_03_27_012757	689	1	Comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	689	2	genomic	genomic	JJ
10_1101-2020_03_27_012757	689	3	characterization	characterization	NN
10_1101-2020_03_27_012757	689	4	of	of	IN
10_1101-2020_03_27_012757	689	5	head	head	NN
10_1101-2020_03_27_012757	689	6	1062	1062	CD
10_1101-2020_03_27_012757	689	7	and	and	CC
10_1101-2020_03_27_012757	689	8	neck	neck	NN
10_1101-2020_03_27_012757	689	9	squamous	squamous	JJ
10_1101-2020_03_27_012757	689	10	cell	cell	NN
10_1101-2020_03_27_012757	689	11	carcinomas	carcinoma	NNS
10_1101-2020_03_27_012757	689	12	.	.	.
10_1101-2020_03_27_012757	690	1	Nature	nature	NN
10_1101-2020_03_27_012757	690	2	517	517	CD
10_1101-2020_03_27_012757	690	3	,	,	,
10_1101-2020_03_27_012757	690	4	576–582	576–582	NNP
10_1101-2020_03_27_012757	690	5	(	(	-LRB-
10_1101-2020_03_27_012757	690	6	2015	2015	CD
10_1101-2020_03_27_012757	690	7	)	)	-RRB-
10_1101-2020_03_27_012757	690	8	.	.	.
10_1101-2020_03_27_012757	691	1	1063	1063	CD
10_1101-2020_03_27_012757	691	2	33	33	CD
10_1101-2020_03_27_012757	691	3	.	.	.
10_1101-2020_03_27_012757	692	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	692	2	Genome	Genome	NNP
10_1101-2020_03_27_012757	692	3	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	692	4	Research	Research	NNP
10_1101-2020_03_27_012757	692	5	Network	Network	NNP
10_1101-2020_03_27_012757	692	6	.	.	.
10_1101-2020_03_27_012757	693	1	Comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	693	2	molecular	molecular	JJ
10_1101-2020_03_27_012757	693	3	1064	1064	CD
10_1101-2020_03_27_012757	693	4	characterization	characterization	NN
10_1101-2020_03_27_012757	693	5	of	of	IN
10_1101-2020_03_27_012757	693	6	clear	clear	JJ
10_1101-2020_03_27_012757	693	7	cell	cell	NN
10_1101-2020_03_27_012757	693	8	renal	renal	JJ
10_1101-2020_03_27_012757	693	9	cell	cell	NN
10_1101-2020_03_27_012757	693	10	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	693	11	.	.	.
10_1101-2020_03_27_012757	694	1	Nature	nature	NN
10_1101-2020_03_27_012757	694	2	499	499	CD
10_1101-2020_03_27_012757	694	3	,	,	,
10_1101-2020_03_27_012757	694	4	43–49	43–49	CD
10_1101-2020_03_27_012757	694	5	(	(	-LRB-
10_1101-2020_03_27_012757	694	6	2013	2013	CD
10_1101-2020_03_27_012757	694	7	)	)	-RRB-
10_1101-2020_03_27_012757	694	8	.	.	.
10_1101-2020_03_27_012757	695	1	1065	1065	CD
10_1101-2020_03_27_012757	695	2	34	34	CD
10_1101-2020_03_27_012757	695	3	.	.	.
10_1101-2020_03_27_012757	696	1	Verhaak	Verhaak	NNP
10_1101-2020_03_27_012757	696	2	,	,	,
10_1101-2020_03_27_012757	696	3	R.	R.	NNP
10_1101-2020_03_27_012757	696	4	G.	G.	NNP
10_1101-2020_03_27_012757	696	5	W.	W.	NNP
10_1101-2020_03_27_012757	696	6	et	et	NNP
10_1101-2020_03_27_012757	696	7	al	al	NNP
10_1101-2020_03_27_012757	696	8	.	.	.
10_1101-2020_03_27_012757	697	1	Integrated	integrate	VBN
10_1101-2020_03_27_012757	697	2	genomic	genomic	JJ
10_1101-2020_03_27_012757	697	3	analysis	analysis	NN
10_1101-2020_03_27_012757	697	4	identifies	identifie	NNS
10_1101-2020_03_27_012757	697	5	clinically	clinically	RB
10_1101-2020_03_27_012757	697	6	relevant	relevant	JJ
10_1101-2020_03_27_012757	697	7	1066	1066	CD
10_1101-2020_03_27_012757	697	8	subtypes	subtype	NNS
10_1101-2020_03_27_012757	697	9	of	of	IN
10_1101-2020_03_27_012757	697	10	glioblastoma	glioblastoma	NNP
10_1101-2020_03_27_012757	697	11	characterized	characterize	VBN
10_1101-2020_03_27_012757	697	12	by	by	IN
10_1101-2020_03_27_012757	697	13	abnormalities	abnormality	NNS
10_1101-2020_03_27_012757	697	14	in	in	IN
10_1101-2020_03_27_012757	697	15	PDGFRA	PDGFRA	NNP
10_1101-2020_03_27_012757	697	16	,	,	,
10_1101-2020_03_27_012757	697	17	IDH1	IDH1	NNP
10_1101-2020_03_27_012757	697	18	,	,	,
10_1101-2020_03_27_012757	697	19	EGFR	EGFR	NNP
10_1101-2020_03_27_012757	697	20	,	,	,
10_1101-2020_03_27_012757	697	21	1067	1067	CD
10_1101-2020_03_27_012757	697	22	and	and	CC
10_1101-2020_03_27_012757	697	23	NF1	NF1	NNP
10_1101-2020_03_27_012757	697	24	.	.	.
10_1101-2020_03_27_012757	698	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	698	2	Cell	Cell	NNP
10_1101-2020_03_27_012757	698	3	17	17	CD
10_1101-2020_03_27_012757	698	4	,	,	,
10_1101-2020_03_27_012757	698	5	98–110	98–110	CD
10_1101-2020_03_27_012757	698	6	(	(	-LRB-
10_1101-2020_03_27_012757	698	7	2010	2010	CD
10_1101-2020_03_27_012757	698	8	)	)	-RRB-
10_1101-2020_03_27_012757	698	9	.	.	.
10_1101-2020_03_27_012757	699	1	1068	1068	CD
10_1101-2020_03_27_012757	699	2	35	35	CD
10_1101-2020_03_27_012757	699	3	.	.	.
10_1101-2020_03_27_012757	700	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	700	2	Genome	Genome	NNP
10_1101-2020_03_27_012757	700	3	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	700	4	Research	Research	NNP
10_1101-2020_03_27_012757	700	5	Network	Network	NNP
10_1101-2020_03_27_012757	700	6	.	.	.
10_1101-2020_03_27_012757	701	1	Comprehensive	comprehensive	JJ
10_1101-2020_03_27_012757	701	2	molecular	molecular	JJ
10_1101-2020_03_27_012757	701	3	profiling	profiling	NN
10_1101-2020_03_27_012757	701	4	of	of	IN
10_1101-2020_03_27_012757	701	5	1069	1069	CD
10_1101-2020_03_27_012757	701	6	lung	lung	NN
10_1101-2020_03_27_012757	701	7	adenocarcinoma	adenocarcinoma	NNP
10_1101-2020_03_27_012757	701	8	.	.	.
10_1101-2020_03_27_012757	702	1	Nature	nature	NN
10_1101-2020_03_27_012757	702	2	511	511	CD
10_1101-2020_03_27_012757	702	3	,	,	,
10_1101-2020_03_27_012757	702	4	543–550	543–550	CD
10_1101-2020_03_27_012757	702	5	(	(	-LRB-
10_1101-2020_03_27_012757	702	6	2014	2014	CD
10_1101-2020_03_27_012757	702	7	)	)	-RRB-
10_1101-2020_03_27_012757	702	8	.	.	.
10_1101-2020_03_27_012757	703	1	1070	1070	CD
10_1101-2020_03_27_012757	703	2	36	36	CD
10_1101-2020_03_27_012757	703	3	.	.	.
10_1101-2020_03_27_012757	704	1	Hu	Hu	NNP
10_1101-2020_03_27_012757	704	2	,	,	,
10_1101-2020_03_27_012757	704	3	B.	B.	NNP
10_1101-2020_03_27_012757	704	4	et	et	NNP
10_1101-2020_03_27_012757	704	5	al	al	NNP
10_1101-2020_03_27_012757	704	6	.	.	.
10_1101-2020_03_27_012757	705	1	Gastric	gastric	JJ
10_1101-2020_03_27_012757	705	2	cancer	cancer	NN
10_1101-2020_03_27_012757	705	3	:	:	:
10_1101-2020_03_27_012757	705	4	Classification	classification	NN
10_1101-2020_03_27_012757	705	5	,	,	,
10_1101-2020_03_27_012757	705	6	histology	histology	NN
10_1101-2020_03_27_012757	705	7	and	and	CC
10_1101-2020_03_27_012757	705	8	application	application	NN
10_1101-2020_03_27_012757	705	9	of	of	IN
10_1101-2020_03_27_012757	705	10	molecular	molecular	JJ
10_1101-2020_03_27_012757	705	11	1071	1071	CD
10_1101-2020_03_27_012757	705	12	pathology	pathology	NN
10_1101-2020_03_27_012757	705	13	.	.	.
10_1101-2020_03_27_012757	706	1	J.	J.	NNP
10_1101-2020_03_27_012757	706	2	Gastrointest	Gastrointest	NNP
10_1101-2020_03_27_012757	706	3	.	.	.
10_1101-2020_03_27_012757	707	1	Oncol	Oncol	NNP
10_1101-2020_03_27_012757	707	2	.	.	.
10_1101-2020_03_27_012757	708	1	3	3	CD
10_1101-2020_03_27_012757	708	2	,	,	,
10_1101-2020_03_27_012757	708	3	251–261	251–261	CD
10_1101-2020_03_27_012757	708	4	(	(	-LRB-
10_1101-2020_03_27_012757	708	5	2012	2012	CD
10_1101-2020_03_27_012757	708	6	)	)	-RRB-
10_1101-2020_03_27_012757	708	7	.	.	.
10_1101-2020_03_27_012757	709	1	1072	1072	CD
10_1101-2020_03_27_012757	709	2	37	37	CD
10_1101-2020_03_27_012757	709	3	.	.	.
10_1101-2020_03_27_012757	710	1	Barretina	Barretina	NNP
10_1101-2020_03_27_012757	710	2	,	,	,
10_1101-2020_03_27_012757	710	3	J.	J.	NNP
10_1101-2020_03_27_012757	710	4	et	et	NNP
10_1101-2020_03_27_012757	710	5	al	al	NNP
10_1101-2020_03_27_012757	710	6	.	.	.
10_1101-2020_03_27_012757	711	1	The	the	DT
10_1101-2020_03_27_012757	711	2	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	711	3	Cell	Cell	NNP
10_1101-2020_03_27_012757	711	4	Line	Line	NNP
10_1101-2020_03_27_012757	711	5	Encyclopedia	Encyclopedia	NNP
10_1101-2020_03_27_012757	711	6	enables	enable	VBZ
10_1101-2020_03_27_012757	711	7	predictive	predictive	JJ
10_1101-2020_03_27_012757	711	8	modelling	modelling	NN
10_1101-2020_03_27_012757	711	9	1073	1073	CD
10_1101-2020_03_27_012757	711	10	of	of	IN
10_1101-2020_03_27_012757	711	11	anticancer	anticancer	NN
10_1101-2020_03_27_012757	711	12	drug	drug	NN
10_1101-2020_03_27_012757	711	13	sensitivity	sensitivity	NN
10_1101-2020_03_27_012757	711	14	.	.	.
10_1101-2020_03_27_012757	712	1	Nature	nature	NN
10_1101-2020_03_27_012757	712	2	483	483	CD
10_1101-2020_03_27_012757	712	3	,	,	,
10_1101-2020_03_27_012757	712	4	603–607	603–607	CD
10_1101-2020_03_27_012757	712	5	(	(	-LRB-
10_1101-2020_03_27_012757	712	6	2012	2012	CD
10_1101-2020_03_27_012757	712	7	)	)	-RRB-
10_1101-2020_03_27_012757	712	8	.	.	.
10_1101-2020_03_27_012757	713	1	1074	1074	CD
10_1101-2020_03_27_012757	713	2	38	38	CD
10_1101-2020_03_27_012757	713	3	.	.	.
10_1101-2020_03_27_012757	714	1	Medico	Medico	NNP
10_1101-2020_03_27_012757	714	2	,	,	,
10_1101-2020_03_27_012757	714	3	E.	E.	NNP
10_1101-2020_03_27_012757	714	4	et	et	NNP
10_1101-2020_03_27_012757	714	5	al	al	NNP
10_1101-2020_03_27_012757	714	6	.	.	.
10_1101-2020_03_27_012757	715	1	The	the	DT
10_1101-2020_03_27_012757	715	2	molecular	molecular	JJ
10_1101-2020_03_27_012757	715	3	landscape	landscape	NN
10_1101-2020_03_27_012757	715	4	of	of	IN
10_1101-2020_03_27_012757	715	5	colorectal	colorectal	JJ
10_1101-2020_03_27_012757	715	6	cancer	cancer	NN
10_1101-2020_03_27_012757	715	7	cell	cell	NN
10_1101-2020_03_27_012757	715	8	lines	line	NNS
10_1101-2020_03_27_012757	715	9	unveils	unveil	NNS
10_1101-2020_03_27_012757	715	10	1075	1075	CD
10_1101-2020_03_27_012757	715	11	clinically	clinically	RB
10_1101-2020_03_27_012757	715	12	actionable	actionable	JJ
10_1101-2020_03_27_012757	715	13	kinase	kinase	NN
10_1101-2020_03_27_012757	715	14	targets	target	NNS
10_1101-2020_03_27_012757	715	15	.	.	.
10_1101-2020_03_27_012757	716	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	716	2	.	.	.
10_1101-2020_03_27_012757	717	1	Commun	Commun	VBN
10_1101-2020_03_27_012757	717	2	.	.	.
10_1101-2020_03_27_012757	718	1	6	6	CD
10_1101-2020_03_27_012757	718	2	,	,	,
10_1101-2020_03_27_012757	718	3	7002	7002	CD
10_1101-2020_03_27_012757	718	4	(	(	-LRB-
10_1101-2020_03_27_012757	718	5	2015	2015	CD
10_1101-2020_03_27_012757	718	6	)	)	-RRB-
10_1101-2020_03_27_012757	718	7	.	.	.
10_1101-2020_03_27_012757	719	1	1076	1076	CD
10_1101-2020_03_27_012757	719	2	39	39	CD
10_1101-2020_03_27_012757	719	3	.	.	.
10_1101-2020_03_27_012757	720	1	Park	Park	NNP
10_1101-2020_03_27_012757	720	2	,	,	,
10_1101-2020_03_27_012757	720	3	J.-G.	J.-G.	NNP
10_1101-2020_03_27_012757	720	4	et	et	NNP
10_1101-2020_03_27_012757	720	5	al	al	NNP
10_1101-2020_03_27_012757	720	6	.	.	.
10_1101-2020_03_27_012757	721	1	Characteristics	Characteristics	NNP
10_1101-2020_03_27_012757	721	2	of	of	IN
10_1101-2020_03_27_012757	721	3	Cell	Cell	NNP
10_1101-2020_03_27_012757	721	4	Lines	Lines	NNPS
10_1101-2020_03_27_012757	721	5	Established	establish	VBN
10_1101-2020_03_27_012757	721	6	from	from	IN
10_1101-2020_03_27_012757	721	7	Human	Human	NNP
10_1101-2020_03_27_012757	721	8	Colorectal	Colorectal	NNP
10_1101-2020_03_27_012757	721	9	1077	1077	CD
10_1101-2020_03_27_012757	721	10	Carcinoma	Carcinoma	NNP
10_1101-2020_03_27_012757	721	11	.	.	.
10_1101-2020_03_27_012757	722	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	722	2	Res	Res	NNP
10_1101-2020_03_27_012757	722	3	.	.	.
10_1101-2020_03_27_012757	723	1	(	(	-LRB-
10_1101-2020_03_27_012757	723	2	1987	1987	CD
10_1101-2020_03_27_012757	723	3	)	)	-RRB-
10_1101-2020_03_27_012757	723	4	.	.	.
10_1101-2020_03_27_012757	724	1	1078	1078	CD
10_1101-2020_03_27_012757	724	2	40	40	CD
10_1101-2020_03_27_012757	724	3	.	.	.
10_1101-2020_03_27_012757	725	1	Jerby	Jerby	NNP
10_1101-2020_03_27_012757	725	2	-	-	HYPH
10_1101-2020_03_27_012757	725	3	Arnon	Arnon	NNP
10_1101-2020_03_27_012757	725	4	,	,	,
10_1101-2020_03_27_012757	725	5	L.	L.	NNP
10_1101-2020_03_27_012757	725	6	et	et	NNP
10_1101-2020_03_27_012757	725	7	al	al	NNP
10_1101-2020_03_27_012757	725	8	.	.	.
10_1101-2020_03_27_012757	726	1	A	a	DT
10_1101-2020_03_27_012757	726	2	cancer	cancer	NN
10_1101-2020_03_27_012757	726	3	cell	cell	NN
10_1101-2020_03_27_012757	726	4	program	program	NN
10_1101-2020_03_27_012757	726	5	promotes	promote	VBZ
10_1101-2020_03_27_012757	726	6	T	T	NNP
10_1101-2020_03_27_012757	726	7	cell	cell	NN
10_1101-2020_03_27_012757	726	8	exclusion	exclusion	NN
10_1101-2020_03_27_012757	726	9	and	and	CC
10_1101-2020_03_27_012757	726	10	1079	1079	CD
10_1101-2020_03_27_012757	726	11	resistance	resistance	NN
10_1101-2020_03_27_012757	726	12	to	to	IN
10_1101-2020_03_27_012757	726	13	checkpoint	checkpoint	JJ
10_1101-2020_03_27_012757	726	14	blockade	blockade	NN
10_1101-2020_03_27_012757	726	15	.	.	.
10_1101-2020_03_27_012757	727	1	Cell	cell	NN
10_1101-2020_03_27_012757	727	2	175	175	CD
10_1101-2020_03_27_012757	727	3	,	,	,
10_1101-2020_03_27_012757	727	4	984–997.e24	984–997.e24	CD
10_1101-2020_03_27_012757	727	5	(	(	-LRB-
10_1101-2020_03_27_012757	727	6	2018	2018	CD
10_1101-2020_03_27_012757	727	7	)	)	-RRB-
10_1101-2020_03_27_012757	727	8	.	.	.
10_1101-2020_03_27_012757	728	1	1080	1080	CD
10_1101-2020_03_27_012757	728	2	41	41	CD
10_1101-2020_03_27_012757	728	3	.	.	.
10_1101-2020_03_27_012757	729	1	Darmanis	Darmanis	NNP
10_1101-2020_03_27_012757	729	2	,	,	,
10_1101-2020_03_27_012757	729	3	S.	S.	NNP
10_1101-2020_03_27_012757	729	4	et	et	NNP
10_1101-2020_03_27_012757	729	5	al	al	NNP
10_1101-2020_03_27_012757	729	6	.	.	.
10_1101-2020_03_27_012757	730	1	Single	single	JJ
10_1101-2020_03_27_012757	730	2	-	-	HYPH
10_1101-2020_03_27_012757	730	3	Cell	Cell	NNP
10_1101-2020_03_27_012757	730	4	RNA	RNA	NNP
10_1101-2020_03_27_012757	730	5	-	-	HYPH
10_1101-2020_03_27_012757	730	6	Seq	Seq	NNP
10_1101-2020_03_27_012757	730	7	Analysis	Analysis	NNP
10_1101-2020_03_27_012757	730	8	of	of	IN
10_1101-2020_03_27_012757	730	9	Infiltrating	infiltrate	VBG
10_1101-2020_03_27_012757	730	10	Neoplastic	neoplastic	JJ
10_1101-2020_03_27_012757	730	11	Cells	cell	NNS
10_1101-2020_03_27_012757	730	12	at	at	IN
10_1101-2020_03_27_012757	730	13	1081	1081	CD
10_1101-2020_03_27_012757	730	14	the	the	DT
10_1101-2020_03_27_012757	730	15	Migrating	Migrating	NNP
10_1101-2020_03_27_012757	730	16	Front	Front	NNP
10_1101-2020_03_27_012757	730	17	of	of	IN
10_1101-2020_03_27_012757	730	18	Human	Human	NNP
10_1101-2020_03_27_012757	730	19	Glioblastoma	Glioblastoma	NNP
10_1101-2020_03_27_012757	730	20	.	.	.
10_1101-2020_03_27_012757	731	1	Cell	Cell	NNP
10_1101-2020_03_27_012757	731	2	Rep.	Rep.	NNP
10_1101-2020_03_27_012757	731	3	21	21	CD
10_1101-2020_03_27_012757	731	4	,	,	,
10_1101-2020_03_27_012757	731	5	1399–1410	1399–1410	CD
10_1101-2020_03_27_012757	731	6	(	(	-LRB-
10_1101-2020_03_27_012757	731	7	2017	2017	CD
10_1101-2020_03_27_012757	731	8	)	)	-RRB-
10_1101-2020_03_27_012757	731	9	.	.	.
10_1101-2020_03_27_012757	732	1	1082	1082	CD
10_1101-2020_03_27_012757	732	2	42	42	CD
10_1101-2020_03_27_012757	732	3	.	.	.
10_1101-2020_03_27_012757	733	1	Patel	Patel	NNP
10_1101-2020_03_27_012757	733	2	,	,	,
10_1101-2020_03_27_012757	733	3	A.	A.	NNP
10_1101-2020_03_27_012757	733	4	P.	P.	NNP
10_1101-2020_03_27_012757	733	5	et	et	NNP
10_1101-2020_03_27_012757	733	6	al	al	NNP
10_1101-2020_03_27_012757	733	7	.	.	.
10_1101-2020_03_27_012757	734	1	Single	single	JJ
10_1101-2020_03_27_012757	734	2	-	-	HYPH
10_1101-2020_03_27_012757	734	3	cell	cell	NN
10_1101-2020_03_27_012757	734	4	RNA	RNA	NNP
10_1101-2020_03_27_012757	734	5	-	-	HYPH
10_1101-2020_03_27_012757	734	6	seq	seq	NN
10_1101-2020_03_27_012757	734	7	highlights	highlight	NNS
10_1101-2020_03_27_012757	734	8	intratumoral	intratumoral	JJ
10_1101-2020_03_27_012757	734	9	heterogeneity	heterogeneity	NN
10_1101-2020_03_27_012757	734	10	in	in	IN
10_1101-2020_03_27_012757	734	11	1083	1083	CD
10_1101-2020_03_27_012757	734	12	primary	primary	JJ
10_1101-2020_03_27_012757	734	13	glioblastoma	glioblastoma	NN
10_1101-2020_03_27_012757	734	14	.	.	.
10_1101-2020_03_27_012757	735	1	Science	science	NN
10_1101-2020_03_27_012757	735	2	344	344	CD
10_1101-2020_03_27_012757	735	3	,	,	,
10_1101-2020_03_27_012757	735	4	1396–1401	1396–1401	CD
10_1101-2020_03_27_012757	735	5	(	(	-LRB-
10_1101-2020_03_27_012757	735	6	2014	2014	CD
10_1101-2020_03_27_012757	735	7	)	)	-RRB-
10_1101-2020_03_27_012757	735	8	.	.	.
10_1101-2020_03_27_012757	736	1	1084	1084	CD
10_1101-2020_03_27_012757	736	2	43	43	CD
10_1101-2020_03_27_012757	736	3	.	.	.
10_1101-2020_03_27_012757	737	1	Xu	Xu	NNP
10_1101-2020_03_27_012757	737	2	,	,	,
10_1101-2020_03_27_012757	737	3	B.	B.	NNP
10_1101-2020_03_27_012757	737	4	et	et	NNP
10_1101-2020_03_27_012757	737	5	al	al	NNP
10_1101-2020_03_27_012757	737	6	.	.	.
10_1101-2020_03_27_012757	738	1	Regulation	regulation	NN
10_1101-2020_03_27_012757	738	2	of	of	IN
10_1101-2020_03_27_012757	738	3	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	738	4	receptivity	receptivity	NN
10_1101-2020_03_27_012757	738	5	by	by	IN
10_1101-2020_03_27_012757	738	6	the	the	DT
10_1101-2020_03_27_012757	738	7	highly	highly	RB
10_1101-2020_03_27_012757	738	8	expressed	express	VBN
10_1101-2020_03_27_012757	738	9	HOXA9	hoxa9	NN
10_1101-2020_03_27_012757	738	10	,	,	,
10_1101-2020_03_27_012757	738	11	1085	1085	CD
10_1101-2020_03_27_012757	738	12	HOXA11	HOXA11	NNP
10_1101-2020_03_27_012757	738	13	and	and	CC
10_1101-2020_03_27_012757	738	14	HOXD10	HOXD10	NNP
10_1101-2020_03_27_012757	738	15	HOX	HOX	NNP
10_1101-2020_03_27_012757	738	16	-	-	HYPH
10_1101-2020_03_27_012757	738	17	class	class	NN
10_1101-2020_03_27_012757	738	18	homeobox	homeobox	NN
10_1101-2020_03_27_012757	738	19	genes	gene	NNS
10_1101-2020_03_27_012757	738	20	.	.	.
10_1101-2020_03_27_012757	739	1	Hum	hum	UH
10_1101-2020_03_27_012757	739	2	.	.	.
10_1101-2020_03_27_012757	740	1	Reprod	Reprod	NNP
10_1101-2020_03_27_012757	740	2	.	.	.
10_1101-2020_03_27_012757	741	1	29	29	CD
10_1101-2020_03_27_012757	741	2	,	,	,
10_1101-2020_03_27_012757	741	3	781–790	781–790	CD
10_1101-2020_03_27_012757	741	4	1086	1086	CD
10_1101-2020_03_27_012757	741	5	(	(	-LRB-
10_1101-2020_03_27_012757	741	6	2014	2014	CD
10_1101-2020_03_27_012757	741	7	)	)	-RRB-
10_1101-2020_03_27_012757	741	8	.	.	.
10_1101-2020_03_27_012757	742	1	1087	1087	CD
10_1101-2020_03_27_012757	742	2	44	44	CD
10_1101-2020_03_27_012757	742	3	.	.	.
10_1101-2020_03_27_012757	743	1	Raines	Raines	NNP
10_1101-2020_03_27_012757	743	2	,	,	,
10_1101-2020_03_27_012757	743	3	A.	A.	NNP
10_1101-2020_03_27_012757	743	4	M.	M.	NNP
10_1101-2020_03_27_012757	743	5	et	et	NNP
10_1101-2020_03_27_012757	743	6	al	al	NNP
10_1101-2020_03_27_012757	743	7	.	.	.
10_1101-2020_03_27_012757	744	1	Recombineering	recombineere	VBG
10_1101-2020_03_27_012757	744	2	-	-	HYPH
10_1101-2020_03_27_012757	744	3	based	base	VBN
10_1101-2020_03_27_012757	744	4	dissection	dissection	NN
10_1101-2020_03_27_012757	744	5	of	of	IN
10_1101-2020_03_27_012757	744	6	flanking	flanking	NN
10_1101-2020_03_27_012757	744	7	and	and	CC
10_1101-2020_03_27_012757	744	8	paralogous	paralogous	JJ
10_1101-2020_03_27_012757	744	9	1088	1088	CD
10_1101-2020_03_27_012757	744	10	Hox	Hox	NNP
10_1101-2020_03_27_012757	744	11	gene	gene	NN
10_1101-2020_03_27_012757	744	12	functions	function	NNS
10_1101-2020_03_27_012757	744	13	in	in	IN
10_1101-2020_03_27_012757	744	14	mouse	mouse	NN
10_1101-2020_03_27_012757	744	15	reproductive	reproductive	NNP
10_1101-2020_03_27_012757	744	16	tracts	tract	NNS
10_1101-2020_03_27_012757	744	17	.	.	.
10_1101-2020_03_27_012757	745	1	Development	development	NN
10_1101-2020_03_27_012757	745	2	140	140	CD
10_1101-2020_03_27_012757	745	3	,	,	,
10_1101-2020_03_27_012757	745	4	2942–2952	2942–2952	CD
10_1101-2020_03_27_012757	745	5	1089	1089	CD
10_1101-2020_03_27_012757	745	6	(	(	-LRB-
10_1101-2020_03_27_012757	745	7	2013	2013	CD
10_1101-2020_03_27_012757	745	8	)	)	-RRB-
10_1101-2020_03_27_012757	745	9	.	.	.
10_1101-2020_03_27_012757	746	1	1090	1090	CD
10_1101-2020_03_27_012757	746	2	45	45	CD
10_1101-2020_03_27_012757	746	3	.	.	.
10_1101-2020_03_27_012757	747	1	Netinatsunthorn	Netinatsunthorn	NNP
10_1101-2020_03_27_012757	747	2	,	,	,
10_1101-2020_03_27_012757	747	3	W.	W.	NNP
10_1101-2020_03_27_012757	747	4	,	,	,
10_1101-2020_03_27_012757	747	5	Hanprasertpong	Hanprasertpong	NNP
10_1101-2020_03_27_012757	747	6	,	,	,
10_1101-2020_03_27_012757	747	7	J.	J.	NNP
10_1101-2020_03_27_012757	747	8	,	,	,
10_1101-2020_03_27_012757	747	9	Dechsukhum	Dechsukhum	NNP
10_1101-2020_03_27_012757	747	10	,	,	,
10_1101-2020_03_27_012757	747	11	C.	C.	NNP
10_1101-2020_03_27_012757	747	12	,	,	,
10_1101-2020_03_27_012757	747	13	Leetanaporn	Leetanaporn	NNP
10_1101-2020_03_27_012757	747	14	,	,	,
10_1101-2020_03_27_012757	747	15	R.	R.	NNP
10_1101-2020_03_27_012757	747	16	&	&	CC
10_1101-2020_03_27_012757	747	17	1091	1091	CD
10_1101-2020_03_27_012757	747	18	Geater	Geater	NNP
10_1101-2020_03_27_012757	747	19	,	,	,
10_1101-2020_03_27_012757	747	20	A.	a.	NN
10_1101-2020_03_27_012757	747	21	WT1	WT1	NNP
10_1101-2020_03_27_012757	747	22	gene	gene	NN
10_1101-2020_03_27_012757	747	23	expression	expression	NN
10_1101-2020_03_27_012757	747	24	as	as	IN
10_1101-2020_03_27_012757	747	25	a	a	DT
10_1101-2020_03_27_012757	747	26	prognostic	prognostic	JJ
10_1101-2020_03_27_012757	747	27	marker	marker	NN
10_1101-2020_03_27_012757	747	28	in	in	IN
10_1101-2020_03_27_012757	747	29	advanced	advanced	JJ
10_1101-2020_03_27_012757	747	30	serous	serous	JJ
10_1101-2020_03_27_012757	747	31	1092	1092	CD
10_1101-2020_03_27_012757	747	32	epithelial	epithelial	JJ
10_1101-2020_03_27_012757	747	33	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	747	34	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	747	35	:	:	:
10_1101-2020_03_27_012757	747	36	an	an	DT
10_1101-2020_03_27_012757	747	37	immunohistochemical	immunohistochemical	JJ
10_1101-2020_03_27_012757	747	38	study	study	NN
10_1101-2020_03_27_012757	747	39	.	.	.
10_1101-2020_03_27_012757	748	1	BMC	BMC	NNP
10_1101-2020_03_27_012757	748	2	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	748	3	6	6	CD
10_1101-2020_03_27_012757	748	4	,	,	,
10_1101-2020_03_27_012757	748	5	90	90	CD
10_1101-2020_03_27_012757	748	6	1093	1093	CD
10_1101-2020_03_27_012757	748	7	(	(	-LRB-
10_1101-2020_03_27_012757	748	8	2006	2006	CD
10_1101-2020_03_27_012757	748	9	)	)	-RRB-
10_1101-2020_03_27_012757	748	10	.	.	.
10_1101-2020_03_27_012757	749	1	1094	1094	CD
10_1101-2020_03_27_012757	749	2	46	46	CD
10_1101-2020_03_27_012757	749	3	.	.	.
10_1101-2020_03_27_012757	750	1	Kelly	Kelly	NNP
10_1101-2020_03_27_012757	750	2	,	,	,
10_1101-2020_03_27_012757	750	3	Z.	Z.	NNP
10_1101-2020_03_27_012757	750	4	et	et	FW
10_1101-2020_03_27_012757	750	5	al	al	NNP
10_1101-2020_03_27_012757	750	6	.	.	.
10_1101-2020_03_27_012757	751	1	The	the	DT
10_1101-2020_03_27_012757	751	2	prognostic	prognostic	JJ
10_1101-2020_03_27_012757	751	3	significance	significance	NN
10_1101-2020_03_27_012757	751	4	of	of	IN
10_1101-2020_03_27_012757	751	5	specific	specific	JJ
10_1101-2020_03_27_012757	751	6	HOX	HOX	NNP
10_1101-2020_03_27_012757	751	7	gene	gene	NN
10_1101-2020_03_27_012757	751	8	expression	expression	NN
10_1101-2020_03_27_012757	751	9	patterns	pattern	NNS
10_1101-2020_03_27_012757	751	10	1095	1095	CD
10_1101-2020_03_27_012757	751	11	in	in	IN
10_1101-2020_03_27_012757	751	12	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	751	13	cancer	cancer	NN
10_1101-2020_03_27_012757	751	14	.	.	.
10_1101-2020_03_27_012757	752	1	Int	Int	NNP
10_1101-2020_03_27_012757	752	2	.	.	.
10_1101-2020_03_27_012757	753	1	J.	J.	NNP
10_1101-2020_03_27_012757	754	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	754	2	139	139	CD
10_1101-2020_03_27_012757	754	3	,	,	,
10_1101-2020_03_27_012757	754	4	1608–1617	1608–1617	CD
10_1101-2020_03_27_012757	754	5	(	(	-LRB-
10_1101-2020_03_27_012757	754	6	2016	2016	CD
10_1101-2020_03_27_012757	754	7	)	)	-RRB-
10_1101-2020_03_27_012757	754	8	.	.	.
10_1101-2020_03_27_012757	755	1	1096	1096	CD
10_1101-2020_03_27_012757	755	2	.CC	.CC	:
10_1101-2020_03_27_012757	755	3	-	-	:
10_1101-2020_03_27_012757	755	4	BY	by	IN
10_1101-2020_03_27_012757	755	5	-	-	HYPH
10_1101-2020_03_27_012757	755	6	NC	NC	NNP
10_1101-2020_03_27_012757	755	7	-	-	HYPH
10_1101-2020_03_27_012757	755	8	ND	ND	NNP
10_1101-2020_03_27_012757	755	9	4.0	4.0	CD
10_1101-2020_03_27_012757	755	10	International	International	NNP
10_1101-2020_03_27_012757	755	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	755	12	under	under	IN
10_1101-2020_03_27_012757	755	13	a	a	DT
10_1101-2020_03_27_012757	755	14	(	(	-LRB-
10_1101-2020_03_27_012757	755	15	which	which	WDT
10_1101-2020_03_27_012757	755	16	was	be	VBD
10_1101-2020_03_27_012757	755	17	not	not	RB
10_1101-2020_03_27_012757	755	18	certified	certify	VBN
10_1101-2020_03_27_012757	755	19	by	by	IN
10_1101-2020_03_27_012757	755	20	peer	peer	NN
10_1101-2020_03_27_012757	755	21	review	review	NN
10_1101-2020_03_27_012757	755	22	)	)	-RRB-
10_1101-2020_03_27_012757	755	23	is	be	VBZ
10_1101-2020_03_27_012757	755	24	the	the	DT
10_1101-2020_03_27_012757	755	25	author	author	NN
10_1101-2020_03_27_012757	755	26	/	/	SYM
10_1101-2020_03_27_012757	755	27	funder	funder	NN
10_1101-2020_03_27_012757	755	28	,	,	,
10_1101-2020_03_27_012757	755	29	who	who	WP
10_1101-2020_03_27_012757	755	30	has	have	VBZ
10_1101-2020_03_27_012757	755	31	granted	grant	VBN
10_1101-2020_03_27_012757	755	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	755	33	a	a	DT
10_1101-2020_03_27_012757	755	34	license	license	NN
10_1101-2020_03_27_012757	755	35	to	to	TO
10_1101-2020_03_27_012757	755	36	display	display	VB
10_1101-2020_03_27_012757	755	37	the	the	DT
10_1101-2020_03_27_012757	755	38	preprint	preprint	NN
10_1101-2020_03_27_012757	755	39	in	in	IN
10_1101-2020_03_27_012757	755	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	755	41	.	.	.
10_1101-2020_03_27_012757	756	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	756	2	is	be	VBZ
10_1101-2020_03_27_012757	756	3	made	make	VBN
10_1101-2020_03_27_012757	756	4	The	the	DT
10_1101-2020_03_27_012757	756	5	copyright	copyright	NN
10_1101-2020_03_27_012757	756	6	holder	holder	NN
10_1101-2020_03_27_012757	756	7	for	for	IN
10_1101-2020_03_27_012757	756	8	this	this	DT
10_1101-2020_03_27_012757	756	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	756	10	version	version	NN
10_1101-2020_03_27_012757	756	11	posted	post	VBD
10_1101-2020_03_27_012757	756	12	January	January	NNP
10_1101-2020_03_27_012757	756	13	9	9	CD
10_1101-2020_03_27_012757	756	14	,	,	,
10_1101-2020_03_27_012757	756	15	2021	2021	CD
10_1101-2020_03_27_012757	756	16	.	.	.
10_1101-2020_03_27_012757	756	17	;	;	:
10_1101-2020_03_27_012757	756	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	756	19	:	:	:
10_1101-2020_03_27_012757	756	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	756	21	preprint	preprint	NN
10_1101-2020_03_27_012757	756	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	756	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	756	24	40	40	CD
10_1101-2020_03_27_012757	756	25	47	47	CD
10_1101-2020_03_27_012757	756	26	.	.	.
10_1101-2020_03_27_012757	757	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	757	2	Genome	Genome	NNP
10_1101-2020_03_27_012757	757	3	Atlas	Atlas	NNP
10_1101-2020_03_27_012757	757	4	Research	Research	NNP
10_1101-2020_03_27_012757	757	5	Network	Network	NNP
10_1101-2020_03_27_012757	757	6	.	.	.
10_1101-2020_03_27_012757	758	1	Integrated	integrate	VBN
10_1101-2020_03_27_012757	758	2	genomic	genomic	JJ
10_1101-2020_03_27_012757	758	3	analyses	analysis	NNS
10_1101-2020_03_27_012757	758	4	of	of	IN
10_1101-2020_03_27_012757	758	5	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	758	6	1097	1097	CD
10_1101-2020_03_27_012757	758	7	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	758	8	.	.	.
10_1101-2020_03_27_012757	759	1	Nature	nature	NN
10_1101-2020_03_27_012757	759	2	474	474	CD
10_1101-2020_03_27_012757	759	3	,	,	,
10_1101-2020_03_27_012757	759	4	609–615	609–615	CD
10_1101-2020_03_27_012757	759	5	(	(	-LRB-
10_1101-2020_03_27_012757	759	6	2011	2011	CD
10_1101-2020_03_27_012757	759	7	)	)	-RRB-
10_1101-2020_03_27_012757	759	8	.	.	.
10_1101-2020_03_27_012757	760	1	1098	1098	CD
10_1101-2020_03_27_012757	760	2	48	48	CD
10_1101-2020_03_27_012757	760	3	.	.	.
10_1101-2020_03_27_012757	761	1	Wiegand	Wiegand	NNP
10_1101-2020_03_27_012757	761	2	,	,	,
10_1101-2020_03_27_012757	761	3	K.	K.	NNP
10_1101-2020_03_27_012757	761	4	C.	C.	NNP
10_1101-2020_03_27_012757	761	5	et	et	NNP
10_1101-2020_03_27_012757	761	6	al	al	NNP
10_1101-2020_03_27_012757	761	7	.	.	.
10_1101-2020_03_27_012757	762	1	ARID1A	arid1a	PRP
10_1101-2020_03_27_012757	762	2	mutations	mutation	NNS
10_1101-2020_03_27_012757	762	3	in	in	IN
10_1101-2020_03_27_012757	762	4	endometriosis	endometriosis	NN
10_1101-2020_03_27_012757	762	5	-	-	HYPH
10_1101-2020_03_27_012757	762	6	associated	associate	VBN
10_1101-2020_03_27_012757	762	7	ovarian	ovarian	NNP
10_1101-2020_03_27_012757	762	8	1099	1099	CD
10_1101-2020_03_27_012757	762	9	carcinomas	carcinoma	NNS
10_1101-2020_03_27_012757	762	10	.	.	.
10_1101-2020_03_27_012757	763	1	N.	N.	NNP
10_1101-2020_03_27_012757	763	2	Engl	Engl	NNP
10_1101-2020_03_27_012757	763	3	.	.	.
10_1101-2020_03_27_012757	764	1	J.	J.	NNP
10_1101-2020_03_27_012757	764	2	Med	Med	NNP
10_1101-2020_03_27_012757	764	3	.	.	.
10_1101-2020_03_27_012757	765	1	363	363	CD
10_1101-2020_03_27_012757	765	2	,	,	,
10_1101-2020_03_27_012757	765	3	1532–1543	1532–1543	CD
10_1101-2020_03_27_012757	765	4	(	(	-LRB-
10_1101-2020_03_27_012757	765	5	2010	2010	CD
10_1101-2020_03_27_012757	765	6	)	)	-RRB-
10_1101-2020_03_27_012757	765	7	.	.	.
10_1101-2020_03_27_012757	766	1	1100	1100	CD
10_1101-2020_03_27_012757	766	2	49	49	CD
10_1101-2020_03_27_012757	766	3	.	.	.
10_1101-2020_03_27_012757	767	1	Murray	Murray	NNP
10_1101-2020_03_27_012757	767	2	,	,	,
10_1101-2020_03_27_012757	767	3	M.	M.	NNP
10_1101-2020_03_27_012757	767	4	J.	J.	NNP
10_1101-2020_03_27_012757	767	5	et	et	NNP
10_1101-2020_03_27_012757	767	6	al	al	NNP
10_1101-2020_03_27_012757	767	7	.	.	.
10_1101-2020_03_27_012757	768	1	LIN28	LIN28	NNP
10_1101-2020_03_27_012757	768	2	Expression	expression	NN
10_1101-2020_03_27_012757	768	3	in	in	IN
10_1101-2020_03_27_012757	768	4	malignant	malignant	JJ
10_1101-2020_03_27_012757	768	5	germ	germ	NN
10_1101-2020_03_27_012757	768	6	cell	cell	NN
10_1101-2020_03_27_012757	768	7	tumors	tumor	NNS
10_1101-2020_03_27_012757	768	8	downregulates	downregulate	VBZ
10_1101-2020_03_27_012757	768	9	1101	1101	CD
10_1101-2020_03_27_012757	768	10	let-7	let-7	NNP
10_1101-2020_03_27_012757	768	11	and	and	CC
10_1101-2020_03_27_012757	768	12	increases	increase	VBZ
10_1101-2020_03_27_012757	768	13	oncogene	oncogene	NN
10_1101-2020_03_27_012757	768	14	levels	level	NNS
10_1101-2020_03_27_012757	768	15	.	.	.
10_1101-2020_03_27_012757	769	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	769	2	Res	Res	NNP
10_1101-2020_03_27_012757	769	3	.	.	.
10_1101-2020_03_27_012757	770	1	73	73	CD
10_1101-2020_03_27_012757	770	2	,	,	,
10_1101-2020_03_27_012757	770	3	4872–4884	4872–4884	CD
10_1101-2020_03_27_012757	770	4	(	(	-LRB-
10_1101-2020_03_27_012757	770	5	2013	2013	CD
10_1101-2020_03_27_012757	770	6	)	)	-RRB-
10_1101-2020_03_27_012757	770	7	.	.	.
10_1101-2020_03_27_012757	771	1	1102	1102	CD
10_1101-2020_03_27_012757	771	2	50	50	CD
10_1101-2020_03_27_012757	771	3	.	.	.
10_1101-2020_03_27_012757	772	1	Biton	Biton	NNP
10_1101-2020_03_27_012757	772	2	,	,	,
10_1101-2020_03_27_012757	772	3	A.	A.	NNP
10_1101-2020_03_27_012757	772	4	et	et	FW
10_1101-2020_03_27_012757	772	5	al	al	NNP
10_1101-2020_03_27_012757	772	6	.	.	.
10_1101-2020_03_27_012757	773	1	Independent	independent	JJ
10_1101-2020_03_27_012757	773	2	component	component	NN
10_1101-2020_03_27_012757	773	3	analysis	analysis	NN
10_1101-2020_03_27_012757	773	4	uncovers	uncover	NNS
10_1101-2020_03_27_012757	773	5	the	the	DT
10_1101-2020_03_27_012757	773	6	landscape	landscape	NN
10_1101-2020_03_27_012757	773	7	of	of	IN
10_1101-2020_03_27_012757	773	8	the	the	DT
10_1101-2020_03_27_012757	773	9	1103	1103	CD
10_1101-2020_03_27_012757	773	10	bladder	bladder	NN
10_1101-2020_03_27_012757	773	11	tumor	tumor	NN
10_1101-2020_03_27_012757	773	12	transcriptome	transcriptome	VBN
10_1101-2020_03_27_012757	773	13	and	and	CC
10_1101-2020_03_27_012757	773	14	reveals	reveal	VBZ
10_1101-2020_03_27_012757	773	15	insights	insight	NNS
10_1101-2020_03_27_012757	773	16	into	into	IN
10_1101-2020_03_27_012757	773	17	luminal	luminal	JJ
10_1101-2020_03_27_012757	773	18	and	and	CC
10_1101-2020_03_27_012757	773	19	basal	basal	NN
10_1101-2020_03_27_012757	773	20	subtypes	subtype	NNS
10_1101-2020_03_27_012757	773	21	.	.	.
10_1101-2020_03_27_012757	774	1	1104	1104	CD
10_1101-2020_03_27_012757	774	2	Cell	Cell	NNP
10_1101-2020_03_27_012757	774	3	Rep.	Rep.	NNP
10_1101-2020_03_27_012757	774	4	9	9	CD
10_1101-2020_03_27_012757	774	5	,	,	,
10_1101-2020_03_27_012757	774	6	1235–1245	1235–1245	CD
10_1101-2020_03_27_012757	774	7	(	(	-LRB-
10_1101-2020_03_27_012757	774	8	2014	2014	CD
10_1101-2020_03_27_012757	774	9	)	)	-RRB-
10_1101-2020_03_27_012757	774	10	.	.	.
10_1101-2020_03_27_012757	775	1	1105	1105	CD
10_1101-2020_03_27_012757	775	2	51	51	CD
10_1101-2020_03_27_012757	775	3	.	.	.
10_1101-2020_03_27_012757	776	1	Fair	Fair	NNP
10_1101-2020_03_27_012757	776	2	,	,	,
10_1101-2020_03_27_012757	776	3	W.	W.	NNP
10_1101-2020_03_27_012757	776	4	R.	R.	NNP
10_1101-2020_03_27_012757	776	5	,	,	,
10_1101-2020_03_27_012757	776	6	Israeli	Israeli	NNP
10_1101-2020_03_27_012757	776	7	,	,	,
10_1101-2020_03_27_012757	776	8	R.	R.	NNP
10_1101-2020_03_27_012757	776	9	S.	S.	NNP
10_1101-2020_03_27_012757	776	10	&	&	CC
10_1101-2020_03_27_012757	776	11	Heston	Heston	NNP
10_1101-2020_03_27_012757	776	12	,	,	,
10_1101-2020_03_27_012757	776	13	W.	W.	NNP
10_1101-2020_03_27_012757	776	14	D.	D.	NNP
10_1101-2020_03_27_012757	776	15	Prostate	Prostate	NNP
10_1101-2020_03_27_012757	776	16	-	-	HYPH
10_1101-2020_03_27_012757	776	17	specific	specific	JJ
10_1101-2020_03_27_012757	776	18	membrane	membrane	NN
10_1101-2020_03_27_012757	776	19	antigen	antigen	NN
10_1101-2020_03_27_012757	776	20	.	.	.
10_1101-2020_03_27_012757	777	1	1106	1106	CD
10_1101-2020_03_27_012757	777	2	Prostate	Prostate	NNP
10_1101-2020_03_27_012757	777	3	32	32	CD
10_1101-2020_03_27_012757	777	4	,	,	,
10_1101-2020_03_27_012757	777	5	140–148	140–148	CD
10_1101-2020_03_27_012757	777	6	(	(	-LRB-
10_1101-2020_03_27_012757	777	7	1997	1997	CD
10_1101-2020_03_27_012757	777	8	)	)	-RRB-
10_1101-2020_03_27_012757	777	9	.	.	.
10_1101-2020_03_27_012757	778	1	1107	1107	CD
10_1101-2020_03_27_012757	778	2	52	52	CD
10_1101-2020_03_27_012757	778	3	.	.	.
10_1101-2020_03_27_012757	779	1	Black	Black	NNP
10_1101-2020_03_27_012757	779	2	,	,	,
10_1101-2020_03_27_012757	779	3	J.	J.	NNP
10_1101-2020_03_27_012757	779	4	D.	D.	NNP
10_1101-2020_03_27_012757	779	5	,	,	,
10_1101-2020_03_27_012757	779	6	English	English	NNP
10_1101-2020_03_27_012757	779	7	,	,	,
10_1101-2020_03_27_012757	779	8	D.	D.	NNP
10_1101-2020_03_27_012757	779	9	P.	P.	NNP
10_1101-2020_03_27_012757	779	10	,	,	,
10_1101-2020_03_27_012757	779	11	Roque	Roque	NNP
10_1101-2020_03_27_012757	779	12	,	,	,
10_1101-2020_03_27_012757	779	13	D.	D.	NNP
10_1101-2020_03_27_012757	779	14	M.	M.	NNP
10_1101-2020_03_27_012757	779	15	&	&	CC
10_1101-2020_03_27_012757	779	16	Santin	Santin	NNP
10_1101-2020_03_27_012757	779	17	,	,	,
10_1101-2020_03_27_012757	779	18	A.	a.	NN
10_1101-2020_03_27_012757	779	19	D.	D.	NNP
10_1101-2020_03_27_012757	779	20	Targeted	Targeted	NNP
10_1101-2020_03_27_012757	779	21	therapy	therapy	NN
10_1101-2020_03_27_012757	779	22	in	in	IN
10_1101-2020_03_27_012757	779	23	1108	1108	CD
10_1101-2020_03_27_012757	779	24	uterine	uterine	JJ
10_1101-2020_03_27_012757	779	25	serous	serous	JJ
10_1101-2020_03_27_012757	779	26	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	779	27	:	:	:
10_1101-2020_03_27_012757	779	28	an	an	DT
10_1101-2020_03_27_012757	779	29	aggressive	aggressive	JJ
10_1101-2020_03_27_012757	779	30	variant	variant	NN
10_1101-2020_03_27_012757	779	31	of	of	IN
10_1101-2020_03_27_012757	779	32	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	779	33	cancer	cancer	NN
10_1101-2020_03_27_012757	779	34	.	.	.
10_1101-2020_03_27_012757	780	1	Womens	Womens	NNP
10_1101-2020_03_27_012757	780	2	1109	1109	CD
10_1101-2020_03_27_012757	780	3	Health	Health	NNP
10_1101-2020_03_27_012757	780	4	(	(	-LRB-
10_1101-2020_03_27_012757	780	5	Lond	Lond	NNP
10_1101-2020_03_27_012757	780	6	.	.	.
10_1101-2020_03_27_012757	781	1	Engl	Engl	NNP
10_1101-2020_03_27_012757	781	2	.	.	.
10_1101-2020_03_27_012757	781	3	)	)	-RRB-
10_1101-2020_03_27_012757	782	1	10	10	CD
10_1101-2020_03_27_012757	782	2	,	,	,
10_1101-2020_03_27_012757	782	3	45–57	45–57	CD
10_1101-2020_03_27_012757	782	4	(	(	-LRB-
10_1101-2020_03_27_012757	782	5	2014	2014	CD
10_1101-2020_03_27_012757	782	6	)	)	-RRB-
10_1101-2020_03_27_012757	782	7	.	.	.
10_1101-2020_03_27_012757	783	1	1110	1110	CD
10_1101-2020_03_27_012757	783	2	53	53	CD
10_1101-2020_03_27_012757	783	3	.	.	.
10_1101-2020_03_27_012757	784	1	Yang	Yang	NNP
10_1101-2020_03_27_012757	784	2	,	,	,
10_1101-2020_03_27_012757	784	3	S.	S.	NNP
10_1101-2020_03_27_012757	784	4	,	,	,
10_1101-2020_03_27_012757	784	5	Thiel	Thiel	NNP
10_1101-2020_03_27_012757	784	6	,	,	,
10_1101-2020_03_27_012757	784	7	K.	K.	NNP
10_1101-2020_03_27_012757	784	8	W.	W.	NNP
10_1101-2020_03_27_012757	784	9	&	&	CC
10_1101-2020_03_27_012757	784	10	Leslie	Leslie	NNP
10_1101-2020_03_27_012757	784	11	,	,	,
10_1101-2020_03_27_012757	784	12	K.	K.	NNP
10_1101-2020_03_27_012757	784	13	K.	K.	NNP
10_1101-2020_03_27_012757	784	14	Progesterone	Progesterone	NNP
10_1101-2020_03_27_012757	784	15	:	:	:
10_1101-2020_03_27_012757	784	16	the	the	DT
10_1101-2020_03_27_012757	784	17	ultimate	ultimate	JJ
10_1101-2020_03_27_012757	784	18	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	784	19	tumor	tumor	NN
10_1101-2020_03_27_012757	784	20	1111	1111	CD
10_1101-2020_03_27_012757	784	21	suppressor	suppressor	NN
10_1101-2020_03_27_012757	784	22	.	.	.
10_1101-2020_03_27_012757	785	1	Trends	Trends	NNPS
10_1101-2020_03_27_012757	785	2	Endocrinol	Endocrinol	NNP
10_1101-2020_03_27_012757	785	3	.	.	.
10_1101-2020_03_27_012757	786	1	Metab	Metab	NNP
10_1101-2020_03_27_012757	786	2	.	.	.
10_1101-2020_03_27_012757	787	1	22	22	CD
10_1101-2020_03_27_012757	787	2	,	,	,
10_1101-2020_03_27_012757	787	3	145–152	145–152	CD
10_1101-2020_03_27_012757	787	4	(	(	-LRB-
10_1101-2020_03_27_012757	787	5	2011	2011	CD
10_1101-2020_03_27_012757	787	6	)	)	-RRB-
10_1101-2020_03_27_012757	787	7	.	.	.
10_1101-2020_03_27_012757	788	1	1112	1112	CD
10_1101-2020_03_27_012757	788	2	54	54	CD
10_1101-2020_03_27_012757	788	3	.	.	.
10_1101-2020_03_27_012757	789	1	Huszar	Huszar	NNP
10_1101-2020_03_27_012757	789	2	,	,	,
10_1101-2020_03_27_012757	789	3	M.	M.	NNP
10_1101-2020_03_27_012757	789	4	et	et	NNP
10_1101-2020_03_27_012757	789	5	al	al	NNP
10_1101-2020_03_27_012757	789	6	.	.	.
10_1101-2020_03_27_012757	790	1	Up	up	IN
10_1101-2020_03_27_012757	790	2	-	-	HYPH
10_1101-2020_03_27_012757	790	3	regulation	regulation	NN
10_1101-2020_03_27_012757	790	4	of	of	IN
10_1101-2020_03_27_012757	790	5	L1CAM	L1CAM	NNP
10_1101-2020_03_27_012757	790	6	is	be	VBZ
10_1101-2020_03_27_012757	790	7	linked	link	VBN
10_1101-2020_03_27_012757	790	8	to	to	IN
10_1101-2020_03_27_012757	790	9	loss	loss	NN
10_1101-2020_03_27_012757	790	10	of	of	IN
10_1101-2020_03_27_012757	790	11	hormone	hormone	NN
10_1101-2020_03_27_012757	790	12	receptors	receptor	NNS
10_1101-2020_03_27_012757	790	13	and	and	CC
10_1101-2020_03_27_012757	790	14	1113	1113	CD
10_1101-2020_03_27_012757	790	15	E	e	NN
10_1101-2020_03_27_012757	790	16	-	-	NN
10_1101-2020_03_27_012757	790	17	cadherin	cadherin	NN
10_1101-2020_03_27_012757	790	18	in	in	IN
10_1101-2020_03_27_012757	790	19	aggressive	aggressive	JJ
10_1101-2020_03_27_012757	790	20	subtypes	subtype	NNS
10_1101-2020_03_27_012757	790	21	of	of	IN
10_1101-2020_03_27_012757	790	22	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	790	23	carcinomas	carcinoma	NNS
10_1101-2020_03_27_012757	790	24	.	.	.
10_1101-2020_03_27_012757	791	1	J.	J.	NNP
10_1101-2020_03_27_012757	791	2	Pathol	Pathol	NNP
10_1101-2020_03_27_012757	791	3	.	.	.
10_1101-2020_03_27_012757	792	1	220	220	CD
10_1101-2020_03_27_012757	792	2	,	,	,
10_1101-2020_03_27_012757	792	3	551–1114	551–1114	NNP
10_1101-2020_03_27_012757	792	4	561	561	CD
10_1101-2020_03_27_012757	792	5	(	(	-LRB-
10_1101-2020_03_27_012757	792	6	2010	2010	CD
10_1101-2020_03_27_012757	792	7	)	)	-RRB-
10_1101-2020_03_27_012757	792	8	.	.	.
10_1101-2020_03_27_012757	793	1	1115	1115	CD
10_1101-2020_03_27_012757	793	2	55	55	CD
10_1101-2020_03_27_012757	793	3	.	.	.
10_1101-2020_03_27_012757	794	1	Kozak	Kozak	NNP
10_1101-2020_03_27_012757	794	2	,	,	,
10_1101-2020_03_27_012757	794	3	J.	J.	NNP
10_1101-2020_03_27_012757	794	4	,	,	,
10_1101-2020_03_27_012757	794	5	Wdowiak	Wdowiak	NNP
10_1101-2020_03_27_012757	794	6	,	,	,
10_1101-2020_03_27_012757	794	7	P.	P.	NNP
10_1101-2020_03_27_012757	794	8	,	,	,
10_1101-2020_03_27_012757	794	9	Maciejewski	Maciejewski	NNP
10_1101-2020_03_27_012757	794	10	,	,	,
10_1101-2020_03_27_012757	794	11	R.	R.	NNP
10_1101-2020_03_27_012757	794	12	&	&	CC
10_1101-2020_03_27_012757	794	13	Torres	Torres	NNP
10_1101-2020_03_27_012757	794	14	,	,	,
10_1101-2020_03_27_012757	794	15	A.	a.	NN
10_1101-2020_03_27_012757	795	1	A	a	DT
10_1101-2020_03_27_012757	795	2	guide	guide	NN
10_1101-2020_03_27_012757	795	3	for	for	IN
10_1101-2020_03_27_012757	795	4	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	795	5	1116	1116	CD
10_1101-2020_03_27_012757	795	6	cancer	cancer	NN
10_1101-2020_03_27_012757	795	7	cell	cell	NN
10_1101-2020_03_27_012757	795	8	lines	line	NNS
10_1101-2020_03_27_012757	795	9	functional	functional	JJ
10_1101-2020_03_27_012757	795	10	assays	assays	RB
10_1101-2020_03_27_012757	795	11	using	use	VBG
10_1101-2020_03_27_012757	795	12	the	the	DT
10_1101-2020_03_27_012757	795	13	measurements	measurement	NNS
10_1101-2020_03_27_012757	795	14	of	of	IN
10_1101-2020_03_27_012757	795	15	electronic	electronic	JJ
10_1101-2020_03_27_012757	795	16	1117	1117	CD
10_1101-2020_03_27_012757	795	17	impedance	impedance	NN
10_1101-2020_03_27_012757	795	18	.	.	.
10_1101-2020_03_27_012757	796	1	Cytotechnology	cytotechnology	NN
10_1101-2020_03_27_012757	796	2	70	70	CD
10_1101-2020_03_27_012757	796	3	,	,	,
10_1101-2020_03_27_012757	796	4	339–350	339–350	CD
10_1101-2020_03_27_012757	796	5	(	(	-LRB-
10_1101-2020_03_27_012757	796	6	2018	2018	CD
10_1101-2020_03_27_012757	796	7	)	)	-RRB-
10_1101-2020_03_27_012757	796	8	.	.	.
10_1101-2020_03_27_012757	797	1	1118	1118	CD
10_1101-2020_03_27_012757	797	2	56	56	CD
10_1101-2020_03_27_012757	797	3	.	.	.
10_1101-2020_03_27_012757	798	1	Korch	Korch	NNP
10_1101-2020_03_27_012757	798	2	,	,	,
10_1101-2020_03_27_012757	798	3	C.	C.	NNP
10_1101-2020_03_27_012757	798	4	et	et	NNP
10_1101-2020_03_27_012757	798	5	al	al	NNP
10_1101-2020_03_27_012757	798	6	.	.	.
10_1101-2020_03_27_012757	799	1	DNA	dna	NN
10_1101-2020_03_27_012757	799	2	profiling	profile	VBG
10_1101-2020_03_27_012757	799	3	analysis	analysis	NN
10_1101-2020_03_27_012757	799	4	of	of	IN
10_1101-2020_03_27_012757	799	5	endometrial	endometrial	JJ
10_1101-2020_03_27_012757	799	6	and	and	CC
10_1101-2020_03_27_012757	799	7	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	799	8	cell	cell	NN
10_1101-2020_03_27_012757	799	9	lines	line	NNS
10_1101-2020_03_27_012757	799	10	reveals	reveal	VBZ
10_1101-2020_03_27_012757	799	11	1119	1119	CD
10_1101-2020_03_27_012757	799	12	misidentification	misidentification	NN
10_1101-2020_03_27_012757	799	13	,	,	,
10_1101-2020_03_27_012757	799	14	redundancy	redundancy	NN
10_1101-2020_03_27_012757	799	15	and	and	CC
10_1101-2020_03_27_012757	799	16	contamination	contamination	NN
10_1101-2020_03_27_012757	799	17	.	.	.
10_1101-2020_03_27_012757	800	1	Gynecol	Gynecol	NNP
10_1101-2020_03_27_012757	800	2	.	.	.
10_1101-2020_03_27_012757	801	1	Oncol	Oncol	NNP
10_1101-2020_03_27_012757	801	2	.	.	.
10_1101-2020_03_27_012757	802	1	127	127	CD
10_1101-2020_03_27_012757	802	2	,	,	,
10_1101-2020_03_27_012757	802	3	241–248	241–248	CD
10_1101-2020_03_27_012757	802	4	1120	1120	CD
10_1101-2020_03_27_012757	802	5	(	(	-LRB-
10_1101-2020_03_27_012757	802	6	2012	2012	CD
10_1101-2020_03_27_012757	802	7	)	)	-RRB-
10_1101-2020_03_27_012757	802	8	.	.	.
10_1101-2020_03_27_012757	803	1	1121	1121	CD
10_1101-2020_03_27_012757	803	2	57	57	CD
10_1101-2020_03_27_012757	803	3	.	.	.
10_1101-2020_03_27_012757	804	1	Wu	Wu	NNP
10_1101-2020_03_27_012757	804	2	,	,	,
10_1101-2020_03_27_012757	804	3	D.	D.	NNP
10_1101-2020_03_27_012757	804	4	et	et	NNP
10_1101-2020_03_27_012757	804	5	al	al	NNP
10_1101-2020_03_27_012757	804	6	.	.	.
10_1101-2020_03_27_012757	805	1	Gene	gene	NN
10_1101-2020_03_27_012757	805	2	-	-	HYPH
10_1101-2020_03_27_012757	805	3	expression	expression	NN
10_1101-2020_03_27_012757	805	4	data	datum	NNS
10_1101-2020_03_27_012757	805	5	integration	integration	NN
10_1101-2020_03_27_012757	805	6	to	to	IN
10_1101-2020_03_27_012757	805	7	squamous	squamous	JJ
10_1101-2020_03_27_012757	805	8	cell	cell	NN
10_1101-2020_03_27_012757	805	9	lung	lung	NN
10_1101-2020_03_27_012757	805	10	cancer	cancer	NN
10_1101-2020_03_27_012757	805	11	1122	1122	CD
10_1101-2020_03_27_012757	805	12	subtypes	subtype	NNS
10_1101-2020_03_27_012757	805	13	reveals	reveal	VBZ
10_1101-2020_03_27_012757	805	14	drug	drug	NN
10_1101-2020_03_27_012757	805	15	sensitivity	sensitivity	NN
10_1101-2020_03_27_012757	805	16	.	.	.
10_1101-2020_03_27_012757	806	1	Br	br	UH
10_1101-2020_03_27_012757	806	2	.	.	.
10_1101-2020_03_27_012757	807	1	J.	J.	NNP
10_1101-2020_03_27_012757	808	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	808	2	109	109	CD
10_1101-2020_03_27_012757	808	3	,	,	,
10_1101-2020_03_27_012757	808	4	1599–1608	1599–1608	CD
10_1101-2020_03_27_012757	808	5	(	(	-LRB-
10_1101-2020_03_27_012757	808	6	2013	2013	CD
10_1101-2020_03_27_012757	808	7	)	)	-RRB-
10_1101-2020_03_27_012757	808	8	.	.	.
10_1101-2020_03_27_012757	809	1	1123	1123	CD
10_1101-2020_03_27_012757	809	2	58	58	CD
10_1101-2020_03_27_012757	809	3	.	.	.
10_1101-2020_03_27_012757	810	1	Walter	Walter	NNP
10_1101-2020_03_27_012757	810	2	,	,	,
10_1101-2020_03_27_012757	810	3	V.	V.	NNP
10_1101-2020_03_27_012757	810	4	et	et	NNP
10_1101-2020_03_27_012757	810	5	al	al	NNP
10_1101-2020_03_27_012757	810	6	.	.	.
10_1101-2020_03_27_012757	811	1	Molecular	molecular	JJ
10_1101-2020_03_27_012757	811	2	subtypes	subtype	NNS
10_1101-2020_03_27_012757	811	3	in	in	IN
10_1101-2020_03_27_012757	811	4	head	head	NN
10_1101-2020_03_27_012757	811	5	and	and	CC
10_1101-2020_03_27_012757	811	6	neck	neck	NN
10_1101-2020_03_27_012757	811	7	cancer	cancer	NN
10_1101-2020_03_27_012757	811	8	exhibit	exhibit	NN
10_1101-2020_03_27_012757	811	9	distinct	distinct	JJ
10_1101-2020_03_27_012757	811	10	1124	1124	CD
10_1101-2020_03_27_012757	811	11	patterns	pattern	NNS
10_1101-2020_03_27_012757	811	12	of	of	IN
10_1101-2020_03_27_012757	811	13	chromosomal	chromosomal	JJ
10_1101-2020_03_27_012757	811	14	gain	gain	NN
10_1101-2020_03_27_012757	811	15	and	and	CC
10_1101-2020_03_27_012757	811	16	loss	loss	NN
10_1101-2020_03_27_012757	811	17	of	of	IN
10_1101-2020_03_27_012757	811	18	canonical	canonical	JJ
10_1101-2020_03_27_012757	811	19	cancer	cancer	NN
10_1101-2020_03_27_012757	811	20	genes	gene	NNS
10_1101-2020_03_27_012757	811	21	.	.	.
10_1101-2020_03_27_012757	812	1	PLoS	plos	ADD
10_1101-2020_03_27_012757	812	2	One	one	CD
10_1101-2020_03_27_012757	812	3	8	8	CD
10_1101-2020_03_27_012757	812	4	,	,	,
10_1101-2020_03_27_012757	812	5	1125	1125	CD
10_1101-2020_03_27_012757	812	6	e56823	e56823	NNP
10_1101-2020_03_27_012757	812	7	(	(	-LRB-
10_1101-2020_03_27_012757	812	8	2013	2013	CD
10_1101-2020_03_27_012757	812	9	)	)	-RRB-
10_1101-2020_03_27_012757	812	10	.	.	.
10_1101-2020_03_27_012757	813	1	1126	1126	CD
10_1101-2020_03_27_012757	813	2	59	59	CD
10_1101-2020_03_27_012757	813	3	.	.	.
10_1101-2020_03_27_012757	814	1	Adeegbe	adeegbe	VB
10_1101-2020_03_27_012757	814	2	,	,	,
10_1101-2020_03_27_012757	814	3	D.	D.	NNP
10_1101-2020_03_27_012757	814	4	O.	O.	NNP
10_1101-2020_03_27_012757	814	5	et	et	NNP
10_1101-2020_03_27_012757	814	6	al	al	NNP
10_1101-2020_03_27_012757	814	7	.	.	.
10_1101-2020_03_27_012757	815	1	BET	BET	NNP
10_1101-2020_03_27_012757	815	2	Bromodomain	bromodomain	JJ
10_1101-2020_03_27_012757	815	3	Inhibition	inhibition	NN
10_1101-2020_03_27_012757	815	4	Cooperates	cooperate	NNS
10_1101-2020_03_27_012757	815	5	with	with	IN
10_1101-2020_03_27_012757	815	6	PD-1	PD-1	NNP
10_1101-2020_03_27_012757	815	7	Blockade	Blockade	NNP
10_1101-2020_03_27_012757	815	8	1127	1127	CD
10_1101-2020_03_27_012757	815	9	to	to	IN
10_1101-2020_03_27_012757	815	10	Facilitate	Facilitate	NNP
10_1101-2020_03_27_012757	815	11	Antitumor	Antitumor	NNP
10_1101-2020_03_27_012757	815	12	Response	Response	NNP
10_1101-2020_03_27_012757	815	13	in	in	IN
10_1101-2020_03_27_012757	815	14	Kras	Kras	NNP
10_1101-2020_03_27_012757	815	15	-	-	HYPH
10_1101-2020_03_27_012757	815	16	Mutant	Mutant	NNP
10_1101-2020_03_27_012757	815	17	Non	non	JJ
10_1101-2020_03_27_012757	815	18	-	-	JJ
10_1101-2020_03_27_012757	815	19	Small	small	JJ
10_1101-2020_03_27_012757	815	20	Cell	Cell	NNP
10_1101-2020_03_27_012757	815	21	Lung	Lung	NNP
10_1101-2020_03_27_012757	815	22	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	815	23	.	.	.
10_1101-2020_03_27_012757	816	1	1128	1128	CD
10_1101-2020_03_27_012757	816	2	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	816	3	Immunol	Immunol	NNP
10_1101-2020_03_27_012757	816	4	Res	Res	NNP
10_1101-2020_03_27_012757	816	5	6	6	CD
10_1101-2020_03_27_012757	816	6	,	,	,
10_1101-2020_03_27_012757	816	7	1234–1245	1234–1245	CD
10_1101-2020_03_27_012757	816	8	(	(	-LRB-
10_1101-2020_03_27_012757	816	9	2018	2018	CD
10_1101-2020_03_27_012757	816	10	)	)	-RRB-
10_1101-2020_03_27_012757	816	11	.	.	.
10_1101-2020_03_27_012757	817	1	1129	1129	CD
10_1101-2020_03_27_012757	817	2	60	60	CD
10_1101-2020_03_27_012757	817	3	.	.	.
10_1101-2020_03_27_012757	818	1	Blaisdell	Blaisdell	NNP
10_1101-2020_03_27_012757	818	2	,	,	,
10_1101-2020_03_27_012757	818	3	A.	A.	NNP
10_1101-2020_03_27_012757	818	4	et	et	FW
10_1101-2020_03_27_012757	818	5	al	al	NNP
10_1101-2020_03_27_012757	818	6	.	.	.
10_1101-2020_03_27_012757	819	1	Neutrophils	neutrophil	NNS
10_1101-2020_03_27_012757	819	2	oppose	oppose	VBP
10_1101-2020_03_27_012757	819	3	uterine	uterine	JJ
10_1101-2020_03_27_012757	819	4	epithelial	epithelial	JJ
10_1101-2020_03_27_012757	819	5	carcinogenesis	carcinogenesis	NN
10_1101-2020_03_27_012757	819	6	via	via	IN
10_1101-2020_03_27_012757	819	7	1130	1130	CD
10_1101-2020_03_27_012757	819	8	debridement	debridement	NN
10_1101-2020_03_27_012757	819	9	of	of	IN
10_1101-2020_03_27_012757	819	10	hypoxic	hypoxic	JJ
10_1101-2020_03_27_012757	819	11	tumor	tumor	NN
10_1101-2020_03_27_012757	819	12	cells	cell	NNS
10_1101-2020_03_27_012757	819	13	.	.	.
10_1101-2020_03_27_012757	820	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	820	2	Cell	Cell	NNP
10_1101-2020_03_27_012757	820	3	28	28	CD
10_1101-2020_03_27_012757	820	4	,	,	,
10_1101-2020_03_27_012757	820	5	785–799	785–799	CD
10_1101-2020_03_27_012757	820	6	(	(	-LRB-
10_1101-2020_03_27_012757	820	7	2015	2015	CD
10_1101-2020_03_27_012757	820	8	)	)	-RRB-
10_1101-2020_03_27_012757	820	9	.	.	.
10_1101-2020_03_27_012757	821	1	1131	1131	CD
10_1101-2020_03_27_012757	821	2	61	61	CD
10_1101-2020_03_27_012757	821	3	.	.	.
10_1101-2020_03_27_012757	822	1	Fitamant	Fitamant	NNP
10_1101-2020_03_27_012757	822	2	,	,	,
10_1101-2020_03_27_012757	822	3	J.	J.	NNP
10_1101-2020_03_27_012757	822	4	et	et	NNP
10_1101-2020_03_27_012757	822	5	al	al	NNP
10_1101-2020_03_27_012757	822	6	.	.	.
10_1101-2020_03_27_012757	823	1	YAP	yap	NN
10_1101-2020_03_27_012757	823	2	inhibition	inhibition	NN
10_1101-2020_03_27_012757	823	3	restores	restore	VBZ
10_1101-2020_03_27_012757	823	4	hepatocyte	hepatocyte	VBD
10_1101-2020_03_27_012757	823	5	differentiation	differentiation	NN
10_1101-2020_03_27_012757	823	6	in	in	IN
10_1101-2020_03_27_012757	823	7	advanced	advanced	JJ
10_1101-2020_03_27_012757	823	8	1132	1132	CD
10_1101-2020_03_27_012757	823	9	HCC	HCC	NNP
10_1101-2020_03_27_012757	823	10	,	,	,
10_1101-2020_03_27_012757	823	11	leading	lead	VBG
10_1101-2020_03_27_012757	823	12	to	to	IN
10_1101-2020_03_27_012757	823	13	tumor	tumor	NN
10_1101-2020_03_27_012757	823	14	regression	regression	NN
10_1101-2020_03_27_012757	823	15	.	.	.
10_1101-2020_03_27_012757	824	1	Cell	Cell	NNP
10_1101-2020_03_27_012757	824	2	Rep.	Rep.	NNP
10_1101-2020_03_27_012757	824	3	10	10	CD
10_1101-2020_03_27_012757	824	4	,	,	,
10_1101-2020_03_27_012757	824	5	1692–1707	1692–1707	CD
10_1101-2020_03_27_012757	824	6	(	(	-LRB-
10_1101-2020_03_27_012757	824	7	2015	2015	CD
10_1101-2020_03_27_012757	824	8	)	)	-RRB-
10_1101-2020_03_27_012757	824	9	.	.	.
10_1101-2020_03_27_012757	825	1	1133	1133	CD
10_1101-2020_03_27_012757	825	2	62	62	CD
10_1101-2020_03_27_012757	825	3	.	.	.
10_1101-2020_03_27_012757	826	1	Jia	Jia	NNP
10_1101-2020_03_27_012757	826	2	,	,	,
10_1101-2020_03_27_012757	826	3	D.	D.	NNP
10_1101-2020_03_27_012757	826	4	et	et	NNP
10_1101-2020_03_27_012757	826	5	al	al	NNP
10_1101-2020_03_27_012757	826	6	.	.	.
10_1101-2020_03_27_012757	827	1	Crebbp	Crebbp	NNP
10_1101-2020_03_27_012757	827	2	loss	loss	NN
10_1101-2020_03_27_012757	827	3	drives	drive	VBZ
10_1101-2020_03_27_012757	827	4	small	small	JJ
10_1101-2020_03_27_012757	827	5	cell	cell	NN
10_1101-2020_03_27_012757	827	6	lung	lung	NN
10_1101-2020_03_27_012757	827	7	cancer	cancer	NN
10_1101-2020_03_27_012757	827	8	and	and	CC
10_1101-2020_03_27_012757	827	9	increases	increase	VBZ
10_1101-2020_03_27_012757	827	10	sensitivity	sensitivity	NN
10_1101-2020_03_27_012757	827	11	to	to	IN
10_1101-2020_03_27_012757	827	12	1134	1134	CD
10_1101-2020_03_27_012757	827	13	HDAC	HDAC	NNP
10_1101-2020_03_27_012757	827	14	inhibition	inhibition	NN
10_1101-2020_03_27_012757	827	15	.	.	.
10_1101-2020_03_27_012757	828	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	828	2	Discov	Discov	NNP
10_1101-2020_03_27_012757	828	3	.	.	.
10_1101-2020_03_27_012757	829	1	8	8	CD
10_1101-2020_03_27_012757	829	2	,	,	,
10_1101-2020_03_27_012757	829	3	1422–1437	1422–1437	CD
10_1101-2020_03_27_012757	829	4	(	(	-LRB-
10_1101-2020_03_27_012757	829	5	2018	2018	CD
10_1101-2020_03_27_012757	829	6	)	)	-RRB-
10_1101-2020_03_27_012757	829	7	.	.	.
10_1101-2020_03_27_012757	830	1	1135	1135	CD
10_1101-2020_03_27_012757	830	2	63	63	CD
10_1101-2020_03_27_012757	830	3	.	.	.
10_1101-2020_03_27_012757	831	1	Kress	Kress	NNP
10_1101-2020_03_27_012757	831	2	,	,	,
10_1101-2020_03_27_012757	831	3	T.	T.	NNP
10_1101-2020_03_27_012757	831	4	R.	R.	NNP
10_1101-2020_03_27_012757	831	5	et	et	NNP
10_1101-2020_03_27_012757	831	6	al	al	NNP
10_1101-2020_03_27_012757	831	7	.	.	.
10_1101-2020_03_27_012757	832	1	Identification	identification	NN
10_1101-2020_03_27_012757	832	2	of	of	IN
10_1101-2020_03_27_012757	832	3	MYC	MYC	NNP
10_1101-2020_03_27_012757	832	4	-	-	HYPH
10_1101-2020_03_27_012757	832	5	Dependent	Dependent	NNP
10_1101-2020_03_27_012757	832	6	Transcriptional	Transcriptional	NNP
10_1101-2020_03_27_012757	832	7	Programs	Programs	NNPS
10_1101-2020_03_27_012757	832	8	in	in	IN
10_1101-2020_03_27_012757	832	9	1136	1136	CD
10_1101-2020_03_27_012757	832	10	Oncogene	Oncogene	NNP
10_1101-2020_03_27_012757	832	11	-	-	HYPH
10_1101-2020_03_27_012757	832	12	Addicted	addict	VBN
10_1101-2020_03_27_012757	832	13	Liver	Liver	NNP
10_1101-2020_03_27_012757	832	14	Tumors	Tumors	NNPS
10_1101-2020_03_27_012757	832	15	.	.	.
10_1101-2020_03_27_012757	833	1	Cancer	cancer	NN
10_1101-2020_03_27_012757	833	2	Res	Res	NNP
10_1101-2020_03_27_012757	833	3	.	.	.
10_1101-2020_03_27_012757	834	1	76	76	CD
10_1101-2020_03_27_012757	834	2	,	,	,
10_1101-2020_03_27_012757	834	3	3463–3472	3463–3472	CD
10_1101-2020_03_27_012757	834	4	(	(	-LRB-
10_1101-2020_03_27_012757	834	5	2016	2016	CD
10_1101-2020_03_27_012757	834	6	)	)	-RRB-
10_1101-2020_03_27_012757	834	7	.	.	.
10_1101-2020_03_27_012757	835	1	1137	1137	CD
10_1101-2020_03_27_012757	835	2	64	64	CD
10_1101-2020_03_27_012757	835	3	.	.	.
10_1101-2020_03_27_012757	836	1	Li	Li	NNP
10_1101-2020_03_27_012757	836	2	,	,	,
10_1101-2020_03_27_012757	836	3	L.	L.	NNP
10_1101-2020_03_27_012757	836	4	et	et	NNP
10_1101-2020_03_27_012757	836	5	al	al	NNP
10_1101-2020_03_27_012757	836	6	.	.	.
10_1101-2020_03_27_012757	837	1	GKAP	GKAP	NNP
10_1101-2020_03_27_012757	837	2	acts	act	VBZ
10_1101-2020_03_27_012757	837	3	as	as	IN
10_1101-2020_03_27_012757	837	4	a	a	DT
10_1101-2020_03_27_012757	837	5	genetic	genetic	JJ
10_1101-2020_03_27_012757	837	6	modulator	modulator	NN
10_1101-2020_03_27_012757	837	7	of	of	IN
10_1101-2020_03_27_012757	837	8	NMDAR	NMDAR	NNS
10_1101-2020_03_27_012757	837	9	signaling	signal	VBG
10_1101-2020_03_27_012757	837	10	to	to	TO
10_1101-2020_03_27_012757	837	11	govern	govern	VB
10_1101-2020_03_27_012757	837	12	1138	1138	CD
10_1101-2020_03_27_012757	837	13	invasive	invasive	JJ
10_1101-2020_03_27_012757	837	14	tumor	tumor	NN
10_1101-2020_03_27_012757	837	15	growth	growth	NN
10_1101-2020_03_27_012757	837	16	.	.	.
10_1101-2020_03_27_012757	838	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	838	2	Cell	Cell	NNP
10_1101-2020_03_27_012757	838	3	33	33	CD
10_1101-2020_03_27_012757	838	4	,	,	,
10_1101-2020_03_27_012757	838	5	736–751.e5	736–751.e5	NNS
10_1101-2020_03_27_012757	838	6	(	(	-LRB-
10_1101-2020_03_27_012757	838	7	2018	2018	CD
10_1101-2020_03_27_012757	838	8	)	)	-RRB-
10_1101-2020_03_27_012757	838	9	.	.	.
10_1101-2020_03_27_012757	839	1	1139	1139	CD
10_1101-2020_03_27_012757	839	2	65	65	CD
10_1101-2020_03_27_012757	839	3	.	.	.
10_1101-2020_03_27_012757	840	1	Mollaoglu	Mollaoglu	NNP
10_1101-2020_03_27_012757	840	2	,	,	,
10_1101-2020_03_27_012757	840	3	G.	G.	NNP
10_1101-2020_03_27_012757	840	4	et	et	NNP
10_1101-2020_03_27_012757	840	5	al	al	NNP
10_1101-2020_03_27_012757	840	6	.	.	.
10_1101-2020_03_27_012757	841	1	The	the	DT
10_1101-2020_03_27_012757	841	2	Lineage	Lineage	NNP
10_1101-2020_03_27_012757	841	3	-	-	HYPH
10_1101-2020_03_27_012757	841	4	Defining	Defining	NNP
10_1101-2020_03_27_012757	841	5	Transcription	Transcription	NNP
10_1101-2020_03_27_012757	841	6	Factors	Factors	NNP
10_1101-2020_03_27_012757	841	7	SOX2	SOX2	NNPS
10_1101-2020_03_27_012757	841	8	and	and	CC
10_1101-2020_03_27_012757	841	9	NKX2	NKX2	NNP
10_1101-2020_03_27_012757	841	10	-	-	HYPH
10_1101-2020_03_27_012757	841	11	1	1	CD
10_1101-2020_03_27_012757	841	12	1140	1140	CD
10_1101-2020_03_27_012757	841	13	Determine	Determine	NNP
10_1101-2020_03_27_012757	841	14	Lung	Lung	NNP
10_1101-2020_03_27_012757	841	15	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	841	16	Cell	Cell	NNP
10_1101-2020_03_27_012757	841	17	Fate	Fate	NNP
10_1101-2020_03_27_012757	841	18	and	and	CC
10_1101-2020_03_27_012757	841	19	Shape	Shape	NNP
10_1101-2020_03_27_012757	841	20	the	the	DT
10_1101-2020_03_27_012757	841	21	Tumor	Tumor	NNP
10_1101-2020_03_27_012757	841	22	Immune	Immune	NNP
10_1101-2020_03_27_012757	841	23	1141	1141	CD
10_1101-2020_03_27_012757	841	24	Microenvironment	Microenvironment	NNP
10_1101-2020_03_27_012757	841	25	.	.	.
10_1101-2020_03_27_012757	842	1	Immunity	immunity	NN
10_1101-2020_03_27_012757	842	2	49	49	CD
10_1101-2020_03_27_012757	842	3	,	,	,
10_1101-2020_03_27_012757	842	4	764–779.e9	764–779.e9	CD
10_1101-2020_03_27_012757	842	5	(	(	-LRB-
10_1101-2020_03_27_012757	842	6	2018	2018	CD
10_1101-2020_03_27_012757	842	7	)	)	-RRB-
10_1101-2020_03_27_012757	842	8	.	.	.
10_1101-2020_03_27_012757	843	1	1142	1142	CD
10_1101-2020_03_27_012757	843	2	.CC	.CC	:
10_1101-2020_03_27_012757	843	3	-	-	:
10_1101-2020_03_27_012757	843	4	BY	BY	NNP
10_1101-2020_03_27_012757	843	5	-	-	HYPH
10_1101-2020_03_27_012757	843	6	NC	NC	NNP
10_1101-2020_03_27_012757	843	7	-	-	HYPH
10_1101-2020_03_27_012757	843	8	ND	ND	NNP
10_1101-2020_03_27_012757	843	9	4.0	4.0	CD
10_1101-2020_03_27_012757	843	10	International	International	NNP
10_1101-2020_03_27_012757	843	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	843	12	under	under	IN
10_1101-2020_03_27_012757	843	13	a	a	DT
10_1101-2020_03_27_012757	843	14	(	(	-LRB-
10_1101-2020_03_27_012757	843	15	which	which	WDT
10_1101-2020_03_27_012757	843	16	was	be	VBD
10_1101-2020_03_27_012757	843	17	not	not	RB
10_1101-2020_03_27_012757	843	18	certified	certify	VBN
10_1101-2020_03_27_012757	843	19	by	by	IN
10_1101-2020_03_27_012757	843	20	peer	peer	NN
10_1101-2020_03_27_012757	843	21	review	review	NN
10_1101-2020_03_27_012757	843	22	)	)	-RRB-
10_1101-2020_03_27_012757	843	23	is	be	VBZ
10_1101-2020_03_27_012757	843	24	the	the	DT
10_1101-2020_03_27_012757	843	25	author	author	NN
10_1101-2020_03_27_012757	843	26	/	/	SYM
10_1101-2020_03_27_012757	843	27	funder	funder	NN
10_1101-2020_03_27_012757	843	28	,	,	,
10_1101-2020_03_27_012757	843	29	who	who	WP
10_1101-2020_03_27_012757	843	30	has	have	VBZ
10_1101-2020_03_27_012757	843	31	granted	grant	VBN
10_1101-2020_03_27_012757	843	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	843	33	a	a	DT
10_1101-2020_03_27_012757	843	34	license	license	NN
10_1101-2020_03_27_012757	843	35	to	to	TO
10_1101-2020_03_27_012757	843	36	display	display	VB
10_1101-2020_03_27_012757	843	37	the	the	DT
10_1101-2020_03_27_012757	843	38	preprint	preprint	NN
10_1101-2020_03_27_012757	843	39	in	in	IN
10_1101-2020_03_27_012757	843	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	843	41	.	.	.
10_1101-2020_03_27_012757	844	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	844	2	is	be	VBZ
10_1101-2020_03_27_012757	844	3	made	make	VBN
10_1101-2020_03_27_012757	844	4	The	the	DT
10_1101-2020_03_27_012757	844	5	copyright	copyright	NN
10_1101-2020_03_27_012757	844	6	holder	holder	NN
10_1101-2020_03_27_012757	844	7	for	for	IN
10_1101-2020_03_27_012757	844	8	this	this	DT
10_1101-2020_03_27_012757	844	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	844	10	version	version	NN
10_1101-2020_03_27_012757	844	11	posted	post	VBD
10_1101-2020_03_27_012757	844	12	January	January	NNP
10_1101-2020_03_27_012757	844	13	9	9	CD
10_1101-2020_03_27_012757	844	14	,	,	,
10_1101-2020_03_27_012757	844	15	2021	2021	CD
10_1101-2020_03_27_012757	844	16	.	.	.
10_1101-2020_03_27_012757	844	17	;	;	:
10_1101-2020_03_27_012757	844	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	844	19	:	:	:
10_1101-2020_03_27_012757	844	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	844	21	preprint	preprint	NN
10_1101-2020_03_27_012757	844	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	NNP
10_1101-2020_03_27_012757	844	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	844	24	41	41	CD
10_1101-2020_03_27_012757	844	25	66	66	CD
10_1101-2020_03_27_012757	844	26	.	.	.
10_1101-2020_03_27_012757	845	1	Pan	Pan	NNP
10_1101-2020_03_27_012757	845	2	,	,	,
10_1101-2020_03_27_012757	845	3	Y.	Y.	NNP
10_1101-2020_03_27_012757	845	4	et	et	NNP
10_1101-2020_03_27_012757	845	5	al	al	NNP
10_1101-2020_03_27_012757	845	6	.	.	.
10_1101-2020_03_27_012757	846	1	Whole	whole	JJ
10_1101-2020_03_27_012757	846	2	tumor	tumor	NN
10_1101-2020_03_27_012757	846	3	RNA	RNA	NNP
10_1101-2020_03_27_012757	846	4	-	-	HYPH
10_1101-2020_03_27_012757	846	5	sequencing	sequencing	NN
10_1101-2020_03_27_012757	846	6	and	and	CC
10_1101-2020_03_27_012757	846	7	deconvolution	deconvolution	NN
10_1101-2020_03_27_012757	846	8	reveal	reveal	VB
10_1101-2020_03_27_012757	846	9	a	a	DT
10_1101-2020_03_27_012757	846	10	clinically-1143	clinically-1143	JJ
10_1101-2020_03_27_012757	846	11	prognostic	prognostic	JJ
10_1101-2020_03_27_012757	846	12	PTEN	PTEN	NNP
10_1101-2020_03_27_012757	846	13	/	/	SYM
10_1101-2020_03_27_012757	846	14	PI3K	PI3K	NNP
10_1101-2020_03_27_012757	846	15	-	-	HYPH
10_1101-2020_03_27_012757	846	16	regulated	regulated	JJ
10_1101-2020_03_27_012757	846	17	glioma	glioma	NNP
10_1101-2020_03_27_012757	846	18	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	846	19	signature	signature	NN
10_1101-2020_03_27_012757	846	20	.	.	.
10_1101-2020_03_27_012757	847	1	Oncotarget	Oncotarget	NNP
10_1101-2020_03_27_012757	847	2	8	8	CD
10_1101-2020_03_27_012757	847	3	,	,	,
10_1101-2020_03_27_012757	847	4	1144	1144	CD
10_1101-2020_03_27_012757	847	5	52474–52487	52474–52487	CD
10_1101-2020_03_27_012757	847	6	(	(	-LRB-
10_1101-2020_03_27_012757	847	7	2017	2017	CD
10_1101-2020_03_27_012757	847	8	)	)	-RRB-
10_1101-2020_03_27_012757	847	9	.	.	.
10_1101-2020_03_27_012757	848	1	1145	1145	CD
10_1101-2020_03_27_012757	848	2	67	67	CD
10_1101-2020_03_27_012757	848	3	.	.	.
10_1101-2020_03_27_012757	849	1	Lissanu	Lissanu	NNP
10_1101-2020_03_27_012757	849	2	Deribe	Deribe	NNP
10_1101-2020_03_27_012757	849	3	,	,	,
10_1101-2020_03_27_012757	849	4	Y.	Y.	NNP
10_1101-2020_03_27_012757	849	5	et	et	NNP
10_1101-2020_03_27_012757	849	6	al	al	NNP
10_1101-2020_03_27_012757	849	7	.	.	.
10_1101-2020_03_27_012757	850	1	Mutations	mutation	NNS
10_1101-2020_03_27_012757	850	2	in	in	IN
10_1101-2020_03_27_012757	850	3	the	the	DT
10_1101-2020_03_27_012757	850	4	SWI	SWI	NNP
10_1101-2020_03_27_012757	850	5	/	/	SYM
10_1101-2020_03_27_012757	850	6	SNF	SNF	NNP
10_1101-2020_03_27_012757	850	7	complex	complex	JJ
10_1101-2020_03_27_012757	850	8	induce	induce	VBP
10_1101-2020_03_27_012757	850	9	a	a	DT
10_1101-2020_03_27_012757	850	10	targetable	targetable	NN
10_1101-2020_03_27_012757	850	11	1146	1146	CD
10_1101-2020_03_27_012757	850	12	dependence	dependence	NN
10_1101-2020_03_27_012757	850	13	on	on	IN
10_1101-2020_03_27_012757	850	14	oxidative	oxidative	JJ
10_1101-2020_03_27_012757	850	15	phosphorylation	phosphorylation	NN
10_1101-2020_03_27_012757	850	16	in	in	IN
10_1101-2020_03_27_012757	850	17	lung	lung	NN
10_1101-2020_03_27_012757	850	18	cancer	cancer	NN
10_1101-2020_03_27_012757	850	19	.	.	.
10_1101-2020_03_27_012757	851	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	851	2	.	.	.
10_1101-2020_03_27_012757	852	1	Med	Med	NNP
10_1101-2020_03_27_012757	852	2	.	.	.
10_1101-2020_03_27_012757	853	1	24	24	CD
10_1101-2020_03_27_012757	853	2	,	,	,
10_1101-2020_03_27_012757	853	3	1047–1057	1047–1057	CD
10_1101-2020_03_27_012757	853	4	1147	1147	CD
10_1101-2020_03_27_012757	853	5	(	(	-LRB-
10_1101-2020_03_27_012757	853	6	2018	2018	CD
10_1101-2020_03_27_012757	853	7	)	)	-RRB-
10_1101-2020_03_27_012757	853	8	.	.	.
10_1101-2020_03_27_012757	854	1	1148	1148	CD
10_1101-2020_03_27_012757	854	2	68	68	CD
10_1101-2020_03_27_012757	854	3	.	.	.
10_1101-2020_03_27_012757	855	1	Xu	Xu	NNP
10_1101-2020_03_27_012757	855	2	,	,	,
10_1101-2020_03_27_012757	855	3	C.	C.	NNP
10_1101-2020_03_27_012757	855	4	et	et	NNP
10_1101-2020_03_27_012757	855	5	al	al	NNP
10_1101-2020_03_27_012757	855	6	.	.	.
10_1101-2020_03_27_012757	856	1	Loss	loss	NN
10_1101-2020_03_27_012757	856	2	of	of	IN
10_1101-2020_03_27_012757	856	3	Lkb1	Lkb1	NNP
10_1101-2020_03_27_012757	856	4	and	and	CC
10_1101-2020_03_27_012757	856	5	Pten	Pten	NNP
10_1101-2020_03_27_012757	856	6	leads	lead	VBZ
10_1101-2020_03_27_012757	856	7	to	to	IN
10_1101-2020_03_27_012757	856	8	lung	lung	VB
10_1101-2020_03_27_012757	856	9	squamous	squamous	JJ
10_1101-2020_03_27_012757	856	10	cell	cell	NN
10_1101-2020_03_27_012757	856	11	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	856	12	with	with	IN
10_1101-2020_03_27_012757	856	13	1149	1149	CD
10_1101-2020_03_27_012757	856	14	elevated	elevated	JJ
10_1101-2020_03_27_012757	856	15	PD	PD	NNP
10_1101-2020_03_27_012757	856	16	-	-	HYPH
10_1101-2020_03_27_012757	856	17	L1	L1	NNP
10_1101-2020_03_27_012757	856	18	expression	expression	NN
10_1101-2020_03_27_012757	856	19	.	.	.
10_1101-2020_03_27_012757	857	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	857	2	Cell	Cell	NNP
10_1101-2020_03_27_012757	857	3	25	25	CD
10_1101-2020_03_27_012757	857	4	,	,	,
10_1101-2020_03_27_012757	857	5	590–604	590–604	CD
10_1101-2020_03_27_012757	857	6	(	(	-LRB-
10_1101-2020_03_27_012757	857	7	2014	2014	CD
10_1101-2020_03_27_012757	857	8	)	)	-RRB-
10_1101-2020_03_27_012757	857	9	.	.	.
10_1101-2020_03_27_012757	858	1	1150	1150	CD
10_1101-2020_03_27_012757	858	2	69	69	CD
10_1101-2020_03_27_012757	858	3	.	.	.
10_1101-2020_03_27_012757	859	1	NCI	NCI	NNP
10_1101-2020_03_27_012757	859	2	-	-	HYPH
10_1101-2020_03_27_012757	859	3	Frederick	Frederick	NNP
10_1101-2020_03_27_012757	859	4	,	,	,
10_1101-2020_03_27_012757	859	5	Frederick	Frederick	NNP
10_1101-2020_03_27_012757	859	6	,	,	,
10_1101-2020_03_27_012757	859	7	MD	MD	NNP
10_1101-2020_03_27_012757	859	8	.	.	.
10_1101-2020_03_27_012757	860	1	National	National	NNP
10_1101-2020_03_27_012757	860	2	Laboratory	Laboratory	NNP
10_1101-2020_03_27_012757	860	3	for	for	IN
10_1101-2020_03_27_012757	860	4	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	860	5	Research	Research	NNP
10_1101-2020_03_27_012757	860	6	.	.	.
10_1101-2020_03_27_012757	861	1	The	the	DT
10_1101-2020_03_27_012757	861	2	NCI	NCI	NNP
10_1101-2020_03_27_012757	861	3	1151	1151	CD
10_1101-2020_03_27_012757	861	4	Patient	Patient	NNP
10_1101-2020_03_27_012757	861	5	-	-	HYPH
10_1101-2020_03_27_012757	861	6	Derived	derive	VBN
10_1101-2020_03_27_012757	861	7	Models	Models	NNP
10_1101-2020_03_27_012757	861	8	Repository	Repository	NNP
10_1101-2020_03_27_012757	861	9	(	(	-LRB-
10_1101-2020_03_27_012757	861	10	PDMR	PDMR	NNP
10_1101-2020_03_27_012757	861	11	)	)	-RRB-
10_1101-2020_03_27_012757	861	12	.	.	.
10_1101-2020_03_27_012757	862	1	(	(	-LRB-
10_1101-2020_03_27_012757	862	2	2019	2019	CD
10_1101-2020_03_27_012757	862	3	)	)	-RRB-
10_1101-2020_03_27_012757	862	4	.	.	.
10_1101-2020_03_27_012757	863	1	at	at	IN
10_1101-2020_03_27_012757	863	2	<	<	XX
10_1101-2020_03_27_012757	863	3	https://pdmr.cancer.gov/	https://pdmr.cancer.gov/	NNP
10_1101-2020_03_27_012757	863	4	>	>	XX
10_1101-2020_03_27_012757	863	5	1152	1152	CD
10_1101-2020_03_27_012757	863	6	70	70	CD
10_1101-2020_03_27_012757	863	7	.	.	.
10_1101-2020_03_27_012757	864	1	Broutier	Broutier	NNP
10_1101-2020_03_27_012757	864	2	,	,	,
10_1101-2020_03_27_012757	864	3	L.	L.	NNP
10_1101-2020_03_27_012757	864	4	et	et	NNP
10_1101-2020_03_27_012757	864	5	al	al	NNP
10_1101-2020_03_27_012757	864	6	.	.	.
10_1101-2020_03_27_012757	865	1	Human	human	JJ
10_1101-2020_03_27_012757	865	2	primary	primary	JJ
10_1101-2020_03_27_012757	865	3	liver	liver	NN
10_1101-2020_03_27_012757	865	4	cancer	cancer	NN
10_1101-2020_03_27_012757	865	5	-	-	HYPH
10_1101-2020_03_27_012757	865	6	derived	derive	VBN
10_1101-2020_03_27_012757	865	7	organoid	organoid	JJ
10_1101-2020_03_27_012757	865	8	cultures	culture	NNS
10_1101-2020_03_27_012757	865	9	for	for	IN
10_1101-2020_03_27_012757	865	10	disease	disease	NN
10_1101-2020_03_27_012757	865	11	1153	1153	CD
10_1101-2020_03_27_012757	865	12	modeling	modeling	NN
10_1101-2020_03_27_012757	865	13	and	and	CC
10_1101-2020_03_27_012757	865	14	drug	drug	NN
10_1101-2020_03_27_012757	865	15	screening	screening	NN
10_1101-2020_03_27_012757	865	16	.	.	.
10_1101-2020_03_27_012757	866	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	866	2	.	.	.
10_1101-2020_03_27_012757	867	1	Med	Med	NNP
10_1101-2020_03_27_012757	867	2	.	.	.
10_1101-2020_03_27_012757	868	1	23	23	CD
10_1101-2020_03_27_012757	868	2	,	,	,
10_1101-2020_03_27_012757	868	3	1424–1435	1424–1435	CD
10_1101-2020_03_27_012757	868	4	(	(	-LRB-
10_1101-2020_03_27_012757	868	5	2017	2017	CD
10_1101-2020_03_27_012757	868	6	)	)	-RRB-
10_1101-2020_03_27_012757	868	7	.	.	.
10_1101-2020_03_27_012757	869	1	1154	1154	CD
10_1101-2020_03_27_012757	869	2	71	71	CD
10_1101-2020_03_27_012757	869	3	.	.	.
10_1101-2020_03_27_012757	870	1	Lee	Lee	NNP
10_1101-2020_03_27_012757	870	2	,	,	,
10_1101-2020_03_27_012757	870	3	S.	S.	NNP
10_1101-2020_03_27_012757	870	4	H.	H.	NNP
10_1101-2020_03_27_012757	870	5	et	et	NNP
10_1101-2020_03_27_012757	870	6	al	al	NNP
10_1101-2020_03_27_012757	870	7	.	.	.
10_1101-2020_03_27_012757	871	1	Tumor	Tumor	NNP
10_1101-2020_03_27_012757	871	2	Evolution	Evolution	NNP
10_1101-2020_03_27_012757	871	3	and	and	CC
10_1101-2020_03_27_012757	871	4	Drug	Drug	NNP
10_1101-2020_03_27_012757	871	5	Response	Response	NNP
10_1101-2020_03_27_012757	871	6	in	in	IN
10_1101-2020_03_27_012757	871	7	Patient	Patient	NNP
10_1101-2020_03_27_012757	871	8	-	-	HYPH
10_1101-2020_03_27_012757	871	9	Derived	derive	VBN
10_1101-2020_03_27_012757	871	10	Organoid	Organoid	NNP
10_1101-2020_03_27_012757	871	11	1155	1155	CD
10_1101-2020_03_27_012757	871	12	Models	Models	NNPS
10_1101-2020_03_27_012757	871	13	of	of	IN
10_1101-2020_03_27_012757	871	14	Bladder	Bladder	NNP
10_1101-2020_03_27_012757	871	15	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	871	16	.	.	.
10_1101-2020_03_27_012757	872	1	Cell	cell	NN
10_1101-2020_03_27_012757	872	2	173	173	CD
10_1101-2020_03_27_012757	872	3	,	,	,
10_1101-2020_03_27_012757	872	4	515–528.e17	515–528.e17	CD
10_1101-2020_03_27_012757	872	5	(	(	-LRB-
10_1101-2020_03_27_012757	872	6	2018	2018	CD
10_1101-2020_03_27_012757	872	7	)	)	-RRB-
10_1101-2020_03_27_012757	872	8	.	.	.
10_1101-2020_03_27_012757	873	1	1156	1156	CD
10_1101-2020_03_27_012757	873	2	72	72	CD
10_1101-2020_03_27_012757	873	3	.	.	.
10_1101-2020_03_27_012757	874	1	Ogawa	Ogawa	NNP
10_1101-2020_03_27_012757	874	2	,	,	,
10_1101-2020_03_27_012757	874	3	J.	J.	NNP
10_1101-2020_03_27_012757	874	4	,	,	,
10_1101-2020_03_27_012757	874	5	Pao	Pao	NNP
10_1101-2020_03_27_012757	874	6	,	,	,
10_1101-2020_03_27_012757	874	7	G.	G.	NNP
10_1101-2020_03_27_012757	874	8	M.	M.	NNP
10_1101-2020_03_27_012757	874	9	,	,	,
10_1101-2020_03_27_012757	874	10	Shokhirev	Shokhirev	NNP
10_1101-2020_03_27_012757	874	11	,	,	,
10_1101-2020_03_27_012757	874	12	M.	M.	NNP
10_1101-2020_03_27_012757	874	13	N.	N.	NNP
10_1101-2020_03_27_012757	874	14	&	&	CC
10_1101-2020_03_27_012757	874	15	Verma	Verma	NNP
10_1101-2020_03_27_012757	874	16	,	,	,
10_1101-2020_03_27_012757	874	17	I.	I.	NNP
10_1101-2020_03_27_012757	874	18	M.	M.	NNP
10_1101-2020_03_27_012757	874	19	Glioblastoma	Glioblastoma	NNP
10_1101-2020_03_27_012757	874	20	model	model	NN
10_1101-2020_03_27_012757	874	21	using	use	VBG
10_1101-2020_03_27_012757	874	22	1157	1157	CD
10_1101-2020_03_27_012757	874	23	human	human	JJ
10_1101-2020_03_27_012757	874	24	cerebral	cerebral	JJ
10_1101-2020_03_27_012757	874	25	organoids	organoid	NNS
10_1101-2020_03_27_012757	874	26	.	.	.
10_1101-2020_03_27_012757	875	1	Cell	Cell	NNP
10_1101-2020_03_27_012757	875	2	Rep.	Rep.	NNP
10_1101-2020_03_27_012757	875	3	23	23	CD
10_1101-2020_03_27_012757	875	4	,	,	,
10_1101-2020_03_27_012757	875	5	1220–1229	1220–1229	CD
10_1101-2020_03_27_012757	875	6	(	(	-LRB-
10_1101-2020_03_27_012757	875	7	2018	2018	CD
10_1101-2020_03_27_012757	875	8	)	)	-RRB-
10_1101-2020_03_27_012757	875	9	.	.	.
10_1101-2020_03_27_012757	876	1	1158	1158	CD
10_1101-2020_03_27_012757	876	2	73	73	CD
10_1101-2020_03_27_012757	876	3	.	.	.
10_1101-2020_03_27_012757	877	1	Ben	Ben	NNP
10_1101-2020_03_27_012757	877	2	-	-	HYPH
10_1101-2020_03_27_012757	877	3	David	David	NNP
10_1101-2020_03_27_012757	877	4	,	,	,
10_1101-2020_03_27_012757	877	5	U.	U.	NNP
10_1101-2020_03_27_012757	877	6	et	et	NNP
10_1101-2020_03_27_012757	877	7	al	al	NNP
10_1101-2020_03_27_012757	877	8	.	.	.
10_1101-2020_03_27_012757	878	1	Patient	patient	NN
10_1101-2020_03_27_012757	878	2	-	-	HYPH
10_1101-2020_03_27_012757	878	3	derived	derive	VBN
10_1101-2020_03_27_012757	878	4	xenografts	xenograft	NNS
10_1101-2020_03_27_012757	878	5	undergo	undergo	VBP
10_1101-2020_03_27_012757	878	6	mouse	mouse	NN
10_1101-2020_03_27_012757	878	7	-	-	HYPH
10_1101-2020_03_27_012757	878	8	specific	specific	JJ
10_1101-2020_03_27_012757	878	9	tumor	tumor	NN
10_1101-2020_03_27_012757	878	10	1159	1159	CD
10_1101-2020_03_27_012757	878	11	evolution	evolution	NN
10_1101-2020_03_27_012757	878	12	.	.	.
10_1101-2020_03_27_012757	879	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	879	2	.	.	.
10_1101-2020_03_27_012757	880	1	Genet	Genet	NNP
10_1101-2020_03_27_012757	880	2	.	.	.
10_1101-2020_03_27_012757	881	1	49	49	CD
10_1101-2020_03_27_012757	881	2	,	,	,
10_1101-2020_03_27_012757	881	3	1567–1575	1567–1575	CD
10_1101-2020_03_27_012757	881	4	(	(	-LRB-
10_1101-2020_03_27_012757	881	5	2017	2017	CD
10_1101-2020_03_27_012757	881	6	)	)	-RRB-
10_1101-2020_03_27_012757	881	7	.	.	.
10_1101-2020_03_27_012757	882	1	1160	1160	CD
10_1101-2020_03_27_012757	882	2	74	74	CD
10_1101-2020_03_27_012757	882	3	.	.	.
10_1101-2020_03_27_012757	883	1	Stratton	Stratton	NNP
10_1101-2020_03_27_012757	883	2	,	,	,
10_1101-2020_03_27_012757	883	3	M.	M.	NNP
10_1101-2020_03_27_012757	883	4	R.	R.	NNP
10_1101-2020_03_27_012757	883	5	,	,	,
10_1101-2020_03_27_012757	883	6	Campbell	Campbell	NNP
10_1101-2020_03_27_012757	883	7	,	,	,
10_1101-2020_03_27_012757	883	8	P.	P.	NNP
10_1101-2020_03_27_012757	883	9	J.	J.	NNP
10_1101-2020_03_27_012757	884	1	&	&	CC
10_1101-2020_03_27_012757	884	2	Futreal	Futreal	NNP
10_1101-2020_03_27_012757	884	3	,	,	,
10_1101-2020_03_27_012757	884	4	P.	P.	NNP
10_1101-2020_03_27_012757	884	5	A.	A.	NNP
10_1101-2020_03_27_012757	885	1	The	the	DT
10_1101-2020_03_27_012757	885	2	cancer	cancer	NN
10_1101-2020_03_27_012757	885	3	genome	genome	NN
10_1101-2020_03_27_012757	885	4	.	.	.
10_1101-2020_03_27_012757	886	1	Nature	nature	NN
10_1101-2020_03_27_012757	886	2	458	458	CD
10_1101-2020_03_27_012757	886	3	,	,	,
10_1101-2020_03_27_012757	886	4	1161	1161	CD
10_1101-2020_03_27_012757	886	5	719–724	719–724	CD
10_1101-2020_03_27_012757	886	6	(	(	-LRB-
10_1101-2020_03_27_012757	886	7	2009	2009	CD
10_1101-2020_03_27_012757	886	8	)	)	-RRB-
10_1101-2020_03_27_012757	886	9	.	.	.
10_1101-2020_03_27_012757	887	1	1162	1162	CD
10_1101-2020_03_27_012757	887	2	75	75	CD
10_1101-2020_03_27_012757	887	3	.	.	.
10_1101-2020_03_27_012757	888	1	Balkwill	Balkwill	NNP
10_1101-2020_03_27_012757	888	2	,	,	,
10_1101-2020_03_27_012757	888	3	F.	F.	NNP
10_1101-2020_03_27_012757	888	4	R.	R.	NNP
10_1101-2020_03_27_012757	888	5	,	,	,
10_1101-2020_03_27_012757	888	6	Capasso	Capasso	NNP
10_1101-2020_03_27_012757	888	7	,	,	,
10_1101-2020_03_27_012757	888	8	M.	M.	NNP
10_1101-2020_03_27_012757	888	9	&	&	CC
10_1101-2020_03_27_012757	888	10	Hagemann	Hagemann	NNP
10_1101-2020_03_27_012757	888	11	,	,	,
10_1101-2020_03_27_012757	888	12	T.	t.	NN
10_1101-2020_03_27_012757	888	13	The	the	DT
10_1101-2020_03_27_012757	888	14	tumor	tumor	NN
10_1101-2020_03_27_012757	888	15	microenvironment	microenvironment	NN
10_1101-2020_03_27_012757	888	16	at	at	IN
10_1101-2020_03_27_012757	888	17	a	a	DT
10_1101-2020_03_27_012757	888	18	1163	1163	CD
10_1101-2020_03_27_012757	888	19	glance	glance	NN
10_1101-2020_03_27_012757	888	20	.	.	.
10_1101-2020_03_27_012757	889	1	J.	J.	NNP
10_1101-2020_03_27_012757	890	1	Cell	Cell	NNP
10_1101-2020_03_27_012757	890	2	Sci	Sci	NNP
10_1101-2020_03_27_012757	890	3	.	.	.
10_1101-2020_03_27_012757	891	1	125	125	CD
10_1101-2020_03_27_012757	891	2	,	,	,
10_1101-2020_03_27_012757	891	3	5591–5596	5591–5596	CD
10_1101-2020_03_27_012757	891	4	(	(	-LRB-
10_1101-2020_03_27_012757	891	5	2012	2012	CD
10_1101-2020_03_27_012757	891	6	)	)	-RRB-
10_1101-2020_03_27_012757	891	7	.	.	.
10_1101-2020_03_27_012757	892	1	1164	1164	CD
10_1101-2020_03_27_012757	892	2	76	76	CD
10_1101-2020_03_27_012757	892	3	.	.	.
10_1101-2020_03_27_012757	893	1	Lancaster	Lancaster	NNP
10_1101-2020_03_27_012757	893	2	,	,	,
10_1101-2020_03_27_012757	893	3	M.	M.	NNP
10_1101-2020_03_27_012757	893	4	A.	A.	NNP
10_1101-2020_03_27_012757	894	1	&	&	CC
10_1101-2020_03_27_012757	894	2	Knoblich	Knoblich	NNP
10_1101-2020_03_27_012757	894	3	,	,	,
10_1101-2020_03_27_012757	894	4	J.	J.	NNP
10_1101-2020_03_27_012757	895	1	A.	A.	NNP
10_1101-2020_03_27_012757	895	2	Organogenesis	Organogenesis	NNP
10_1101-2020_03_27_012757	895	3	in	in	IN
10_1101-2020_03_27_012757	895	4	a	a	DT
10_1101-2020_03_27_012757	895	5	dish	dish	NN
10_1101-2020_03_27_012757	895	6	:	:	:
10_1101-2020_03_27_012757	895	7	modeling	model	VBG
10_1101-2020_03_27_012757	895	8	development	development	NN
10_1101-2020_03_27_012757	895	9	1165	1165	CD
10_1101-2020_03_27_012757	895	10	and	and	CC
10_1101-2020_03_27_012757	895	11	disease	disease	NN
10_1101-2020_03_27_012757	895	12	using	use	VBG
10_1101-2020_03_27_012757	895	13	organoid	organoid	JJ
10_1101-2020_03_27_012757	895	14	technologies	technology	NNS
10_1101-2020_03_27_012757	895	15	.	.	.
10_1101-2020_03_27_012757	896	1	Science	science	NN
10_1101-2020_03_27_012757	896	2	345	345	CD
10_1101-2020_03_27_012757	896	3	,	,	,
10_1101-2020_03_27_012757	896	4	1247125	1247125	CD
10_1101-2020_03_27_012757	896	5	(	(	-LRB-
10_1101-2020_03_27_012757	896	6	2014	2014	CD
10_1101-2020_03_27_012757	896	7	)	)	-RRB-
10_1101-2020_03_27_012757	896	8	.	.	.
10_1101-2020_03_27_012757	897	1	1166	1166	CD
10_1101-2020_03_27_012757	897	2	77	77	CD
10_1101-2020_03_27_012757	897	3	.	.	.
10_1101-2020_03_27_012757	898	1	Bregenzer	Bregenzer	NNP
10_1101-2020_03_27_012757	898	2	,	,	,
10_1101-2020_03_27_012757	898	3	M.	M.	NNP
10_1101-2020_03_27_012757	898	4	E.	E.	NNP
10_1101-2020_03_27_012757	898	5	et	et	NNP
10_1101-2020_03_27_012757	898	6	al	al	NNP
10_1101-2020_03_27_012757	898	7	.	.	.
10_1101-2020_03_27_012757	899	1	Integrated	integrate	VBN
10_1101-2020_03_27_012757	899	2	cancer	cancer	NN
10_1101-2020_03_27_012757	899	3	tissue	tissue	NN
10_1101-2020_03_27_012757	899	4	engineering	engineering	NN
10_1101-2020_03_27_012757	899	5	models	model	NNS
10_1101-2020_03_27_012757	899	6	for	for	IN
10_1101-2020_03_27_012757	899	7	precision	precision	NN
10_1101-2020_03_27_012757	899	8	1167	1167	CD
10_1101-2020_03_27_012757	899	9	medicine	medicine	NN
10_1101-2020_03_27_012757	899	10	.	.	.
10_1101-2020_03_27_012757	900	1	PLoS	plos	ADD
10_1101-2020_03_27_012757	900	2	One	one	CD
10_1101-2020_03_27_012757	900	3	14	14	CD
10_1101-2020_03_27_012757	900	4	,	,	,
10_1101-2020_03_27_012757	900	5	e0216564	e0216564	NNP
10_1101-2020_03_27_012757	900	6	(	(	-LRB-
10_1101-2020_03_27_012757	900	7	2019	2019	CD
10_1101-2020_03_27_012757	900	8	)	)	-RRB-
10_1101-2020_03_27_012757	900	9	.	.	.
10_1101-2020_03_27_012757	901	1	1168	1168	CD
10_1101-2020_03_27_012757	901	2	78	78	CD
10_1101-2020_03_27_012757	901	3	.	.	.
10_1101-2020_03_27_012757	902	1	Wang	Wang	NNP
10_1101-2020_03_27_012757	902	2	,	,	,
10_1101-2020_03_27_012757	902	3	D.	D.	NNP
10_1101-2020_03_27_012757	902	4	H.	H.	NNP
10_1101-2020_03_27_012757	902	5	&	&	CC
10_1101-2020_03_27_012757	902	6	Souza	Souza	NNP
10_1101-2020_03_27_012757	902	7	,	,	,
10_1101-2020_03_27_012757	902	8	R.	R.	NNP
10_1101-2020_03_27_012757	902	9	F.	F.	NNP
10_1101-2020_03_27_012757	902	10	Biology	Biology	NNP
10_1101-2020_03_27_012757	902	11	of	of	IN
10_1101-2020_03_27_012757	902	12	Barrett	Barrett	NNP
10_1101-2020_03_27_012757	902	13	’s	’s	POS
10_1101-2020_03_27_012757	902	14	esophagus	esophagus	JJ
10_1101-2020_03_27_012757	902	15	and	and	CC
10_1101-2020_03_27_012757	902	16	esophageal	esophageal	JJ
10_1101-2020_03_27_012757	902	17	1169	1169	CD
10_1101-2020_03_27_012757	902	18	adenocarcinoma	adenocarcinoma	NN
10_1101-2020_03_27_012757	902	19	.	.	.
10_1101-2020_03_27_012757	903	1	Gastrointest	Gastrointest	NNP
10_1101-2020_03_27_012757	903	2	Endosc	Endosc	NNP
10_1101-2020_03_27_012757	903	3	Clin	Clin	NNP
10_1101-2020_03_27_012757	903	4	N	N	NNP
10_1101-2020_03_27_012757	903	5	Am	Am	NNP
10_1101-2020_03_27_012757	903	6	21	21	CD
10_1101-2020_03_27_012757	903	7	,	,	,
10_1101-2020_03_27_012757	903	8	25–38	25–38	CD
10_1101-2020_03_27_012757	903	9	(	(	-LRB-
10_1101-2020_03_27_012757	903	10	2011	2011	CD
10_1101-2020_03_27_012757	903	11	)	)	-RRB-
10_1101-2020_03_27_012757	903	12	.	.	.
10_1101-2020_03_27_012757	904	1	1170	1170	CD
10_1101-2020_03_27_012757	904	2	79	79	CD
10_1101-2020_03_27_012757	904	3	.	.	.
10_1101-2020_03_27_012757	905	1	Lee	Lee	NNP
10_1101-2020_03_27_012757	905	2	,	,	,
10_1101-2020_03_27_012757	905	3	J.	J.	NNP
10_1101-2020_03_27_012757	905	4	et	et	NNP
10_1101-2020_03_27_012757	905	5	al	al	NNP
10_1101-2020_03_27_012757	905	6	.	.	.
10_1101-2020_03_27_012757	906	1	Tumor	tumor	NN
10_1101-2020_03_27_012757	906	2	stem	stem	NN
10_1101-2020_03_27_012757	906	3	cells	cell	NNS
10_1101-2020_03_27_012757	906	4	derived	derive	VBN
10_1101-2020_03_27_012757	906	5	from	from	IN
10_1101-2020_03_27_012757	906	6	glioblastomas	glioblastoma	NNS
10_1101-2020_03_27_012757	906	7	cultured	culture	VBN
10_1101-2020_03_27_012757	906	8	in	in	IN
10_1101-2020_03_27_012757	906	9	bFGF	bFGF	NNP
10_1101-2020_03_27_012757	906	10	and	and	CC
10_1101-2020_03_27_012757	906	11	1171	1171	CD
10_1101-2020_03_27_012757	906	12	EGF	EGF	NNP
10_1101-2020_03_27_012757	906	13	more	more	RBR
10_1101-2020_03_27_012757	906	14	closely	closely	RB
10_1101-2020_03_27_012757	906	15	mirror	mirror	VBP
10_1101-2020_03_27_012757	906	16	the	the	DT
10_1101-2020_03_27_012757	906	17	phenotype	phenotype	NN
10_1101-2020_03_27_012757	906	18	and	and	CC
10_1101-2020_03_27_012757	906	19	genotype	genotype	NN
10_1101-2020_03_27_012757	906	20	of	of	IN
10_1101-2020_03_27_012757	906	21	primary	primary	JJ
10_1101-2020_03_27_012757	906	22	tumors	tumor	NNS
10_1101-2020_03_27_012757	906	23	than	than	IN
10_1101-2020_03_27_012757	906	24	do	do	VB
10_1101-2020_03_27_012757	906	25	1172	1172	CD
10_1101-2020_03_27_012757	906	26	serum	serum	NN
10_1101-2020_03_27_012757	906	27	-	-	HYPH
10_1101-2020_03_27_012757	906	28	cultured	cultured	JJ
10_1101-2020_03_27_012757	906	29	cell	cell	NN
10_1101-2020_03_27_012757	906	30	lines	line	NNS
10_1101-2020_03_27_012757	906	31	.	.	.
10_1101-2020_03_27_012757	907	1	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	907	2	Cell	Cell	NNP
10_1101-2020_03_27_012757	907	3	9	9	CD
10_1101-2020_03_27_012757	907	4	,	,	,
10_1101-2020_03_27_012757	907	5	391–403	391–403	CD
10_1101-2020_03_27_012757	907	6	(	(	-LRB-
10_1101-2020_03_27_012757	907	7	2006	2006	CD
10_1101-2020_03_27_012757	907	8	)	)	-RRB-
10_1101-2020_03_27_012757	907	9	.	.	.
10_1101-2020_03_27_012757	908	1	1173	1173	CD
10_1101-2020_03_27_012757	908	2	80	80	CD
10_1101-2020_03_27_012757	908	3	.	.	.
10_1101-2020_03_27_012757	909	1	Wenger	Wenger	NNP
10_1101-2020_03_27_012757	909	2	,	,	,
10_1101-2020_03_27_012757	909	3	S.	S.	NNP
10_1101-2020_03_27_012757	909	4	L.	L.	NNP
10_1101-2020_03_27_012757	909	5	et	et	NNP
10_1101-2020_03_27_012757	909	6	al	al	NNP
10_1101-2020_03_27_012757	909	7	.	.	.
10_1101-2020_03_27_012757	910	1	Comparison	comparison	NN
10_1101-2020_03_27_012757	910	2	of	of	IN
10_1101-2020_03_27_012757	910	3	established	establish	VBN
10_1101-2020_03_27_012757	910	4	cell	cell	NN
10_1101-2020_03_27_012757	910	5	lines	line	NNS
10_1101-2020_03_27_012757	910	6	at	at	IN
10_1101-2020_03_27_012757	910	7	different	different	JJ
10_1101-2020_03_27_012757	910	8	passages	passage	NNS
10_1101-2020_03_27_012757	910	9	by	by	IN
10_1101-2020_03_27_012757	910	10	1174	1174	CD
10_1101-2020_03_27_012757	910	11	karyotype	karyotype	NNP
10_1101-2020_03_27_012757	910	12	and	and	CC
10_1101-2020_03_27_012757	910	13	comparative	comparative	JJ
10_1101-2020_03_27_012757	910	14	genomic	genomic	JJ
10_1101-2020_03_27_012757	910	15	hybridization	hybridization	NN
10_1101-2020_03_27_012757	910	16	.	.	.
10_1101-2020_03_27_012757	911	1	Biosci	Biosci	NNP
10_1101-2020_03_27_012757	911	2	.	.	.
10_1101-2020_03_27_012757	912	1	Rep.	Rep.	NNP
10_1101-2020_03_27_012757	912	2	24	24	CD
10_1101-2020_03_27_012757	912	3	,	,	,
10_1101-2020_03_27_012757	912	4	631–639	631–639	CD
10_1101-2020_03_27_012757	912	5	(	(	-LRB-
10_1101-2020_03_27_012757	912	6	2004	2004	CD
10_1101-2020_03_27_012757	912	7	)	)	-RRB-
10_1101-2020_03_27_012757	912	8	.	.	.
10_1101-2020_03_27_012757	913	1	1175	1175	CD
10_1101-2020_03_27_012757	913	2	81	81	CD
10_1101-2020_03_27_012757	913	3	.	.	.
10_1101-2020_03_27_012757	914	1	Ben	Ben	NNP
10_1101-2020_03_27_012757	914	2	-	-	HYPH
10_1101-2020_03_27_012757	914	3	David	David	NNP
10_1101-2020_03_27_012757	914	4	,	,	,
10_1101-2020_03_27_012757	914	5	U.	U.	NNP
10_1101-2020_03_27_012757	914	6	et	et	NNP
10_1101-2020_03_27_012757	914	7	al	al	NNP
10_1101-2020_03_27_012757	914	8	.	.	.
10_1101-2020_03_27_012757	915	1	Genetic	genetic	JJ
10_1101-2020_03_27_012757	915	2	and	and	CC
10_1101-2020_03_27_012757	915	3	transcriptional	transcriptional	JJ
10_1101-2020_03_27_012757	915	4	evolution	evolution	NN
10_1101-2020_03_27_012757	915	5	alters	alter	NNS
10_1101-2020_03_27_012757	915	6	cancer	cancer	NN
10_1101-2020_03_27_012757	915	7	cell	cell	NN
10_1101-2020_03_27_012757	915	8	line	line	NN
10_1101-2020_03_27_012757	915	9	drug	drug	NN
10_1101-2020_03_27_012757	915	10	1176	1176	CD
10_1101-2020_03_27_012757	915	11	response	response	NN
10_1101-2020_03_27_012757	915	12	.	.	.
10_1101-2020_03_27_012757	916	1	Nature	nature	NN
10_1101-2020_03_27_012757	916	2	560	560	CD
10_1101-2020_03_27_012757	916	3	,	,	,
10_1101-2020_03_27_012757	916	4	325–330	325–330	CD
10_1101-2020_03_27_012757	916	5	(	(	-LRB-
10_1101-2020_03_27_012757	916	6	2018	2018	CD
10_1101-2020_03_27_012757	916	7	)	)	-RRB-
10_1101-2020_03_27_012757	916	8	.	.	.
10_1101-2020_03_27_012757	917	1	1177	1177	CD
10_1101-2020_03_27_012757	917	2	82	82	CD
10_1101-2020_03_27_012757	917	3	.	.	.
10_1101-2020_03_27_012757	918	1	Cooke	Cooke	NNP
10_1101-2020_03_27_012757	918	2	,	,	,
10_1101-2020_03_27_012757	918	3	S.	S.	NNP
10_1101-2020_03_27_012757	918	4	L.	L.	NNP
10_1101-2020_03_27_012757	918	5	et	et	NNP
10_1101-2020_03_27_012757	918	6	al	al	NNP
10_1101-2020_03_27_012757	918	7	.	.	.
10_1101-2020_03_27_012757	919	1	Genomic	genomic	JJ
10_1101-2020_03_27_012757	919	2	analysis	analysis	NN
10_1101-2020_03_27_012757	919	3	of	of	IN
10_1101-2020_03_27_012757	919	4	genetic	genetic	JJ
10_1101-2020_03_27_012757	919	5	heterogeneity	heterogeneity	NN
10_1101-2020_03_27_012757	919	6	and	and	CC
10_1101-2020_03_27_012757	919	7	evolution	evolution	NN
10_1101-2020_03_27_012757	919	8	in	in	IN
10_1101-2020_03_27_012757	919	9	high-1178	high-1178	NNP
10_1101-2020_03_27_012757	919	10	grade	grade	NN
10_1101-2020_03_27_012757	919	11	serous	serous	JJ
10_1101-2020_03_27_012757	919	12	ovarian	ovarian	JJ
10_1101-2020_03_27_012757	919	13	carcinoma	carcinoma	NN
10_1101-2020_03_27_012757	919	14	.	.	.
10_1101-2020_03_27_012757	920	1	Oncogene	oncogene	NN
10_1101-2020_03_27_012757	920	2	29	29	CD
10_1101-2020_03_27_012757	920	3	,	,	,
10_1101-2020_03_27_012757	920	4	4905–4913	4905–4913	CD
10_1101-2020_03_27_012757	920	5	(	(	-LRB-
10_1101-2020_03_27_012757	920	6	2010	2010	CD
10_1101-2020_03_27_012757	920	7	)	)	-RRB-
10_1101-2020_03_27_012757	920	8	.	.	.
10_1101-2020_03_27_012757	921	1	1179	1179	CD
10_1101-2020_03_27_012757	921	2	83	83	CD
10_1101-2020_03_27_012757	921	3	.	.	.
10_1101-2020_03_27_012757	922	1	Hristova	Hristova	NNP
10_1101-2020_03_27_012757	922	2	,	,	,
10_1101-2020_03_27_012757	922	3	V.	V.	NNP
10_1101-2020_03_27_012757	922	4	A.	A.	NNP
10_1101-2020_03_27_012757	923	1	&	&	CC
10_1101-2020_03_27_012757	923	2	Chan	Chan	NNP
10_1101-2020_03_27_012757	923	3	,	,	,
10_1101-2020_03_27_012757	923	4	D.	D.	NNP
10_1101-2020_03_27_012757	923	5	W.	W.	NNP
10_1101-2020_03_27_012757	923	6	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	923	7	biomarker	biomarker	NN
10_1101-2020_03_27_012757	923	8	discovery	discovery	NN
10_1101-2020_03_27_012757	923	9	and	and	CC
10_1101-2020_03_27_012757	923	10	translation	translation	NN
10_1101-2020_03_27_012757	923	11	:	:	:
10_1101-2020_03_27_012757	923	12	1180	1180	CD
10_1101-2020_03_27_012757	923	13	proteomics	proteomic	NNS
10_1101-2020_03_27_012757	923	14	and	and	CC
10_1101-2020_03_27_012757	923	15	beyond	beyond	IN
10_1101-2020_03_27_012757	923	16	.	.	.
10_1101-2020_03_27_012757	924	1	Expert	expert	NN
10_1101-2020_03_27_012757	924	2	Rev	Rev	NNP
10_1101-2020_03_27_012757	924	3	Proteomics	Proteomics	NNP
10_1101-2020_03_27_012757	924	4	16	16	CD
10_1101-2020_03_27_012757	924	5	,	,	,
10_1101-2020_03_27_012757	924	6	93–103	93–103	NNP
10_1101-2020_03_27_012757	924	7	(	(	-LRB-
10_1101-2020_03_27_012757	924	8	2019	2019	CD
10_1101-2020_03_27_012757	924	9	)	)	-RRB-
10_1101-2020_03_27_012757	924	10	.	.	.
10_1101-2020_03_27_012757	925	1	1181	1181	CD
10_1101-2020_03_27_012757	925	2	84	84	CD
10_1101-2020_03_27_012757	925	3	.	.	.
10_1101-2020_03_27_012757	926	1	Dawson	Dawson	NNP
10_1101-2020_03_27_012757	926	2	,	,	,
10_1101-2020_03_27_012757	926	3	M.	M.	NNP
10_1101-2020_03_27_012757	926	4	A.	A.	NNP
10_1101-2020_03_27_012757	927	1	&	&	CC
10_1101-2020_03_27_012757	927	2	Kouzarides	Kouzarides	NNP
10_1101-2020_03_27_012757	927	3	,	,	,
10_1101-2020_03_27_012757	927	4	T.	T.	NNP
10_1101-2020_03_27_012757	927	5	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	927	6	epigenetics	epigenetic	NNS
10_1101-2020_03_27_012757	927	7	:	:	:
10_1101-2020_03_27_012757	927	8	from	from	IN
10_1101-2020_03_27_012757	927	9	mechanism	mechanism	NN
10_1101-2020_03_27_012757	927	10	to	to	IN
10_1101-2020_03_27_012757	927	11	therapy	therapy	NN
10_1101-2020_03_27_012757	927	12	.	.	.
10_1101-2020_03_27_012757	928	1	1182	1182	CD
10_1101-2020_03_27_012757	928	2	Cell	Cell	NNP
10_1101-2020_03_27_012757	928	3	150	150	CD
10_1101-2020_03_27_012757	928	4	,	,	,
10_1101-2020_03_27_012757	928	5	12–27	12–27	CD
10_1101-2020_03_27_012757	928	6	(	(	-LRB-
10_1101-2020_03_27_012757	928	7	2012	2012	CD
10_1101-2020_03_27_012757	928	8	)	)	-RRB-
10_1101-2020_03_27_012757	928	9	.	.	.
10_1101-2020_03_27_012757	929	1	1183	1183	CD
10_1101-2020_03_27_012757	929	2	85	85	CD
10_1101-2020_03_27_012757	929	3	.	.	.
10_1101-2020_03_27_012757	930	1	Silva	silva	NN
10_1101-2020_03_27_012757	930	2	,	,	,
10_1101-2020_03_27_012757	930	3	T.	T.	NNP
10_1101-2020_03_27_012757	930	4	C.	C.	NNP
10_1101-2020_03_27_012757	930	5	et	et	NNP
10_1101-2020_03_27_012757	930	6	al	al	NNP
10_1101-2020_03_27_012757	930	7	.	.	.
10_1101-2020_03_27_012757	931	1	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	931	2	Workflow	workflow	NN
10_1101-2020_03_27_012757	931	3	:	:	:
10_1101-2020_03_27_012757	931	4	Analyze	analyze	VB
10_1101-2020_03_27_012757	931	5	cancer	cancer	NN
10_1101-2020_03_27_012757	931	6	genomics	genomic	NNS
10_1101-2020_03_27_012757	931	7	and	and	CC
10_1101-2020_03_27_012757	931	8	epigenomics	epigenomic	NNS
10_1101-2020_03_27_012757	931	9	data	data	NNP
10_1101-2020_03_27_012757	931	10	1184	1184	CD
10_1101-2020_03_27_012757	931	11	using	use	VBG
10_1101-2020_03_27_012757	931	12	Bioconductor	Bioconductor	NNP
10_1101-2020_03_27_012757	931	13	packages	package	NNS
10_1101-2020_03_27_012757	931	14	.	.	.
10_1101-2020_03_27_012757	932	1	[	[	-LRB-
10_1101-2020_03_27_012757	932	2	version	version	NN
10_1101-2020_03_27_012757	932	3	2	2	CD
10_1101-2020_03_27_012757	932	4	;	;	:
10_1101-2020_03_27_012757	932	5	peer	peer	NN
10_1101-2020_03_27_012757	932	6	review	review	NN
10_1101-2020_03_27_012757	932	7	:	:	:
10_1101-2020_03_27_012757	932	8	1	1	CD
10_1101-2020_03_27_012757	932	9	approved	approve	VBD
10_1101-2020_03_27_012757	932	10	,	,	,
10_1101-2020_03_27_012757	932	11	2	2	CD
10_1101-2020_03_27_012757	932	12	approved	approve	VBN
10_1101-2020_03_27_012757	932	13	with	with	IN
10_1101-2020_03_27_012757	932	14	1185	1185	CD
10_1101-2020_03_27_012757	932	15	reservations	reservation	NNS
10_1101-2020_03_27_012757	932	16	]	]	-RRB-
10_1101-2020_03_27_012757	932	17	.	.	.
10_1101-2020_03_27_012757	933	1	F1000Res	f1000re	NNS
10_1101-2020_03_27_012757	933	2	.	.	.
10_1101-2020_03_27_012757	934	1	5	5	CD
10_1101-2020_03_27_012757	934	2	,	,	,
10_1101-2020_03_27_012757	934	3	1542	1542	CD
10_1101-2020_03_27_012757	934	4	(	(	-LRB-
10_1101-2020_03_27_012757	934	5	2016	2016	CD
10_1101-2020_03_27_012757	934	6	)	)	-RRB-
10_1101-2020_03_27_012757	934	7	.	.	.
10_1101-2020_03_27_012757	935	1	1186	1186	CD
10_1101-2020_03_27_012757	935	2	86	86	CD
10_1101-2020_03_27_012757	935	3	.	.	.
10_1101-2020_03_27_012757	936	1	Morgan	Morgan	NNP
10_1101-2020_03_27_012757	936	2	,	,	,
10_1101-2020_03_27_012757	936	3	M.	M.	NNP
10_1101-2020_03_27_012757	936	4	,	,	,
10_1101-2020_03_27_012757	936	5	Obenchain	Obenchain	NNP
10_1101-2020_03_27_012757	936	6	,	,	,
10_1101-2020_03_27_012757	936	7	V.	V.	NNP
10_1101-2020_03_27_012757	936	8	,	,	,
10_1101-2020_03_27_012757	936	9	Hester	Hester	NNP
10_1101-2020_03_27_012757	936	10	,	,	,
10_1101-2020_03_27_012757	936	11	J.	J.	NNP
10_1101-2020_03_27_012757	937	1	&	&	CC
10_1101-2020_03_27_012757	937	2	Pag`es	Pag`es	NNP
10_1101-2020_03_27_012757	937	3	,	,	,
10_1101-2020_03_27_012757	937	4	H.	H.	NNP
10_1101-2020_03_27_012757	937	5	SummarizedExperiment	SummarizedExperiment	NNP
10_1101-2020_03_27_012757	937	6	:	:	:
10_1101-2020_03_27_012757	937	7	1187	1187	CD
10_1101-2020_03_27_012757	937	8	SummarizedExperiment	SummarizedExperiment	NNP
10_1101-2020_03_27_012757	937	9	container	container	NN
10_1101-2020_03_27_012757	937	10	.	.	.
10_1101-2020_03_27_012757	938	1	(	(	-LRB-
10_1101-2020_03_27_012757	938	2	2018	2018	CD
10_1101-2020_03_27_012757	938	3	)	)	-RRB-
10_1101-2020_03_27_012757	938	4	.	.	.
10_1101-2020_03_27_012757	939	1	1188	1188	CD
10_1101-2020_03_27_012757	939	2	.CC	.CC	:
10_1101-2020_03_27_012757	939	3	-	-	:
10_1101-2020_03_27_012757	939	4	BY	by	IN
10_1101-2020_03_27_012757	939	5	-	-	HYPH
10_1101-2020_03_27_012757	939	6	NC	NC	NNP
10_1101-2020_03_27_012757	939	7	-	-	HYPH
10_1101-2020_03_27_012757	939	8	ND	ND	NNP
10_1101-2020_03_27_012757	939	9	4.0	4.0	CD
10_1101-2020_03_27_012757	939	10	International	International	NNP
10_1101-2020_03_27_012757	939	11	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	939	12	under	under	IN
10_1101-2020_03_27_012757	939	13	a	a	DT
10_1101-2020_03_27_012757	939	14	(	(	-LRB-
10_1101-2020_03_27_012757	939	15	which	which	WDT
10_1101-2020_03_27_012757	939	16	was	be	VBD
10_1101-2020_03_27_012757	939	17	not	not	RB
10_1101-2020_03_27_012757	939	18	certified	certify	VBN
10_1101-2020_03_27_012757	939	19	by	by	IN
10_1101-2020_03_27_012757	939	20	peer	peer	NN
10_1101-2020_03_27_012757	939	21	review	review	NN
10_1101-2020_03_27_012757	939	22	)	)	-RRB-
10_1101-2020_03_27_012757	939	23	is	be	VBZ
10_1101-2020_03_27_012757	939	24	the	the	DT
10_1101-2020_03_27_012757	939	25	author	author	NN
10_1101-2020_03_27_012757	939	26	/	/	SYM
10_1101-2020_03_27_012757	939	27	funder	funder	NN
10_1101-2020_03_27_012757	939	28	,	,	,
10_1101-2020_03_27_012757	939	29	who	who	WP
10_1101-2020_03_27_012757	939	30	has	have	VBZ
10_1101-2020_03_27_012757	939	31	granted	grant	VBN
10_1101-2020_03_27_012757	939	32	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	939	33	a	a	DT
10_1101-2020_03_27_012757	939	34	license	license	NN
10_1101-2020_03_27_012757	939	35	to	to	TO
10_1101-2020_03_27_012757	939	36	display	display	VB
10_1101-2020_03_27_012757	939	37	the	the	DT
10_1101-2020_03_27_012757	939	38	preprint	preprint	NN
10_1101-2020_03_27_012757	939	39	in	in	IN
10_1101-2020_03_27_012757	939	40	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	939	41	.	.	.
10_1101-2020_03_27_012757	940	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	940	2	is	be	VBZ
10_1101-2020_03_27_012757	940	3	made	make	VBN
10_1101-2020_03_27_012757	940	4	The	the	DT
10_1101-2020_03_27_012757	940	5	copyright	copyright	NN
10_1101-2020_03_27_012757	940	6	holder	holder	NN
10_1101-2020_03_27_012757	940	7	for	for	IN
10_1101-2020_03_27_012757	940	8	this	this	DT
10_1101-2020_03_27_012757	940	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	940	10	version	version	NN
10_1101-2020_03_27_012757	940	11	posted	post	VBD
10_1101-2020_03_27_012757	940	12	January	January	NNP
10_1101-2020_03_27_012757	940	13	9	9	CD
10_1101-2020_03_27_012757	940	14	,	,	,
10_1101-2020_03_27_012757	940	15	2021	2021	CD
10_1101-2020_03_27_012757	940	16	.	.	.
10_1101-2020_03_27_012757	940	17	;	;	:
10_1101-2020_03_27_012757	940	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	940	19	:	:	:
10_1101-2020_03_27_012757	940	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	940	21	preprint	preprint	NN
10_1101-2020_03_27_012757	940	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	940	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	CD
10_1101-2020_03_27_012757	940	24	42	42	CD
10_1101-2020_03_27_012757	940	25	87	87	CD
10_1101-2020_03_27_012757	940	26	.	.	.
10_1101-2020_03_27_012757	941	1	Pavlidis	Pavlidis	NNP
10_1101-2020_03_27_012757	941	2	,	,	,
10_1101-2020_03_27_012757	941	3	P.	P.	NNP
10_1101-2020_03_27_012757	941	4	&	&	CC
10_1101-2020_03_27_012757	941	5	Noble	Noble	NNP
10_1101-2020_03_27_012757	941	6	,	,	,
10_1101-2020_03_27_012757	941	7	W.	W.	NNP
10_1101-2020_03_27_012757	941	8	S.	S.	NNP
10_1101-2020_03_27_012757	941	9	Analysis	Analysis	NNP
10_1101-2020_03_27_012757	941	10	of	of	IN
10_1101-2020_03_27_012757	941	11	strain	strain	NN
10_1101-2020_03_27_012757	941	12	and	and	CC
10_1101-2020_03_27_012757	941	13	regional	regional	JJ
10_1101-2020_03_27_012757	941	14	variation	variation	NN
10_1101-2020_03_27_012757	941	15	in	in	IN
10_1101-2020_03_27_012757	941	16	gene	gene	NN
10_1101-2020_03_27_012757	941	17	1189	1189	CD
10_1101-2020_03_27_012757	941	18	expression	expression	NN
10_1101-2020_03_27_012757	941	19	in	in	IN
10_1101-2020_03_27_012757	941	20	mouse	mouse	NN
10_1101-2020_03_27_012757	941	21	brain	brain	NN
10_1101-2020_03_27_012757	941	22	.	.	.
10_1101-2020_03_27_012757	942	1	Genome	Genome	NNP
10_1101-2020_03_27_012757	942	2	Biol	Biol	NNP
10_1101-2020_03_27_012757	942	3	.	.	.
10_1101-2020_03_27_012757	943	1	2	2	LS
10_1101-2020_03_27_012757	943	2	,	,	,
10_1101-2020_03_27_012757	943	3	RESEARCH0042	RESEARCH0042	NNP
10_1101-2020_03_27_012757	943	4	(	(	-LRB-
10_1101-2020_03_27_012757	943	5	2001	2001	CD
10_1101-2020_03_27_012757	943	6	)	)	-RRB-
10_1101-2020_03_27_012757	943	7	.	.	.
10_1101-2020_03_27_012757	944	1	1190	1190	CD
10_1101-2020_03_27_012757	944	2	88	88	CD
10_1101-2020_03_27_012757	944	3	.	.	.
10_1101-2020_03_27_012757	945	1	Geman	Geman	NNP
10_1101-2020_03_27_012757	945	2	,	,	,
10_1101-2020_03_27_012757	945	3	D.	D.	NNP
10_1101-2020_03_27_012757	945	4	,	,	,
10_1101-2020_03_27_012757	945	5	d	d	NNP
10_1101-2020_03_27_012757	945	6	Avignon	Avignon	NNP
10_1101-2020_03_27_012757	945	7	,	,	,
10_1101-2020_03_27_012757	945	8	C.	C.	NNP
10_1101-2020_03_27_012757	945	9	,	,	,
10_1101-2020_03_27_012757	945	10	Naiman	Naiman	NNP
10_1101-2020_03_27_012757	945	11	,	,	,
10_1101-2020_03_27_012757	945	12	D.	D.	NNP
10_1101-2020_03_27_012757	945	13	Q.	Q.	NNP
10_1101-2020_03_27_012757	946	1	&	&	CC
10_1101-2020_03_27_012757	946	2	Winslow	Winslow	NNP
10_1101-2020_03_27_012757	946	3	,	,	,
10_1101-2020_03_27_012757	946	4	R.	R.	NNP
10_1101-2020_03_27_012757	946	5	L.	L.	NNP
10_1101-2020_03_27_012757	946	6	Classifying	Classifying	NNP
10_1101-2020_03_27_012757	946	7	gene	gene	NN
10_1101-2020_03_27_012757	946	8	1191	1191	CD
10_1101-2020_03_27_012757	946	9	expression	expression	NN
10_1101-2020_03_27_012757	946	10	profiles	profile	NNS
10_1101-2020_03_27_012757	946	11	from	from	IN
10_1101-2020_03_27_012757	946	12	pairwise	pairwise	NN
10_1101-2020_03_27_012757	946	13	mRNA	mRNA	NNP
10_1101-2020_03_27_012757	946	14	comparisons	comparison	NNS
10_1101-2020_03_27_012757	946	15	.	.	.
10_1101-2020_03_27_012757	947	1	Stat	stat	JJ
10_1101-2020_03_27_012757	947	2	Appl	Appl	NNP
10_1101-2020_03_27_012757	947	3	Genet	Genet	NNP
10_1101-2020_03_27_012757	947	4	Mol	Mol	NNP
10_1101-2020_03_27_012757	947	5	Biol	Biol	NNP
10_1101-2020_03_27_012757	947	6	3	3	CD
10_1101-2020_03_27_012757	947	7	,	,	,
10_1101-2020_03_27_012757	947	8	1192	1192	CD
10_1101-2020_03_27_012757	947	9	Article19	Article19	NNP
10_1101-2020_03_27_012757	947	10	(	(	-LRB-
10_1101-2020_03_27_012757	947	11	2004	2004	CD
10_1101-2020_03_27_012757	947	12	)	)	-RRB-
10_1101-2020_03_27_012757	947	13	.	.	.
10_1101-2020_03_27_012757	948	1	1193	1193	CD
10_1101-2020_03_27_012757	948	2	89	89	CD
10_1101-2020_03_27_012757	948	3	.	.	.
10_1101-2020_03_27_012757	949	1	Krstajic	Krstajic	NNP
10_1101-2020_03_27_012757	949	2	,	,	,
10_1101-2020_03_27_012757	949	3	D.	D.	NNP
10_1101-2020_03_27_012757	949	4	,	,	,
10_1101-2020_03_27_012757	949	5	Buturovic	Buturovic	NNP
10_1101-2020_03_27_012757	949	6	,	,	,
10_1101-2020_03_27_012757	949	7	L.	L.	NNP
10_1101-2020_03_27_012757	949	8	J.	J.	NNP
10_1101-2020_03_27_012757	949	9	,	,	,
10_1101-2020_03_27_012757	949	10	Leahy	Leahy	NNP
10_1101-2020_03_27_012757	949	11	,	,	,
10_1101-2020_03_27_012757	949	12	D.	D.	NNP
10_1101-2020_03_27_012757	949	13	E.	E.	NNP
10_1101-2020_03_27_012757	949	14	&	&	CC
10_1101-2020_03_27_012757	949	15	Thomas	Thomas	NNP
10_1101-2020_03_27_012757	949	16	,	,	,
10_1101-2020_03_27_012757	949	17	S.	S.	NNP
10_1101-2020_03_27_012757	949	18	Cross	Cross	NNP
10_1101-2020_03_27_012757	949	19	-	-	NN
10_1101-2020_03_27_012757	949	20	validation	validation	NN
10_1101-2020_03_27_012757	949	21	pitfalls	pitfall	NNS
10_1101-2020_03_27_012757	949	22	1194	1194	CD
10_1101-2020_03_27_012757	949	23	when	when	WRB
10_1101-2020_03_27_012757	949	24	selecting	select	VBG
10_1101-2020_03_27_012757	949	25	and	and	CC
10_1101-2020_03_27_012757	949	26	assessing	assess	VBG
10_1101-2020_03_27_012757	949	27	regression	regression	NN
10_1101-2020_03_27_012757	949	28	and	and	CC
10_1101-2020_03_27_012757	949	29	classification	classification	NN
10_1101-2020_03_27_012757	949	30	models	model	NNS
10_1101-2020_03_27_012757	949	31	.	.	.
10_1101-2020_03_27_012757	950	1	J.	J.	NNP
10_1101-2020_03_27_012757	950	2	Cheminform	Cheminform	NNP
10_1101-2020_03_27_012757	950	3	.	.	.
10_1101-2020_03_27_012757	951	1	1195	1195	CD
10_1101-2020_03_27_012757	951	2	6	6	CD
10_1101-2020_03_27_012757	951	3	,	,	,
10_1101-2020_03_27_012757	951	4	10	10	CD
10_1101-2020_03_27_012757	951	5	(	(	-LRB-
10_1101-2020_03_27_012757	951	6	2014	2014	CD
10_1101-2020_03_27_012757	951	7	)	)	-RRB-
10_1101-2020_03_27_012757	951	8	.	.	.
10_1101-2020_03_27_012757	952	1	1196	1196	CD
10_1101-2020_03_27_012757	952	2	90	90	CD
10_1101-2020_03_27_012757	952	3	.	.	.
10_1101-2020_03_27_012757	953	1	Lipton	Lipton	NNP
10_1101-2020_03_27_012757	953	2	,	,	,
10_1101-2020_03_27_012757	953	3	Z.	Z.	NNP
10_1101-2020_03_27_012757	953	4	C.	C.	NNP
10_1101-2020_03_27_012757	953	5	,	,	,
10_1101-2020_03_27_012757	953	6	Elkan	Elkan	NNP
10_1101-2020_03_27_012757	953	7	,	,	,
10_1101-2020_03_27_012757	953	8	C.	C.	NNP
10_1101-2020_03_27_012757	953	9	&	&	CC
10_1101-2020_03_27_012757	953	10	Naryanaswamy	Naryanaswamy	NNP
10_1101-2020_03_27_012757	953	11	,	,	,
10_1101-2020_03_27_012757	953	12	B.	B.	NNP
10_1101-2020_03_27_012757	953	13	Optimal	Optimal	NNP
10_1101-2020_03_27_012757	953	14	Thresholding	Thresholding	NNP
10_1101-2020_03_27_012757	953	15	of	of	IN
10_1101-2020_03_27_012757	953	16	Classifiers	Classifiers	NNPS
10_1101-2020_03_27_012757	953	17	to	to	IN
10_1101-2020_03_27_012757	953	18	1197	1197	CD
10_1101-2020_03_27_012757	953	19	Maximize	Maximize	NNP
10_1101-2020_03_27_012757	953	20	F1	F1	NNP
10_1101-2020_03_27_012757	953	21	Measure	measure	NN
10_1101-2020_03_27_012757	953	22	.	.	.
10_1101-2020_03_27_012757	954	1	Mach	Mach	NNP
10_1101-2020_03_27_012757	954	2	.	.	.
10_1101-2020_03_27_012757	955	1	Learn	learn	VB
10_1101-2020_03_27_012757	955	2	.	.	.
10_1101-2020_03_27_012757	956	1	Knowl	Knowl	NNP
10_1101-2020_03_27_012757	956	2	.	.	.
10_1101-2020_03_27_012757	957	1	Discov	Discov	NNP
10_1101-2020_03_27_012757	957	2	.	.	.
10_1101-2020_03_27_012757	958	1	Databases	Databases	NNP
10_1101-2020_03_27_012757	958	2	8725	8725	CD
10_1101-2020_03_27_012757	958	3	,	,	,
10_1101-2020_03_27_012757	958	4	225–239	225–239	CD
10_1101-2020_03_27_012757	958	5	1198	1198	CD
10_1101-2020_03_27_012757	958	6	(	(	-LRB-
10_1101-2020_03_27_012757	958	7	2014	2014	CD
10_1101-2020_03_27_012757	958	8	)	)	-RRB-
10_1101-2020_03_27_012757	958	9	.	.	.
10_1101-2020_03_27_012757	959	1	1199	1199	CD
10_1101-2020_03_27_012757	959	2	91	91	CD
10_1101-2020_03_27_012757	959	3	.	.	.
10_1101-2020_03_27_012757	960	1	Grow	grow	VB
10_1101-2020_03_27_012757	960	2	,	,	,
10_1101-2020_03_27_012757	960	3	E.	E.	NNP
10_1101-2020_03_27_012757	960	4	J.	J.	NNP
10_1101-2020_03_27_012757	960	5	et	et	NNP
10_1101-2020_03_27_012757	960	6	al	al	NNP
10_1101-2020_03_27_012757	960	7	.	.	.
10_1101-2020_03_27_012757	961	1	Intrinsic	intrinsic	JJ
10_1101-2020_03_27_012757	961	2	retroviral	retroviral	JJ
10_1101-2020_03_27_012757	961	3	reactivation	reactivation	NN
10_1101-2020_03_27_012757	961	4	in	in	IN
10_1101-2020_03_27_012757	961	5	human	human	JJ
10_1101-2020_03_27_012757	961	6	preimplantation	preimplantation	NN
10_1101-2020_03_27_012757	961	7	embryos	embryo	NNS
10_1101-2020_03_27_012757	961	8	1200	1200	CD
10_1101-2020_03_27_012757	961	9	and	and	CC
10_1101-2020_03_27_012757	961	10	pluripotent	pluripotent	NN
10_1101-2020_03_27_012757	961	11	cells	cell	NNS
10_1101-2020_03_27_012757	961	12	.	.	.
10_1101-2020_03_27_012757	962	1	Nature	nature	NN
10_1101-2020_03_27_012757	962	2	522	522	CD
10_1101-2020_03_27_012757	962	3	,	,	,
10_1101-2020_03_27_012757	962	4	221–225	221–225	CD
10_1101-2020_03_27_012757	962	5	(	(	-LRB-
10_1101-2020_03_27_012757	962	6	2015	2015	CD
10_1101-2020_03_27_012757	962	7	)	)	-RRB-
10_1101-2020_03_27_012757	962	8	.	.	.
10_1101-2020_03_27_012757	963	1	1201	1201	CD
10_1101-2020_03_27_012757	963	2	92	92	CD
10_1101-2020_03_27_012757	963	3	.	.	.
10_1101-2020_03_27_012757	964	1	Kolde	Kolde	NNP
10_1101-2020_03_27_012757	964	2	,	,	,
10_1101-2020_03_27_012757	964	3	R.	R.	NNP
10_1101-2020_03_27_012757	964	4	pheatmap	pheatmap	NN
10_1101-2020_03_27_012757	964	5	:	:	:
10_1101-2020_03_27_012757	964	6	Pretty	Pretty	NNP
10_1101-2020_03_27_012757	964	7	Heatmaps	Heatmaps	NNP
10_1101-2020_03_27_012757	964	8	.	.	.
10_1101-2020_03_27_012757	965	1	(	(	-LRB-
10_1101-2020_03_27_012757	965	2	CRAN	CRAN	NNP
10_1101-2020_03_27_012757	965	3	,	,	,
10_1101-2020_03_27_012757	965	4	2019	2019	CD
10_1101-2020_03_27_012757	965	5	)	)	-RRB-
10_1101-2020_03_27_012757	965	6	.	.	.
10_1101-2020_03_27_012757	966	1	1202	1202	CD
10_1101-2020_03_27_012757	966	2	93	93	CD
10_1101-2020_03_27_012757	966	3	.	.	.
10_1101-2020_03_27_012757	967	1	Wickham	Wickham	NNP
10_1101-2020_03_27_012757	967	2	,	,	,
10_1101-2020_03_27_012757	967	3	H.	H.	NNP
10_1101-2020_03_27_012757	967	4	ggplot2	ggplot2	NN
10_1101-2020_03_27_012757	967	5	-	-	HYPH
10_1101-2020_03_27_012757	967	6	Elegant	elegant	JJ
10_1101-2020_03_27_012757	967	7	Graphics	Graphics	NNPS
10_1101-2020_03_27_012757	967	8	for	for	IN
10_1101-2020_03_27_012757	967	9	Data	Data	NNP
10_1101-2020_03_27_012757	967	10	Analysis	Analysis	NNP
10_1101-2020_03_27_012757	967	11	.	.	.
10_1101-2020_03_27_012757	968	1	(	(	-LRB-
10_1101-2020_03_27_012757	968	2	Springer	Springer	NNP
10_1101-2020_03_27_012757	968	3	-	-	HYPH
10_1101-2020_03_27_012757	968	4	Verlag	Verlag	NNP
10_1101-2020_03_27_012757	968	5	New	New	NNP
10_1101-2020_03_27_012757	968	6	1203	1203	CD
10_1101-2020_03_27_012757	968	7	York	York	NNP
10_1101-2020_03_27_012757	968	8	,	,	,
10_1101-2020_03_27_012757	968	9	2016	2016	CD
10_1101-2020_03_27_012757	968	10	)	)	-RRB-
10_1101-2020_03_27_012757	968	11	.	.	.
10_1101-2020_03_27_012757	969	1	doi:10.1007/978	doi:10.1007/978	LS
10_1101-2020_03_27_012757	969	2	-	-	HYPH
10_1101-2020_03_27_012757	969	3	0	0	CD
10_1101-2020_03_27_012757	969	4	-	-	HYPH
10_1101-2020_03_27_012757	969	5	387	387	CD
10_1101-2020_03_27_012757	969	6	-	-	HYPH
10_1101-2020_03_27_012757	969	7	98141	98141	CD
10_1101-2020_03_27_012757	969	8	-	-	HYPH
10_1101-2020_03_27_012757	969	9	3	3	CD
10_1101-2020_03_27_012757	969	10	1204	1204	CD
10_1101-2020_03_27_012757	969	11	94	94	CD
10_1101-2020_03_27_012757	969	12	.	.	.
10_1101-2020_03_27_012757	970	1	Gu	Gu	NNP
10_1101-2020_03_27_012757	970	2	,	,	,
10_1101-2020_03_27_012757	970	3	Z.	Z.	NNP
10_1101-2020_03_27_012757	970	4	,	,	,
10_1101-2020_03_27_012757	970	5	Eils	Eils	NNP
10_1101-2020_03_27_012757	970	6	,	,	,
10_1101-2020_03_27_012757	970	7	R.	R.	NNP
10_1101-2020_03_27_012757	970	8	&	&	CC
10_1101-2020_03_27_012757	970	9	Schlesner	Schlesner	NNP
10_1101-2020_03_27_012757	970	10	,	,	,
10_1101-2020_03_27_012757	970	11	M.	M.	NNP
10_1101-2020_03_27_012757	970	12	Complex	Complex	NNP
10_1101-2020_03_27_012757	970	13	heatmaps	heatmap	NNS
10_1101-2020_03_27_012757	970	14	reveal	reveal	VBP
10_1101-2020_03_27_012757	970	15	patterns	pattern	NNS
10_1101-2020_03_27_012757	970	16	and	and	CC
10_1101-2020_03_27_012757	970	17	correlations	correlation	NNS
10_1101-2020_03_27_012757	970	18	1205	1205	CD
10_1101-2020_03_27_012757	970	19	in	in	IN
10_1101-2020_03_27_012757	970	20	multidimensional	multidimensional	JJ
10_1101-2020_03_27_012757	970	21	genomic	genomic	JJ
10_1101-2020_03_27_012757	970	22	data	datum	NNS
10_1101-2020_03_27_012757	970	23	.	.	.
10_1101-2020_03_27_012757	971	1	Bioinformatics	Bioinformatics	NNP
10_1101-2020_03_27_012757	971	2	32	32	CD
10_1101-2020_03_27_012757	971	3	,	,	,
10_1101-2020_03_27_012757	971	4	2847–2849	2847–2849	CD
10_1101-2020_03_27_012757	971	5	(	(	-LRB-
10_1101-2020_03_27_012757	971	6	2016	2016	CD
10_1101-2020_03_27_012757	971	7	)	)	-RRB-
10_1101-2020_03_27_012757	971	8	.	.	.
10_1101-2020_03_27_012757	972	1	1206	1206	CD
10_1101-2020_03_27_012757	972	2	95	95	CD
10_1101-2020_03_27_012757	972	3	.	.	.
10_1101-2020_03_27_012757	973	1	Yoshihara	Yoshihara	NNP
10_1101-2020_03_27_012757	973	2	,	,	,
10_1101-2020_03_27_012757	973	3	K.	K.	NNP
10_1101-2020_03_27_012757	973	4	et	et	NNP
10_1101-2020_03_27_012757	973	5	al	al	NNP
10_1101-2020_03_27_012757	973	6	.	.	.
10_1101-2020_03_27_012757	974	1	Inferring	infer	VBG
10_1101-2020_03_27_012757	974	2	tumour	tumour	NN
10_1101-2020_03_27_012757	974	3	purity	purity	NN
10_1101-2020_03_27_012757	974	4	and	and	CC
10_1101-2020_03_27_012757	974	5	stromal	stromal	NN
10_1101-2020_03_27_012757	974	6	and	and	CC
10_1101-2020_03_27_012757	974	7	immune	immune	JJ
10_1101-2020_03_27_012757	974	8	cell	cell	NN
10_1101-2020_03_27_012757	974	9	admixture	admixture	NN
10_1101-2020_03_27_012757	974	10	1207	1207	CD
10_1101-2020_03_27_012757	974	11	from	from	IN
10_1101-2020_03_27_012757	974	12	expression	expression	NN
10_1101-2020_03_27_012757	974	13	data	datum	NNS
10_1101-2020_03_27_012757	974	14	.	.	.
10_1101-2020_03_27_012757	975	1	Nat	Nat	NNP
10_1101-2020_03_27_012757	975	2	.	.	.
10_1101-2020_03_27_012757	976	1	Commun	Commun	VBN
10_1101-2020_03_27_012757	976	2	.	.	.
10_1101-2020_03_27_012757	977	1	4	4	CD
10_1101-2020_03_27_012757	977	2	,	,	,
10_1101-2020_03_27_012757	977	3	2612	2612	CD
10_1101-2020_03_27_012757	977	4	(	(	-LRB-
10_1101-2020_03_27_012757	977	5	2013	2013	CD
10_1101-2020_03_27_012757	977	6	)	)	-RRB-
10_1101-2020_03_27_012757	977	7	.	.	.
10_1101-2020_03_27_012757	978	1	1208	1208	CD
10_1101-2020_03_27_012757	978	2	96	96	CD
10_1101-2020_03_27_012757	978	3	.	.	.
10_1101-2020_03_27_012757	979	1	Kovalchik	Kovalchik	NNP
10_1101-2020_03_27_012757	979	2	,	,	,
10_1101-2020_03_27_012757	979	3	S.	S.	NNP
10_1101-2020_03_27_012757	979	4	RISmed	RISmed	NNP
10_1101-2020_03_27_012757	979	5	:	:	:
10_1101-2020_03_27_012757	979	6	Download	Download	NNP
10_1101-2020_03_27_012757	979	7	Content	Content	NNP
10_1101-2020_03_27_012757	979	8	from	from	IN
10_1101-2020_03_27_012757	979	9	NCBI	NCBI	NNP
10_1101-2020_03_27_012757	979	10	Databases	Databases	NNP
10_1101-2020_03_27_012757	979	11	.	.	.
10_1101-2020_03_27_012757	980	1	(	(	-LRB-
10_1101-2020_03_27_012757	980	2	CRAN.R	CRAN.R	NNP
10_1101-2020_03_27_012757	980	3	-	-	HYPH
10_1101-2020_03_27_012757	980	4	project	project	NN
10_1101-2020_03_27_012757	980	5	,	,	,
10_1101-2020_03_27_012757	980	6	1209	1209	CD
10_1101-2020_03_27_012757	980	7	2017	2017	CD
10_1101-2020_03_27_012757	980	8	)	)	-RRB-
10_1101-2020_03_27_012757	980	9	.	.	.
10_1101-2020_03_27_012757	981	1	1210	1210	CD
10_1101-2020_03_27_012757	981	2	1211	1211	CD
10_1101-2020_03_27_012757	981	3	.CC	.CC	:
10_1101-2020_03_27_012757	981	4	-	-	:
10_1101-2020_03_27_012757	981	5	BY	by	IN
10_1101-2020_03_27_012757	981	6	-	-	HYPH
10_1101-2020_03_27_012757	981	7	NC	NC	NNP
10_1101-2020_03_27_012757	981	8	-	-	HYPH
10_1101-2020_03_27_012757	981	9	ND	ND	NNP
10_1101-2020_03_27_012757	981	10	4.0	4.0	CD
10_1101-2020_03_27_012757	981	11	International	International	NNP
10_1101-2020_03_27_012757	981	12	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	981	13	under	under	IN
10_1101-2020_03_27_012757	981	14	a	a	DT
10_1101-2020_03_27_012757	981	15	(	(	-LRB-
10_1101-2020_03_27_012757	981	16	which	which	WDT
10_1101-2020_03_27_012757	981	17	was	be	VBD
10_1101-2020_03_27_012757	981	18	not	not	RB
10_1101-2020_03_27_012757	981	19	certified	certify	VBN
10_1101-2020_03_27_012757	981	20	by	by	IN
10_1101-2020_03_27_012757	981	21	peer	peer	NN
10_1101-2020_03_27_012757	981	22	review	review	NN
10_1101-2020_03_27_012757	981	23	)	)	-RRB-
10_1101-2020_03_27_012757	981	24	is	be	VBZ
10_1101-2020_03_27_012757	981	25	the	the	DT
10_1101-2020_03_27_012757	981	26	author	author	NN
10_1101-2020_03_27_012757	981	27	/	/	SYM
10_1101-2020_03_27_012757	981	28	funder	funder	NN
10_1101-2020_03_27_012757	981	29	,	,	,
10_1101-2020_03_27_012757	981	30	who	who	WP
10_1101-2020_03_27_012757	981	31	has	have	VBZ
10_1101-2020_03_27_012757	981	32	granted	grant	VBN
10_1101-2020_03_27_012757	981	33	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	981	34	a	a	DT
10_1101-2020_03_27_012757	981	35	license	license	NN
10_1101-2020_03_27_012757	981	36	to	to	TO
10_1101-2020_03_27_012757	981	37	display	display	VB
10_1101-2020_03_27_012757	981	38	the	the	DT
10_1101-2020_03_27_012757	981	39	preprint	preprint	NN
10_1101-2020_03_27_012757	981	40	in	in	IN
10_1101-2020_03_27_012757	981	41	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	981	42	.	.	.
10_1101-2020_03_27_012757	982	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	982	2	is	be	VBZ
10_1101-2020_03_27_012757	982	3	made	make	VBN
10_1101-2020_03_27_012757	982	4	The	the	DT
10_1101-2020_03_27_012757	982	5	copyright	copyright	NN
10_1101-2020_03_27_012757	982	6	holder	holder	NN
10_1101-2020_03_27_012757	982	7	for	for	IN
10_1101-2020_03_27_012757	982	8	this	this	DT
10_1101-2020_03_27_012757	982	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	982	10	version	version	NN
10_1101-2020_03_27_012757	982	11	posted	post	VBD
10_1101-2020_03_27_012757	982	12	January	January	NNP
10_1101-2020_03_27_012757	982	13	9	9	CD
10_1101-2020_03_27_012757	982	14	,	,	,
10_1101-2020_03_27_012757	982	15	2021	2021	CD
10_1101-2020_03_27_012757	982	16	.	.	.
10_1101-2020_03_27_012757	982	17	;	;	:
10_1101-2020_03_27_012757	982	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	982	19	:	:	:
10_1101-2020_03_27_012757	982	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	982	21	preprint	preprint	NN
10_1101-2020_03_27_012757	982	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	982	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	982	24	A	a	DT
10_1101-2020_03_27_012757	982	25	B	B	NNP
10_1101-2020_03_27_012757	982	26	Figure	figure	NN
10_1101-2020_03_27_012757	982	27	1	1	CD
10_1101-2020_03_27_012757	982	28	HighLow	HighLow	NNP
10_1101-2020_03_27_012757	982	29	C	C	NNP
10_1101-2020_03_27_012757	982	30	an	an	DT
10_1101-2020_03_27_012757	982	31	ce	ce	NNP
10_1101-2020_03_27_012757	982	32	r	r	NN
10_1101-2020_03_27_012757	982	33	T	t	NN
10_1101-2020_03_27_012757	982	34	yp	yp	NN
10_1101-2020_03_27_012757	982	35	es	es	XX
10_1101-2020_03_27_012757	982	36	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	982	37	models	model	NNS
10_1101-2020_03_27_012757	982	38	Classification	classification	NN
10_1101-2020_03_27_012757	982	39	score	score	NN
10_1101-2020_03_27_012757	982	40	Cancer	Cancer	NNP
10_1101-2020_03_27_012757	982	41	cell	cell	NN
10_1101-2020_03_27_012757	982	42	lines	line	NNS
10_1101-2020_03_27_012757	982	43	(	(	-LRB-
10_1101-2020_03_27_012757	982	44	CCL	CCL	NNP
10_1101-2020_03_27_012757	982	45	)	)	-RRB-
10_1101-2020_03_27_012757	982	46	Patient	Patient	NNP
10_1101-2020_03_27_012757	982	47	derived	derive	VBN
10_1101-2020_03_27_012757	982	48	xenograft	xenograft	NN
10_1101-2020_03_27_012757	982	49	(	(	-LRB-
10_1101-2020_03_27_012757	982	50	PDX	PDX	NNP
10_1101-2020_03_27_012757	982	51	)	)	-RRB-
10_1101-2020_03_27_012757	982	52	Genetically	genetically	RB
10_1101-2020_03_27_012757	982	53	engineered	engineer	VBN
10_1101-2020_03_27_012757	982	54	mouse	mouse	NN
10_1101-2020_03_27_012757	982	55	model	model	NN
10_1101-2020_03_27_012757	982	56	(	(	-LRB-
10_1101-2020_03_27_012757	982	57	GEMM	GEMM	NNP
10_1101-2020_03_27_012757	982	58	)	)	-RRB-
10_1101-2020_03_27_012757	982	59	Tumoroids	Tumoroids	NNP
10_1101-2020_03_27_012757	982	60	Select	Select	NNP
10_1101-2020_03_27_012757	982	61	parameter	parameter	NN
10_1101-2020_03_27_012757	982	62	set	set	VBN
10_1101-2020_03_27_012757	982	63	with	with	IN
10_1101-2020_03_27_012757	982	64	maximum	maximum	JJ
10_1101-2020_03_27_012757	982	65	mean	mean	NN
10_1101-2020_03_27_012757	982	66	AUPRC	AUPRC	NNP
10_1101-2020_03_27_012757	982	67	.	.	.
10_1101-2020_03_27_012757	983	1	Train	train	VB
10_1101-2020_03_27_012757	983	2	on	on	IN
10_1101-2020_03_27_012757	983	3	all	all	DT
10_1101-2020_03_27_012757	983	4	TCGA	TCGA	NNP
10_1101-2020_03_27_012757	983	5	data	datum	NNS
10_1101-2020_03_27_012757	983	6	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	983	7	Set	Set	VBN
10_1101-2020_03_27_012757	983	8	parameters	parameter	NNS
10_1101-2020_03_27_012757	983	9	n	n	IN
10_1101-2020_03_27_012757	983	10	,	,	,
10_1101-2020_03_27_012757	983	11	m	m	NNP
10_1101-2020_03_27_012757	983	12	Randomly	randomly	RB
10_1101-2020_03_27_012757	983	13	select	select	VB
10_1101-2020_03_27_012757	983	14	2/3	2/3	CD
10_1101-2020_03_27_012757	983	15	TCGA	tcga	NN
10_1101-2020_03_27_012757	983	16	data	datum	NNS
10_1101-2020_03_27_012757	983	17	;	;	:
10_1101-2020_03_27_012757	983	18	run	run	VB
10_1101-2020_03_27_012757	983	19	training	training	NN
10_1101-2020_03_27_012757	983	20	process	process	NN
10_1101-2020_03_27_012757	983	21	Assess	Assess	NNP
10_1101-2020_03_27_012757	983	22	performance	performance	NN
10_1101-2020_03_27_012757	983	23	on	on	IN
10_1101-2020_03_27_012757	983	24	1/3	1/3	CD
10_1101-2020_03_27_012757	983	25	held	hold	VBN
10_1101-2020_03_27_012757	983	26	out	out	RP
10_1101-2020_03_27_012757	983	27	data	datum	NNS
10_1101-2020_03_27_012757	983	28	Repeat	Repeat	NNP
10_1101-2020_03_27_012757	983	29	steps	step	NNS
10_1101-2020_03_27_012757	983	30	(	(	-LRB-
10_1101-2020_03_27_012757	983	31	2	2	CD
10_1101-2020_03_27_012757	983	32	-	-	SYM
10_1101-2020_03_27_012757	983	33	3	3	CD
10_1101-2020_03_27_012757	983	34	)	)	-RRB-
10_1101-2020_03_27_012757	983	35	5	5	CD
10_1101-2020_03_27_012757	983	36	times	time	NNS
10_1101-2020_03_27_012757	983	37	(	(	-LRB-
10_1101-2020_03_27_012757	983	38	1	1	CD
10_1101-2020_03_27_012757	983	39	)	)	-RRB-
10_1101-2020_03_27_012757	983	40	(	(	-LRB-
10_1101-2020_03_27_012757	983	41	2	2	CD
10_1101-2020_03_27_012757	983	42	)	)	-RRB-
10_1101-2020_03_27_012757	983	43	(	(	-LRB-
10_1101-2020_03_27_012757	983	44	3	3	CD
10_1101-2020_03_27_012757	983	45	)	)	-RRB-
10_1101-2020_03_27_012757	983	46	(	(	-LRB-
10_1101-2020_03_27_012757	983	47	4	4	LS
10_1101-2020_03_27_012757	983	48	)	)	-RRB-
10_1101-2020_03_27_012757	983	49	Repeat	Repeat	NNP
10_1101-2020_03_27_012757	983	50	steps	step	NNS
10_1101-2020_03_27_012757	983	51	(	(	-LRB-
10_1101-2020_03_27_012757	983	52	1	1	CD
10_1101-2020_03_27_012757	983	53	-	-	SYM
10_1101-2020_03_27_012757	983	54	4	4	CD
10_1101-2020_03_27_012757	983	55	)	)	-RRB-
10_1101-2020_03_27_012757	983	56	for	for	IN
10_1101-2020_03_27_012757	983	57	each	each	DT
10_1101-2020_03_27_012757	983	58	parameter	parameter	NN
10_1101-2020_03_27_012757	983	59	set	set	NN
10_1101-2020_03_27_012757	983	60	(	(	-LRB-
10_1101-2020_03_27_012757	983	61	5	5	CD
10_1101-2020_03_27_012757	983	62	)	)	-RRB-
10_1101-2020_03_27_012757	983	63	CancerCellNet	cancercellnet	JJ
10_1101-2020_03_27_012757	983	64	RNA	RNA	NNP
10_1101-2020_03_27_012757	983	65	-	-	HYPH
10_1101-2020_03_27_012757	983	66	seq	seq	NN
10_1101-2020_03_27_012757	983	67	from	from	IN
10_1101-2020_03_27_012757	983	68	…	…	NFP
10_1101-2020_03_27_012757	983	69	G	G	NNP
10_1101-2020_03_27_012757	983	70	en	en	NNP
10_1101-2020_03_27_012757	983	71	e	e	NNP
10_1101-2020_03_27_012757	983	72	pa	pa	NNP
10_1101-2020_03_27_012757	983	73	irs	irs	NNP
10_1101-2020_03_27_012757	983	74	Training	Training	NNP
10_1101-2020_03_27_012757	983	75	data	datum	NNS
10_1101-2020_03_27_012757	983	76	Training	Training	NNP
10_1101-2020_03_27_012757	983	77	process	process	NN
10_1101-2020_03_27_012757	983	78	Train	Train	NNP
10_1101-2020_03_27_012757	983	79	Random	Random	NNP
10_1101-2020_03_27_012757	983	80	Forest	Forest	NNP
10_1101-2020_03_27_012757	983	81	classifier	classifier	NN
10_1101-2020_03_27_012757	983	82	G	g	NN
10_1101-2020_03_27_012757	983	83	en	en	FW
10_1101-2020_03_27_012757	983	84	es	es	FW
10_1101-2020_03_27_012757	983	85	Samples	sample	NNS
10_1101-2020_03_27_012757	983	86	G	G	NNP
10_1101-2020_03_27_012757	983	87	en	en	FW
10_1101-2020_03_27_012757	983	88	es	es	XX
10_1101-2020_03_27_012757	983	89	Labeled	Labeled	NNP
10_1101-2020_03_27_012757	983	90	RNA	RNA	NNP
10_1101-2020_03_27_012757	983	91	-	-	HYPH
10_1101-2020_03_27_012757	983	92	seq	seq	NN
10_1101-2020_03_27_012757	983	93	data	datum	NNS
10_1101-2020_03_27_012757	983	94	Select	Select	NNP
10_1101-2020_03_27_012757	983	95	n	n	DT
10_1101-2020_03_27_012757	983	96	genes	gene	NNS
10_1101-2020_03_27_012757	983	97	Gene	gene	NN
10_1101-2020_03_27_012757	983	98	pair	pair	NN
10_1101-2020_03_27_012757	983	99	transform	transform	NN
10_1101-2020_03_27_012757	983	100	Select	Select	NNP
10_1101-2020_03_27_012757	983	101	m	m	NNP
10_1101-2020_03_27_012757	983	102	gene	gene	NN
10_1101-2020_03_27_012757	983	103	pairs	pairs	NNP
10_1101-2020_03_27_012757	983	104	G	G	NNP
10_1101-2020_03_27_012757	983	105	en	en	NNP
10_1101-2020_03_27_012757	983	106	e	e	NNP
10_1101-2020_03_27_012757	983	107	pa	pa	NNP
10_1101-2020_03_27_012757	983	108	irs	irs	NNP
10_1101-2020_03_27_012757	983	109	G	G	NNP
10_1101-2020_03_27_012757	983	110	en	en	FW
10_1101-2020_03_27_012757	983	111	es	es	XX
10_1101-2020_03_27_012757	983	112	Samples	Samples	NNP
10_1101-2020_03_27_012757	983	113	Samples	Samples	NNP
10_1101-2020_03_27_012757	983	114	Samples	Samples	NNP
10_1101-2020_03_27_012757	983	115	Samples	Samples	NNP
10_1101-2020_03_27_012757	983	116	Samples	Samples	NNP
10_1101-2020_03_27_012757	983	117	CancerCellNet	cancercellnet	NN
10_1101-2020_03_27_012757	983	118	C	c	NN
10_1101-2020_03_27_012757	983	119	D	d	NN
10_1101-2020_03_27_012757	983	120	E	e	NN
10_1101-2020_03_27_012757	983	121	.CC	.CC	NFP
10_1101-2020_03_27_012757	983	122	-	-	HYPH
10_1101-2020_03_27_012757	983	123	BY	by	IN
10_1101-2020_03_27_012757	983	124	-	-	HYPH
10_1101-2020_03_27_012757	983	125	NC	NC	NNP
10_1101-2020_03_27_012757	983	126	-	-	HYPH
10_1101-2020_03_27_012757	983	127	ND	ND	NNP
10_1101-2020_03_27_012757	983	128	4.0	4.0	CD
10_1101-2020_03_27_012757	983	129	International	International	NNP
10_1101-2020_03_27_012757	983	130	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	983	131	under	under	IN
10_1101-2020_03_27_012757	983	132	a	a	DT
10_1101-2020_03_27_012757	983	133	(	(	-LRB-
10_1101-2020_03_27_012757	983	134	which	which	WDT
10_1101-2020_03_27_012757	983	135	was	be	VBD
10_1101-2020_03_27_012757	983	136	not	not	RB
10_1101-2020_03_27_012757	983	137	certified	certify	VBN
10_1101-2020_03_27_012757	983	138	by	by	IN
10_1101-2020_03_27_012757	983	139	peer	peer	NN
10_1101-2020_03_27_012757	983	140	review	review	NN
10_1101-2020_03_27_012757	983	141	)	)	-RRB-
10_1101-2020_03_27_012757	983	142	is	be	VBZ
10_1101-2020_03_27_012757	983	143	the	the	DT
10_1101-2020_03_27_012757	983	144	author	author	NN
10_1101-2020_03_27_012757	983	145	/	/	SYM
10_1101-2020_03_27_012757	983	146	funder	funder	NN
10_1101-2020_03_27_012757	983	147	,	,	,
10_1101-2020_03_27_012757	983	148	who	who	WP
10_1101-2020_03_27_012757	983	149	has	have	VBZ
10_1101-2020_03_27_012757	983	150	granted	grant	VBN
10_1101-2020_03_27_012757	983	151	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	983	152	a	a	DT
10_1101-2020_03_27_012757	983	153	license	license	NN
10_1101-2020_03_27_012757	983	154	to	to	TO
10_1101-2020_03_27_012757	983	155	display	display	VB
10_1101-2020_03_27_012757	983	156	the	the	DT
10_1101-2020_03_27_012757	983	157	preprint	preprint	NN
10_1101-2020_03_27_012757	983	158	in	in	IN
10_1101-2020_03_27_012757	983	159	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	983	160	.	.	.
10_1101-2020_03_27_012757	984	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	984	2	is	be	VBZ
10_1101-2020_03_27_012757	984	3	made	make	VBN
10_1101-2020_03_27_012757	984	4	The	the	DT
10_1101-2020_03_27_012757	984	5	copyright	copyright	NN
10_1101-2020_03_27_012757	984	6	holder	holder	NN
10_1101-2020_03_27_012757	984	7	for	for	IN
10_1101-2020_03_27_012757	984	8	this	this	DT
10_1101-2020_03_27_012757	984	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	984	10	version	version	NN
10_1101-2020_03_27_012757	984	11	posted	post	VBD
10_1101-2020_03_27_012757	984	12	January	January	NNP
10_1101-2020_03_27_012757	984	13	9	9	CD
10_1101-2020_03_27_012757	984	14	,	,	,
10_1101-2020_03_27_012757	984	15	2021	2021	CD
10_1101-2020_03_27_012757	984	16	.	.	.
10_1101-2020_03_27_012757	984	17	;	;	:
10_1101-2020_03_27_012757	984	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	984	19	:	:	:
10_1101-2020_03_27_012757	984	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	984	21	preprint	preprint	NN
10_1101-2020_03_27_012757	984	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	984	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	984	24	Figure	figure	NN
10_1101-2020_03_27_012757	984	25	2	2	CD
10_1101-2020_03_27_012757	984	26	A	A	NNP
10_1101-2020_03_27_012757	984	27	F	f	NN
10_1101-2020_03_27_012757	984	28	C	c	NN
10_1101-2020_03_27_012757	984	29	D	d	NN
10_1101-2020_03_27_012757	984	30	E	e	NN
10_1101-2020_03_27_012757	984	31	CCN	ccn	NN
10_1101-2020_03_27_012757	984	32	Score	score	NN
10_1101-2020_03_27_012757	984	33	B	b	NN
10_1101-2020_03_27_012757	984	34	.CC	.CC	,
10_1101-2020_03_27_012757	984	35	-	-	:
10_1101-2020_03_27_012757	984	36	BY	by	IN
10_1101-2020_03_27_012757	984	37	-	-	HYPH
10_1101-2020_03_27_012757	984	38	NC	NC	NNP
10_1101-2020_03_27_012757	984	39	-	-	HYPH
10_1101-2020_03_27_012757	984	40	ND	ND	NNP
10_1101-2020_03_27_012757	984	41	4.0	4.0	CD
10_1101-2020_03_27_012757	984	42	International	International	NNP
10_1101-2020_03_27_012757	984	43	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	984	44	under	under	IN
10_1101-2020_03_27_012757	984	45	a	a	DT
10_1101-2020_03_27_012757	984	46	(	(	-LRB-
10_1101-2020_03_27_012757	984	47	which	which	WDT
10_1101-2020_03_27_012757	984	48	was	be	VBD
10_1101-2020_03_27_012757	984	49	not	not	RB
10_1101-2020_03_27_012757	984	50	certified	certify	VBN
10_1101-2020_03_27_012757	984	51	by	by	IN
10_1101-2020_03_27_012757	984	52	peer	peer	NN
10_1101-2020_03_27_012757	984	53	review	review	NN
10_1101-2020_03_27_012757	984	54	)	)	-RRB-
10_1101-2020_03_27_012757	984	55	is	be	VBZ
10_1101-2020_03_27_012757	984	56	the	the	DT
10_1101-2020_03_27_012757	984	57	author	author	NN
10_1101-2020_03_27_012757	984	58	/	/	SYM
10_1101-2020_03_27_012757	984	59	funder	funder	NN
10_1101-2020_03_27_012757	984	60	,	,	,
10_1101-2020_03_27_012757	984	61	who	who	WP
10_1101-2020_03_27_012757	984	62	has	have	VBZ
10_1101-2020_03_27_012757	984	63	granted	grant	VBN
10_1101-2020_03_27_012757	984	64	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	984	65	a	a	DT
10_1101-2020_03_27_012757	984	66	license	license	NN
10_1101-2020_03_27_012757	984	67	to	to	TO
10_1101-2020_03_27_012757	984	68	display	display	VB
10_1101-2020_03_27_012757	984	69	the	the	DT
10_1101-2020_03_27_012757	984	70	preprint	preprint	NN
10_1101-2020_03_27_012757	984	71	in	in	IN
10_1101-2020_03_27_012757	984	72	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	984	73	.	.	.
10_1101-2020_03_27_012757	985	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	985	2	is	be	VBZ
10_1101-2020_03_27_012757	985	3	made	make	VBN
10_1101-2020_03_27_012757	985	4	The	the	DT
10_1101-2020_03_27_012757	985	5	copyright	copyright	NN
10_1101-2020_03_27_012757	985	6	holder	holder	NN
10_1101-2020_03_27_012757	985	7	for	for	IN
10_1101-2020_03_27_012757	985	8	this	this	DT
10_1101-2020_03_27_012757	985	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	985	10	version	version	NN
10_1101-2020_03_27_012757	985	11	posted	post	VBD
10_1101-2020_03_27_012757	985	12	January	January	NNP
10_1101-2020_03_27_012757	985	13	9	9	CD
10_1101-2020_03_27_012757	985	14	,	,	,
10_1101-2020_03_27_012757	985	15	2021	2021	CD
10_1101-2020_03_27_012757	985	16	.	.	.
10_1101-2020_03_27_012757	985	17	;	;	:
10_1101-2020_03_27_012757	985	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	985	19	:	:	:
10_1101-2020_03_27_012757	985	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	985	21	preprint	preprint	NN
10_1101-2020_03_27_012757	985	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	985	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	985	24	CCN	CCN	NNP
10_1101-2020_03_27_012757	985	25	Score	Score	NNP
10_1101-2020_03_27_012757	985	26	A	a	NN
10_1101-2020_03_27_012757	985	27	B	b	NN
10_1101-2020_03_27_012757	985	28	C	c	NN
10_1101-2020_03_27_012757	985	29	Figure	figure	NN
10_1101-2020_03_27_012757	985	30	3	3	CD
10_1101-2020_03_27_012757	985	31	.CC	.CC	:
10_1101-2020_03_27_012757	985	32	-	-	HYPH
10_1101-2020_03_27_012757	985	33	BY	by	IN
10_1101-2020_03_27_012757	985	34	-	-	HYPH
10_1101-2020_03_27_012757	985	35	NC	NC	NNP
10_1101-2020_03_27_012757	985	36	-	-	HYPH
10_1101-2020_03_27_012757	985	37	ND	ND	NNP
10_1101-2020_03_27_012757	985	38	4.0	4.0	CD
10_1101-2020_03_27_012757	985	39	International	International	NNP
10_1101-2020_03_27_012757	985	40	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	985	41	under	under	IN
10_1101-2020_03_27_012757	985	42	a	a	DT
10_1101-2020_03_27_012757	985	43	(	(	-LRB-
10_1101-2020_03_27_012757	985	44	which	which	WDT
10_1101-2020_03_27_012757	985	45	was	be	VBD
10_1101-2020_03_27_012757	985	46	not	not	RB
10_1101-2020_03_27_012757	985	47	certified	certify	VBN
10_1101-2020_03_27_012757	985	48	by	by	IN
10_1101-2020_03_27_012757	985	49	peer	peer	NN
10_1101-2020_03_27_012757	985	50	review	review	NN
10_1101-2020_03_27_012757	985	51	)	)	-RRB-
10_1101-2020_03_27_012757	985	52	is	be	VBZ
10_1101-2020_03_27_012757	985	53	the	the	DT
10_1101-2020_03_27_012757	985	54	author	author	NN
10_1101-2020_03_27_012757	985	55	/	/	SYM
10_1101-2020_03_27_012757	985	56	funder	funder	NN
10_1101-2020_03_27_012757	985	57	,	,	,
10_1101-2020_03_27_012757	985	58	who	who	WP
10_1101-2020_03_27_012757	985	59	has	have	VBZ
10_1101-2020_03_27_012757	985	60	granted	grant	VBN
10_1101-2020_03_27_012757	985	61	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	985	62	a	a	DT
10_1101-2020_03_27_012757	985	63	license	license	NN
10_1101-2020_03_27_012757	985	64	to	to	TO
10_1101-2020_03_27_012757	985	65	display	display	VB
10_1101-2020_03_27_012757	985	66	the	the	DT
10_1101-2020_03_27_012757	985	67	preprint	preprint	NN
10_1101-2020_03_27_012757	985	68	in	in	IN
10_1101-2020_03_27_012757	985	69	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	985	70	.	.	.
10_1101-2020_03_27_012757	986	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	986	2	is	be	VBZ
10_1101-2020_03_27_012757	986	3	made	make	VBN
10_1101-2020_03_27_012757	986	4	The	the	DT
10_1101-2020_03_27_012757	986	5	copyright	copyright	NN
10_1101-2020_03_27_012757	986	6	holder	holder	NN
10_1101-2020_03_27_012757	986	7	for	for	IN
10_1101-2020_03_27_012757	986	8	this	this	DT
10_1101-2020_03_27_012757	986	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	986	10	version	version	NN
10_1101-2020_03_27_012757	986	11	posted	post	VBD
10_1101-2020_03_27_012757	986	12	January	January	NNP
10_1101-2020_03_27_012757	986	13	9	9	CD
10_1101-2020_03_27_012757	986	14	,	,	,
10_1101-2020_03_27_012757	986	15	2021	2021	CD
10_1101-2020_03_27_012757	986	16	.	.	.
10_1101-2020_03_27_012757	986	17	;	;	:
10_1101-2020_03_27_012757	986	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	986	19	:	:	:
10_1101-2020_03_27_012757	986	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	986	21	preprint	preprint	NN
10_1101-2020_03_27_012757	986	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	986	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	986	24	D	d	NN
10_1101-2020_03_27_012757	986	25	A	A	NNP
10_1101-2020_03_27_012757	986	26	B	B	NNP
10_1101-2020_03_27_012757	986	27	Figure	figure	NN
10_1101-2020_03_27_012757	986	28	4	4	CD
10_1101-2020_03_27_012757	986	29	C	c	NN
10_1101-2020_03_27_012757	986	30	General	general	JJ
10_1101-2020_03_27_012757	986	31	classification	classification	NN
10_1101-2020_03_27_012757	986	32	General	General	NNP
10_1101-2020_03_27_012757	986	33	CCN	CCN	NNP
10_1101-2020_03_27_012757	986	34	score	score	NN
10_1101-2020_03_27_012757	986	35	(	(	-LRB-
10_1101-2020_03_27_012757	986	36	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	986	37	)	)	-RRB-
10_1101-2020_03_27_012757	986	38	Sub	Sub	NNP
10_1101-2020_03_27_012757	986	39	-	-	HYPH
10_1101-2020_03_27_012757	986	40	type	type	NN
10_1101-2020_03_27_012757	986	41	classification	classification	NN
10_1101-2020_03_27_012757	986	42	Endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	986	43	Serous	Serous	NNP
10_1101-2020_03_27_012757	986	44	Normal	Normal	NNP
10_1101-2020_03_27_012757	986	45	Unknown	unknown	JJ
10_1101-2020_03_27_012757	986	46	General	general	JJ
10_1101-2020_03_27_012757	986	47	classification	classification	NN
10_1101-2020_03_27_012757	986	48	General	General	NNP
10_1101-2020_03_27_012757	986	49	CCN	CCN	NNP
10_1101-2020_03_27_012757	986	50	score	score	NN
10_1101-2020_03_27_012757	986	51	(	(	-LRB-
10_1101-2020_03_27_012757	986	52	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	986	53	)	)	-RRB-
10_1101-2020_03_27_012757	986	54	Sub	Sub	NNP
10_1101-2020_03_27_012757	986	55	-	-	HYPH
10_1101-2020_03_27_012757	986	56	type	type	NN
10_1101-2020_03_27_012757	986	57	classification	classification	NN
10_1101-2020_03_27_012757	986	58	basal	basal	NN
10_1101-2020_03_27_012757	986	59	classical	classical	JJ
10_1101-2020_03_27_012757	986	60	primitive	primitive	JJ
10_1101-2020_03_27_012757	986	61	secretory	secretory	NN
10_1101-2020_03_27_012757	986	62	Unknown	Unknown	NNP
10_1101-2020_03_27_012757	986	63	General	General	NNP
10_1101-2020_03_27_012757	986	64	classification	classification	NN
10_1101-2020_03_27_012757	986	65	General	General	NNP
10_1101-2020_03_27_012757	986	66	CCN	CCN	NNP
10_1101-2020_03_27_012757	986	67	score	score	NN
10_1101-2020_03_27_012757	986	68	(	(	-LRB-
10_1101-2020_03_27_012757	986	69	LUAD	luad	RB
10_1101-2020_03_27_012757	986	70	)	)	-RRB-
10_1101-2020_03_27_012757	986	71	Sub	Sub	NNP
10_1101-2020_03_27_012757	986	72	-	-	HYPH
10_1101-2020_03_27_012757	986	73	type	type	NNP
10_1101-2020_03_27_012757	986	74	classification	classification	NN
10_1101-2020_03_27_012757	986	75	prox.-inflam	prox.-inflam	NN
10_1101-2020_03_27_012757	986	76	prox.-prolif	prox.-prolif	NNP
10_1101-2020_03_27_012757	986	77	TRU	TRU	NNP
10_1101-2020_03_27_012757	986	78	Unknown	unknown	JJ
10_1101-2020_03_27_012757	986	79	.CC	.CC	NFP
10_1101-2020_03_27_012757	986	80	-	-	HYPH
10_1101-2020_03_27_012757	986	81	BY	by	IN
10_1101-2020_03_27_012757	986	82	-	-	HYPH
10_1101-2020_03_27_012757	986	83	NC	NC	NNP
10_1101-2020_03_27_012757	986	84	-	-	HYPH
10_1101-2020_03_27_012757	986	85	ND	ND	NNP
10_1101-2020_03_27_012757	986	86	4.0	4.0	CD
10_1101-2020_03_27_012757	986	87	International	International	NNP
10_1101-2020_03_27_012757	986	88	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	986	89	under	under	IN
10_1101-2020_03_27_012757	986	90	a	a	DT
10_1101-2020_03_27_012757	986	91	(	(	-LRB-
10_1101-2020_03_27_012757	986	92	which	which	WDT
10_1101-2020_03_27_012757	986	93	was	be	VBD
10_1101-2020_03_27_012757	986	94	not	not	RB
10_1101-2020_03_27_012757	986	95	certified	certify	VBN
10_1101-2020_03_27_012757	986	96	by	by	IN
10_1101-2020_03_27_012757	986	97	peer	peer	NN
10_1101-2020_03_27_012757	986	98	review	review	NN
10_1101-2020_03_27_012757	986	99	)	)	-RRB-
10_1101-2020_03_27_012757	986	100	is	be	VBZ
10_1101-2020_03_27_012757	986	101	the	the	DT
10_1101-2020_03_27_012757	986	102	author	author	NN
10_1101-2020_03_27_012757	986	103	/	/	SYM
10_1101-2020_03_27_012757	986	104	funder	funder	NN
10_1101-2020_03_27_012757	986	105	,	,	,
10_1101-2020_03_27_012757	986	106	who	who	WP
10_1101-2020_03_27_012757	986	107	has	have	VBZ
10_1101-2020_03_27_012757	986	108	granted	grant	VBN
10_1101-2020_03_27_012757	986	109	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	986	110	a	a	DT
10_1101-2020_03_27_012757	986	111	license	license	NN
10_1101-2020_03_27_012757	986	112	to	to	TO
10_1101-2020_03_27_012757	986	113	display	display	VB
10_1101-2020_03_27_012757	986	114	the	the	DT
10_1101-2020_03_27_012757	986	115	preprint	preprint	NN
10_1101-2020_03_27_012757	986	116	in	in	IN
10_1101-2020_03_27_012757	986	117	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	986	118	.	.	.
10_1101-2020_03_27_012757	987	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	987	2	is	be	VBZ
10_1101-2020_03_27_012757	987	3	made	make	VBN
10_1101-2020_03_27_012757	987	4	The	the	DT
10_1101-2020_03_27_012757	987	5	copyright	copyright	NN
10_1101-2020_03_27_012757	987	6	holder	holder	NN
10_1101-2020_03_27_012757	987	7	for	for	IN
10_1101-2020_03_27_012757	987	8	this	this	DT
10_1101-2020_03_27_012757	987	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	987	10	version	version	NN
10_1101-2020_03_27_012757	987	11	posted	post	VBD
10_1101-2020_03_27_012757	987	12	January	January	NNP
10_1101-2020_03_27_012757	987	13	9	9	CD
10_1101-2020_03_27_012757	987	14	,	,	,
10_1101-2020_03_27_012757	987	15	2021	2021	CD
10_1101-2020_03_27_012757	987	16	.	.	.
10_1101-2020_03_27_012757	987	17	;	;	:
10_1101-2020_03_27_012757	987	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	987	19	:	:	:
10_1101-2020_03_27_012757	987	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	987	21	preprint	preprint	NN
10_1101-2020_03_27_012757	987	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	987	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	NN
10_1101-2020_03_27_012757	987	24	CCN	CCN	NNP
10_1101-2020_03_27_012757	987	25	Score	Score	NNP
10_1101-2020_03_27_012757	987	26	Figure	figure	NN
10_1101-2020_03_27_012757	987	27	5	5	CD
10_1101-2020_03_27_012757	987	28	A	A	NNP
10_1101-2020_03_27_012757	987	29	B	b	NN
10_1101-2020_03_27_012757	987	30	C	c	NN
10_1101-2020_03_27_012757	987	31	D	d	NN
10_1101-2020_03_27_012757	987	32	E	e	NN
10_1101-2020_03_27_012757	987	33	General	general	JJ
10_1101-2020_03_27_012757	987	34	classification	classification	NN
10_1101-2020_03_27_012757	987	35	General	General	NNP
10_1101-2020_03_27_012757	987	36	CCN	CCN	NNP
10_1101-2020_03_27_012757	987	37	score	score	NN
10_1101-2020_03_27_012757	987	38	(	(	-LRB-
10_1101-2020_03_27_012757	987	39	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	987	40	)	)	-RRB-
10_1101-2020_03_27_012757	987	41	Sub	Sub	NNP
10_1101-2020_03_27_012757	987	42	-	-	HYPH
10_1101-2020_03_27_012757	987	43	type	type	NN
10_1101-2020_03_27_012757	987	44	classification	classification	NN
10_1101-2020_03_27_012757	987	45	Endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	987	46	Serous	Serous	NNP
10_1101-2020_03_27_012757	987	47	Normal	Normal	NNP
10_1101-2020_03_27_012757	987	48	Unknown	unknown	JJ
10_1101-2020_03_27_012757	987	49	General	general	JJ
10_1101-2020_03_27_012757	987	50	classification	classification	NN
10_1101-2020_03_27_012757	987	51	General	General	NNP
10_1101-2020_03_27_012757	987	52	CCN	CCN	NNP
10_1101-2020_03_27_012757	987	53	score	score	NN
10_1101-2020_03_27_012757	987	54	(	(	-LRB-
10_1101-2020_03_27_012757	987	55	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	987	56	)	)	-RRB-
10_1101-2020_03_27_012757	987	57	Sub	Sub	NNP
10_1101-2020_03_27_012757	987	58	-	-	HYPH
10_1101-2020_03_27_012757	987	59	type	type	NN
10_1101-2020_03_27_012757	987	60	classification	classification	NN
10_1101-2020_03_27_012757	987	61	basal	basal	NN
10_1101-2020_03_27_012757	987	62	classical	classical	JJ
10_1101-2020_03_27_012757	987	63	primitive	primitive	JJ
10_1101-2020_03_27_012757	987	64	secretory	secretory	NN
10_1101-2020_03_27_012757	987	65	Unknown	Unknown	NNP
10_1101-2020_03_27_012757	987	66	General	General	NNP
10_1101-2020_03_27_012757	987	67	classification	classification	NN
10_1101-2020_03_27_012757	987	68	General	General	NNP
10_1101-2020_03_27_012757	987	69	CCN	CCN	NNP
10_1101-2020_03_27_012757	987	70	score	score	NN
10_1101-2020_03_27_012757	987	71	(	(	-LRB-
10_1101-2020_03_27_012757	987	72	LUAD	luad	RB
10_1101-2020_03_27_012757	987	73	)	)	-RRB-
10_1101-2020_03_27_012757	987	74	Sub	Sub	NNP
10_1101-2020_03_27_012757	987	75	-	-	HYPH
10_1101-2020_03_27_012757	987	76	type	type	NNP
10_1101-2020_03_27_012757	987	77	classification	classification	NN
10_1101-2020_03_27_012757	987	78	prox.-inflam	prox.-inflam	NN
10_1101-2020_03_27_012757	987	79	prox.-prolif	prox.-prolif	NNP
10_1101-2020_03_27_012757	987	80	TRU	TRU	NNP
10_1101-2020_03_27_012757	987	81	Unknown	unknown	JJ
10_1101-2020_03_27_012757	987	82	.CC	.CC	NFP
10_1101-2020_03_27_012757	987	83	-	-	HYPH
10_1101-2020_03_27_012757	987	84	BY	by	IN
10_1101-2020_03_27_012757	987	85	-	-	HYPH
10_1101-2020_03_27_012757	987	86	NC	NC	NNP
10_1101-2020_03_27_012757	987	87	-	-	HYPH
10_1101-2020_03_27_012757	987	88	ND	ND	NNP
10_1101-2020_03_27_012757	987	89	4.0	4.0	CD
10_1101-2020_03_27_012757	987	90	International	International	NNP
10_1101-2020_03_27_012757	987	91	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	987	92	under	under	IN
10_1101-2020_03_27_012757	987	93	a	a	DT
10_1101-2020_03_27_012757	987	94	(	(	-LRB-
10_1101-2020_03_27_012757	987	95	which	which	WDT
10_1101-2020_03_27_012757	987	96	was	be	VBD
10_1101-2020_03_27_012757	987	97	not	not	RB
10_1101-2020_03_27_012757	987	98	certified	certify	VBN
10_1101-2020_03_27_012757	987	99	by	by	IN
10_1101-2020_03_27_012757	987	100	peer	peer	NN
10_1101-2020_03_27_012757	987	101	review	review	NN
10_1101-2020_03_27_012757	987	102	)	)	-RRB-
10_1101-2020_03_27_012757	987	103	is	be	VBZ
10_1101-2020_03_27_012757	987	104	the	the	DT
10_1101-2020_03_27_012757	987	105	author	author	NN
10_1101-2020_03_27_012757	987	106	/	/	SYM
10_1101-2020_03_27_012757	987	107	funder	funder	NN
10_1101-2020_03_27_012757	987	108	,	,	,
10_1101-2020_03_27_012757	987	109	who	who	WP
10_1101-2020_03_27_012757	987	110	has	have	VBZ
10_1101-2020_03_27_012757	987	111	granted	grant	VBN
10_1101-2020_03_27_012757	987	112	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	987	113	a	a	DT
10_1101-2020_03_27_012757	987	114	license	license	NN
10_1101-2020_03_27_012757	987	115	to	to	TO
10_1101-2020_03_27_012757	987	116	display	display	VB
10_1101-2020_03_27_012757	987	117	the	the	DT
10_1101-2020_03_27_012757	987	118	preprint	preprint	NN
10_1101-2020_03_27_012757	987	119	in	in	IN
10_1101-2020_03_27_012757	987	120	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	987	121	.	.	.
10_1101-2020_03_27_012757	988	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	988	2	is	be	VBZ
10_1101-2020_03_27_012757	988	3	made	make	VBN
10_1101-2020_03_27_012757	988	4	The	the	DT
10_1101-2020_03_27_012757	988	5	copyright	copyright	NN
10_1101-2020_03_27_012757	988	6	holder	holder	NN
10_1101-2020_03_27_012757	988	7	for	for	IN
10_1101-2020_03_27_012757	988	8	this	this	DT
10_1101-2020_03_27_012757	988	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	988	10	version	version	NN
10_1101-2020_03_27_012757	988	11	posted	post	VBD
10_1101-2020_03_27_012757	988	12	January	January	NNP
10_1101-2020_03_27_012757	988	13	9	9	CD
10_1101-2020_03_27_012757	988	14	,	,	,
10_1101-2020_03_27_012757	988	15	2021	2021	CD
10_1101-2020_03_27_012757	988	16	.	.	.
10_1101-2020_03_27_012757	988	17	;	;	:
10_1101-2020_03_27_012757	988	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	988	19	:	:	:
10_1101-2020_03_27_012757	988	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	988	21	preprint	preprint	NN
10_1101-2020_03_27_012757	988	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	988	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	988	24	Figure	figure	NN
10_1101-2020_03_27_012757	988	25	6	6	CD
10_1101-2020_03_27_012757	988	26	C	c	NN
10_1101-2020_03_27_012757	988	27	BA	ba	NN
10_1101-2020_03_27_012757	988	28	D	d	NN
10_1101-2020_03_27_012757	988	29	E	e	NN
10_1101-2020_03_27_012757	988	30	General	general	JJ
10_1101-2020_03_27_012757	988	31	classification	classification	NN
10_1101-2020_03_27_012757	988	32	General	General	NNP
10_1101-2020_03_27_012757	988	33	CCN	CCN	NNP
10_1101-2020_03_27_012757	988	34	score	score	NN
10_1101-2020_03_27_012757	988	35	(	(	-LRB-
10_1101-2020_03_27_012757	988	36	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	988	37	)	)	-RRB-
10_1101-2020_03_27_012757	988	38	Sub	Sub	NNP
10_1101-2020_03_27_012757	988	39	-	-	HYPH
10_1101-2020_03_27_012757	988	40	type	type	NN
10_1101-2020_03_27_012757	988	41	classification	classification	NN
10_1101-2020_03_27_012757	988	42	Genotype	Genotype	NNP
10_1101-2020_03_27_012757	988	43	Endometrioid	Endometrioid	NNP
10_1101-2020_03_27_012757	988	44	Serous	Serous	NNP
10_1101-2020_03_27_012757	988	45	Normal	Normal	NNP
10_1101-2020_03_27_012757	988	46	Unknown	unknown	JJ
10_1101-2020_03_27_012757	988	47	General	general	JJ
10_1101-2020_03_27_012757	988	48	classification	classification	NN
10_1101-2020_03_27_012757	988	49	General	General	NNP
10_1101-2020_03_27_012757	988	50	CCN	CCN	NNP
10_1101-2020_03_27_012757	988	51	score	score	NN
10_1101-2020_03_27_012757	988	52	(	(	-LRB-
10_1101-2020_03_27_012757	988	53	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	988	54	)	)	-RRB-
10_1101-2020_03_27_012757	988	55	Sub	Sub	NNP
10_1101-2020_03_27_012757	988	56	-	-	HYPH
10_1101-2020_03_27_012757	988	57	type	type	NN
10_1101-2020_03_27_012757	988	58	classification	classification	NN
10_1101-2020_03_27_012757	988	59	Genotype	Genotype	NNP
10_1101-2020_03_27_012757	988	60	basal	basal	NN
10_1101-2020_03_27_012757	988	61	classical	classical	JJ
10_1101-2020_03_27_012757	988	62	primitive	primitive	JJ
10_1101-2020_03_27_012757	988	63	secretory	secretory	NN
10_1101-2020_03_27_012757	988	64	Unknown	Unknown	NNP
10_1101-2020_03_27_012757	988	65	General	General	NNP
10_1101-2020_03_27_012757	988	66	classification	classification	NN
10_1101-2020_03_27_012757	988	67	General	General	NNP
10_1101-2020_03_27_012757	988	68	CCN	CCN	NNP
10_1101-2020_03_27_012757	988	69	score	score	NN
10_1101-2020_03_27_012757	988	70	(	(	-LRB-
10_1101-2020_03_27_012757	988	71	LUAD	luad	RB
10_1101-2020_03_27_012757	988	72	)	)	-RRB-
10_1101-2020_03_27_012757	988	73	Sub	Sub	NNP
10_1101-2020_03_27_012757	988	74	-	-	HYPH
10_1101-2020_03_27_012757	988	75	type	type	NN
10_1101-2020_03_27_012757	988	76	classification	classification	NN
10_1101-2020_03_27_012757	988	77	Genotype	Genotype	NNP
10_1101-2020_03_27_012757	988	78	prox.-inflam	prox.-inflam	NNP
10_1101-2020_03_27_012757	988	79	prox.-prolif	prox.-prolif	NNP
10_1101-2020_03_27_012757	988	80	TRU	TRU	NNP
10_1101-2020_03_27_012757	988	81	Unknown	unknown	JJ
10_1101-2020_03_27_012757	988	82	CCN	CCN	NNP
10_1101-2020_03_27_012757	988	83	Score	score	NN
10_1101-2020_03_27_012757	988	84	.CC	.cc	NN
10_1101-2020_03_27_012757	988	85	-	-	:
10_1101-2020_03_27_012757	988	86	BY	by	IN
10_1101-2020_03_27_012757	988	87	-	-	HYPH
10_1101-2020_03_27_012757	988	88	NC	NC	NNP
10_1101-2020_03_27_012757	988	89	-	-	HYPH
10_1101-2020_03_27_012757	988	90	ND	ND	NNP
10_1101-2020_03_27_012757	988	91	4.0	4.0	CD
10_1101-2020_03_27_012757	988	92	International	International	NNP
10_1101-2020_03_27_012757	988	93	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	988	94	under	under	IN
10_1101-2020_03_27_012757	988	95	a	a	DT
10_1101-2020_03_27_012757	988	96	(	(	-LRB-
10_1101-2020_03_27_012757	988	97	which	which	WDT
10_1101-2020_03_27_012757	988	98	was	be	VBD
10_1101-2020_03_27_012757	988	99	not	not	RB
10_1101-2020_03_27_012757	988	100	certified	certify	VBN
10_1101-2020_03_27_012757	988	101	by	by	IN
10_1101-2020_03_27_012757	988	102	peer	peer	NN
10_1101-2020_03_27_012757	988	103	review	review	NN
10_1101-2020_03_27_012757	988	104	)	)	-RRB-
10_1101-2020_03_27_012757	988	105	is	be	VBZ
10_1101-2020_03_27_012757	988	106	the	the	DT
10_1101-2020_03_27_012757	988	107	author	author	NN
10_1101-2020_03_27_012757	988	108	/	/	SYM
10_1101-2020_03_27_012757	988	109	funder	funder	NN
10_1101-2020_03_27_012757	988	110	,	,	,
10_1101-2020_03_27_012757	988	111	who	who	WP
10_1101-2020_03_27_012757	988	112	has	have	VBZ
10_1101-2020_03_27_012757	988	113	granted	grant	VBN
10_1101-2020_03_27_012757	988	114	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	988	115	a	a	DT
10_1101-2020_03_27_012757	988	116	license	license	NN
10_1101-2020_03_27_012757	988	117	to	to	TO
10_1101-2020_03_27_012757	988	118	display	display	VB
10_1101-2020_03_27_012757	988	119	the	the	DT
10_1101-2020_03_27_012757	988	120	preprint	preprint	NN
10_1101-2020_03_27_012757	988	121	in	in	IN
10_1101-2020_03_27_012757	988	122	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	988	123	.	.	.
10_1101-2020_03_27_012757	989	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	989	2	is	be	VBZ
10_1101-2020_03_27_012757	989	3	made	make	VBN
10_1101-2020_03_27_012757	989	4	The	the	DT
10_1101-2020_03_27_012757	989	5	copyright	copyright	NN
10_1101-2020_03_27_012757	989	6	holder	holder	NN
10_1101-2020_03_27_012757	989	7	for	for	IN
10_1101-2020_03_27_012757	989	8	this	this	DT
10_1101-2020_03_27_012757	989	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	989	10	version	version	NN
10_1101-2020_03_27_012757	989	11	posted	post	VBD
10_1101-2020_03_27_012757	989	12	January	January	NNP
10_1101-2020_03_27_012757	989	13	9	9	CD
10_1101-2020_03_27_012757	989	14	,	,	,
10_1101-2020_03_27_012757	989	15	2021	2021	CD
10_1101-2020_03_27_012757	989	16	.	.	.
10_1101-2020_03_27_012757	989	17	;	;	:
10_1101-2020_03_27_012757	989	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	989	19	:	:	:
10_1101-2020_03_27_012757	989	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	989	21	preprint	preprint	NN
10_1101-2020_03_27_012757	989	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	989	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	989	24	Figure	figure	NN
10_1101-2020_03_27_012757	989	25	7	7	CD
10_1101-2020_03_27_012757	989	26	A	A	NNP
10_1101-2020_03_27_012757	989	27	B	b	NN
10_1101-2020_03_27_012757	989	28	C	c	NN
10_1101-2020_03_27_012757	989	29	D	d	NN
10_1101-2020_03_27_012757	989	30	E	e	NN
10_1101-2020_03_27_012757	989	31	General	general	JJ
10_1101-2020_03_27_012757	989	32	classification	classification	NN
10_1101-2020_03_27_012757	989	33	General	General	NNP
10_1101-2020_03_27_012757	989	34	CCN	CCN	NNP
10_1101-2020_03_27_012757	989	35	score	score	NN
10_1101-2020_03_27_012757	989	36	(	(	-LRB-
10_1101-2020_03_27_012757	989	37	UCEC	UCEC	NNP
10_1101-2020_03_27_012757	989	38	)	)	-RRB-
10_1101-2020_03_27_012757	989	39	Sub	Sub	NNP
10_1101-2020_03_27_012757	989	40	-	-	HYPH
10_1101-2020_03_27_012757	989	41	type	type	NN
10_1101-2020_03_27_012757	989	42	classification	classification	NN
10_1101-2020_03_27_012757	989	43	Endometrioid	endometrioid	NN
10_1101-2020_03_27_012757	989	44	Serous	Serous	NNP
10_1101-2020_03_27_012757	989	45	Normal	Normal	NNP
10_1101-2020_03_27_012757	989	46	Unknown	unknown	JJ
10_1101-2020_03_27_012757	989	47	General	general	JJ
10_1101-2020_03_27_012757	989	48	classification	classification	NN
10_1101-2020_03_27_012757	989	49	General	General	NNP
10_1101-2020_03_27_012757	989	50	CCN	CCN	NNP
10_1101-2020_03_27_012757	989	51	score	score	NN
10_1101-2020_03_27_012757	989	52	(	(	-LRB-
10_1101-2020_03_27_012757	989	53	LUSC	LUSC	NNP
10_1101-2020_03_27_012757	989	54	)	)	-RRB-
10_1101-2020_03_27_012757	989	55	Sub	Sub	NNP
10_1101-2020_03_27_012757	989	56	-	-	HYPH
10_1101-2020_03_27_012757	989	57	type	type	NN
10_1101-2020_03_27_012757	989	58	classification	classification	NN
10_1101-2020_03_27_012757	989	59	basal	basal	NN
10_1101-2020_03_27_012757	989	60	classical	classical	JJ
10_1101-2020_03_27_012757	989	61	primitive	primitive	JJ
10_1101-2020_03_27_012757	989	62	secretory	secretory	NN
10_1101-2020_03_27_012757	989	63	Unknown	Unknown	NNP
10_1101-2020_03_27_012757	989	64	General	General	NNP
10_1101-2020_03_27_012757	989	65	classification	classification	NN
10_1101-2020_03_27_012757	989	66	General	General	NNP
10_1101-2020_03_27_012757	989	67	CCN	CCN	NNP
10_1101-2020_03_27_012757	989	68	score	score	NN
10_1101-2020_03_27_012757	989	69	(	(	-LRB-
10_1101-2020_03_27_012757	989	70	LUAD	luad	RB
10_1101-2020_03_27_012757	989	71	)	)	-RRB-
10_1101-2020_03_27_012757	989	72	Sub	Sub	NNP
10_1101-2020_03_27_012757	989	73	-	-	HYPH
10_1101-2020_03_27_012757	989	74	type	type	NNP
10_1101-2020_03_27_012757	989	75	classification	classification	NN
10_1101-2020_03_27_012757	989	76	prox.-inflam	prox.-inflam	NN
10_1101-2020_03_27_012757	989	77	prox.-prolif	prox.-prolif	NNP
10_1101-2020_03_27_012757	989	78	TRU	TRU	NNP
10_1101-2020_03_27_012757	989	79	Unknown	unknown	JJ
10_1101-2020_03_27_012757	989	80	CCN	CCN	NNP
10_1101-2020_03_27_012757	989	81	Score	score	NN
10_1101-2020_03_27_012757	989	82	.CC	.cc	NN
10_1101-2020_03_27_012757	989	83	-	-	:
10_1101-2020_03_27_012757	989	84	BY	by	IN
10_1101-2020_03_27_012757	989	85	-	-	HYPH
10_1101-2020_03_27_012757	989	86	NC	NC	NNP
10_1101-2020_03_27_012757	989	87	-	-	HYPH
10_1101-2020_03_27_012757	989	88	ND	ND	NNP
10_1101-2020_03_27_012757	989	89	4.0	4.0	CD
10_1101-2020_03_27_012757	989	90	International	International	NNP
10_1101-2020_03_27_012757	989	91	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	989	92	under	under	IN
10_1101-2020_03_27_012757	989	93	a	a	DT
10_1101-2020_03_27_012757	989	94	(	(	-LRB-
10_1101-2020_03_27_012757	989	95	which	which	WDT
10_1101-2020_03_27_012757	989	96	was	be	VBD
10_1101-2020_03_27_012757	989	97	not	not	RB
10_1101-2020_03_27_012757	989	98	certified	certify	VBN
10_1101-2020_03_27_012757	989	99	by	by	IN
10_1101-2020_03_27_012757	989	100	peer	peer	NN
10_1101-2020_03_27_012757	989	101	review	review	NN
10_1101-2020_03_27_012757	989	102	)	)	-RRB-
10_1101-2020_03_27_012757	989	103	is	be	VBZ
10_1101-2020_03_27_012757	989	104	the	the	DT
10_1101-2020_03_27_012757	989	105	author	author	NN
10_1101-2020_03_27_012757	989	106	/	/	SYM
10_1101-2020_03_27_012757	989	107	funder	funder	NN
10_1101-2020_03_27_012757	989	108	,	,	,
10_1101-2020_03_27_012757	989	109	who	who	WP
10_1101-2020_03_27_012757	989	110	has	have	VBZ
10_1101-2020_03_27_012757	989	111	granted	grant	VBN
10_1101-2020_03_27_012757	989	112	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	989	113	a	a	DT
10_1101-2020_03_27_012757	989	114	license	license	NN
10_1101-2020_03_27_012757	989	115	to	to	TO
10_1101-2020_03_27_012757	989	116	display	display	VB
10_1101-2020_03_27_012757	989	117	the	the	DT
10_1101-2020_03_27_012757	989	118	preprint	preprint	NN
10_1101-2020_03_27_012757	989	119	in	in	IN
10_1101-2020_03_27_012757	989	120	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	989	121	.	.	.
10_1101-2020_03_27_012757	990	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	990	2	is	be	VBZ
10_1101-2020_03_27_012757	990	3	made	make	VBN
10_1101-2020_03_27_012757	990	4	The	the	DT
10_1101-2020_03_27_012757	990	5	copyright	copyright	NN
10_1101-2020_03_27_012757	990	6	holder	holder	NN
10_1101-2020_03_27_012757	990	7	for	for	IN
10_1101-2020_03_27_012757	990	8	this	this	DT
10_1101-2020_03_27_012757	990	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	990	10	version	version	NN
10_1101-2020_03_27_012757	990	11	posted	post	VBD
10_1101-2020_03_27_012757	990	12	January	January	NNP
10_1101-2020_03_27_012757	990	13	9	9	CD
10_1101-2020_03_27_012757	990	14	,	,	,
10_1101-2020_03_27_012757	990	15	2021	2021	CD
10_1101-2020_03_27_012757	990	16	.	.	.
10_1101-2020_03_27_012757	990	17	;	;	:
10_1101-2020_03_27_012757	990	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	990	19	:	:	:
10_1101-2020_03_27_012757	990	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	990	21	preprint	preprint	NN
10_1101-2020_03_27_012757	990	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	990	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	990	24	Figure	figure	NN
10_1101-2020_03_27_012757	990	25	8	8	CD
10_1101-2020_03_27_012757	990	26	.CC	.CC	:
10_1101-2020_03_27_012757	990	27	-	-	HYPH
10_1101-2020_03_27_012757	990	28	BY	by	IN
10_1101-2020_03_27_012757	990	29	-	-	HYPH
10_1101-2020_03_27_012757	990	30	NC	NC	NNP
10_1101-2020_03_27_012757	990	31	-	-	HYPH
10_1101-2020_03_27_012757	990	32	ND	ND	NNP
10_1101-2020_03_27_012757	990	33	4.0	4.0	CD
10_1101-2020_03_27_012757	990	34	International	International	NNP
10_1101-2020_03_27_012757	990	35	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	990	36	under	under	IN
10_1101-2020_03_27_012757	990	37	a	a	DT
10_1101-2020_03_27_012757	990	38	(	(	-LRB-
10_1101-2020_03_27_012757	990	39	which	which	WDT
10_1101-2020_03_27_012757	990	40	was	be	VBD
10_1101-2020_03_27_012757	990	41	not	not	RB
10_1101-2020_03_27_012757	990	42	certified	certify	VBN
10_1101-2020_03_27_012757	990	43	by	by	IN
10_1101-2020_03_27_012757	990	44	peer	peer	NN
10_1101-2020_03_27_012757	990	45	review	review	NN
10_1101-2020_03_27_012757	990	46	)	)	-RRB-
10_1101-2020_03_27_012757	990	47	is	be	VBZ
10_1101-2020_03_27_012757	990	48	the	the	DT
10_1101-2020_03_27_012757	990	49	author	author	NN
10_1101-2020_03_27_012757	990	50	/	/	SYM
10_1101-2020_03_27_012757	990	51	funder	funder	NN
10_1101-2020_03_27_012757	990	52	,	,	,
10_1101-2020_03_27_012757	990	53	who	who	WP
10_1101-2020_03_27_012757	990	54	has	have	VBZ
10_1101-2020_03_27_012757	990	55	granted	grant	VBN
10_1101-2020_03_27_012757	990	56	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	990	57	a	a	DT
10_1101-2020_03_27_012757	990	58	license	license	NN
10_1101-2020_03_27_012757	990	59	to	to	TO
10_1101-2020_03_27_012757	990	60	display	display	VB
10_1101-2020_03_27_012757	990	61	the	the	DT
10_1101-2020_03_27_012757	990	62	preprint	preprint	NN
10_1101-2020_03_27_012757	990	63	in	in	IN
10_1101-2020_03_27_012757	990	64	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	990	65	.	.	.
10_1101-2020_03_27_012757	991	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	991	2	is	be	VBZ
10_1101-2020_03_27_012757	991	3	made	make	VBN
10_1101-2020_03_27_012757	991	4	The	the	DT
10_1101-2020_03_27_012757	991	5	copyright	copyright	NN
10_1101-2020_03_27_012757	991	6	holder	holder	NN
10_1101-2020_03_27_012757	991	7	for	for	IN
10_1101-2020_03_27_012757	991	8	this	this	DT
10_1101-2020_03_27_012757	991	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	991	10	version	version	NN
10_1101-2020_03_27_012757	991	11	posted	post	VBD
10_1101-2020_03_27_012757	991	12	January	January	NNP
10_1101-2020_03_27_012757	991	13	9	9	CD
10_1101-2020_03_27_012757	991	14	,	,	,
10_1101-2020_03_27_012757	991	15	2021	2021	CD
10_1101-2020_03_27_012757	991	16	.	.	.
10_1101-2020_03_27_012757	991	17	;	;	:
10_1101-2020_03_27_012757	991	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	991	19	:	:	:
10_1101-2020_03_27_012757	991	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	991	21	preprint	preprint	NN
10_1101-2020_03_27_012757	991	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	991	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	991	24	Supplemental	Supplemental	NNP
10_1101-2020_03_27_012757	991	25	Figure	Figure	NNP
10_1101-2020_03_27_012757	991	26	1	1	CD
10_1101-2020_03_27_012757	991	27	BA	ba	NN
10_1101-2020_03_27_012757	991	28	D	d	NN
10_1101-2020_03_27_012757	991	29	E	E	NNP
10_1101-2020_03_27_012757	991	30	Training	Training	NNP
10_1101-2020_03_27_012757	991	31	data	datum	NNS
10_1101-2020_03_27_012757	991	32	Samples	Samples	NNPS
10_1101-2020_03_27_012757	991	33	G	g	NN
10_1101-2020_03_27_012757	991	34	en	en	FW
10_1101-2020_03_27_012757	991	35	es	es	FW
10_1101-2020_03_27_012757	991	36	RNA	RNA	NNP
10_1101-2020_03_27_012757	991	37	-	-	HYPH
10_1101-2020_03_27_012757	991	38	Seq	seq	VB
10_1101-2020_03_27_012757	991	39	TCGA	tcga	NN
10_1101-2020_03_27_012757	991	40	Training	Training	NNP
10_1101-2020_03_27_012757	991	41	process	process	NN
10_1101-2020_03_27_012757	991	42	Gene	Gene	NNP
10_1101-2020_03_27_012757	991	43	Pair	Pair	NNP
10_1101-2020_03_27_012757	991	44	Transform	Transform	NNP
10_1101-2020_03_27_012757	991	45	Feature	feature	NN
10_1101-2020_03_27_012757	991	46	Selection	selection	NN
10_1101-2020_03_27_012757	991	47	Train	train	NN
10_1101-2020_03_27_012757	991	48	Random	random	JJ
10_1101-2020_03_27_012757	991	49	forest	forest	NN
10_1101-2020_03_27_012757	991	50	classifier	classifier	NN
10_1101-2020_03_27_012757	991	51	G	g	NN
10_1101-2020_03_27_012757	991	52	en	en	FW
10_1101-2020_03_27_012757	991	53	es	es	XX
10_1101-2020_03_27_012757	991	54	G	g	NN
10_1101-2020_03_27_012757	991	55	en	en	NN
10_1101-2020_03_27_012757	991	56	e	e	NNP
10_1101-2020_03_27_012757	991	57	P	p	NN
10_1101-2020_03_27_012757	991	58	ai	ai	VBP
10_1101-2020_03_27_012757	991	59	rs	rs	NN
10_1101-2020_03_27_012757	991	60	CancerCellNetBroad	cancercellnetbroad	CD
10_1101-2020_03_27_012757	991	61	Class	class	NN
10_1101-2020_03_27_012757	991	62	Classification	Classification	NNP
10_1101-2020_03_27_012757	991	63	Add	Add	NNP
10_1101-2020_03_27_012757	991	64	on	on	IN
10_1101-2020_03_27_012757	991	65	to	to	IN
10_1101-2020_03_27_012757	991	66	Gene	Gene	NNP
10_1101-2020_03_27_012757	991	67	Pairs	Pairs	NNP
10_1101-2020_03_27_012757	991	68	as	as	IN
10_1101-2020_03_27_012757	991	69	Additional	Additional	NNP
10_1101-2020_03_27_012757	991	70	Features	Features	NNP
10_1101-2020_03_27_012757	991	71	C	C	NNP
10_1101-2020_03_27_012757	991	72	C	C	NNP
10_1101-2020_03_27_012757	991	73	N	N	NNP
10_1101-2020_03_27_012757	991	74	S	S	NNP
10_1101-2020_03_27_012757	991	75	co	co	NN
10_1101-2020_03_27_012757	991	76	re	re	NN
10_1101-2020_03_27_012757	991	77	s	s	PRP
10_1101-2020_03_27_012757	991	78	G	g	NN
10_1101-2020_03_27_012757	991	79	en	en	NN
10_1101-2020_03_27_012757	991	80	e	e	NN
10_1101-2020_03_27_012757	991	81	P	p	NN
10_1101-2020_03_27_012757	991	82	ai	ai	VBP
10_1101-2020_03_27_012757	991	83	rs	rs	NN
10_1101-2020_03_27_012757	991	84	C	c	NN
10_1101-2020_03_27_012757	991	85	.CC	.CC	,
10_1101-2020_03_27_012757	991	86	-	-	:
10_1101-2020_03_27_012757	991	87	BY	by	IN
10_1101-2020_03_27_012757	991	88	-	-	HYPH
10_1101-2020_03_27_012757	991	89	NC	NC	NNP
10_1101-2020_03_27_012757	991	90	-	-	HYPH
10_1101-2020_03_27_012757	991	91	ND	ND	NNP
10_1101-2020_03_27_012757	991	92	4.0	4.0	CD
10_1101-2020_03_27_012757	991	93	International	International	NNP
10_1101-2020_03_27_012757	991	94	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	991	95	under	under	IN
10_1101-2020_03_27_012757	991	96	a	a	DT
10_1101-2020_03_27_012757	991	97	(	(	-LRB-
10_1101-2020_03_27_012757	991	98	which	which	WDT
10_1101-2020_03_27_012757	991	99	was	be	VBD
10_1101-2020_03_27_012757	991	100	not	not	RB
10_1101-2020_03_27_012757	991	101	certified	certify	VBN
10_1101-2020_03_27_012757	991	102	by	by	IN
10_1101-2020_03_27_012757	991	103	peer	peer	NN
10_1101-2020_03_27_012757	991	104	review	review	NN
10_1101-2020_03_27_012757	991	105	)	)	-RRB-
10_1101-2020_03_27_012757	991	106	is	be	VBZ
10_1101-2020_03_27_012757	991	107	the	the	DT
10_1101-2020_03_27_012757	991	108	author	author	NN
10_1101-2020_03_27_012757	991	109	/	/	SYM
10_1101-2020_03_27_012757	991	110	funder	funder	NN
10_1101-2020_03_27_012757	991	111	,	,	,
10_1101-2020_03_27_012757	991	112	who	who	WP
10_1101-2020_03_27_012757	991	113	has	have	VBZ
10_1101-2020_03_27_012757	991	114	granted	grant	VBN
10_1101-2020_03_27_012757	991	115	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	991	116	a	a	DT
10_1101-2020_03_27_012757	991	117	license	license	NN
10_1101-2020_03_27_012757	991	118	to	to	TO
10_1101-2020_03_27_012757	991	119	display	display	VB
10_1101-2020_03_27_012757	991	120	the	the	DT
10_1101-2020_03_27_012757	991	121	preprint	preprint	NN
10_1101-2020_03_27_012757	991	122	in	in	IN
10_1101-2020_03_27_012757	991	123	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	991	124	.	.	.
10_1101-2020_03_27_012757	992	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	992	2	is	be	VBZ
10_1101-2020_03_27_012757	992	3	made	make	VBN
10_1101-2020_03_27_012757	992	4	The	the	DT
10_1101-2020_03_27_012757	992	5	copyright	copyright	NN
10_1101-2020_03_27_012757	992	6	holder	holder	NN
10_1101-2020_03_27_012757	992	7	for	for	IN
10_1101-2020_03_27_012757	992	8	this	this	DT
10_1101-2020_03_27_012757	992	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	992	10	version	version	NN
10_1101-2020_03_27_012757	992	11	posted	post	VBD
10_1101-2020_03_27_012757	992	12	January	January	NNP
10_1101-2020_03_27_012757	992	13	9	9	CD
10_1101-2020_03_27_012757	992	14	,	,	,
10_1101-2020_03_27_012757	992	15	2021	2021	CD
10_1101-2020_03_27_012757	992	16	.	.	.
10_1101-2020_03_27_012757	992	17	;	;	:
10_1101-2020_03_27_012757	992	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	992	19	:	:	:
10_1101-2020_03_27_012757	992	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	992	21	preprint	preprint	NN
10_1101-2020_03_27_012757	992	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	992	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	992	24	Supplemental	Supplemental	NNP
10_1101-2020_03_27_012757	992	25	Figure	Figure	NNP
10_1101-2020_03_27_012757	992	26	2	2	CD
10_1101-2020_03_27_012757	992	27	A	a	NN
10_1101-2020_03_27_012757	992	28	B	b	NN
10_1101-2020_03_27_012757	992	29	D	d	NN
10_1101-2020_03_27_012757	992	30	E	e	NN
10_1101-2020_03_27_012757	992	31	C	c	NN
10_1101-2020_03_27_012757	992	32	.CC	.CC	,
10_1101-2020_03_27_012757	992	33	-	-	:
10_1101-2020_03_27_012757	992	34	BY	by	IN
10_1101-2020_03_27_012757	992	35	-	-	HYPH
10_1101-2020_03_27_012757	992	36	NC	NC	NNP
10_1101-2020_03_27_012757	992	37	-	-	HYPH
10_1101-2020_03_27_012757	992	38	ND	ND	NNP
10_1101-2020_03_27_012757	992	39	4.0	4.0	CD
10_1101-2020_03_27_012757	992	40	International	International	NNP
10_1101-2020_03_27_012757	992	41	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	992	42	under	under	IN
10_1101-2020_03_27_012757	992	43	a	a	DT
10_1101-2020_03_27_012757	992	44	(	(	-LRB-
10_1101-2020_03_27_012757	992	45	which	which	WDT
10_1101-2020_03_27_012757	992	46	was	be	VBD
10_1101-2020_03_27_012757	992	47	not	not	RB
10_1101-2020_03_27_012757	992	48	certified	certify	VBN
10_1101-2020_03_27_012757	992	49	by	by	IN
10_1101-2020_03_27_012757	992	50	peer	peer	NN
10_1101-2020_03_27_012757	992	51	review	review	NN
10_1101-2020_03_27_012757	992	52	)	)	-RRB-
10_1101-2020_03_27_012757	992	53	is	be	VBZ
10_1101-2020_03_27_012757	992	54	the	the	DT
10_1101-2020_03_27_012757	992	55	author	author	NN
10_1101-2020_03_27_012757	992	56	/	/	SYM
10_1101-2020_03_27_012757	992	57	funder	funder	NN
10_1101-2020_03_27_012757	992	58	,	,	,
10_1101-2020_03_27_012757	992	59	who	who	WP
10_1101-2020_03_27_012757	992	60	has	have	VBZ
10_1101-2020_03_27_012757	992	61	granted	grant	VBN
10_1101-2020_03_27_012757	992	62	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	992	63	a	a	DT
10_1101-2020_03_27_012757	992	64	license	license	NN
10_1101-2020_03_27_012757	992	65	to	to	TO
10_1101-2020_03_27_012757	992	66	display	display	VB
10_1101-2020_03_27_012757	992	67	the	the	DT
10_1101-2020_03_27_012757	992	68	preprint	preprint	NN
10_1101-2020_03_27_012757	992	69	in	in	IN
10_1101-2020_03_27_012757	992	70	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	992	71	.	.	.
10_1101-2020_03_27_012757	993	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	993	2	is	be	VBZ
10_1101-2020_03_27_012757	993	3	made	make	VBN
10_1101-2020_03_27_012757	993	4	The	the	DT
10_1101-2020_03_27_012757	993	5	copyright	copyright	NN
10_1101-2020_03_27_012757	993	6	holder	holder	NN
10_1101-2020_03_27_012757	993	7	for	for	IN
10_1101-2020_03_27_012757	993	8	this	this	DT
10_1101-2020_03_27_012757	993	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	993	10	version	version	NN
10_1101-2020_03_27_012757	993	11	posted	post	VBD
10_1101-2020_03_27_012757	993	12	January	January	NNP
10_1101-2020_03_27_012757	993	13	9	9	CD
10_1101-2020_03_27_012757	993	14	,	,	,
10_1101-2020_03_27_012757	993	15	2021	2021	CD
10_1101-2020_03_27_012757	993	16	.	.	.
10_1101-2020_03_27_012757	993	17	;	;	:
10_1101-2020_03_27_012757	993	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	993	19	:	:	:
10_1101-2020_03_27_012757	993	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	993	21	preprint	preprint	NN
10_1101-2020_03_27_012757	993	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	993	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	993	24	Supplemental	Supplemental	NNP
10_1101-2020_03_27_012757	993	25	Figure	Figure	NNP
10_1101-2020_03_27_012757	993	26	3	3	CD
10_1101-2020_03_27_012757	993	27	C	c	NN
10_1101-2020_03_27_012757	993	28	D	d	NN
10_1101-2020_03_27_012757	993	29	A	a	NN
10_1101-2020_03_27_012757	993	30	B	b	NN
10_1101-2020_03_27_012757	993	31	.CC	.CC	,
10_1101-2020_03_27_012757	993	32	-	-	HYPH
10_1101-2020_03_27_012757	993	33	BY	by	IN
10_1101-2020_03_27_012757	993	34	-	-	HYPH
10_1101-2020_03_27_012757	993	35	NC	NC	NNP
10_1101-2020_03_27_012757	993	36	-	-	HYPH
10_1101-2020_03_27_012757	993	37	ND	ND	NNP
10_1101-2020_03_27_012757	993	38	4.0	4.0	CD
10_1101-2020_03_27_012757	993	39	International	International	NNP
10_1101-2020_03_27_012757	993	40	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	993	41	under	under	IN
10_1101-2020_03_27_012757	993	42	a	a	DT
10_1101-2020_03_27_012757	993	43	(	(	-LRB-
10_1101-2020_03_27_012757	993	44	which	which	WDT
10_1101-2020_03_27_012757	993	45	was	be	VBD
10_1101-2020_03_27_012757	993	46	not	not	RB
10_1101-2020_03_27_012757	993	47	certified	certify	VBN
10_1101-2020_03_27_012757	993	48	by	by	IN
10_1101-2020_03_27_012757	993	49	peer	peer	NN
10_1101-2020_03_27_012757	993	50	review	review	NN
10_1101-2020_03_27_012757	993	51	)	)	-RRB-
10_1101-2020_03_27_012757	993	52	is	be	VBZ
10_1101-2020_03_27_012757	993	53	the	the	DT
10_1101-2020_03_27_012757	993	54	author	author	NN
10_1101-2020_03_27_012757	993	55	/	/	SYM
10_1101-2020_03_27_012757	993	56	funder	funder	NN
10_1101-2020_03_27_012757	993	57	,	,	,
10_1101-2020_03_27_012757	993	58	who	who	WP
10_1101-2020_03_27_012757	993	59	has	have	VBZ
10_1101-2020_03_27_012757	993	60	granted	grant	VBN
10_1101-2020_03_27_012757	993	61	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	993	62	a	a	DT
10_1101-2020_03_27_012757	993	63	license	license	NN
10_1101-2020_03_27_012757	993	64	to	to	TO
10_1101-2020_03_27_012757	993	65	display	display	VB
10_1101-2020_03_27_012757	993	66	the	the	DT
10_1101-2020_03_27_012757	993	67	preprint	preprint	NN
10_1101-2020_03_27_012757	993	68	in	in	IN
10_1101-2020_03_27_012757	993	69	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	993	70	.	.	.
10_1101-2020_03_27_012757	994	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	994	2	is	be	VBZ
10_1101-2020_03_27_012757	994	3	made	make	VBN
10_1101-2020_03_27_012757	994	4	The	the	DT
10_1101-2020_03_27_012757	994	5	copyright	copyright	NN
10_1101-2020_03_27_012757	994	6	holder	holder	NN
10_1101-2020_03_27_012757	994	7	for	for	IN
10_1101-2020_03_27_012757	994	8	this	this	DT
10_1101-2020_03_27_012757	994	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	994	10	version	version	NN
10_1101-2020_03_27_012757	994	11	posted	post	VBD
10_1101-2020_03_27_012757	994	12	January	January	NNP
10_1101-2020_03_27_012757	994	13	9	9	CD
10_1101-2020_03_27_012757	994	14	,	,	,
10_1101-2020_03_27_012757	994	15	2021	2021	CD
10_1101-2020_03_27_012757	994	16	.	.	.
10_1101-2020_03_27_012757	994	17	;	;	:
10_1101-2020_03_27_012757	994	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	994	19	:	:	:
10_1101-2020_03_27_012757	994	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	994	21	preprint	preprint	NN
10_1101-2020_03_27_012757	994	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	994	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	994	24	Supplemental	Supplemental	NNP
10_1101-2020_03_27_012757	994	25	Figure	Figure	NNP
10_1101-2020_03_27_012757	994	26	4	4	CD
10_1101-2020_03_27_012757	994	27	.CC	.CC	:
10_1101-2020_03_27_012757	994	28	-	-	HYPH
10_1101-2020_03_27_012757	994	29	BY	by	IN
10_1101-2020_03_27_012757	994	30	-	-	HYPH
10_1101-2020_03_27_012757	994	31	NC	NC	NNP
10_1101-2020_03_27_012757	994	32	-	-	HYPH
10_1101-2020_03_27_012757	994	33	ND	ND	NNP
10_1101-2020_03_27_012757	994	34	4.0	4.0	CD
10_1101-2020_03_27_012757	994	35	International	International	NNP
10_1101-2020_03_27_012757	994	36	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	994	37	under	under	IN
10_1101-2020_03_27_012757	994	38	a	a	DT
10_1101-2020_03_27_012757	994	39	(	(	-LRB-
10_1101-2020_03_27_012757	994	40	which	which	WDT
10_1101-2020_03_27_012757	994	41	was	be	VBD
10_1101-2020_03_27_012757	994	42	not	not	RB
10_1101-2020_03_27_012757	994	43	certified	certify	VBN
10_1101-2020_03_27_012757	994	44	by	by	IN
10_1101-2020_03_27_012757	994	45	peer	peer	NN
10_1101-2020_03_27_012757	994	46	review	review	NN
10_1101-2020_03_27_012757	994	47	)	)	-RRB-
10_1101-2020_03_27_012757	994	48	is	be	VBZ
10_1101-2020_03_27_012757	994	49	the	the	DT
10_1101-2020_03_27_012757	994	50	author	author	NN
10_1101-2020_03_27_012757	994	51	/	/	SYM
10_1101-2020_03_27_012757	994	52	funder	funder	NN
10_1101-2020_03_27_012757	994	53	,	,	,
10_1101-2020_03_27_012757	994	54	who	who	WP
10_1101-2020_03_27_012757	994	55	has	have	VBZ
10_1101-2020_03_27_012757	994	56	granted	grant	VBN
10_1101-2020_03_27_012757	994	57	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	994	58	a	a	DT
10_1101-2020_03_27_012757	994	59	license	license	NN
10_1101-2020_03_27_012757	994	60	to	to	TO
10_1101-2020_03_27_012757	994	61	display	display	VB
10_1101-2020_03_27_012757	994	62	the	the	DT
10_1101-2020_03_27_012757	994	63	preprint	preprint	NN
10_1101-2020_03_27_012757	994	64	in	in	IN
10_1101-2020_03_27_012757	994	65	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	994	66	.	.	.
10_1101-2020_03_27_012757	995	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	995	2	is	be	VBZ
10_1101-2020_03_27_012757	995	3	made	make	VBN
10_1101-2020_03_27_012757	995	4	The	the	DT
10_1101-2020_03_27_012757	995	5	copyright	copyright	NN
10_1101-2020_03_27_012757	995	6	holder	holder	NN
10_1101-2020_03_27_012757	995	7	for	for	IN
10_1101-2020_03_27_012757	995	8	this	this	DT
10_1101-2020_03_27_012757	995	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	995	10	version	version	NN
10_1101-2020_03_27_012757	995	11	posted	post	VBD
10_1101-2020_03_27_012757	995	12	January	January	NNP
10_1101-2020_03_27_012757	995	13	9	9	CD
10_1101-2020_03_27_012757	995	14	,	,	,
10_1101-2020_03_27_012757	995	15	2021	2021	CD
10_1101-2020_03_27_012757	995	16	.	.	.
10_1101-2020_03_27_012757	995	17	;	;	:
10_1101-2020_03_27_012757	995	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	995	19	:	:	:
10_1101-2020_03_27_012757	995	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	995	21	preprint	preprint	NN
10_1101-2020_03_27_012757	995	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	995	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	JJ
10_1101-2020_03_27_012757	995	24	Supplemental	Supplemental	NNP
10_1101-2020_03_27_012757	995	25	Figure	Figure	NNP
10_1101-2020_03_27_012757	995	26	5	5	CD
10_1101-2020_03_27_012757	995	27	.CC	.cc	SYM
10_1101-2020_03_27_012757	995	28	-	-	HYPH
10_1101-2020_03_27_012757	995	29	BY	by	IN
10_1101-2020_03_27_012757	995	30	-	-	HYPH
10_1101-2020_03_27_012757	995	31	NC	NC	NNP
10_1101-2020_03_27_012757	995	32	-	-	HYPH
10_1101-2020_03_27_012757	995	33	ND	ND	NNP
10_1101-2020_03_27_012757	995	34	4.0	4.0	CD
10_1101-2020_03_27_012757	995	35	International	International	NNP
10_1101-2020_03_27_012757	995	36	licenseavailable	licenseavailable	NN
10_1101-2020_03_27_012757	995	37	under	under	IN
10_1101-2020_03_27_012757	995	38	a	a	DT
10_1101-2020_03_27_012757	995	39	(	(	-LRB-
10_1101-2020_03_27_012757	995	40	which	which	WDT
10_1101-2020_03_27_012757	995	41	was	be	VBD
10_1101-2020_03_27_012757	995	42	not	not	RB
10_1101-2020_03_27_012757	995	43	certified	certify	VBN
10_1101-2020_03_27_012757	995	44	by	by	IN
10_1101-2020_03_27_012757	995	45	peer	peer	NN
10_1101-2020_03_27_012757	995	46	review	review	NN
10_1101-2020_03_27_012757	995	47	)	)	-RRB-
10_1101-2020_03_27_012757	995	48	is	be	VBZ
10_1101-2020_03_27_012757	995	49	the	the	DT
10_1101-2020_03_27_012757	995	50	author	author	NN
10_1101-2020_03_27_012757	995	51	/	/	SYM
10_1101-2020_03_27_012757	995	52	funder	funder	NN
10_1101-2020_03_27_012757	995	53	,	,	,
10_1101-2020_03_27_012757	995	54	who	who	WP
10_1101-2020_03_27_012757	995	55	has	have	VBZ
10_1101-2020_03_27_012757	995	56	granted	grant	VBN
10_1101-2020_03_27_012757	995	57	bioRxiv	biorxiv	IN
10_1101-2020_03_27_012757	995	58	a	a	DT
10_1101-2020_03_27_012757	995	59	license	license	NN
10_1101-2020_03_27_012757	995	60	to	to	TO
10_1101-2020_03_27_012757	995	61	display	display	VB
10_1101-2020_03_27_012757	995	62	the	the	DT
10_1101-2020_03_27_012757	995	63	preprint	preprint	NN
10_1101-2020_03_27_012757	995	64	in	in	IN
10_1101-2020_03_27_012757	995	65	perpetuity	perpetuity	NN
10_1101-2020_03_27_012757	995	66	.	.	.
10_1101-2020_03_27_012757	996	1	It	-PRON-	PRP
10_1101-2020_03_27_012757	996	2	is	be	VBZ
10_1101-2020_03_27_012757	996	3	made	make	VBN
10_1101-2020_03_27_012757	996	4	The	the	DT
10_1101-2020_03_27_012757	996	5	copyright	copyright	NN
10_1101-2020_03_27_012757	996	6	holder	holder	NN
10_1101-2020_03_27_012757	996	7	for	for	IN
10_1101-2020_03_27_012757	996	8	this	this	DT
10_1101-2020_03_27_012757	996	9	preprintthis	preprintthis	NN
10_1101-2020_03_27_012757	996	10	version	version	NN
10_1101-2020_03_27_012757	996	11	posted	post	VBD
10_1101-2020_03_27_012757	996	12	January	January	NNP
10_1101-2020_03_27_012757	996	13	9	9	CD
10_1101-2020_03_27_012757	996	14	,	,	,
10_1101-2020_03_27_012757	996	15	2021	2021	CD
10_1101-2020_03_27_012757	996	16	.	.	.
10_1101-2020_03_27_012757	996	17	;	;	:
10_1101-2020_03_27_012757	996	18	https://doi.org/10.1101/2020.03.27.012757doi	https://doi.org/10.1101/2020.03.27.012757doi	LS
10_1101-2020_03_27_012757	996	19	:	:	:
10_1101-2020_03_27_012757	996	20	bioRxiv	biorxiv	VB
10_1101-2020_03_27_012757	996	21	preprint	preprint	NN
10_1101-2020_03_27_012757	996	22	https://doi.org/10.1101/2020.03.27.012757	https://doi.org/10.1101/2020.03.27.012757	UH
10_1101-2020_03_27_012757	996	23	http://creativecommons.org/licenses/by-nc-nd/4.0/	http://creativecommons.org/licenses/by-nc-nd/4.0/	XX